<SEC-DOCUMENT>0000014272-22-000114.txt : 20220429
<SEC-HEADER>0000014272-22-000114.hdr.sgml : 20220429
<ACCEPTANCE-DATETIME>20220429104747
ACCESSION NUMBER:		0000014272-22-000114
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220429
DATE AS OF CHANGE:		20220429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRISTOL MYERS SQUIBB CO
		CENTRAL INDEX KEY:			0000014272
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				220790350
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01136
		FILM NUMBER:		22871448

	BUSINESS ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		2125464000

	MAIL ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRISTOL MYERS CO
		DATE OF NAME CHANGE:	19891012
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bmy-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:5a14e930-e849-45eb-bcad-119c402123d7,g:c84cb2fd-f418-4547-ab26-f641c106cb69,d:de471947286340dd92506f80fe047642--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:bmy="http://www.bms.com/20220331" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bmy-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF80LTEtMS0xLTI3Mjk1_04310f9f-bc51-4096-bf87-fdc40ac632cb">0000014272</ix:nonNumeric><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF82LTEtMS0xLTI3Mjk1_852979c7-816d-4ff5-a279-cfed5ba3d983">2022</ix:nonNumeric><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF83LTEtMS0xLTI3Mjk1_0689c6eb-202d-47e1-bc23-0d69496f0437">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF84LTEtMS0xLTI3Mjk1_c0d4078c-b886-4ab7-b83c-71252e9627c0">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF85LTEtMS0xLTI3Mjk1_933dc8ec-838d-433d-9251-ae18e09bb312">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF8xMC0xLTEtMS0yNzI5NQ_3e65bb46-dae1-4cab-8304-67180c2e8aff">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bmy-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf793dd12ca7489fb055121b1a3bdaf0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a3d0b17544a425bb39a530b30667d24_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41a411e531884341ba547408f3ea5589_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia5cba459b4604d78a2eb2e37cd615400_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i121f0f315b1344b1bbc371d09d847028_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if23774cb38994a048379d7991560faf3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ae83d03fd39427cb3c287eed7f29f40_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6306d4449874dffb35d51a933fb469c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9dc415da6a41559015929ff4b2fe33_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f792c2e37a74691a4b596f3e72d75f7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d314318c51d4cd28e75d7001c766243_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide94636b0fb9453b865109199e79c164_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88fccac5bb1b44b584ed539c4961816c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibecb66199abc42ad9586b7704e21a96d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a19efd071324236943f9b6a79698499_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if66c2ddf63414c1da2708bd02f444e26_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c290a93ce1414cba872464493792e7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab5b5b3eca5a4bf6b7a3fc275f47e800_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f764a709228490cb729d3069830bef8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafcc828129bf453b96defa43e5ade811_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a206daed414aaca2b5ea0669036b4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib42f8d6ac6434217ad0fcc5291152cd1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i833468c7bf03479e8d799e7e25575955_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if29d6014ae774728b9c351ed9adb5183_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb627f6367e04f72b873f7093f6faf99_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i786e2d92971d47f986b8c786305a835e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57b03a8caa5b4300851ef8b7fea7189c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4667f06c84c4e3d81ccdc395f8a42e3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i377bc58a38a9497aac85eb38d8f77344_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i620f145ddb8d41cc99f91a9eefdec0be_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7e69fb982e40929bf32259d04c7e4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d92f4fbdf7240a987fb28ecbaee2567_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib36d56bded844dce9f6c54b7a75f2476_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife5940f31f184d2583926339d46b6fb2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b18d7498184e29a11bdf5c0452dfd7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ee5dc7e67f14911aa2893ad8777ecef_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c64261ddacf4d27b95761bdf567761c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac447b2aea184eabafe621a6a696092e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0760f12dccde4f049c0d2d5521e2308f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04fb13c03f7545ee881c787c4d295cb3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16bc3dfbe6534e50827c954ef689f936_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2c11a8ffa114cfcb627155e46eb9da2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaa96276ff5744b79e5a0e0affc668d8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id634989c491e4b0e83256f5dfd53b780_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d8859fa6c2b478ebc39980d73bafcbb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie182e216caea49158bf722fa85814ad2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0fa0dc5d78d499fb86b70327b3a973d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a29d887f67747a3b9f15f234fdcaa11_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245341e9dc7f42f09fe5c3b260ae0b00_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba82d969c984e76baeb0c4efd07d7a9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e6bb5e19053475593dc55eb7a511cab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e86669f8888451993e27f92cec0f586_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic40d1ed6e151472bbc67c2993924ab34_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4a1e02638b14ced8f45c79321610b71_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a5dd69022804169bff3d491d0b5bc66_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6141b14c69f141b18709f232e7245e2f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id59ae704af7f443397b0d5d71bd61538_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i354824d64a0547219c5143a42c38faa5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb8f774b5ae64c91aa84544f0b95bd1c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1105952851aa4f00a91d7d07748e2299_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i562d61545be0472f8e43f9bf2d78869a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i110fc233fca2409280cedc632a84cd9b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0628f1291202410694bad853976cd58f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88b651390f6e4112bf4d018573ef376e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i232e253c036243df8733675ba5284e0c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2844029f1c864491a3839ffdb5436a62_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:CheplapharmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e1e9ad646d44d5b8ca8791b5c49163_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4ce232de8d94ca89a2d4818aca93f9b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e59050a88c4c7b8c32aaa347079239_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c64b0fb4f194220a4e3ad3bf15dffa9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41718b51a26b430a814b359ab230049d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d0e6be826d471580d3022cfd601f5c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a5bbf0f5b504271a5ed86f80698f1aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:ImmaticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7b4f093fb64e948e41d2fae883ac49_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:DragonflyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f344a3a508440a9c3136fc21f9a315_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e86a84eeff547878681f2285bc056c0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib2128162b71942e4b776ba571db5378e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f783f786f9448a0b27d839e744d1bc9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12d6db6adf774cdabcbacab2830666d9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i516e76f80cdd42359e04bf1ea96e1dac_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>bmy:employee</xbrli:measure></xbrli:unit><xbrli:context id="i23137846d9234c9fb78c793ddf4c010d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i139b81c5b6a346bf9ef0abd2a73d799c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie701346b5a5142f0878b322864036d13_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd467c02ad904fbcb8a3366dc0661626_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aa2fd0728f24dffbe302d8dc80f1127_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec5dffc23244b5680735c1a0cc27bf5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i089a12daf0d440d892db99bd3cdae571_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8081637c0eb14bdbb47de184d2f39db5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f9bd83ec7e541a99e93bba471901a6f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d88b3f3d9e0482a8367f95ffe5a0705_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie820e29dd7454feeadcfda2589792e32_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac15ff867ba945e08768717f71115a24_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3737ead734c472998387ed737334fc1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094847c77fb343f2ae6b1fc831c2c140_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id81a792f755b44c7bf4c6b878d13f35a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65dc0d7fa7d446be88f8eb295d016860_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e64717c46e2400a97f81398c8d0374c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a1e87b23874c8eacd18f1ad4aa9add_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d63750fda014807bbcd56fb175d10a9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5de987abfdb443b93461d539e729e92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07a6c1fe57b34a058a7de4f31cf06e2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5440b5726884812b270641d64a0dd80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8730c16fa2124420ad23b93d7bff6eae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id84841d50f3446ed84387ba6ada423f6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f98b5adf714f79bd06b87cb1ca1c47_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07436549e87f4e09ba843a7f11c2ef4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i657d695839694e69b3011d5fdff9bfcf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ee548ed4d014862a23a2e41e04dcfb8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9417f816d8346449f70d564c31c8232_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18ef79d98b8b458b8d5ae10afecfa045_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1eb561378dd46158ad6987dfa95b2e9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia562dbc127b64bca93c9e0e3a0c509f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c4d4e0667e4d429b61aaf7baf0828b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd8959f86cb435ba9b5ced3da83baa2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id45f66ca4c144aad9c93d9577eb6610f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5eeb90de7b546b38702bb042382ad6c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af25476ca044b10b93598d008520e3a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ided76e89faa14fb89fea1a513818349d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76259749605b40899b4e06aab3db1dd9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55d8abd26bae40a881d0203c7f5d26f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if46527a7d9d040a89955d6678f7dd798_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b15840afac84e27867bc9638f1a02ca_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i827262d1464b41e18c2ea4b9f616c5b6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a1b1b455dec4c84be7953f38d2d9bb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d0dd974b62542bd9f7d4c17c8f19a91_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8000b84b6b4ec1847d7fc23d26aef2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9b034eee41f46d6adaf1974b8f3b173_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43abbff1f262401fb3df50f9b876709d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0b4add97b0248e29be39ea97307e4ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie65d93959a1c4c44be1dedff4f283412_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ec862f58d95421887612d3ca08ef64f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba04377d339644409c75c7a51794a485_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i5a219ea76db64e0e8730984c387c5cce_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="iaf91d20822624a328fbe024d1ac258de_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bdb869eecbb469c9bf0310b8e728219_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa8aa0d818c149aa92bb61f130372893_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c471c3a99b34ecda06e75a57da1ce44_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e0b11c565d843cd800a00cce43f9006_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A60BillionUnsecuredSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3ea42357cdc414391b58ca0ccf786db_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i163f0d0fccd34d7385555f74e0a794a7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9206328440464f8e839a11661b43c8a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55598a609c114f67a4cd37885de32e1d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic177dd5bb64d454c86bc6072ebd749cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113230baa650402d97981ca827bc4de6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if54b70af5b76417a806e38ea5e1d407d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia276049873e54e59b3bf07c8d5e24ab4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba35d244942447b99ebc571324ef1dee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15954e5f8f0e40debb23d733b33aaa1e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9389451e47486e902034a32c3e09c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a9ada9042874bf182eaadf231a4c890_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92f31c4fa40457aba15667be923fd82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id16452daa2024ee899435e33c8107110_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3096f2c934e04de28c49313517b1c847_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91abf09684ca431e82f000c3018b6f09_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f017519dcc04d71a28d222bc83fa92b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90219dc5ee1b4ec399ce30e3c157467c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice8a3ac0991c4c81bd0f404665c335f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic465ba0286fb496c8fae21240e7d3f20_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4813222bf3b4237ba720be703e50ec0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61598df0bf2f4820b2d1aa70b7ebdec2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97cdafa0cdbb43d1a935dd3533f1c50f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58a89f11019b4792a01527b1d0647136_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaeaf5cae69a45de99a6f4a1e9213d18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cb747a19155484fb0a6e5942ee35dae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936bc96f5135495e83a811e835de4a2b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32cf6ce35e3d4d049918c1ce536767fe_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c8517489c824a32aa5646d0832375df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fa5bfd2bd145b2ad628c77bd80cb19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80cf390abecb4fe5b76b4c01abe05068_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b589631ea674d988596b27dfe9491d0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b1608a17e14eb7b4319cb2fed7bd5f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89e5eb4f2fc54341a81746b993921e88_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c22056c58444adbcb1e2bc577ceb6e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a2104a59240458e98947f2acda759e4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78573b9f974642299bc3a4a346f6d3cf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64626f3fe0164c9c82c44f1051505316_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cdfda20ae8a4ab98ea04f90f98a6432_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0511d5a39094272ac5c6248e8167fa4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83d83401572a4528805417b147f0bbc5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fcdfacdd7c24cc7abd9cc7e5da883d5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i261481db1532401aba4104d90a4ea56e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie37f56aa23264798a7f027c4249e913d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3c98aa282840c49d1057bd807271bc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89c5148aeb1d4af989c7f56cfcd9e51d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if068c2cd34c84c29aba8109de255a3f1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i770251dbb1814ce4a3a299dd66902cb9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5f476f6d59c4d2f8abff0b07711d3ee_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic877b4ebba4a4d2f83ee4834c3bc717a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eb52be0aee44612b177866eb6f7332c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc01c81d46124cf59f361dbae533ad7c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4a9c40fe3e64397a7a9af57cdbd9f2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00f392936d8e4b9f8959e00956d66d32_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01d1accdb09342a1a2cc72896080888b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccb557e1b6ae4ed18e4f9c9ea9685c16_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2052Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42a8df9288214a7ba80d4c2e2cea5cd0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2062Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0487706aaf654d899b5f17f8e3b4d1b1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.875SeniorNotesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="creditfacility"><xbrli:measure>bmy:creditFacility</xbrli:measure></xbrli:unit><xbrli:context id="i39644068dc2e42e5bcca7dba89dc84f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb0c682ec8e94e719bfd0b0e8c33a3d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d28a8538925455ea6ce8a6e6c60af90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b5f5c10b37c44cab92705107745235c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22388c8b54454a828847139982eb6182_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41cc28991d204c169ba5bb001d925552_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5792b37bfd964932bfdc0eec0a2d49b4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="customers"><xbrli:measure>bmy:customers</xbrli:measure></xbrli:unit><xbrli:context id="id15c48a3d81c47aeae083ac08257cad4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b430687b90f47298aca5585a93c5694_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib591208aeba1490ababd9ab1c130dc54_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i662965b18d274bd4906976d530ef4ae5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf698719af47427688c9bbce6908e931_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:FairValueAdjustmentToInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36e61c39dfd400c8b4956a1177b4898_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:FairValueAdjustmentToInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i933b74eb6ef2454e82c1e129ff3a4cf9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d1a44cdc0ce421ab0a6afc5c7148f8d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c8fe212155e47398c07ac122c4d25db_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i813eb01fc49e456daa2b0d45dbf8903a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c163fb38d5e483a957be472e84d0b08_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib51a898c07794b4a919b257dcc42208c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i483be3c323184f15b35cc7d81776ecc4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8493c14f9b494a61ba4d49df885de3a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b3beca4fb5a42a08d14874a43fb86a0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia288c0fb88974230b4554c68b96e40c0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357734b23ccc4244aea0717e29ca8fad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0e3744106ea411ba17e209a5e2dc279_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c61398032f94cb8bd85669f01cdd4b5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9dd431d277f4046b343051457c073a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890c7a1dec204f3a915c8bfcce2acedf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib947345d6e024c65bb07480f1c5e4624_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697dadbed2b44257b50760bc65e2719b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c750c097be14ed1b3f961e0ba4d7de3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92f35f33ac5447c685cb91ab35c69fc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b2566864734436ac9a373ddafbcbb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i608fa9b9ad254f68bd39d1a463a30350_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c3e82138344640a0c4435cba106ff5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78f12ffadf16415ea1fe727617391027_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe2dda1e1a844b94a00d230f1dc9a71b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0aa70f8ef374fb39ffdf7368e669776_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67fdaace616b4f16855ab0159be80320_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f0491e5151b468687df3f28023d25c1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b25fb727064bc7a48b809cd18417d0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d5887cf1864cefa96ae37a8e8e1c96_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2feca3e743478f9a47b2a58c1a227c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7d3446ea3641d08fb57b9e5e60c00f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07ee78978c0642dabebb87cbae54be3f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f9303f5188c4013be07916ae2eca837_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1f0dedce40941d2abd5021b6192fa7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd70bdc8a914f2e8317196accc17156_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic452639b46024f62a782fd7dd48397d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd355c9ad4e04db9835b36253ee62303_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55c155c4e22f470f85c6fe894ca67745_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aadaa427a1f4883932758e3886fc82d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b408d47b276475ab6ccab44f5ca4af1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72c2ec55ae104cb1a3d45c1093330949_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1685419f0f5b445ebf4b83320b185816_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4e8bafee98c40e1af0ea0c26079e6d5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddc410e277f944d999382cf1f25d8280_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f83b09252a4c5186eac51e8b3c4f10_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486782a204b048d79c8c4b6688f16ddb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaf77c8298f84b9ca929be543d0bdf11_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e06670aa924cd2a542b65a45076e7f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893daceb21d24a07803ca9c59fb74f4f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1153bc1078943e684090d6448e72a28_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdcc9669f9ef4756ab04f684b3f2016f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd031bc2a3194da4930ebfbe59a6c5fa_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b1a43d479945f78f6ba2f8ef93edae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a4494aa926f4aafb4d4f13e1bc379c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07493150d868420687804e8b350888ae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d74d60f32f84b198678df8d911c9b3c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i590050289ff34ed9b5d3577bac6f2c84_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief8394f86b214f7d9f855003ba6e8de0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c7bf5611944b89b000936b86b2afff_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ccde1b9c7584766b2b7209f2916527d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d9865ddc7954c648849d381362ca98e_D20150901-20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-09-01</xbrli:startDate><xbrli:endDate>2015-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patents"><xbrli:measure>bmy:patents</xbrli:measure></xbrli:unit><xbrli:context id="ib14a424b066040b5bef8059066e64306_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d6fa7d30f14437eaa258bc9961b99aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9446604f2db5490f98213dcf99cf2ac0_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43df7495f1924291aea1c8aaa040cf1e_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i733d93df91dc48439bdd9ef3a9e1b05a_D20100301-20100331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-03-01</xbrli:startDate><xbrli:endDate>2010-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="i3006be3445994b7b9d2b9407bafa2026_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c0db74c54043a48910aadd9e2028f4_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b238679663048e29218b5914560ecea_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">bmy:BristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i668ad442deb24bfd83ce136a88b8f854_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuits"><xbrli:measure>bmy:lawsuits</xbrli:measure></xbrli:unit><xbrli:unit id="numberofplaintiffs"><xbrli:measure>bmy:numberOfPlaintiffs</xbrli:measure></xbrli:unit><xbrli:context id="iec03ab8dc1e74dc78cce7f33bcf80a19_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id19c69223ac34dbf8350b9e50ffbf637_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee6991d7144c4ff5982b421baf4a28cc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe66d937c77841249eedd821c141f3ec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d29be57add402ab3461c9dc80fe525_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0xLTEtMS0yNzI5NQ_48524f70-69e2-4b2e-8874-e1282761b818 id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0zLTEtMS0yNzI5NQ_a476dbbc-df36-4cbd-ae30-6dcbd01382d8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RleHRyZWdpb246N2Q5YjRkZmRiZDM4NDljNDhjOTk2MWY1NjZkMGIyODFfMzYy_a932c4fd-6e60-41e7-96da-4585dfa23e35" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ide471947286340dd92506f80fe047642_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDcx_9a35cca5-dc3d-45f5-b2b2-3e5c1f6f8511">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYx_57dfe16e-6ef8-487f-9037-f81dde695605">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNjc_acd9f2b3-49f8-4846-95ee-3840a4647e0f">March&#160;31, 2022</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY5_101e0d79-337a-4154-84a1-39e71f1ece7d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ______ to _______</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDcw_ea72f647-7ba3-4c58-b88f-2d65a9cbddc3">001-01136</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV82NTk3MDY5NzY5MTMw_c6a3388d-8ec9-47af-b3c5-1d24e2b60d31">BRISTOL-MYERS SQUIBB COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6YWM4MzQxMmQwNGE3NDM2NmEyOGM1YzBjZWQ0YTZlY2EvdGFibGVyYW5nZTphYzgzNDEyZDA0YTc0MzY2YTI4YzVjMGNlZDRhNmVjYV8wLTAtMS0xLTI3Mjk1_071be5ba-56e1-42ab-9996-47e3d07655ee">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6YWM4MzQxMmQwNGE3NDM2NmEyOGM1YzBjZWQ0YTZlY2EvdGFibGVyYW5nZTphYzgzNDEyZDA0YTc0MzY2YTI4YzVjMGNlZDRhNmVjYV8wLTItMS0xLTI3Mjk1_256ac4ae-7df8-47ed-b7c8-1bb37690795c">22-0790350</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">I.R.S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"> Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDU3_3a1b8432-61c6-4456-98ba-28845cd0d609">430 E. 29th Street, 14FL</ix:nonNumeric>, <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDU4_651b2dba-c856-494b-b062-d0beb387b212">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDU5_a57d77f1-b97c-44c1-a9a7-40e8a459e010">NY</ix:nonNumeric> <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY4_dc6f9be0-9d90-4ee0-9c31-a7fdbe73f978">10016</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY0_275119db-8dd0-4ec3-ab00-57e89314b939">212</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY1_7448830e-b06d-414b-933b-52ade05b5965">546-4200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8xLTAtMS0xLTI3Mjk1_02f96c3f-3af0-4261-afe1-f0d99116caf7">Common Stock, $0.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8xLTEtMS0xLTI3Mjk1_1d3258c4-e391-441e-b074-c13073770dd1">BMY</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8xLTItMS0xLTI3Mjk1_fdbd53fe-4e3a-4b71-9e64-2f9be50e1f29">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8yLTAtMS0xLTI3Mjk1_9459a5ad-92b6-489b-9863-7f3a64ae83f5">1.000% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8yLTEtMS0xLTI3Mjk1_b53c965c-e68b-438f-8878-b192212b0ff1">BMY25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8yLTItMS0xLTI3Mjk1_b8581523-7b91-4afe-a393-21620979a312">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8zLTAtMS0xLTI3Mjk1_4a8c461f-54fe-43fc-b9f0-b16e0266b17d">1.750% Notes due 2035</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8zLTEtMS0xLTI3Mjk1_c3e86530-0c30-4ad7-b7a4-1cfc1e5c1c8f">BMY35</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8zLTItMS0xLTI3Mjk1_480472b3-8ef6-4270-812a-460e4ae419df">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV80LTAtMS0xLTI3Mjk1_4a57dd52-b626-4061-810d-59545c5985f1">Celgene Contingent Value Rights</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV80LTEtMS0xLTI3Mjk1_25200b4f-ffb3-4215-9070-63ad06f3d3c2">CELG RT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV80LTItMS0xLTI3Mjk1_c5acfb11-32f7-47e7-83e1-3b1383aa8315">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to the filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY2_804949e5-7e09-4861-97c2-04d763cc2393">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160; No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY3_1cd8bcaf-c0b4-4e8b-975e-e7cbf902f179">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of &#8220;<ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYz_000bd87d-7d10-4edc-a69b-85dc6940c3de">large accelerated filer</ix:nonNumeric>,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Smaller&#160;reporting&#160;company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYy_c2e2c99b-54d8-4592-998d-41782ad0d5cb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;Yes&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYw_5a53cb5f-cdaf-40a0-8179-acb9773f3896">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  &#160; No &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPLICABLE ONLY TO CORPORATE ISSUERS:</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">At March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yMzg1_ddbd03f2-147e-42c4-a22e-d6b4938cb067">2,129,064,271</ix:nonFraction> shares outstanding of the Registrant&#8217;s $0.10 par value common stock.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ide471947286340dd92506f80fe047642_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2022</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I&#8212;FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_13">Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_16">Consolidated Statements of Earnings and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_19">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_25">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_28">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_28">6</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_88">30</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_157">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_157">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_160">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_160">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II&#8212;OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_166">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_166">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_169">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_169">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_172">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_172">50</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_175">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_175">51</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_178">Summary of Abbreviated Terms</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_178">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_181">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide471947286340dd92506f80fe047642_181">53</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates brand names of products which are trademarks not owned by BMS. Specific trademark ownership information is included in the Exhibit Index at the end of this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ide471947286340dd92506f80fe047642_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. FINANCIAL STATEMENTS</span></div><div id="ide471947286340dd92506f80fe047642_16"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions, Except Per Share Data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EARNINGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMi0xLTEtMS0yNzI5NQ_9765f97b-26cb-402f-8a53-0fa82ddd081d">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMi0zLTEtMS0yNzI5NQ_ea5b2d62-f0ad-4f8e-95b6-4a1ee1eb35be">10,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance and other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf793dd12ca7489fb055121b1a3bdaf0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMy0xLTEtMS0yNzI5NQ_39e8fe88-cdc5-47a7-9d8b-a9c38be4519a">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3d0b17544a425bb39a530b30667d24_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMy0zLTEtMS0yNzI5NQ_6bd8634f-113c-45dc-b747-5838ecd1854c">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNC0xLTEtMS0yNzI5NQ_8908325a-dcf8-49e1-9618-791dd8a9c14e">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNC0zLTEtMS0yNzI5NQ_2b7a538e-1cb3-4044-a674-886fc81bed8d">11,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0xLTEtMS0yNzI5NQ_48524f70-69e2-4b2e-8874-e1282761b818">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0zLTEtMS0yNzI5NQ_a476dbbc-df36-4cbd-ae30-6dcbd01382d8">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNy0xLTEtMS0yNzI5NQ_39bcf7c3-928f-4c82-86d2-a1ddc58c8ead">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNy0zLTEtMS0yNzI5NQ_4fccf79d-fd2c-4cf2-bb75-4a2242690ded">1,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOC0xLTEtMS0yNzI5NQ_dbcb0680-6a49-4a69-8c00-ff29dd04a7b8">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOC0zLTEtMS0yNzI5NQ_7448520d-9d14-4fa5-8a95-7334ac043b0f">2,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0xLTEtMS03OTc4Nw_c8fb527e-2f8c-442e-b58a-e9e7053e8277">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0zLTEtMS03OTc5MA_a6397cd8-dfd7-49c2-8321-8741c454f7b6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0xLTEtMS0yNzI5NQ_87132521-bf49-41e5-b9b9-b93c7d22002d">2,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0zLTEtMS0yNzI5NQ_635aaab8-ac77-440d-8873-1a1b60d9b48e">2,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTAtMS0xLTEtMjcyOTU_7117b6ad-8571-4366-970c-6b0a14084c0f">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTAtMy0xLTEtMjcyOTU_82f6aa97-8cbc-4c55-92d4-b31d8a95bf6c">702</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTEtMS0xLTEtMjcyOTU_e31f1c29-cf30-499f-a46f-44560cab8dff">9,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTEtMy0xLTEtMjcyOTU_3eb5df90-13fa-47a2-8711-659b59c4d2fc">8,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTMtMS0xLTEtMjcyOTU_fcb10733-789a-414b-9208-7e84f8fd0c2f">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTMtMy0xLTEtMjcyOTU_3d15704a-b018-4c35-8ce6-4a06469d94e6">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTQtMS0xLTEtMjcyOTU_c65c390b-50df-4ca5-9bee-13c9b53fa6bf">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTQtMy0xLTEtMjcyOTU_ba9e4dc0-1994-4f35-8d2c-01da05240612">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTUtMS0xLTEtMjcyOTU_84f42743-e424-4e5d-ad5a-fca15d057949">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTUtMy0xLTEtMjcyOTU_6359c842-7753-4b55-8196-5c33438b15f3">2,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling Interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTYtMS0xLTEtMjcyOTU_fe2007a9-d60a-4e8e-b77e-9df2e6636cd1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTYtMy0xLTEtMjcyOTU_0c78584a-9a3e-4454-971b-472c4003abec">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTctMS0xLTEtMjcyOTU_733f7b53-d6f5-401f-a13c-351b48b5e33c">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTctMy0xLTEtMjcyOTU_1e7b70f3-d339-4d75-8842-e7dc2118129d">2,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjAtMS0xLTEtMjcyOTU_c3cb1530-a5cb-4292-a87e-f41613687c32">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjAtMy0xLTEtMjcyOTU_9d470f8d-9915-4d81-9818-fcb2a62d8372">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjEtMS0xLTEtMjcyOTU_8563ad67-9da6-4c9f-94e1-0303dbac7be1">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjEtMy0xLTEtMjcyOTU_c2a9f8cd-a749-47c2-ad7f-02b093f649f9">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RleHRyZWdpb246N2Q5YjRkZmRiZDM4NDljNDhjOTk2MWY1NjZkMGIyODFfMzYy_a932c4fd-6e60-41e7-96da-4585dfa23e35" footnoteRole="http://www.xbrl.org/2003/role/footnote">Excludes amortization of acquired intangible assets</ix:footnote>.</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMi0xLTEtMS0yNzI5NQ_9a97e0ab-6a05-4fde-a92e-27e62249d0fc">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMi0zLTEtMS0yNzI5NQ_b706532e-d47e-49d7-907d-0ea0d05042e0">2,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income, net of taxes and reclassifications to earnings:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNC0xLTEtMS0yNzI5NQ_2f205a96-a140-4862-ab99-a3895a783331">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNC0zLTEtMS0yNzI5NQ_396b5742-9029-446a-b034-3eda7810321f">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNS0xLTEtMS0yNzI5NQ_db77b169-9702-4fe1-bd3b-45af9f3ff797">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNS0zLTEtMS0yNzI5NQ_91d4f2c8-d0d8-48f4-b58a-8e9cc97a4da3">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNi0xLTEtMS0yNzI5NQ_5c4729e2-e6ac-48ab-9230-680529ad9feb">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNi0zLTEtMS0yNzI5NQ_41ab3375-1564-427c-8c9c-97e742a23a63">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNy0xLTEtMS0yNzI5NQ_01816ae8-b3ac-47e3-b8e5-3863d8b4d6e0">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNy0zLTEtMS0yNzI5NQ_c066fca6-4cd4-4ccd-8d07-93e2c8328321">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfOC0xLTEtMS0yNzI5NQ_f90cbf7b-4a7e-41ec-8f28-0044e5805b62">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfOC0zLTEtMS0yNzI5NQ_0940a9bb-c9d6-4eb8-b83e-d8ecf0402d80">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTAtMS0xLTEtMjcyOTU_03e637c4-c982-4d1c-b79f-85e0f3f6ae55">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTAtMy0xLTEtMjcyOTU_ac3f3ea7-27c4-444a-8ba4-a758da384900">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income Attributable to Noncontrolling Interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTEtMS0xLTEtMjcyOTU_fe2007a9-d60a-4e8e-b77e-9df2e6636cd1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTEtMy0xLTEtMjcyOTU_0c78584a-9a3e-4454-971b-472c4003abec">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income Attributable to BMS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTItMS0xLTEtMjcyOTU_5614a848-a80d-40c1-b5b4-e89495ac495b">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTItMy0xLTEtMjcyOTU_f76507aa-ede4-4398-a562-1b044813f26c">2,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ide471947286340dd92506f80fe047642_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMi0xLTEtMS0yNzI5NQ_8195b31c-ed2d-47ae-a399-8e2c75efa1cd">12,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMi0zLTEtMS0yNzI5NQ_5859b0d1-b9e3-4602-ade1-86886dff4a71">13,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMy0xLTEtMS0yNzI5NQ_2e562d7c-8163-4c0a-aa28-8c14740406b7">2,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMy0zLTEtMS0yNzI5NQ_976ba272-5ffe-42ed-9a15-aed451c70bc1">2,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNC0xLTEtMS0yNzI5NQ_3ba88a3a-dbf2-4c23-8dfa-78ec503b7a05">8,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNC0zLTEtMS0yNzI5NQ_926860bc-cef8-42be-aa90-2a27220a7d31">9,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNS0xLTEtMS0yNzI5NQ_8c2db212-8b0d-4802-8cdf-4c31fe2d55f4">2,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNS0zLTEtMS0yNzI5NQ_66798a62-0ec3-4fa7-b358-8cc127d86bf3">2,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNi0xLTEtMS0yNzI5NQ_b8c9bcc9-7977-431d-9ea6-befbd518c1fb">4,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNi0zLTEtMS0yNzI5NQ_531b9aa4-a6bf-4f29-b713-d963eaba9e1b">4,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNy0xLTEtMS0yNzI5NQ_6f0cfa12-b91c-43b7-92dc-84f8e4b03389">30,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNy0zLTEtMS0yNzI5NQ_a356bf38-5405-40a7-a556-4cb3c74b8cb3">33,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOC0xLTEtMS0yNzI5NQ_74c28541-2474-4bcc-9a47-708723b7247e">6,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOC0zLTEtMS0yNzI5NQ_48708cce-8f38-43a8-9ae0-08f93ced0332">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOS0xLTEtMS0yNzI5NQ_62922bdf-0cf2-4a57-bb59-0b77dad89f5f">20,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOS0zLTEtMS0yNzI5NQ_f6c60c3a-0bd8-400d-8dc7-73a9c81f96e8">20,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTAtMS0xLTEtMjcyOTU_f57f151a-a190-4217-aafd-363cc48cfb71">40,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTAtMy0xLTEtMjcyOTU_49244b6d-2b72-4afb-95f2-d7bf3b422c41">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTEtMS0xLTEtMjcyOTU_daa28a40-cd24-456c-915b-485221e88d35">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTEtMy0xLTEtMjcyOTU_920e4fcd-d6ed-4aed-8980-2ceeeb7bd637">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTMtMS0xLTEtMjcyOTU_8d753150-7a39-4610-aef0-e02b8ec33578">4,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTMtMy0xLTEtMjcyOTU_42727595-edad-4757-b7d5-a36d587dea73">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTQtMS0xLTEtMjcyOTU_d9ea922c-036f-4d8a-bd30-9693aa444136">103,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTQtMy0xLTEtMjcyOTU_e1e1b634-4bc7-40a2-8528-1e1598bc7eba">109,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTgtMS0xLTEtMjcyOTU_ffffef63-5fe6-4124-b0cf-78de5fc2431c">7,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTgtMy0xLTEtMjcyOTU_1fd821bb-b778-47c2-bb3a-04492ef18238">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTktMS0xLTEtMjcyOTU_10402693-28b2-417a-a1cf-11de38b034a1">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTktMy0xLTEtMjcyOTU_dfb22faa-649a-443b-b331-08dbaccafbd8">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjAtMS0xLTEtMjcyOTU_edee1dce-38dd-4765-a346-bd54f654006c">12,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjAtMy0xLTEtMjcyOTU_c2e4322b-ea69-4bb4-b45a-d78ed727439d">13,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjEtMS0xLTEtMjcyOTU_1562dfe0-2c79-4523-9229-23c5ab6788ed">22,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjEtMy0xLTEtMjcyOTU_44402aa9-505e-44bf-9e53-82c8d4e351cf">21,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjItMS0xLTEtMjcyOTU_cb3ca565-84ce-47b8-9f9c-6bbf1b2ea416">3,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjItMy0xLTEtMjcyOTU_0942e914-7ea0-4088-9175-0e27364de71e">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjMtMS0xLTEtMjcyOTU_30ec543e-898c-4b31-a20c-abf7eeb1deb0">37,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjMtMy0xLTEtMjcyOTU_9ad9237f-2912-42f7-b4a0-d3910d5f12d3">39,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjQtMS0xLTEtMjcyOTU_bfdee2bb-c28f-4305-9364-e4ac865e06f0">7,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjQtMy0xLTEtMjcyOTU_bdf6740e-1173-42e2-af47-b62447d0060d">7,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjUtMS0xLTEtMjcyOTU_187b6860-c88c-4a43-8971-156399a33644">71,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjUtMy0xLTEtMjcyOTU_b59a83ee-a8d8-47d5-81cb-a6d441ef4b04">73,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bristol-Myers Squibb Company Shareholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzEtMS0xLTEtMjcyOTU_75cbf5bd-5382-45fe-95f8-96a753c30b08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzEtMy0xLTEtMjcyOTU_dab07ce2-be04-43a9-9887-44a397778459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzItMS0xLTEtMjcyOTU_6d297f2a-9557-40dd-bbe5-fdf0548deccc">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzItMy0xLTEtMjcyOTU_2bc43262-0c71-46fd-9947-4f2457175759">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value of stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzMtMS0xLTEtMjcyOTU_9011d54f-2588-4b15-af5d-e85ec7ab44cc">43,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzMtMy0xLTEtMjcyOTU_f3c4dfd2-5640-40ac-8504-e3c6f3980442">44,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzQtMS0xLTEtMjcyOTU_d9a2c7f9-51eb-4206-9e31-5512982b7add">1,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzQtMy0xLTEtMjcyOTU_0bbc230f-8480-4b60-8566-fb31cd8f99aa">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzUtMS0xLTEtMjcyOTU_46a941a8-2330-42d1-8766-ef92968bbb3a">23,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzUtMy0xLTEtMjcyOTU_8f56fead-9393-4bff-8773-36f68f816a15">23,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cost of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzYtMS0xLTEtMjcyOTU_8320bdc9-edf6-406c-bac0-2993d35c1107">35,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzYtMy0xLTEtMjcyOTU_284635fd-4858-41c0-905c-7477c4bdb414">31,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bristol-Myers Squibb Company Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzctMS0xLTEtMjcyOTU_66552e71-3f78-4197-8880-85c134a4953d">31,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzctMy0xLTEtMjcyOTU_d3a13f4b-4e42-43b0-a0a1-6dacd06194a0">35,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzgtMS0xLTEtMjcyOTU_5497fb79-5fa4-49f8-8396-eeb8acc36abe">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzgtMy0xLTEtMjcyOTU_f44e8bd9-7df4-40ed-b0aa-75e3592e80c9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzktMS0xLTEtMjcyOTU_6c8b7b0d-4bf5-4928-b79e-f1acc4a1618f">31,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzktMy0xLTEtMjcyOTU_6918b3a6-0a29-4583-b7e0-29dcc47efdc3">36,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNDAtMS0xLTEtMjcyOTU_208b32fc-05b4-4fd7-bda4-4c538bc38124">103,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNDAtMy0xLTEtMjcyOTU_a9038573-9463-468f-9418-8b769c4b6b20">109,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ide471947286340dd92506f80fe047642_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMy0xLTEtMS0yNzI5NQ_0e317584-d80d-4721-8c34-67fecaa62747">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMy0zLTEtMS0yNzI5NQ_81d18da2-42ab-4912-bc0d-a7d89d7c4dcb">2,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNS0xLTEtMS0yNzI5NQ_3f295764-3372-4ba3-aba3-ad5063d62d6f">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNS0zLTEtMS0yNzI5NQ_72d2ba11-02e3-4dea-b16a-271c3fe7ed34">2,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNi0xLTEtMS0yNzI5NQ_a540e068-dc11-4eec-a16c-590604eb2060">687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNi0zLTEtMS0yNzI5NQ_28d9f514-cdb3-4508-8a3b-638c586b18b8">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNy0xLTEtMS0yNzI5NQ_ef2e8e3d-2368-4709-a5fd-85bc63385f54">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNy0zLTEtMS0yNzI5NQ_4c16e9c3-870d-4798-aee9-9d419c44a142">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOC0xLTEtMS0yNzI5NQ_3758d8fd-6ea4-461e-b5ac-a32afde63d61">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOC0zLTEtMS0yNzI5NQ_9586d440-e492-4a33-b546-07fd0350ced6">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlements and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:Pensionsettlementsandamortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOS0xLTEtMS0yNzI5NQ_f5f9c207-ad0b-4265-b252-f58b35a79f7e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:Pensionsettlementsandamortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOS0zLTEtMS0yNzI5NQ_21fc67d3-de53-4c27-9f0b-7ea9600ad70e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTAtMS0xLTEtMjcyOTU_ee81ad0a-831a-4494-ad88-5e47eb975732">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTAtMy0xLTEtMjcyOTU_e6874efb-7f1e-4ad4-9a01-9df523e3d88d">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTEtMS0xLTEtMjcyOTU_a3cb01e7-d0ab-4a41-895b-2394bee16058">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTEtMy0xLTEtMjcyOTU_97d14e94-98b3-41eb-a60d-1a91c4e35a6b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTItMS0xLTEtMjcyOTU_dc7daae3-d1df-4659-bea8-162c94087f90">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTItMy0xLTEtMjcyOTU_3fe0b88a-14ad-4d10-977d-754e373ff341">601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration fair value adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTMtMS0xLTEtMjcyOTU_1734a893-fd47-4e80-9dfa-ccbe1a854fd7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTMtMy0xLTEtMjcyOTU_ca06d272-83a4-4215-b46f-e888f0d4616f">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTQtMS0xLTEtMjcyOTU_6cd8105b-cd07-4bb7-89c6-31622badb25d">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTQtMy0xLTEtMjcyOTU_fe87f4cb-b88d-4773-ba45-61b551bd0ed8">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTYtMS0xLTEtMjcyOTU_de710779-ccf0-4290-89c2-818990772084">786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTYtMy0xLTEtMjcyOTU_7b4a70f1-48eb-4ef4-9d8a-7c7a4144b77f">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTctMS0xLTEtMjcyOTU_ff7f7d5e-0556-4106-a7cd-00ed22047e43">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTctMy0xLTEtMjcyOTU_10aa3fda-9014-413f-a41b-ae9060971397">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTgtMS0xLTEtMjcyOTU_d9922e42-af4a-4790-96af-b59c24b02df3">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTgtMy0xLTEtMjcyOTU_b164be57-61cc-44bf-9ace-e651e20fa2e1">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMS0xLTEtNjExNzc_53738558-ca3c-4103-81b3-7b72e894227a">930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMy0xLTEtNjExNzA_e36584a4-4c02-4333-ac69-9944c7a1790f">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMS0xLTEtMjcyOTU_22fcd29d-0acb-448e-a0d6-2964312e3be9">831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMy0xLTEtMjcyOTU_5da69901-1c78-4459-b44f-ebf8afd2dda5">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjAtMS0xLTEtMjcyOTU_3212357e-796c-4527-9b48-78118d0fa319">1,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjAtMy0xLTEtMjcyOTU_1b2a5f00-9be0-49ea-940c-be8b9d272325">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Operating Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjEtMS0xLTEtMjcyOTU_1d3e2d0b-100b-4637-ae76-6f9d1ac1eb45">3,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjEtMy0xLTEtMjcyOTU_d7aab6f3-7539-437e-888b-ad8356f066ba">3,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale and maturities of marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjMtMS0xLTEtMjcyOTU_84495b7b-f462-45b9-adb4-8dda974c261d">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjMtMy0xLTEtMjcyOTU_de7fb224-4ec1-40ad-9748-66b3dbcee28a">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjQtMS0xLTEtMjcyOTU_5935de70-03c4-48f8-a7f6-368bfaf345bd">1,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjQtMy0xLTEtMjcyOTU_1fedfdfa-1d79-422a-b50e-50ca640d4de1">1,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of equity investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjUtMS0xLTEtMjcyOTU_f5cb9996-cf07-4a8e-869f-6ae29d1b3b9e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjUtMy0xLTEtMjcyOTU_d93d19de-ba6b-49b0-b537-11b644371903">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjYtMS0xLTEtMjcyOTU_820f4451-594a-4ba7-8329-7f49ce4b7aab">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjYtMy0xLTEtMjcyOTU_14dad936-5aaf-45c0-8ff7-59265dacd761">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture and other proceeds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjctMS0xLTEtMjcyOTU_8e3b8bce-fe35-456d-b462-32d8c8cdf54a">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjctMy0xLTEtMjcyOTU_2acbb8ac-60e8-4ea7-b83a-e1ea17dfe2a4">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other payments, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjgtMS0xLTEtMjcyOTU_e1b65069-a8b0-4f0f-bbb4-147005a18cf3">442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjgtMy0xLTEtMjcyOTU_aa779e47-43e0-4716-be4b-ce63660bbefd">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by/(Used in) Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjktMS0xLTEtMjcyOTU_8b93c976-f1d1-4d2f-8132-6941842127c0">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjktMy0xLTEtMjcyOTU_e677cbd7-4718-485a-91f3-54bfc7fe2223">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzEtMS0xLTEtMjcyOTU_d1fa0683-e2ca-4109-abd8-adbb041ac6bf">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzEtMy0xLTEtMjcyOTU_2830349f-2ae8-428c-8b8e-c4e978e72f62">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzItMS0xLTEtMjcyOTU_7fa7840f-a62a-48d3-a527-5e8e7e0c82f7">5,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzItMy0xLTEtMjcyOTU_36904476-83a0-47dc-8ef5-4b3e31ad9f40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzMtMS0xLTEtMjcyOTU_e2ab907a-cdce-41be-871b-9c7174060261">5,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzMtMy0xLTEtMjcyOTU_0f24b9fd-1116-4d58-b4f1-3dd51a0e727a">4,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzQtMS0xLTEtMjcyOTU_b403ff7d-7f75-4248-b1ac-e4568fcd79ad">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzQtMy0xLTEtMjcyOTU_4703a9e4-e910-493c-b5ff-47c009fd4a28">1,775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzUtMS0xLTEtMjcyOTU_29aebe80-4b6d-4afe-ab5a-10111ca24ce4">1,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzUtMy0xLTEtMjcyOTU_5dc1eb51-bcfd-4820-bb63-524b98de5eb5">1,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzYtMS0xLTEtMjcyOTU_3af4c088-49a1-4623-9821-ed44771cbb2b">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzYtMy0xLTEtMjcyOTU_6989a5cd-9bde-4221-89a9-89cf06b32e07">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used in Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzctMS0xLTEtMjcyOTU_9da2b2ac-c741-4361-9ba3-96053ee296a5">5,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzctMy0xLTEtMjcyOTU_b2e97a2d-8d0a-4d20-8a36-c75c40cf75ad">7,295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzgtMS0xLTEtMjcyOTU_fb2f0287-e72a-4d7a-8640-c98e800c1e65">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzgtMy0xLTEtMjcyOTU_613c987b-51d4-4784-a38e-570e9b7563a7">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzktMS0xLTEtMjcyOTU_cbbcb15d-7a1a-43c7-8077-9fd6784e14d3">1,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzktMy0xLTEtMjcyOTU_d74f613a-fb23-4abc-a20e-25a3d5ba1221">3,652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDAtMS0xLTEtMjcyOTU_3d6ac895-d002-4388-973b-89d50c6b626c">14,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i121f0f315b1344b1bbc371d09d847028_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDAtMy0xLTEtMjcyOTU_162747e1-8f41-4042-95bb-85f61396c1b4">14,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, Cash Equivalents and Restricted Cash at End of Period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDEtMS0xLTEtMjcyOTU_ee640e09-2e66-4e1d-b07a-4705c25c5323">12,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if23774cb38994a048379d7991560faf3_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDEtMy0xLTEtMjcyOTU_5edc77f5-2a7e-47b2-8672-9cd2071c6535">11,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ide471947286340dd92506f80fe047642_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 1. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yOC9mcmFnOmMwYzVkMDRlMWNjNDQ0NTk5ODViYWNiMmQ1YTA0NTFmL3RleHRyZWdpb246YzBjNWQwNGUxY2M0NDQ1OTk4NWJhY2IyZDVhMDQ1MWZfNjU5NzA2OTc2NjczMg_2c201ba2-5792-4841-92de-2ca8335a48ca" continuedAt="i9b46cdac95d4477c878378ac2f05e7be" escape="true">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</ix:nonNumeric></span></div><div><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_31"></div><ix:continuation id="i9b46cdac95d4477c878378ac2f05e7be"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY3Mw_4d087c12-a2eb-48af-9aca-8797ea3ceb3f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221; or &#8220;the Company&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at March&#160;31, 2022 and December&#160;31, 2021 and the results of operations and cash flows for the three months ended March&#160;31, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY1Mw_93bbaf7c-6c54-4f74-84b5-43742d81b3cc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue&#8221;.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY1NQ_04a82016-21af-4568-b50a-4ffef62bef4c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of goodwill and intangible assets; chargebacks, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY1Nw_f04cb611-717a-4d2a-a66d-9e2bffe255c1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Up-front and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statement of earnings. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows is now presented separately in Rebates and discounts.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY2OQ_b6ad49c0-393a-412e-a7b9-3e100b8d391d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective approach. Early adoption is permitted.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ide471947286340dd92506f80fe047642_34"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTY0MQ_fe062ddc-3822-4207-ab61-2bbba3444550" continuedAt="i7cf8b7b85cec4a5aa9d6b36d60e4144a" escape="true">REVENUE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7cf8b7b85cec4a5aa9d6b36d60e4144a" continuedAt="i71c44a4cc00d48e49abdf77e07fc9749"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTYzMQ_397d3474-af4e-480d-b961-5f1e4f04e473" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMi0xLTEtMS0yNzI5NQ_9765f97b-26cb-402f-8a53-0fa82ddd081d">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMi0zLTEtMS0yNzI5NQ_ea5b2d62-f0ad-4f8e-95b6-4a1ee1eb35be">10,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae83d03fd39427cb3c287eed7f29f40_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMy0xLTEtMS0yNzI5NQ_10a1e368-2040-4591-917a-80ffa96e2ac5">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6306d4449874dffb35d51a933fb469c_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMy0zLTEtMS0yNzI5NQ_4488dd68-c17d-4e0d-96d2-98a6d90c0e27">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9dc415da6a41559015929ff4b2fe33_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNC0xLTEtMS0yNzI5NQ_a7843cc4-0a77-4d31-bf55-d03cd4ca8379">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f792c2e37a74691a4b596f3e72d75f7_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNC0zLTEtMS0yNzI5NQ_d8abec7b-61be-4b3d-8bed-46d8f5a8d866">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNS0xLTEtMS0yNzI5NQ_9e90798e-5647-4e98-a9b9-b1c192111477">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNS0zLTEtMS0yNzI5NQ_f496a7ef-0b06-432d-ae39-5002886928c0">11,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTYzOA_d50d0271-8a06-4308-961e-aa486ca95e3f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d314318c51d4cd28e75d7001c766243_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfMi0xLTEtMS0yNzI5NQ_40055681-55f8-4866-a109-644345b70e05">16,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide94636b0fb9453b865109199e79c164_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfMi0zLTEtMS0yNzI5NQ_8bb10dfc-a1e6-4b7f-8bee-ad24f7ba125b">15,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88fccac5bb1b44b584ed539c4961816c_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNC0xLTEtMS0yNzI5NQ_579b64f0-11d2-453e-98ca-5202a8eeacd1">1,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibecb66199abc42ad9586b7704e21a96d_D20210101-20210331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNC0zLTEtMS0yNzI5NQ_c0949d7f-b9db-4fec-b1ea-b668ac85b95e">1,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a19efd071324236943f9b6a79698499_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNS0xLTEtMS0yNzI5NQ_f6214d56-d219-4b50-a8dd-0f5a02ee49f4">2,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if66c2ddf63414c1da2708bd02f444e26_D20210101-20210331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNS0zLTEtMS0yNzI5NQ_902ae4c4-936e-4f01-b08d-c8a2aad68eb5">1,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30c290a93ce1414cba872464493792e7_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNi0xLTEtMS0yNzI5NQ_5fa13cb6-bdfc-4ddd-96c8-795d01c827e9">1,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab5b5b3eca5a4bf6b7a3fc275f47e800_D20210101-20210331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNi0zLTEtMS0yNzI5NQ_f6d2f977-e3c1-4f59-8c37-e735b9c5f701">1,457</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNy0xLTEtMS0yNzI5NQ_5d3978b6-cefb-4ede-846a-bb94e8e8d813">5,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNy0zLTEtMS0yNzI5NQ_2b4694b6-ece7-430c-824f-bca97b365b82">4,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfOC0xLTEtMS0yNzI5NQ_cb4e8370-72fa-4045-84ed-5dd082917440">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfOC0zLTEtMS0yNzI5NQ_23e665ef-b464-4b63-879c-ba618966dce1">10,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTAwNA_a03737cb-b105-4f99-8e36-3d7fbe3c6c68">74</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTA5OTUxMTYzMDIwNw_26a6ae25-510a-4598-97fd-92c6e0ff268d">217</ix:nonFraction> million for the three months ended March&#160;31, 2022, and 2021, respectively.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTY0OA_562e36ea-ea60-4c96-a885-1f2e0ec2a999" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f764a709228490cb729d3069830bef8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNC0xLTEtMS0yNzI5NQ_007cb2a6-306b-45f6-aef0-009cb911b3fa">3,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafcc828129bf453b96defa43e5ade811_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNC0zLTEtMS0yNzI5NQ_c25b754a-3696-40d4-8edf-d6786b9f9e93">2,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a206daed414aaca2b5ea0669036b4b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0xLTEtMS0yNzI5NQ_564210fe-b9d8-4c18-ac8f-f1eb01c70db9">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib42f8d6ac6434217ad0fcc5291152cd1_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0zLTEtMS0yNzI5NQ_e19145de-195a-4de6-b26a-88e0a652beb2">1,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i833468c7bf03479e8d799e7e25575955_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0xLTEtMS02MTQxNQ_c5d324e4-d4d9-4e0b-8134-2cc965e41037">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if29d6014ae774728b9c351ed9adb5183_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0zLTEtMS02MTQxNQ_950c130d-1a90-4c47-bdba-fe0fd3e2c5a8">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb627f6367e04f72b873f7093f6faf99_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNi0xLTEtMS0yNzI5NQ_b1034d94-09ff-4027-93b1-80c8ccbaeefb">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786e2d92971d47f986b8c786305a835e_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNi0zLTEtMS0yNzI5NQ_5dad1e28-ff9d-46ad-a230-edbfd3228afc">758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57b03a8caa5b4300851ef8b7fea7189c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOC0xLTEtMS0yNzI5NQ_90024cdf-434d-4974-b649-912e2df64bdf">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4667f06c84c4e3d81ccdc395f8a42e3_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOC0zLTEtMS0yNzI5NQ_864afecf-d2e0-4329-8e6a-d2d132235e9e">470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377bc58a38a9497aac85eb38d8f77344_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0xLTEtMS0yNzI5NQ_6a08d60c-248b-4185-8113-1dbce428d4d9">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620f145ddb8d41cc99f91a9eefdec0be_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0zLTEtMS0yNzI5NQ_e138e6df-6c98-465f-89b7-029fdc65ff98">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7e69fb982e40929bf32259d04c7e4b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0xLTEtMS02NTUyNw_cf5053d0-0211-4a4a-8995-97d4937eb328">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d92f4fbdf7240a987fb28ecbaee2567_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0zLTEtMS02NTUyNw_7d501352-c960-4ba6-a457-b6f4829367bd">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36d56bded844dce9f6c54b7a75f2476_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMS0xLTEtMjcyOTU_91b533d8-0577-4e83-93a5-bd79251dcca0">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5940f31f184d2583926339d46b6fb2_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMy0xLTEtMjcyOTU_5b466ec1-1367-435e-8229-cc0e1017dd70">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b18d7498184e29a11bdf5c0452dfd7_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMS0xLTEtNjE0MjI_0da97817-69b8-48ec-90c8-317207c72172">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee5dc7e67f14911aa2893ad8777ecef_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMy0xLTEtNjE0MjI_63718129-fabb-4fc8-a5b7-f438b3a77cbf">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c64261ddacf4d27b95761bdf567761c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTItMS0xLTEtMjcyOTU_4ea73596-0b68-4ad3-a89e-115ff6b14634">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac447b2aea184eabafe621a6a696092e_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTItMy0xLTEtMjcyOTU_91647cca-2a6a-4d3d-859f-8835b45a0cf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0760f12dccde4f049c0d2d5521e2308f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMS0xLTEtNjE0Mjk_eea3d8ee-1a71-46be-a23b-7e08fbde8363">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04fb13c03f7545ee881c787c4d295cb3_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMy0xLTEtNjE0Mjk_faad9aa4-9f1b-4113-9684-ec6e81839f9b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16bc3dfbe6534e50827c954ef689f936_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMS0xLTEtNjE0MzM_0f5584ab-fb8d-464e-834b-88b4c44cdd31">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c11a8ffa114cfcb627155e46eb9da2_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMy0xLTEtNjE0MzM_36b9daec-12f7-4ce5-8eb5-8c331c7a740e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa96276ff5744b79e5a0e0affc668d8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMS0xLTEtMjcyOTU_c0a2b2ee-faed-44f0-a7ea-287d494d82c5">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id634989c491e4b0e83256f5dfd53b780_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMy0xLTEtMjcyOTU_53de4504-52da-4c84-850f-295f02f7faae">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8859fa6c2b478ebc39980d73bafcbb_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMS0xLTEtMjcyOTU_b33397b2-1755-471a-9b90-5c05169f78b0">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie182e216caea49158bf722fa85814ad2_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMy0xLTEtMjcyOTU_f4cd43d9-2c2c-4875-b960-6a5b7b0e2bb4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0fa0dc5d78d499fb86b70327b3a973d_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTgtMS0xLTEtNzYzNjE_160ab19d-b128-46d0-b827-0289014f48d8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a29d887f67747a3b9f15f234fdcaa11_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTgtMy0xLTEtNzYzNjg_f0f54078-9446-47e7-9379-6e89f365a680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245341e9dc7f42f09fe5c3b260ae0b00_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMS0xLTEtNjU1MTI_3bb6f6d8-512e-4ea6-9ece-fac11fb8c691">2,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba82d969c984e76baeb0c4efd07d7a9_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMy0xLTEtNjU1MTI_23b8d69a-bcec-42a7-9bd6-4a3d41d3045d">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e6bb5e19053475593dc55eb7a511cab_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMS0xLTEtNjU1MTU_a194e745-5f3d-4af4-8395-dffc8b29c523">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e86669f8888451993e27f92cec0f586_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMy0xLTEtNjU1MTU_e7020eda-6dbd-4de6-aa65-1a96b61e5ada">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjMtMS0xLTEtMjcyOTU_05e754ca-c369-4b0e-b52c-f3c17368fa37">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjMtMy0xLTEtMjcyOTU_5e15dc2a-762b-4abb-9bbb-f9478f408cdd">11,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40d1ed6e151472bbc67c2993924ab34_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMS0xLTEtMjcyOTU_c7a8595b-c188-460d-87e7-babd84e00f63">7,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1e02638b14ced8f45c79321610b71_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMy0xLTEtMjcyOTU_cf21aa41-e796-456d-815f-ae5c1cd2b6b2">7,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a5dd69022804169bff3d491d0b5bc66_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMS0xLTEtMjcyOTU_4ab68cc8-6c91-4f1e-a168-e897545fb690">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6141b14c69f141b18709f232e7245e2f_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMy0xLTEtMjcyOTU_ad31cf87-6c88-4e4b-9938-fdb3179cb539">2,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59ae704af7f443397b0d5d71bd61538_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjctMS0xLTEtMjcyOTU_6c27752b-c47e-4786-9d1a-79be931a075b">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i354824d64a0547219c5143a42c38faa5_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjctMy0xLTEtMjcyOTU_5b22ced9-7db4-4d95-9851-ceeae3d1a87d">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8f774b5ae64c91aa84544f0b95bd1c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjgtMS0xLTEtMjcyOTU_cd7660d2-f33a-440d-8770-5ab6c445567f">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1105952851aa4f00a91d7d07748e2299_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjgtMy0xLTEtMjcyOTU_2f7e902d-ac13-46a9-b9f7-b03e5c08f380">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjktMS0xLTEtMjcyOTU_cdd5894b-921c-424c-ba8a-eda652f8677e">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjktMy0xLTEtMjcyOTU_bae290a5-b7ee-47da-804e-769383464fc6">11,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i71c44a4cc00d48e49abdf77e07fc9749">Revenue recognized from performance obligations satisfied in prior periods was $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTM3Mg_26ab43ea-f55f-4a94-8ee2-b4667aa913bc">147</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTA5OTUxMTYzMDI0Mw_a1df620f-c7d8-4ff9-8e46-16c370a5c11f">284</ix:nonFraction> million for the three months ended March&#160;31, 2022 and 2021, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RleHRyZWdpb246NjkyNWViYTVjMjQ1NDU5MmJmYTZkYmI4N2E4YzFmYmRfMjgyMg_b984fd86-10e7-4397-b3ec-36d8b64ad451" continuedAt="if42ba297fee54f9ab9c8a8ff7686f236" escape="true">ALLIANCES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if42ba297fee54f9ab9c8a8ff7686f236"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:CollaborativeArrangementAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RleHRyZWdpb246NjkyNWViYTVjMjQ1NDU5MmJmYTZkYmI4N2E4YzFmYmRfMjgxNw_a934aed0-980d-4288-896d-a50af31b2c22" escape="true">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RleHRyZWdpb246NjkyNWViYTVjMjQ1NDU5MmJmYTZkYmI4N2E4YzFmYmRfMjgxOA_c67082ea-9dcc-4252-b5e6-e1453d1636f6" continuedAt="i82d576a30a3e4ebea711a220198d914c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i562d61545be0472f8e43f9bf2d78869a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMy0xLTEtMS0yNzI5NQ_d2a4354a-7f8d-436b-a1fa-e69dfa7a5d8f">3,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110fc233fca2409280cedc632a84cd9b_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMy0zLTEtMS0yNzI5NQ_81f71b24-0c91-4a5c-9dc3-481a67fd50be">2,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae83d03fd39427cb3c287eed7f29f40_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNC0xLTEtMS0yNzI5NQ_10a1e368-2040-4591-917a-80ffa96e2ac5">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6306d4449874dffb35d51a933fb469c_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNC0zLTEtMS0yNzI5NQ_4488dd68-c17d-4e0d-96d2-98a6d90c0e27">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNS0xLTEtMS0yNzI5NQ_19efe211-1666-4f16-b876-312e8453efac">3,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNS0zLTEtMS0yNzI5NQ_2c62db99-24a8-42b3-8c08-a233432a4dfc">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOC0xLTEtMS0yNzI5NQ_982606eb-aff4-4b1b-a95f-5e1b6c31361d">1,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOC0zLTEtMS0yNzI5NQ_d3cb24f9-38a5-4d21-ae61-3a158b1461ff">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOS0xLTEtMS0yNzI5NQ_42d062b5-a432-4b1f-86dc-e31cd6118364">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOS0zLTEtMS0yNzI5NQ_eca85c86-98ba-4627-9852-d5d0b9fa8f8d">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTAtMS0xLTEtMjcyOTU_75f00f57-5f99-4262-b813-21ba86c1313b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTAtMy0xLTEtMjcyOTU_050ad0a4-ec06-4edc-8d71-5d1b74d2f37d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTEtMS0xLTEtMjcyOTU_5bc21a75-03a1-4c4f-ac9f-8372a24789a3">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTEtMy0xLTEtMjcyOTU_5fb9bca1-14ae-493d-9fc5-2ae3c9c1c52b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b651390f6e4112bf4d018573ef376e_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMi0xLTEtMS0yNzI5NQ_f823c37f-c005-4f65-8bfa-096feec83520">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMi0zLTEtMS0yNzI5NQ_08650b69-f2a2-40f5-a7d2-57b04f5d9918">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b651390f6e4112bf4d018573ef376e_I20220331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMy0xLTEtMS0yNzI5NQ_f5d6dc93-e23f-4a08-9e2a-17bb0215658f">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMy0zLTEtMS0yNzI5NQ_ba95cd93-5c51-442f-bc8f-3a1dd77b2f16">1,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b651390f6e4112bf4d018573ef376e_I20220331" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfNC0xLTEtMS0yNzI5NQ_a999fc4c-209e-46a9-8320-979cd0380c05">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfNC0zLTEtMS0yNzI5NQ_d406ea91-3690-4097-8e9b-6e345da117ed">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i82d576a30a3e4ebea711a220198d914c">(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2021 Form 10-K. Significant developments and updates related to alliances during the three months ended March 31, 2022 are set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nektar</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, BMS and Nektar announced that the companies have jointly decided to end the global clinical development program for bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> based on results from pre-planned analyses of two late-stage clinical studies in RCC and bladder cancer. These studies and all other ongoing studies in the program will be discontinued.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ide471947286340dd92506f80fe047642_40"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTQ4NQ_4742b3b1-604f-4eff-adda-90161de4ec45" continuedAt="i43239380424545e89ac105fbd8351467" escape="true">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i43239380424545e89ac105fbd8351467" continuedAt="i2833bdb347f140ac8f33f49b857fe48b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTQ5MQ_b9684161-7085-4461-8353-8406b4d41bf4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy0xLTEtMS0yNzI5NQ_04520eeb-2883-41d7-8aaa-ea61e99fced7">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy0zLTEtMS0yNzI5NQ_c0727fbf-f33d-469f-a78c-87808f609aab">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy01LTEtMS0yNzI5NQ_c744f82b-0001-4c24-b1f0-dd0999bdfcf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy03LTEtMS0yNzI5NQ_bdcf9440-dba5-47da-8185-cd348ec2f5a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy05LTEtMS0yNzI5NQ_eda16186-b67a-4235-b407-d9c398fcb534">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy0xMS0xLTEtMjcyOTU_7e6c84c6-5bb3-4ac7-b60b-0a9981944976">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy0xLTEtMS0yNzI5NQ_4872c1cf-f659-434e-931a-9906838d8886">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232e253c036243df8733675ba5284e0c_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy0zLTEtMS0yNzI5NQ_4c668f38-e3fc-49ba-b94b-3b992e367edd">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy01LTEtMS0yNzI5NQ_c230ea73-7f59-4c28-b5ce-b940e0c59b62">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232e253c036243df8733675ba5284e0c_D20210101-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy03LTEtMS0yNzI5NQ_0672ce2e-0e62-4225-9640-cc68d1be5177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy05LTEtMS0yNzI5NQ_67f25d29-25eb-4949-85eb-69e26edea572">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i232e253c036243df8733675ba5284e0c_D20210101-20210331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy0xMS0xLTEtMjcyOTU_424f5d78-0de7-4df3-983b-c6a2471c609f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC0xLTEtMS0yNzI5NQ_0e0e67f1-a287-466c-984b-014f55a2b541">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC0zLTEtMS0yNzI5NQ_8ee320a4-54bf-4865-af8e-246de77dfeb8">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC01LTEtMS0yNzI5NQ_6d59ebbb-ae3a-4b23-9cdd-20052f7204b7">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC03LTEtMS0yNzI5NQ_72a78db5-3f35-4dcb-b984-6115d4546819">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC05LTEtMS0yNzI5NQ_9343a42b-42dd-4350-8f0e-6b704b3a5ace">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC0xMS0xLTEtMjcyOTU_057234e5-52f6-44a1-9706-feb6b26a6271">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mature Products and Other</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, product rights to several mature products were sold to Cheplapharm resulting in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i2844029f1c864491a3839ffdb5436a62_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzODI0MA_3d2f777f-09f8-4ced-a0d1-cebc385bf497">221</ix:nonFraction>&#160;million and divestiture gain of $<ix:nonFraction unitRef="usd" contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzODI1NA_6c5f0ce1-108f-4102-bf7e-13bce5681d2b">211</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="bmy:LicensingAndOtherArrangementsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTUwMw_6833b60a-4940-466b-9d30-29e9b29e3fd2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48e1e9ad646d44d5b8ca8791b5c49163_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMi0xLTEtMS0yNzI5NQ_862479b3-de0c-4a58-aca9-5bd5a9577960">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4ce232de8d94ca89a2d4818aca93f9b_D20210101-20210331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMi0zLTEtMS0yNzI5NQ_addcd226-2eb3-4088-9df4-d619c19db290">192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5e59050a88c4c7b8c32aaa347079239_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMy0xLTEtMS0yNzI5NQ_b328dfa5-5a76-4dc0-aba4-44584cb8a209">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c64b0fb4f194220a4e3ad3bf15dffa9_D20210101-20210331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMy0zLTEtMS0yNzI5NQ_efa11da9-70c3-463f-9115-0e84c0201cbc">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNS0xLTEtMS0yNzI5NQ_83f262cc-5d3b-4314-b965-fa23d2f86523">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNS0zLTEtMS0yNzI5NQ_5e235b8a-9eb5-47a6-8d3b-53d467a657cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNi0xLTEtMS0yNzI5NQ_6769ffbe-a01c-4408-81f8-d027e798709a">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNi0zLTEtMS0yNzI5NQ_573baa61-e4c9-4c65-8fc8-1cad2a48fe70">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41718b51a26b430a814b359ab230049d_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNy0xLTEtMS0yNzI5NQ_ce42d58c-6ca2-4dc6-abb0-8a0b2cecbb8b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86d0e6be826d471580d3022cfd601f5c_D20210101-20210331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNy0zLTEtMS0yNzI5NQ_e9eb0783-6153-44a1-a058-3c2d19f8ccfa">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfOC0xLTEtMS0yNzI5NQ_f59f652b-c973-4daa-95c9-25a357383ff4">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfOC0zLTEtMS0yNzI5NQ_5a1d93f8-41e8-4d06-88a1-67aa4aec88f8">232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">In-license Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Immatics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, BMS obtained a global exclusive license to Immatics&#8217; TCR bispecific IMA401 program. IMA401 is being studied in oncology and a Clinical Trial Application has been approved by the German federal regulatory authority and the trial is planned to commence in the first half of 2022. BMS and Immatics will collaborate on the development and BMS will be responsible for the commercialization of IMA401 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an up-front payment of $<ix:nonFraction unitRef="usd" contextRef="i3a5bbf0f5b504271a5ed86f80698f1aa_I20220331" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzMTk2OA_eb28c080-3e49-47d8-9046-c1d076ad311e">150</ix:nonFraction>&#160;million which was included in Acquired IPRD and Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $<ix:nonFraction unitRef="usd" contextRef="i3a5bbf0f5b504271a5ed86f80698f1aa_I20220331" decimals="-6" name="bmy:ContingentAndRegulatoryMilestonePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzMTk4Mg_2d43a13d-5622-490d-8cd3-b57ad59ef003">770</ix:nonFraction>&#160;million as well as royalties on global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dragonfly</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, a Phase I development milestone for interlukin-12 (&#8220;IL-12&#8221;) was achieved resulting in a $<ix:nonFraction unitRef="usd" contextRef="ied7b4f093fb64e948e41d2fae883ac49_I20220331" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzNDUxMg_3acc663c-975b-4bc6-81a5-48c59ec3454c">175</ix:nonFraction>&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. These milestones continue to be considered substantive and contingent because the decision to proceed will be based on an assessment of clinical data prior to the specified dates.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2833bdb347f140ac8f33f49b857fe48b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoKardia</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, BMS amended the terms of a license arrangement and paid a third party $<ix:nonFraction unitRef="usd" contextRef="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430" decimals="-6" name="bmy:PaymentToExtinguishFutureRoyaltyObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTY0ODExMg_c7e79fc1-a86c-4b0c-a619-d05737e47f05">295</ix:nonFraction>&#160;million to extinguish a future royalty obligation related to mavacamten prior to its FDA approval which will result in an Acquired IPRD charge.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RleHRyZWdpb246MDU4N2YxYzhjNGJhNGRhNGFiMzZlN2FhYzI0ZGFiOTdfNTE_5e35ccc8-66de-45d7-80e2-dd1ad0e37988" continuedAt="i34d31e70cdb447a4a7baca39b23b7274" escape="true">OTHER (INCOME)/EXPENSE, NET</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i34d31e70cdb447a4a7baca39b23b7274"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="bmy:ScheduleOfOtherIncomeExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RleHRyZWdpb246MDU4N2YxYzhjNGJhNGRhNGFiMzZlN2FhYzI0ZGFiOTdfNTQ_993d83af-43ed-42c3-80fd-7d873b14d9e9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMi0xLTEtMS0yNzI5NQ_d5a5e0d2-452f-44cc-82e2-2a6d16d5ad59">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMi0zLTEtMS0yNzI5NQ_b407bd90-72a9-41b9-84a3-81f662f96a47">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0xLTEtMS04MjE2MQ_cb315d67-f62e-4b99-8562-4d1137357111">477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0zLTEtMS04MjE2MQ_5b95e939-7beb-4550-bf91-ece06470315c">367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0xLTEtMS04MjE4Nw_fc0be4a8-3aad-455c-8932-614d6e0f78bf">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0zLTEtMS04MjE4Nw_6bdd6311-600a-4664-82b0-060d4e2b7cf0">601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0xLTEtMS0yNzI5NQ_f3738aad-ed33-430a-820e-ecf1b15caf3a">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0zLTEtMS0yNzI5NQ_b82d9597-1ea2-462c-99df-8bc833f9deee">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0xLTEtMS0yNzI5NQ_dd43aa43-0bb3-4692-8b9e-64cf5aa78814">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0zLTEtMS0yNzI5NQ_9cbd1148-1c70-441d-8336-13bc7d007928">510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNS0xLTEtMS0yNzI5NQ_3071bc1c-f9b3-470e-b218-6126c3d29971">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNS0zLTEtMS0yNzI5NQ_7309891c-a1f7-45c0-adc8-9eba3ca9de09">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNi0xLTEtMS0yNzI5NQ_9bd9897b-5a40-43c9-bc3b-30a93d34641a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNi0zLTEtMS0yNzI5NQ_39bf5192-4bc0-415b-8df2-1bf0c0e94d1f">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOC0xLTEtMS0yNzI5NQ_7b052859-4b7d-46cc-af2e-6dc17c3b34bc">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOC0zLTEtMS0yNzI5NQ_6f71d14c-1e1c-4116-b81a-05479d50cc64">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:AllianceTransitionalServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOS0xLTEtMS0yNzI5NQ_c27f666d-6c84-4a25-8e20-691fdbc6234c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:AllianceTransitionalServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOS0zLTEtMS0yNzI5NQ_9d2982d9-96f7-4a26-9b87-5bc74d248f93">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTAtMS0xLTEtMjcyOTU_3240a23f-b94f-4cf5-b086-3e4aa38a23af">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTAtMy0xLTEtMjcyOTU_376103fb-4c4b-4253-85a0-f9c93e015a78">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTItMS0xLTEtMjcyOTU_0e9fb960-ac5b-460d-9ccd-c5175ea0bd20">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTItMy0xLTEtMjcyOTU_6a5862bf-5bde-4bb6-a202-72814312b55b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTgtMS0xLTEtMjcyOTU_f1941667-2112-4042-978b-694ce9e17629">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTgtMy0xLTEtMjcyOTU_71248fff-63b2-4989-9bf2-27e230a7d0a5">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTktMS0xLTEtMjcyOTU_80a12b51-76e7-4221-9fad-46c1a80913c6">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTktMy0xLTEtMjcyOTU_4f31c58f-2e2c-4948-bbb7-4f009544aa4d">702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE5MA_57a0db55-118a-4fa0-a600-e74823511571" continuedAt="i944601a5249a42b0bd04983f053025df" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i944601a5249a42b0bd04983f053025df" continuedAt="if38dda228f2e41d28211b053ee4550e9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition that are currently expected to be approximately $<ix:nonFraction unitRef="usd" contextRef="i54f344a3a508440a9c3136fc21f9a315_I20191231" decimals="-8" name="bmy:RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjk1_42cd306b-2d10-49d8-94aa-54696d9b0f01">3.0</ix:nonFraction>&#160;billion. The synergies are expected to be realized in Cost of products sold (<ix:nonFraction unitRef="number" contextRef="i9e86a84eeff547878681f2285bc056c0_I20220331" decimals="2" name="bmy:ExpectedSynergiesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNjU5NzA2OTc3MDczOA_3b0e7b36-e1b3-485b-91e4-c5b123fb1652">5</ix:nonFraction>%), Marketing, selling and administrative expenses (<ix:nonFraction unitRef="number" contextRef="ib2128162b71942e4b776ba571db5378e_I20220331" decimals="2" name="bmy:ExpectedSynergiesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNjU5NzA2OTc3MDc0Nw_077f3f38-588a-49f3-ac21-ecbab862c0b3">65</ix:nonFraction>%) and Research and development expenses (<ix:nonFraction unitRef="number" contextRef="i2f783f786f9448a0b27d839e744d1bc9_I20220331" decimals="2" name="bmy:ExpectedSynergiesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNjU5NzA2OTc3MDc0Mg_b7044946-a617-41bb-9184-4b324817ae5a">30</ix:nonFraction>%). Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i12d6db6adf774cdabcbacab2830666d9_I20220331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNDk2_59f2c6f1-0bf9-4bde-a07b-cddeb6d5f777">3.3</ix:nonFraction>&#160;billion are expected to be incurred. The majority of the charges are expected to be incurred through 2022. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i12d6db6adf774cdabcbacab2830666d9_I20220331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNTc3_a4b81344-d429-4a79-b2ac-ad2d8dea197a">2.7</ix:nonFraction>&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. Cash outlays in connection with these actions are expected to be approximately $<ix:nonFraction unitRef="usd" contextRef="i12d6db6adf774cdabcbacab2830666d9_I20220331" decimals="-8" name="bmy:Cashoutlays" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfOTAw_0fa0993e-2778-461a-8690-dbb2de3f71bd">3.0</ix:nonFraction>&#160;billion. Employee workforce reductions were approximately <ix:nonFraction unitRef="employee" contextRef="i516e76f80cdd42359e04bf1ea96e1dac_D20220101-20220331" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfOTUz_e4c870e0-d7aa-4048-929d-5d288b0f2901">60</ix:nonFraction> for the three months ended March&#160;31, 2022 and 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MyoKardia Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, a restructuring and integration plan was initiated to realize expected cost synergies resulting from cost savings and avoidance from the MyoKardia acquisition. Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i23137846d9234c9fb78c793ddf4c010d_I20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMTIyMg_b077a501-9eae-4541-b901-17024bfb1389">150</ix:nonFraction>&#160;million are expected to be incurred through 2022, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i23137846d9234c9fb78c793ddf4c010d_I20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE5OTAyMzI1ODIzMQ_f271b7d7-3f25-4eeb-a9df-385487905539">120</ix:nonFraction> million have been recognized for these actions to date.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if38dda228f2e41d28211b053ee4550e9"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE4OA_5487fcb3-5511-4497-890c-d3faf838003d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516e76f80cdd42359e04bf1ea96e1dac_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMi0xLTEtMS0yNzI5NQ_96f1049a-c1e5-49eb-9a7e-e001d795cbdd">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i139b81c5b6a346bf9ef0abd2a73d799c_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMi0zLTEtMS0yNzI5NQ_5f7b6162-f2d6-4c16-bd3c-8efb80530566">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia Acquisition Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie701346b5a5142f0878b322864036d13_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMy0xLTEtMS0yNzI5NQ_6de0d6cf-e130-453a-b57e-b67133bc5ba5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd467c02ad904fbcb8a3366dc0661626_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMy0zLTEtMS0yNzI5NQ_c8ca4e22-19ae-45d4-bfb3-01b890faeb00">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNS0xLTEtMS0yNzI5NQ_3cfd0c37-e26a-4923-9a55-61005ec6d9bb">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNS0zLTEtMS0yNzI5NQ_470d75c1-11a0-4fea-b471-c2d7f53615d6">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNy0xLTEtMS0yNzI5NQ_9ffaaa55-caee-40c9-b055-ccfa3986bff7">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNy0zLTEtMS0yNzI5NQ_6b8ac51c-6d1a-40a8-b04f-27c5bdd453ab">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOC0xLTEtMS0yNzI5NQ_56893c72-7df0-44ca-a28c-05da2b26cf7f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOC0zLTEtMS0yNzI5NQ_98312e46-1784-41d6-b361-3845554b3c12">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOS0xLTEtMS0yNzI5NQ_5b6003c7-6d98-45d1-a1d3-9fee363bdb9f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOS0zLTEtMS0yNzI5NQ_8b093615-8fe5-4164-9b37-f622934b0381">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTAtMS0xLTEtMjcyOTU_ceb74098-83ba-4a43-b1a3-2edb47e7b433">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTAtMy0xLTEtMjcyOTU_5de737b0-2d5b-4979-bab6-029a17d66ba9">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTEtMS0xLTEtMjcyOTU_306ffa7a-0dd1-4ac7-b9af-796a3c625d7b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTEtMy0xLTEtMjcyOTU_33c1dc1a-1a8d-4895-a807-9b44f5b51fb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTItMS0xLTEtMjcyOTU_b65bb14f-c3b0-4a06-b61b-d0ce68f6b5c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTItMy0xLTEtMjcyOTU_6ddd6a9d-d24a-42db-b852-3380da1b09fc">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTQtMS0xLTEtMjcyOTU_13d9b33f-90cd-4674-a500-f175c73ca96b">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTQtMy0xLTEtMjcyOTU_ffffdf62-5dc2-44ff-8c9d-67f27965cdc3">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa2fd0728f24dffbe302d8dc80f1127_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTYtMS0xLTEtMjcyOTU_a09a7b55-d995-4012-8176-6634023787be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec5dffc23244b5680735c1a0cc27bf5_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTYtMy0xLTEtMjcyOTU_69fabaf2-d1d3-43d7-8b75-238cc261f319">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i089a12daf0d440d892db99bd3cdae571_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTctMS0xLTEtMjcyOTU_e6d3c323-a2f1-415e-8fcc-e877d0ca9e3c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8081637c0eb14bdbb47de184d2f39db5_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTctMy0xLTEtMjcyOTU_402bfec5-a437-45aa-a173-df05d540ef83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9bd83ec7e541a99e93bba471901a6f_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTktMS0xLTEtMjcyOTU_d01cbacc-0837-4353-b62d-e2d1dd1d2785">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d88b3f3d9e0482a8367f95ffe5a0705_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTktMy0xLTEtMjcyOTU_9f1eb377-ea72-4b8e-a515-ae3e7caee5c0">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMjAtMS0xLTEtMjcyOTU_a4909dc9-c7d0-4575-ba5b-98ddd80f0277">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMjAtMy0xLTEtMjcyOTU_68a2e9ab-562b-48fc-923b-07de3c4ca6c5">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE4OQ_296ef8e3-3095-436d-9c3f-dd0828019db1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMi0xLTEtMS0yNzI5NQ_2596ff18-b380-41b8-9003-329cf4bb36f5">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i121f0f315b1344b1bbc371d09d847028_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMi0zLTEtMS0yNzI5NQ_b563aef6-464a-4678-8aa4-544df7d2c2bc">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMy0xLTEtMS0yNzI5NQ_1e61f55b-c53f-4820-b07e-b7b7794db519">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMy0zLTEtMS0yNzI5NQ_e8de5187-6749-4655-9d29-3b4dcdf8121f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNC0xLTEtMS0yNzI5NQ_812371b6-c5f2-4484-8344-f586d27e61eb">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNC0zLTEtMS0yNzI5NQ_7e613ede-a5a5-45b3-bced-ecfd9ac0c8e2">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNS0xLTEtMS0yNzI5NQ_d866a923-df66-4505-bfa7-128b47f9a88c">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNS0zLTEtMS0yNzI5NQ_f9e1edab-ff71-4baf-b4f0-a7b69cf1a319">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at March 31</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNi0xLTEtMS0yNzI5NQ_5eba60b2-d27a-4169-8863-b77362f41d8a">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if23774cb38994a048379d7991560faf3_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNi0zLTEtMS0yNzI5NQ_260c8868-ee52-4023-819b-15065e63cd19">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjAxMQ_c7b46a22-6611-416a-8d4d-2b304e0cff25">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjAxOA_93bd0580-1a8c-4b11-8520-9e2d39c28ef5">1</ix:nonFraction> million for the three months ended March 31, 2022 and 2021, respectively. Excludes $<ix:nonFraction unitRef="usd" contextRef="ie820e29dd7454feeadcfda2589792e32_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjA3MA_d7cd832f-a9e6-4161-b565-156d864b6cd4">6</ix:nonFraction> million for the three months ended March 31, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMjIzNg_151648ee-223c-4b18-8afe-7b1c9ffad359" continuedAt="i0cd8abdc90e24d94a90723ab6f7cc36f" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i0cd8abdc90e24d94a90723ab6f7cc36f"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMjIyOQ_aee68269-57fd-4ffa-8dff-66c20da1be48" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMi0xLTEtMS0yNzI5NQ_fcb10733-789a-414b-9208-7e84f8fd0c2f">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMi0zLTEtMS0yNzI5NQ_3d15704a-b018-4c35-8ce6-4a06469d94e6">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMy0xLTEtMS0yNzI5NQ_c65c390b-50df-4ca5-9bee-13c9b53fa6bf">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMy0zLTEtMS0yNzI5NQ_ba9e4dc0-1994-4f35-8d2c-01da05240612">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfNC0xLTEtMS0yNzI5NQ_a2415179-d9ad-486b-9856-0de6be5fcb6a">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfNC0zLTEtMS0yNzI5NQ_096c92e3-bf64-4c6f-bec9-4aadd63da907">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2022 and 2021 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that were not taxable in 2021. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits at March&#160;31, 2022 could decrease in the range of approximately $<ix:nonFraction unitRef="usd" contextRef="iac15ff867ba945e08768717f71115a24_I20220331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMTExMQ_e212e304-ae7f-4e0e-a471-cce1d75df896">450</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="if3737ead734c472998387ed737334fc1_I20220331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMTExNw_08dfdf96-9c0c-4606-89dc-19ea1255360a">500</ix:nonFraction> million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#8217;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RleHRyZWdpb246MTY2OWVlMGVjZTgyNDU2ZTk3Njk5MDJlOWY1ODY5YmVfMjc1_a249c75c-e5a3-4bcc-bb69-48af2d9e56d4" continuedAt="ie80600b50ab040ab8c65dda07ebb8e6c" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="ie80600b50ab040ab8c65dda07ebb8e6c"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RleHRyZWdpb246MTY2OWVlMGVjZTgyNDU2ZTk3Njk5MDJlOWY1ODY5YmVfMjkz_e5fa0212-e14c-4c07-a5a4-f9e3121cf216" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMi0xLTEtMS0yNzI5NQ_9edbba8f-57fc-45da-9c03-b1a57fe1e17e">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMi0zLTEtMS0yNzI5NQ_c7e6445f-f3d8-4d08-ae19-ba01525a8ce7">2,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNC0xLTEtMS0yNzI5NQ_046f228b-6a9d-4642-b09b-a3d60d8cd639">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNC0zLTEtMS0yNzI5NQ_293a4566-8ffb-443f-90c3-067f91cf9ebc">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNS0xLTEtMS0yNzI5NQ_8247ad3c-aea3-4294-83da-abf276e794d3">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNS0zLTEtMS0yNzI5NQ_ef595dc1-34b4-4a8f-b5a1-cecfd5587eb4">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNi0xLTEtMS0yNzI5NQ_a2b87c14-3b32-4f0b-9a8c-94edb5fd4724">2,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNi0zLTEtMS0yNzI5NQ_32a3c183-ca85-486c-bbd4-935eb417ab07">2,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfOS0xLTEtMS0yNzI5NQ_c3cb1530-a5cb-4292-a87e-f41613687c32">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfOS0zLTEtMS0yNzI5NQ_9d470f8d-9915-4d81-9818-fcb2a62d8372">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMTAtMS0xLTEtMjcyOTU_8563ad67-9da6-4c9f-94e1-0303dbac7be1">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMTAtMy0xLTEtMjcyOTU_c2a9f8cd-a749-47c2-ad7f-02b093f649f9">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three months ended March&#160;31, 2022 and 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY5OA_151243fc-6efd-4145-b844-bef478a8f76e" continuedAt="i1d36a302af1f4891ad320b9ce7302479" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1d36a302af1f4891ad320b9ce7302479" continuedAt="i8b41cc0e91f34af6bad946605b28c808"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcyNA_0bae2b43-d34b-4134-8d4f-970e26a6c8a3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi0xLTEtMS0yNzI5NQ_4fd6d59f-21d6-4b79-8632-7bf4c3e70921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi0zLTEtMS0yNzI5NQ_c733c6eb-e74c-4158-b0c5-bd21d4d0dd7c">9,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi01LTEtMS0yNzI5NQ_2953f426-937d-47e4-b02f-1c6b5904d8ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi03LTEtMS0yNzI5NQ_f1c0a7ba-c1d2-4962-b37c-273241dc757b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi05LTEtMS0yNzI5NQ_535b2adc-d5dd-44ad-93fa-4115731d2bc0">12,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi0xMS0xLTEtMjcyOTU_b6dc8d5f-6f9b-403f-8235-c164591dfe8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e64717c46e2400a97f81398c8d0374c_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC0xLTEtMS0yNzI5NQ_98ee5f32-cdd1-49fd-b078-1ed73b9f1b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a1e87b23874c8eacd18f1ad4aa9add_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC0zLTEtMS0yNzI5NQ_a657ea4a-844b-4c99-b028-fedf7ca2af08">2,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d63750fda014807bbcd56fb175d10a9_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC01LTEtMS0yNzI5NQ_6f2bc1a7-57fa-407c-b5f7-36d45dd8989a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5de987abfdb443b93461d539e729e92_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC03LTEtMS0yNzI5NQ_21e9dac1-b62e-4f73-820e-56f38ba76c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a6c1fe57b34a058a7de4f31cf06e2c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC05LTEtMS0yNzI5NQ_59583998-6bcb-4b58-8012-32c9b64d112c">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5440b5726884812b270641d64a0dd80_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC0xMS0xLTEtMjcyOTU_672616fe-39a1-4759-8209-8fe4f9f692bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8730c16fa2124420ad23b93d7bff6eae_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS0xLTEtMS0yNzI5NQ_e22ada9a-f976-4139-9400-f3fd4f163a6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id84841d50f3446ed84387ba6ada423f6_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS0zLTEtMS0yNzI5NQ_4c99f6d0-9da7-48d2-ba0d-6039685188e0">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f98b5adf714f79bd06b87cb1ca1c47_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS01LTEtMS0yNzI5NQ_e6b86918-ed89-411c-b44f-09fdf1d87aa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07436549e87f4e09ba843a7f11c2ef4b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS03LTEtMS0yNzI5NQ_9824a5d9-c29f-4818-9e3c-5de37680e87c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657d695839694e69b3011d5fdff9bfcf_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS05LTEtMS0yNzI5NQ_4fb19395-747f-4706-9e8d-c673e5e27a8e">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee548ed4d014862a23a2e41e04dcfb8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS0xMS0xLTEtMjcyOTU_5c5bf4b9-12a5-4029-a71a-0cd738a68492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9417f816d8346449f70d564c31c8232_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi0xLTEtMS0yNzI5NQ_93649112-fb0c-4e9c-a39d-975ce77a159a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18ef79d98b8b458b8d5ae10afecfa045_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi0zLTEtMS0yNzI5NQ_34b88870-dd4b-4e08-90a9-9c9660bf55e2">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1eb561378dd46158ad6987dfa95b2e9_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi01LTEtMS0yNzI5NQ_b9d6f521-81a7-4519-a20a-37c1abd383d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia562dbc127b64bca93c9e0e3a0c509f0_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi03LTEtMS0yNzI5NQ_657a3394-5a04-4b1c-a1b2-9ec6d54df697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c4d4e0667e4d429b61aaf7baf0828b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi05LTEtMS0yNzI5NQ_90a3d51f-7bbc-443c-adb0-c923feb5c4a1">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd8959f86cb435ba9b5ced3da83baa2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi0xMS0xLTEtMjcyOTU_3a85aa47-0c33-4987-8450-2b1d4374d934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy0xLTEtMS0yNzI5NQ_2c66ad08-8c51-4597-97fe-f71237081c90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy0zLTEtMS0yNzI5NQ_963d0e55-fc68-4378-bc7e-ce0e9cc95313">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy01LTEtMS0yNzI5NQ_6dda514e-0a8e-4ec2-a610-6fd7963524bf">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy03LTEtMS0yNzI5NQ_bbf23459-7258-4524-9bd3-ec87b42494b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy05LTEtMS0yNzI5NQ_8eeb027f-b7fe-4e54-bd72-082e5275dd7c">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy0xMS0xLTEtMjcyOTU_099d9720-7edc-46d1-bdda-fb1aae77a937">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45f66ca4c144aad9c93d9577eb6610f_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC0xLTEtMS0yNzI5NQ_f47dac98-6056-41bf-af82-eebee7738ecd">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5eeb90de7b546b38702bb042382ad6c_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC0zLTEtMS0yNzI5NQ_d89bade2-100a-4545-adb3-8461886020eb">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af25476ca044b10b93598d008520e3a_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC01LTEtMS0yNzI5NQ_06902d9e-044c-4f0a-a742-09fad554d879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ided76e89faa14fb89fea1a513818349d_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC03LTEtMS0yNzI5NQ_3b81a400-df71-4889-806b-b30e4067570c">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76259749605b40899b4e06aab3db1dd9_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC05LTEtMS0yNzI5NQ_a7156e83-8f45-4b8c-a7c7-a97d6539902b">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8abd26bae40a881d0203c7f5d26f7_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC0xMS0xLTEtMjcyOTU_a0e49ae8-4962-4b90-97a2-aebf58447606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS0xLTEtMS0yNzI5NQ_1d8d05bd-525d-4d52-8c9b-eedb18c01cfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS0zLTEtMS0yNzI5NQ_4fbbac74-4e2d-457e-8252-cb08caccb6bf">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS01LTEtMS0yNzI5NQ_eb34a72f-83ea-4adb-82db-67aa193dc3cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS03LTEtMS0yNzI5NQ_1c072510-d78a-4b48-9ea0-3ddcae929920">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS05LTEtMS0yNzI5NQ_b8f8ba53-fb1c-431a-a59a-ba68cd3a3a31">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS0xMS0xLTEtMjcyOTU_dd195b79-7c87-4c8e-9d36-2a78d942c641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46527a7d9d040a89955d6678f7dd798_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtMS0xLTEtMjcyOTU_0f532e48-c4b0-4443-977d-08a940189266">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b15840afac84e27867bc9638f1a02ca_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtMy0xLTEtMjcyOTU_20fa5a5b-4943-4e3d-ac12-a0a88a45b31b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827262d1464b41e18c2ea4b9f616c5b6_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtNS0xLTEtMjcyOTU_27bed916-0952-44b5-b595-db150f440a20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1b1b455dec4c84be7953f38d2d9bb5_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtNy0xLTEtMjcyOTU_7c991b43-605f-4bef-a3b9-32f3045a6341">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d0dd974b62542bd9f7d4c17c8f19a91_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtOS0xLTEtMjcyOTU_984ab3a3-5fd0-46a5-974f-53c945fd42dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c8000b84b6b4ec1847d7fc23d26aef2_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtMTEtMS0xLTI3Mjk1_7c99f6f0-98fe-4777-aec8-d576150b408f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItMS0xLTEtMjcyOTU_14723d6e-a4f1-40af-a038-7624f05858d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItMy0xLTEtMjcyOTU_7bc20124-6b03-4cc4-8c81-d508252c3481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItNS0xLTEtMjcyOTU_c3fed2b8-cf39-4c67-9c1d-17b9440dedd7">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItNy0xLTEtMjcyOTU_78e4fafd-d382-44f1-b867-2916b2bd072c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItOS0xLTEtMjcyOTU_8b8d13ef-f9e9-4eea-88f2-998cc7eb2241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItMTEtMS0xLTI3Mjk1_135d56c8-91e4-4daf-a058-8d1f36396112">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; in the Company&#8217;s 2021 Form 10-K, the Company&#8217;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs).</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8b41cc0e91f34af6bad946605b28c808" continuedAt="i75d0ce09865e417db838ca94c0b635e0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Debt Securities and Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY1MA_325a7682-6fb1-42aa-8cd2-33e929d306a3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xLTEtMS0yNzI5NQ_79035f37-2e49-4dd6-babc-25df5969bd1a">2,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0zLTEtMS0yNzI5NQ_d340a40b-dd5b-44a1-a6ce-70babb893106">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy01LTEtMS0yNzI5NQ_41c08c6d-c7c4-4ac7-bc31-5e1f328910e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy03LTEtMS0yNzI5NQ_f8119236-0f33-4e68-95e3-55b5277bd446">2,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy05LTEtMS0yNzI5NQ_58ec6b83-bcbc-437c-9f7b-df003bc97f69">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xMS0xLTEtMjcyOTU_d6134e80-5564-4302-9456-81737fa7ef3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xMy0xLTEtMjcyOTU_238bbe04-eca4-4a48-bbb5-189d788c9295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xNS0xLTEtMjcyOTU_836ad72e-6e7e-4a93-b906-f3750f828ed7">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xLTEtMS0yNzI5NQ_1a4c41a3-cf79-42f6-9d6b-a89f7ffcc1d4">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0zLTEtMS0yNzI5NQ_af1bea93-1148-4387-8ce9-11e64a3cdc9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC01LTEtMS0yNzI5NQ_439892ee-13ad-49c1-83e0-46b4ce1a798d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC03LTEtMS0yNzI5NQ_7a6eefc8-7cec-4c0a-a31c-13505f68ccfa">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC05LTEtMS0yNzI5NQ_6aa32e68-3840-456b-84d2-b4c6e889e9ac">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xMS0xLTEtMjcyOTU_0b13e770-aff5-4c7a-8f4a-f332110b3bfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xMy0xLTEtMjcyOTU_8a2842d6-f663-4156-8834-013bec6221bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xNS0xLTEtMjcyOTU_1b99bc3c-786b-4097-8ba1-14ed9491da8d">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xLTEtMS0yNzI5NQ_bae89cd8-2c19-4aa3-9af2-98d3e4f88e82">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0zLTEtMS0yNzI5NQ_8ec1ccb7-99cc-43dd-80a7-a538e2a8d877">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS01LTEtMS0yNzI5NQ_2de10b30-efe8-48c8-a80d-030742f57868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS03LTEtMS0yNzI5NQ_ce2d5d44-3315-4589-afcf-72e42b598c4d">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS05LTEtMS0yNzI5NQ_14d77178-6d5d-47bb-906d-11b0d5e2cf72">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xMS0xLTEtMjcyOTU_6e8bce69-ae28-4ac8-9db9-4caf7502971d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xMy0xLTEtMjcyOTU_c60e7a15-60c3-403a-8260-c0105af8075d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xNS0xLTEtMjcyOTU_99160e10-9160-45bf-bb28-89100533b2a6">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xLTEtMS0yNzI5NQ_c07c6fed-c25b-4020-b6d9-9f2f82d1eaa1">2,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0zLTEtMS0yNzI5NQ_5cef8070-0465-4532-989a-34241f27cff0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi01LTEtMS0yNzI5NQ_f9a794fd-c97c-4d93-9496-82b8dceaa64e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi03LTEtMS0yNzI5NQ_4708c804-fe24-4b01-94ed-dcf0ea4dbdd1">2,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi05LTEtMS0yNzI5NQ_13ede9e3-94e2-4529-963b-311db43e44a3">2,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xMS0xLTEtMjcyOTU_697514d4-c03c-4794-b99d-2f460769614f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xMy0xLTEtMjcyOTU_327e47ec-9d4b-4dd4-9e8c-9ebf6b4649a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xNS0xLTEtMjcyOTU_e794ebf0-acb7-486c-a74c-fa2bf7c06d36">2,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2022 and December&#160;31, 2021.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="bmy:ScheduleOfEquityInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY2NQ_340d8521-d02c-4a50-8d98-8df40b1bb197" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMS0xLTEtMS0yNzI5NQ_fe35d97d-31fe-46c0-9980-a9f407f61bf1">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMS0zLTEtMS0yNzI5NQ_243df356-1173-48ba-becb-c552558a95ea">2,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMi0xLTEtMS0yNzI5NQ_34db866c-2dde-4a40-9286-dc2e6ffe3fde">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMi0zLTEtMS0yNzI5NQ_ffd4b52f-fb0b-4cb1-9711-1c4557ebf4c9">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMy0xLTEtMS0yNzI5NQ_5d0df849-4d46-483b-9415-b5df408f5410">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMy0zLTEtMS0yNzI5NQ_9330da2a-3f46-47fb-a8cf-72d791d9a5aa">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfNC0xLTEtMS0yNzI5NQ_229c4e5d-e688-4088-a751-1725bec46432">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfNC0zLTEtMS0yNzI5NQ_e9101bbc-8887-4247-bbb2-8a1def2a6a1c">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcyOA_52a505ff-370c-4902-9b38-e799b4ba0ccb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determined fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss/(gain) recognized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMi0xLTEtMS0yNzI5NQ_d0378f05-8d1c-444f-85cb-43e774f258ba">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMi0zLTEtMS0yNzI5NQ_3918b44b-c1cc-4658-8d8e-10e42b660cbf">196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized on investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMy0xLTEtMS0yNzI5NQ_d1ebd563-787b-451b-a85c-7459bec4ca5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMy0zLTEtMS0yNzI5NQ_9386b62b-10fe-4a7d-961a-df1906b79da2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss/(gain) recognized on investments still held</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNC0xLTEtMS0yNzI5NQ_28e032c3-7780-4bc6-a450-bd9abe779475">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNC0zLTEtMS0yNzI5NQ_4aecebe9-ad60-4270-8c78-7837cc99cce7">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNi0xLTEtMS0yNzI5NQ_dde1cc53-3361-45aa-b5f5-43503d174766">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNi0zLTEtMS0yNzI5NQ_9f403bed-7043-478c-8930-5ae8c6209e5a">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNy0xLTEtMS0yNzI5NQ_d4ee5843-2de2-4508-a7d4-2e3c0f43a7b7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNy0zLTEtMS0yNzI5NQ_0cba1ae1-e31f-40cd-ab52-50afe285e14c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfOS0xLTEtMS0yODAyNw_3f1b6c3f-874e-46e7-80c2-37682649967c">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if23774cb38994a048379d7991560faf3_I20210331" sign="-" xsi:nil="true" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfOS0zLTEtMS0yNzYzNQ_3ee21869-76a9-4c87-a732-c6481839787e"></ix:nonFraction></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTAtMS0xLTEtMjgwMjc_f873df08-17be-4a59-8c43-d72bdebb1e86">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if23774cb38994a048379d7991560faf3_I20210331" xsi:nil="true" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTAtMy0xLTEtMjc2MzU_7f072882-57b4-4571-8491-2c85f2b80236"></ix:nonFraction></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net (income)/loss of affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTItMS0xLTEtMjcyOTU_b73cb0a2-c9e3-4daf-aaff-bbdd9b92f3f8">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTItMy0xLTEtMjcyOTU_84df8100-90b7-4033-b9bf-417480d0ea36">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges is temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold and Other (income)/expense, net) within the next 24 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $<ix:nonFraction unitRef="eur" contextRef="iba04377d339644409c75c7a51794a485_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzMxMA_d232c678-5af1-48a1-882a-b311c71f82f0">5.3</ix:nonFraction> billion and Japanese yen of $<ix:nonFraction unitRef="jpy" contextRef="i5a219ea76db64e0e8730984c387c5cce_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzMzMw_a0b5f9fe-37bf-4bf7-b239-665918f27767">1.3</ix:nonFraction> billion at March&#160;31, 2022.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i75d0ce09865e417db838ca94c0b635e0" continuedAt="ib77acdca204846f185e15d2fdcc0fdc7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-U.S. dollar borrowings of &#8364;<ix:nonFraction unitRef="eur" contextRef="iaf91d20822624a328fbe024d1ac258de_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNTQxMw_3f31415a-5380-4565-aa76-35900bd09c28">950</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="iaf91d20822624a328fbe024d1ac258de_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNTQxNw_4881d0e6-b021-4b26-8df4-13c77b396a0c">1.1</ix:nonFraction> billion) at March&#160;31, 2022 are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency interest rate swap contracts of $<ix:nonFraction unitRef="usd" contextRef="i9bdb869eecbb469c9bf0310b8e728219_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNTg2MQ_a65b2c6c-942c-428b-8336-b45509bb38ba">600</ix:nonFraction> million at March&#160;31, 2022 are designated to hedge Japanese yen currency exposure of BMS&#8217;s net investment in its Japan subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Accumulated other comprehensive loss with a related offset in Other non-current assets or Other non-current liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (<ix:nonFraction unitRef="number" contextRef="ifa8aa0d818c149aa92bb61f130372893_I20220331" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU2OQ_9b0a29d3-e1c5-4077-8f97-6c5e3efaf53e">0.45</ix:nonFraction>% as of March&#160;31, 2022) plus an interest rate spread of <ix:nonFraction unitRef="number" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="3" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjYxNA_d3d55403-b9ea-45c0-b0be-62f2c73a2427">4.6</ix:nonFraction>%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Treasury lock contracts were entered into with a total notional value of $<ix:nonFraction unitRef="usd" contextRef="i8c471c3a99b34ecda06e75a57da1ce44_I20220228" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY1MTI0NA_aeb582b0-7584-4917-88be-5ab980ed8070">3.0</ix:nonFraction>&#160;billion to hedge interest rate risk associated with the anticipated issuance of long-term debt. The Treasury lock contracts were terminated upon the issuance of the aggregate $<ix:nonFraction unitRef="usd" contextRef="i1e0b11c565d843cd800a00cce43f9006_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY1MTI0MQ_555edd07-1a09-4558-ae7f-b6237559074c">6.0</ix:nonFraction>&#160;billion of unsecured senior notes. These contracts were not designated for hedge accounting. The settlement of these contracts were not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Treasury lock contracts were entered into with a total notional value of $<ix:nonFraction unitRef="usd" contextRef="if3ea42357cdc414391b58ca0ccf786db_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY1MTI1OA_0fa4403f-2a5f-4984-beab-8b9dfff5230e">2.3</ix:nonFraction>&#160;billion to hedge cash payment for the anticipated redemption of long-term debt. The Treasury lock contracts were terminated upon pricing the debt redemption. These contracts were not designated for hedge accounting. The settlement of these contracts were not material.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY1OQ_ecd8eb49-8941-4052-8abb-be3577801257" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:34.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i163f0d0fccd34d7385555f74e0a794a7_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xLTEtMS0yNzI5NQ_9dd07696-2cde-4806-9dab-af200d9169b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9206328440464f8e839a11661b43c8a8_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0zLTEtMS0yNzI5NQ_73c301e4-39f3-4ba4-b751-c6706cf9ec3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55598a609c114f67a4cd37885de32e1d_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC01LTEtMS0yNzI5NQ_4e455a18-6bf1-4233-b0be-ff21f2eb28b6">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9206328440464f8e839a11661b43c8a8_I20220331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC03LTEtMS0yNzI5NQ_c44a97f7-acb2-4adb-9c5d-929100c9d409">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic177dd5bb64d454c86bc6072ebd749cb_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC05LTEtMS0yNzI5NQ_55a43b23-648a-4118-b9f5-41fbde758094">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i113230baa650402d97981ca827bc4de6_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xMS0xLTEtMjcyOTU_8043e3ce-1793-4c92-aa1e-24df62d86383">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54b70af5b76417a806e38ea5e1d407d_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xMy0xLTEtMjcyOTU_021a0ceb-91ef-4686-800e-b73bd1be30b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i113230baa650402d97981ca827bc4de6_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xNS0xLTEtMjcyOTU_6e9ac854-80e0-4e25-aedb-90d8d682757d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia276049873e54e59b3bf07c8d5e24ab4_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xLTEtMS0yNzI5NQ_d12c8ccb-9ecd-4be2-9e2f-95a2f8ada21f">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba35d244942447b99ebc571324ef1dee_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0zLTEtMS0yNzI5NQ_32b3168f-f3c0-4ed6-8cda-c564cfa6879f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15954e5f8f0e40debb23d733b33aaa1e_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS01LTEtMS0yNzI5NQ_5dfc60c4-dd8e-43df-86fd-1c9114ad927d">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba35d244942447b99ebc571324ef1dee_I20220331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS03LTEtMS0yNzI5NQ_3fcb2729-796a-42fd-90a0-b60a1d08b90d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9389451e47486e902034a32c3e09c0_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS05LTEtMS0yNzI5NQ_8b41a2ef-418d-43b1-91f8-5b001ca4a9e2">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9ada9042874bf182eaadf231a4c890_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xMS0xLTEtMjcyOTU_3b525538-424e-4c83-91d7-e08edf0b6f6e">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92f31c4fa40457aba15667be923fd82_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xMy0xLTEtMjcyOTU_1f185f05-d677-4329-a007-ff32e0dac0f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9ada9042874bf182eaadf231a4c890_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xNS0xLTEtMjcyOTU_b9775df1-d8ea-4210-98b4-5497eb2f90ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16452daa2024ee899435e33c8107110_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xLTEtMS0yNzI5NQ_0543c2ac-5609-4804-861d-7ddbae05b0d2">5,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3096f2c934e04de28c49313517b1c847_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0zLTEtMS0yNzI5NQ_505b9c56-673d-4366-91cb-10100fb2cdb9">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91abf09684ca431e82f000c3018b6f09_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi01LTEtMS0yNzI5NQ_fa33e5b8-f6c5-4a59-9a4e-3c1f594a2915">2,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3096f2c934e04de28c49313517b1c847_I20220331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi03LTEtMS0yNzI5NQ_1808c978-dbf1-40e4-9bd7-eac18eda1d6d">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f017519dcc04d71a28d222bc83fa92b_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi05LTEtMS0yNzI5NQ_7b21edcc-97df-4462-83aa-522de11424aa">3,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90219dc5ee1b4ec399ce30e3c157467c_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xMS0xLTEtMjcyOTU_4683d6c1-5245-41e5-9a17-ef8d940323dd">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice8a3ac0991c4c81bd0f404665c335f3_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xMy0xLTEtMjcyOTU_d353267a-4797-435d-9c1c-d40e0b971543">1,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90219dc5ee1b4ec399ce30e3c157467c_I20211231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xNS0xLTEtMjcyOTU_6119b4c7-890e-4a7d-aa55-a6818f67aabc">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic465ba0286fb496c8fae21240e7d3f20_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xLTEtMS0yNzI5NQ_fdee5e8d-f846-4741-9d65-f92d62d0295f">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4813222bf3b4237ba720be703e50ec0_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0zLTEtMS0yNzI5NQ_359a3226-b8ea-454b-b26f-e4f04279bf65">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61598df0bf2f4820b2d1aa70b7ebdec2_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS01LTEtMS0yNzI5NQ_db7ce0b8-6cf1-4ab4-b589-9f8b50708a90">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4813222bf3b4237ba720be703e50ec0_I20220331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS03LTEtMS0yNzI5NQ_0fb885b9-131c-49d4-a488-5ebae6f72b47">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97cdafa0cdbb43d1a935dd3533f1c50f_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS05LTEtMS0yNzI5NQ_4c9550eb-9ff1-4442-9adb-566be5de69bb">883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58a89f11019b4792a01527b1d0647136_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xMS0xLTEtMjcyOTU_4729efcf-362a-4ed5-a031-006f394f0b77">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaeaf5cae69a45de99a6f4a1e9213d18_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xMy0xLTEtMjcyOTU_585444f9-5a2a-44f3-a782-6776dce2413e">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58a89f11019b4792a01527b1d0647136_I20211231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xNS0xLTEtMjcyOTU_68fe1960-0bea-4522-afce-1d754d529b72">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cb747a19155484fb0a6e5942ee35dae_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMS0xLTEtMjcyOTU_c0c9f1a4-8431-4203-9846-c7809b8f1080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936bc96f5135495e83a811e835de4a2b_I20220331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMy0xLTEtMjcyOTU_6e7f676d-cc64-46ae-8deb-0fe3d7dcd952">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32cf6ce35e3d4d049918c1ce536767fe_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtNS0xLTEtMjcyOTU_faa664f0-3c8a-4560-b758-31409fd3d0e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936bc96f5135495e83a811e835de4a2b_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtNy0xLTEtMjcyOTU_1f16f07a-111f-4a15-b11c-41de1160a1db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c8517489c824a32aa5646d0832375df_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtOS0xLTEtMjcyOTU_81485805-e7c7-4145-b5c6-d20b6ef71557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fa5bfd2bd145b2ad628c77bd80cb19_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMTEtMS0xLTI3Mjk1_b8c676bc-2475-481f-a96a-39ada52cdbfc">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80cf390abecb4fe5b76b4c01abe05068_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMTMtMS0xLTI3Mjk1_6c0f265b-4b07-4924-8ead-f378795a8000">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fa5bfd2bd145b2ad628c77bd80cb19_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMTUtMS0xLTI3Mjk1_6c270609-bb51-4778-881b-b864c82fbd56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib77acdca204846f185e15d2fdcc0fdc7" continuedAt="idc77d47d95084ab1859add2c8306f1b4"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcwOQ_5b1c2bee-65b4-4692-afbe-afb4ecd70a7e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b589631ea674d988596b27dfe9491d0_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi0xLTEtMS0yNzI5NQ_6830bbee-c8ee-4f07-b0e4-76646fcbb1dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5b1608a17e14eb7b4319cb2fed7bd5f_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi0zLTEtMS0yNzI5NQ_fa41221d-4f4e-4d97-a5f1-3d02b7f5080b">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e5eb4f2fc54341a81746b993921e88_D20210101-20210331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi01LTEtMS0yNzI5NQ_39a1b1ba-8b49-45f3-b315-3e243e9af259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9c22056c58444adbcb1e2bc577ceb6e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi03LTEtMS0yNzI5NQ_c30857b7-923b-40b5-b48f-e7459b433327">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a2104a59240458e98947f2acda759e4_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy0xLTEtMS0yNzI5NQ_2f3d7fe8-789d-4dcd-a785-fe8a55502b83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78573b9f974642299bc3a4a346f6d3cf_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy0zLTEtMS0yNzI5NQ_93b8b1b8-ca9c-4eba-a65e-2df4f671b5ff">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64626f3fe0164c9c82c44f1051505316_D20210101-20210331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy01LTEtMS0yNzI5NQ_f1280663-0c4f-432b-abc7-7c254f9953ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cdfda20ae8a4ab98ea04f90f98a6432_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy03LTEtMS0yNzI5NQ_50e1b7ad-8e56-4256-b298-0f530644c737">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0511d5a39094272ac5c6248e8167fa4_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC0xLTEtMS0yNzI5NQ_51ca0989-109b-4cbc-bcc6-cd66b472327c">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83d83401572a4528805417b147f0bbc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC0zLTEtMS0yNzI5NQ_d15b9afd-ea7f-4f79-9861-7efe4f769f65">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcdfacdd7c24cc7abd9cc7e5da883d5_D20210101-20210331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC01LTEtMS0yNzI5NQ_4e114422-e470-49be-abbd-08bcd60f450c">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i261481db1532401aba4104d90a4ea56e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC03LTEtMS0yNzI5NQ_2e1e733b-e6d0-434a-8136-69bbc8a3bcf3">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37f56aa23264798a7f027c4249e913d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNC0xLTEtMS0yNzI5NQ_14f7e348-9699-4917-a03d-70e4ff41690f">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3c98aa282840c49d1057bd807271bc_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNC0zLTEtMS0yNzI5NQ_2d3e696e-0882-48b0-97e7-11aa23ee5a7c">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0511d5a39094272ac5c6248e8167fa4_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNS0xLTEtMS0yNzI5NQ_2b45775a-3601-412d-86f6-644efd8f2286">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcdfacdd7c24cc7abd9cc7e5da883d5_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNS0zLTEtMS0yNzI5NQ_3f9e8035-2c65-48f6-bbdb-a1923cf13670">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89c5148aeb1d4af989c7f56cfcd9e51d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNi0xLTEtMS03NTM0Mg_952a2f13-5a8f-452c-9d87-b3ee3e54d226">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if068c2cd34c84c29aba8109de255a3f1_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNi0zLTEtMS03NTM0Mg_e95f2967-4c49-4e1c-80bf-2f0ce9445496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770251dbb1814ce4a3a299dd66902cb9_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTItMS0xLTEtMjcyOTU_7b55bb92-46a6-4d63-b026-47f9c991cddf">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5f476f6d59c4d2f8abff0b07711d3ee_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTItMy0xLTEtMjcyOTU_9a3b51d6-814d-402f-915c-b4dcc3015e97">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic877b4ebba4a4d2f83ee4834c3bc717a_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTYtMS0xLTEtMjcyOTU_f9f616ae-a488-449c-b68d-c3f2003de026">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb52be0aee44612b177866eb6f7332c_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTYtMy0xLTEtMjcyOTU_ece739d7-b05e-48f1-b471-7f806a725593">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 18 months.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY2Ng_f0f6f7c2-9f4e-4443-9d60-08984ea4cce5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMS0xLTEtMS0yNzI5NQ_2d837c1e-2c46-4da8-9e5e-9e9b7b7eb27a">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMS0zLTEtMS0yNzI5NQ_681bc2d0-7df3-4779-96b6-35b9ed302d97">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMi0xLTEtMS0yNzI5NQ_8f8199af-ce28-4ae7-81e0-dbd6a20bf40f">7,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMi0zLTEtMS0yNzI5NQ_b9c81c57-2506-4c62-aac7-97e17e595df4">4,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMy0xLTEtMS0yNzI5NQ_85cf0d31-840f-41a0-bc5c-cfef82ed5f33">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMy0zLTEtMS0yNzI5NQ_00e56433-23c4-4430-8be5-ec4aded57995">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfNC0xLTEtMS0yNzI5NQ_80ca20c0-e02f-4727-a977-1f39acceba26">7,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfNC0zLTEtMS0yNzI5NQ_94047438-966e-410d-a0d2-4df63741ffbd">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idc77d47d95084ab1859add2c8306f1b4"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcwMw_8644e38f-a198-466e-80a8-c8e210134ad9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMS0xLTEtMS0yNzI5NQ_cf2b8fc6-344c-4531-97a2-210f22cba344">43,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMS0zLTEtMS0yNzI5NQ_b7cfb7b9-d809-4106-9e12-e1818d39b19b">43,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc01c81d46124cf59f361dbae533ad7c_I20220331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNC0xLTEtMS0yNzI5NQ_a3285be5-9dd9-4e6d-85f5-b1db6eaa334a">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a9c40fe3e64397a7a9af57cdbd9f2e_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNC0zLTEtMS0yNzI5NQ_732a213f-8c4c-4a0e-9d29-4763c8714278">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNS0xLTEtMS0yNzI5NQ_6b300801-53b0-43f9-8a23-cc7874d45c97">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNS0zLTEtMS0yNzI5NQ_ded39c89-7764-4ba9-a38d-7eb23a3ce59f">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNi0xLTEtMS0yNzI5NQ_ffaff6d0-2a5a-433c-88ff-0d42314ce8a2">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNi0zLTEtMS0yNzI5NQ_a94394b6-8473-48c5-8133-0b6483b2562d">263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNy0xLTEtMS0yNzI5NQ_edd09f16-58a5-41f1-8e8d-19cce9d4590e">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNy0zLTEtMS0yNzI5NQ_90887090-448a-4563-8cf6-dfe289551936">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfOC0xLTEtMS0yNzI5NQ_70ebd085-425b-4791-9088-da1d0afb0645">44,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfOC0zLTEtMS0yNzI5NQ_fd798d8b-8c56-42a8-a4a9-360dbbcfeb13">44,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTAtMS0xLTEtMjcyOTU_393a11f4-6251-4934-af28-bf3caa46e358">7,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTAtMy0xLTEtMjcyOTU_49880a2a-f7c3-40fd-b959-f99328745c8c">4,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTEtMS0xLTEtMjcyOTU_55b82868-8827-496c-bd6c-4aabb9343713">37,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTEtMy0xLTEtMjcyOTU_c19143e8-d0e1-4a13-b74f-3619809c72d1">39,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTItMS0xLTEtMjcyOTU_d4a834ad-60b6-44ce-aaba-c9f7438711cf">44,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTItMy0xLTEtMjcyOTU_c68cc951-551d-4468-8392-345e542b1dc3">44,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODEzMA_ee038c82-5fb4-496d-9905-42d258fa8978">45.8</ix:nonFraction> billion at March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODE0Mw_410706c8-91ad-4527-a1ab-094af4f40b65">49.1</ix:nonFraction> billion at December&#160;31, 2021 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, BMS issued an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i1e0b11c565d843cd800a00cce43f9006_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzI5ODUzNDg5NDczNg_555edd07-1a09-4558-ae7f-b6237559074c">6.0</ix:nonFraction>&#160;billion of debt consisting of $<ix:nonFraction unitRef="usd" contextRef="i00f392936d8e4b9f8959e00956d66d32_I20220331" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDUxMw_863e820e-1add-4b3e-95d8-0ce245be8856">1.75</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="i00f392936d8e4b9f8959e00956d66d32_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE1NQ_a98746d8-285a-4e10-90a3-1b8118c1e06f">2.950</ix:nonFraction>% Notes due 2032, $<ix:nonFraction unitRef="usd" contextRef="i01d1accdb09342a1a2cc72896080888b_I20220331" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDUyOA_397e147b-f7bd-4a85-ae3d-99410d26074e">1.25</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="i01d1accdb09342a1a2cc72896080888b_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE2Mw_3ee78539-44bf-498c-b9fb-a45498da6f23">3.550</ix:nonFraction>% Notes due 2042, $<ix:nonFraction unitRef="usd" contextRef="iccb557e1b6ae4ed18e4f9c9ea9685c16_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDU0Mw_9ca617d0-d9cd-47df-b3a3-5f2d69187906">2.0</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="iccb557e1b6ae4ed18e4f9c9ea9685c16_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE3MQ_bdd2d9d4-9c29-41dc-8de0-43cea79f53ca">3.700</ix:nonFraction>% Notes due 2052 and $<ix:nonFraction unitRef="usd" contextRef="i42a8df9288214a7ba80d4c2e2cea5cd0_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDU1Nw_74c17811-0f6a-4a4b-b387-cb777cf6c046">1.0</ix:nonFraction>&#160;billion of <ix:nonFraction unitRef="number" contextRef="i42a8df9288214a7ba80d4c2e2cea5cd0_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE3OQ_08446939-ab72-48e6-8df3-092526ff306c">3.900</ix:nonFraction>% Notes due 2062 with proceeds net of discount and deferred loan issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzI5ODUzNDg5NDc1MA_8938e5ec-848b-4a1a-8b7f-f837cd2d0de7">5.9</ix:nonFraction>&#160;billion. The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, BMS purchased aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTY0OTI2NzQ1MzQ3NA_8cec6a94-ab97-4658-bc15-0e64b5e45012">5.2</ix:nonFraction>&#160;billion of certain of its debt securities for approximately $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-8" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTY0OTI2NzQ1MzQ2MA_8dcb9f7e-6d00-4dec-b9a5-17c9878dabe6">5.8</ix:nonFraction>&#160;billion of cash in tender offers. In connection with these transactions, a $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTY0OTI2NzQ1MzQ4OA_a1761cbc-acf2-4bfc-a6b1-e5364c2cf376">275</ix:nonFraction>&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, BMS purchased aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDEzMA_fd969f26-099d-4fd0-b9fb-79ff7c4897a1">849</ix:nonFraction>&#160;million of certain of its debt securities for approximately $<ix:nonFraction unitRef="usd" contextRef="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDE1Ng_0a91c3c9-3644-400d-9d3c-4b09366f1d0e">880</ix:nonFraction>&#160;million of cash pursuant to &#8220;make whole&#8221; redemptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2021, BMS purchased aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODQ3MA_944c883b-c8f8-414f-b344-2874622ffa88">3.5</ix:nonFraction>&#160;billion of certain of its debt securities for approximately $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-8" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODUyNQ_b96b727c-1f39-410f-9967-c508e4657ed6">4.0</ix:nonFraction>&#160;billion of cash in a series of tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODYzNg_ebdfe871-d945-4cfc-9e57-59953b5ba450">281</ix:nonFraction>&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. In addition, the $<ix:nonFraction unitRef="usd" contextRef="i0487706aaf654d899b5f17f8e3b4d1b1_I20210331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODgxNw_c432397b-a58d-46f5-b298-99f258512361">500</ix:nonFraction>&#160;million 2.875% Notes matured and were repaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODkxOQ_b076e2e7-32e7-4c40-ad71-f80c1e8d54f1">377</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODkyNg_b57e2733-0297-4f2f-a572-f57b6e4f4216">435</ix:nonFraction> million for the three months ended March 31, 2022 and 2021, respectively, net of amounts related to interest rate swap contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had <ix:nonFraction unitRef="creditfacility" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="INF" name="bmy:NumberofRevolvingCreditFacilities" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDIwNw_f4591119-3243-4267-b909-055bb8e25975">four</ix:nonFraction> separate revolving credit facilities totaling $<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQxMw_43c87825-4ca7-4dc6-bf31-773c615901c8">6.0</ix:nonFraction>&#160;billion, which consisted of a 364-day $<ix:nonFraction unitRef="usd" contextRef="i39644068dc2e42e5bcca7dba89dc84f8_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQyNw_dd59db11-323f-4ec8-969b-213fdf4b48c9">2.0</ix:nonFraction>&#160;billion facility which expired in January 2022, a three-year $<ix:nonFraction unitRef="usd" contextRef="ifb0c682ec8e94e719bfd0b0e8c33a3d6_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ0MQ_1eafe7cf-0120-49da-bc8f-f86f032e2bfc">1.0</ix:nonFraction>&#160;billion facility which expired in January 2022 and two five-year $<ix:nonFraction unitRef="usd" contextRef="i1d28a8538925455ea6ce8a6e6c60af90_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ1NQ_b78cee2a-310f-440f-a7ef-f4eca3782779">1.5</ix:nonFraction>&#160;billion facilities that were extended to September 2025 and July 2026, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we entered into a <ix:nonNumeric contextRef="i2b5f5c10b37c44cab92705107745235c_I20220331" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE5NQ_00553a85-931e-41f4-8407-38adf922967d">five-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="i2b5f5c10b37c44cab92705107745235c_I20220331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODM5OQ_0b3542ca-2a4f-494b-a922-52c8cb7b355f">5.0</ix:nonFraction>&#160;billion facility expiring in January 2027, which is extendable annually by <ix:nonNumeric contextRef="i2b5f5c10b37c44cab92705107745235c_I20220331" name="bmy:LongTermDebtRenewalPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE5Nw_07dd54ab-758c-43e5-97aa-4b6b75100ecd">one year</ix:nonNumeric> with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing <ix:nonNumeric contextRef="i22388c8b54454a828847139982eb6182_I20220331" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE5OQ_dc9c8b75-9e51-4fb0-81f0-8ec03b01d9b7">five-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="i22388c8b54454a828847139982eb6182_I20220331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ2OQ_c5062bb3-f99c-4136-88b1-624628c39fd5">1.5</ix:nonFraction>&#160;billion facilities were terminated and the three-year $<ix:nonFraction unitRef="usd" contextRef="i41cc28991d204c169ba5bb001d925552_I20220331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ4Mw_7c090e58-477e-4efa-b23e-75c24de4e4e6">1.0</ix:nonFraction>&#160;billion facility and 364-day $<ix:nonFraction unitRef="usd" contextRef="i5792b37bfd964932bfdc0eec0a2d49b4_I20220331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ5Nw_544c5a2d-a25d-4de1-b42b-4c296c8bc1fe">2.0</ix:nonFraction>&#160;billion facility expired in accordance with their terms in January 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No borrowings were outstanding under any revolving credit facility at March&#160;31, 2022 or December&#160;31, 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ide471947286340dd92506f80fe047642_58"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjY2_135fd73d-cf5c-4bdb-853c-e5f6548449c5" continuedAt="icbae4a0d384d4eca8127a4997ccbbcce" escape="true">RECEIVABLES</ix:nonNumeric></span></div><ix:continuation id="icbae4a0d384d4eca8127a4997ccbbcce"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjY4_afeec1ae-1e37-4c63-a102-b5b854bdf365" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMS0xLTEtMS0yNzI5NQ_442f9b59-fea4-4bed-a147-cf68e69dfde1">7,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMS0zLTEtMS0yNzI5NQ_44e48cf5-4559-4298-bbd8-5ac86b651595">8,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMi0xLTEtMS0yNzI5NQ_ef2d597b-36ca-4b4c-bcc8-8ea9e5df4809">561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMi0zLTEtMS0yNzI5NQ_9a94bdd2-2e79-48a4-84a4-6d6f2a4cb53d">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMy0xLTEtMS0yNzI5NQ_9b0a1e79-ac5e-477c-acbb-f052b45ddbdf">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMy0zLTEtMS0yNzI5NQ_d0f83f8c-64a1-4088-9054-a7db2f840e4d">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNC0xLTEtMS0yNzI5NQ_bc7cc594-567f-4e92-95b3-8f2a763bf2e8">7,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNC0zLTEtMS0yNzI5NQ_a4bcb29e-0662-49c1-9686-fb1d134f6f2c">7,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, Royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNS0xLTEtMS0yNzI5NQ_2b83bc23-bb4a-447f-824f-2c1c1325f46b">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNS0zLTEtMS0yNzI5NQ_436fb64c-b8db-488e-8f0f-ab1b84c2f98f">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNi0xLTEtMS0yNzI5NQ_fd5841d1-bdc7-4f43-8b3f-30d18f3884a9">8,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNi0zLTEtMS0yNzI5NQ_0e29399a-3642-43ff-8495-2884be29a7c2">9,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfODM_6fc5ac9d-1291-4040-8151-92fceefce92f">423</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfOTA_7de62b2c-1d28-4a95-9e8b-fa2cdc499609">318</ix:nonFraction> million for the three months ended March 31, 2022 and 2021, respectively. Receivables from the <ix:nonFraction unitRef="customers" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="INF" name="bmy:NumberOfLargestPharmaceuticalWholesalers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMTQ3_efce52db-04bd-4a94-86c1-2d5cd978a593">three</ix:nonFraction> largest customers in the U.S. represented approximately <ix:nonFraction unitRef="number" contextRef="id15c48a3d81c47aeae083ac08257cad4_I20220331" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjA2_123e902d-23d2-4365-8437-ff30353b6ed3">60</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i8b430687b90f47298aca5585a93c5694_I20211231" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjE5OTAyMzI1NTg0MA_9a0f0dac-a226-4ca6-a380-1a00103297f7">59</ix:nonFraction>% of total trade receivables at March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMjU0_5464068b-ffd5-4e85-ad7a-b8f96d50ccab" continuedAt="ib5a1d42895e4449487267878fdb547b8" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="ib5a1d42895e4449487267878fdb547b8"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMjU4_edaea792-fb79-4d12-9aab-e3e683616c93" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMS0xLTEtMS0yNzI5NQ_e470ff1f-4abe-475e-aae2-242490522263">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMS0zLTEtMS0yNzI5NQ_7e72f3d2-44ce-419e-83bb-91d514e02688">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMi0xLTEtMS0yNzI5NQ_2c6dc50c-fc0d-41d4-88a4-36635c167de5">2,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMi0zLTEtMS0yNzI5NQ_81566e3d-5d53-4c1d-89c7-b897e90a7e7d">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMy0xLTEtMS0yNzI5NQ_d481dfa8-da67-4c82-b140-c399ac440637">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMy0zLTEtMS0yNzI5NQ_cea2e786-2103-4472-a00c-8af7249fb51f">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNC0xLTEtMS0yNzI5NQ_c8e5bb91-28e3-43b0-ba22-1e6c136313ff">2,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNC0zLTEtMS0yNzI5NQ_f279cbb9-e919-472a-a3df-39ee2072aee2">3,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNi0xLTEtMS0yNzI5NQ_8c2db212-8b0d-4802-8cdf-4c31fe2d55f4">2,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNi0zLTEtMS0yNzI5NQ_66798a62-0ec3-4fa7-b358-8cc127d86bf3">2,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNy0xLTEtMS0yNzI5NQ_64b8e695-e86b-44be-8d16-900e0d700081">843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNy0zLTEtMS0yNzI5NQ_36c70a5a-71c7-44f5-84ca-91cd1ca29f51">909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories include fair value adjustments resulting from the Celgene acquisition of $<ix:nonFraction unitRef="usd" contextRef="ib591208aeba1490ababd9ab1c130dc54_I20220331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTIw_c3a2560b-6cb3-4460-8efd-d61ca8645042">368</ix:nonFraction> million at March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i662965b18d274bd4906976d530ef4ae5_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTMz_104ac39a-151d-4505-82e8-d32c1655be37">508</ix:nonFraction> million at December&#160;31, 2021. Other non-current assets include inventory expected to remain on hand beyond 12 months in both periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An out of period adjustment was included in the three months ended March&#160;31, 2022 to reduce the remaining amount of inventory fair value adjustments resulting from the Celgene acquisition by $<ix:nonFraction unitRef="usd" contextRef="ibf698719af47427688c9bbce6908e931_I20220331" decimals="-6" name="us-gaap:InventoryAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTA5OTUxMTYyOTMyNQ_8c84f8cf-6d75-4159-bc6c-3ab84c05bce8">114</ix:nonFraction>&#160;million with a corresponding increase to Cost of products sold of $<ix:nonFraction unitRef="usd" contextRef="id36e61c39dfd400c8b4956a1177b4898_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTA5OTUxMTYyOTM4Nw_c81d0e01-081b-4077-90e7-004cc7aa6fcf">32</ix:nonFraction>&#160;million and Research and development expense of $<ix:nonFraction unitRef="usd" contextRef="id36e61c39dfd400c8b4956a1177b4898_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTA5OTUxMTYyOTQzMQ_0fd3934f-706b-4cb2-8ef0-eef635097478">82</ix:nonFraction>&#160;million. The adjustment was not material to previously reported balance sheets or results of operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfMTUx_1372cbed-4ec3-4131-92bc-2de8d46f6906" continuedAt="ica4bfc14ee97481e902f33a370543dd8" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="ica4bfc14ee97481e902f33a370543dd8"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfMTQx_c3a5a99e-b1f7-494a-8bc0-27c145040681" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMS0xLTEtMS0yNzI5NQ_dfaa1081-b063-4b6e-939c-08d722f90071">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMS0zLTEtMS0yNzI5NQ_54c48202-0644-4b75-b6eb-5b71f1ea8e46">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMi0xLTEtMS0yNzI5NQ_b673d4e8-113a-4147-8083-0aef214aeeb8">5,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMi0zLTEtMS0yNzI5NQ_c09aec49-c47e-46dd-9fea-a26d7db97593">5,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMy0xLTEtMS0yNzI5NQ_b4341f88-ba90-4919-9880-d0513890c917">3,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMy0zLTEtMS0yNzI5NQ_28872730-46a8-4d92-8344-67637a15b0e8">3,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNC0xLTEtMS0yNzI5NQ_e89f6f08-f37a-471e-ac40-5fb097be76c1">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNC0zLTEtMS0yNzI5NQ_b209fe00-6b67-4fe7-9086-9abc4c9d4763">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNS0xLTEtMS0yNzI5NQ_1a5244b4-d097-4955-b69a-c22e7469f9d2">10,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNS0zLTEtMS0yNzI5NQ_3a29c485-511d-4e98-aa3b-5b796ffd4bd3">10,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNi0xLTEtMS0yNzI5NQ_4d4b6222-8f1a-4400-aa18-c0fdc612bd5c">4,168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNi0zLTEtMS0yNzI5NQ_b0d51c70-2596-4b2f-8936-2e4b00b8962c">4,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNy0xLTEtMS0yNzI5NQ_0a61a1f7-e729-4d0f-ae05-145aa922e8ec">6,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNy0zLTEtMS0yNzI5NQ_c6ce23a4-ca13-45bb-a384-12f118c70a35">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfNzI_f32dda61-a415-49a1-ae1f-ccba024c98f8">145</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfMTA5OTUxMTYyNzkzNQ_99be4631-ff66-4725-a2b9-b9599715c4c7">135</ix:nonFraction> million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ide471947286340dd92506f80fe047642_70"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTg4Mg_de034f16-f775-4ae5-99e7-88ae4217b37f" continuedAt="i8ff1b8309e504b118730f22beac77804" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i8ff1b8309e504b118730f22beac77804"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTg3Mw_011fc1aa-40dd-4b50-b01a-a86e28244f85" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:62.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMS0zLTEtMS0yNzI5NQ_555545c0-8447-4d0d-b887-6d2556f638fd">20,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMS01LTEtMS0yNzI5NQ_d575c91b-a54c-45cf-b964-2eec50f1d610">20,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i933b74eb6ef2454e82c1e129ff3a4cf9_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmZlYTRjMGI2MGJmYjQ4Yjk5OTFjYzZkZGJiMWIxMmYwXzQ_ac8a4a4f-29c5-4109-9ee9-1175a67b650c">5</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="i9d1a44cdc0ce421ab0a6afc5c7148f8d_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmZlYTRjMGI2MGJmYjQ4Yjk5OTFjYzZkZGJiMWIxMmYwXzk_1f24c3ee-159e-4d6b-b1cc-36d8dba14e52">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c8fe212155e47398c07ac122c4d25db_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC0zLTEtMS0yNzI5NQ_63904f12-1cbc-4445-bbb4-5d1baa26df0d">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i813eb01fc49e456daa2b0d45dbf8903a_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC01LTEtMS0yNzI5NQ_d8c45295-612e-4eb4-b3a5-2a134254402f">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1c163fb38d5e483a957be472e84d0b08_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmQ0Y2JhZjU3N2VmNjRmOGE4ZTdhNDM3ZDU2YjM1YjlmXzQ_18aebdb3-956d-4807-84a4-3c78f313ba24">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="ib51a898c07794b4a919b257dcc42208c_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmQ0Y2JhZjU3N2VmNjRmOGE4ZTdhNDM3ZDU2YjM1YjlmXzk_fc0f70bd-7485-4df9-a3e7-dad7042f5e6b">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i483be3c323184f15b35cc7d81776ecc4_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS0zLTEtMS0yNzI5NQ_4a236cce-e620-479c-90c7-f0d652686071">60,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8493c14f9b494a61ba4d49df885de3a1_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS01LTEtMS0yNzI5NQ_ce6ab06e-d3c3-4f0b-9201-5811fb010ef5">60,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b3beca4fb5a42a08d14874a43fb86a0_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOjAwMjk0ZDI1ZTc4MjRhZjg5OGIxNTg1ZWEyMjYyZDc1XzQ_295b3e4d-7821-4813-914b-36c98ddb6ef9">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="ia288c0fb88974230b4554c68b96e40c0_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOjAwMjk0ZDI1ZTc4MjRhZjg5OGIxNTg1ZWEyMjYyZDc1Xzk_a8cf17e3-1228-4ea4-b988-43da2134c335">10</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357734b23ccc4244aea0717e29ca8fad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi0zLTEtMS0yNzI5NQ_4807bc71-a3ef-4ae9-9ed0-b61bad091261">1,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e3744106ea411ba17e209a5e2dc279_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi01LTEtMS0yNzI5NQ_5f1aac05-5e13-4804-ad19-664ebb9f8484">1,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c61398032f94cb8bd85669f01cdd4b5_I20220331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNy0zLTEtMS0yNzI5NQ_d86352f3-3fc9-42df-81e1-82bc825e257a">3,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dd431d277f4046b343051457c073a0_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNy01LTEtMS0yNzI5NQ_5e520fcc-9d44-429f-8d2b-0360d6755da6">3,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOC0zLTEtMS0yNzI5NQ_1a42ac24-9a49-4f3e-b088-9ebe6cbaa622">66,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOC01LTEtMS0yNzI5NQ_d65f4f4f-bb6a-4fd0-a84d-f15817e0713a">66,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOS0zLTEtMS0yNzI5NQ_4f79c024-a0ae-4666-a3a7-5674f1b39cce">25,935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOS01LTEtMS0yNzI5NQ_86c0a883-2067-48ee-b106-ff1c79131c47">23,483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMTAtMy0xLTEtMjcyOTU_b114591b-f593-4561-9e15-89000e2c897d">40,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMTAtNS0xLTEtMjcyOTU_ccc4d2d9-0d50-4845-8826-cea71e1fe9d8">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of other intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMjMz_227803ce-1b5c-44c0-b724-f8e91a3e62ad">2.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTA5OTUxMTYyOTc5MA_4373d016-9b55-458f-92cd-a2199a12e052">2.6</ix:nonFraction> billion for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, a $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTA5OTUxMTYzMjk0Mg_18706ccc-fc7c-4a55-844f-8d249b82d945">40</ix:nonFraction>&#160;million IPRD impairment charge was recorded in Research and development expense following a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Celgene and was being studied as a potential treatment for autoimmune diseases. The charge represented a full write-down.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones of $<ix:nonFraction unitRef="usd" contextRef="i890c7a1dec204f3a915c8bfcce2acedf_I20210331" decimals="-6" name="bmy:ContingentAndRegulatoryMilestoneNonCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTQxMw_923cde87-f0b2-4572-aee4-5e9529cfcd9a">300</ix:nonFraction>&#160;million were achieved resulting in a $<ix:nonFraction unitRef="usd" contextRef="ib947345d6e024c65bb07480f1c5e4624_D20210101-20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTQ0NQ_cffe9e28-e583-4fe5-8884-7b650c21dcfa">385</ix:nonFraction>&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ib947345d6e024c65bb07480f1c5e4624_D20210101-20210331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTU5Nw_91bc4046-caa2-4409-bd2e-ed354b050585">315</ix:nonFraction>&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzcx_a9879f03-cf0a-48fc-abaf-9628f7e13f88" continuedAt="i1257ad5ca1b642bbb3cedd94e8d81dc0" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i1257ad5ca1b642bbb3cedd94e8d81dc0" continuedAt="i4f95ea8a0ce1484b8e879e194c3ccb2a"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzcy_2efe26cb-89db-422f-8263-7262833a6604" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMS0xLTEtMS0yNzI5NQ_50fe05e5-1d60-4639-835c-3db5876f3ca5">2,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMS0zLTEtMS0yNzI5NQ_7bdcda30-5753-4f18-984a-7ca078239f83">2,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMi0xLTEtMS0yNzI5NQ_a223f52f-3eb4-43d1-9f77-b926f7d8c184">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMi0zLTEtMS0yNzI5NQ_39a8f2fe-0bb5-4b80-840a-2b9aa39d68a8">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0xLTEtMS01OTQ3Mg_2bfb272f-b751-4453-a397-80ad860341e7">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0zLTEtMS01OTQ2Nw_89d800ef-9098-4016-a696-2d3c505fee47">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:EquityInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0xLTEtMS0yNzI5NQ_688fb3f1-6891-4624-aa5f-51a622d1bd5a">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:EquityInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0zLTEtMS0yNzI5NQ_4ee5cf17-ef5f-429a-a6cf-a26c72c460b2">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNC0xLTEtMS0yNzI5NQ_40d479af-5375-4e19-b9fb-c28741416a3c">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNC0zLTEtMS0yNzI5NQ_3b4f6f49-6449-42b6-a88d-d40db066c8b3">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNS0xLTEtMS0yNzI5NQ_a0c915e3-3115-40fe-a4a4-c1852d75b0be">959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNS0zLTEtMS0yNzI5NQ_a9d04cd8-7089-40f6-b29c-6783d2f05b3b">776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNi0xLTEtMS0yNzI5NQ_3b35026c-b8cc-4126-a793-9c73c0050dfe">4,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNi0zLTEtMS0yNzI5NQ_256943d6-a0a4-4acc-9e67-c79da2a493cf">4,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzc1_ca681f47-f258-445b-909b-69ded5697847" escape="true"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMS0xLTEtMS0yNzI5NQ_16fe1343-7f0c-41fc-b569-e0e1e1d8414c">2,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMS0zLTEtMS0yNzI5NQ_fee2a9ab-edc7-4191-992c-2ccd2b07b926">2,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMi0xLTEtMS0yNzI5NQ_a9362ee0-c303-43c3-a55c-d4acad163df4">843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMi0zLTEtMS0yNzI5NQ_e7e1dc6a-565b-421f-b580-364f4791ebb3">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMy0xLTEtMS0yNzI5NQ_cefc409a-1bb5-4dfa-a554-4fb83b0a7292">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMy0zLTEtMS0yNzI5NQ_f975dea1-7408-407c-a985-83b95ab91769">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNC0xLTEtMS0yNzI5NQ_ccd93cc5-1c1d-403d-a822-6cae98453c36">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNC0zLTEtMS0yNzI5NQ_f0af96f4-3f33-45cb-b804-ec416cd0406c">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0xLTEtMS01OTQ3OQ_b7426c59-5c09-4d86-94ed-c1dfc358b57a">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0zLTEtMS01OTQ5Ng_3379f054-85f9-4c96-baf8-55a6ea66d96a">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0xLTEtMS0yNzI5NQ_8daa6ffb-61d1-43ae-8cca-9cd24bd9b04e">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0zLTEtMS0yNzI5NQ_79f31f7c-1a19-4854-a7f3-34f6691e6170">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNi0xLTEtMS0yNzI5NQ_16e98168-0058-492d-82ba-14568f20337e">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNi0zLTEtMS0yNzI5NQ_44fe89b0-defd-486e-8526-60c70bdb1242">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNy0xLTEtMS0yNzI5NQ_1d8fcaf6-fe0a-4310-954d-d69e49367222">4,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNy0zLTEtMS0yNzI5NQ_75b6078e-00c4-4de8-b88e-a061a2532f00">5,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4f95ea8a0ce1484b8e879e194c3ccb2a"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzcw_18554a1e-2616-48b4-b4d8-666c2772c1aa" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMS0xLTEtMS0yNzI5NQ_14bcae9e-8554-466f-b6da-cfefc0612021">5,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMS0zLTEtMS0yNzI5NQ_c7dc7366-69e7-4a13-8109-309565a71a61">6,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMi0xLTEtMS0yNzI5NQ_abc10ec9-2c57-425e-bbea-589bb8abf8c5">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMi0zLTEtMS0yNzI5NQ_413be784-bb7e-485f-8d62-93dba4765ad1">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMy0xLTEtMS0yNzI5NQ_bce25b45-f131-4fb6-bdb3-932e3cabecbc">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMy0zLTEtMS0yNzI5NQ_6e61fb0e-0fc5-4dd3-85fe-04c8427dab32">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNC0xLTEtMS0yNzI5NQ_90a7f424-ebe4-4629-bbdb-c15651e57bc1">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNC0zLTEtMS0yNzI5NQ_6f130165-788a-4412-8aef-5a734d6b80ad">1,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNS0xLTEtMS0yNzI5NQ_ebe525a5-b2e5-4283-89b5-b8ea9ff9c091">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNS0zLTEtMS0yNzI5NQ_58ff674e-743b-4632-b083-4de8ba3bbdff">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNi0xLTEtMS0yNzI5NQ_fdccaa1b-bf8e-49bc-8dee-b64a2c01fcd6">356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNi0zLTEtMS0yNzI5NQ_b127a9f8-bd2a-454f-ab91-1d69a0798855">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNy0xLTEtMS0yNzI5NQ_a183a756-43c8-4d2e-a7b9-f796472d53c8">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNy0zLTEtMS0yNzI5NQ_98ed966d-39a8-4679-a86c-19ef63a998a6">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfOC0xLTEtMS0yNzI5NQ_c07ec80e-3585-4633-a553-192e3fd63806">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfOC0zLTEtMS0yNzI5NQ_af22ff9c-c150-4ddd-9ab9-1f0e6af0301f">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTAtMS0xLTEtMjcyOTU_505f5b80-e1fc-4978-9a81-79d613b58ea9">1,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTAtMy0xLTEtMjcyOTU_05757552-0682-409e-b411-92e3131ee5bc">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTEtMS0xLTEtMjcyOTU_31548193-821c-4eb9-853b-6a21663ab9ad">12,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTEtMy0xLTEtMjcyOTU_5bb48fb5-0e2f-432b-ac30-ebe27f80c7e6">13,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzgz_2a9e1126-0998-4904-949c-5de9f58b95f1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMS0xLTEtMS0yNzI5NQ_b23950c0-e5fd-47c3-9bc7-43f677505231">4,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMS0zLTEtMS0yNzI5NQ_52b42b61-dade-4c93-94d7-9ca862573d7b">4,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMi0xLTEtMS0yNzI5NQ_f0d0ec68-7082-4e73-a39e-f3163d8cd74a">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMi0zLTEtMS0yNzI5NQ_43e24499-a028-4b7e-98eb-868cd3cf124d">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMy0xLTEtMS0yNzI5NQ_0fcc70b6-10a5-4f4c-a836-38a9286d6ba9">852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMy0zLTEtMS0yNzI5NQ_2ac7cda1-39d5-4aac-acf2-1d219263acbd">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNC0xLTEtMS0yNzI5NQ_b2376698-e486-4887-89b4-e74a21527961">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNC0zLTEtMS0yNzI5NQ_715b7f61-aeee-4f65-8467-ba548ce512a3">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNS0xLTEtMS0yNzI5NQ_d4ac5434-b16e-47d5-870c-78d42bdeb4fe">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNS0zLTEtMS0yNzI5NQ_33a23102-6378-43c2-8cbd-1f28041e420f">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNi0xLTEtMS0yNzI5NQ_d44cd371-ee55-4f5b-be9d-dc8618673af4">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNi0zLTEtMS0yNzI5NQ_4c172e14-4b7e-4ddd-b71d-9b6a52c01dee">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNy0xLTEtMS0yNzI5NQ_475e5b17-f8d9-4b11-9716-b2a0cec63a33">7,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNy0zLTEtMS0yNzI5NQ_08ae21ee-af39-4d4c-a611-54c454d389ab">7,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjA5NA_725ece5f-5d44-43bd-a7a7-8ac681e43da2" continuedAt="ia014ae1f1c6643e0b5695706b91d8467" escape="true">EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ia014ae1f1c6643e0b5695706b91d8467" continuedAt="i15cf5217062d4b09ae5c4b26aa80c9dc"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjA4Mg_19d2731a-d1af-4ae8-a7d3-f31fb0639cb2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.660%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i697dadbed2b44257b50760bc65e2719b_I20211231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xLTEtMS0yNzI5NQ_740d393a-815f-4475-9862-aa780334344b">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i697dadbed2b44257b50760bc65e2719b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0zLTEtMS0yNzI5NQ_c32e1875-1da3-4d69-aa5d-263b24991b8b">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c750c097be14ed1b3f961e0ba4d7de3_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi01LTEtMS0yNzI5NQ_9fe74e7c-5b69-48f1-9d81-61b6a3fe69ec">44,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92f35f33ac5447c685cb91ab35c69fc2_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi03LTEtMS0yNzI5NQ_6a63456a-efc4-4d5d-81d9-5a47a4d8b4b8">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b2566864734436ac9a373ddafbcbb0_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi05LTEtMS0yNzI5NQ_49b6e827-cb89-4df3-8849-919af1e835b0">23,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i608fa9b9ad254f68bd39d1a463a30350_I20211231" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xMS0xLTEtMjcyOTU_d941bd55-7946-4efe-b685-37f4c0a703d0">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i608fa9b9ad254f68bd39d1a463a30350_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xMy0xLTEtMjcyOTU_a61ca77d-d6b1-4eb7-a533-e233b8c07b62">31,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c3e82138344640a0c4435cba106ff5_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xNS0xLTEtMjcyOTU_dd825ab1-bda9-4bd8-af0c-b251b74b1044">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78f12ffadf16415ea1fe727617391027_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMy05LTEtMS0yNzI5NQ_6e9381a2-a9da-48a6-bdc0-4a4d0d5e1a9a">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2dda1e1a844b94a00d230f1dc9a71b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMy0xNS0xLTEtMjcyOTU_66662785-27ea-41bc-96ef-5029a1e87b7d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0aa70f8ef374fb39ffdf7368e669776_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNC03LTEtMS0yNzI5NQ_ff474faf-6b5e-480e-8b29-8aed5dc10eb2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78f12ffadf16415ea1fe727617391027_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNS05LTEtMS0yNzI5NQ_91c16133-39a1-4171-8641-ce5899a28fcf">1,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67fdaace616b4f16855ab0159be80320_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNi01LTEtMS0yNzI5NQ_203c2e37-ad17-4add-86e0-ec354968c897">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNi0xMS0xLTEtMjcyOTU_9fee33db-6c08-4605-828d-5dc9e316bcac">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNi0xMy0xLTEtMjcyOTU_7df9e593-557a-4bf3-a1e5-ed0f8ae56d05">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67fdaace616b4f16855ab0159be80320_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNy01LTEtMS0yNzI5NQ_0abbd69d-eb02-48d4-bd54-c8be40892e3a">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNy0xMS0xLTEtMjcyOTU_087abe00-9548-4b4b-b52b-4028a0077a09">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNy0xMy0xLTEtMjcyOTU_86df7de6-d80f-49af-8533-bfa4e897b01a">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f0491e5151b468687df3f28023d25c1_I20220331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xLTEtMS0yNzI5NQ_529593de-40b6-47bf-b663-44726604227f">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0491e5151b468687df3f28023d25c1_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0zLTEtMS0yNzI5NQ_c7128c77-e182-4b67-a4b5-604c145b938b">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b25fb727064bc7a48b809cd18417d0_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS01LTEtMS0yNzI5NQ_ab918149-3ee6-4fab-9619-e1a18bee5889">43,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25d5887cf1864cefa96ae37a8e8e1c96_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS03LTEtMS0yNzI5NQ_29cbb5f9-9e4d-4bd0-ac39-7647fd4b7f76">1,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2feca3e743478f9a47b2a58c1a227c_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS05LTEtMS0yNzI5NQ_b5284073-629b-4424-a88e-e521e87d443d">23,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied7d3446ea3641d08fb57b9e5e60c00f_I20220331" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xMS0xLTEtMjcyOTU_dec90457-b931-463f-ac1d-bed8644ba980">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied7d3446ea3641d08fb57b9e5e60c00f_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xMy0xLTEtMjcyOTU_e90c7e0d-7b18-4bfa-b3d7-7efd7737031e">35,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ee78978c0642dabebb87cbae54be3f_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xNS0xLTEtMjcyOTU_9208b1db-f336-41e4-8750-4bcecb99dd54">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $<ix:nonFraction unitRef="usdPerShare" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjE5OTAyMzI1Nzc2OA_bfa4464a-b7ef-4944-9829-4f6f512a5c86">0.54</ix:nonFraction> for the three months ended March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.660%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f9303f5188c4013be07916ae2eca837_I20201231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xLTEtMS0yNzI5NQ_57d03837-8acb-4997-8b22-367853ea4045">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9303f5188c4013be07916ae2eca837_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0zLTEtMS0yNzI5NQ_0313a45c-a6dc-4408-b926-2f060bb3ef45">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f0dedce40941d2abd5021b6192fa7a_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi01LTEtMS0yNzI5NQ_2521fdf6-a743-4f0f-b385-fbac8f6d2adb">44,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd70bdc8a914f2e8317196accc17156_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi03LTEtMS0yNzI5NQ_20a85a3e-0388-46db-9f2f-7d4daef0ae9a">1,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452639b46024f62a782fd7dd48397d9_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi05LTEtMS0yNzI5NQ_a3de8c21-5f76-4536-92b8-b2547ab98d10">21,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd355c9ad4e04db9835b36253ee62303_I20201231" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xMS0xLTEtMjcyOTU_3e480ec4-5eab-49e8-80b3-61e2e098276b">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd355c9ad4e04db9835b36253ee62303_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xMy0xLTEtMjcyOTU_989cdba6-8aaa-4065-8300-e869fbc67430">26,237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c155c4e22f470f85c6fe894ca67745_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xNS0xLTEtMjcyOTU_c371ff97-d761-415f-bedd-4b96cc66f093">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aadaa427a1f4883932758e3886fc82d_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMy05LTEtMS0yNzI5NQ_45e323c0-1aa3-4de6-8d5b-6cb6a15e4078">2,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b408d47b276475ab6ccab44f5ca4af1_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMy0xNS0xLTEtMjcyOTU_d371e31f-c1c0-45a3-8d7e-5e6c2326e73d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c2ec55ae104cb1a3d45c1093330949_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNC03LTEtMS0yNzI5NQ_2a608795-360e-4c15-819e-d23e9e1ce87e">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aadaa427a1f4883932758e3886fc82d_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNS05LTEtMS0yNzI5NQ_1dcda713-94b3-47d1-a1fa-44ce278eb96c">1,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNi0xMS0xLTEtMjcyOTU_45b385c7-6262-4a3f-9fc7-e3d53dd0f5db">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNi0xMy0xLTEtMjcyOTU_c896c781-568b-4532-abb8-4882f3a17d44">1,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1685419f0f5b445ebf4b83320b185816_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNy01LTEtMS0yNzI5NQ_9cb9d2e8-4f3e-49bb-816e-b31a68c1dca2">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNy0xMS0xLTEtMjcyOTU_3a101a7e-30bc-42b0-b58e-fe2e592dffdd">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNy0xMy0xLTEtMjcyOTU_94a137dd-751d-4970-b955-a80184fa278a">806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4e8bafee98c40e1af0ea0c26079e6d5_I20210331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xLTEtMS0yNzI5NQ_24550c7a-d34a-42ac-aaea-b67e244fb7f5">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e8bafee98c40e1af0ea0c26079e6d5_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0zLTEtMS0yNzI5NQ_eca59feb-4075-4d48-a4ae-df3a96f24afc">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc410e277f944d999382cf1f25d8280_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS01LTEtMS0yNzI5NQ_7c56f0b1-b131-4cd7-a1cb-1f2d9aed3e23">43,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f83b09252a4c5186eac51e8b3c4f10_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS03LTEtMS0yNzI5NQ_7f4a6d0b-94ab-45fe-bb07-b48503b80f5c">1,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486782a204b048d79c8c4b6688f16ddb_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS05LTEtMS0yNzI5NQ_62355dcf-e4cd-4e5c-b17e-fa6727838c74">22,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaf77c8298f84b9ca929be543d0bdf11_I20210331" decimals="-6" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xMS0xLTEtMjcyOTU_01af6238-1e8a-476b-89c9-a53dba734d1d">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaf77c8298f84b9ca929be543d0bdf11_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xMy0xLTEtMjcyOTU_3e08f3b7-0731-4fe9-bb01-cba0c0c38896">27,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e06670aa924cd2a542b65a45076e7f_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xNS0xLTEtMjcyOTU_5631bab3-0443-4ff4-880f-85050e3d3e83">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $<ix:nonFraction unitRef="usdPerShare" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjE5OTAyMzI1Nzc2NA_de11a6ee-456b-4895-82d2-9332538e7aaf">0.49</ix:nonFraction> for the three months ended March&#160;31, 2021.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i15cf5217062d4b09ae5c4b26aa80c9dc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding share repurchase authorization under the program was approximately $<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfODg1_cca37af9-b4a1-4839-b1e0-38da2e19d33c">15.2</ix:nonFraction> billion as of December 31, 2021. In the three months ended March, 31, 2022, BMS executed accelerated share repurchase ("ASR") agreements to repurchase an aggregate $<ix:nonFraction unitRef="usd" contextRef="i893daceb21d24a07803ca9c59fb74f4f_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTA5OTUxMTYzNzA1OA_7f5d755c-9b86-45c6-ba4e-3b61559ac1fe">5.0</ix:nonFraction>&#160;billion of common stock. These ASR agreements were funded with cash on-hand and are expected to settle during the second and third quarters of 2022. Approximately <ix:nonFraction unitRef="shares" contextRef="ia1153bc1078943e684090d6448e72a28_D20220101-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTA5OTUxMTYzNzIxNw_07474c7c-f5e8-4c26-8658-78174ba450b4">65</ix:nonFraction>&#160;million shares of common stock (85% of the $<ix:nonFraction unitRef="usd" contextRef="i893daceb21d24a07803ca9c59fb74f4f_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTA5OTUxMTYzNzI1Ng_2c355528-628a-4b22-92f2-40c970358c92">5.0</ix:nonFraction>&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. The total number of shares to be repurchased under the ASR agreements will be based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements. The remaining share repurchase capacity under the share repurchase program was approximately $<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTIwNQ_2f99791b-be1b-4be3-8631-295a5842c255">10.2</ix:nonFraction> billion as of March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS repurchased <ix:nonFraction unitRef="shares" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTIzNQ_d96e93fd-3b45-4858-a2f9-9eb872b2ddd3">28</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTI2OQ_9335c82f-998a-431a-9eb4-abffa9eec3f2">1.8</ix:nonFraction>&#160;billion in the three months ended March&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjEwOA_81f1d0ba-f96e-4981-a8b0-afc08e3c11d7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC0xLTEtMS0yNzI5NQ_86a08e23-d60d-4414-80e4-2b34d6aa09e2">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC0zLTEtMS0yNzI5NQ_bdd0af73-50b5-4d6c-a7fb-25baf368d5d3">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC01LTEtMS0yNzI5NQ_c9afc525-3165-4a3c-8026-6fa9246c4370">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC03LTEtMS0yNzI5NQ_e6beda4c-a7e6-4b7c-9437-0fcffd83db05">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC05LTEtMS0yNzI5NQ_ff2e1cd1-6d55-42ab-b376-c63438592088">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC0xMS0xLTEtMjcyOTU_4acfcebf-51c3-4cea-a7b5-e9ec025e0303">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS0xLTEtMS0yNzI5NQ_324c607b-0e49-4798-a6f1-d889ccd08111">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS0zLTEtMS0yNzI5NQ_51a6f523-6cef-45dd-b44a-a26086db88ea">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS01LTEtMS0yNzI5NQ_17e977a7-5747-4523-b8b0-7641f1750902">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS03LTEtMS0yNzI5NQ_9f07cd1d-2336-4fce-92a7-7a902f81f947">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS05LTEtMS0yNzI5NQ_1229b0b0-6ff9-4cd4-8258-cd037a186c4e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS0xMS0xLTEtMjcyOTU_67295899-6446-4391-981c-68f17b88b491">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi0xLTEtMS0yNzI5NQ_a330dd88-0373-42c3-a969-57b37b76fcbf">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi0zLTEtMS0yNzI5NQ_768ee582-f4e5-40a7-82f5-2e2e4e178ef9">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi01LTEtMS0yNzI5NQ_30910c64-3d82-445d-aa45-3f4430d65020">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi03LTEtMS0yNzI5NQ_6b502cae-a897-4cc8-9d12-13486349ea62">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi05LTEtMS0yNzI5NQ_24f9c63d-7983-4c48-9eb6-885ed1dd345a">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi0xMS0xLTEtMjcyOTU_edf78902-9235-4b1d-a992-6c91968e355c">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS0xLTEtMS0yNzI5NQ_792d4fff-839b-4ad1-b994-39d1acd3819c">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS0zLTEtMS0yNzI5NQ_43b75118-54ff-49c9-a6ba-8a1ba01e2f15">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS01LTEtMS0yNzI5NQ_0df9380c-efeb-4d2e-bbc9-961ea56373af">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS03LTEtMS0yNzI5NQ_54bce399-a147-4422-ba79-4eb1755be598">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS05LTEtMS0yNzI5NQ_e0648a33-255e-470c-b038-45135aa42605">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS0xMS0xLTEtMjcyOTU_c4719a83-1819-41b4-bdbf-299ce18b6b94">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtMS0xLTEtMjcyOTU_44ccb393-bf1b-427c-b200-d86d45621b3d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtMy0xLTEtMjcyOTU_ff4d3af7-2a3b-47cf-a7c9-dc27c55ef10b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtNS0xLTEtMjcyOTU_4440e135-1b24-444b-a6e5-a0a5ff7b8e8d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtNy0xLTEtMjcyOTU_321f20c4-a6a9-4a4c-849c-3c2e033e2fb8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtOS0xLTEtMjcyOTU_dd889fd5-9f26-428b-a8ba-6e4d55101441">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtMTEtMS0xLTI3Mjk1_36b42f24-e6b4-402b-8f98-bb3a5edfee68">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtMS0xLTEtMjcyOTU_77ff2abb-a4b6-4069-906b-d24b1fe94aaa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtMy0xLTEtMjcyOTU_00a6206e-7f46-4cd2-8ed8-2c6f60d30462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtNS0xLTEtMjcyOTU_4f67d2ea-7382-4e93-9376-886d60574d83">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtNy0xLTEtMjcyOTU_80a7dd8b-1fe3-48d8-b05a-68b47d83ca27">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtOS0xLTEtMjcyOTU_ffcb311a-6cf6-4a68-9772-23e6f63d8de2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtMTEtMS0xLTI3Mjk1_11d6fcf9-c00e-4619-aa44-cd71bf673806">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItMS0xLTEtMjcyOTU_b0a0b982-750a-4e06-b121-471592e36ebd">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItMy0xLTEtMjcyOTU_3b87e772-dc34-433d-83fc-31c17937c89e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItNS0xLTEtMjcyOTU_e2881945-3c17-4184-b0ce-245bdc30a77d">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItNy0xLTEtMjcyOTU_cfcda4c0-1108-46f0-970e-46f91b721138">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItOS0xLTEtMjcyOTU_3d4db5a8-c973-4c2f-895a-6b8524a330c8">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItMTEtMS0xLTI3Mjk1_42e97db9-4181-4b58-bffb-adb5d70ffc87">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtMS0xLTEtMjcyOTU_ef295358-f579-4c75-83c2-acea72096225">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtMy0xLTEtMjcyOTU_8b13bb7f-06f9-4b8e-be85-3d9b18054de0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtNS0xLTEtMjcyOTU_4d2fd180-82c4-4ca1-9875-c2532b573008">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtNy0xLTEtMjcyOTU_9736ff6b-b8d0-4cf2-9ae2-61d03e592ae6">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtOS0xLTEtMjcyOTU_739a8df2-1ed6-484d-bf45-f8d278f18a2e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtMTEtMS0xLTI3Mjk1_32fd842f-b829-4446-955f-516a657d20b3">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctMS0xLTEtMjcyOTU_f04d1ae1-f225-4fc5-9f29-1c3eae7a2985">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctMy0xLTEtMjcyOTU_2cf72b1f-3d37-4133-9982-7f684a1f358e">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctNS0xLTEtMjcyOTU_e69a2557-3f73-4d05-b1ea-9849cb4224eb">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctNy0xLTEtMjcyOTU_20638f70-0714-48b2-b0d0-77af2152f8e6">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctOS0xLTEtMjcyOTU_a0c1a134-9e46-404e-b33a-70af0e3b97be">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctMTEtMS0xLTI3Mjk1_26635677-b90e-42f8-9c7d-d1e9aa7f15a4">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktMS0xLTEtMjcyOTU_2cd18ae7-8c1d-4dbd-87c2-9cd3a408c19e">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktMy0xLTEtMjcyOTU_b2826b83-762a-40e2-8a91-ff1d09968e0c">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktNS0xLTEtMjcyOTU_928e9e66-b829-458c-8e32-7227b0e1ceb0">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktNy0xLTEtMjcyOTU_c3cf775e-55b9-4a9c-bc66-741f7e3361f8">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktOS0xLTEtMjcyOTU_56e90117-29f6-45e2-bf8e-1ed3cc1b47d1">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktMTEtMS0xLTI3Mjk1_61d5f227-0042-41a6-a466-08e27837d3ac">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjEwNw_2437a561-7799-421e-a29b-f9bc39cffd5b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMS0xLTEtMS0yNzI5NQ_5ad599ee-107d-4ca5-a8e0-f36b3640749a">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMS0zLTEtMS0yNzI5NQ_c37aed12-c2df-4dbf-9b9b-b5332cdb1b97">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMi0xLTEtMS0yNzI5NQ_3a717885-820f-45f6-b354-608771bbb940">747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMi0zLTEtMS0yNzI5NQ_c1ce77c3-496c-432c-94d6-c0849d2acaf9">768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMy0xLTEtMS0yNzI5NQ_2b5498f9-21f1-493c-9c1d-688e8afe407e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMy0zLTEtMS0yNzI5NQ_cab9463d-4e81-4cf1-bc9a-d2c78b658bad">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNC0xLTEtMS0yNzI5NQ_75c0dfe0-19c5-4e60-8d53-69d8b8ab3261">692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNC0zLTEtMS0yNzI5NQ_966b9b9c-e8ab-4b75-b841-7526524e0af1">680</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNS0xLTEtMS0yNzI5NQ_dce9a5f3-16eb-4f2b-8de9-544cc633229e">1,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNS0zLTEtMS0yNzI5NQ_2052b2f4-cc78-443f-915b-0cadf58ea163">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ide471947286340dd92506f80fe047642_82"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDAy_472b8173-27a6-470e-9c31-0721182143f4" continuedAt="i3c908a1a40744418a2927f747afa98d5" escape="true">EMPLOYEE STOCK BENEFIT PLANS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i3c908a1a40744418a2927f747afa98d5"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDA0_cc35419f-5684-4d92-aba9-f1b4cd27e5ca" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa2fd0728f24dffbe302d8dc80f1127_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMi0xLTEtMS0yNzI5NQ_0d15a6e9-174e-40a5-8427-8acc27fe5151">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec5dffc23244b5680735c1a0cc27bf5_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMi0zLTEtMS0yNzI5NQ_a7c2f6c8-574d-4000-b2e1-d839e8298bac">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i089a12daf0d440d892db99bd3cdae571_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMy0xLTEtMS0yNzI5NQ_c0825b2a-3a86-4102-add7-5077511de426">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8081637c0eb14bdbb47de184d2f39db5_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMy0zLTEtMS0yNzI5NQ_21615c31-8c35-4cbb-b39e-b9e47a5e34fd">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdcc9669f9ef4756ab04f684b3f2016f_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNC0xLTEtMS0yNzI5NQ_c9383b63-b3dd-4aa8-bb5a-5ee170e3f291">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd031bc2a3194da4930ebfbe59a6c5fa_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNC0zLTEtMS0yNzI5NQ_088a6fec-719d-42ed-b81d-82a1275bba6d">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b1a43d479945f78f6ba2f8ef93edae_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNS0xLTEtMS0yNzI5NQ_94e4588f-9e37-46ef-94fb-d35496070bc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a4494aa926f4aafb4d4f13e1bc379c0_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNS0zLTEtMS0yNzI5NQ_2e7f6c0e-2b74-4925-83c1-7fa515521889">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNi0xLTEtMS0yNzI5NQ_ed041e76-1f4a-4605-8dc4-4df3b48f403e">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNi0zLTEtMS0yNzI5NQ_4eff98d1-d2d7-4527-8059-6af793e4563c">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfOC0xLTEtMS0yNzI5NQ_130868a9-ee14-4500-a23c-2a013d74ccab">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfOC0zLTEtMS0yNzI5NQ_36c3cc96-7019-4e09-a9c1-f7dfef90f243">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $<ix:nonFraction unitRef="usd" contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfMjE3_192f2583-aacb-4bcc-a91d-20c40bf3b792">40</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfMjI0_1e5d25ba-e662-41ef-88af-c5f615464970">17</ix:nonFraction> million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDA2_39283e65-59f3-4fd5-852b-3961600e33f2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07493150d868420687804e8b350888ae_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMi0xLTEtMS0yNzI5NQ_3a2553a7-a8eb-4e82-9cdf-273f60c58e75">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07493150d868420687804e8b350888ae_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMi0zLTEtMS0yNzI5NQ_80349bb0-140e-4b05-96ce-85533128b3d6">63.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMy0xLTEtMS0yNzI5NQ_5504f1d0-eed4-4ef0-b35a-aa5b9b493544">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMy0zLTEtMS0yNzI5NQ_07cac7f7-e401-4261-a5df-2aaa380d60ed">60.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfNC0xLTEtMS0yNzI5NQ_8817fbd9-9f24-4a9f-9bd0-4507fc0eb88e">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfNC0zLTEtMS0yNzI5NQ_f795824f-9c48-407e-b92f-61e086d0a0bf">66.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDAx_caf05ce7-06b1-4d37-b3f4-bf1a40e29e94" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:50.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d74d60f32f84b198678df8d911c9b3c_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS0xLTEtMS0yNzI5NQ_c1244acc-644c-477e-b9ef-85b5fd9ff9a2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590050289ff34ed9b5d3577bac6f2c84_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS0zLTEtMS0yNzI5NQ_a8cd6272-d497-4a15-b112-fa494975db8f">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8394f86b214f7d9f855003ba6e8de0_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS01LTEtMS0yNzI5NQ_e5018af2-5ae5-43d1-ba67-9a28b7258d82">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c7bf5611944b89b000936b86b2afff_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS03LTEtMS0yNzI5NQ_cfcdbe57-d323-4690-895f-a4ea5982ca66">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ccde1b9c7584766b2b7209f2916527d_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi0xLTEtMS0yNzI5NQ_349df3ef-1327-4978-be2b-ef4c15f1abd1">0.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07493150d868420687804e8b350888ae_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi0zLTEtMS0yNzI5NQ_94a3a2b9-5d2d-4f0b-a5d1-ebf0c920f038">3.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi01LTEtMS0yNzI5NQ_8c5068c7-dbd4-4150-9e46-2d09af051858">3.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi03LTEtMS0yNzI5NQ_f3bba49a-ddc7-45e0-ab28-6755104c033a">2.2</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17. <ix:nonNumeric contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDI4Mzg_1d53567c-35d2-4b4d-b7ed-a24883f98223" continuedAt="i54e6dc9af5334058bc14a80e1c11e837" escape="true">LEGAL PROCEEDINGS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i54e6dc9af5334058bc14a80e1c11e837" continuedAt="ic358fd5fca6e4d0ea1680a7c25a2b91f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#8217;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#8217;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS&#8217;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see &#8220;&#8212;Note&#160;7. Income Taxes&#8221;.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic358fd5fca6e4d0ea1680a7c25a2b91f" continuedAt="i03eb4e595b62439fa74475f8c33e9281"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 and Anti-PD-L1 Antibody Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute (&#8220;Dana-Farber&#8221;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to <ix:nonFraction unitRef="patents" contextRef="i9d9865ddc7954c648849d381362ca98e_D20150901-20150930" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMjY4NA_39453b51-4535-4e70-9bc9-ed50eb773a93">six</ix:nonFraction> related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber&#8217;s claims for damages before May 17, 2019&#8212;the date of the District Court&#8217;s ruling that Dana-Farber was a co-inventor of the patents&#8212;are preempted by federal patent law. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd ("AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR T</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#8220;SKI&#8221;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#8220;Kite&#8221;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 Patent&#8221;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#8217;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#8217;s defenses, finding that Kite willfully infringed the &#8217;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $<ix:nonFraction unitRef="usd" contextRef="ib14a424b066040b5bef8059066e64306_D20191201-20191231" decimals="-6" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDY1NQ_f61ab3f3-69ad-4f16-ac1f-e743a34d908e">585</ix:nonFraction> million up-front payment and a <ix:nonFraction unitRef="number" contextRef="i6d6fa7d30f14437eaa258bc9961b99aa_I20191231" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDY4MA_a7ef0793-5541-4308-ad56-8fe6d88bf726">27.6</ix:nonFraction>% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the &#8217;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#8217;s motions in their entirety. In April 2020, the Court granted in part Juno&#8217;s motion and entered a final judgment awarding to Juno and SKI approximately $<ix:nonFraction unitRef="usd" contextRef="i9446604f2db5490f98213dcf99cf2ac0_D20200401-20200430" decimals="-8" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNTIxNA_39da3860-308b-48ad-9478-04f570943477">1.2</ix:nonFraction> billion in royalties, interest and enhanced damages and a <ix:nonFraction unitRef="number" contextRef="i43df7495f1924291aea1c8aaa040cf1e_I20200430" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNTI2Nw_7ea62269-087b-4e5c-95b2-ba999c8baff7">27.6</ix:nonFraction>% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the &#8217;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the &#8217;190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing which the Federal Circuit denied on January 14, 2022. Juno and SKI intend to file a petition for a writ of certiorari with the U.S. Supreme Court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Europe</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2020 and January 2021, Sandoz Limited (&#8220;Sandoz&#8221;) and Teva Pharmaceutical Industries Ltd. (&#8220;Teva Limited&#8221;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate (&#8220;SPC&#8221;). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgement issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. We disagree with the ruling and plan to appeal the decision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are similar lawsuits filed in France, Italy, the Netherlands, Portugal, the Republic of Ireland, and Sweden seeking revocation of a composition of matter patent relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, Sandoz informed BMS that it intends to launch its generic apixaban product in the Netherlands as soon as possible. In response, we have requested that the Dutch court issue a preliminary injunction to prevent any infringement of the Dutch apixaban composition of matter patent and related SPC as long as the patent and SPC are in force.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents may be filed in various countries in Europe in the coming months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an aNDA containing a paragraph IV certification seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging the one FDA Orange Book-listed formulation patent expiring in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. No trial date has been scheduled.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i03eb4e595b62439fa74475f8c33e9281" continuedAt="ifad3ad43cecb4c769802217510fd8017"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#8220;GenRx&#8221;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#8220;GenRx-Apotex&#8221;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#8217;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#8217;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#8220;Full Court&#8221;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to <ix:nonFraction unitRef="aud" contextRef="i733d93df91dc48439bdd9ef3a9e1b05a_D20100301-20100331" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfOTkyNg_62b86fd7-e3d6-49bb-86bf-8ed5fbfc48d3">449</ix:nonFraction> million AUD ($<ix:nonFraction unitRef="usd" contextRef="i3006be3445994b7b9d2b9407bafa2026_D20220101-20220331" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfOTkzNA_7038ef21-14d0-4a43-93b8-4c040eb08e97">337</ix:nonFraction> million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#8217;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#8217;s decision and an appeal hearing concluded in February 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Celgene received a Notice Letter from MSN Laboratories Pvt. Ltd. (&#8220;MSN&#8221;) notifying Celgene that MSN had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against MSN in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene has received a Notice Letter from Alembic Pharmaceuticals Limited, Alembic Global Holding SA, and Alembic Pharmaceuticals, Inc. (&#8220;Alembic&#8221;) notifying Celgene that Alembic had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against Alembic in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. Alembic has filed answers and counterclaims alleging that the asserted patents are invalid and/or not infringed. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray") notifying BMS that Xspray had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC (&#8220;Actelion&#8221;), filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the &#8220;&#8217;867 Patent&#8221;). The Complaint alleges that the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringes certain claims of the &#8217;867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $<ix:nonFraction unitRef="usd" contextRef="id7c0db74c54043a48910aadd9e2028f4_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1OA_b06cf715-0470-4c9d-973c-ac4e7cecd25e">834</ix:nonFraction>&#160;million, with $<ix:nonFraction unitRef="usd" contextRef="i2b238679663048e29218b5914560ecea_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTc3MjA_5f7b3ab9-1be0-4851-896f-0d15ea03f50b">417</ix:nonFraction>&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. A trial in the New Mexico matter was previously scheduled for April 2022, but was adjourned due to statewide trial delays arising from the COVID-19 pandemic. Trial has been rescheduled for January 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifad3ad43cecb4c769802217510fd8017" continuedAt="i678dd0e68bec4b58b38bb729cfbda494"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. There have been over <ix:nonFraction unitRef="lawsuits" contextRef="i668ad442deb24bfd83ce136a88b8f854_I20220331" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTg1OTY_6af32cd7-8300-4278-a43c-2d709b4fedd4">2,500</ix:nonFraction> cases filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately <ix:nonFraction unitRef="lawsuits" contextRef="i668ad442deb24bfd83ce136a88b8f854_I20220331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberDismissed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTkxNTA_687277cc-06d9-47f6-8121-a9273f9fc841">2,700</ix:nonFraction> cases, comprising approximately <ix:nonFraction unitRef="numberofplaintiffs" contextRef="i668ad442deb24bfd83ce136a88b8f854_I20220331" decimals="INF" name="bmy:LossContingencyNumberOfPlaintiffsDismissed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTkxODU_549b2c08-2925-44fb-ae20-5bb454ef8ae0">3,900</ix:nonFraction> plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders. In the U.S., less than <ix:nonFraction unitRef="lawsuits" contextRef="iec03ab8dc1e74dc78cce7f33bcf80a19_I20220331" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTkzNTE_cd8b99ff-f00e-47f2-bce4-d894419c430f">five</ix:nonFraction> cases remain pending in state or federal courts (New Jersey and Massachusetts). There are <ix:nonFraction unitRef="lawsuits" contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTk1Mjk_fc6fa93f-763a-4e1a-9504-15353aef726a">eleven</ix:nonFraction> cases pending in Canada (<ix:nonFraction unitRef="lawsuits" contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1Mw_364e33ff-2c83-49d0-8479-d5b83925357f">four</ix:nonFraction> class actions, <ix:nonFraction unitRef="lawsuits" contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1NA_ed8fc5ff-5b2c-4640-8aca-fc4ab8047ca1">seven</ix:nonFraction> individual injury claims). Out of the <ix:nonFraction unitRef="lawsuits" contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTk2MjE_fc6fa93f-763a-4e1a-9504-15353aef726a">eleven</ix:nonFraction> cases, only <ix:nonFraction unitRef="lawsuits" contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331" decimals="0" name="bmy:LossContingencyPendingClaimsNumberActive" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1NQ_612471b6-586d-4aee-99ba-92455745821b">two</ix:nonFraction> are active (the class actions in Quebec and Ontario). Both class actions have now been certified and will proceed separately, subject to a potential further appeal of the Ontario class certification decision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Byetta*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta*.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This litigation involved lawsuits on behalf of plaintiffs, which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases are pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#8220;JCCP&#8221;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The orders will result in the dismissal of all claims alleging an injury of pancreatic cancer in the MDL and JCCP. Plaintiffs initially appealed the MDL order, but subsequently filed a motion to dismiss their appeal as to Amylin and Lilly. That motion to dismiss was granted on October 5, 2021 making the MDL decision final as to Amylin and Lilly. Plaintiffs may seek appeals in the JCCP. As of March 2022, Plaintiffs&#8217; counsel have submitted dismissals with prejudice in exchange for a waiver of costs on behalf of approximately 75% of the plaintiffs in the JCCP (including injury plaintiffs and spouse/beneficiary plaintiffs) alleging claims against Amylin and Lilly. Additional dismissals are anticipated. BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* to AstraZeneca in February 2014 as part of BMS&#8217;s global diabetes business divestiture and any additional liability to Amylin with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of April 2022, claims are pending in federal and NY state court on behalf of approximately <ix:nonFraction unitRef="numberofplaintiffs" contextRef="iee6991d7144c4ff5982b421baf4a28cc_D20220101-20220331" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMjIxNzE_3c443a34-e6a5-43f2-9dc0-48baa81e058b">252</ix:nonFraction> individuals who allege they ingested the product and suffered an injury. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all federal cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco (&#8220;JCCP&#8221;). In August 2021, the MDL and JCCP courts jointly heard evidence regarding the parties&#8217; motions to exclude general causation experts. On September 24, 2021, the JCCP court granted defendants&#8217; motion to exclude plaintiffs&#8217; only general causation expert and largely denied plaintiffs&#8217; motions to exclude defendants&#8217; general causation experts; on January 5, 2022, the MDL court likewise granted defendants&#8217; motion to exclude plaintiffs&#8217; expert and denied entirely plaintiffs&#8217; motions. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the 18 claims previously pending in California state court. As part of BMS&#8217;s global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i678dd0e68bec4b58b38bb729cfbda494" continuedAt="icb1c19dc87d44a3190cffab4e37d0e8d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BMS Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2018, two separate putative class action complaints were filed in the U.S. District for the Northern District of California and in the U.S. District Court for the Southern District of New York against BMS, BMS&#8217;s Chief Executive Officer, Giovanni Caforio, BMS&#8217;s Chief Financial Officer at the time, Charles A. Bancroft and certain former and current executives of BMS. The case in California was voluntarily dismissed. The remaining complaint alleged violations of securities laws for BMS&#8217;s disclosures related to the CheckMate-026 clinical trial in lung cancer. In September 2019, the Court granted BMS&#8217;s motion to dismiss, but allowed the plaintiffs leave to file an amended complaint. In October 2019, the plaintiffs filed an amended complaint. In September 2020, the Court granted BMS&#8217;s motion to dismiss the amended complaint with prejudice. The plaintiffs appealed the Court&#8217;s decision in October 2020. On March 11, 2022, the Second Circuit affirmed the dismissal with prejudice of the amended complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene Securities Litigations</span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2018, </span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#8220;Celgene Securities Class Action&#8221;). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#8217;s 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#8217;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the &#8220;Schwab Action&#8221;). In July 2020, the defendants filed a motion to dismiss the plaintiffs&#8217; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#8217; motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees&#8217; Retirement System in April 2021 (the &#8220;CalPERS Action&#8221;); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the &#8220;DFA Action&#8221; and the &#8220;American Century Action&#8221;), and GIC Private Limited in September 2021 (the &#8220;GIC Action&#8221;), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above Celgene Securities Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#8220;CVR Agreement&#8221;) entered into in connection with the closing of BMS&#8217;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#8220;diligent efforts&#8221; to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $<ix:nonFraction unitRef="usd" contextRef="ibe66d937c77841249eedd821c141f3ec_I20210630" decimals="-8" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk2NzQyNQ_54b3572e-f85c-41dc-a92f-625b9db0692f">6.4</ix:nonFraction>&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#8217; fees. BMS disputes the successor trustee&#8217;s allegations and filed a Motion to Dismiss on July 23, 2021. All discovery is stayed until there is a decision on the Motion to Dismiss.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icb1c19dc87d44a3190cffab4e37d0e8d" continuedAt="i647427ae31b7499e847e3bb5bc0dd873"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 relating to the joint proxy statement. That action later was consolidated with another action filed in the same court asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a) and 20(2) of the Securities Exchange Act of 1934. In asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the merger and persons who purchased CVRs for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a), and 20(a) of the Securities Exchange Act of 1934. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants have moved to dismiss the complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff has filed a motion to remand the action to the state court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene&#8217;s former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff has filed a motion to remand the action to the state court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above CVR Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIV Medication Antitrust Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and two other manufacturers of HIV medications are defendants in related lawsuits pending in the Northern District of California. The lawsuits, filed on behalf of indirect purchasers, allege that the defendants&#8217; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evotaz&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, violate antitrust laws. In July 2020, the Court granted in part defendants&#8217; motion to dismiss, including dismissing with prejudice plaintiffs&#8217; claims as to an overarching conspiracy and plaintiffs&#8217; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remain. In September and October 2020, two purported class actions were also filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. On September 22, 2021, two additional non-class action direct purchaser complaints were filed by a number of retail pharmacy and grocery store chains against BMS and two other manufacturers of HIV medications. These complaints make allegations similar to those raised in the other federal court cases and the New Mexico state court case described below. In October 2021 and March 2022, BMS entered into settlement agreements with the putative class of indirect purchasers and the putative class of direct purchasers, respectively. Both settlements are subject to court approval. In January 2022, BMS reached an agreement to settle the cases filed against it by the retail pharmacy and grocery store chains.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#8217; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. No trial date has been scheduled.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i647427ae31b7499e847e3bb5bc0dd873" continuedAt="i17869aee68164a7bb120194957470363"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, five additional non-class-action indirect purchaser cases were filed in the Northern District of California, and one additional non-class-action indirect purchaser case was filed in California state court naming BMS and two other manufacturers as defendants. These complaints make allegations similar to those in the other federal court cases. In February 2022, BMS reached a settlement agreement with one of the non-class-action indirect purchaser plaintiffs and in April 2022, two additional indirect purchaser plaintiffs filed non-class suits against BMS and other defendants. In total, there are now seven non-class action indirect purchaser cases pending against BMS among others. No trial date has been scheduled for these remaining cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana, Inc. (&#8220;Humana&#8221;) filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana&#8217;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#8217;s Racketeer Influenced and Corrupt Organizations Act. Humana subsequently dismissed its claims for breach of contract voluntarily. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. A trial has been scheduled for January 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#8217;s complaint makes largely the same claims and allegations as were made in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint, and the Court has stayed discovery pending adjudication of that motion. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, United HealthCare Services, Inc. (&#8220;UHS&#8221;), affiliates of which opted out of the first settlement in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation, filed a lawsuit against Celgene in the U.S. District Court for the District of Minnesota. UHS&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation in addition to certain claims regarding donations directed to copay assistance. The complaint purports to assert claims on behalf of UHS and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In December 2020, Celgene&#8217;s motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. In January 2021, Celgene filed a motion to dismiss UHS&#8217;s complaint, which the Court administratively terminated in June 2021 pending its decision on Celgene&#8217;s pending motion to dismiss Humana&#8217;s complaint. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#8220;HPI&#8221;), a Humana subsidiary, in Delaware Superior Court. Celgene&#8217;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#8217;s breach as well as a declaratory judgment. A trial has been scheduled for March 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Blue Cross Blue Shield Association (&#8220;BCBSA&#8221;) sued Celgene and BMS on behalf of the Federal Employee Program in the U.S. District Court for the District of Columbia. BCBSA&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In April 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i17869aee68164a7bb120194957470363" continuedAt="i76a6771d34ff42b2954d6808dc2f84d4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, BCBSM Inc., Health Care Service Corporation (&#8220;HCSC&#8221;), Blue Cross and Blue Shield of Florida Inc., and Molina Healthcare, Inc. (&#8220;Molina&#8221;) sued Celgene and BMS in a Minnesota state court. The complaint makes largely the same claims and allegations as were made in the class action litigation but adds allegations on behalf of HCSC only as to alleged off-label marketing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In September 2020, Celgene and BMS removed the action to the U.S. District Court for the District of Minnesota. In March 2021, that Court denied plaintiffs&#8217; motion to remand the action to state court, dismissed Molina for lack of personal jurisdiction and granted defendants&#8217; motion to transfer the action to the District of New Jersey. The case is now pending in the District of New Jersey. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, Cigna Corporation (&#8220;Cigna&#8221;) sued Celgene and BMS in the U.S. District Court for the Eastern District of Pennsylvania. Cigna&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. Cigna&#8217;s complaint purports to assert claims on behalf of Cigna and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser. In May 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In July 2021, Celgene and BMS removed the action to the U.S. District Court for the Northern District of California, and in January 2022, that court granted Molina&#8217;s motion to remand to San Francisco Superior Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, a group of plaintiffs&#8212;MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, &#8220;MSP&#8221;)&#8212;sued Celgene and BMS in the U.S. District Court for the District of New Jersey. MSP&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. MSP purports to pursue assignments from certain named and unnamed entities that allegedly purchased or otherwise provided reimbursement for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and/or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and purports to bring direct and indirect purchaser claims. In February 2022, MSP filed an amended complaint, adding claims arising from the Company's donations to charitable organizations, and adding those organizations as defendants. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BeiGene Arbitration Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2017, Celgene Logistics S&#224;rl (&#8220;Celgene Logistics&#8221;) and BeiGene, Ltd. (together with its assignees, &#8220;BeiGene&#8221;), entered into a License and Supply Agreement (the &#8220;LSA&#8221;) pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As has been disclosed publicly, BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSK Contract Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, &#8220;Plaintiffs&#8221;) filed a complaint against BMS, Celgene and Juno (collectively, &#8220;Defendants&#8221;) alleging that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least <ix:nonFraction unitRef="number" contextRef="i04d29be57add402ab3461c9dc80fe525_I20220401" decimals="INF" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk4MjExOQ_1e23f8a2-d8f2-47d4-82f8-15bcce6bfbb2">1.5</ix:nonFraction>% of worldwide sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs&#8217; claims. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#8217;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i76a6771d34ff42b2954d6808dc2f84d4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#8220;potentially responsible parties,&#8221; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $<ix:nonFraction unitRef="usd" contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDI0MTI_eecd706b-d072-4fa9-87ac-642dffee1826">89</ix:nonFraction> million at March&#160;31, 2022, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ide471947286340dd92506f80fe047642_88"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of results of operations and financial condition is provided as a supplement to and should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q to enhance the understanding of our results of operations, financial condition and cash flows.</span></div><div><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE SUMMARY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our principal strategy is to combine the resources, scale and capability of a pharmaceutical company with the speed and focus on innovation of the biotech industry. Our focus as a biopharmaceutical company is on discovering, developing and delivering transformational medicines for patients facing serious diseases in areas where we believe that we have an opportunity to make a meaningful difference: oncology (both solid tumors and hematology), immunology, cardiovascular and neurology. Our priorities are to continue to renew and diversify our portfolio through launching our new product portfolio, advancing our early, mid and late-stage pipeline, and executing disciplined business development. We remain committed to reducing our debt and returning capital to shareholders. For further information on our strategy, see &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations-Executive Summary-Strategy&#8221; in our 2021 Form 10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we received nine approvals for new medicines and additional indications and formulations of currently marketed medicines in major markets (the U.S., EU and Japan), including advancement in oncology through regulatory approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the first LAG-3 blocking antibody combination, for the treatment of unresectable or metastatic melanoma and of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in combination with chemotherapy for the treatment of NSCLC in the neoadjuvant setting. We continue to advance and invest in our cell therapy portfolio through the approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Japan for the treatment of multiple myeloma, the approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the EU for the third-line treatment of relapsed or refractory diffuse large B-cell lymphoma and the expansion of our manufacturing capabilities through the construction of new state-of-the-art cell therapy manufacturing facilities in Devens, Massachusetts and Leiden, Netherlands. We continue to expand our portfolio in immunology with an important opportunity for deucravacitinib, our TYK2 inhibitor, for the treatment of psoriasis and other diseases. In the cardiovascular space, we broadened our New Product Portfolio with the FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (mavacamten) in April 2022 for patients with symptomatic obstructive HCM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues increased by 5% for the three months ended March&#160;31, 2022 due to In-Line Products (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Opdivo)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and New Product Portfolio (primarily cell therapy products and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), partially offset by</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent LOE Products (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and foreign exchange impacts. The $0.30 decrease in GAAP EPS primarily resulted from specified items, including equity investment and contingent consideration fair value adjustments, partially offset by lower impairment charges and divestiture gains in 2022. After adjusting for specified items, non-GAAP EPS increased $0.22 as a result of higher revenues and lower weighted-average common shares outstanding, partially offset by Acquired IPRD.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, including non-GAAP earnings and related EPS information, are adjusted to exclude specified items that represent certain costs, expenses, gains and losses and other items impacting the comparability of financial results. For a detailed listing of all specified items and further information, reconciliations and changes to our non-GAAP financial measures refer to &#8220;&#8212;Non-GAAP Financial Measures.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ide471947286340dd92506f80fe047642_94"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic and Market Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, international, federal, state and local public health and governmental authorities have taken, and continue to take, a number of actions to limit the spread of COVID-19 and address related disruptions in the U.S. and global economy. While we continue to experience impacts on revenues from COVID-19 primarily due to lower new patient starts and patient visits, the pandemic has not significantly impacted our results of operations. The situation remains dynamic and it is difficult to reasonably assess or predict the full extent of the negative impact that the COVID-19 pandemic may have on our business, financial condition, results of operations and cash flows. The future financial and operational impact of the COVID-19 pandemic on BMS will depend on future developments such as the ultimate duration and the severity of the spread of COVID-19 and any variant strains in the U.S. and globally, the effectiveness and outreach of vaccines, the effectiveness of federal, state, local and international government's mitigation actions, the pandemic's impact on the U.S. and global economies, changes in the behavior of patients and medical professionals and the timing for resumption to our normal operations, as well as developments affecting healthcare and the delivery of medicines to patients. See &#8220;Part I&#8212;Item 1A. Risk Factors&#8212;General Risks&#8212;The COVID-19 pandemic is affecting our business and could have a material adverse effect on us&#8221; in our 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic affected global healthcare systems as well as major economic and financial markets, we adopted several procedures focused on ensuring the continued supply of our medicines to our patients and protecting the health, wellbeing and safety of our workforce. Additional information on the procedures adopted are available at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.bms.com/about-us/responsibility/coronavirus-updates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental Actions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products continue to be subject to increasing pressures across the portfolio from pharmaceutical market access and pricing controls and discounting, changes to tax and importation laws and other restrictions in the U.S., the EU and other regions around the world that result in lower prices, lower reimbursement rates and smaller populations for whom payers will reimburse, which can negatively impact our results of operations (including intangible asset impairment charges), operating cash flow, liquidity and financial flexibility. For example, Congress is currently considering a number of different proposals that would potentially: (i) allow the government to set or negotiate prices for prescription drugs, including benchmarking those prices to prices paid in other countries, (ii) penalize manufacturers for price increases beyond inflationary measures, (iii) redesign the Part D benefit with new out of pocket limits for patients and new mandated discounts for manufacturers, and (iv) change U.S. income tax laws resulting in an increase to our income tax expense, including through increased taxation of our international operations. The outcome of these Congressional actions remains highly uncertain. In addition, the Organization for Economic Co-operation and Development recently reached agreement on a global minimum tax pursuant to which countries are expected to implement changes to their tax laws and updates to international tax treaties. See risk factor on the Company&#8217;s risk factors on these items included under &#8220;Part I&#8212;Item 1A. Risk Factors&#8212;Product, Industry and Operational Risks&#8212;Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins&#8221; and &#8220;&#8212;Changes to tax regulations could negatively impact our earnings&#8221; in our 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Russian Federation invaded Ukraine. As a result, the U.S. and many other countries have implemented extensive sanctions on the Russian Federation, with which BMS intends to fully comply. The situation remains dynamic, and it is difficult to reasonably assess or predict the full extent of the negative impact that the Russian Federation-Ukraine conflict may have on our business, financial condition, results of operations and cash flows. Although the Russian Federation and Ukraine represent less than 1% of our total revenues, net assets and workforce, the evolving situation could result in significant negative impacts on our business. For example, while the Russia/Ukraine region represents approximately 1% of our overall clinical trial enrollment, as a result of growing operational challenges in the region, we have suspended new enrollment and new clinical trial activations in the region, which could impact our ability to timely complete trials and meet projected regulatory timelines. We also continue to assess our ability to continue operations in Russia, including our ability to provide medicines to patients in this region. For a more complete discussion on the risks we encounter in our business, please refer to &#8220;Part I&#8212;Item 1A. Risk Factors&#8221; in our 2021 Form 10-K.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ide471947286340dd92506f80fe047642_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Product and Pipeline Approvals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the significant approvals received as of April 29, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approval</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Camzyos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(mavacamten)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (mavacamten) for the treatment of adults with symptomatic obstructive HCM.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma and follicular lymphoma grade 3B after two or more lines of systemic therapy.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo+Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic ESCC with tumor cell PD-L1 expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1%. </span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the adjuvant treatment of adults with muscle-invasive urothelial carcinoma with tumor cell PD-LI expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1% who are at risk of recurrence after undergoing radical resection.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with fluoropyrimidine- and platinum-based chemotherapy for the first-line treatment of adult patients with unresectable advanced, recurrent, or metastatic ESCC with PD-L1 expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1%.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdualag</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a fixed-dose combination of nivolumab and relatlimab, for the treatment of adult and pediatric patients 12 years of age and older with unresectable or metastatic melanoma.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with platinum-doublet chemotherapy for adult patients with resectable NSCLC in the neoadjuvant setting.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the adjuvant treatment of urothelial carcinoma.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan&#8217;s Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least three prior therapies.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to &#8220;&#8212;Product and Pipeline Developments&#8221; for all of the developments in our marketed products and late-stage pipeline in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures, Licensing and Other Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Item 1. Financial Statements&#8212;Note 3. Alliances&#8221; and &#8220;&#8212;Note 4. Divestitures, Licensing and Other Arrangements&#8221; for information on significant divestitures, licensing and other arrangements during the first quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ide471947286340dd92506f80fe047642_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_106"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regional Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the changes in revenues was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.792%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by our regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Foreign exchange impacts were derived by applying the prior period average currency rates to the current period sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues for the first quarter of 2022 increased due to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis, Opdivo, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our New Product Portfolio and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by lower demand for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Average U.S. net selling prices increased 2% compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Europe</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Europe revenues for the first quarter of 2022 decreased due to foreign exchange impacts and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Average net selling prices decreased compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of the World</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rest of the World revenues for the first quarter of 2022 decreased due to foreign exchange impacts and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Average net selling prices decreased compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single country outside the U.S. contributed more than 10% of total revenues during the first quarter of 2022 and 2021. Our business is typically not seasonal.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ide471947286340dd92506f80fe047642_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GTN Adjustments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of gross product sales to net product sales by each significant category of GTN adjustments was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.792%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,586)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,718)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,761)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments percentage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to provisions for product sales made in prior periods resulting from changes in estimates were $74&#160;million and $217&#160;million for the three months ended March 31, 2022 and 2021, respectively. The reductions to provisions was primarily related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> co-pay and coverage gap discounts. GTN adjustments are primarily a function of product sales volume, regional and payer channel mix, contractual or legislative discounts and rebates. U.S. GTN adjustments percentage increased primarily due to higher government channel mix, which has higher GTN adjustment percentages.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,648</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,073</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,694</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,010</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,954</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">** Change in excess of 100%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from a prior reporting period as a result of a loss of exclusivity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="ide471947286340dd92506f80fe047642_115"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (apixaban)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; an oral Factor Xa inhibitor, indicated for the reduction in risk of stroke/systemic embolism in NVAF and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 12% in the first quarter of 2022 due to higher demand and higher average net selling prices.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 10% in the first quarter of 2022 due to higher demand, partially offset by foreign exchange impacts of 7% and lower average net selling prices. Excluding foreign exchange impacts, revenues increased by 17%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Following the May 2021 expiration of regulatory exclusivity for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe, generic manufacturers may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe prior to the expiration of our patents, which may lead to additional, infringement and invalidity actions involving our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe. We believe in the innovative science behind </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the strength of our intellectual property, which we will defend against infringement. Refer to &#8220;Item 1. Financial Statements&#8212;Note 17. Legal Proceedings and Contingencies&#8212;Intellectual Property&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab)&#160;&#8212;&#160;a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells that has been approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM and stomach. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, CRC and various gastric and esophageal cancers. There are several ongoing potentially registrational studies for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> across other tumor types and disease areas, in monotherapy and in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and various anti-cancer agents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 16% in the first quarter of 2022 due to higher demand across multiple indications including the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combinations for NSCLC, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* combination for kidney cancer and various gastric and esophageal cancers, partially offset by declining second-line eligibility across tumor indications and increased competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 6% in the first quarter of 2022 due to higher demand as a result of additional indication launches and core indications, partially offset by foreign exchange impacts of 7%. Excluding foreign exchange impacts, revenues increased 13%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pomalidomide) &#8212; a proprietary, distinct, small molecule that is administered orally and modulates the immune system and other biologically important targets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 9% in the first quarter of 2022 due to higher average net selling prices and higher demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 3% in the first quarter of 2022 due to higher demand, partially offset by foreign exchange impacts of 6% and lower average net selling prices. Excluding foreign exchange impacts, revenues increased by 9%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(abatacept) &#8212; a fusion protein indicated for adult patients with moderate to severe active RA and PsA and is also indicated for reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular JIA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 10% in the first quarter of 2022 due to higher demand.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 10% in the first quarter of 2022 due to foreign exchange impacts of 6% and lower demand. Excluding foreign exchange impacts, revenues decreased by 4%.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S. and EU, estimated LOE dates are based on method of use patents that expired in 2021. Formulation and additional patents expire in 2026 and beyond. There are no </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> biosimilars on the market in the U.S., EU or Japan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dasatinib)&#160;&#8212;&#160;an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromosome-positive CML in chronic phase and the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase CML with resistance or intolerance to prior therapy, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* (imatinib mesylate) and the treatment of children and adolescents aged 1 year to 18 years with chronic phase Philadelphia chromosome-positive CML.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 11% in the first quarter of 2022 due to higher average net selling prices and higher demand.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 9% in the first quarter of 2022 due to foreign exchange impacts of 7%. Excluding foreign exchange impacts, revenues decreased by 2%.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ipilimumab)&#160;&#8212;&#160;a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, and CRC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 6% in the first quarter of 2022 due to higher average net selling prices and higher demand primarily from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combination for NSCLC.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 26% in the first quarter of 2022 due to higher demand as a result of additional indication launches and core indications, partially offset by lower average net selling prices and foreign exchange impacts of 8%. Excluding foreign exchange impacts, revenues increased by 34%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Empliciti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (elotuzumab) &#8212; a humanized monoclonal antibody for the treatment of multiple myeloma.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mature and other products &#8212; includes all other products, including those which have lost exclusivity in major markets, OTC products, royalty revenue and mature products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 7% in the first quarter of 2022 primarily due to continued generic erosion and foreign exchange impacts of 2%. Excluding foreign exchange impacts, revenues decreased by 5%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(luspatercept-aamt) &#8212; an erythroid maturation agent indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions and for the treatment of anemia failing an ESA in adult patients with very low- to intermediate-risk MDS who have ring sideroblasts and require RBC transfusions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 37% in the first quarter of 2022 due to higher demand primarily from the launch of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in April 2020 for the treatment of adult patients with MDS previously treated with ESA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (idecabtagene vicleucel) &#8212; is a B-cell maturation antigen-directed genetically modified autologous CAR T cell therapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in May 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ozanimod) &#8212; an oral immunomodulatory drug used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and to treat moderately to severely active UC in adults. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (lisocabtagene maraleucel) &#8212; is a CD19-directed genetically modified autologous CAR T cell therapy indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (fedratinib) &#8212; an oral kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in August 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (azacitidine) &#8212; an oral hypomethylating agent that incorporates into DNA and RNA, indicated for continued treatment of adult patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag (nivolumab and relatlimab-rmbw)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; a combination of nivolumab, a PD-1 blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody, indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in March 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(lenalidomide)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;as a single agent is also indicated as a maintenance therapy in patients with multiple myeloma following autologous hematopoietic stem cell transplant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 4% in the first quarter of 2022 due to higher demand and higher average net selling prices. The impact of generic erosion was not material in the first quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 23% in the first quarter of 2022 due to generic erosion across several EU countries and Canada, foreign exchange impacts of 4% and lower average net selling prices. Excluding foreign exchange impacts, revenues decreased by 19%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S., certain third parties have been granted volume-limited licenses to sell generic lenalidomide beginning in March 2022 or thereafter. In the EU, licenses have been granted to third parties to market generic lenalidomide products prior to expiry of our patent and supplementary protection certificate rights beginning in the UK in January 2022 and in various other major market European countries (e.g. France, Germany, Italy and Spain) where our supplementary protection certificate is in force beginning in February 2022. In Japan, the estimated minimum market exclusivity date is based on a composition of matter patent, which expires in July 2022. Global revenues for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are expected to decline to approximately $9.0 billion to $9.5 billion in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(paclitaxel albumin-bound particles for injectable suspension)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a solvent-free protein-bound chemotherapy product that combines paclitaxel with albumin using our proprietary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform, and is used to treat breast cancer, NSCLC and pancreatic cancer, among others.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 23% in the first quarter of 2022 due to lower demand due to manufacturing delays partially offset by higher average selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 54% in the first quarter of 2022 due to generic erosion, lower demand as a result of manufacturing delays and foreign exchange impacts of 2%. Excluding foreign exchange impacts, revenues decreased by 52%. During the first quarter of 2022, the manufacturing delays experienced in the U.S. and International were substantially resolved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S., based on settlements reached we anticipate generic entry in the second quarter of 2022. In the EU, generics have entered the market. In Japan, the estimated minimum market exclusivity date is 2023 based on a method of use patent. Global revenues for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are expected to decline by approximately 25% to 30% in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ide471947286340dd92506f80fe047642_118"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated End-User Demand</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SEC Consent Order described in our 2021 Form 10-K, we monitor inventory levels on hand in the U.S. wholesaler distribution channel and outside of the U.S. in the direct customer distribution channel. We are obligated to disclose products with levels of inventory in excess of one month on hand or expected demand, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception. Estimated levels of inventory in the distribution channel in excess of one month on hand for the following products were not material to our results of operations as of the dates indicated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> had 1.1 months of inventory on hand internationally in the distribution channel at December 31, 2021 compared to 1.0 months of inventory on hand at September 30, 2021 primarily to support the product launch in Saudi Arabia and Israel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we generally determine our months on hand estimates using inventory levels of product on hand and the amount of out-movement provided by our three largest wholesalers, which account for approximately 76% of total gross sales of U.S. products for the three months ended March 31, 2022. Factors that may influence our estimates include generic competition, seasonality of products, wholesaler purchases in light of increases in wholesaler list prices, new product launches, new warehouse openings by wholesalers and new customer stockings by wholesalers. In addition, these estimates are calculated using third-party data, which may be impacted by their recordkeeping processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed in the U.S. primarily through contracted pharmacies under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;REMS and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> REMS&#160;programs, respectively. These are proprietary risk-management distribution programs tailored specifically to provide for the safe and appropriate distribution and use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed under mandatory risk-management distribution programs tailored to meet local authorities&#8217; specifications to provide for the products&#8217; safe and appropriate distribution and use. These programs may vary by country and, depending upon the country and the design of the risk-management program, the product may be sold through hospitals or retail pharmacies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-U.S. businesses have significantly more direct customers. Information on available direct customer product level inventory and corresponding out-movement information and the reliability of third-party demand information varies widely. We limit our direct customer sales channel inventory reporting to where we can influence demand. When this information does not exist or is otherwise not available, we have developed a variety of methodologies to estimate such data, including using historical sales made to direct customers and third-party market research data related to prescription trends and end-user demand. Given the difficulties inherent in estimating third-party demand information, we evaluate our methodologies to estimate direct customer product level inventory and to calculate months on hand on an ongoing basis and make changes as necessary. Factors that may affect our estimates include generic competition, seasonality of products, price increases, new product launches, new warehouse openings by direct customers, new customer stockings by direct customers and expected direct customer purchases for governmental bidding situations. As such, all of the information required to estimate months on hand in the direct customer distribution channel for non-U.S. business for the quarter ended March&#160;31, 2022 is not available prior to the filing of this Quarterly Report on Form 10-Q. We will disclose any product with levels of inventory in excess of one month on hand or expected demand for the current quarter, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception, in our next quarterly report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ide471947286340dd92506f80fe047642_121"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.792%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;In excess of +/- 100%.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Excludes amortization of acquired intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products sold decreased by $370&#160;million in the first quarter of 2022, primarily due to the impairment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones ($315 million) in 2021 and foreign exchange, partially offset by higher profit sharing and royalties due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> revenue growth ($170 million).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing, Selling and Administrative</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Marketing, selling and administrative expenses increased by $165&#160;million in the first quarter of 2022, primarily due to higher charitable giving and expenses to support new product launches.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense increased $41&#160;million in the first quarter of 2022, primarily due to an out of period adjustment relating to the unwinding of inventory purchase price adjustments ($82 million) and an IPRD impairment charge ($40 million), partially offset by timing of spend.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquired IPRD</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquired IPRD charges resulting from up-front or contingent milestone payments in connection with asset acquisitions or licensing of third-party intellectual property rights were as follows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly milestone</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics up-front license fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Acquired IPRD charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amortization of acquired intangible assets decreased by $96&#160;million in the first quarter of 2022, due to a longer than previously expected market exclusivity period for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Income)/Expense, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other (income)/expense, net changed by $1.4&#160;billion in the first quarter of 2022, primarily due to equity investments, contingent value rights and other items discussed below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Royalties and licensing income includes diabetes business royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, up-front licensing fees and milestones for products that have not obtained commercial approval. Refer to &#8220;Item 1. Financial Statements&#8212;Note 4. Divestitures, Licensing and Other Arrangements&#8221; for further information.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investment losses/(gains) includes fair value adjustments for investments that have readily determinable fair value and observable price changes for investments without readily determinable fair values resulting primarily from initial public offerings or third-party acquisitions of entities which we held an ownership interest. Our share of income or loss from equity method investments is primarily due to fair value adjustments attributed to limited partnerships. Refer to &#8220;Item 1. Financial Statements&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; for more information.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integration expenses primarily includes consulting fees to implement Celgene integration initiatives related to processes and systems.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contingent consideration primarily includes fair value adjustments resulting from the change in the traded price of contingent value rights issued with the Celgene acquisition. The contractual obligation to pay the contingent value rights terminated in January 2021 because the FDA did not approve liso-cel (JCAR017) by December 31, 2020.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Losses on debt redemption resulted from the early redemption of long-term debt of $5.2 billion in 2022 and $3.5 billion in 2021.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provision for restructuring includes exit and other costs primarily related to the Celgene acquisition plan. We are on track to achieve the annualized pre-tax cost savings of approximately $3.0 billion through 2022 as detailed in the restructuring activities. Refer to &#8220;Item 1. Financial Statements&#8212;Note 6. Restructuring&#8221; for further information.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Litigation and other settlements includes income of $40&#160;million resulting from a settlement resolving all legal claims and business interests pertaining to Nimbus&#8217; TYK2 inhibitor in the first quarter of 2022. The settlement also provides for contingent development, regulatory and sales-based milestones payable to BMS upon the occurrence of certain events.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Divestiture gains resulted from the divestiture of product rights for several mature products in the first quarter of 2022</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ide471947286340dd92506f80fe047642_124"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Specified Items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate Excluding Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impact attributed to specified items was primarily due to low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that were not taxable in 2021. The 0.9% decrease in the effective tax rate excluding specified items during 2022 was due to jurisdictional earnings mix. Refer to &#8220;Item 1. Financial Statements&#8212;Note 7. Income Taxes&#8221; for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="ide471947286340dd92506f80fe047642_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, such as non-GAAP earnings and related EPS information, are adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of past or future operating results. These items are excluded from non-GAAP earnings and related EPS information because the Company believes they neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business performance. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods including (i) amortization of acquired intangible assets, including product rights that generate a significant portion of our ongoing revenue and will recur until the intangible assets are fully amortized, (ii) unwind of inventory purchase price adjustments, (iii) acquisition and integration expenses, (iv) restructuring costs, (v) accelerated depreciation and impairment of property, plant and equipment and intangible assets, (vi) divestiture gains or losses, (vii) stock compensation resulting from accelerated vesting of Celgene awards and certain retention-related employee compensation charges related to the Celgene transaction, (viii) pension, legal and other contractual settlement charges, (ix) equity investment and contingent value rights fair value adjustments (including fair value adjustments attributed to limited partnership equity method investments) and (x) amortization of fair value adjustments of debt acquired from Celgene in our 2019 exchange offer, among other items. Deferred and current income taxes attributed to these items are also adjusted for considering their individual impact to the overall tax expense, deductibility and jurisdictional tax rates. We also provide international revenues for our priority products excluding the impact of foreign exchange. We calculate foreign exchange impacts by converting our current-period local currency financial results using the prior period average currency rates and comparing these adjusted amounts to our current-period results. Reconciliations of these non-GAAP measures to the most comparable GAAP measures are included in Exhibit 99.2 to our Form 8-K filed on April&#160;29, 2022 and are incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning with the first quarter of 2022, significant R&amp;D charges or other income resulting from upfront or contingent milestone payments in connection with asset acquisitions or licensing of third-party intellectual property rights are no longer excluded from our non-GAAP financial measures. We are making these changes to our presentation of non-GAAP financial measures following comments from and discussions with the SEC. For purposes of comparability, the non-GAAP financial measures for the three months ended March 31, 2021 have been updated to reflect this change.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP information is intended to portray the results of our baseline performance, supplement or enhance management, analysts and investors&#8217; overall understanding of our underlying financial performance and facilitate comparisons among current, past and future periods. This information is not intended to be considered in isolation or as a substitute for the related financial measures prepared in accordance with GAAP and may not be the same as or comparable to similarly titled measures presented by other companies due to possible differences in method and in the items being adjusted. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specified items were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to pretax income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on items above</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to net earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes amortization of purchase price adjustments to Celgene debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_130"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations from GAAP to Non-GAAP were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Diluted EPS Calculation &#8211; GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Diluted EPS Calculation &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share Attributable to BMS &#8211; GAAP</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS Attributable to Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS Attributable to BMS &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="ide471947286340dd92506f80fe047642_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_136"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net debt position was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt position</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,004)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,587)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_139"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly assess our anticipated working capital needs, debt and leverage levels, debt maturities, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions in order to maximize shareholder return, efficiently finance our ongoing operations and maintain flexibility for future strategic transactions. We also regularly evaluate our capital structure to ensure financial risks, adequate liquidity access and lower cost of capital are efficiently managed, which may lead to the issuance of additional debt securities, the repurchase of debt securities prior to maturity or the issuance or repurchase of common stock. Under the Tax Cuts and Jobs Act of 2017, research and development costs are required to be capitalized and amortized for US tax purposes effective January 1, 2022. Absent a change in law, we estimate our US income tax payments will increase by nearly $2.0 billion as compared to 2021. We believe that our existing cash, cash equivalents and marketable debt securities together with cash generated from operations and, if required, from the issuance of commercial paper will be sufficient to satisfy our anticipated cash needs for at least the next few years, including dividends, capital expenditures, milestone payments, working capital, income taxes, restructuring initiatives, business development, repurchase of common stock, debt maturities of approximately $16.3&#160;billion through 2026 as well as any debt repurchases through redemptions or tender offers. The net debt position increased by $2.4 billion due to common stock repurchases and dividends of $6.2 billion, partially offset by cash from operating activities of $3.8 billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a share repurchase program authorized by our Board of Directors allowing for repurchases of our shares. The specific timing and number of shares repurchased will be determined by our management at its discretion and will vary based on market conditions, securities law limitations and other factors. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. The repurchases may be effected through a combination of one or more open market repurchases, privately negotiated transactions, transactions structured through investment banking institutions and other derivative transactions, relying on Rule 10b-18 and Rule 10b5-1 under the Exchange Act. The outstanding share repurchase authorization under the program was $15.2 billion as of December 31, 2021. In the first quarter of 2022, we executed ASR agreements to repurchase an aggregate $5.0 billion of common stock. The remaining share repurchase capacity under the share repurchase program was approximately $10.2 billion as of March&#160;31, 2022. Refer to &#8220;Item 1. Financial Statements&#8212;Note 15. Equity&#8221; for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend payments were $1.2 billion in the first quarter of 2022. Dividends declared per common share were $0.54 in the first quarter of 2022. Dividend decisions are made on a quarterly basis by our Board of Directors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual capital expenditures were approximately $970 million in 2021 and are expected to be approximately $1.2 billion in 2022 and 2023. We continue to make capital expenditures in connection with the expansion of our manufacturing capabilities, research and development and other facility-related activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we issued an aggregate principal amount of $6.0&#160;billion of debt consisting of $1.75 billion of 2.950% Notes due 2032, $1.25 billion of 3.550% Notes due 2042, $2.0 billion of 3.700% Notes due 2052 and $1.0 billion of 3.900% Notes due 2062 with net proceeds of $5.9&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we purchased aggregate principal amount of $5.2&#160;billion of certain of our debt securities for approximately $5.8&#160;billion of cash in tender offers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, we purchased aggregate principal amount of $849&#160;million of certain of our debt securities for approximately $880&#160;million of cash pursuant to &#8220;make whole&#8221; redemptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had four separate revolving credit facilities t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">otaling $6.0 billion, which consisted of a 364-day $2.0 billion facility which expired in January 2022, a three-year $1.0 billion facility which expired in January 2022 and two five-year $1.5 billion facilities that were extended to September 2025 and July 2026, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we entered into a five-year $5.0 billion facility expiring in January 2027, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing five-year $1.5 billion facilities were terminated and the three-year $1.0 billion facility and 364-day $2.0 billion facility expired in accordance with their terms in January 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No borrowings were outstanding under revolving credit facilities at March&#160;31, 2022 or December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our commercial paper program, we may issue a maximum of $5.0 billion unsecured notes that have maturities of not more than 366 days from the date of issuance. There were no commercial paper borrowings outstanding as of March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment portfolio includes non-current marketable debt securities, which are subject to changes in fair value as a result of interest rate fluctuations and other market factors. Our investment policy establishes limits on the amount and time to maturity of investments with any institution. The policy also requires that investments are only entered into with corporate and financial institutions that meet high credit quality standards. Refer to &#8220;Item 1. Financial Statements&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_142"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Ratings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current long-term and short-term credit ratings assigned by Moody&#8217;s Investors Service are A2 and Prime-1, respectively, with a stable long-term credit outlook, and our current long-term and short-term credit ratings assigned by Standard &amp; Poor&#8217;s are A+ and A-1, respectively with a stable long-term credit outlook. The long-term ratings reflect the agencies&#8217; opinion that we have a low default risk but are somewhat susceptible to adverse effects of changes in circumstances and economic conditions. The short-term ratings reflect the agencies&#8217; opinion that we have good to extremely strong capacity for timely repayment. Any credit rating downgrade may affect the interest rate of any debt we may incur, the fair market value of existing debt and our ability to access the capital markets generally.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_145"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of cash flow activities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow provided by/(used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from operating activities represents the cash receipts and disbursements from all of our activities other than investing and financing activities. Operating cash flow is derived by adjusting net earnings for noncontrolling interest, non-cash operating items, gains and losses attributed to investing and financing activities and changes in operating assets and liabilities resulting from timing differences between the receipts and payments of cash and when the transactions are recognized in our results of operations. As a result, changes in cash from operating activities reflect the timing of cash collections from customers and alliance partners; payments to suppliers, alliance partners and employees; customer discounts and rebates; and tax payments in the ordinary course of business. For example, annual employee bonuses are typically paid in the first quarter of the subsequent year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from operating activities decreased by $12 million compared to 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash requirements from investing activities include cash used for acquisitions, manufacturing and facility-related capital expenditures and purchases of marketable securities with original maturities greater than 90 days at the time of purchase, proceeds from business divestitures (including royalties), the sale and maturity of marketable securities, sale of equity investments and upfront and contingent milestones from licensing arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $238 million change in cash flow from investing activities compared to 2021 was primarily attributable to changes in the amount of marketable debt securities held of $900 million and higher proceeds from divestitures, partially offset by lower proceeds from sales of equity investments of $400 million and higher Acquired IPRD payments of $330 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash requirements from financing activities include cash used to pay dividends, repurchase common stock and repay long-term debt and other borrowings reduced by proceeds from the exercise of stock options and issuance of long-term debt and other borrowings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.6 billion change in cash flow from financing activities compared to 2021 was primarily due to changes in the amount of debt securities of $4.7 billion resulting from debt issuances and repayments, partially offset by higher repurchases of common stock ($3.2 billion).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="ide471947286340dd92506f80fe047642_148"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product and Pipeline Developments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D programs are managed on a portfolio basis from early discovery through late-stage development and include a balance of early-stage and late-stage programs to support future growth. Our late stage R&amp;D programs in Phase III development include both investigational compounds for initial indications and additional indications or formulations for marketed products. The following are the developments in our marketed products and our late-stage pipeline since the start of the first quarter:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:47pt"><td colspan="3" rowspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bladder</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the adjuvant treatment of adults with muscle-invasive urothelial carcinoma with tumor cell PD-LI expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 1% who are at risk of recurrence after undergoing radical resection. The approval is based on results from the Phase III CheckMate -274 trial.</span></div></td></tr><tr style="height:47pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ono, our alliance partner for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in Japan, announced that the Japan's Ministry of Health, Labour and Welfare approved </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the adjuvant treatment of urothelial carcinoma, for partial change in approved items of the manufacturing and marketing approval. The approval is based on results from the Phase III CheckMate-274 (ONO-4538-33) trial.</span></div></td></tr><tr style="height:47pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Esophageal </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in combination with fluoropyrimidine- and platinum-based chemotherapy for the first-line treatment of adult patients with unresectable advanced, recurrent, or metastatic ESCC with PD-L1 expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 1%. The approval is based on results from the Phase III CheckMate -648 trial. </span></div></td></tr><tr style="height:132pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melanoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that the Phase III PIVOT IO-001 trial did not meet the primary endpoints of progression-free survival (PFS) and objective response rate (ORR) in patients with previously untreated unresectable or metastatic melanoma who were treated with bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> compared to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">monotherapy. The DMC notified the companies that the third primary endpoint of overall survival (OS) did not meet statistical significance at the first interim analysis. The trial was conducted in collaboration with Nektar. The trial will be unblinded and no additional analyses for the OS endpoint will be performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on subsequent results from pre-planned analyses of two late-stage clinical studies in RCC and bladder cancer, coupled with the results of PIVOT IO-001 noted above, BMS and Nektar have jointly decided to end the global clinical development program for bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div></td></tr><tr style="height:57pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced results from the Phase III CheckMate-816 trial which showed that neoadjuvant treatment with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in combination with chemotherapy significantly improved event-free survival, a primary endpoint, compared to chemotherapy alone in patients with resectable NSCLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in combination with chemotherapy reduced the risk of disease recurrence, progression or death by 37%, and demonstrated favorable early overall survival trend.</span></div></td></tr><tr style="height:35pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that the EMA validated the Type II Variation application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in combination with chemotherapy for the neoadjuvant treatment of patients with resectable stage IB to IIIA NSCLC. The application is based on results from the Phase III CheckMate-816 trial.</span></div></td></tr><tr style="height:35pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in combination with platinum-doublet chemotherapy for the treatment of adult patients with resectable NSCLC in the neoadjuvant setting. The approval is based on the Phase III CheckMate-816 trial.</span></div></td></tr><tr style="height:57pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced, with our alliance partner Nektar, that based on results from pre-planned analysis of two late-stage clinical studies of bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in RCC and bladder cancer, to jointly end the global clinical development program for bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These studies and all other ongoing studies in the program will be discontinued.</span></div></td></tr><tr style="height:44pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced two-year follow-up results from analysis of the Phase III CheckMate-9ER trial, demonstrating sustained survival, response rate benefits, and health-related quality of life improvements, with the combination of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">CABOMETYX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> versus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">sunitinib in the first-line treatment of advanced RCC.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo + Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Esophageal</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic ESCC with tumor cell PD-L1 expression &gt; 1%. The approval is based on results from the Phase III CheckMate -648 trial.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Reblozyl</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beta Thalassemia</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that the FDA has extended the review of the sBLA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of anemia in adults with non-transfusion dependent beta thalassemia to June 27, 2022 to allow sufficient time to review a written response to an information request. The sBLA was based on results from the Phase II BEYOND trial. </span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multiple Myeloma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody, and have either experienced disease progression on the last therapy or relapse after the last therapy. The approval is based on results from the Phase II BB2121-MM-001 and Phase I CRB-401 trials.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Zeposia</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced interim results from the Phase III True North open-label extension trial evaluating the long-term efficacy and safety profile of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in patients with moderately to severely active UC through Week 142. Findings show that the percentage of patients achieving clinical remission, clinical response, endoscopic improvement and corticosteroid-free remission was maintained.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:47pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lymphoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B after two or more lines of systemic therapy. The approval is based on results from the TRANSCEND WORLD and TRANSCEND NHL 001 trials.</span></div></td></tr><tr style="height:47pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that Japan's Ministry of Health, Labour and Welfare has accepted the sNDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the second-line treatment of patients with relapsed or refractory large B-cell lymphoma. The acceptance is based on results from the Phase III TRANSFORM trial and other studies.</span></div></td></tr><tr style="height:57pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that the FDA has accepted for priority review the sBLA to expand its current indication to include earlier use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of adults with relapsed or refractory large B-cell lymphoma after failure of first-line therapy. The FDA has assigned a PDUFA goal date of June 24, 2022. The sBLA is based on results from the Phase III TRANSFORM trial.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdualag </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(nivolumab and relatlimab-rmbw)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melanoma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opdualag </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(nivolumab and relatlimab-rmbw)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a fixed-dose combination of nivolumab and relatlimab, a novel LAG-3 inhibitor, for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. The approval is based on results from the Phase II/III RELATIVITY-047 trial.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Camzyos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(mavacamten)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Obstructive HCM</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (mavacamten) for the treatment of adults with symptomatic New York Heart Association class II-III obstructive HCM to improve functional capacity and symptoms. The approval is based on results from the Phase III EXPLORER-HCM trial.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:57pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">mavacamten</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Obstructive HCM</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that Phase 3 VALOR-HCM trial met its primary and secondary endpoints, significantly reducing the need for septal reduction therapy (SRT) in patients with severely symptomatic obstructive HCM who had been appropriate for SRT per the 2011 American College of Cardiology/American Heart Association Guidelines at baseline, after 16 weeks of treatment with mavacamten.</span></div></td></tr><tr style="height:35pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that interim results from the EXPLORER-LTE cohort of the MAVA-LTE trial in patients with symptomatic obstructive HCM showed sustained improvements in cardiovascular outcomes at 48 and 84-weeks, no new safety signals were observed.</span></div></td></tr><tr style="height:35pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that VALOR-HCM, the Phase III randomized, double-blind, placebo-controlled trial evaluating mavacamten in adults with symptomatic obstructive HCM who are eligible for septal reduction therapy, met its primary endpoint at Week 16.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_151"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses. Our critical accounting policies are those that significantly impact our financial condition and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results may vary from these estimates. For a discussion of our critical accounting policies, refer to &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our 2021 Form 10-K. There have been no material changes to our critical accounting policies during the three months ended March 31, 2022. For information regarding the impact of recently adopted accounting standards, refer to &#8220;Item 1. Financial Statements&#8212;Note.1 Basis of Presentation and Recently Issued Accounting Standards.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ide471947286340dd92506f80fe047642_154"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (including documents incorporated by reference) and other written and oral statements we make from time to time contain certain &#8220;forward-looking&#8221; statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. You can identify these forward-looking statements by the fact they use words such as &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;target,&#8221; &#8220;may,&#8221; &#8220;project,&#8221; &#8220;guidance,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will&#8221; and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. One can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements are based on current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These statements are likely to relate to, among other things, our goals, plans and objectives regarding our financial position, results of operations, cash flows, market position, product development, product approvals, sales efforts, expenses, performance or results of current and anticipated products, our business development strategy and in relation to our ability to realize the projected benefits of our acquisitions of Celgene and MyoKardia, the impact of the COVID-19 pandemic on our operations and the development and commercialization of our products, potential laws and regulations to lower drug costs, market actions taken by private and government payers to manage drug utilization and contain costs, the expiration of patents or data protection on certain products, including assumptions about our ability to retain marketing exclusivity of certain products, and the outcome of contingencies such as legal proceedings and financial results. No forward-looking statement can be guaranteed. This Quarterly Report on Form 10-Q, our 2021 Form 10-K, particularly under the section &#8220;Item 1A. Risk Factors,&#8221; and our other filings with the SEC, include additional information on the factors that we believe could cause actual results to differ materially from any forward-looking statement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we have been prudent in our plans and assumptions, no assurance can be given that any goal or plan set forth in forward-looking statements can be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Additional risks that we may currently deem immaterial or that are not presently known to us could also cause the forward-looking events discussed in this Quarterly Report on Form 10-Q not to occur. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise after the date of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_157"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our market risk, refer to &#8220;Item 7A. Quantitative and Qualitative Disclosures about Market Risk&#8221; in our 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_160"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management carried out an evaluation, under the supervision and with the participation of its chief executive officer and chief financial officer, of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of March&#160;31, 2022, such disclosure controls and procedures are effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company&#8217;s internal control over financial reporting during the quarter ended March&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in &#8220;Item 1. Financial Statements&#8212;Note 17. Legal Proceedings and Contingencies,&#8221; to the interim consolidated financial statements, and is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ide471947286340dd92506f80fe047642_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes from the risk factors disclosed in the Company&#8217;s 2021 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ide471947286340dd92506f80fe047642_172"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the surrenders of our equity securities during the three months ended March 31, 2022:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:34.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of Shares&#160;Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price Paid per&#160;Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares&#160;Purchased&#160;as Part of Publicly Announced Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares&#160;that May Yet Be Purchased Under the Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, Except Per Share Data</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 to 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 to 28, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,583,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,501,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 to 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,754,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,501,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Includes shares repurchased as part of publicly announced programs and shares of common stock surrendered to the Company to satisfy tax-withholding obligations in connection with the vesting of awards under our long-term incentive program. Shares surrendered for tax-withholding included 840,489 in January, 81,786 in February and 2,330,783 in March, with average prices of $64.75, $66.13 and $68.44, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In May 2010, the Board of Directors authorized the repurchase of up to $3.0 billion of our common stock and in June 2012 increased its authorization for the repurchase of our common stock by an additional $3.0 billion. The Board of Directors approved a new share repurchase program authorizing the repurchase of an additional $3.0 billion of our common stock in October 2016 and further increased its authorization for the repurchase of our common stock by approximately $7.0 billion in November 2019 and $5.0 billion in February 2020. In January and December 2021, the Board of Directors approved an increase of $2.0 billion and $15.0 billion, respectively, to the share repurchase authorization for our common stock. The remaining share repurchase capacity under the program is approximately $10.2 billion as of March 31, 2022. Refer to &#8220;Item 1. Financial Statements-Note 15. Equity&#8221; for information on the share repurchase program.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">On February 8, 2022, as part of our existing share repurchase program, BMS executed accelerated share repurchase (&#8220;ASR&#8221;) agreements to repurchase an aggregate $5.0 billion of common stock. Approximately 65 million shares of common stock (85% of the $5.0 billion aggregate purchase price calculated on the basis of a price of $65.89 per share, the closing share price of the Company's common stock on February 8, 2022) were received by BMS and included in treasury stock. The total number of shares to be repurchased under the ASR agreements, and the average price paid per share, will be determined at the settlement of the ASR agreements and will be based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ide471947286340dd92506f80fe047642_175"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. EXHIBITS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits (listed by number corresponding to the Exhibit Table of Item&#160;601 in Regulation S-K).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036122007493/ny20002727x6_ex4-1.htm">Thirteenth Supplemental Indenture, dated as of March 2, 2022, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as of June 1, 1993 (incorporated herein by reference to Exhibit 4.1 to the Form 8-K dated and filed on March 2, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036122007493/ny20002727x6_ex4-1.htm">Form of $1,750,000,000 2.950% Notes due 2032 (incorporated herein by reference to Exhibit 4.2 to the Form 8-K dated and filed on March 2, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4c.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036122007493/ny20002727x6_ex4-1.htm">Form of $1,250,000,000 3.550% Notes due 2042 (incorporated herein by reference to Exhibit 4.3 to the Form 8-K dated and filed on March 2, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4d.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036122007493/ny20002727x6_ex4-1.htm">Form of $2,000,000,000 3.700% Notes due 2052 (incorporated herein by reference to Exhibit 4.4 to the Form 8-K dated and filed on March 2, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4e.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036122007493/ny20002727x6_ex4-1.htm">Form of $1,000,000,000 3.900% Notes due 2062 (incorporated herein by reference to Exhibit 4.5 to the Form 8-K dated and filed on March 2, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31a_20220331.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31b_20220331.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32a_20220331.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32b_20220331.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates, in this Quarterly Report on Form 10-Q, brand names of products, which are registered trademarks not solely owned by the Company or its subsidiaries.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Otsuka Pharmaceutical Co., Ltd.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Gilead Sciences, LLC.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Amylin Pharmaceuticals, LLC; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Exelixis, Inc.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of AstraZeneca AB; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Merck Sharp &amp; Dohme Corp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Amgen Inc.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Genentech, Inc.; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Kite Pharma, Inc. Brand names of products that are in all italicized letters, without an asterisk, are registered trademarks of BMS and/or one of its subsidiaries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ide471947286340dd92506f80fe047642_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF ABBREVIATED TERMS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company and its consolidated subsidiaries may be referred to as Bristol Myers Squibb, BMS, the Company, we, our or us in this Quarterly Report on Form 10-Q, unless the context otherwise indicates. Throughout this Quarterly Report on Form 10-Q we have used terms which are defined below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Form 10-K</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the fiscal year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agenus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agenus Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lilly</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eli Lilly and Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AML</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">acute myeloid leukemia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOE</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">loss of exclusivity</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin Pharmaceuticals, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MAA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">marketing authorization application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">aNDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">abbreviated new drug application</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">multi-district litigation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca PLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDS</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myelodysplastic syndromes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">biologics license application</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPM</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">malignant pleural mesothelioma</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bluebird</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bluebird bio, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAR T</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chimeric antigen receptor T-cell</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">new drug application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NKT</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">natural killer T cells</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CERCLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Comprehensive Environmental Response, Compensation and Liability Act</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-small cell lung cancer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHMP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committee for Medicinal Products for Human Use</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NVAF</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-valvular atrial fibrillation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CML</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chronic myeloid leukemia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over-the-counter</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorectal carcinoma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka Pharmaceutical Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">contingent value rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-1</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed cell death protein 1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-L1</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed death-ligand 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai Co., Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PDUFA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Prescription Drug User Fee Act</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PsA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">psoriatic arthritis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESCC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">esophageal squamous cell carcinoma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rheumatoid arthritis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RBC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">red blood cell</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. generally accepted accounting principles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">renal cell carcinoma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GILTI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REMS</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">risk evaluation and mitigation strategy</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">gross-to-net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hepatocellular carcinoma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sBLA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental Biologics License Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCM</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hypertrophic cardiomyopathy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIV</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">human immunodeficiency viruses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sNDA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental new drug application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IO</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">immuno-oncology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ulcerative colitis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal Revenue Service</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JIA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">juvenile idiopathic arthritis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">value added tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="ide471947286340dd92506f80fe047642_181"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY<br/>(REGISTRANT)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Giovanni Caforio, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David V. Elkins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.A
<SEQUENCE>2
<FILENAME>bmyex31a_20220331.htm
<DESCRIPTION>EXHIBIT 31.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1b75ea8e64fc473fb527fb63821010c8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Giovanni Caforio, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2022&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;29, 2022 </font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.B
<SEQUENCE>3
<FILENAME>bmyex31b_20220331.htm
<DESCRIPTION>EXHIBIT 31.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i57b135ea38a140cb91d76825d5287b05_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David V. Elkins, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2022&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;29, 2022 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.A
<SEQUENCE>4
<FILENAME>bmyex32a_20220331.htm
<DESCRIPTION>EXHIBIT 32.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i93b18f632d194d3a97d9ccb457d4f8d0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Executive Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, Giovanni Caforio, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2022 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on April&#160;29, 2022, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.520%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;29, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.B
<SEQUENCE>5
<FILENAME>bmyex32b_20220331.htm
<DESCRIPTION>EXHIBIT 32.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iee1430ddf0ba466c80671a66a6fd8363_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Financial Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, David V. Elkins, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2022 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on April&#160;29, 2022, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;29, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bmy-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5a14e930-e849-45eb-bcad-119c402123d7,g:c84cb2fd-f418-4547-ab26-f641c106cb69-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bmy="http://www.bms.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bms.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.bms.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes">
        <link:definition>2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies">
        <link:definition>2202201 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.bms.com/role/Revenue">
        <link:definition>2103102 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.bms.com/role/RevenueTables">
        <link:definition>2304301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofRevenueDetails" roleURI="http://www.bms.com/role/RevenueDisaggregationofRevenueDetails">
        <link:definition>2405401 - Disclosure - Revenue - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueReconciliationofGrossProductSalestoNetProductSalesDetails" roleURI="http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails">
        <link:definition>2406402 - Disclosure - Revenue - Reconciliation of Gross Product Sales to Net Product Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofRevenuebyProductandRegionDetails" roleURI="http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails">
        <link:definition>2407403 - Disclosure - Revenue - Disaggregation of Revenue by Product and Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCES" roleURI="http://www.bms.com/role/ALLIANCES">
        <link:definition>2108103 - Disclosure - ALLIANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESTables" roleURI="http://www.bms.com/role/ALLIANCESTables">
        <link:definition>2309302 - Disclosure - ALLIANCES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESDetails" roleURI="http://www.bms.com/role/ALLIANCESDetails">
        <link:definition>2410404 - Disclosure - ALLIANCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes">
        <link:definition>2111104 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables">
        <link:definition>2312303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails">
        <link:definition>2413405 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails">
        <link:definition>2414406 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails">
        <link:definition>2415407 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENET" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENET">
        <link:definition>2116105 - Disclosure - OTHER (INCOME)/EXPENSE, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENETTables" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables">
        <link:definition>2317304 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails">
        <link:definition>2418408 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.bms.com/role/RESTRUCTURING">
        <link:definition>2119106 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.bms.com/role/RESTRUCTURINGTables">
        <link:definition>2320305 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGAdditionalInformationDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails">
        <link:definition>2421409 - Disclosure - RESTRUCTURING - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
        <link:definition>2422410 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>2423411 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.bms.com/role/INCOMETAXES">
        <link:definition>2124107 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.bms.com/role/INCOMETAXESTables">
        <link:definition>2325306 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" roleURI="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>2426412 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESAdditionalInformationDetails" roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails">
        <link:definition>2427413 - Disclosure - INCOME TAXES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.bms.com/role/EARNINGSPERSHARE">
        <link:definition>2128108 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.bms.com/role/EARNINGSPERSHARETables">
        <link:definition>2329307 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails">
        <link:definition>2430414 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>2131109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>2332308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails">
        <link:definition>2433415 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails">
        <link:definition>2434416 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails">
        <link:definition>2435417 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails">
        <link:definition>2436418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails">
        <link:definition>2437419 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails">
        <link:definition>2438420 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails">
        <link:definition>2439421 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails">
        <link:definition>2440422 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails">
        <link:definition>2441423 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails">
        <link:definition>2442424 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLES" roleURI="http://www.bms.com/role/RECEIVABLES">
        <link:definition>2143110 - Disclosure - RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESTables" roleURI="http://www.bms.com/role/RECEIVABLESTables">
        <link:definition>2344309 - Disclosure - RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESScheduleofReceivablesDetails" roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails">
        <link:definition>2445425 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESDetails" roleURI="http://www.bms.com/role/RECEIVABLESDetails">
        <link:definition>2446426 - Disclosure - RECEIVABLES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.bms.com/role/INVENTORIES">
        <link:definition>2147111 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.bms.com/role/INVENTORIESTables">
        <link:definition>2348310 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.bms.com/role/INVENTORIESDetails">
        <link:definition>2449427 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>2150112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>2351311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>2452428 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>2153113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2354312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails">
        <link:definition>2455429 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails">
        <link:definition>2456430 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>2157114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables">
        <link:definition>2358313 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails">
        <link:definition>2459431 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails">
        <link:definition>2460432 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails">
        <link:definition>2461433 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails">
        <link:definition>2462434 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITY" roleURI="http://www.bms.com/role/EQUITY">
        <link:definition>2163115 - Disclosure - EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYTables" roleURI="http://www.bms.com/role/EQUITYTables">
        <link:definition>2364314 - Disclosure - EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofStockholdersEquityDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails">
        <link:definition>2465435 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYAdditionalInformationDetails" roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails">
        <link:definition>2466436 - Disclosure - EQUITY - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofComprehensiveIncomeLossDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails">
        <link:definition>2467437 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2468438 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes">
        <link:definition>2169116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSTables" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables">
        <link:definition>2370315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails">
        <link:definition>2471439 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails">
        <link:definition>2472440 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
        <link:definition>2473441 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIES" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES">
        <link:definition>2174117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIESDetails" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails">
        <link:definition>2475442 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bmy_OpdualagMember" abstract="true" name="OpdualagMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LitigationTable" abstract="true" name="LitigationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_AbraxaneMember" abstract="true" name="AbraxaneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyNumberOfPlaintiffsDismissed" abstract="false" name="LossContingencyNumberOfPlaintiffsDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_NumberOfLargestPharmaceuticalWholesalers" abstract="false" name="NumberOfLargestPharmaceuticalWholesalers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_LongTermDebtRenewalPeriod" abstract="false" name="LongTermDebtRenewalPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bmy_ScheduleOfEquityInvestmentsTableTextBlock" abstract="false" name="ScheduleOfEquityInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_LicensingCompaniesAxis" abstract="true" name="LicensingCompaniesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_MarketShareUnitsMember" abstract="true" name="MarketShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_Cashoutlays" abstract="false" name="Cashoutlays" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_NetproductsalesMember" abstract="true" name="NetproductsalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingArrangementsTable" abstract="true" name="LicensingArrangementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_AmortizationofAcquiredIntangibleAssets" abstract="false" name="AmortizationofAcquiredIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_EquityTable" abstract="true" name="EquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_MedicaidandMedicarerebatesMember" abstract="true" name="MedicaidandMedicarerebatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsIncome" abstract="false" name="LicensingAndOtherArrangementsIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AcquiredIPRD" abstract="false" name="AcquiredIPRD" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ResearchAndDevelopmentNonCurrent" abstract="false" name="ResearchAndDevelopmentNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" abstract="false" name="ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_EquityInvestments" abstract="false" name="EquityInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" abstract="false" name="RestructuringChargesExcludingAcceleratedStockbasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ContingentValueRightsMember" abstract="true" name="ContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentAndRegulatoryMilestonePayments" abstract="false" name="ContingentAndRegulatoryMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ReceivablesSoldOnNonrecourseBasis" abstract="false" name="ReceivablesSoldOnNonrecourseBasis" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_SprycelMember" abstract="true" name="SprycelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AcceleratedStockBasedCompensationMember" abstract="true" name="AcceleratedStockBasedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2.875SeniorNotesdue2021Member" abstract="true" name="A2.875SeniorNotesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SeniorUnsecuredNotesDue2052Member" abstract="true" name="SeniorUnsecuredNotesDue2052Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A60BillionUnsecuredSeniorNotesMember" abstract="true" name="A60BillionUnsecuredSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingArrangementsLineItems" abstract="true" name="LicensingArrangementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_CelgeneContingentValueRightsMember" abstract="true" name="CelgeneContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsDomain" abstract="true" name="GrosstoNetAdjustmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.5BillionMaximumBorrowingCapacityMember" abstract="true" name="A1.5BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherrevenuesMember" abstract="true" name="OtherrevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberDismissed" abstract="false" name="LossContingencyPendingClaimsNumberDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_ImmaticsMember" abstract="true" name="ImmaticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EmplicitiMember" abstract="true" name="EmplicitiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsLineItems" abstract="true" name="GrosstoNetAdjustmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" abstract="true" name="AcquisitionsDivestituresandOtherArrangementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_Totalinventories" abstract="false" name="Totalinventories" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsAxis" abstract="true" name="GrosstoNetAdjustmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_PlavixAustraliaIntellectualPropertyMember" abstract="true" name="PlavixAustraliaIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" abstract="false" name="ScheduleOfProvisionForIncomeTaxesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_A2BillionMaximumBorrowingCapacityMember" abstract="true" name="A2BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_PomalystImnovidMember" abstract="true" name="PomalystImnovidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InrebicMember" abstract="true" name="InrebicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ReblozylMember" abstract="true" name="ReblozylMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CelgeneIntegrationMember" abstract="true" name="CelgeneIntegrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentRegulatoryMilestoneIncome" abstract="false" name="ContingentRegulatoryMilestoneIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AllianceTransitionalServices" abstract="false" name="AllianceTransitionalServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_CheplapharmMember" abstract="true" name="CheplapharmMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2022ASRMember" abstract="true" name="A2022ASRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbecmaMember" abstract="true" name="AbecmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SeniorUnsecuredNotesDue2042Member" abstract="true" name="SeniorUnsecuredNotesDue2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EliquisMember" abstract="true" name="EliquisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MatureAndOtherBrandsMember" abstract="true" name="MatureAndOtherBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsAxis" abstract="true" name="LicensingAndOtherArrangementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_Pensionsettlementsandamortization" abstract="false" name="Pensionsettlementsandamortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_UnamortizedBasisAdjustmentFromSwapTerminations" abstract="false" name="UnamortizedBasisAdjustmentFromSwapTerminations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsTableTextBlock" abstract="false" name="LicensingAndOtherArrangementsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_ExpectedSynergiesPercentage" abstract="false" name="ExpectedSynergiesPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bmy_SupplementalFinancialInformationAbstract" abstract="true" name="SupplementalFinancialInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" abstract="false" name="SellingGeneralandAdministrativeExpenseCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_PaymentToExtinguishFutureRoyaltyObligation" abstract="false" name="PaymentToExtinguishFutureRoyaltyObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_BristolMyersSquibbMember" abstract="true" name="BristolMyersSquibbMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InventoryPurchasePriceFairValueAdjustmentMember" abstract="true" name="InventoryPurchasePriceFairValueAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherIncomeReceivedFromAlliancePartners" abstract="false" name="OtherIncomeReceivedFromAlliancePartners" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_EquityInvestmentsCurrent" abstract="false" name="EquityInvestmentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_CommonStock0.10ParValueMember" abstract="true" name="CommonStock0.10ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicenseAndOtherArrangementsUpfrontPayments" abstract="false" name="LicenseAndOtherArrangementsUpfrontPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_NumberofRevolvingCreditFacilities" abstract="false" name="NumberofRevolvingCreditFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_LicensingCompaniesDomain" abstract="true" name="LicensingCompaniesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EquityLineItems" abstract="true" name="EquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_YervoyMember" abstract="true" name="YervoyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CARTKiteLitigationMember" abstract="true" name="CARTKiteLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OnuregMember" abstract="true" name="OnuregMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AmortizationOfDeferredIncome" abstract="false" name="AmortizationOfDeferredIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_KeytrudaRoyaltiesMember" abstract="true" name="KeytrudaRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AccruedRebatesAndReturns" abstract="false" name="AccruedRebatesAndReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_DiabetesbusinessMember" abstract="true" name="DiabetesbusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_DragonflyMember" abstract="true" name="DragonflyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OrenciaMember" abstract="true" name="OrenciaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MatureBrandsAndOtherMember" abstract="true" name="MatureBrandsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherRoyaltiesMember" abstract="true" name="OtherRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AvaproAvalideAndPlavixMember" abstract="true" name="AvaproAvalideAndPlavixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_PercentageOfAggregateTotalTradeReceivablesDue" abstract="false" name="PercentageOfAggregateTotalTradeReceivablesDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bmy_SeniorUnsecuredNotesDue2062Member" abstract="true" name="SeniorUnsecuredNotesDue2062Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AllianceandotherrevenuesMember" abstract="true" name="AllianceandotherrevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AccruedResearchAndDevelopment" abstract="false" name="AccruedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ResearchandDevelopment" abstract="false" name="ResearchandDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RevlimidMember" abstract="true" name="RevlimidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ZeposiaMember" abstract="true" name="ZeposiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfOtherIncomeExpenseTextBlock" abstract="false" name="ScheduleOfOtherIncomeExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_ALLIANCESAbstract" abstract="true" name="ALLIANCESAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_OtherOtherIncomeExpense" abstract="false" name="OtherOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_BreyanziMember" abstract="true" name="BreyanziMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.000Notesdue2025Member" abstract="true" name="A1.000Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbilifyProductLiabilityLitigationMember" abstract="true" name="AbilifyProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" abstract="true" name="OtherrebatesreturnsdiscountsandadjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A5BillionMaximumBorrowingCapacityMember" abstract="true" name="A5BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_ChargebacksandcashdiscountsMember" abstract="true" name="ChargebacksandcashdiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SalesRevenueGrossMember" abstract="true" name="SalesRevenueGrossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_IntangibleAssetNameDomain" abstract="true" name="IntangibleAssetNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SeniorUnsecuredNotesDue2032Member" abstract="true" name="SeniorUnsecuredNotesDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherRegionMember" abstract="true" name="OtherRegionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OnglyzaProductLiabilityLitigationMember" abstract="true" name="OnglyzaProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.750Notesdue2035Member" abstract="true" name="A1.750Notesdue2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbilifyProductLiabilityMember" abstract="true" name="AbilifyProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LegalProceedingsAndContingenciesLineItems" abstract="true" name="LegalProceedingsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_A1BillionMaximumBorrowingCapacityMember" abstract="true" name="A1BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_IntangibleAssetNameAxis" abstract="true" name="IntangibleAssetNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberClassAction" abstract="false" name="LossContingencyPendingClaimsNumberClassAction" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_RestructuringRelatedCostsAssetImpairments" abstract="false" name="RestructuringRelatedCostsAssetImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" abstract="false" name="RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_CashDiscounts" abstract="false" name="CashDiscounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ContingentAndRegulatoryMilestoneNonCash" abstract="false" name="ContingentAndRegulatoryMilestoneNonCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_MyoKardiaAcquisitionPlanMember" abstract="true" name="MyoKardiaAcquisitionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberActive" abstract="false" name="LossContingencyPendingClaimsNumberActive" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" abstract="false" name="AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_EquityInvestmentsNonCurrent" abstract="false" name="EquityInvestmentsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RoyaltyGuaranteesCommitmentsPercent" abstract="false" name="RoyaltyGuaranteesCommitmentsPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bmy_OpdivoMember" abstract="true" name="OpdivoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_TecentriqRoyaltiesMember" abstract="true" name="TecentriqRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AntiPD1AntibodyLitigationMember" abstract="true" name="AntiPD1AntibodyLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsDomain" abstract="true" name="LicensingAndOtherArrangementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustments" abstract="false" name="GrosstoNetAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Divestituregainsandroyalties" abstract="false" name="Divestituregainsandroyalties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Divestitureandotherproceeds" abstract="false" name="Divestitureandotherproceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" abstract="false" name="LossContingencyPendingClaimsNumberIndividualInjuryClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bmy-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5a14e930-e849-45eb-bcad-119c402123d7,g:c84cb2fd-f418-4547-ab26-f641c106cb69-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1acb7e4a-d62f-4634-9e69-5958c0a6ea89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ed832f24-863e-4b68-aa6a-4157ff98c28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1acb7e4a-d62f-4634-9e69-5958c0a6ea89" xlink:to="loc_us-gaap_Revenues_ed832f24-863e-4b68-aa6a-4157ff98c28c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_083c0be0-39ad-4bc4-b0c7-a24fba732feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1acb7e4a-d62f-4634-9e69-5958c0a6ea89" xlink:to="loc_us-gaap_CostsAndExpenses_083c0be0-39ad-4bc4-b0c7-a24fba732feb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c81998ca-6b96-4b4d-8615-eb1831ced769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_84866c0a-51a0-41c5-ad34-3bee53a2ebb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c81998ca-6b96-4b4d-8615-eb1831ced769" xlink:to="loc_us-gaap_ProfitLoss_84866c0a-51a0-41c5-ad34-3bee53a2ebb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b66ca13b-70fd-47f3-bf8e-128bdc4aa6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c81998ca-6b96-4b4d-8615-eb1831ced769" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b66ca13b-70fd-47f3-bf8e-128bdc4aa6a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_10350053-aad8-47d9-87b4-8d3d546b9e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59c69f16-fd02-4026-89fa-c032abab76d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_10350053-aad8-47d9-87b4-8d3d546b9e0f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59c69f16-fd02-4026-89fa-c032abab76d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_34ad7751-e6c7-4db3-82d8-9a358cdeda87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_10350053-aad8-47d9-87b4-8d3d546b9e0f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_34ad7751-e6c7-4db3-82d8-9a358cdeda87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a97751c4-7ba5-49a6-9660-4d939d2cb238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_38e94510-2b9c-40f9-b299-92811f5706fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a97751c4-7ba5-49a6-9660-4d939d2cb238" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_38e94510-2b9c-40f9-b299-92811f5706fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_236b7823-063f-4b26-b038-fe67cf6d7d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a97751c4-7ba5-49a6-9660-4d939d2cb238" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_236b7823-063f-4b26-b038-fe67cf6d7d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_83277894-a498-4547-8f20-1bc7f2b51b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a97751c4-7ba5-49a6-9660-4d939d2cb238" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_83277894-a498-4547-8f20-1bc7f2b51b81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_ca360445-402b-4122-a670-3bf1d3d4ad83" xlink:href="bmy-20220331.xsd#bmy_AcquiredIPRD"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a97751c4-7ba5-49a6-9660-4d939d2cb238" xlink:to="loc_bmy_AcquiredIPRD_ca360445-402b-4122-a670-3bf1d3d4ad83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_91852fba-710b-4a96-878f-be9c72ee6b34" xlink:href="bmy-20220331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a97751c4-7ba5-49a6-9660-4d939d2cb238" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_91852fba-710b-4a96-878f-be9c72ee6b34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a78be26e-eb16-4b57-90eb-d383022ad0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a97751c4-7ba5-49a6-9660-4d939d2cb238" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a78be26e-eb16-4b57-90eb-d383022ad0f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4ec2aafa-ae23-49e0-b93c-8d0ae64185c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_31cc2ed1-625b-4eb8-bf2c-c490e89b02fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4ec2aafa-ae23-49e0-b93c-8d0ae64185c3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_31cc2ed1-625b-4eb8-bf2c-c490e89b02fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f0687f0f-75fb-49ed-96b6-8433368b5704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4ec2aafa-ae23-49e0-b93c-8d0ae64185c3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f0687f0f-75fb-49ed-96b6-8433368b5704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1b323997-8a18-4fcf-bee7-0297eb06b771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a732573f-869a-4a71-a03f-6956e7ff57fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1b323997-8a18-4fcf-bee7-0297eb06b771" xlink:to="loc_us-gaap_ProfitLoss_a732573f-869a-4a71-a03f-6956e7ff57fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa21e842-4f16-477d-8fcb-1d6fd4c4069b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1b323997-8a18-4fcf-bee7-0297eb06b771" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa21e842-4f16-477d-8fcb-1d6fd4c4069b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5def5754-58bd-4b75-8de3-27209d32bcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0d629223-ca82-409c-86f6-247815ea811d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5def5754-58bd-4b75-8de3-27209d32bcb6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0d629223-ca82-409c-86f6-247815ea811d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a20159b7-4bd1-4f4b-a9fc-b127cb0b074e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5def5754-58bd-4b75-8de3-27209d32bcb6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a20159b7-4bd1-4f4b-a9fc-b127cb0b074e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_be8911ce-87b6-4652-95f5-5830aca5914c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5def5754-58bd-4b75-8de3-27209d32bcb6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_be8911ce-87b6-4652-95f5-5830aca5914c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6255987c-cd42-4852-8c29-89f463ac1a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5def5754-58bd-4b75-8de3-27209d32bcb6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6255987c-cd42-4852-8c29-89f463ac1a7d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_033071dc-4223-47dd-a44d-88ab8766fd00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a41abb57-e55f-4865-9929-0c27385d1696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_033071dc-4223-47dd-a44d-88ab8766fd00" xlink:to="loc_us-gaap_Liabilities_a41abb57-e55f-4865-9929-0c27385d1696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194244b8-e658-464b-91f7-16ebd8fa3d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_033071dc-4223-47dd-a44d-88ab8766fd00" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194244b8-e658-464b-91f7-16ebd8fa3d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_008281e9-4c48-47a4-829f-35ac95633e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d0cba354-a482-4daf-b5ba-618dd5441a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_008281e9-4c48-47a4-829f-35ac95633e6e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d0cba354-a482-4daf-b5ba-618dd5441a7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4c9174d2-57a3-4be4-a833-8ebf666b5abb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_008281e9-4c48-47a4-829f-35ac95633e6e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4c9174d2-57a3-4be4-a833-8ebf666b5abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_5b82b4b8-0331-429e-83b7-84ef35537f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_008281e9-4c48-47a4-829f-35ac95633e6e" xlink:to="loc_us-gaap_ReceivablesNetCurrent_5b82b4b8-0331-429e-83b7-84ef35537f67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a496d9d3-d714-468c-9b5c-c7411feddd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_008281e9-4c48-47a4-829f-35ac95633e6e" xlink:to="loc_us-gaap_InventoryNet_a496d9d3-d714-468c-9b5c-c7411feddd37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b9c82729-deb0-4c45-9a4d-1420725df1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_008281e9-4c48-47a4-829f-35ac95633e6e" xlink:to="loc_us-gaap_OtherAssetsCurrent_b9c82729-deb0-4c45-9a4d-1420725df1a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab5b375d-a406-4bb9-8fd0-1942504b0cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_11806772-27b4-46cb-8db6-06731be934c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab5b375d-a406-4bb9-8fd0-1942504b0cf0" xlink:to="loc_us-gaap_StockholdersEquity_11806772-27b4-46cb-8db6-06731be934c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_dd06a449-e238-4330-bb90-17a926ad7186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab5b375d-a406-4bb9-8fd0-1942504b0cf0" xlink:to="loc_us-gaap_MinorityInterest_dd06a449-e238-4330-bb90-17a926ad7186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ef1c74f7-803e-4849-9a9f-5e329b42f430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fc3a794f-8c12-40b4-b569-00b307f7b96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ef1c74f7-803e-4849-9a9f-5e329b42f430" xlink:to="loc_us-gaap_LiabilitiesCurrent_fc3a794f-8c12-40b4-b569-00b307f7b96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4189bb9d-f85a-41c2-97db-3ff55d78ae1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ef1c74f7-803e-4849-9a9f-5e329b42f430" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4189bb9d-f85a-41c2-97db-3ff55d78ae1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a5489cfe-c4dc-49be-a5ce-318e559cbef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ef1c74f7-803e-4849-9a9f-5e329b42f430" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a5489cfe-c4dc-49be-a5ce-318e559cbef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e00e61fc-b3cf-4548-9667-042b6af65ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ef1c74f7-803e-4849-9a9f-5e329b42f430" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e00e61fc-b3cf-4548-9667-042b6af65ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f527dc4a-1eb0-4857-a87f-da07ed449516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a50a675d-06ec-4d77-bf01-2830c80b898a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f527dc4a-1eb0-4857-a87f-da07ed449516" xlink:to="loc_us-gaap_AssetsCurrent_a50a675d-06ec-4d77-bf01-2830c80b898a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cdfda08a-b04b-4d95-b744-3bda88c36826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f527dc4a-1eb0-4857-a87f-da07ed449516" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cdfda08a-b04b-4d95-b744-3bda88c36826" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8e8b31f1-5cf2-4b6e-ba27-72f174136cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f527dc4a-1eb0-4857-a87f-da07ed449516" xlink:to="loc_us-gaap_Goodwill_8e8b31f1-5cf2-4b6e-ba27-72f174136cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_88dc025d-1c1d-4fbb-b44c-0d03adfb5cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f527dc4a-1eb0-4857-a87f-da07ed449516" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_88dc025d-1c1d-4fbb-b44c-0d03adfb5cd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fd643be0-0025-481c-b392-52c7aaf97d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f527dc4a-1eb0-4857-a87f-da07ed449516" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fd643be0-0025-481c-b392-52c7aaf97d4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b1901fab-2fec-4e23-9a7f-d22620b1cd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f527dc4a-1eb0-4857-a87f-da07ed449516" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b1901fab-2fec-4e23-9a7f-d22620b1cd6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_186b6508-50f6-42a6-8e9b-829208aa682a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_24a26e5d-b2d4-4669-bd19-422b25436a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_186b6508-50f6-42a6-8e9b-829208aa682a" xlink:to="loc_us-gaap_PreferredStockValue_24a26e5d-b2d4-4669-bd19-422b25436a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e83c47ae-efe4-40d4-91b2-c3179d46f5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_186b6508-50f6-42a6-8e9b-829208aa682a" xlink:to="loc_us-gaap_CommonStockValue_e83c47ae-efe4-40d4-91b2-c3179d46f5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4accc8b9-277e-4517-accd-f65366b2eea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_186b6508-50f6-42a6-8e9b-829208aa682a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4accc8b9-277e-4517-accd-f65366b2eea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16b6dd55-bcf3-4115-9173-c5ae803cfd85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_186b6508-50f6-42a6-8e9b-829208aa682a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16b6dd55-bcf3-4115-9173-c5ae803cfd85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4bc92fbb-4e50-4bcc-8989-68eba4f50ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_186b6508-50f6-42a6-8e9b-829208aa682a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4bc92fbb-4e50-4bcc-8989-68eba4f50ac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_368d3048-14d0-479a-9f9c-01096a735c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_186b6508-50f6-42a6-8e9b-829208aa682a" xlink:to="loc_us-gaap_TreasuryStockValue_368d3048-14d0-479a-9f9c-01096a735c3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a077974a-e5f3-4cbe-b563-fd00ad6d579f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d9671242-94f0-4762-bdf0-81612c72ce5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a077974a-e5f3-4cbe-b563-fd00ad6d579f" xlink:to="loc_us-gaap_DebtCurrent_d9671242-94f0-4762-bdf0-81612c72ce5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_01df277f-e153-4182-90a3-90493e7d6b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a077974a-e5f3-4cbe-b563-fd00ad6d579f" xlink:to="loc_us-gaap_AccountsPayableCurrent_01df277f-e153-4182-90a3-90493e7d6b02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bbeb8ed1-722f-4060-9fac-2d705dd677c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a077974a-e5f3-4cbe-b563-fd00ad6d579f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bbeb8ed1-722f-4060-9fac-2d705dd677c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ab75b8e-3927-4142-aefc-7aa0f1dd972c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_030149bf-8677-46b5-a33e-08de9e4f6469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ab75b8e-3927-4142-aefc-7aa0f1dd972c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_030149bf-8677-46b5-a33e-08de9e4f6469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_424b582e-407d-492b-ae0e-ed366c5650eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ab75b8e-3927-4142-aefc-7aa0f1dd972c" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_424b582e-407d-492b-ae0e-ed366c5650eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_547c225a-bca0-4729-9ee4-deb2c552ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ab75b8e-3927-4142-aefc-7aa0f1dd972c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_547c225a-bca0-4729-9ee4-deb2c552ccc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_135cf759-17d7-48d0-8d76-5304a03285e9" xlink:href="bmy-20220331.xsd#bmy_Divestitureandotherproceeds"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ab75b8e-3927-4142-aefc-7aa0f1dd972c" xlink:to="loc_bmy_Divestitureandotherproceeds_135cf759-17d7-48d0-8d76-5304a03285e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b0295ec5-4783-4605-bce0-4eda1007b4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ab75b8e-3927-4142-aefc-7aa0f1dd972c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b0295ec5-4783-4605-bce0-4eda1007b4a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_9bd4635c-fd50-4cb5-863e-eafcaa42d4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ab75b8e-3927-4142-aefc-7aa0f1dd972c" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_9bd4635c-fd50-4cb5-863e-eafcaa42d4df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3695c63f-c06b-43ad-921e-423185c9c7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_ProfitLoss_3695c63f-c06b-43ad-921e-423185c9c7e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_59f58f65-3439-40ba-83d1-2a6c20f8ccef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_59f58f65-3439-40ba-83d1-2a6c20f8ccef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0556940c-074c-4122-8b8e-a8feee875704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0556940c-074c-4122-8b8e-a8feee875704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c0008376-94de-4fd1-8230-d094e694937a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_ShareBasedCompensation_c0008376-94de-4fd1-8230-d094e694937a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2fc5960f-53bd-4cea-a930-1ded57889819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2fc5960f-53bd-4cea-a930-1ded57889819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Pensionsettlementsandamortization_e07f15f8-fda6-4b75-83c3-e6f5e3926dcb" xlink:href="bmy-20220331.xsd#bmy_Pensionsettlementsandamortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_bmy_Pensionsettlementsandamortization_e07f15f8-fda6-4b75-83c3-e6f5e3926dcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_0cd91598-8561-4628-a18a-c69b6aac6848" xlink:href="bmy-20220331.xsd#bmy_Divestituregainsandroyalties"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_bmy_Divestituregainsandroyalties_0cd91598-8561-4628-a18a-c69b6aac6848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_6bf3f9a5-f9fb-4ffe-95f4-990941f606d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_GainLossOnInvestments_6bf3f9a5-f9fb-4ffe-95f4-990941f606d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f31ab22-0d2d-49d8-946f-f708b1afd678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f31ab22-0d2d-49d8-946f-f708b1afd678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_bd36bf71-cbb5-476d-9f66-9f846ddbe1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_bd36bf71-cbb5-476d-9f66-9f846ddbe1a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_687718b1-d134-493c-b778-96b211ef1358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_687718b1-d134-493c-b778-96b211ef1358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ece21343-7572-4fb7-892b-4ced39c181c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ece21343-7572-4fb7-892b-4ced39c181c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_53dd6fe6-0ce0-4e80-b075-ca168af7126a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_53dd6fe6-0ce0-4e80-b075-ca168af7126a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9f11b587-86b2-4ab0-abe7-c6312591b773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9f11b587-86b2-4ab0-abe7-c6312591b773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c5a2f861-a8dd-41ff-a832-0c4b25112c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c5a2f861-a8dd-41ff-a832-0c4b25112c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_ad9b2225-25f2-4b34-b1ed-b81fbc555cdb" xlink:href="bmy-20220331.xsd#bmy_AcquiredIPRD"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_bmy_AcquiredIPRD_ad9b2225-25f2-4b34-b1ed-b81fbc555cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_c4d4acfc-f884-4c64-8f82-0cd07bfce542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2812d63c-e483-4771-8d9f-feacdea71f70" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_c4d4acfc-f884-4c64-8f82-0cd07bfce542" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3ef660b4-d8d4-470e-9a51-f1e7a7caa670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_536ebe49-ae16-4ad7-9fd5-40a21c1f0893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3ef660b4-d8d4-470e-9a51-f1e7a7caa670" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_536ebe49-ae16-4ad7-9fd5-40a21c1f0893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1c877edc-f5ad-4a1f-b5a5-3ddfa2839a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3ef660b4-d8d4-470e-9a51-f1e7a7caa670" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1c877edc-f5ad-4a1f-b5a5-3ddfa2839a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_237e9afb-0867-4506-ad3a-cb7e7af459d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3ef660b4-d8d4-470e-9a51-f1e7a7caa670" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_237e9afb-0867-4506-ad3a-cb7e7af459d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_586e4902-04b7-4133-9d73-913ca02cb680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3ef660b4-d8d4-470e-9a51-f1e7a7caa670" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_586e4902-04b7-4133-9d73-913ca02cb680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df645d79-dd48-4af9-addb-c68b7cda0302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_add9ef3a-655d-450c-b600-ee07a20de9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df645d79-dd48-4af9-addb-c68b7cda0302" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_add9ef3a-655d-450c-b600-ee07a20de9e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d8c8a2ce-6537-481e-85e6-2cbb5c611003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df645d79-dd48-4af9-addb-c68b7cda0302" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d8c8a2ce-6537-481e-85e6-2cbb5c611003" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d6fed431-ddb7-4881-8986-a14ab97d9fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df645d79-dd48-4af9-addb-c68b7cda0302" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d6fed431-ddb7-4881-8986-a14ab97d9fa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_da94a6bb-8c35-427b-9fb2-ffbdf8719561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df645d79-dd48-4af9-addb-c68b7cda0302" xlink:to="loc_us-gaap_PaymentsOfDividends_da94a6bb-8c35-427b-9fb2-ffbdf8719561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_14e40893-cfcb-4002-84b6-992bfbb9a559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df645d79-dd48-4af9-addb-c68b7cda0302" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_14e40893-cfcb-4002-84b6-992bfbb9a559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_e65b2a03-207c-476f-a26b-dc531707b5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_df645d79-dd48-4af9-addb-c68b7cda0302" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_e65b2a03-207c-476f-a26b-dc531707b5f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f51dd0d4-368f-44f8-8df6-f42c2afd1be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_InterestExpense_f51dd0d4-368f-44f8-8df6-f42c2afd1be6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b900bde5-d45e-4a76-948b-46cfe4fc8525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b900bde5-d45e-4a76-948b-46cfe4fc8525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners_c9cb42f7-5d25-481a-80ed-78ad83ce600d" xlink:href="bmy-20220331.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_bmy_OtherIncomeReceivedFromAlliancePartners_c9cb42f7-5d25-481a-80ed-78ad83ce600d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_c967cf33-8ebb-479c-8331-2ccfc89ac87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_GainLossOnInvestments_c967cf33-8ebb-479c-8331-2ccfc89ac87d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_759b0b75-d7c1-473d-94a3-6decbb6e92ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_759b0b75-d7c1-473d-94a3-6decbb6e92ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c01c60b3-585f-4baf-bd68-652ee8ad5b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_RestructuringCharges_c01c60b3-585f-4baf-bd68-652ee8ad5b44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_7e003aad-a0b3-45fb-96dd-012fa1aca7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_7e003aad-a0b3-45fb-96dd-012fa1aca7b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceTransitionalServices_2ad19cec-802d-4a5a-a582-b012ed08f5b9" xlink:href="bmy-20220331.xsd#bmy_AllianceTransitionalServices"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_bmy_AllianceTransitionalServices_2ad19cec-802d-4a5a-a582-b012ed08f5b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_7297bc58-d511-4455-8e10-e9cd52b1e929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_InvestmentIncomeInterest_7297bc58-d511-4455-8e10-e9cd52b1e929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ec003c29-ff06-400a-af2f-a11cf8d90e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ec003c29-ff06-400a-af2f-a11cf8d90e28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9a3ea0a1-ee37-4d21-9c4e-6e9391176523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9a3ea0a1-ee37-4d21-9c4e-6e9391176523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_a3579e28-93cf-4926-a25f-63d7d5c56098" xlink:href="bmy-20220331.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_e2571f67-b4bd-491a-b1ee-28150a7e8c80" xlink:to="loc_bmy_OtherOtherIncomeExpense_a3579e28-93cf-4926-a25f-63d7d5c56098" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f22197df-a971-48eb-98e4-844d9fc52a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_7196e515-1721-44c1-bede-47f16026c986" xlink:href="bmy-20220331.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f22197df-a971-48eb-98e4-844d9fc52a83" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_7196e515-1721-44c1-bede-47f16026c986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_fcb519a8-01a8-4f99-85bd-ecfc976ab62f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f22197df-a971-48eb-98e4-844d9fc52a83" xlink:to="loc_us-gaap_RestructuringCharges_fcb519a8-01a8-4f99-85bd-ecfc976ab62f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_7c6deaeb-005e-470f-8ce1-69eab4730cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f22197df-a971-48eb-98e4-844d9fc52a83" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_7c6deaeb-005e-470f-8ce1-69eab4730cac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_b09ef3f4-1357-4c07-b942-0dbc4631a040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f22197df-a971-48eb-98e4-844d9fc52a83" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_b09ef3f4-1357-4c07-b942-0dbc4631a040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3633a341-cb43-479f-a53f-4d72bf3e0a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_cf025be5-dca1-49dc-a48f-6461a0a7163b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_3633a341-cb43-479f-a53f-4d72bf3e0a68" xlink:to="loc_us-gaap_SeveranceCosts1_cf025be5-dca1-49dc-a48f-6461a0a7163b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_1ac2fdaa-1639-45d1-943c-300a754c8aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_3633a341-cb43-479f-a53f-4d72bf3e0a68" xlink:to="loc_us-gaap_OtherRestructuringCosts_1ac2fdaa-1639-45d1-943c-300a754c8aa3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e8bad29-cd6d-4ff9-94f1-1cb2ea611d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e2d86b5-cd0f-4154-a4a2-f30c1a245e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e8bad29-cd6d-4ff9-94f1-1cb2ea611d44" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e2d86b5-cd0f-4154-a4a2-f30c1a245e07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5b4aafb3-c453-4ecf-84f0-a44a70e765b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e8bad29-cd6d-4ff9-94f1-1cb2ea611d44" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5b4aafb3-c453-4ecf-84f0-a44a70e765b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07d83c27-313c-48fa-9bba-3bfba5d68631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_89ea79d3-1e6f-43cd-b583-62d32574f958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07d83c27-313c-48fa-9bba-3bfba5d68631" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_89ea79d3-1e6f-43cd-b583-62d32574f958" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1aec31cf-f387-43ed-bdeb-d887625e58b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07d83c27-313c-48fa-9bba-3bfba5d68631" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1aec31cf-f387-43ed-bdeb-d887625e58b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_07794eae-b36b-4f58-a47c-f5b352320ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07d83c27-313c-48fa-9bba-3bfba5d68631" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_07794eae-b36b-4f58-a47c-f5b352320ec8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments_5630981e-3cc9-4e14-9980-dae4b72db422" xlink:href="bmy-20220331.xsd#bmy_EquityInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_53fdc253-6c7d-426f-9f25-5e3f0b76b77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_5630981e-3cc9-4e14-9980-dae4b72db422" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_53fdc253-6c7d-426f-9f25-5e3f0b76b77f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_af2b1ec6-bd46-4347-8916-ba98eb836fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_5630981e-3cc9-4e14-9980-dae4b72db422" xlink:to="loc_us-gaap_EquityMethodInvestments_af2b1ec6-bd46-4347-8916-ba98eb836fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_95f11e61-7132-4fe9-abaa-97de92c7100c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_EquityInvestments_5630981e-3cc9-4e14-9980-dae4b72db422" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_95f11e61-7132-4fe9-abaa-97de92c7100c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_16692b36-66bd-4746-aac3-025e706eb57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d202ffa8-8f3a-405d-8306-80c2dc159542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_16692b36-66bd-4746-aac3-025e706eb57b" xlink:to="loc_us-gaap_LongTermDebtCurrent_d202ffa8-8f3a-405d-8306-80c2dc159542" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_87f699e7-b3f4-430a-a05e-9260e67e25ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_16692b36-66bd-4746-aac3-025e706eb57b" xlink:to="loc_us-gaap_OtherShortTermBorrowings_87f699e7-b3f4-430a-a05e-9260e67e25ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_103fbbf6-c3ed-4095-b85d-ae06f85b03b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_16692b36-66bd-4746-aac3-025e706eb57b" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_103fbbf6-c3ed-4095-b85d-ae06f85b03b7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a6396e6a-68a3-4703-9ab1-ed58c8d80e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ebd84c82-fa82-4046-8140-c0b679ac1eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a6396e6a-68a3-4703-9ab1-ed58c8d80e5e" xlink:to="loc_us-gaap_LongTermDebtCurrent_ebd84c82-fa82-4046-8140-c0b679ac1eb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5edf3e5b-aed5-4634-b14b-c9e00fd50fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a6396e6a-68a3-4703-9ab1-ed58c8d80e5e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5edf3e5b-aed5-4634-b14b-c9e00fd50fab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RECEIVABLESScheduleofReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c1c8cfce-70fa-4345-a240-003075fa00bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_018f012d-7e37-40c7-87f9-3883ca29a922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_c1c8cfce-70fa-4345-a240-003075fa00bc" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_018f012d-7e37-40c7-87f9-3883ca29a922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_5fe0591e-a60d-4773-bd6e-9e5d2239317a" xlink:href="bmy-20220331.xsd#bmy_CashDiscounts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_c1c8cfce-70fa-4345-a240-003075fa00bc" xlink:to="loc_bmy_CashDiscounts_5fe0591e-a60d-4773-bd6e-9e5d2239317a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_fae03193-667a-40fa-9cc8-a8464b66b731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_c1c8cfce-70fa-4345-a240-003075fa00bc" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_fae03193-667a-40fa-9cc8-a8464b66b731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_96a15708-ef6c-4c4b-aec2-4f6b0b846691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_5ac2fe36-3c83-44c7-836b-4af2a8879f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_96a15708-ef6c-4c4b-aec2-4f6b0b846691" xlink:to="loc_us-gaap_OtherReceivables_5ac2fe36-3c83-44c7-836b-4af2a8879f5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_27ad2f9b-d581-4bfa-8692-973fecc57e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_96a15708-ef6c-4c4b-aec2-4f6b0b846691" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_27ad2f9b-d581-4bfa-8692-973fecc57e1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_739f311c-431a-4acb-a292-82ca197de90e" xlink:href="bmy-20220331.xsd#bmy_Totalinventories"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_47e62a9f-774a-4ee6-b9da-de3761b41e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_739f311c-431a-4acb-a292-82ca197de90e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_47e62a9f-774a-4ee6-b9da-de3761b41e5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a05109ba-cab2-4155-8a09-5b5f0ee4ce1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_739f311c-431a-4acb-a292-82ca197de90e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a05109ba-cab2-4155-8a09-5b5f0ee4ce1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_cc5e30e5-1e1c-44d9-9be3-e64ee9dacf59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_739f311c-431a-4acb-a292-82ca197de90e" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_cc5e30e5-1e1c-44d9-9be3-e64ee9dacf59" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b5e5a8f3-8fb7-43b6-97b3-1e9c01471650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e61c5122-42bb-4794-bcde-e83cf4900ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b5e5a8f3-8fb7-43b6-97b3-1e9c01471650" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e61c5122-42bb-4794-bcde-e83cf4900ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c59bdaaf-2b83-41c6-bc0f-d00f9a5cd11e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b5e5a8f3-8fb7-43b6-97b3-1e9c01471650" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c59bdaaf-2b83-41c6-bc0f-d00f9a5cd11e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8ee5c8d0-e8e8-4f49-8ebf-d12297b694cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4a468ca8-df79-4ab0-920f-5f90bfbb6667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8ee5c8d0-e8e8-4f49-8ebf-d12297b694cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4a468ca8-df79-4ab0-920f-5f90bfbb6667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_202f253d-fc54-4629-8162-3ffcd764eec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8ee5c8d0-e8e8-4f49-8ebf-d12297b694cd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_202f253d-fc54-4629-8162-3ffcd764eec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56c3eb8a-ddf0-4518-8946-585c9065ad44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e077e04e-c952-473e-a71f-a8852a49e1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56c3eb8a-ddf0-4518-8946-585c9065ad44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e077e04e-c952-473e-a71f-a8852a49e1f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_77741ceb-4103-416b-a414-39878291dd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56c3eb8a-ddf0-4518-8946-585c9065ad44" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_77741ceb-4103-416b-a414-39878291dd1a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_98764e40-3a23-4edf-a1b3-d36b858822a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment_29596a12-fa39-4984-a12b-df54563e66af" xlink:href="bmy-20220331.xsd#bmy_ResearchandDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_98764e40-3a23-4edf-a1b3-d36b858822a0" xlink:to="loc_bmy_ResearchandDevelopment_29596a12-fa39-4984-a12b-df54563e66af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_78668f07-7213-4932-9dc1-cbb658ec695a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_98764e40-3a23-4edf-a1b3-d36b858822a0" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_78668f07-7213-4932-9dc1-cbb658ec695a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent_67bc340b-aae5-43fd-be2f-d5a1143e0d6d" xlink:href="bmy-20220331.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_98764e40-3a23-4edf-a1b3-d36b858822a0" xlink:to="loc_bmy_EquityInvestmentsCurrent_67bc340b-aae5-43fd-be2f-d5a1143e0d6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_138cabb8-0ee9-49e9-8b27-9a5bdc30e190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_98764e40-3a23-4edf-a1b3-d36b858822a0" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_138cabb8-0ee9-49e9-8b27-9a5bdc30e190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_d0a2cfba-5a4e-41d9-847a-3693d7a024c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_98764e40-3a23-4edf-a1b3-d36b858822a0" xlink:to="loc_us-gaap_PrepaidTaxes_d0a2cfba-5a4e-41d9-847a-3693d7a024c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_61e5f43b-b58b-44cc-83b8-f794c0883ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_98764e40-3a23-4edf-a1b3-d36b858822a0" xlink:to="loc_us-gaap_RestrictedCash_61e5f43b-b58b-44cc-83b8-f794c0883ccb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6bb8a5d5-d966-411b-a4da-416edcaabf72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6bb8a5d5-d966-411b-a4da-416edcaabf72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent_e702ffda-510c-45db-a77a-b641b53128ec" xlink:href="bmy-20220331.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:to="loc_bmy_ResearchAndDevelopmentNonCurrent_e702ffda-510c-45db-a77a-b641b53128ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_b4ec072f-ed2c-470f-9ea5-0a53a6abe1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:to="loc_us-gaap_InventoryNoncurrent_b4ec072f-ed2c-470f-9ea5-0a53a6abe1f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_15d6cf0c-d315-4453-a59c-0968b40396f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_15d6cf0c-d315-4453-a59c-0968b40396f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bc02d2fa-bd01-4bf0-b0eb-43c20c23eb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bc02d2fa-bd01-4bf0-b0eb-43c20c23eb4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent_d3cb22ce-8684-4b9a-ae9f-701f83bbd73c" xlink:href="bmy-20220331.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:to="loc_bmy_EquityInvestmentsNonCurrent_d3cb22ce-8684-4b9a-ae9f-701f83bbd73c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ee65f903-0685-44ad-9dae-4b6c482379e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460847e0-f7db-4eda-b729-58837df7c094" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ee65f903-0685-44ad-9dae-4b6c482379e7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b2235dff-7cd9-4a72-9338-2556d3cf75b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b2235dff-7cd9-4a72-9338-2556d3cf75b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment_0b4755d6-a38e-40e1-9edb-6f7f13a989be" xlink:href="bmy-20220331.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_bmy_AccruedResearchAndDevelopment_0b4755d6-a38e-40e1-9edb-6f7f13a989be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_a5b82989-26c0-4b05-a2cb-c1b2590f8387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_us-gaap_DividendsPayableCurrent_a5b82989-26c0-4b05-a2cb-c1b2590f8387" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest_3cd64b30-fe3a-4c3f-8adb-8f35de8999d1" xlink:href="bmy-20220331.xsd#bmy_AccruedInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_bmy_AccruedInterest_3cd64b30-fe3a-4c3f-8adb-8f35de8999d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d65612df-8f34-47de-9e0c-9b37df15b625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d65612df-8f34-47de-9e0c-9b37df15b625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_ac6564ef-ff36-4600-961e-8730dba5103a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_ac6564ef-ff36-4600-961e-8730dba5103a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns_aa4735a3-4592-44ee-a149-c9ce517ef62f" xlink:href="bmy-20220331.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_bmy_AccruedRebatesAndReturns_aa4735a3-4592-44ee-a149-c9ce517ef62f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8903a97d-ad6f-4a6f-838b-87e764ec2be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8903a97d-ad6f-4a6f-838b-87e764ec2be2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_135511aa-5c33-4814-956a-0ba69428e25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_f156a712-79ce-4299-89fd-89d0356d8efd" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_135511aa-5c33-4814-956a-0ba69428e25b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f7730f2b-871d-47a4-a8b1-0cfe541732eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_941694e9-6003-42ce-921f-ad84348b4929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_f7730f2b-871d-47a4-a8b1-0cfe541732eb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_941694e9-6003-42ce-921f-ad84348b4929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_73e831bf-64be-4436-afaf-7435e808d961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_f7730f2b-871d-47a4-a8b1-0cfe541732eb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_73e831bf-64be-4436-afaf-7435e808d961" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a930f454-b6af-428a-98f6-833b44cb11f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_f7730f2b-871d-47a4-a8b1-0cfe541732eb" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_a930f454-b6af-428a-98f6-833b44cb11f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_e83dcc5a-0dcc-4e93-bbd1-dcbb5d0ba29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_f7730f2b-871d-47a4-a8b1-0cfe541732eb" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_e83dcc5a-0dcc-4e93-bbd1-dcbb5d0ba29e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_e8571bf4-278d-4c07-9494-32a623c9b904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_f7730f2b-871d-47a4-a8b1-0cfe541732eb" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_e8571bf4-278d-4c07-9494-32a623c9b904" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5bb05f1a-2e41-44d5-9cf3-17a362b2411f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_f7730f2b-871d-47a4-a8b1-0cfe541732eb" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_5bb05f1a-2e41-44d5-9cf3-17a362b2411f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYScheduleofComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_89ac83e9-fa58-473d-9dd1-a7de60897a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_457af346-acff-4d3d-87fb-ec157194c265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_89ac83e9-fa58-473d-9dd1-a7de60897a28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_457af346-acff-4d3d-87fb-ec157194c265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a4e2b578-aab6-47e2-ab36-93967390127f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_89ac83e9-fa58-473d-9dd1-a7de60897a28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a4e2b578-aab6-47e2-ab36-93967390127f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_d5faca30-820d-46a7-9da9-82ac22f2a350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_89ac83e9-fa58-473d-9dd1-a7de60897a28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_d5faca30-820d-46a7-9da9-82ac22f2a350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_53c4e7bf-e30d-4179-8b8c-f26a116f7692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_89ac83e9-fa58-473d-9dd1-a7de60897a28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_53c4e7bf-e30d-4179-8b8c-f26a116f7692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_92df2301-b508-425d-9a70-b68c5fb89a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_4e9e99fb-2d02-4fdb-80b9-2d997ee5bfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_92df2301-b508-425d-9a70-b68c5fb89a97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_4e9e99fb-2d02-4fdb-80b9-2d997ee5bfb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c191aa15-607a-436f-84f1-48b74171809d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_92df2301-b508-425d-9a70-b68c5fb89a97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c191aa15-607a-436f-84f1-48b74171809d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_d2245198-8e3e-4ad2-884f-33d11398b6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_92df2301-b508-425d-9a70-b68c5fb89a97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_d2245198-8e3e-4ad2-884f-33d11398b6e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_553b2672-bb01-4bc1-8296-5a5179964b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_92df2301-b508-425d-9a70-b68c5fb89a97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_553b2672-bb01-4bc1-8296-5a5179964b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_f3e623af-9ea1-448f-9465-fa07ccff71f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_c7647e61-1951-4dd2-be29-8bb15f0144ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_f3e623af-9ea1-448f-9465-fa07ccff71f5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_c7647e61-1951-4dd2-be29-8bb15f0144ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_bfb20b54-c082-4517-aa56-c1521d69ff76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_f3e623af-9ea1-448f-9465-fa07ccff71f5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_bfb20b54-c082-4517-aa56-c1521d69ff76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_febaf92a-c272-4c46-b064-5dbfd312e611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_f3e623af-9ea1-448f-9465-fa07ccff71f5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_febaf92a-c272-4c46-b064-5dbfd312e611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_114cd723-149f-4d2c-9609-ad9a2abf3492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_1e5ad234-e3f7-47b6-b872-5fbeaee135b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_114cd723-149f-4d2c-9609-ad9a2abf3492" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_1e5ad234-e3f7-47b6-b872-5fbeaee135b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f765c0d9-22cb-440c-93f9-86cca92a4cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_114cd723-149f-4d2c-9609-ad9a2abf3492" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f765c0d9-22cb-440c-93f9-86cca92a4cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_dee968f5-12e1-42cf-bb74-2a1282a695f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d07ce8b8-1291-4aa7-971b-91226eac06b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_dee968f5-12e1-42cf-bb74-2a1282a695f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d07ce8b8-1291-4aa7-971b-91226eac06b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_d8a50b48-6c63-49a2-a8ce-62d87d3ac9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_dee968f5-12e1-42cf-bb74-2a1282a695f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_d8a50b48-6c63-49a2-a8ce-62d87d3ac9c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_e59b459f-daab-4047-b004-6d40f5843491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c0119e74-cfd1-4010-9073-f644d553ebde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_e59b459f-daab-4047-b004-6d40f5843491" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c0119e74-cfd1-4010-9073-f644d553ebde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5f81b345-e011-46a6-8af4-422c992c3ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_e59b459f-daab-4047-b004-6d40f5843491" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5f81b345-e011-46a6-8af4-422c992c3ccf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9ca7e0cb-a3ab-46b6-9797-089e0d7e670b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_56e34108-5f65-4d6e-9574-7c4a61d90320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9ca7e0cb-a3ab-46b6-9797-089e0d7e670b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_56e34108-5f65-4d6e-9574-7c4a61d90320" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_dea04cb6-e2d2-4320-bc36-c184669b1e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9ca7e0cb-a3ab-46b6-9797-089e0d7e670b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_dea04cb6-e2d2-4320-bc36-c184669b1e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_2eb56e1b-95df-4946-8f89-6d93d85dceb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9ca7e0cb-a3ab-46b6-9797-089e0d7e670b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_2eb56e1b-95df-4946-8f89-6d93d85dceb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_df83f6cc-5c21-4a02-b905-e9587a7b3be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_fe0a6dc6-88b5-4af3-8c95-258fcf25f104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_df83f6cc-5c21-4a02-b905-e9587a7b3be5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_fe0a6dc6-88b5-4af3-8c95-258fcf25f104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0ce253e8-c3d6-49c2-8a57-2ec7ef13a383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_df83f6cc-5c21-4a02-b905-e9587a7b3be5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0ce253e8-c3d6-49c2-8a57-2ec7ef13a383" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_7a340185-dc50-4fee-a1f8-6a569d006653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_df83f6cc-5c21-4a02-b905-e9587a7b3be5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_7a340185-dc50-4fee-a1f8-6a569d006653" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7969d6d3-3eaa-4284-a66c-871c0e8e3257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_97fd7fc9-9102-4eff-aba5-e0ebe725ded2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7969d6d3-3eaa-4284-a66c-871c0e8e3257" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_97fd7fc9-9102-4eff-aba5-e0ebe725ded2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_717bbe3b-e637-48c7-8266-025c6f804bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7969d6d3-3eaa-4284-a66c-871c0e8e3257" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_717bbe3b-e637-48c7-8266-025c6f804bfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_58358a88-7073-49ea-aa39-7bed0466bec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7969d6d3-3eaa-4284-a66c-871c0e8e3257" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_58358a88-7073-49ea-aa39-7bed0466bec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_38d62d63-7511-4e82-90c2-fdc6573b82fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7969d6d3-3eaa-4284-a66c-871c0e8e3257" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_38d62d63-7511-4e82-90c2-fdc6573b82fb" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bmy-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5a14e930-e849-45eb-bcad-119c402123d7,g:c84cb2fd-f418-4547-ab26-f641c106cb69-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="bmy-20220331.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="extended" id="i05dd5e1f91384493b290979e41733de8_DocumentandEntityInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fd53f6c3-c2b9-4948-8be4-2974b0fd40e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentType_fd53f6c3-c2b9-4948-8be4-2974b0fd40e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4c873ddf-91e8-446e-aeed-b1df679c3166" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentQuarterlyReport_4c873ddf-91e8-446e-aeed-b1df679c3166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b1d5ebba-6a41-408f-89a4-c4f0a12b4c80" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentPeriodEndDate_b1d5ebba-6a41-408f-89a4-c4f0a12b4c80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_397417ca-796a-42dc-afa5-bb5d2b5fddb0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentTransitionReport_397417ca-796a-42dc-afa5-bb5d2b5fddb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_93886dcc-88a9-4603-a7c7-a79ad1026597" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityFileNumber_93886dcc-88a9-4603-a7c7-a79ad1026597" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b48e9091-63d0-4c26-8dcb-961197425069" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityRegistrantName_b48e9091-63d0-4c26-8dcb-961197425069" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_343e18ac-ece7-4d1f-bab2-74e5d816482b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_343e18ac-ece7-4d1f-bab2-74e5d816482b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6e5ca6cb-72eb-4499-ac09-2f133d751cca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityTaxIdentificationNumber_6e5ca6cb-72eb-4499-ac09-2f133d751cca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_fa1d331c-baea-45f9-b150-789c6a18d009" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressAddressLine1_fa1d331c-baea-45f9-b150-789c6a18d009" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_09a9f3e3-0830-4a86-aae9-d40787bbece0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressCityOrTown_09a9f3e3-0830-4a86-aae9-d40787bbece0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d6d08390-df1a-4253-83c9-4331e043528d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressStateOrProvince_d6d08390-df1a-4253-83c9-4331e043528d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7ceb8334-9d96-409c-b0b6-00ba90f5e48b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressPostalZipCode_7ceb8334-9d96-409c-b0b6-00ba90f5e48b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d82577cc-5318-49c7-a51e-c41098924a0c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_CityAreaCode_d82577cc-5318-49c7-a51e-c41098924a0c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f7f4a671-5017-485c-99a9-b075c1064143" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_LocalPhoneNumber_f7f4a671-5017-485c-99a9-b075c1064143" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_88c9b14a-c139-4d81-847e-c1ed91d5a782" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_Security12bTitle_88c9b14a-c139-4d81-847e-c1ed91d5a782" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8c932a8d-564a-4ec3-9b8a-d7e583ef746a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_TradingSymbol_8c932a8d-564a-4ec3-9b8a-d7e583ef746a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fa4f77d7-a7f1-42e2-bdcb-33d67a4adec3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_SecurityExchangeName_fa4f77d7-a7f1-42e2-bdcb-33d67a4adec3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f41480a7-03b0-4457-8fea-be3a2f698c5f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityCurrentReportingStatus_f41480a7-03b0-4457-8fea-be3a2f698c5f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a1c3dab5-bb29-458d-90d4-779142e6c494" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityInteractiveDataCurrent_a1c3dab5-bb29-458d-90d4-779142e6c494" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e9dc40d9-9868-48af-8214-5acebd57b72e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityFilerCategory_e9dc40d9-9868-48af-8214-5acebd57b72e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e5430a81-92a3-4b7b-884f-c8343362267d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityEmergingGrowthCompany_e5430a81-92a3-4b7b-884f-c8343362267d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_06dd6604-917e-4a23-abf5-2da0564ad3e6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityShellCompany_06dd6604-917e-4a23-abf5-2da0564ad3e6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_582ba36b-d532-4c2a-b4d5-567699a2357f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_582ba36b-d532-4c2a-b4d5-567699a2357f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0c2be1cf-df7f-4a78-92f4-d858d3f7d08b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityCentralIndexKey_0c2be1cf-df7f-4a78-92f4-d858d3f7d08b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ab785ddc-44ba-4dec-bd2e-f6bc242f0d86" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentFiscalYearFocus_ab785ddc-44ba-4dec-bd2e-f6bc242f0d86" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_22106f08-df82-4c11-98b7-4261a8215a96" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_22106f08-df82-4c11-98b7-4261a8215a96" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_107926ec-d14e-42fe-b6cf-6ee926156b2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_CurrentFiscalYearEndDate_107926ec-d14e-42fe-b6cf-6ee926156b2d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a322adf3-0c07-4605-934c-6dffa23cd7fa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_AmendmentFlag_a322adf3-0c07-4605-934c-6dffa23cd7fa" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2716e36f-eece-4a05-922f-d52dc7939403" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntitySmallBusiness_2716e36f-eece-4a05-922f-d52dc7939403" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e8865568-aadb-4bdd-b13b-e022285aa2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_us-gaap_StatementTable_e8865568-aadb-4bdd-b13b-e022285aa2e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5716ade1-a3b5-4937-93ce-98dd0005f8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e8865568-aadb-4bdd-b13b-e022285aa2e3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5716ade1-a3b5-4937-93ce-98dd0005f8e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5716ade1-a3b5-4937-93ce-98dd0005f8e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5716ade1-a3b5-4937-93ce-98dd0005f8e3" xlink:to="loc_us-gaap_ClassOfStockDomain_5716ade1-a3b5-4937-93ce-98dd0005f8e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5716ade1-a3b5-4937-93ce-98dd0005f8e3" xlink:to="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_a1bbe15e-2513-499e-8c87-42942eba4fe8" xlink:href="bmy-20220331.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_CommonStock0.10ParValueMember_a1bbe15e-2513-499e-8c87-42942eba4fe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_cbe951fa-bc7d-4e6a-9dda-75328b1a901f" xlink:href="bmy-20220331.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_A1.000Notesdue2025Member_cbe951fa-bc7d-4e6a-9dda-75328b1a901f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_77953759-3e35-405b-ac21-7716f7614211" xlink:href="bmy-20220331.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_A1.750Notesdue2035Member_77953759-3e35-405b-ac21-7716f7614211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_7accb542-82cc-4453-838a-c238473740f7" xlink:href="bmy-20220331.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_7accb542-82cc-4453-838a-c238473740f7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="extended" id="i2685d25f763f4a8dbd7b1b9a73485234_CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9b486b2b-c0bc-48f3-8ac6-49b83051c408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_Revenues_9b486b2b-c0bc-48f3-8ac6-49b83051c408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bc57e02a-e6f8-4f6d-89d4-9a41970936ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bc57e02a-e6f8-4f6d-89d4-9a41970936ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05bb1d91-47a6-44ca-8b9e-b8beb133df13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05bb1d91-47a6-44ca-8b9e-b8beb133df13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5aa89fef-0a85-4a01-96af-5e4c59af7aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5aa89fef-0a85-4a01-96af-5e4c59af7aed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_cee63996-5425-4070-bfbc-2a8d7e0c7892" xlink:href="bmy-20220331.xsd#bmy_AcquiredIPRD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_bmy_AcquiredIPRD_cee63996-5425-4070-bfbc-2a8d7e0c7892" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_790b4558-ba82-48ff-bc91-e473feb60210" xlink:href="bmy-20220331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_790b4558-ba82-48ff-bc91-e473feb60210" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_09ef6ada-f6e3-4407-9a08-deb7afd77849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_09ef6ada-f6e3-4407-9a08-deb7afd77849" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9d056898-8fc7-45a4-9316-809478bd732c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_CostsAndExpenses_9d056898-8fc7-45a4-9316-809478bd732c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4f673f8-52f0-4f83-8f6b-e285a7c1aa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4f673f8-52f0-4f83-8f6b-e285a7c1aa94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7990a191-af21-4fcd-93d4-94e44c6dfa90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7990a191-af21-4fcd-93d4-94e44c6dfa90" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b2ac9ba5-9324-4def-ad08-28ee4f39f1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_ProfitLoss_b2ac9ba5-9324-4def-ad08-28ee4f39f1f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb2a38ae-e7fe-4161-b1d0-a76a39c57247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb2a38ae-e7fe-4161-b1d0-a76a39c57247" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aa93abe1-edc3-4390-8147-2b493018d7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_NetIncomeLoss_aa93abe1-edc3-4390-8147-2b493018d7ce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_319c3f38-9a45-4794-a14a-1f4ac5294dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_EarningsPerShareBasic_319c3f38-9a45-4794-a14a-1f4ac5294dca" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_56d4e7bb-30b0-42ab-aa07-1cb5ac58ddd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_EarningsPerShareDiluted_56d4e7bb-30b0-42ab-aa07-1cb5ac58ddd0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3ab31667-3b70-44e2-bb11-5f68bdd84bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_StatementTable_3ab31667-3b70-44e2-bb11-5f68bdd84bd2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_2ae9dfd2-607b-4b04-b956-23089602d99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3ab31667-3b70-44e2-bb11-5f68bdd84bd2" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_2ae9dfd2-607b-4b04-b956-23089602d99d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_2ae9dfd2-607b-4b04-b956-23089602d99d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_2ae9dfd2-607b-4b04-b956-23089602d99d" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_2ae9dfd2-607b-4b04-b956-23089602d99d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_2ae9dfd2-607b-4b04-b956-23089602d99d" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_da63c49b-b698-4419-973a-80b731f869b4" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:to="loc_bmy_NetproductsalesMember_da63c49b-b698-4419-973a-80b731f869b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_c8ea5656-784a-46a8-8d0f-b07435c5a250" xlink:href="bmy-20220331.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:to="loc_bmy_AllianceandotherrevenuesMember_c8ea5656-784a-46a8-8d0f-b07435c5a250" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended" id="i0dfccd5c32bd474ba1ba7eaf3ff295d5_RevenueDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b1d7b0-604d-439e-a8b9-219e4534a7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5c7e0347-a7a8-4ac0-b965-4c63f78f74d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b1d7b0-604d-439e-a8b9-219e4534a7d9" xlink:to="loc_us-gaap_Revenues_5c7e0347-a7a8-4ac0-b965-4c63f78f74d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b1d7b0-604d-439e-a8b9-219e4534a7d9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_77e23460-38a6-4553-a8f0-d016ca7424e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:to="loc_us-gaap_TypeOfArrangementAxis_77e23460-38a6-4553-a8f0-d016ca7424e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_77e23460-38a6-4553-a8f0-d016ca7424e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_77e23460-38a6-4553-a8f0-d016ca7424e7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_77e23460-38a6-4553-a8f0-d016ca7424e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_034c4807-a34f-49d8-afe5-c9102bf035c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_77e23460-38a6-4553-a8f0-d016ca7424e7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_034c4807-a34f-49d8-afe5-c9102bf035c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_88cb9cc4-bef5-41ea-857a-d9d4a6d1a3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_034c4807-a34f-49d8-afe5-c9102bf035c1" xlink:to="loc_us-gaap_CollaborativeArrangementMember_88cb9cc4-bef5-41ea-857a-d9d4a6d1a3ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a642867c-e85a-4774-bdca-06ae7e333d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a642867c-e85a-4774-bdca-06ae7e333d84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_a642867c-e85a-4774-bdca-06ae7e333d84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a642867c-e85a-4774-bdca-06ae7e333d84" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_a642867c-e85a-4774-bdca-06ae7e333d84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a642867c-e85a-4774-bdca-06ae7e333d84" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_3f49279b-b1d9-470d-8041-a66fd975db96" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:to="loc_bmy_NetproductsalesMember_3f49279b-b1d9-470d-8041-a66fd975db96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_fc44a42a-4c00-4c4b-966f-4b539b05dd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:to="loc_us-gaap_CollaborativeArrangementMember_fc44a42a-4c00-4c4b-966f-4b539b05dd19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember_99b95273-b48a-4403-989a-efafb3c79dd0" xlink:href="bmy-20220331.xsd#bmy_OtherrevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:to="loc_bmy_OtherrevenuesMember_99b95273-b48a-4403-989a-efafb3c79dd0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="extended" id="ia42a0fa2dda8408eac2338935cfd1ee8_RevenueReconciliationofGrossProductSalestoNetProductSalesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_53f3db5f-68b6-42b4-b178-ed82c072cd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:to="loc_us-gaap_Revenues_53f3db5f-68b6-42b4-b178-ed82c072cd89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_79bbaa81-2b99-4696-9a82-1e2bade3043c" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:to="loc_bmy_GrosstoNetAdjustments_79bbaa81-2b99-4696-9a82-1e2bade3043c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_de78e48d-de28-4252-8242-8729914387c1" xlink:href="bmy-20220331.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:to="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_de78e48d-de28-4252-8242-8729914387c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5_default" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_68205f46-c77c-4630-b85b-8d6fbf8889fb" xlink:href="bmy-20220331.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_68205f46-c77c-4630-b85b-8d6fbf8889fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_e2fe8883-f4cc-4c48-8a5d-62ae79e7ee11" xlink:href="bmy-20220331.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_e2fe8883-f4cc-4c48-8a5d-62ae79e7ee11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_05022156-b475-4fc9-99b5-fb6997350711" xlink:href="bmy-20220331.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_05022156-b475-4fc9-99b5-fb6997350711" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_95674de8-5a83-4e00-a6a4-77f4f9886b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_95674de8-5a83-4e00-a6a4-77f4f9886b97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_95674de8-5a83-4e00-a6a4-77f4f9886b97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_95674de8-5a83-4e00-a6a4-77f4f9886b97" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_95674de8-5a83-4e00-a6a4-77f4f9886b97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_95674de8-5a83-4e00-a6a4-77f4f9886b97" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_b6d50597-a034-458f-97e7-175ce74d7e3c" xlink:href="bmy-20220331.xsd#bmy_SalesRevenueGrossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:to="loc_bmy_SalesRevenueGrossMember_b6d50597-a034-458f-97e7-175ce74d7e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_aeb8d327-e8b2-4ca1-86fb-0618eb2fb010" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:to="loc_bmy_NetproductsalesMember_aeb8d327-e8b2-4ca1-86fb-0618eb2fb010" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RevenueDisaggregationofRevenuebyProductandRegionDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails" xlink:type="extended" id="ia2754f85a9ac40d1a47ee77154c9b424_RevenueDisaggregationofRevenuebyProductandRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_89248fef-6045-4552-ae99-a755f95807f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:to="loc_us-gaap_Revenues_89248fef-6045-4552-ae99-a755f95807f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_c6d47c62-4b94-4604-83d4-335112a663a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_c6d47c62-4b94-4604-83d4-335112a663a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1fdae943-2eaa-492d-b31d-bb884aaff780" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:to="loc_srt_ProductOrServiceAxis_1fdae943-2eaa-492d-b31d-bb884aaff780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1fdae943-2eaa-492d-b31d-bb884aaff780_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1fdae943-2eaa-492d-b31d-bb884aaff780" xlink:to="loc_srt_ProductsAndServicesDomain_1fdae943-2eaa-492d-b31d-bb884aaff780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1fdae943-2eaa-492d-b31d-bb884aaff780" xlink:to="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_b1459eb1-5905-49bb-ac76-4e0c0774a5a5" xlink:href="bmy-20220331.xsd#bmy_EliquisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_EliquisMember_b1459eb1-5905-49bb-ac76-4e0c0774a5a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_b9404218-32db-4c78-802d-428e18db243a" xlink:href="bmy-20220331.xsd#bmy_OpdivoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OpdivoMember_b9404218-32db-4c78-802d-428e18db243a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_5bb92f28-28df-4a5a-8735-5e721b154c74" xlink:href="bmy-20220331.xsd#bmy_PomalystImnovidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_PomalystImnovidMember_5bb92f28-28df-4a5a-8735-5e721b154c74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_41b14576-3f1e-449f-9b26-27c894875da2" xlink:href="bmy-20220331.xsd#bmy_OrenciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OrenciaMember_41b14576-3f1e-449f-9b26-27c894875da2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_26d4366c-e66c-4c12-a8fd-83b5881ab58c" xlink:href="bmy-20220331.xsd#bmy_SprycelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_SprycelMember_26d4366c-e66c-4c12-a8fd-83b5881ab58c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_87bb2ded-f1e9-4614-a0d8-c5c32b61adcc" xlink:href="bmy-20220331.xsd#bmy_YervoyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_YervoyMember_87bb2ded-f1e9-4614-a0d8-c5c32b61adcc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember_4e1d674c-2310-4e06-92f0-39bdb1d76a6b" xlink:href="bmy-20220331.xsd#bmy_EmplicitiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_EmplicitiMember_4e1d674c-2310-4e06-92f0-39bdb1d76a6b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember_920e7407-3f12-4388-9aa2-1c7124498f48" xlink:href="bmy-20220331.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_MatureAndOtherBrandsMember_920e7407-3f12-4388-9aa2-1c7124498f48" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_b1bc6277-81e4-41d4-9460-4ab4150c4508" xlink:href="bmy-20220331.xsd#bmy_ReblozylMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_ReblozylMember_b1bc6277-81e4-41d4-9460-4ab4150c4508" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_c2f9eb22-0524-4511-bea3-cc969c6367fb" xlink:href="bmy-20220331.xsd#bmy_AbecmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_AbecmaMember_c2f9eb22-0524-4511-bea3-cc969c6367fb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_6421c64a-da5b-46ca-8b79-18b280c5bb72" xlink:href="bmy-20220331.xsd#bmy_ZeposiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_ZeposiaMember_6421c64a-da5b-46ca-8b79-18b280c5bb72" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_1e9c988c-ad0e-4bab-9f1f-3009d445469d" xlink:href="bmy-20220331.xsd#bmy_BreyanziMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_BreyanziMember_1e9c988c-ad0e-4bab-9f1f-3009d445469d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_7e80dcf1-742b-42ea-b087-7dc8d478ac78" xlink:href="bmy-20220331.xsd#bmy_InrebicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_InrebicMember_7e80dcf1-742b-42ea-b087-7dc8d478ac78" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_7c2f39ae-de87-4258-a5df-42ba13225ad9" xlink:href="bmy-20220331.xsd#bmy_OnuregMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OnuregMember_7c2f39ae-de87-4258-a5df-42ba13225ad9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember_91189c6e-4c73-4293-9eed-71d4e1c5b1cc" xlink:href="bmy-20220331.xsd#bmy_OpdualagMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OpdualagMember_91189c6e-4c73-4293-9eed-71d4e1c5b1cc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_9af1aaeb-bcd1-4610-bd7b-14f92986acd4" xlink:href="bmy-20220331.xsd#bmy_RevlimidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_RevlimidMember_9af1aaeb-bcd1-4610-bd7b-14f92986acd4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_30306060-9373-4783-ac5e-0a7864bca855" xlink:href="bmy-20220331.xsd#bmy_AbraxaneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_AbraxaneMember_30306060-9373-4783-ac5e-0a7864bca855" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0d122e5-9849-4e2a-9da1-7751781ec539" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:to="loc_srt_StatementGeographicalAxis_a0d122e5-9849-4e2a-9da1-7751781ec539" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a0d122e5-9849-4e2a-9da1-7751781ec539_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a0d122e5-9849-4e2a-9da1-7751781ec539" xlink:to="loc_srt_SegmentGeographicalDomain_a0d122e5-9849-4e2a-9da1-7751781ec539_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a0d122e5-9849-4e2a-9da1-7751781ec539" xlink:to="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_660ab4a3-2a4a-41c4-9d5e-6d3ee63aae0a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_country_US_660ab4a3-2a4a-41c4-9d5e-6d3ee63aae0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_21fd762f-0ea8-47bb-9a54-596b467c8c6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_srt_EuropeMember_21fd762f-0ea8-47bb-9a54-596b467c8c6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestOfWorldMember_9a582851-ebad-4bd3-b982-33eb49fdc320" xlink:href="bmy-20220331.xsd#bmy_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_bmy_RestOfWorldMember_9a582851-ebad-4bd3-b982-33eb49fdc320" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_c4a100cc-7cbe-4825-9fe5-0c9f6902be87" xlink:href="bmy-20220331.xsd#bmy_OtherRegionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_bmy_OtherRegionMember_c4a100cc-7cbe-4825-9fe5-0c9f6902be87" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#ALLIANCESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended" id="icf8c542f0ff24672922792d97860ca71_ALLIANCESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bbf84692-136c-4021-b771-19f578a7b899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_Revenues_bbf84692-136c-4021-b771-19f578a7b899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_689f7f8d-1328-4212-9548-7397841e5664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_689f7f8d-1328-4212-9548-7397841e5664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_d2476718-4d85-4382-903f-dbfd542370e0" xlink:href="bmy-20220331.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_d2476718-4d85-4382-903f-dbfd542370e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ecec5d04-02ab-40bd-a9f7-f06a40406be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ecec5d04-02ab-40bd-a9f7-f06a40406be0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2994a8e7-d7e6-4970-87f0-0785b40fb875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2994a8e7-d7e6-4970-87f0-0785b40fb875" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_b1eea8aa-d39c-4bfc-9c33-233966912afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_ReceivablesNetCurrent_b1eea8aa-d39c-4bfc-9c33-233966912afe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_123d78b6-5a79-47ea-9b66-3f2ec8d351c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_AccountsPayableCurrent_123d78b6-5a79-47ea-9b66-3f2ec8d351c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_0c093a4f-35db-4ced-af9d-4ce0bf52e5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_DeferredIncome_0c093a4f-35db-4ced-af9d-4ce0bf52e5dd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_6bee7e22-2263-4fc6-bba6-023b6dcea3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_6bee7e22-2263-4fc6-bba6-023b6dcea3e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_6bee7e22-2263-4fc6-bba6-023b6dcea3e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_6bee7e22-2263-4fc6-bba6-023b6dcea3e2" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_6bee7e22-2263-4fc6-bba6-023b6dcea3e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_6bee7e22-2263-4fc6-bba6-023b6dcea3e2" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_37225e08-507e-4436-8e2a-0224dc1adc26" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:to="loc_bmy_NetproductsalesMember_37225e08-507e-4436-8e2a-0224dc1adc26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_c32a787c-aa5a-4216-9bef-0548e4b49de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:to="loc_us-gaap_CollaborativeArrangementMember_c32a787c-aa5a-4216-9bef-0548e4b49de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c994c021-ee64-44aa-9cab-40d4145884be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c994c021-ee64-44aa-9cab-40d4145884be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_860754d2-0f3c-417c-b972-b50e5147e41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c994c021-ee64-44aa-9cab-40d4145884be" xlink:to="loc_us-gaap_CollaborativeArrangementMember_860754d2-0f3c-417c-b972-b50e5147e41d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="extended" id="iec5c2aea19b84cc1b791ec93a7f81dab_DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e0732e93-cf8a-4b33-9e2e-022def7d7c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e0732e93-cf8a-4b33-9e2e-022def7d7c3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ce858bfe-eaf6-4c7a-b255-7ca98961a779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ce858bfe-eaf6-4c7a-b255-7ca98961a779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_2386fad0-2238-46fd-b256-8cd608c9fdac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_2386fad0-2238-46fd-b256-8cd608c9fdac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9d2b1715-7ca3-43cc-a6fb-80bbf770498e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9d2b1715-7ca3-43cc-a6fb-80bbf770498e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9d2b1715-7ca3-43cc-a6fb-80bbf770498e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9d2b1715-7ca3-43cc-a6fb-80bbf770498e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9d2b1715-7ca3-43cc-a6fb-80bbf770498e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9d2b1715-7ca3-43cc-a6fb-80bbf770498e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_748183b1-11ad-421e-b166-d9dfc11f113c" xlink:href="bmy-20220331.xsd#bmy_DiabetesbusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:to="loc_bmy_DiabetesbusinessMember_748183b1-11ad-421e-b166-d9dfc11f113c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AvaproAvalideAndPlavixMember_1bc1c014-15e7-463a-bd29-89d70d1cf693" xlink:href="bmy-20220331.xsd#bmy_AvaproAvalideAndPlavixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:to="loc_bmy_AvaproAvalideAndPlavixMember_1bc1c014-15e7-463a-bd29-89d70d1cf693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_24d444db-7875-4a15-8d30-1035121a3431" xlink:href="bmy-20220331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:to="loc_bmy_MatureBrandsAndOtherMember_24d444db-7875-4a15-8d30-1035121a3431" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b09a79b2-f074-423e-a20d-2cefcea34b8c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:to="loc_srt_CounterpartyNameAxis_b09a79b2-f074-423e-a20d-2cefcea34b8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b09a79b2-f074-423e-a20d-2cefcea34b8c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b09a79b2-f074-423e-a20d-2cefcea34b8c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b09a79b2-f074-423e-a20d-2cefcea34b8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc446d47-e570-44a6-9972-e0be356db1ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b09a79b2-f074-423e-a20d-2cefcea34b8c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc446d47-e570-44a6-9972-e0be356db1ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember_dfe54342-5835-40e2-b128-8c7a44c1d133" xlink:href="bmy-20220331.xsd#bmy_CheplapharmMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc446d47-e570-44a6-9972-e0be356db1ce" xlink:to="loc_bmy_CheplapharmMember_dfe54342-5835-40e2-b128-8c7a44c1d133" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended" id="ib143c3f351684e539338d49f3d037d4f_DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_1abc7265-dcec-490b-b858-b32e7f743286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_1abc7265-dcec-490b-b858-b32e7f743286" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_5abe472d-3ed0-43db-aa95-ccee60bfb09e" xlink:href="bmy-20220331.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_5abe472d-3ed0-43db-aa95-ccee60bfb09e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_5601cf36-0b3a-424e-bfe5-2145ac3a14a5" xlink:href="bmy-20220331.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_AmortizationOfDeferredIncome_5601cf36-0b3a-424e-bfe5-2145ac3a14a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_e28654d7-38f0-4797-81c4-53c8f7558771" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_e28654d7-38f0-4797-81c4-53c8f7558771" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_68aa674c-3127-497b-b9f2-b8790a3047e3" xlink:href="bmy-20220331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_68aa674c-3127-497b-b9f2-b8790a3047e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_61818f23-5ef3-47fd-a8d3-cbe76101f2c4" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_61818f23-5ef3-47fd-a8d3-cbe76101f2c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_61818f23-5ef3-47fd-a8d3-cbe76101f2c4_default" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_61818f23-5ef3-47fd-a8d3-cbe76101f2c4" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_61818f23-5ef3-47fd-a8d3-cbe76101f2c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_61818f23-5ef3-47fd-a8d3-cbe76101f2c4" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_e7329260-8490-4999-baed-09fedabd8f91" xlink:href="bmy-20220331.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_e7329260-8490-4999-baed-09fedabd8f91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_ed3a6605-f907-4b7a-8896-b15a55017364" xlink:href="bmy-20220331.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:to="loc_bmy_TecentriqRoyaltiesMember_ed3a6605-f907-4b7a-8896-b15a55017364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_96eeb181-6b38-4327-9e33-c898d6914d1d" xlink:href="bmy-20220331.xsd#bmy_OtherRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:to="loc_bmy_OtherRoyaltiesMember_96eeb181-6b38-4327-9e33-c898d6914d1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_11bb1553-e260-41e8-9715-31824e15056f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:to="loc_srt_CounterpartyNameAxis_11bb1553-e260-41e8-9715-31824e15056f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_11bb1553-e260-41e8-9715-31824e15056f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_11bb1553-e260-41e8-9715-31824e15056f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_11bb1553-e260-41e8-9715-31824e15056f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_11bb1553-e260-41e8-9715-31824e15056f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_4caf1622-5ad0-448f-b02e-41d49e72271f" xlink:href="bmy-20220331.xsd#bmy_ImmaticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:to="loc_bmy_ImmaticsMember_4caf1622-5ad0-448f-b02e-41d49e72271f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_5885dd94-c9a4-4ce4-b295-fdd810c3740b" xlink:href="bmy-20220331.xsd#bmy_DragonflyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:to="loc_bmy_DragonflyMember_5885dd94-c9a4-4ce4-b295-fdd810c3740b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended" id="i80c91aa544cd4aee84f1f8061ffa6178_DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:href="bmy-20220331.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_4ae14a6f-23dd-4c7b-99b7-217ffbbd5fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_4ae14a6f-23dd-4c7b-99b7-217ffbbd5fcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_b950ff25-4161-4aca-aac6-7d07d57851bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_b950ff25-4161-4aca-aac6-7d07d57851bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_1c09554d-3dc7-4be9-9c2a-6c0f554a00eb" xlink:href="bmy-20220331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_1c09554d-3dc7-4be9-9c2a-6c0f554a00eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_06c9fe89-db82-44fc-aab2-49cad169c195" xlink:href="bmy-20220331.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_06c9fe89-db82-44fc-aab2-49cad169c195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_cc632e24-4c41-4f56-bddf-905af7800d5b" xlink:href="bmy-20220331.xsd#bmy_PaymentToExtinguishFutureRoyaltyObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_cc632e24-4c41-4f56-bddf-905af7800d5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:href="bmy-20220331.xsd#bmy_LicensingArrangementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesAxis_b94ef71b-8fc2-40d4-90ac-782e9a704c61" xlink:href="bmy-20220331.xsd#bmy_LicensingCompaniesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_bmy_LicensingCompaniesAxis_b94ef71b-8fc2-40d4-90ac-782e9a704c61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain_b94ef71b-8fc2-40d4-90ac-782e9a704c61_default" xlink:href="bmy-20220331.xsd#bmy_LicensingCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingCompaniesAxis_b94ef71b-8fc2-40d4-90ac-782e9a704c61" xlink:to="loc_bmy_LicensingCompaniesDomain_b94ef71b-8fc2-40d4-90ac-782e9a704c61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain_d2efefc6-0f34-4ec0-929d-8cdf66f6b811" xlink:href="bmy-20220331.xsd#bmy_LicensingCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingCompaniesAxis_b94ef71b-8fc2-40d4-90ac-782e9a704c61" xlink:to="loc_bmy_LicensingCompaniesDomain_d2efefc6-0f34-4ec0-929d-8cdf66f6b811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd899095-8629-4ac4-b190-64404339620e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd899095-8629-4ac4-b190-64404339620e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cd899095-8629-4ac4-b190-64404339620e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd899095-8629-4ac4-b190-64404339620e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cd899095-8629-4ac4-b190-64404339620e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ef72af87-0596-4ee2-88ed-01a642278110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd899095-8629-4ac4-b190-64404339620e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ef72af87-0596-4ee2-88ed-01a642278110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_5c95e866-434f-4de5-9360-de63214847b8" xlink:href="bmy-20220331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ef72af87-0596-4ee2-88ed-01a642278110" xlink:to="loc_bmy_MatureBrandsAndOtherMember_5c95e866-434f-4de5-9360-de63214847b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_a821a13e-9f58-45cf-8472-09ae9db4dbb9" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_a821a13e-9f58-45cf-8472-09ae9db4dbb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_a821a13e-9f58-45cf-8472-09ae9db4dbb9_default" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_a821a13e-9f58-45cf-8472-09ae9db4dbb9" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_a821a13e-9f58-45cf-8472-09ae9db4dbb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_30d38b25-718c-4697-a52a-04d64e08f151" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_a821a13e-9f58-45cf-8472-09ae9db4dbb9" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_30d38b25-718c-4697-a52a-04d64e08f151" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_816ed444-e035-4589-9a7c-7ba693cba669" xlink:href="bmy-20220331.xsd#bmy_DragonflyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_30d38b25-718c-4697-a52a-04d64e08f151" xlink:to="loc_bmy_DragonflyMember_816ed444-e035-4589-9a7c-7ba693cba669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cdee19d1-0667-4340-9770-aee57db2f1ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_srt_CounterpartyNameAxis_cdee19d1-0667-4340-9770-aee57db2f1ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cdee19d1-0667-4340-9770-aee57db2f1ab_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_cdee19d1-0667-4340-9770-aee57db2f1ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cdee19d1-0667-4340-9770-aee57db2f1ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5e135c-4d74-4a29-8bb9-044ff2960ef9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_cdee19d1-0667-4340-9770-aee57db2f1ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5e135c-4d74-4a29-8bb9-044ff2960ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_24e635d0-13fa-455b-a242-f58a7b76c21f" xlink:href="bmy-20220331.xsd#bmy_ImmaticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5e135c-4d74-4a29-8bb9-044ff2960ef9" xlink:to="loc_bmy_ImmaticsMember_24e635d0-13fa-455b-a242-f58a7b76c21f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bae774cb-85f7-457b-8f85-d73780d32a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bae774cb-85f7-457b-8f85-d73780d32a98" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bae774cb-85f7-457b-8f85-d73780d32a98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bae774cb-85f7-457b-8f85-d73780d32a98" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bae774cb-85f7-457b-8f85-d73780d32a98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0bd3d411-9783-406b-ba37-49de7af3ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bae774cb-85f7-457b-8f85-d73780d32a98" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0bd3d411-9783-406b-ba37-49de7af3ff55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0301b140-bcb5-465b-a79d-71946a869f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0bd3d411-9783-406b-ba37-49de7af3ff55" xlink:to="loc_us-gaap_SubsequentEventMember_0301b140-bcb5-465b-a79d-71946a869f86" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGTables"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended" id="ibb33d995948e4366b6f436fd0a51b749_RESTRUCTURINGTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61de6375-e197-4090-be43-4d497e1de929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61de6375-e197-4090-be43-4d497e1de929" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_dbb8bce5-4137-4455-a21f-e78a85d70689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_dbb8bce5-4137-4455-a21f-e78a85d70689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61c2dfa0-893f-4bfe-a1a9-186157f171f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61c2dfa0-893f-4bfe-a1a9-186157f171f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6417ac06-4280-46c6-b76f-8eccde2348b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61c2dfa0-893f-4bfe-a1a9-186157f171f1" xlink:to="loc_us-gaap_RestructuringPlanAxis_6417ac06-4280-46c6-b76f-8eccde2348b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_6417ac06-4280-46c6-b76f-8eccde2348b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_6417ac06-4280-46c6-b76f-8eccde2348b5" xlink:to="loc_us-gaap_RestructuringPlanDomain_6417ac06-4280-46c6-b76f-8eccde2348b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bd97f863-4a6a-4d7f-a733-acd4b4af1015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_6417ac06-4280-46c6-b76f-8eccde2348b5" xlink:to="loc_us-gaap_RestructuringPlanDomain_bd97f863-4a6a-4d7f-a733-acd4b4af1015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_52192eb4-55f5-4a4d-9a96-bf260e73b99d" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bd97f863-4a6a-4d7f-a733-acd4b4af1015" xlink:to="loc_bmy_CelgeneIntegrationMember_52192eb4-55f5-4a4d-9a96-bf260e73b99d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="extended" id="ic0bbaf4abf044d568fc6a2a408e3ea39_RESTRUCTURINGAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_1238939b-b90b-48ac-aba8-797296cd5d8f" xlink:href="bmy-20220331.xsd#bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_1238939b-b90b-48ac-aba8-797296cd5d8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ExpectedSynergiesPercentage_92c6edf3-62e1-45d4-b410-513722bb338d" xlink:href="bmy-20220331.xsd#bmy_ExpectedSynergiesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_bmy_ExpectedSynergiesPercentage_92c6edf3-62e1-45d4-b410-513722bb338d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f1bae41a-680c-4925-90b1-d78f7ac79c52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f1bae41a-680c-4925-90b1-d78f7ac79c52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_200dd12d-59fb-429d-811f-1c8fe3ddfdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_200dd12d-59fb-429d-811f-1c8fe3ddfdcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_cf86b640-37e2-4dd8-95c4-808afdf46a55" xlink:href="bmy-20220331.xsd#bmy_Cashoutlays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_bmy_Cashoutlays_cf86b640-37e2-4dd8-95c4-808afdf46a55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_45ca107b-2e0a-4500-97c2-df045928b324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_45ca107b-2e0a-4500-97c2-df045928b324" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_4a9ac127-5a66-413d-ab28-f42cb97422b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:to="loc_us-gaap_RestructuringPlanAxis_4a9ac127-5a66-413d-ab28-f42cb97422b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4a9ac127-5a66-413d-ab28-f42cb97422b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_4a9ac127-5a66-413d-ab28-f42cb97422b4" xlink:to="loc_us-gaap_RestructuringPlanDomain_4a9ac127-5a66-413d-ab28-f42cb97422b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_4a9ac127-5a66-413d-ab28-f42cb97422b4" xlink:to="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_80272ed3-13eb-4f35-80ea-17a92a67d6d7" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:to="loc_bmy_CelgeneIntegrationMember_80272ed3-13eb-4f35-80ea-17a92a67d6d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_bf4ac460-21cc-43ba-8d44-db3431546caf" xlink:href="bmy-20220331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_bf4ac460-21cc-43ba-8d44-db3431546caf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a8bc7b5f-3335-427a-9133-75fa70c3aaea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a8bc7b5f-3335-427a-9133-75fa70c3aaea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a8bc7b5f-3335-427a-9133-75fa70c3aaea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a8bc7b5f-3335-427a-9133-75fa70c3aaea" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a8bc7b5f-3335-427a-9133-75fa70c3aaea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a8bc7b5f-3335-427a-9133-75fa70c3aaea" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_81e7c636-25e4-4331-95a3-4e3ed3d0892c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:to="loc_us-gaap_CostOfSalesMember_81e7c636-25e4-4331-95a3-4e3ed3d0892c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_853a5b5c-8dd1-4e68-9545-eb92ec4cbbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_853a5b5c-8dd1-4e68-9545-eb92ec4cbbb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4bda4b96-30ee-4790-af0c-0ae48e1dcda7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4bda4b96-30ee-4790-af0c-0ae48e1dcda7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended" id="icfaa06ae9ddb4815815896c4714bf2a2_RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_fabbcdb8-3ca7-4576-a909-4d6a899797c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_fabbcdb8-3ca7-4576-a909-4d6a899797c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_b172e752-2049-422b-a88f-89d61b0a3ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_SeveranceCosts1_b172e752-2049-422b-a88f-89d61b0a3ccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_da919684-b01e-403a-b07b-fe9d4ea42f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_OtherRestructuringCosts_da919684-b01e-403a-b07b-fe9d4ea42f4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a4c83a49-5252-4dbb-a95c-86ec1dc7f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_RestructuringCharges_a4c83a49-5252-4dbb-a95c-86ec1dc7f7b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f88e7f3b-a1f4-488d-ad8d-708ce1129a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f88e7f3b-a1f4-488d-ad8d-708ce1129a0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_a6e427f3-20d9-4485-ad7a-0032f396963f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_a6e427f3-20d9-4485-ad7a-0032f396963f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_1449e510-0d6b-4441-b9cb-d459553acaa3" xlink:href="bmy-20220331.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_1449e510-0d6b-4441-b9cb-d459553acaa3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_eb92691c-3aba-4674-81c0-ff1d6b2a6016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:to="loc_us-gaap_RestructuringPlanAxis_eb92691c-3aba-4674-81c0-ff1d6b2a6016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_eb92691c-3aba-4674-81c0-ff1d6b2a6016_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_eb92691c-3aba-4674-81c0-ff1d6b2a6016" xlink:to="loc_us-gaap_RestructuringPlanDomain_eb92691c-3aba-4674-81c0-ff1d6b2a6016_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_eb92691c-3aba-4674-81c0-ff1d6b2a6016" xlink:to="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_9857cd2c-70af-4129-8025-95ef2efaffd4" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:to="loc_bmy_CelgeneIntegrationMember_9857cd2c-70af-4129-8025-95ef2efaffd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_5f564c79-3071-4631-8ef5-9c00e5418596" xlink:href="bmy-20220331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_5f564c79-3071-4631-8ef5-9c00e5418596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ad69288d-4257-431e-a9d9-75ec4dd56095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ad69288d-4257-431e-a9d9-75ec4dd56095" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad69288d-4257-431e-a9d9-75ec4dd56095_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ad69288d-4257-431e-a9d9-75ec4dd56095" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad69288d-4257-431e-a9d9-75ec4dd56095_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ad69288d-4257-431e-a9d9-75ec4dd56095" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4b522728-9895-4923-bf64-02d30b3f352e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:to="loc_us-gaap_CostOfSalesMember_4b522728-9895-4923-bf64-02d30b3f352e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f71fefa-920b-4bcd-893b-c366a3e9cbed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f71fefa-920b-4bcd-893b-c366a3e9cbed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_01d773a4-8a29-418a-8ee8-c67a6ebf4f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_01d773a4-8a29-418a-8ee8-c67a6ebf4f2c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended" id="i632fdac6481d40d8acc3aac82e36fb94_RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_dfa367c3-0323-4970-8575-b1d49f6067d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringReserve_dfa367c3-0323-4970-8575-b1d49f6067d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_66e03b32-68f7-4301-81af-2280828b222e" xlink:href="bmy-20220331.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_66e03b32-68f7-4301-81af-2280828b222e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_9686ee27-1dcc-4948-a097-6188cfaa2fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_9686ee27-1dcc-4948-a097-6188cfaa2fca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4e3e6ea1-4e42-437b-8eae-883f6cd8db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_PaymentsForRestructuring_4e3e6ea1-4e42-437b-8eae-883f6cd8db6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4332a697-22e8-431b-b488-f1d1567a0c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_80b867cc-48f7-4bf7-b065-75e521237ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_80b867cc-48f7-4bf7-b065-75e521237ab9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_55eda4e0-872f-4846-93c5-3048ac338c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringCharges_55eda4e0-872f-4846-93c5-3048ac338c50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e3012aac-d6ed-41c5-8178-d72504602cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:to="loc_us-gaap_RestructuringPlanAxis_e3012aac-d6ed-41c5-8178-d72504602cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e3012aac-d6ed-41c5-8178-d72504602cee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_e3012aac-d6ed-41c5-8178-d72504602cee" xlink:to="loc_us-gaap_RestructuringPlanDomain_e3012aac-d6ed-41c5-8178-d72504602cee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_579c50ec-d478-4292-8583-0285fdc326fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_e3012aac-d6ed-41c5-8178-d72504602cee" xlink:to="loc_us-gaap_RestructuringPlanDomain_579c50ec-d478-4292-8583-0285fdc326fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_e3571a77-040f-4d88-9a4f-d816c07f6768" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c50ec-d478-4292-8583-0285fdc326fc" xlink:to="loc_bmy_CelgeneIntegrationMember_e3571a77-040f-4d88-9a4f-d816c07f6768" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0532689e-8bdd-45f4-b023-b004b6c3cb14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0532689e-8bdd-45f4-b023-b004b6c3cb14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0532689e-8bdd-45f4-b023-b004b6c3cb14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0532689e-8bdd-45f4-b023-b004b6c3cb14" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0532689e-8bdd-45f4-b023-b004b6c3cb14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a1b39510-4781-409f-91cb-1caaf1fe34b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0532689e-8bdd-45f4-b023-b004b6c3cb14" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a1b39510-4781-409f-91cb-1caaf1fe34b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember_6eb732cd-417f-4af1-a59c-a7549887afdd" xlink:href="bmy-20220331.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a1b39510-4781-409f-91cb-1caaf1fe34b4" xlink:to="loc_bmy_AcceleratedStockBasedCompensationMember_6eb732cd-417f-4af1-a59c-a7549887afdd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended" id="i64aa56a260b34013ba764a964b4ce9a7_INCOMETAXESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_05ce5090-ae86-4769-9105-84102749c7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_c2d44f79-f422-4e6a-955a-e7fb792e02ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05ce5090-ae86-4769-9105-84102749c7cd" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_c2d44f79-f422-4e6a-955a-e7fb792e02ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f63058a7-3c13-4d1e-9431-8e36fe04f6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_05ce5090-ae86-4769-9105-84102749c7cd" xlink:to="loc_us-gaap_StatementTable_f63058a7-3c13-4d1e-9431-8e36fe04f6b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_28b28373-effb-4a2c-921c-a9407bc197a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f63058a7-3c13-4d1e-9431-8e36fe04f6b8" xlink:to="loc_srt_RangeAxis_28b28373-effb-4a2c-921c-a9407bc197a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_28b28373-effb-4a2c-921c-a9407bc197a9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_28b28373-effb-4a2c-921c-a9407bc197a9" xlink:to="loc_srt_RangeMember_28b28373-effb-4a2c-921c-a9407bc197a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_28b28373-effb-4a2c-921c-a9407bc197a9" xlink:to="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c90e854f-0643-4b1b-b038-989e2a1b1785" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:to="loc_srt_MinimumMember_c90e854f-0643-4b1b-b038-989e2a1b1785" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ffc174aa-7a74-4202-a2ff-9c89373da0d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:to="loc_srt_MaximumMember_ffc174aa-7a74-4202-a2ff-9c89373da0d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended" id="ie9880c25289a4b6a833cbf9b35bb6a34_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a7c92c4-8fe0-4f41-bcaa-72fd9e11437d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a7c92c4-8fe0-4f41-bcaa-72fd9e11437d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d4f87251-afb9-45cb-9e3a-23a51caec627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d4f87251-afb9-45cb-9e3a-23a51caec627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_be96aab8-af45-4ecc-95fe-ff8099a6602a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_DerivativeAssets_be96aab8-af45-4ecc-95fe-ff8099a6602a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_d6d81d79-2135-4e61-b769-eca9c8c30ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_d6d81d79-2135-4e61-b769-eca9c8c30ba3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_f3af30af-ee29-47e0-b059-c5035ee2ddc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_DerivativeLiabilities_f3af30af-ee29-47e0-b059-c5035ee2ddc0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f54418f0-f38b-4a3a-8ccc-0bc802f7a3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f54418f0-f38b-4a3a-8ccc-0bc802f7a3ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d365226c-8682-4adb-9437-288e6f439583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d365226c-8682-4adb-9437-288e6f439583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d365226c-8682-4adb-9437-288e6f439583_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d365226c-8682-4adb-9437-288e6f439583" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d365226c-8682-4adb-9437-288e6f439583_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d365226c-8682-4adb-9437-288e6f439583" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_39b35489-dded-4729-8959-af1ea7cb34b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_39b35489-dded-4729-8959-af1ea7cb34b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c87dc6e8-3f8d-4190-90b8-c00559c60b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c87dc6e8-3f8d-4190-90b8-c00559c60b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3988bcd7-9b03-4f42-aa0f-fac58bd8bf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3988bcd7-9b03-4f42-aa0f-fac58bd8bf02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8322391c-e4a2-470b-96c6-367b5087cd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8322391c-e4a2-470b-96c6-367b5087cd7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8322391c-e4a2-470b-96c6-367b5087cd7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8322391c-e4a2-470b-96c6-367b5087cd7b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8322391c-e4a2-470b-96c6-367b5087cd7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8322391c-e4a2-470b-96c6-367b5087cd7b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_9bb20fbd-140e-472c-a323-8bba3ee8cbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:to="loc_us-gaap_CertificatesOfDepositMember_9bb20fbd-140e-472c-a323-8bba3ee8cbd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_311102aa-2062-4863-8bf1-285074ebd333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:to="loc_us-gaap_CommercialPaperMember_311102aa-2062-4863-8bf1-285074ebd333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_38acf8b2-82f3-4f27-a6f4-fb4bf9515a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_38acf8b2-82f3-4f27-a6f4-fb4bf9515a18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_763bcbbd-fce1-4b0c-814a-36987c390885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_763bcbbd-fce1-4b0c-814a-36987c390885" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_763bcbbd-fce1-4b0c-814a-36987c390885_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_763bcbbd-fce1-4b0c-814a-36987c390885" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_763bcbbd-fce1-4b0c-814a-36987c390885_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_ee5a3669-3424-4301-9eb7-f9aacba5d458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_763bcbbd-fce1-4b0c-814a-36987c390885" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_ee5a3669-3424-4301-9eb7-f9aacba5d458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_39401ff5-9010-419b-94b4-81ce3e9e52c0" xlink:href="bmy-20220331.xsd#bmy_ContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_ee5a3669-3424-4301-9eb7-f9aacba5d458" xlink:to="loc_bmy_ContingentValueRightsMember_39401ff5-9010-419b-94b4-81ce3e9e52c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1915c1df-46af-4482-8b58-ff60f041027d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1915c1df-46af-4482-8b58-ff60f041027d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1915c1df-46af-4482-8b58-ff60f041027d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1915c1df-46af-4482-8b58-ff60f041027d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1915c1df-46af-4482-8b58-ff60f041027d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16f637b9-8369-4738-ae69-525bc65eff80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1915c1df-46af-4482-8b58-ff60f041027d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16f637b9-8369-4738-ae69-525bc65eff80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_56f313a8-62af-460c-8ba2-2741dd04402a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16f637b9-8369-4738-ae69-525bc65eff80" xlink:to="loc_us-gaap_OtherAssetsMember_56f313a8-62af-460c-8ba2-2741dd04402a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended" id="i44bca3b520054d90ad068be6b5253d96_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5c8afb76-3a13-4d86-aec4-606fc815f5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5c8afb76-3a13-4d86-aec4-606fc815f5c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_796ae484-7fa3-4423-b35c-4180e6c623ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_796ae484-7fa3-4423-b35c-4180e6c623ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6b0c31bc-fbdf-4810-8373-428899425dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6b0c31bc-fbdf-4810-8373-428899425dfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_12970815-7acf-48c2-8e1d-620282913512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_12970815-7acf-48c2-8e1d-620282913512" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddfd2083-ccbf-43e1-800e-04fd802a1bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddfd2083-ccbf-43e1-800e-04fd802a1bfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e27208c6-58c9-407c-988a-0a4f119fe3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddfd2083-ccbf-43e1-800e-04fd802a1bfa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e27208c6-58c9-407c-988a-0a4f119fe3c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e27208c6-58c9-407c-988a-0a4f119fe3c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e27208c6-58c9-407c-988a-0a4f119fe3c2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e27208c6-58c9-407c-988a-0a4f119fe3c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e27208c6-58c9-407c-988a-0a4f119fe3c2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_78994c9b-a085-4d7e-9198-1dad5f073445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:to="loc_us-gaap_CertificatesOfDepositMember_78994c9b-a085-4d7e-9198-1dad5f073445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e3973507-1352-486f-8db9-29843a5c14fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:to="loc_us-gaap_CommercialPaperMember_e3973507-1352-486f-8db9-29843a5c14fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_001d9e29-d22a-48ad-9d4c-208ac376f4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_001d9e29-d22a-48ad-9d4c-208ac376f4f4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended" id="idf8ec9805cc44f2f9502f032aa2604fc_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5c83aa23-ec1a-484e-9ef4-31c9871a87e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5c83aa23-ec1a-484e-9ef4-31c9871a87e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_45342d18-9def-4ce8-b3dd-3a48afd7ce20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_45342d18-9def-4ce8-b3dd-3a48afd7ce20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_bc52860a-7bcc-46d2-8c9e-2244a9900e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_bc52860a-7bcc-46d2-8c9e-2244a9900e0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_345f0113-ac22-4fcc-8fd0-4c1ff138deff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_345f0113-ac22-4fcc-8fd0-4c1ff138deff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d3be3a4c-fb60-4028-aabf-45be70a31d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d3be3a4c-fb60-4028-aabf-45be70a31d2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b0b96e2-e971-421a-97c1-922f1f3d63e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b0b96e2-e971-421a-97c1-922f1f3d63e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_9056faa2-aefb-4179-bcae-5ad529b9fe54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_9056faa2-aefb-4179-bcae-5ad529b9fe54" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_ba8a17f3-b93e-4d94-a82b-9ef679b0caf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_ba8a17f3-b93e-4d94-a82b-9ef679b0caf9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_173f4e87-f2d2-42d2-964a-54aede67c27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_173f4e87-f2d2-42d2-964a-54aede67c27f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd4cc7cb-176a-4166-b3e0-33608c733405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd4cc7cb-176a-4166-b3e0-33608c733405" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4a9cbbb1-bade-4c87-818b-45f3febcaf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_InterestPaidNet_4a9cbbb1-bade-4c87-818b-45f3febcaf8e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities_154a99a7-0dd9-4f54-a685-e3840fced4c6" xlink:href="bmy-20220331.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_bmy_NumberofRevolvingCreditFacilities_154a99a7-0dd9-4f54-a685-e3840fced4c6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3acf39a1-cb71-46f8-8be0-f22435e4d306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3acf39a1-cb71-46f8-8be0-f22435e4d306" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_b50c593d-e0d5-4a97-8e6f-608a121dfcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_LongTermDebtTerm_b50c593d-e0d5-4a97-8e6f-608a121dfcf8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod_d9b26def-5cbf-4618-8579-b13e34f495d7" xlink:href="bmy-20220331.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_bmy_LongTermDebtRenewalPeriod_d9b26def-5cbf-4618-8579-b13e34f495d7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_8f983675-5205-46b6-b6b3-b1fa96a5bd6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_srt_CurrencyAxis_8f983675-5205-46b6-b6b3-b1fa96a5bd6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_8f983675-5205-46b6-b6b3-b1fa96a5bd6c_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_8f983675-5205-46b6-b6b3-b1fa96a5bd6c" xlink:to="loc_currency_AllCurrenciesDomain_8f983675-5205-46b6-b6b3-b1fa96a5bd6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_8f983675-5205-46b6-b6b3-b1fa96a5bd6c" xlink:to="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_886c07c1-6557-4d06-842a-5a4681c64add" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:to="loc_currency_EUR_886c07c1-6557-4d06-842a-5a4681c64add" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_f69acec7-5c73-47cd-98e2-fcc731c88ece" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:to="loc_currency_JPY_f69acec7-5c73-47cd-98e2-fcc731c88ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_88e232de-339c-4b8a-a948-1f6898368a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_HedgingDesignationAxis_88e232de-339c-4b8a-a948-1f6898368a1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_88e232de-339c-4b8a-a948-1f6898368a1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_88e232de-339c-4b8a-a948-1f6898368a1c" xlink:to="loc_us-gaap_HedgingDesignationDomain_88e232de-339c-4b8a-a948-1f6898368a1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8ba5e0a0-be29-4356-b20e-b9c2708e73b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_88e232de-339c-4b8a-a948-1f6898368a1c" xlink:to="loc_us-gaap_HedgingDesignationDomain_8ba5e0a0-be29-4356-b20e-b9c2708e73b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_81ad3a73-a9f7-463c-837b-fd95e295e75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8ba5e0a0-be29-4356-b20e-b9c2708e73b9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_81ad3a73-a9f7-463c-837b-fd95e295e75e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea79442e-02a5-44cc-b510-80933f89b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_VariableRateAxis_ea79442e-02a5-44cc-b510-80933f89b6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea79442e-02a5-44cc-b510-80933f89b6bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ea79442e-02a5-44cc-b510-80933f89b6bd" xlink:to="loc_us-gaap_VariableRateDomain_ea79442e-02a5-44cc-b510-80933f89b6bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a3db8e73-0b9a-4609-9583-b397e5217d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ea79442e-02a5-44cc-b510-80933f89b6bd" xlink:to="loc_us-gaap_VariableRateDomain_a3db8e73-0b9a-4609-9583-b397e5217d6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d7cef420-b124-422e-912d-6a4af56ba622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a3db8e73-0b9a-4609-9583-b397e5217d6b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d7cef420-b124-422e-912d-6a4af56ba622" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_DebtInstrumentAxis_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A60BillionUnsecuredSeniorNotesMember_31b2ceed-14f2-430f-96d1-4000f7a3d2fd" xlink:href="bmy-20220331.xsd#bmy_A60BillionUnsecuredSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_A60BillionUnsecuredSeniorNotesMember_31b2ceed-14f2-430f-96d1-4000f7a3d2fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2032Member_c781f476-fd70-41cc-9ba4-712c06ade710" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2032Member_c781f476-fd70-41cc-9ba4-712c06ade710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2042Member_59217a97-f0f2-40e8-8e07-ddb952920c00" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2042Member_59217a97-f0f2-40e8-8e07-ddb952920c00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2052Member_b2beee70-2964-4a40-80fc-82b83e4b98aa" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2052Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2052Member_b2beee70-2964-4a40-80fc-82b83e4b98aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2062Member_9f6da88c-22dc-42ac-a27d-dc2becb9d424" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2062Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2062Member_9f6da88c-22dc-42ac-a27d-dc2becb9d424" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_4f68404f-1635-4da2-861d-74e5a7ba2c83" xlink:href="bmy-20220331.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_4f68404f-1635-4da2-861d-74e5a7ba2c83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4c1a0e67-8651-49a3-8271-87a83ea6fcac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_CreditFacilityAxis_4c1a0e67-8651-49a3-8271-87a83ea6fcac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4c1a0e67-8651-49a3-8271-87a83ea6fcac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4c1a0e67-8651-49a3-8271-87a83ea6fcac" xlink:to="loc_us-gaap_CreditFacilityDomain_4c1a0e67-8651-49a3-8271-87a83ea6fcac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4c1a0e67-8651-49a3-8271-87a83ea6fcac" xlink:to="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember_dfb371ea-66e7-4d31-a915-ae904a97502f" xlink:href="bmy-20220331.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A2BillionMaximumBorrowingCapacityMember_dfb371ea-66e7-4d31-a915-ae904a97502f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember_6c9735aa-dd70-4b25-b928-c415baaccbbc" xlink:href="bmy-20220331.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A1BillionMaximumBorrowingCapacityMember_6c9735aa-dd70-4b25-b928-c415baaccbbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_82119c4c-d69b-4c0c-95d5-4763916a3c12" xlink:href="bmy-20220331.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_82119c4c-d69b-4c0c-95d5-4763916a3c12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember_aa1e478c-fcc8-46bf-bd59-e19ce70f1eb1" xlink:href="bmy-20220331.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A5BillionMaximumBorrowingCapacityMember_aa1e478c-fcc8-46bf-bd59-e19ce70f1eb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d260f97-8b74-4f61-9b08-302c6e08f5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d260f97-8b74-4f61-9b08-302c6e08f5d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d260f97-8b74-4f61-9b08-302c6e08f5d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d260f97-8b74-4f61-9b08-302c6e08f5d5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d260f97-8b74-4f61-9b08-302c6e08f5d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f642c748-a575-4fa1-9e86-597bcd22aa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d260f97-8b74-4f61-9b08-302c6e08f5d5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f642c748-a575-4fa1-9e86-597bcd22aa30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8c1ee6be-5801-4677-853d-eeca59630947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f642c748-a575-4fa1-9e86-597bcd22aa30" xlink:to="loc_us-gaap_SeniorNotesMember_8c1ee6be-5801-4677-853d-eeca59630947" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_52196923-9176-499b-9482-d501fa1878f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_52196923-9176-499b-9482-d501fa1878f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_52196923-9176-499b-9482-d501fa1878f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_52196923-9176-499b-9482-d501fa1878f4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_52196923-9176-499b-9482-d501fa1878f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_52196923-9176-499b-9482-d501fa1878f4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_583ed4b4-9f1a-4f38-b1fc-33c2afc51ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_583ed4b4-9f1a-4f38-b1fc-33c2afc51ff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_304be913-b0d2-408e-ad00-9864b0d76344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_304be913-b0d2-408e-ad00-9864b0d76344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_d20f3fc1-b8b0-487e-8344-558b36374241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:to="loc_us-gaap_TreasuryLockMember_d20f3fc1-b8b0-487e-8344-558b36374241" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9673a365-f1e3-4439-8ea9-e9f54cc4a75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9673a365-f1e3-4439-8ea9-e9f54cc4a75d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9673a365-f1e3-4439-8ea9-e9f54cc4a75d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9673a365-f1e3-4439-8ea9-e9f54cc4a75d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9673a365-f1e3-4439-8ea9-e9f54cc4a75d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f942bf9a-9bee-444d-91ba-78cdfa9b2d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9673a365-f1e3-4439-8ea9-e9f54cc4a75d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f942bf9a-9bee-444d-91ba-78cdfa9b2d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ec57ef12-bf5f-4f6d-8a13-9aaf0a2b8fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f942bf9a-9bee-444d-91ba-78cdfa9b2d3f" xlink:to="loc_us-gaap_SubsequentEventMember_ec57ef12-bf5f-4f6d-8a13-9aaf0a2b8fec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="extended" id="if8bb356d57d947d5babcdbca8bfeaf51_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7e368457-b9f1-4896-87ad-cc1b4f71cd83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7e368457-b9f1-4896-87ad-cc1b4f71cd83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9e76e7c4-6a83-488e-9588-c437e2dbde49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:to="loc_us-gaap_DerivativeAssets_9e76e7c4-6a83-488e-9588-c437e2dbde49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_11020571-9540-4a9b-8b50-6e7f81c6f01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:to="loc_us-gaap_DerivativeLiabilities_11020571-9540-4a9b-8b50-6e7f81c6f01d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_069ac608-9268-4480-a380-fab5851c2e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:to="loc_us-gaap_HedgingDesignationAxis_069ac608-9268-4480-a380-fab5851c2e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_069ac608-9268-4480-a380-fab5851c2e07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_069ac608-9268-4480-a380-fab5851c2e07" xlink:to="loc_us-gaap_HedgingDesignationDomain_069ac608-9268-4480-a380-fab5851c2e07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_069ac608-9268-4480-a380-fab5851c2e07" xlink:to="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b62b978d-8eb2-49e5-8eec-397a0313ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b62b978d-8eb2-49e5-8eec-397a0313ab9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b58fdb7e-4dbc-466d-ab93-d16fc1b6f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:to="loc_us-gaap_NondesignatedMember_b58fdb7e-4dbc-466d-ab93-d16fc1b6f2d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_55cfe1f0-0aef-426e-b4a3-85d955095f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_InterestRateSwapMember_55cfe1f0-0aef-426e-b4a3-85d955095f7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_263a85c6-33e0-480e-9785-2c0a22eb2f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_263a85c6-33e0-480e-9785-2c0a22eb2f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ea94c6ef-69eb-41f7-8a02-751785e6d730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ea94c6ef-69eb-41f7-8a02-751785e6d730" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_95270c07-168e-4eb1-930c-a5597be7ecb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_OtherContractMember_95270c07-168e-4eb1-930c-a5597be7ecb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9f855939-6272-4b00-924d-376d615b7dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9f855939-6272-4b00-924d-376d615b7dba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9f855939-6272-4b00-924d-376d615b7dba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9f855939-6272-4b00-924d-376d615b7dba" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9f855939-6272-4b00-924d-376d615b7dba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9f855939-6272-4b00-924d-376d615b7dba" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_85a8db8c-51e4-4ee2-a8d8-328f32325754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:to="loc_us-gaap_AssetsMember_85a8db8c-51e4-4ee2-a8d8-328f32325754" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_06c043cb-a652-4547-befe-ae0ed4aa5255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:to="loc_us-gaap_LiabilityMember_06c043cb-a652-4547-befe-ae0ed4aa5255" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="extended" id="i9997b5d578a54c088005d3d7e49cfaa3_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ce247dda-8637-4039-8334-5e46236ac9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_876537e9-dc41-4545-a288-af55cedca686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ce247dda-8637-4039-8334-5e46236ac9a8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_876537e9-dc41-4545-a288-af55cedca686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ce247dda-8637-4039-8334-5e46236ac9a8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_771650ad-e1f2-4227-af66-c61b8023a989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_771650ad-e1f2-4227-af66-c61b8023a989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_771650ad-e1f2-4227-af66-c61b8023a989_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_771650ad-e1f2-4227-af66-c61b8023a989" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_771650ad-e1f2-4227-af66-c61b8023a989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_771650ad-e1f2-4227-af66-c61b8023a989" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_071cd225-63e9-451f-b4ff-ce4c2e82071d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:to="loc_us-gaap_InterestRateSwapMember_071cd225-63e9-451f-b4ff-ce4c2e82071d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_88c3d815-af10-4ceb-a216-3297fd257dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_88c3d815-af10-4ceb-a216-3297fd257dba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_18a8d9c9-8c7b-43f3-a876-2ca9c855e71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_18a8d9c9-8c7b-43f3-a876-2ca9c855e71e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_89959cdb-6f16-4258-9bf4-ffe2accc8e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_89959cdb-6f16-4258-9bf4-ffe2accc8e23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_89959cdb-6f16-4258-9bf4-ffe2accc8e23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89959cdb-6f16-4258-9bf4-ffe2accc8e23" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_89959cdb-6f16-4258-9bf4-ffe2accc8e23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89959cdb-6f16-4258-9bf4-ffe2accc8e23" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2c322843-5da6-4848-90fd-cab583334eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:to="loc_us-gaap_CostOfSalesMember_2c322843-5da6-4848-90fd-cab583334eb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_e36644c5-a866-4832-a0ae-3eb634843be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:to="loc_us-gaap_OtherIncomeMember_e36644c5-a866-4832-a0ae-3eb634843be4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="extended" id="ie51121ef8bda4e7aa2d01642ba408bbc_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_59bfdee9-5411-448b-8a7c-239f8262da27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:to="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_59bfdee9-5411-448b-8a7c-239f8262da27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_59bfdee9-5411-448b-8a7c-239f8262da27" xlink:to="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1150c952-9f37-4b1a-9958-18afb8a4e711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1150c952-9f37-4b1a-9958-18afb8a4e711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_dbbebd95-63e8-46f3-bfc9-a02b756e63ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_dbbebd95-63e8-46f3-bfc9-a02b756e63ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0e67daa4-3a3e-44a5-ac20-6a820555f390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0e67daa4-3a3e-44a5-ac20-6a820555f390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract_ad7fb947-d1b9-4b81-ae36-2afe4ede8b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0e67daa4-3a3e-44a5-ac20-6a820555f390" xlink:to="loc_us-gaap_ForeignCurrencyTransactionAbstract_ad7fb947-d1b9-4b81-ae36-2afe4ede8b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_2550a57f-169e-4bbc-bdbf-6bfc699b6ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract_ad7fb947-d1b9-4b81-ae36-2afe4ede8b91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_2550a57f-169e-4bbc-bdbf-6bfc699b6ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7c59f587-990f-42da-8dd0-ad4880f39230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7c59f587-990f-42da-8dd0-ad4880f39230" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_24d79640-de9d-4c99-86b1-26b3f374e2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7c59f587-990f-42da-8dd0-ad4880f39230" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_24d79640-de9d-4c99-86b1-26b3f374e2b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_95b1b17a-6a20-468f-b113-0a2cc0a1929e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_24d79640-de9d-4c99-86b1-26b3f374e2b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_95b1b17a-6a20-468f-b113-0a2cc0a1929e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f4978825-b2f0-440d-81ea-b638c66a79b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f4978825-b2f0-440d-81ea-b638c66a79b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f4978825-b2f0-440d-81ea-b638c66a79b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4978825-b2f0-440d-81ea-b638c66a79b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f4978825-b2f0-440d-81ea-b638c66a79b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4978825-b2f0-440d-81ea-b638c66a79b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_4b2767a6-4a93-4e47-a005-1d6befa33344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_4b2767a6-4a93-4e47-a005-1d6befa33344" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_91b38f62-e612-4639-99a2-3c9b6d789c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:to="loc_us-gaap_InterestRateSwapMember_91b38f62-e612-4639-99a2-3c9b6d789c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_de561035-edf9-4333-bbf6-52cbd0fee143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_de561035-edf9-4333-bbf6-52cbd0fee143" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_484a42aa-5f68-4afd-b88d-9d16f224fa12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_484a42aa-5f68-4afd-b88d-9d16f224fa12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_484a42aa-5f68-4afd-b88d-9d16f224fa12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_484a42aa-5f68-4afd-b88d-9d16f224fa12" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_484a42aa-5f68-4afd-b88d-9d16f224fa12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_484a42aa-5f68-4afd-b88d-9d16f224fa12" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1fba0749-4a79-483b-ad9f-559af46fd9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:to="loc_us-gaap_CostOfSalesMember_1fba0749-4a79-483b-ad9f-559af46fd9c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_431006fb-0380-4b20-8bed-9c63c8504aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_431006fb-0380-4b20-8bed-9c63c8504aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0192b5e1-3223-43e6-9c5e-61f59f4859d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:to="loc_us-gaap_HedgingDesignationAxis_0192b5e1-3223-43e6-9c5e-61f59f4859d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0192b5e1-3223-43e6-9c5e-61f59f4859d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0192b5e1-3223-43e6-9c5e-61f59f4859d6" xlink:to="loc_us-gaap_HedgingDesignationDomain_0192b5e1-3223-43e6-9c5e-61f59f4859d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3c1255c4-2aa0-4272-805c-53c3ff55f808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0192b5e1-3223-43e6-9c5e-61f59f4859d6" xlink:to="loc_us-gaap_HedgingDesignationDomain_3c1255c4-2aa0-4272-805c-53c3ff55f808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_651e9b45-d160-4075-a31c-4d241eef7aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3c1255c4-2aa0-4272-805c-53c3ff55f808" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_651e9b45-d160-4075-a31c-4d241eef7aa6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="extended" id="idcc89fc891d94aca8bc2f93f9717c915_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_dbe2e025-1827-4c57-9479-a1ed0d505e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_dbe2e025-1827-4c57-9479-a1ed0d505e8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_04ac867f-da49-4623-8b36-c91dcc3b7ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DerivativeLiabilities_04ac867f-da49-4623-8b36-c91dcc3b7ff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_0815c060-461f-4ce7-a209-95436f50421b" xlink:href="bmy-20220331.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_0815c060-461f-4ce7-a209-95436f50421b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b35b9369-84c0-42a3-8c96-d0c011b28580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b35b9369-84c0-42a3-8c96-d0c011b28580" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_8f5134f1-d1d7-4fed-bb5d-c1c7d5a7d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_8f5134f1-d1d7-4fed-bb5d-c1c7d5a7d7f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3de808b7-8411-4635-928f-52ba08753c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_LongTermDebt_3de808b7-8411-4635-928f-52ba08753c8f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9450b383-5a63-4199-b854-1746a405c33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_LongTermDebtCurrent_9450b383-5a63-4199-b854-1746a405c33f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ede772f6-9127-4c02-b667-5783461d1a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ede772f6-9127-4c02-b667-5783461d1a71" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e1efc520-e97f-4354-a4cd-97c1a07aef9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DebtInstrumentTable_e1efc520-e97f-4354-a4cd-97c1a07aef9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e1efc520-e97f-4354-a4cd-97c1a07aef9b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b19b178e-4ae4-4926-867c-eeb819af50b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b19b178e-4ae4-4926-867c-eeb819af50b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_577b142c-d3e9-4e9f-a519-5bdf06d241bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b19b178e-4ae4-4926-867c-eeb819af50b7" xlink:to="loc_us-gaap_InterestRateSwapMember_577b142c-d3e9-4e9f-a519-5bdf06d241bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RECEIVABLESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended" id="i41272f9086cd48bbaf3bae8224d0e990_RECEIVABLESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_c6759c20-0128-46b7-8546-a9c6b34632ec" xlink:href="bmy-20220331.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_c6759c20-0128-46b7-8546-a9c6b34632ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_3a552eba-d52d-4a5a-a290-cdc9093aa074" xlink:href="bmy-20220331.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_3a552eba-d52d-4a5a-a290-cdc9093aa074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_852c1fc9-c884-411e-9ea5-5e89e96461b1" xlink:href="bmy-20220331.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_852c1fc9-c884-411e-9ea5-5e89e96461b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9686d2bb-513b-40cb-aa29-b89c76a49237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:to="loc_us-gaap_ConcentrationRiskTable_9686d2bb-513b-40cb-aa29-b89c76a49237" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_163eca0f-ffbd-47e6-8015-51a962bddd30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9686d2bb-513b-40cb-aa29-b89c76a49237" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_163eca0f-ffbd-47e6-8015-51a962bddd30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_163eca0f-ffbd-47e6-8015-51a962bddd30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_163eca0f-ffbd-47e6-8015-51a962bddd30" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_163eca0f-ffbd-47e6-8015-51a962bddd30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b54273dd-568a-4102-a5a4-85d3d291ee70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_163eca0f-ffbd-47e6-8015-51a962bddd30" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b54273dd-568a-4102-a5a4-85d3d291ee70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_e4ee8179-cbe8-4b16-8a36-fce444a17514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b54273dd-568a-4102-a5a4-85d3d291ee70" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_e4ee8179-cbe8-4b16-8a36-fce444a17514" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#INVENTORIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended" id="i823133835e5d4fc58ad03b68d848399b_INVENTORIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70f97eee-df43-4290-8562-e6d30e30095e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70f97eee-df43-4290-8562-e6d30e30095e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7e8c0342-1700-45c5-b73e-6221acc49084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7e8c0342-1700-45c5-b73e-6221acc49084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_19a817ea-6b35-42b8-ae2f-12a3a1932e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_19a817ea-6b35-42b8-ae2f-12a3a1932e28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_f5038e0c-45b7-427e-ac78-51c7385db8d3" xlink:href="bmy-20220331.xsd#bmy_Totalinventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_bmy_Totalinventories_f5038e0c-45b7-427e-ac78-51c7385db8d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a1147e05-199e-4ad0-8bd4-2a84139ee1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryNet_a1147e05-199e-4ad0-8bd4-2a84139ee1a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_13fc20ea-cbf9-454e-8fe8-39689379b8de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryNoncurrent_13fc20ea-cbf9-454e-8fe8-39689379b8de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2245f473-1d47-4572-9b8c-806073b530e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2245f473-1d47-4572-9b8c-806073b530e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments_11da5171-5ea4-457a-8062-578b1e346bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryAdjustments_11da5171-5ea4-457a-8062-578b1e346bbb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ee03dec7-2792-4355-8286-2b5f3846d5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ee03dec7-2792-4355-8286-2b5f3846d5b2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5caa6059-36cf-4cbb-9d24-75f4365ef869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5caa6059-36cf-4cbb-9d24-75f4365ef869" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8446390f-703e-4379-81f1-bd403281b308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8446390f-703e-4379-81f1-bd403281b308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_850fd326-358d-4a4f-b9e9-757a795bba12" xlink:href="bmy-20220331.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8446390f-703e-4379-81f1-bd403281b308" xlink:to="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_850fd326-358d-4a4f-b9e9-757a795bba12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_632be52e-0886-4b30-97c8-906bcc8aacb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_632be52e-0886-4b30-97c8-906bcc8aacb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_632be52e-0886-4b30-97c8-906bcc8aacb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_632be52e-0886-4b30-97c8-906bcc8aacb2" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_632be52e-0886-4b30-97c8-906bcc8aacb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_198a6318-2f29-4169-a3e7-d28533f6e608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_632be52e-0886-4b30-97c8-906bcc8aacb2" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_198a6318-2f29-4169-a3e7-d28533f6e608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentToInventoryMember_831955e2-04fa-4826-8118-785ed5f9731a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentToInventoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_198a6318-2f29-4169-a3e7-d28533f6e608" xlink:to="loc_us-gaap_FairValueAdjustmentToInventoryMember_831955e2-04fa-4826-8118-785ed5f9731a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="extended" id="ief6b89a968ee4540838f180659819358_GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_58795455-6e1e-4b1e-b358-82be0eadb2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_Goodwill_58795455-6e1e-4b1e-b358-82be0eadb2d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_99ca327e-90c4-48f6-b2fc-559a2bd60b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_99ca327e-90c4-48f6-b2fc-559a2bd60b5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ecf652b1-fd24-4449-820d-b8334a50332d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ecf652b1-fd24-4449-820d-b8334a50332d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_01724b81-109d-411f-b9e8-70fcf455bca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_01724b81-109d-411f-b9e8-70fcf455bca0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_61df1051-4cdb-4a0d-9996-b8684ce9d994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_61df1051-4cdb-4a0d-9996-b8684ce9d994" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e894e097-8e77-4e80-a681-7060fa1f0422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e894e097-8e77-4e80-a681-7060fa1f0422" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f407599-e050-4007-a440-08cb68b5518c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f407599-e050-4007-a440-08cb68b5518c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_25ab7892-b2f5-490e-851b-032866464fcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:to="loc_srt_RangeAxis_25ab7892-b2f5-490e-851b-032866464fcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_25ab7892-b2f5-490e-851b-032866464fcb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_25ab7892-b2f5-490e-851b-032866464fcb" xlink:to="loc_srt_RangeMember_25ab7892-b2f5-490e-851b-032866464fcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_25ab7892-b2f5-490e-851b-032866464fcb" xlink:to="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a754814e-5d4f-4654-a905-8c2d3ba11fbe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:to="loc_srt_MinimumMember_a754814e-5d4f-4654-a905-8c2d3ba11fbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_576cabe3-c983-45cf-898b-af22ee2cb314" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:to="loc_srt_MaximumMember_576cabe3-c983-45cf-898b-af22ee2cb314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9fda5f2-057f-44f5-898c-15efeb8c0c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9fda5f2-057f-44f5-898c-15efeb8c0c62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9fda5f2-057f-44f5-898c-15efeb8c0c62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9fda5f2-057f-44f5-898c-15efeb8c0c62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9fda5f2-057f-44f5-898c-15efeb8c0c62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9fda5f2-057f-44f5-898c-15efeb8c0c62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_0c11ab3e-13ce-488b-a624-c819692c37ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:to="loc_us-gaap_LicensingAgreementsMember_0c11ab3e-13ce-488b-a624-c819692c37ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ed48138c-16dd-4ac1-951b-0971f357b589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ed48138c-16dd-4ac1-951b-0971f357b589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_662b4e2a-d77d-4cd1-844b-6b9d03f1b10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_662b4e2a-d77d-4cd1-844b-6b9d03f1b10d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f5fbc7ba-d615-4395-a95d-39db31916d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f5fbc7ba-d615-4395-a95d-39db31916d65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f5fbc7ba-d615-4395-a95d-39db31916d65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f5fbc7ba-d615-4395-a95d-39db31916d65" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f5fbc7ba-d615-4395-a95d-39db31916d65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_39641236-6842-4a8c-97b0-41e2b0cbeaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f5fbc7ba-d615-4395-a95d-39db31916d65" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_39641236-6842-4a8c-97b0-41e2b0cbeaa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c64184a5-191b-47b6-ace3-aa77dc94cdec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_39641236-6842-4a8c-97b0-41e2b0cbeaa2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c64184a5-191b-47b6-ace3-aa77dc94cdec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended" id="i4171de8008c14753a05923b39c7031e2_GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f4c7546d-2a9c-435f-8eef-d2a340618e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f4c7546d-2a9c-435f-8eef-d2a340618e2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fb0d8433-209a-450c-bde3-447d37468eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fb0d8433-209a-450c-bde3-447d37468eb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_c07d56cf-e4a7-42b2-913f-df8993dbde7a" xlink:href="bmy-20220331.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_c07d56cf-e4a7-42b2-913f-df8993dbde7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_b3d55b18-7d5c-41dd-a49e-f83ba5ac5b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_b3d55b18-7d5c-41dd-a49e-f83ba5ac5b61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_257059b1-f446-4703-bbbe-4e000d808686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_257059b1-f446-4703-bbbe-4e000d808686" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a" xlink:href="bmy-20220331.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_257059b1-f446-4703-bbbe-4e000d808686" xlink:to="loc_bmy_IntangibleAssetNameAxis_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a_default" xlink:href="bmy-20220331.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_IntangibleAssetNameAxis_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a" xlink:to="loc_bmy_IntangibleAssetNameDomain_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_0706e62f-dfbe-4a57-84c4-c793a4966c27" xlink:href="bmy-20220331.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_IntangibleAssetNameAxis_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a" xlink:to="loc_bmy_IntangibleAssetNameDomain_0706e62f-dfbe-4a57-84c4-c793a4966c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_08175bc1-ad48-432f-9abd-a72602c3ba02" xlink:href="bmy-20220331.xsd#bmy_InrebicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_IntangibleAssetNameDomain_0706e62f-dfbe-4a57-84c4-c793a4966c27" xlink:to="loc_bmy_InrebicMember_08175bc1-ad48-432f-9abd-a72602c3ba02" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYScheduleofStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="extended" id="ib625f4d88dc14dadb6d4f93d27b7e74a_EQUITYScheduleofStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:href="bmy-20220331.xsd#bmy_EquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_52f2de39-0b93-42ee-bc27-52fd1dd13937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_SharesIssued_52f2de39-0b93-42ee-bc27-52fd1dd13937" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5ed7ed5a-6f85-4a97-8e69-4f99b650e337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_StockholdersEquity_5ed7ed5a-6f85-4a97-8e69-4f99b650e337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_724f39b5-23f3-4169-9c10-dd0dc813e593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_NetIncomeLoss_724f39b5-23f3-4169-9c10-dd0dc813e593" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d0a51f12-de95-4748-8aff-f868039c0613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d0a51f12-de95-4748-8aff-f868039c0613" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4b421e75-cc28-4f46-9604-1242f30a07bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4b421e75-cc28-4f46-9604-1242f30a07bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_1f6844e8-20a4-4646-9986-6e9791521ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_DividendsCommonStockCash_1f6844e8-20a4-4646-9986-6e9791521ae4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6e947f8e-6117-4144-b6d2-7b1e38f7f6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6e947f8e-6117-4144-b6d2-7b1e38f7f6bc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_edf1e409-48d5-4164-b5d0-d81ec2812ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_edf1e409-48d5-4164-b5d0-d81ec2812ce2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_95ae2f79-c12e-4a64-8770-b136e7d0bdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_95ae2f79-c12e-4a64-8770-b136e7d0bdf6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_50634e02-10a9-473d-be48-1572e6d5c3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_50634e02-10a9-473d-be48-1572e6d5c3a9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_4cdf0cd2-d633-4659-b681-be9c1f1019b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1eac7b57-45d4-4cb8-9f75-bf2286b1135d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_3eb1647a-fd70-4cea-a653-ed4cbfe598e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_3eb1647a-fd70-4cea-a653-ed4cbfe598e0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_02d25855-ece5-41a3-bf8c-5179b0fb8d7f" xlink:href="bmy-20220331.xsd#bmy_EquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_bmy_EquityTable_02d25855-ece5-41a3-bf8c-5179b0fb8d7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c1482c1-d06d-4f15-a40f-ed8c1c31efca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_EquityTable_02d25855-ece5-41a3-bf8c-5179b0fb8d7f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c1482c1-d06d-4f15-a40f-ed8c1c31efca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c1482c1-d06d-4f15-a40f-ed8c1c31efca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c1482c1-d06d-4f15-a40f-ed8c1c31efca" xlink:to="loc_us-gaap_EquityComponentDomain_2c1482c1-d06d-4f15-a40f-ed8c1c31efca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c1482c1-d06d-4f15-a40f-ed8c1c31efca" xlink:to="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_03c2d14b-5f6a-4c67-9e46-43d82d58e013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_CommonStockMember_03c2d14b-5f6a-4c67-9e46-43d82d58e013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fa47648f-6b84-4666-b487-5b9ef2b8549f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fa47648f-6b84-4666-b487-5b9ef2b8549f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_660883fb-9a03-4ae5-8fa2-ad7b3636c468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_660883fb-9a03-4ae5-8fa2-ad7b3636c468" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4b604f82-f2ee-4f3c-a013-f2913c6e74c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_RetainedEarningsMember_4b604f82-f2ee-4f3c-a013-f2913c6e74c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4517933e-0d49-49c4-8a8f-63040d853b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_TreasuryStockMember_4517933e-0d49-49c4-8a8f-63040d853b88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c13f73d9-8bde-41c7-be4c-09e4c85f1359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c13f73d9-8bde-41c7-be4c-09e4c85f1359" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="extended" id="idcb695471f4747cfb97c656333e0ea09_EQUITYAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:href="bmy-20220331.xsd#bmy_EquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_67c8f71a-9838-4a5d-b053-cf4ec4c8f679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_67c8f71a-9838-4a5d-b053-cf4ec4c8f679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_3673a087-af16-45dc-af96-805606819ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_3673a087-af16-45dc-af96-805606819ceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_a4c0d7db-14b6-446f-9477-e4eced43b245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_a4c0d7db-14b6-446f-9477-e4eced43b245" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2612871-b29c-453d-8da9-050707e01611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2612871-b29c-453d-8da9-050707e01611" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_a443841e-7fac-4409-a3af-e6028849c5fa" xlink:href="bmy-20220331.xsd#bmy_EquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_bmy_EquityTable_a443841e-7fac-4409-a3af-e6028849c5fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_342fc10b-a6b9-44e2-b45b-30c108c68e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_EquityTable_a443841e-7fac-4409-a3af-e6028849c5fa" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_342fc10b-a6b9-44e2-b45b-30c108c68e1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_342fc10b-a6b9-44e2-b45b-30c108c68e1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_342fc10b-a6b9-44e2-b45b-30c108c68e1f" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_342fc10b-a6b9-44e2-b45b-30c108c68e1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_cd996120-e8a8-4758-b131-39f605eca143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_342fc10b-a6b9-44e2-b45b-30c108c68e1f" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_cd996120-e8a8-4758-b131-39f605eca143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember_83d04c13-00d4-4a7c-9d79-9685a39993d2" xlink:href="bmy-20220331.xsd#bmy_A2022ASRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_cd996120-e8a8-4758-b131-39f605eca143" xlink:to="loc_bmy_A2022ASRMember_83d04c13-00d4-4a7c-9d79-9685a39993d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended" id="i12b519f49a5f4955b7cd85b13d9e13dd_EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b604fba4-ef97-42c6-afad-c04da22a89a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b604fba4-ef97-42c6-afad-c04da22a89a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_89c32a96-6c31-411d-b44c-cda554c1c9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_89c32a96-6c31-411d-b44c-cda554c1c9b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2f25fa5f-d209-4cbd-a978-31750696e71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2f25fa5f-d209-4cbd-a978-31750696e71b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:to="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1e107d7f-af40-44bb-bf2d-63634e02a651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1e107d7f-af40-44bb-bf2d-63634e02a651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e107d7f-af40-44bb-bf2d-63634e02a651_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e107d7f-af40-44bb-bf2d-63634e02a651" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e107d7f-af40-44bb-bf2d-63634e02a651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4211e106-7372-4644-a1b1-ab5ce891611f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e107d7f-af40-44bb-bf2d-63634e02a651" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4211e106-7372-4644-a1b1-ab5ce891611f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6b97d2fa-33c6-453a-a852-82955007ad4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_CostOfSalesMember_6b97d2fa-33c6-453a-a852-82955007ad4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c39c7e23-d891-46ae-bf30-366c49a701ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c39c7e23-d891-46ae-bf30-366c49a701ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1cc0c464-2175-467c-a7c5-e8cb1f3bcf8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1cc0c464-2175-467c-a7c5-e8cb1f3bcf8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_95a45c26-8f8a-436d-8e3a-855e1a9bddac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_OtherIncomeMember_95a45c26-8f8a-436d-8e3a-855e1a9bddac" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="extended" id="ib72e9dd76c214592954f13497da2ef85_EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_694aadf4-8447-4d2e-a6c9-795baa1a6e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_694aadf4-8447-4d2e-a6c9-795baa1a6e0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9230544-fbea-4def-937c-d4795e5f6888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9230544-fbea-4def-937c-d4795e5f6888" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_231fa7c6-2624-4db3-9989-a3ebb445caaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:to="loc_us-gaap_StatementTable_231fa7c6-2624-4db3-9989-a3ebb445caaf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_109ddcaa-f0e8-4487-aa32-270c26bab9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_231fa7c6-2624-4db3-9989-a3ebb445caaf" xlink:to="loc_us-gaap_AwardTypeAxis_109ddcaa-f0e8-4487-aa32-270c26bab9b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109ddcaa-f0e8-4487-aa32-270c26bab9b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_109ddcaa-f0e8-4487-aa32-270c26bab9b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109ddcaa-f0e8-4487-aa32-270c26bab9b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_109ddcaa-f0e8-4487-aa32-270c26bab9b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3f3e632e-1d6e-42ac-9256-99f888dd10cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3f3e632e-1d6e-42ac-9256-99f888dd10cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_f8a694a8-a04a-4cfa-87c0-4134ed2da003" xlink:href="bmy-20220331.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:to="loc_bmy_MarketShareUnitsMember_f8a694a8-a04a-4cfa-87c0-4134ed2da003" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_78acec38-b29d-43e2-ad5d-61034602898b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:to="loc_us-gaap_PerformanceSharesMember_78acec38-b29d-43e2-ad5d-61034602898b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended" id="id5cf18ea4432445488bcd10dca64e814_EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_28f2da71-97f6-4916-b867-2adc103731ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_28f2da71-97f6-4916-b867-2adc103731ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca70750d-40dd-4c4d-b881-4af9865bd8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca70750d-40dd-4c4d-b881-4af9865bd8aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_edbd0c27-682f-4beb-a40f-ed6d2860acc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:to="loc_us-gaap_StatementTable_edbd0c27-682f-4beb-a40f-ed6d2860acc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2dcfd6b9-bda1-45ee-9a23-ccce9a998272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_edbd0c27-682f-4beb-a40f-ed6d2860acc4" xlink:to="loc_us-gaap_AwardTypeAxis_2dcfd6b9-bda1-45ee-9a23-ccce9a998272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2dcfd6b9-bda1-45ee-9a23-ccce9a998272_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2dcfd6b9-bda1-45ee-9a23-ccce9a998272" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2dcfd6b9-bda1-45ee-9a23-ccce9a998272_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2dcfd6b9-bda1-45ee-9a23-ccce9a998272" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ec848543-d0be-4c09-ad28-b197558b3a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ec848543-d0be-4c09-ad28-b197558b3a23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_cd2a9d48-8046-4a6b-a14e-6e5ac7995d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_cd2a9d48-8046-4a6b-a14e-6e5ac7995d41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_aa8edefe-41c9-48a5-a14b-ff474530f27e" xlink:href="bmy-20220331.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_bmy_MarketShareUnitsMember_aa8edefe-41c9-48a5-a14b-ff474530f27e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7b687918-7c73-4c5e-84b7-87b522168dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_us-gaap_PerformanceSharesMember_7b687918-7c73-4c5e-84b7-87b522168dd0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended" id="i732ac34d70b94a4c942787449cab7522_LEGALPROCEEDINGSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:href="bmy-20220331.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_9f5159c9-0beb-4bf9-a345-1008494bf163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_9f5159c9-0beb-4bf9-a345-1008494bf163" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_6cfeb38b-1dd8-4ed5-8150-6e8ea2d80732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_PaymentsForRoyalties_6cfeb38b-1dd8-4ed5-8150-6e8ea2d80732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_226f06a2-0e84-4c48-a244-897326a5884b" xlink:href="bmy-20220331.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_226f06a2-0e84-4c48-a244-897326a5884b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_545eeeb6-37a0-4b20-a584-44bf07fd5faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_545eeeb6-37a0-4b20-a584-44bf07fd5faa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_772772c1-0a13-4e43-982d-168ef6447f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_772772c1-0a13-4e43-982d-168ef6447f45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_0021a28c-2a7e-44eb-9182-0db517bfea25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_0021a28c-2a7e-44eb-9182-0db517bfea25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed_5ebbee70-ce04-41cf-9edc-6b84d6bd5604" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberDismissed_5ebbee70-ce04-41cf-9edc-6b84d6bd5604" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_8014ff8c-40f9-4a63-96d6-907c7e8c1a12" xlink:href="bmy-20220331.xsd#bmy_LossContingencyNumberOfPlaintiffsDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_8014ff8c-40f9-4a63-96d6-907c7e8c1a12" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_58abd497-c6c3-4014-a338-c43926cff971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_58abd497-c6c3-4014-a338-c43926cff971" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction_fe69069e-10fd-44aa-a9eb-9d7e1a86a54a" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberClassAction_fe69069e-10fd-44aa-a9eb-9d7e1a86a54a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_69fd9f7b-76be-44af-8797-cf4064186bac" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_69fd9f7b-76be-44af-8797-cf4064186bac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive_3fb84a49-9442-4bd5-afdd-0cb7605a31d1" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberActive_3fb84a49-9442-4bd5-afdd-0cb7605a31d1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_c3d90471-bb98-4686-96c3-f7bca698f625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_ContractualObligation_c3d90471-bb98-4686-96c3-f7bca698f625" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_9e8e9d63-dc3d-4095-871a-59e4390325da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_9e8e9d63-dc3d-4095-871a-59e4390325da" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:href="bmy-20220331.xsd#bmy_LitigationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_de37da69-300b-43c7-b5c7-096e2b153eff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_srt_LitigationCaseAxis_de37da69-300b-43c7-b5c7-096e2b153eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_de37da69-300b-43c7-b5c7-096e2b153eff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_de37da69-300b-43c7-b5c7-096e2b153eff" xlink:to="loc_srt_LitigationCaseTypeDomain_de37da69-300b-43c7-b5c7-096e2b153eff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_de37da69-300b-43c7-b5c7-096e2b153eff" xlink:to="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_990e0ebc-62ec-4739-9dd2-a135212b3eca" xlink:href="bmy-20220331.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_990e0ebc-62ec-4739-9dd2-a135212b3eca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_3cbe8baf-098b-4193-86fe-780899b31b4a" xlink:href="bmy-20220331.xsd#bmy_CARTKiteLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_CARTKiteLitigationMember_3cbe8baf-098b-4193-86fe-780899b31b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_446cc7c6-87d4-4bf3-a6ba-82f22951118c" xlink:href="bmy-20220331.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_446cc7c6-87d4-4bf3-a6ba-82f22951118c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_56c4abc0-8436-4840-b82f-ddc2a2b32130" xlink:href="bmy-20220331.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_AbilifyProductLiabilityMember_56c4abc0-8436-4840-b82f-ddc2a2b32130" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember_7ca71c1f-4a9b-4ef9-9d53-446697e01343" xlink:href="bmy-20220331.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_AbilifyProductLiabilityLitigationMember_7ca71c1f-4a9b-4ef9-9d53-446697e01343" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_2da7a592-6aa8-4a87-8bc0-89dd48252fd7" xlink:href="bmy-20220331.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_2da7a592-6aa8-4a87-8bc0-89dd48252fd7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_c17a9ee1-a8e0-4810-92e7-17c6baaa6262" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_srt_CurrencyAxis_c17a9ee1-a8e0-4810-92e7-17c6baaa6262" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_c17a9ee1-a8e0-4810-92e7-17c6baaa6262_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_c17a9ee1-a8e0-4810-92e7-17c6baaa6262" xlink:to="loc_currency_AllCurrenciesDomain_c17a9ee1-a8e0-4810-92e7-17c6baaa6262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_c17a9ee1-a8e0-4810-92e7-17c6baaa6262" xlink:to="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_6419a9ac-379d-41dd-91f9-12484577419e" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:to="loc_currency_AUD_6419a9ac-379d-41dd-91f9-12484577419e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_746e6f72-2417-4b91-a2cf-38c1c3727d0a" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:to="loc_currency_USD_746e6f72-2417-4b91-a2cf-38c1c3727d0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_aff04c44-a0c3-4f47-b335-f520627c6b86" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_dei_LegalEntityAxis_aff04c44-a0c3-4f47-b335-f520627c6b86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_aff04c44-a0c3-4f47-b335-f520627c6b86_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_aff04c44-a0c3-4f47-b335-f520627c6b86" xlink:to="loc_dei_EntityDomain_aff04c44-a0c3-4f47-b335-f520627c6b86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bd39d89f-5fb8-42f7-be17-7950242eb41b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_aff04c44-a0c3-4f47-b335-f520627c6b86" xlink:to="loc_dei_EntityDomain_bd39d89f-5fb8-42f7-be17-7950242eb41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember_b05e722b-e303-4ddf-8ea0-6efcd1804514" xlink:href="bmy-20220331.xsd#bmy_BristolMyersSquibbMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bd39d89f-5fb8-42f7-be17-7950242eb41b" xlink:to="loc_bmy_BristolMyersSquibbMember_b05e722b-e303-4ddf-8ea0-6efcd1804514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_30200b60-e063-401d-a1a2-8faac6cebeed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_srt_StatementGeographicalAxis_30200b60-e063-401d-a1a2-8faac6cebeed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_30200b60-e063-401d-a1a2-8faac6cebeed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_30200b60-e063-401d-a1a2-8faac6cebeed" xlink:to="loc_srt_SegmentGeographicalDomain_30200b60-e063-401d-a1a2-8faac6cebeed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_89af510e-0dab-4bde-802c-7b2afaeb0445" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_30200b60-e063-401d-a1a2-8faac6cebeed" xlink:to="loc_srt_SegmentGeographicalDomain_89af510e-0dab-4bde-802c-7b2afaeb0445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_fc23e5fa-f2ea-4127-ac65-da6bda14402f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_89af510e-0dab-4bde-802c-7b2afaeb0445" xlink:to="loc_country_CA_fc23e5fa-f2ea-4127-ac65-da6bda14402f" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bmy-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5a14e930-e849-45eb-bcad-119c402123d7,g:c84cb2fd-f418-4547-ab26-f641c106cb69-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_522a0e2b-d4f7-43e3-8ee9-d1e2b2d0c2b1_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_779cc675-ba7e-4c55-a56a-f07623b02ef5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityLineItems_07747762-cd08-4737-9cb6-491f342f0b23_verboseLabel_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_9efba65f-7eca-4258-a557-3ba03eedabe5_terseLabel_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_label_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:label id="lab_bmy_EquityLineItems_documentation_en-US" xlink:label="lab_bmy_EquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems" xlink:href="bmy-20220331.xsd#bmy_EquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityLineItems" xlink:to="lab_bmy_EquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_962b3e85-b2c4-47f7-94bf-770900538a06_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings and Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_57389872-a06b-484d-8414-77ddd95ee62b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_42387922-b68c-4a87-a9aa-2c3022dcc80a_terseLabel_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021</link:label>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_label_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_documentation_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member" xlink:href="bmy-20220331.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2.875SeniorNotesdue2021Member" xlink:to="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_f196f96b-0a86-4327-8e4e-5b43463defd8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5dfcb91c-c6fb-434f-9088-356732c8b79a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d02275f5-6613-4a3d-9507-6ed11abbb199_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Attributable to BMS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_55e36e86-1913-42c8-bd39-da8218b33e5a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4db0fc12-fa92-4c24-b614-14ea98b83adb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_c0fb267a-7012-43ed-b66e-b1535cbd2462_terseLabel_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_label_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Aggregate Total Trade Receivables Due</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_documentation_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:href="bmy-20220331.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:to="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b42a2e68-8fc4-472d-a850-df0c058284c7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_2265c97a-962c-4da3-a5bd-3bbf590ce22e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_9d42e6e1-708a-4f9d-b893-a9b2f7e6cf0e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1fa9b924-1685-459c-b083-6ea594c1dfef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4061525b-9b8c-4ef5-b8ef-c8848506efa1_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_991d54d4-7fd9-4bac-8669-0b42f5d0fc1b_terseLabel_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_label_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs, Asset Impairments</link:label>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_documentation_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs, Asset Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments" xlink:href="bmy-20220331.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringRelatedCostsAssetImpairments" xlink:to="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_6511e877-a3b7-4e5d-814f-a661ae939441_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual injury claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Individual Injury Claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Individual Injury Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentValueRightsMember_49d7794b-031f-4b4c-a8d5-9594719e28f0_terseLabel_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent value rights</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMY Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember" xlink:href="bmy-20220331.xsd#bmy_ContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentValueRightsMember" xlink:to="lab_bmy_ContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_d40fa1dd-942c-4f5a-bfbb-76c4a0a755cf_terseLabel_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_label_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_documentation_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:href="bmy-20220331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:to="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRoyaltiesMember_4da3e286-984a-41f7-83ec-1f30f6cec3ef_terseLabel_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_label_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties [Member]</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember" xlink:href="bmy-20220331.xsd#bmy_OtherRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRoyaltiesMember" xlink:to="lab_bmy_OtherRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_4e8f98e9-6b6c-4746-83db-5e8ff6a43136_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_b626d704-1a5c-4017-8942-e9b42ea619ec_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_8c3b914c-e8da-4844-9980-e442bbcd3296_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_3caf4121-cd3e-42bb-a092-260bd5f49c77_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_6f3a7487-2f45-4187-a6b0-80117fedcbd6_terseLabel_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_label_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_documentation_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember" xlink:href="bmy-20220331.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MedicaidandMedicarerebatesMember" xlink:to="lab_bmy_MedicaidandMedicarerebatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9169ba7b-b7fb-4fc5-9e88-78ac3665f73a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_a9ecb62e-c975-4f48-ace7-bf8f17386a73_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_f0f844d4-9372-4936-bfc8-8d17c6f8dd3f_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b677e9ff-98b9-4198-8d7c-e93fef216684_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_f0dd3b78-fd04-450e-9beb-779791ff3a6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation_3de9b2c6-69b1-4c14-8b9e-7c36c72f23c8_terseLabel_en-US" xlink:label="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to extinguish future royalty obligation</link:label>
    <link:label id="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation_label_en-US" xlink:label="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment To Extinguish Future Royalty Obligation</link:label>
    <link:label id="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation_documentation_en-US" xlink:label="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment To Extinguish Future Royalty Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:href="bmy-20220331.xsd#bmy_PaymentToExtinguishFutureRoyaltyObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:to="lab_bmy_PaymentToExtinguishFutureRoyaltyObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_0634f5c1-db64-4515-8c9e-7b623fbf3ab3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2e9c945f-0cbf-4d50-ac5d-ddb397fc4871_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of other intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_8b0a81d1-8104-4d77-a90a-88bb8702ee52_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquiredIPRD_df873564-0d1c-481f-965c-4267b3d698cc_terseLabel_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:label id="lab_bmy_AcquiredIPRD_label_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:label id="lab_bmy_AcquiredIPRD_documentation_en-US" xlink:label="lab_bmy_AcquiredIPRD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPRD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD" xlink:href="bmy-20220331.xsd#bmy_AcquiredIPRD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquiredIPRD" xlink:to="lab_bmy_AcquiredIPRD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c9285f01-5652-425b-bc9e-290a8317498d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityTable_0c2b0073-f350-4d21-9402-99493dc09abc_terseLabel_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Table]</link:label>
    <link:label id="lab_bmy_EquityTable_label_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Table]</link:label>
    <link:label id="lab_bmy_EquityTable_documentation_en-US" xlink:label="lab_bmy_EquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable" xlink:href="bmy-20220331.xsd#bmy_EquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityTable" xlink:to="lab_bmy_EquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_4840dede-a532-4238-8c53-6a1209eb934c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_cf9b4021-ec37-4b9a-bc44-714054b25d3d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_ad2ef2fa-cbd5-4808-9852-0bb6b834ed70_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPRD</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8975fbfb-8b7c-4ca9-91b5-597b45af2d79_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_6bc725be-4152-4c7c-8797-507fd57e3c82_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw and packaging materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_05e53c28-c636-48f6-843c-b24c40ff5556_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_909bc495-8394-4a77-a3c2-c60ac49bba24_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_e0cb4598-080c-468e-8f83-c4e5fcdf051c_terseLabel_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember" xlink:href="bmy-20220331.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbilifyProductLiabilityLitigationMember" xlink:to="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_6c9ba542-0b19-4a88-8b1c-034531665c00_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AllianceTransitionalServices_ad717381-96af-4d38-85f3-652031b26e7b_negatedTerseLabel_en-US" xlink:label="lab_bmy_AllianceTransitionalServices" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition and other service fees</link:label>
    <link:label id="lab_bmy_AllianceTransitionalServices_label_en-US" xlink:label="lab_bmy_AllianceTransitionalServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Transitional Services</link:label>
    <link:label id="lab_bmy_AllianceTransitionalServices_documentation_en-US" xlink:label="lab_bmy_AllianceTransitionalServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents other income recognized during the period related to transitional services provided to a former alliance partner.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceTransitionalServices" xlink:href="bmy-20220331.xsd#bmy_AllianceTransitionalServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AllianceTransitionalServices" xlink:to="lab_bmy_AllianceTransitionalServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_805879af-3684-4ba1-8449-416f92a988bb_terseLabel_en-US" xlink:label="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Transaction Revenue, Description of Reporting Category [Axis]</link:label>
    <link:label id="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_label_en-US" xlink:label="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Transaction Revenue, Description of Reporting Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:to="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_5392109a-a652-49df-a617-22a18673252b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d1c4bab6-b9a7-4f83-8a2a-ba1860bc18a0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_ca309c1d-9641-4427-8b0f-756de3c7c561_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c617b028-ebef-4a66-bdbb-bfbe168e9f38_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2d37d205-2f23-4e5e-9d8e-1a6b534e663f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_51252d38-d590-458c-b150-ed472541358c_terseLabel_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_label_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_documentation_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:href="bmy-20220331.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:to="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_1e4fa8f7-25de-4840-a14e-dc8f68d1a431_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense</link:label>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:to="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_26e8485d-67eb-4c92-b429-267ee6a7ea3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_a6b6ec56-4391-4cf3-a092-9857f71b33ec_terseLabel_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_label_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates and returns</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_documentation_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns" xlink:href="bmy-20220331.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedRebatesAndReturns" xlink:to="lab_bmy_AccruedRebatesAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_686b3be3-148d-4a7a-9c5e-4ee6eca752f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_f4f47db0-d848-4261-be9a-5c5b4545b15f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherrevenuesMember_bffe5b9c-832f-40eb-a50c-cb48223ee00a_terseLabel_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_bmy_OtherrevenuesMember_label_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:label id="lab_bmy_OtherrevenuesMember_documentation_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember" xlink:href="bmy-20220331.xsd#bmy_OtherrevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherrevenuesMember" xlink:to="lab_bmy_OtherrevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NetproductsalesMember_120ac5b6-d05f-4054-9665-6d187aaf2fdf_terseLabel_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales</link:label>
    <link:label id="lab_bmy_NetproductsalesMember_label_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:label id="lab_bmy_NetproductsalesMember_documentation_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NetproductsalesMember" xlink:to="lab_bmy_NetproductsalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_8a75b433-9b23-4ea6-a676-93ef1f25f910_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_9b39ca8f-457c-44ee-b2e8-d7bda03136a2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_df6ab94f-f981-43f1-a67e-0bd8d2fda319_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:to="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_bc17078e-be81-438c-a815-8637708aae0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed_3ca3eaee-0b2d-49c5-90f0-af028ee121d7_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs, dismissed cases</link:label>
    <link:label id="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed_label_en-US" xlink:label="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs, Dismissed</link:label>
    <link:label id="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed_documentation_en-US" xlink:label="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs, Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:href="bmy-20220331.xsd#bmy_LossContingencyNumberOfPlaintiffsDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:to="lab_bmy_LossContingencyNumberOfPlaintiffsDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8493c693-badd-450f-adda-faf87bf50197_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_63b6700d-f808-44cf-83f5-c5e8b9743b01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_695c63f1-536c-448e-9ad2-28c273791526_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_c8207ea7-8ca3-47db-9931-5af6c85a59c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_be40b63c-4332-4854-a4b3-6cc52e23c87b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d39e628e-985d-409b-b200-8aa79937f71c_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e6240cd6-ddd6-4cb6-95e4-d133b6c5919a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_5d0f641a-0106-4ed7-a3d1-b6a838320685_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fbe6e34b-7081-4a7b-9e88-148e8a5963c9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_de32342a-d1d2-4a05-a3dd-279f31e201cc_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_e2bb6a96-e9c2-4a93-9a01-2f0cacc4ff9a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTerm_66152b75-da39-4922-8df3-3ef54a14f932_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, term (in years)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTerm_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTerm" xlink:to="lab_us-gaap_LongTermDebtTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_d79784a4-6f11-4a35-b990-701dfc7c7588_negatedTerseLabel_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_label_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Other Income Expense</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_documentation_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense" xlink:href="bmy-20220331.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherOtherIncomeExpense" xlink:to="lab_bmy_OtherOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fbba1e88-e870-498b-99bd-080350de0b2a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4fa85d7d-6200-4409-aa1c-1cfd16d28a67_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reasonably possible decrease in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9fe39538-0226-40c5-9829-08cc1aeee70a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_1b7f1e4f-37cb-40f7-a153-6a7b92a48f44_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_9245f5d7-a8f6-4b1c-95b4-a00eb27dd21a_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action claims</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Class Action</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberClassAction_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Class Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberClassAction" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_4315c9a2-285e-41e4-880e-2bb7b22897e7_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b6e024dc-73f7-4be2-b07a-d8252e8d1ef7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_415175cb-6613-47c3-904a-69584f27b65f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_5c68471e-d4bf-485b-be56-6d21de86f4d3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_f0d37e24-66b4-480e-876a-8c6a631784be_terseLabel_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_label_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_documentation_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember" xlink:href="bmy-20220331.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AllianceandotherrevenuesMember" xlink:to="lab_bmy_AllianceandotherrevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_77959e95-6888-4828-af92-ec74ddaf7ed7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative impairments and downward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_54a05579-58fa-4d60-b02a-4f69dd972368_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-derivatives qualifying as net investment hedges</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_57a8d9e9-a1c3-4945-bf2e-e082e410a3c7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, fair value adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_590470a6-c5df-4bc2-bb3b-b295ccb0e3fa_terseLabel_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_label_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - current</link:label>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_documentation_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent" xlink:href="bmy-20220331.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestmentsCurrent" xlink:to="lab_bmy_EquityInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_888ebc40-3262-4469-a9e4-f9a36200a8bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a93692af-dfc8-4e96-a9ff-20c25ea3b0bb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_77d12517-3d83-4d2c-9fd5-3fd4163af98c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ef2e15b8-8e4a-4da6-a0c6-a33feec2a0f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_275942df-d2f2-4a75-be59-471d1305e598_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_d1de28ed-d6f8-4b21-a3a5-08ae9bf9ffab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermBorrowings" xlink:to="lab_us-gaap_OtherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsTable_e1369bd8-e3ca-42db-95c1-df0e99445845_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_label_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable" xlink:href="bmy-20220331.xsd#bmy_LicensingArrangementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsTable" xlink:to="lab_bmy_LicensingArrangementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_02c209ad-87ba-4a7d-ba4f-68f75624a72d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income/(Loss), pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_2ce433d3-1530-4815-b571-e9cdc539c795_terseLabel_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of revolving credit facilities</link:label>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_label_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Revolving Credit Facilities</link:label>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_documentation_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities" xlink:href="bmy-20220331.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NumberofRevolvingCreditFacilities" xlink:to="lab_bmy_NumberofRevolvingCreditFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_b0af0452-becb-4407-b55a-c791118918e4_terseLabel_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal period</link:label>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_label_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Renewal Period</link:label>
    <link:label id="lab_bmy_LongTermDebtRenewalPeriod_documentation_en-US" xlink:label="lab_bmy_LongTermDebtRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Renewal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod" xlink:href="bmy-20220331.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LongTermDebtRenewalPeriod" xlink:to="lab_bmy_LongTermDebtRenewalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_012e20f5-590b-4d2d-88c7-718cde4ceb5a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d3eaa1a4-73dd-4629-9647-a5afcd32e517_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share attributable to BMS, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_f1183005-a28f-4600-9a23-7133d3879309_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24500e04-156a-4061-a18b-814da210055b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_24cfaeef-75ff-4943-92eb-67ed693af457_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss recognized on investments sold</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b0e18c62-bece-4134-919a-e2e8bf1059bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2c848ff4-bd3d-4bcc-babe-dd22d57bbc77_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_046d3462-6e85-44fb-9344-2da7bdb5c4f9_terseLabel_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of largest pharmaceutical wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_label_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Largest Pharmaceutical Wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_documentation_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of the largest pharmaceutical wholesalers used by the company in the territory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:href="bmy-20220331.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:to="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_3feb1f3e-1885-4f2c-9851-ae7c30a04ec1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_86c4677d-4d76-47f5-a7fc-8a2d3493f627_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation and other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_c288b506-5f9b-43e3-a150-9a744f9756ce_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_9586ed07-7c18-47a3-854a-fa23f784c79a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RevlimidMember_818a6caa-ea23-4f5c-9f71-e74661f85299_terseLabel_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid</link:label>
    <link:label id="lab_bmy_RevlimidMember_label_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:label id="lab_bmy_RevlimidMember_documentation_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember" xlink:href="bmy-20220331.xsd#bmy_RevlimidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RevlimidMember" xlink:to="lab_bmy_RevlimidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_00493289-5e6e-4be4-9fef-e09d6e10206f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustments_06c3a2f2-695d-48ef-872a-99036f930618_negatedTerseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustments" xlink:to="lab_bmy_GrosstoNetAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_cc743b58-94d9-49e2-a822-1f08edcf287c_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment and fixtures</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_1b4e236c-4e04-4f6d-b32d-b528bbde3ffa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_30418e21-5986-4232-afbe-4a1b35cffb43_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_3c230e23-e77f-43af-a388-f52228136aba_terseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_c7ccd1d5-6274-4c83-94f5-3e9c8441b6a6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_51f9dda9-7270-4d33-b2fe-d2c12ea921fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_c87070a4-cccb-44af-92f3-00e679b7e908_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_c0128242-737e-4d32-8a0d-900075af4e3b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reduction of manufacturing, selling, administrative, and research and development personnel</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_8503aa72-354e-4563-8730-e14314089e1f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9e835d4f-37e0-44f6-a185-2db83f85f899_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains/(losses), pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_76c58966-2eb8-487c-9007-e1fd2a1bd035_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_6caffe36-23d7-403f-9529-798dd434cd68_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_e48306e9-9015-4248-9325-eb826defbabb_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_3228a4cd-7e27-41d0-960b-ec42a4ec9b75_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables &#8211; from alliance partners</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_c6f94764-6337-4d16-b3bd-e7bf1b6d868a_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_aa3256d2-a4ec-44c7-b5cc-0856c44acaee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_202c7454-9959-4730-a4a1-a2bef07090ad_terseLabel_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_label_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_documentation_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:href="bmy-20220331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:to="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryAdjustments_b07a13b5-7cb0-4918-ad48-d3cf02c18009_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory adjustments</link:label>
    <link:label id="lab_us-gaap_InventoryAdjustments_label_en-US" xlink:label="lab_us-gaap_InventoryAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryAdjustments" xlink:to="lab_us-gaap_InventoryAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_12394d10-667e-492f-8789-dfb80928b6ca_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimates</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_e2cbe36b-ed42-4a83-9b81-6af26c7a7d30_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_996d7de3-7d80-458d-82e6-c5e66a17637a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_59e0ea60-ba9a-4d0f-bd69-e08b15191ca2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SalesRevenueGrossMember_8f89ba49-306c-4d15-9b67-da168e8014c9_terseLabel_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross product sales</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_label_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_documentation_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember" xlink:href="bmy-20220331.xsd#bmy_SalesRevenueGrossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SalesRevenueGrossMember" xlink:to="lab_bmy_SalesRevenueGrossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_cf690aaf-9287-4923-91fe-ba164b6eb8cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7988b834-5b1b-45f1-b671-fad40c02dcd6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_cca80990-e174-43e4-8cd8-66ff482a8cbe_terseLabel_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_label_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense - Collaborative Arrangement</link:label>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_documentation_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:href="bmy-20220331.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:to="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BreyanziMember_8c4631b4-b072-44c9-8505-833f507c41df_terseLabel_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:label id="lab_bmy_BreyanziMember_label_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi [Member]</link:label>
    <link:label id="lab_bmy_BreyanziMember_documentation_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember" xlink:href="bmy-20220331.xsd#bmy_BreyanziMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BreyanziMember" xlink:to="lab_bmy_BreyanziMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_52cd87e6-4ee8-4453-80f3-82e1205a9284_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f623a12f-da69-4552-a513-58aacf567e5b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4155f305-3c2a-498f-a563-c0970d98a668_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativesAbstract_3d579263-d772-4a9a-b601-2567564ee836_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts gain/(loss):</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativesAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivatives [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:to="lab_us-gaap_ForeignCurrencyDerivativesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract_768f76ec-94e7-4b29-a38d-f095f932716d_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract_label_en-US" xlink:label="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Cash Flow Hedge Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:to="lab_us-gaap_GeneralCashFlowHedgeInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4eb43c7a-5d00-4224-aeb3-c28b218ca52e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_03203ba9-480f-442f-96e0-59297f6c7baf_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_5301e8ca-4b4b-49f8-9a84-a7379fac8a5d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses)/gains, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_209508a1-b6f4-48b5-a664-49ea010422ed_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_290d3401-7b84-4b19-9285-3c6b7023cb60_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2894cb83-5d29-465b-9076-dafbd8126d1e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value of stock</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_44374eab-1adf-4c71-a70f-08bde94bd5df_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e0ab5d24-c8a5-4bc3-bba1-66ca3e36b6d1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from share-based compensation awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_624d5838-d3a8-4337-8d6c-89988417c682_terseLabel_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and other products</link:label>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_label_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and Other Brands [Member]</link:label>
    <link:label id="lab_bmy_MatureAndOtherBrandsMember_documentation_en-US" xlink:label="lab_bmy_MatureAndOtherBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature and Other Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember" xlink:href="bmy-20220331.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureAndOtherBrandsMember" xlink:to="lab_bmy_MatureAndOtherBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_ea451a5a-48b5-457f-b510-7c0f287b5e9d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_2c889f68-f6bd-48c2-9cee-069f24ce6a59_terseLabel_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember" xlink:href="bmy-20220331.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneContingentValueRightsMember" xlink:to="lab_bmy_CelgeneContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_5f9f109a-8f79-4f2e-aae2-0562f6b374ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestituregainsandroyalties_1acd2392-25f7-4369-beca-a6739728bc49_negatedTerseLabel_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_label_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_documentation_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the amount of gains and royalties as a result of business divestitures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties" xlink:href="bmy-20220331.xsd#bmy_Divestituregainsandroyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestituregainsandroyalties" xlink:to="lab_bmy_Divestituregainsandroyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_f2971b2a-49fb-420e-8051-831f319b8517_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_fe312add-dacf-4c4d-bd1c-470bde933ba8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_daf88541-3586-436e-b57a-4107faa4797b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_f2264c6f-7d98-485d-af14-16ecd9874167_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_1a07ac3c-bf01-4bed-9243-00e75a6edcb0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_fd9556e8-414e-48fe-b85f-ccc49c9a41d1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_YervoyMember_9d2f86fd-7207-4c89-bd25-2b7d7e5e629f_terseLabel_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy</link:label>
    <link:label id="lab_bmy_YervoyMember_label_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember" xlink:href="bmy-20220331.xsd#bmy_YervoyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_YervoyMember" xlink:to="lab_bmy_YervoyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_0aaaac8e-f476-41c6-a503-8eb86166fd44_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_b35c9bc6-abd1-42a0-87d9-34a1936bce12_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:to="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f70d089f-6c8a-452a-aaf6-1ff8b59281d1_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c773ece8-23f7-4923-8f7c-57df48fd651c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cba56f06-dbd5-4e03-a9ca-b59040a64761_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bf2e16a0-87c5-4e6f-8855-ba6d60011a68_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_ce60c910-9e0b-4a5e-992d-aa57f7a9270e_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c4d9949-8505-4a41-91a9-d8e183e2c350_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3afd5a98-a910-4a62-9727-e5133e86f6c4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_efe22d36-924a-4280-a59f-68884fc92aa1_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:to="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchandDevelopment_c0b785f2-d8d8-4de6-84f8-afa3eb142192_terseLabel_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_label_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_documentation_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment" xlink:href="bmy-20220331.xsd#bmy_ResearchandDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchandDevelopment" xlink:to="lab_bmy_ResearchandDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ff519bd0-2735-4b61-b586-732f37736d1c_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_30f4e982-2af2-4e69-a83e-0f079e9100ce_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_b76c86cc-c86f-45bb-8c58-c63f5bf0828f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_89f4fa15-d032-49b2-a49b-a864f9cf0253_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ee176ae5-8741-4a0c-a40b-6bc4dbd3a9cf_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_a862483d-1697-4a09-9368-fc25b7569721_terseLabel_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Running royalty</link:label>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_label_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Guarantees Commitments, Percent</link:label>
    <link:label id="lab_bmy_RoyaltyGuaranteesCommitmentsPercent_documentation_en-US" xlink:label="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Guarantees Commitments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:href="bmy-20220331.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:to="lab_bmy_RoyaltyGuaranteesCommitmentsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_e3116306-4d92-46ff-a443-e5b24d8cbf5e_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CARTKiteLitigationMember_f0c85610-f201-497e-a970-90ff9817a701_terseLabel_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_label_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_documentation_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember" xlink:href="bmy-20220331.xsd#bmy_CARTKiteLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CARTKiteLitigationMember" xlink:to="lab_bmy_CARTKiteLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7b24f382-87b7-4e1f-830c-9a393adb4ef8_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_37eea2f7-6cfe-46e9-87cc-3f1d97c7a450_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_530b09d8-cb6c-45d9-a8bd-ae57a3187053_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_70ab47eb-27b7-4c54-a976-e7ca0023ba36_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_8484d7de-adf7-432c-bae0-4298d4b5cbbc_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_19699c4e-45d3-4fef-81e5-60f1c6064252_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_dd7a0ff1-7a98-4add-bc2d-f809cd8065f3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_550809a5-53ac-4999-8bbd-ee4b9f30198b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_4fe80917-16ec-4b83-ba5f-05e0fa34901c_terseLabel_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation</link:label>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_label_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation [Member]</link:label>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_documentation_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember" xlink:href="bmy-20220331.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcceleratedStockBasedCompensationMember" xlink:to="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ALLIANCESAbstract_574024c1-8aaf-45f8-8ea9-62b1d6a1ef9d_terseLabel_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_label_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_documentation_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract" xlink:href="bmy-20220331.xsd#bmy_ALLIANCESAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ALLIANCESAbstract" xlink:to="lab_bmy_ALLIANCESAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d3a969f7-beeb-4216-bb33-c02282a9bc31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other payments, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_1391019b-12a2-41a4-892c-6c37958878b7_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:to="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_7b81c5a7-c811-4537-ab3a-0644823f0f19_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8ef18242-f779-41e0-a88e-d07a25b1252e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Benefit Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_361bdf13-5c11-40df-955e-6d100687b621_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncome_d6004fd7-d126-4633-9597-9ec2611c3dd5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income from alliance</link:label>
    <link:label id="lab_us-gaap_DeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncome" xlink:to="lab_us-gaap_DeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_8f65f384-08d3-47fc-8218-c7c05cb6b238_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_38240ad8-9645-4e40-b19b-76cc6b662e3d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_46962949-af39-446a-888e-10fdf6e3e48f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligation to holders of the contingent value rights</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_60cdc47e-aeec-49da-879a-c625daea11ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_fef29d18-542d-4063-b7ed-c76a903f53a0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_18bdd663-2011-47c4-88ab-f7bd89b36125_terseLabel_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_label_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_documentation_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent" xlink:href="bmy-20220331.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestmentsNonCurrent" xlink:to="lab_bmy_EquityInvestmentsNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_833c4820-5b07-44c7-86e8-4574a481688d_terseLabel_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition Gross-To-Net Adjustments</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_label_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:href="bmy-20220331.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:to="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_95753485-f605-4593-a619-a726361d7ea8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1271d17f-9c2e-415f-adab-a4b9a7e42247_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_40d3aacb-4434-48b9-9127-b2b0202f25e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_e4d73d49-9d74-4ff3-b31c-e88bc02e981a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_9308aff1-f7c0-41a1-b9b7-7b9f546f0488_terseLabel_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_label_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_documentation_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract" xlink:href="bmy-20220331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract" xlink:to="lab_bmy_SupplementalFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_db76acda-61a8-4625-b2a7-9fe026d69f1e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_59a37815-141b-4ca8-9f3b-925ccb6a24e8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected weighted-average period in years of compensation cost to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_99caebd6-2bf7-45be-8fa3-99d24896bf0c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_6b0e8912-edc6-4195-b045-3edadabcb4ef_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_a32cf18b-fb26-4ba4-9a53-eaa8d8b587ca_terseLabel_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_label_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_documentation_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment" xlink:href="bmy-20220331.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedResearchAndDevelopment" xlink:to="lab_bmy_AccruedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_6c284ea4-0b88-44e4-af5f-f99af9220536_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_ec42eaed-6115-4a9c-9767-a05bc0ccdb07_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of businesses, net of cash divested</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b541874e-be7f-4d9d-bcef-613feb201108_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b690a183-28a1-49c4-be1e-8605df641312_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b5c50362-e255-4c4a-9c16-9985b4857cd3_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1e744177-da2a-4791-abbc-532815b3e5b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowance for expected credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_c9b30777-c0f1-4189-80d0-43f31ad85639_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_b7a785ed-df65-41c7-b4d0-e670225db04d_terseLabel_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_label_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_documentation_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:href="bmy-20220331.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:to="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_0eb2fcdb-88b0-4c68-a7c4-8f28394f6b32_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_38c71430-12e9-4b19-97a0-9d7bbdd89e4a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred loan issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AvaproAvalideAndPlavixMember_6fcaa39d-566c-4336-bd93-7947d0abe168_terseLabel_en-US" xlink:label="lab_bmy_AvaproAvalideAndPlavixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix* and Avapro*/Avalide*</link:label>
    <link:label id="lab_bmy_AvaproAvalideAndPlavixMember_label_en-US" xlink:label="lab_bmy_AvaproAvalideAndPlavixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Avapro, Avalide, and Plavix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AvaproAvalideAndPlavixMember" xlink:href="bmy-20220331.xsd#bmy_AvaproAvalideAndPlavixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AvaproAvalideAndPlavixMember" xlink:to="lab_bmy_AvaproAvalideAndPlavixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_64f666c5-2b09-46e1-ae0c-c46480db4f2b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_aa7caf6e-7744-4db8-ac63-be4f92b29b03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_24fd0db0-fb97-429c-b204-d740afbef1a4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_ed699422-b632-4b94-8dc6-ea42e27936da_terseLabel_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment</link:label>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_label_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment [Member]</link:label>
    <link:label id="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember_documentation_en-US" xlink:label="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Purchase Price Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:href="bmy-20220331.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:to="lab_bmy_InventoryPurchasePriceFairValueAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_863ffcc9-3dc2-4334-81b3-8d17095c704d_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental shares attributable to share-based compensation plans (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_8c39d5f9-c1ef-4a96-9735-765136f61a04_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_label_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems" xlink:href="bmy-20220331.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsLineItems" xlink:to="lab_bmy_LicensingArrangementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_71bd710b-0c16-46a1-836e-35f767f1fa96_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Cashoutlays_f0c3dd74-da94-412d-91bb-5f8d96fbb88d_terseLabel_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_label_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_documentation_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays" xlink:href="bmy-20220331.xsd#bmy_Cashoutlays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Cashoutlays" xlink:to="lab_bmy_Cashoutlays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_7f8425a6-7b80-4cdd-8933-14d14aafb579_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_389d7dee-a0e8-4a11-a365-b131d7968441_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_dcbaec14-66eb-43d3-810b-f65d617c0dcf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_2cf4401d-d3ed-40df-84fb-67decb2d633a_terseLabel_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_label_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_documentation_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:href="bmy-20220331.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:to="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_34cd23e7-4c7f-44a8-a2e8-23a1e7a1ca42_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedInterest_89bd5b5d-7892-40d4-9415-8ef242e42ab3_terseLabel_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_label_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_documentation_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest" xlink:href="bmy-20220331.xsd#bmy_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedInterest" xlink:to="lab_bmy_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_8a2a4a13-70eb-4cf4-b985-e690d78e7db1_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Table Text Block]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:to="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_2a4a6bfc-a3ac-4a9e-b279-4574369739db_terseLabel_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_label_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan [Member]</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_documentation_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:href="bmy-20220331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:to="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_3fae74f6-8364-466b-bc5e-9373d52a2b24_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_abc72471-db76-4d0f-bd1f-5daa2f945af2_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_d956d0ad-35b1-4148-babb-b01ca42c4917_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4aa38f88-4740-4b5a-b860-07d51f168f00_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_3683365d-9199-40b1-b702-25e21946f493_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_f70f530f-f45d-4956-b88a-f6fc6d7202ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_116a0176-033a-49f6-bc54-b6150ad63a31_terseLabel_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_label_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties [Member]</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember" xlink:href="bmy-20220331.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_TecentriqRoyaltiesMember" xlink:to="lab_bmy_TecentriqRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_03238db4-a5dd-40c6-bedd-7b903f06652c_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3c365899-4932-4389-8af5-0d5ebb93f2ac_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_2e233ba9-376b-4956-bbe0-47079fe510ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_22aaa535-cbef-4e39-b469-03870132d299_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2032Member_d9ad61fd-c198-4918-9a39-9769f8342454_terseLabel_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2032</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2032Member_label_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2032 [Member]</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2032Member_documentation_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2032Member" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SeniorUnsecuredNotesDue2032Member" xlink:to="lab_bmy_SeniorUnsecuredNotesDue2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_43d5690c-2dc7-4bcf-bb40-cdf4cea0ee78_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_cc583465-6429-4f9f-b89c-70fcc24c39af_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2042Member_64f5dcd3-68cf-4504-b5d4-45a5df67f17f_terseLabel_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2042</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2042Member_label_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2042 [Member]</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2042Member_documentation_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2042</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2042Member" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SeniorUnsecuredNotesDue2042Member" xlink:to="lab_bmy_SeniorUnsecuredNotesDue2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_60b8e0d5-e9a1-490e-93db-17aadfdfa420_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_2928aa2d-569d-4c00-bc58-59b8c2cdf9d3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_44022699-7132-4d92-aeeb-4be2f8a28372_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_aa55d137-3273-4cab-bf30-cb8050ed03c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_a9022645-55c8-4d66-b51b-9bac69e4c97b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_5f19acbd-7bc3-41d5-85b2-04b50d48a0d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fca7f6c8-ec64-47a9-b3c1-6572c19bd4f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d691b482-cc6f-4b2c-80cd-45c3a0c2d41e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_43e48e4e-fa3a-424f-a416-ba44dc3a6e49_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_b8fca42c-131d-4b92-aec4-1c4447840f65_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_db7ca9d8-900b-414d-a785-55d65f137e1d_terseLabel_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Axis]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_label_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Axis]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_documentation_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis" xlink:href="bmy-20220331.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IntangibleAssetNameAxis" xlink:to="lab_bmy_IntangibleAssetNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_69d07a71-a2c0-48ae-9ee1-7dc098e1a0c7_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3af44d99-1666-41c5-b2ac-252a46681cc9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_9a31f79f-52c7-4b7d-9c74-1f1ed238dc62_terseLabel_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_label_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value [Member]</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_documentation_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommonStock010ParValueMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember" xlink:href="bmy-20220331.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CommonStock0.10ParValueMember" xlink:to="lab_bmy_CommonStock0.10ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_c7042388-5b5e-4a29-b3ef-47e3cba8e784_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0fa27d11-f5f8-475f-94ce-145231b93c20_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4a63ef33-fec3-4c32-95a8-aa37624dce85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b915b9d9-c827-4116-9fad-03851f616131_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6ebc297a-c7bc-421a-b958-3a12beaff9a1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1a9c30ba-9158-4c9b-bd01-ac194f6e83bb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital&#160;in Excess of Par Value of&#160;Stock</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ace3d4bd-b77c-4535-929c-f47eb27ab117_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_0aef55f5-6a0f-4cba-a55b-2c2b3833227f_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_207cb693-e39c-498e-b376-5f6fb4a0ea09_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired marketed product rights</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_0a8d393d-8331-474b-a3dd-289cf3c40fc7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_8e7ce666-cf7f-4016-9413-0e8a27e60e93_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4361db8e-fe70-468d-af3d-6b57b4c2c604_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3a96bef4-5f53-4298-969e-b3dad5bd1e18_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_0335487b-3562-41e4-b596-6b79ffdb1bf9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_8e7c5e9a-0715-4bb5-a131-513e52f126b7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_6089de6a-5b46-41c9-b8ce-39c28a25b190_terseLabel_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_label_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_documentation_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:href="bmy-20220331.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:to="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_1d3f7e0b-c0e3-40ec-8d7b-aa82e101ba5b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e75e2146-2ab4-422e-b307-3b48dc5eadc6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_44bd0cf4-b3b4-42e1-b357-4f227020a918_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_21cf62a5-0d80-4b55-8b19-d09622ca422f_terseLabel_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220331.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_2164be6f-d8be-43e1-a672-1cde83c5e955_negatedTerseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:to="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3c2e4f0f-8156-4272-8ced-b4e98c83e099_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_3c7d7ef9-0041-4255-9a8d-96df348ce05a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_fb9d7f3e-92a4-4dd1-9559-5d5312763e3f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_0243c1e0-5f49-4a68-b734-ec3d0cda6b86_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_1266a4b2-7931-4dde-8e99-60cdbb645515_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ef5d60e9-bdc9-4219-b7ba-64d762a91869_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_97d4ba2d-b6e9-4968-9199-47f587d4ffed_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:to="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_e623d39e-77c6-4e91-ad1d-f7def605f465_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_7db50a45-91eb-4b7d-99f6-23a69bf497ee_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_160c3e1a-3cb6-4696-95fc-726618ce873d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for debt extinguishment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9f644495-a903-4847-826a-d0f0c7bb11d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_adc1bdac-726d-4a4b-bde7-0ea38c5d28de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_efe28371-f53d-446a-8435-5f3f4c53f7f1_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5b360d89-2fd9-4662-8bb1-d389027b18df_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_cb1a31fb-8873-43d7-b5c2-71c1d87a1c0c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_d207cfe7-324b-4bb9-99e6-4260c97cfd35_terseLabel_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_label_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties [Member]</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember" xlink:href="bmy-20220331.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_KeytrudaRoyaltiesMember" xlink:to="lab_bmy_KeytrudaRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ff403286-697c-4872-8416-7a39dde7404b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Bristol-Myers Squibb Company Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_47df6aea-7a21-4d7b-9d36-947b581a3a47_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f4b78ed8-1b9c-4c5f-ba9b-7f741e32fcd1_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MarketShareUnitsMember_03f6fcca-da22-4082-bacf-700a90abc94b_terseLabel_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units</link:label>
    <link:label id="lab_bmy_MarketShareUnitsMember_label_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember" xlink:href="bmy-20220331.xsd#bmy_MarketShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MarketShareUnitsMember" xlink:to="lab_bmy_MarketShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_9b1987ec-c8c9-45ef-83df-ee58d62510be_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d979e52f-865c-4108-ad00-92df1388528e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_29233845-8e48-40bf-b4f3-e4ab3350c6b1_negatedTerseLabel_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_label_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:label id="lab_bmy_AmortizationOfDeferredIncome_documentation_en-US" xlink:label="lab_bmy_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome" xlink:href="bmy-20220331.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AmortizationOfDeferredIncome" xlink:to="lab_bmy_AmortizationOfDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_0ec57b2c-5c2c-45de-b043-e1ddccb05ebc_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_a3ce7767-9a2b-48c2-a6db-8eb1e1967b80_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. dollar borrowings gain:</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_0f0a6b0d-2831-4e03-a732-c94fa34a33eb_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78b622c2-922c-40cb-a6b2-0ed9fd34333d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b45c000f-c238-4abf-a73e-8f643e4c380a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_721a6b05-f508-4dfb-8b89-a76606298e52_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt redemption</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_14b7e0fc-4ab8-4fe2-931e-e29b069d7964_terseLabel_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_label_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_documentation_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:href="bmy-20220331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:to="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_7121dd7a-4584-461d-92d6-9c7896130881_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_e9cfbd81-9e80-4477-a192-07f4ce74c7b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and discounts</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1cdadb05-347a-4643-8b4d-8421bb4c5085_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InrebicMember_297f74fb-0137-437c-8391-29f854b45243_terseLabel_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic</link:label>
    <link:label id="lab_bmy_InrebicMember_label_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:label id="lab_bmy_InrebicMember_documentation_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember" xlink:href="bmy-20220331.xsd#bmy_InrebicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InrebicMember" xlink:to="lab_bmy_InrebicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_11497a21-24d8-4cd2-86cb-6f9ff030e52a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb Company Shareholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bdfd4954-fa23-4843-81e8-72b0f9d210bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f84b8fb5-48f1-473d-8587-e94d6698e70c_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture (Gains)/Losses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6968138f-2076-4198-8ac3-d64c5fb0df49_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_9ad2e72d-7aab-4fb2-894e-81d050665af2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_165f5659-6c3e-4bee-980e-5d4c81d1ee5f_terseLabel_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:href="bmy-20220331.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:to="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_eb06ac55-5a93-4ad9-b509-e047525ff5cc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation satisfied in previous period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b2e8a6be-1fa4-4e9d-9f7e-d03c73376a20_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_429da40e-e44c-4fc1-959c-bd32679c49a0_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f355e878-b466-408e-aef4-540ed828f441_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NameOfReportingCategoryDomain_7931f5dc-16f5-42e7-89a6-05de937c47d8_terseLabel_en-US" xlink:label="lab_us-gaap_NameOfReportingCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Reporting Category [Domain]</link:label>
    <link:label id="lab_us-gaap_NameOfReportingCategoryDomain_label_en-US" xlink:label="lab_us-gaap_NameOfReportingCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Reporting Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain" xlink:to="lab_us-gaap_NameOfReportingCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_a1a36c85-e612-4639-8ad9-0eaaf87f73fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_1070cae6-a426-49e2-a227-cb06d738edde_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_75124b64-549f-4060-90fe-f236b3824d7e_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3389be17-308d-4b76-8205-7951641c08b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d729e6d2-058e-4841-8e6c-64dd5bc846bc_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9c946910-926d-43ee-ade9-df619ec4e761_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3cf4f657-a49d-46d3-83b6-677c15ca7db8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_a42a99fe-464f-4ad2-9ee2-5387c39c4bf2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_0563f608-5fc7-4160-a587-8667da26b9da_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_07e287ec-965c-4bd8-bea4-cfe94d9a8087_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LitigationTable_331381c1-1bd7-4033-97a7-d63bc94d22fe_terseLabel_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:label id="lab_bmy_LitigationTable_label_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable" xlink:href="bmy-20220331.xsd#bmy_LitigationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LitigationTable" xlink:to="lab_bmy_LitigationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_eb8efacf-42f4-4520-9edf-b20e9be4d1b0_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d122d9f3-6bb3-44a8-81a9-5a7fa706a5f3_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_c060d7e2-d27b-4b4f-9d1f-d4e21a5babeb_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_efcc2409-808b-49a4-8caf-61bb6b7340f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_25abd83d-330c-4375-a3a2-4e92503ddd57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment losses/(gains)</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_68c32ea8-393d-4c2d-b648-5ce7b6c60db4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_63693ac9-b8a2-4404-be16-e723aed6c4f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_31aada70-10a6-4d33-a64f-f78d010018ae_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_793a8688-13cd-4814-b95a-d9477a7190cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_2f84240d-6d6c-4c47-99aa-49701ec85279_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7b98c8c2-7a24-4deb-942f-57984c270e32_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A60BillionUnsecuredSeniorNotesMember_4d2fc1a5-3a8e-4ebe-b7fa-d9534ded73a1_terseLabel_en-US" xlink:label="lab_bmy_A60BillionUnsecuredSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$6.0 Billion Fixed Rate Unsecured Senior Notes</link:label>
    <link:label id="lab_bmy_A60BillionUnsecuredSeniorNotesMember_label_en-US" xlink:label="lab_bmy_A60BillionUnsecuredSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$6.0 Billion Unsecured Senior Notes [Member]</link:label>
    <link:label id="lab_bmy_A60BillionUnsecuredSeniorNotesMember_documentation_en-US" xlink:label="lab_bmy_A60BillionUnsecuredSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$6.0 Billion Unsecured Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A60BillionUnsecuredSeniorNotesMember" xlink:href="bmy-20220331.xsd#bmy_A60BillionUnsecuredSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A60BillionUnsecuredSeniorNotesMember" xlink:to="lab_bmy_A60BillionUnsecuredSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_86986ff3-e4f2-402e-9e4c-3ff0ab3e07b0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPRD</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e1f87428-b2f7-4348-87f9-bd2f72d2a6e5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8cd8a053-5223-47f0-bea9-85aeeac7466b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_196b8bd1-84a5-43da-93ea-3519139be375_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_8c20f088-09fa-4e04-a8dc-365d97693dc9_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:to="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3a54bd55-8f81-4a7c-9dc4-0b64d4e94577_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bb310d31-0f52-4ff3-9cff-5dce1ce0c41c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_09f66787-0fa2-4bd7-8893-1ba3dcf2edb2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_e3c9bc49-d205-4984-83be-fb94a3ce4941_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Gross to Net Adjustments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:to="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2d8928aa-7783-4a5d-be61-6506b0b7cfcf_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_fe9efdc9-8b95-4dc2-86a3-e8e0255f45db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_68e64299-75a6-447a-b18e-bccdd988b909_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0c7e8756-c8ad-466a-a47c-1012765bfc25_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_fdee492a-f789-408f-93be-316b76596c55_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_361991b2-eae3-409c-98e2-0945f41a1855_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_5505f129-9696-41e8-87c1-9088a7ad7ce5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c0d64f0e-5217-40e3-af1b-72a2ccd80f51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_6048516a-cac4-4086-9d51-2569d2b87e97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_100961a1-3736-4ed9-942d-747ddc714da9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_63ab3aa9-c554-4f05-b3be-9667346e9243_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_863d0c21-0d84-4797-bd58-7970f70c3fe7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_64ae5651-c386-4b57-bc07-573033e45c46_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_787ce54d-0eba-4c1b-9f1b-df3db26e5e98_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_d6096182-26b2-4c2b-9b77-51f25feaf92c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_7bb3dfb1-d16c-44f8-b67d-4c7271ac4f58_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_59f9339d-adcc-4eb5-bcbe-a8510600afa1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_cc534ddc-e159-4856-a72b-09ab74691f07_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_c733b6ea-bf01-411b-bd9a-8b621394c7e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_141ef044-7d56-42df-92eb-15b77d62bdd4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_efe74f35-1ac2-442b-8e45-1b792dc2524e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_471b9364-df96-4948-8576-d93878051833_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income)/Expense, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestOfWorldMember_45f21f16-6b3e-40f1-8b16-aabfeb14070e_terseLabel_en-US" xlink:label="lab_bmy_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the World</link:label>
    <link:label id="lab_bmy_RestOfWorldMember_label_en-US" xlink:label="lab_bmy_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestOfWorldMember" xlink:href="bmy-20220331.xsd#bmy_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestOfWorldMember" xlink:to="lab_bmy_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_b353b8a1-abf6-4bf9-857f-932c326f53b0_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dismissed cases</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Dismissed</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberDismissed_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_8fa66ad2-5958-40ed-8ba8-d54c100d8c10_terseLabel_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized basis adjustment from swap terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_label_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Basis Adjustment From Swap Terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_documentation_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:href="bmy-20220331.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:to="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_fab9e517-0f1b-44f6-9cc1-9701553607e6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury lock contracts</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNIAbstract_bd6190f9-cc7f-4620-8b9f-50e37860ab41_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determined fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNIAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNIAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFVNIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFVNIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c7399721-b66a-40a9-be45-f87d9619f5a5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_54fa3423-e31e-4051-8754-fb9f8273256b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance, Royalties, VAT and other</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_1d6fa50f-4899-46a0-bbda-db0bf8d80ec0_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_37fd07a4-cf56-4017-9364-52bd962fa4a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_32f5157c-b704-44c2-9b89-8c818dfc9a8b_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:to="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7108c6cb-3b24-4859-8713-8777ce7f618b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_31e513f9-3eaf-4288-ab50-d0f6c61f69f9_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b5a87475-8485-4184-9aab-79edf14553e3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains/(losses), after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Totalinventories_0ecedec6-f88e-4457-b932-f611113d43d7_totalLabel_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_label_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_documentation_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the total inventory, current and non-current, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories" xlink:href="bmy-20220331.xsd#bmy_Totalinventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Totalinventories" xlink:to="lab_bmy_Totalinventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_8c9f9343-3652-4800-9c1a-9ae9bbb838f1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_a572fe59-a21c-46e7-a17a-bae4d391d46c_terseLabel_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Domain]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_label_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Domain]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_documentation_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain" xlink:href="bmy-20220331.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IntangibleAssetNameDomain" xlink:to="lab_bmy_IntangibleAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_ebbe113b-b0e2-4c90-afce-fcf5c0a10740_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cd8dcc21-005c-45e9-b3b2-f68554d6d656_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_28698742-2c30-47fb-92a5-b251d67b6702_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2617e8df-43b6-4717-9c9c-09b59246b70b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d29c1596-ba23-4da0-9cdc-e55928e8da58_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_03585ac4-6cd6-402b-a525-338108828057_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities, fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_dbf6bdf6-3078-4923-821d-341ee6ab0aa3_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d164aec5-5643-4728-b3bd-6ebc02e9d01d_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_47932c45-b357-48f1-80f1-77d29c6ca38e_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74c36d53-f5f5-4da2-8d1a-f6b9e97d0cba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_d43a3341-dead-478a-a0b9-27e339b21dcc_terseLabel_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_label_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development - Non-Current</link:label>
    <link:label id="lab_bmy_ResearchAndDevelopmentNonCurrent_documentation_en-US" xlink:label="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development - Non-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent" xlink:href="bmy-20220331.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchAndDevelopmentNonCurrent" xlink:to="lab_bmy_ResearchAndDevelopmentNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_7a41fde8-6c95-42b6-a8d6-c0329c97270c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8a1b9205-dae5-4798-b125-0d273442e87f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_290b3c6b-e792-4d6a-a241-6e4e92cfe73d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a41b7e46-d025-4070-bf70-25f229c7da3f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_54a55744-0bed-456d-b934-1e255d9248a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_01b3707b-fc59-4b05-b5b1-4b484e73b4ca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PomalystImnovidMember_cda78090-6b5f-4c28-923b-80f164b498b9_terseLabel_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_label_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_documentation_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember" xlink:href="bmy-20220331.xsd#bmy_PomalystImnovidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PomalystImnovidMember" xlink:to="lab_bmy_PomalystImnovidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_34ec5c00-80f8-4094-9f2e-2b51aac1aca3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative, net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_522f8b8d-6b4f-4fb3-aba0-e4f6cea667e8_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_464112d3-4591-4d5a-b169-b3700483431d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_1ebdd396-7cca-4ff9-821b-25641260fc52_terseLabel_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and regulatory milestone</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_label_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone, Non-Cash</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_documentation_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:href="bmy-20220331.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:to="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_871ef430-ec91-4ac7-a4b8-8c6d8324a7d4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DragonflyMember_ac11ff6d-6e56-4a8b-b184-ee1977160704_terseLabel_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly</link:label>
    <link:label id="lab_bmy_DragonflyMember_label_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly [Member]</link:label>
    <link:label id="lab_bmy_DragonflyMember_documentation_en-US" xlink:label="lab_bmy_DragonflyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dragonfly</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember" xlink:href="bmy-20220331.xsd#bmy_DragonflyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DragonflyMember" xlink:to="lab_bmy_DragonflyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e5366f6d-eccb-42b4-8356-8fe8266b54d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_a37b5517-42e3-4aeb-82af-4871f4a6932c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_65a466cb-27a2-4cef-b691-c852c9d53d8c_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates and Judgements</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0158d4e4-6535-4c73-b6f3-90f851397c25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings/(Loss) Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_336ad841-d412-4714-8689-fd79c3eedb51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2052Member_a7c798f0-fbce-4630-91ad-549b28406c5c_terseLabel_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2052Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2052</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2052Member_label_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2052Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2052 [Member]</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2052Member_documentation_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2052Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2052</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2052Member" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2052Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SeniorUnsecuredNotesDue2052Member" xlink:to="lab_bmy_SeniorUnsecuredNotesDue2052Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2022ASRMember_dcdfd4f7-3a70-4eea-8f34-57adbc486ada_terseLabel_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR</link:label>
    <link:label id="lab_bmy_A2022ASRMember_label_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR [Member]</link:label>
    <link:label id="lab_bmy_A2022ASRMember_documentation_en-US" xlink:label="lab_bmy_A2022ASRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember" xlink:href="bmy-20220331.xsd#bmy_A2022ASRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2022ASRMember" xlink:to="lab_bmy_A2022ASRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_730d4cfb-d29c-4929-9671-c3da2d47b08b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_968d52f6-d397-48ad-ba7e-418ce55a20a2_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income/(loss), Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_1d3fd8f0-ac40-4655-a7e2-fdc8dc5fd9ac_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_83adf7ce-ac53-41cf-8f05-67d40c528256_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_3dfacb9c-8474-4f4b-b91d-4b47a4294f25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and other settlements</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_878a9034-4689-4c28-8a0c-e55c301ecbb5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Pensionsettlementsandamortization_c46fe20f-552e-4ad5-a576-b384ba9c2a9c_terseLabel_en-US" xlink:label="lab_bmy_Pensionsettlementsandamortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlements and amortization</link:label>
    <link:label id="lab_bmy_Pensionsettlementsandamortization_label_en-US" xlink:label="lab_bmy_Pensionsettlementsandamortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlements and amortization</link:label>
    <link:label id="lab_bmy_Pensionsettlementsandamortization_documentation_en-US" xlink:label="lab_bmy_Pensionsettlementsandamortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate amount of expense recognized due to defined benefit pension settlements and curtailments and the amortization of prior service credits and net actuarial loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Pensionsettlementsandamortization" xlink:href="bmy-20220331.xsd#bmy_Pensionsettlementsandamortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Pensionsettlementsandamortization" xlink:to="lab_bmy_Pensionsettlementsandamortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_befc2594-c156-4750-bd15-f37bed55cef8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b3675368-6dfd-4ce9-b0c1-f327a20cfa38_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_44df3c5a-1d6a-40a0-91e5-821aa9dc4680_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_edee74fc-7141-48b3-ac12-75637540542e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneIntegrationMember_066aea88-2b61-4070-b5fc-b08031c83248_terseLabel_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Acquisition Plan</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_label_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_documentation_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneIntegrationMember" xlink:to="lab_bmy_CelgeneIntegrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_dced8c80-e0f0-4003-a584-0b67868e5c87_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_e158bc35-4d51-4ceb-b07c-a85ca34a191a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_6d59c570-9296-4ac9-95aa-8f24f2a67cc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_05a04715-2e1d-4142-87a7-da3c0596ceb4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rates</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentToInventoryMember_25121fb5-97f2-4386-97b9-ba5df527a9e3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentToInventoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment to Inventory</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentToInventoryMember_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentToInventoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment to Inventory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentToInventoryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentToInventoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentToInventoryMember" xlink:to="lab_us-gaap_FairValueAdjustmentToInventoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_f1f842fb-e69b-4870-90e2-87f0de04318c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_2dd5555a-e770-4b58-89f5-cfd30f9a1eaa_negatedLabel_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income</link:label>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_5b84b985-4030-4841-b2a3-4f231bf20780_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty income, nonoperating</link:label>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:to="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_bc9ed10a-dae3-4309-aa0a-1d71c0b882da_terseLabel_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_label_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035 [Member]</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_documentation_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One750NotesDue2035Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member" xlink:href="bmy-20220331.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.750Notesdue2035Member" xlink:to="lab_bmy_A1.750Notesdue2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_be3877c7-f0b9-4985-acea-6b330832b80a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings, noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f1ecb750-78ea-4161-b107-48324d6f00da_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_b4111872-fb48-4fcf-869e-9f544f20d7f4_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:to="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_c5d74eff-877b-43f0-9aab-2d2c74f8797b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_d69b4420-ddbe-40bb-b474-1e050d70ec84_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_c5e97233-d6e8-4fa2-b42f-57c7c9d4bf3c_verboseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_0a4710b3-51f5-4c67-9f19-376165aecc65_totalLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, total</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_deedf990-2566-4a34-8dfe-986b41bd1943_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_c6787f45-af1b-435e-82e0-e72abfeddec6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Account Receivables [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_25e76190-0ac0-4968-85fa-80d6adcfd4da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_40261f87-5614-484e-bb9a-3593a1dd058d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_9657bcfc-6507-4c0d-b126-52e1d8452d77_terseLabel_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_label_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:href="bmy-20220331.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:to="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_6fd76bd1-b9bc-4c15-8c04-81c7650f8fa0_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_8491bf85-bd54-405b-929e-fb9bcd1c97c0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0752676-9efb-4a88-aed9-9e356c286a12_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bd7bf2d9-2c82-4666-b3fc-48495c2efd93_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share attributable to BMS, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnuregMember_9a728981-79aa-47b8-8028-d0fd98a5aaa2_terseLabel_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg</link:label>
    <link:label id="lab_bmy_OnuregMember_label_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg [Member]</link:label>
    <link:label id="lab_bmy_OnuregMember_documentation_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember" xlink:href="bmy-20220331.xsd#bmy_OnuregMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnuregMember" xlink:to="lab_bmy_OnuregMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_d42a38b2-0f01-417e-ad82-1e5f69388361_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages paid</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_80de8a5a-a060-4ff3-926b-f2becbc406e3_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures, Licensing and Other Arrangements</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CashDiscounts_9be76ab3-b65f-4db6-a2e3-c9424fb63ea3_negatedTerseLabel_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less charge-backs and cash discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_label_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_documentation_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts" xlink:href="bmy-20220331.xsd#bmy_CashDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CashDiscounts" xlink:to="lab_bmy_CashDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_a97cd938-2ab1-4920-bd1c-3e4e4ec25d2c_negatedTerseLabel_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties and licensing income</link:label>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_label_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Received From Alliance Partners</link:label>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_documentation_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:href="bmy-20220331.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:to="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_9953207e-ba8e-472a-af37-c7aa5e3f5187_terseLabel_en-US" xlink:label="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost savings and avoidance</link:label>
    <link:label id="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_label_en-US" xlink:label="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance</link:label>
    <link:label id="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_documentation_en-US" xlink:label="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:href="bmy-20220331.xsd#bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:to="lab_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96b93d46-bd41-4eef-adf6-29522ae627c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_406a7c50-e5be-4e87-9978-1ef0fff84226_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4e1b320f-cf54-4c9b-a303-a5b6d2d00663_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6e6798c6-3006-49a3-a6dd-a41fa1767dde_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income Attributable to BMS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_52c17f44-9b84-4e7b-8541-0e5a079eb6b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss/(gain) recognized on investments still held</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_054aa34f-8136-49f4-8b65-b9f9b8480fe2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_8581d6c5-cf09-4b61-8846-81d2051d7605_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cost of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4fd49fb7-0f81-463c-94ce-dc4577cda6d3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_74b5891d-4fa2-4840-bc92-38cef30c95c6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_819a6e3c-6565-44f3-bd0f-e298e64bc1dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net (income)/loss of affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_2a621c10-752e-41f1-bf84-23191c10fbc2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_c8510459-8122-470b-b519-f708f2ded758_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionAbstract_9faa7ed4-08d6-4bbd-8d9d-06c82ca9db54_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency interest rate swap contracts gain:</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract" xlink:to="lab_us-gaap_ForeignCurrencyTransactionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_c738a767-79ae-4df3-812f-324e221494bb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_62c00229-1ed3-4b91-9e8f-a4e1621b3d5d_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_3f4d33ec-86d0-4a89-9a92-853b728bbeab_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0c880795-4c33-4dca-8b19-3d81f3aac746_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable &#8211; to alliance partners</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_eaaf9675-ea14-46d7-a385-f1141a410674_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OpdivoMember_883976b0-0d1d-4f4e-896f-0e9872310ca3_terseLabel_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo</link:label>
    <link:label id="lab_bmy_OpdivoMember_label_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo [Member]</link:label>
    <link:label id="lab_bmy_OpdivoMember_documentation_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember" xlink:href="bmy-20220331.xsd#bmy_OpdivoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OpdivoMember" xlink:to="lab_bmy_OpdivoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_b751c2a5-ff28-4c22-af58-d8f08d39f7b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_label_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Bank Loans and Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c436372d-3ea1-4d5e-99fb-75ed534f60bb_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization, net</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_1256b9e7-e011-47df-8e8d-a45c6b0e3a2f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and downward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_67e164c3-09f1-4b1f-a949-0f275de90d58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OpdualagMember_36ffd0a9-e61e-4a23-bdaa-4925a75a5916_terseLabel_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag</link:label>
    <link:label id="lab_bmy_OpdualagMember_label_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag [Member]</link:label>
    <link:label id="lab_bmy_OpdualagMember_documentation_en-US" xlink:label="lab_bmy_OpdualagMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdualag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember" xlink:href="bmy-20220331.xsd#bmy_OpdualagMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OpdualagMember" xlink:to="lab_bmy_OpdualagMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0eb33d10-ff28-49be-8548-48acdceb0156_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2a22f0e5-5770-4a0e-b987-79cfa4a65947_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_177adc06-67da-498d-b2b9-0a0a52266681_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_023077ed-df90-4bae-a3a2-8a0eb4cd3e57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_93a92e11-60db-4fe3-a4d0-74bd4913b95f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2afeffab-80ca-4a42-9ebd-b477c8b691d6_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_8e1acf28-6902-40ee-909b-b31d314f120a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestitureandotherproceeds_59c4b7b7-3507-47dd-a57b-9ba44268b878_terseLabel_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_label_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_documentation_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds" xlink:href="bmy-20220331.xsd#bmy_Divestitureandotherproceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestitureandotherproceeds" xlink:to="lab_bmy_Divestitureandotherproceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_64f170ba-5497-4822-b508-43be37e31b21_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_abc0e60b-bee9-49d2-90ad-c5c296c87a32_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_1044787a-7207-455f-8fc1-c8f17d57ddc6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9138f614-4b45-4a69-a92e-ab080ec3fbfa_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_57588eed-f541-4ab5-8f5b-dbdfa73e51fc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_db453803-7a19-4a2f-9509-f55e98936e65_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_6b42d3a4-4ae3-4b41-b902-9d78a179a626_terseLabel_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Products and Other</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_label_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other [Member]</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_documentation_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember" xlink:href="bmy-20220331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureBrandsAndOtherMember" xlink:to="lab_bmy_MatureBrandsAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SprycelMember_e2360cf8-5544-4a3c-a857-2fa9c873afbe_terseLabel_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel</link:label>
    <link:label id="lab_bmy_SprycelMember_label_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember" xlink:href="bmy-20220331.xsd#bmy_SprycelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SprycelMember" xlink:to="lab_bmy_SprycelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BristolMyersSquibbMember_c0f55db9-62fd-4f97-beaa-60a723705368_terseLabel_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb</link:label>
    <link:label id="lab_bmy_BristolMyersSquibbMember_label_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb [Member]</link:label>
    <link:label id="lab_bmy_BristolMyersSquibbMember_documentation_en-US" xlink:label="lab_bmy_BristolMyersSquibbMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember" xlink:href="bmy-20220331.xsd#bmy_BristolMyersSquibbMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BristolMyersSquibbMember" xlink:to="lab_bmy_BristolMyersSquibbMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_da8a5083-66a0-46be-98e6-977168d79bf2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ba16c49b-fbeb-41d4-b0cd-7dc793c83c89_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_662fdc39-1ed9-4df7-9324-b966640eb796_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7f17b503-fef0-47ba-9aa1-e2ae48f3e72c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_667d0030-bf38-4570-b1c9-1ebffab164de_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_19ea6fcc-f219-4c9c-8a24-f57fd540e941_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_bc4f9c31-c953-4ec3-9a38-b45f03718be7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3a56dc45-460c-46dc-9bd7-1b7295ea6ddf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3d69ffb4-ddbc-4261-83e6-8ff38f11e327_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_e081057e-d159-475f-aab5-5a63589488ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ea054761-2fce-422f-8b70-3f9a1767836b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_490130d4-9398-48d9-b510-6d47b683ce9a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d720cdca-353e-4e50-8f85-7a89979c4354_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_e089c253-ba9d-4457-ba83-161f1fb170f5_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_bffcd18b-a823-4186-94a9-2faaa9ac4252_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_8ff36bd7-043c-480d-8613-dd1469f4d959_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9cbb95fc-877b-4181-9275-131d7de18728_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value and Other Adjustments to Long Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_156a9569-73ae-4cfd-97b6-411b05a650c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_91df8b9d-c346-4def-9c8f-41237f6a0fe6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_032800ca-358a-49ca-b48a-c8d6cbddd0c2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_67b050bf-9c9c-4e6b-ba8d-9ae040b7690f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_6b85184f-d2f7-42a9-9bf0-d2b50f4f1673_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_a6d41d39-5b3f-4693-9c21-72a8ed331917_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance revenues</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_cadb940a-8a71-4ef5-b2f9-f9ee8934cb4f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_fdb616fa-537a-455e-ba1c-0be0b9be6377_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_0f696166-0604-4811-8279-121a767e7f5b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_c9789f08-28f8-4c15-afcc-5cdab795ded5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss/(gain) recognized</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_9b84a41e-05c1-418a-9f5b-2d637d728be5_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_05dcb849-1534-4167-ba13-bf91ed107788_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_34b3032d-0166-440d-b974-a39760237b30_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized purchase price adjustments of Celgene debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_864a3beb-83b5-48d9-b6ce-0695462d4b42_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_70acab0f-e3a3-4a7c-9169-26be8aeb740b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_a0a12571-1e58-46c1-ae86-26f6a4c3ad67_terseLabel_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_label_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_documentation_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember" xlink:href="bmy-20220331.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbilifyProductLiabilityMember" xlink:to="lab_bmy_AbilifyProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_93125d8c-2872-492b-bb4f-8927fb07bbe9_terseLabel_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims, active</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_label_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Active</link:label>
    <link:label id="lab_bmy_LossContingencyPendingClaimsNumberActive_documentation_en-US" xlink:label="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number, Active</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LossContingencyPendingClaimsNumberActive" xlink:to="lab_bmy_LossContingencyPendingClaimsNumberActive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_ff92194d-72b2-447a-902d-8215c62fcf36_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains/(losses), tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingCompaniesDomain_4b2210e6-14ba-4fcb-bd74-dc2c95564993_terseLabel_en-US" xlink:label="lab_bmy_LicensingCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Domain]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesDomain_label_en-US" xlink:label="lab_bmy_LicensingCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Domain]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesDomain_documentation_en-US" xlink:label="lab_bmy_LicensingCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain" xlink:href="bmy-20220331.xsd#bmy_LicensingCompaniesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingCompaniesDomain" xlink:to="lab_bmy_LicensingCompaniesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestments_83178e54-ff99-4b85-88ce-8ad132e13734_totalLabel_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestments_label_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestments_documentation_en-US" xlink:label="lab_bmy_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments" xlink:href="bmy-20220331.xsd#bmy_EquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestments" xlink:to="lab_bmy_EquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_34bd47a1-6ed0-4b20-b80e-afb05505da0d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingCompaniesAxis_eb3b3861-27d7-46ea-9f03-2260226e4f48_terseLabel_en-US" xlink:label="lab_bmy_LicensingCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Axis]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesAxis_label_en-US" xlink:label="lab_bmy_LicensingCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Axis]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesAxis_documentation_en-US" xlink:label="lab_bmy_LicensingCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesAxis" xlink:href="bmy-20220331.xsd#bmy_LicensingCompaniesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingCompaniesAxis" xlink:to="lab_bmy_LicensingCompaniesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_5e702578-93e2-4558-a7d7-d00a850a9798_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_846d71f6-0569-49cf-bf7f-d4856df632ed_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_c5be1411-fc08-4ef1-b4b8-0e18414a38ac_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_88e4ff4a-e02e-4477-a775-f176b217aa1e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_6ba1dc2b-edb9-4ef7-a9eb-235ab3f12f70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OrenciaMember_f7d92e95-6799-41e2-91d9-c421eddc22b5_terseLabel_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia</link:label>
    <link:label id="lab_bmy_OrenciaMember_label_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember" xlink:href="bmy-20220331.xsd#bmy_OrenciaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OrenciaMember" xlink:to="lab_bmy_OrenciaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_c930f9e8-81a7-4b4d-bca8-543c41eea14e_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_7486ea32-f091-4cb8-82f5-36ab3f8b1c29_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_bf277438-eb65-4b2a-ac24-64307a0182b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DiabetesbusinessMember_73cb354c-5289-4ca7-9e55-028073d25b0b_terseLabel_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Business</link:label>
    <link:label id="lab_bmy_DiabetesbusinessMember_label_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:label id="lab_bmy_DiabetesbusinessMember_documentation_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember" xlink:href="bmy-20220331.xsd#bmy_DiabetesbusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DiabetesbusinessMember" xlink:to="lab_bmy_DiabetesbusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_237e1d11-f732-4147-94aa-c2851a77834a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_6a30bf23-f523-48f3-994f-52459b7781b8_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_19e6571a-31c3-4c8a-952c-7215d49d5cff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24a0a3e7-4292-4501-8d38-e89adcfb01ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ed8e89a2-fed8-4f6f-aaad-8636608b2c3c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at End of Period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_0d633e67-154c-425a-8c26-2ddc72a34136_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_67b318b4-cdf6-41d6-bf36-e8907ffc91ea_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_ee727aab-3193-44b7-aeca-6616f81c9245_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ExpectedSynergiesPercentage_f9d85aaf-c06c-490c-8233-487749658d8f_terseLabel_en-US" xlink:label="lab_bmy_ExpectedSynergiesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected synergies, percentage</link:label>
    <link:label id="lab_bmy_ExpectedSynergiesPercentage_label_en-US" xlink:label="lab_bmy_ExpectedSynergiesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Synergies, Percentage</link:label>
    <link:label id="lab_bmy_ExpectedSynergiesPercentage_documentation_en-US" xlink:label="lab_bmy_ExpectedSynergiesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Synergies, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ExpectedSynergiesPercentage" xlink:href="bmy-20220331.xsd#bmy_ExpectedSynergiesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ExpectedSynergiesPercentage" xlink:to="lab_bmy_ExpectedSynergiesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_eedcea49-17ce-45c7-ab7d-e2eda4f35bf7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c5a69a2a-676e-4dd5-800c-a7bf14b27415_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cfa8a5dc-2258-4f74-9b25-0c93efc67a55_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EliquisMember_a3d5fa70-29e6-4309-9921-fde5570d6027_terseLabel_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis</link:label>
    <link:label id="lab_bmy_EliquisMember_label_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember" xlink:href="bmy-20220331.xsd#bmy_EliquisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EliquisMember" xlink:to="lab_bmy_EliquisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_a17f8a0d-cc5e-4d15-b07d-0ac549d10464_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_63c25d9a-c706-49dd-b99e-eb9987a6d08b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - money market and other securities</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b2f50461-34cb-4d72-9970-e7446dbc396d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_90489dfc-6c59-4a8c-9e74-8ef3560327f7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_5cdd9f6d-06e8-4a3d-96da-b613d0f5a774_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_907a7cf5-2890-44a5-8359-2da58ec3ec09_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EmplicitiMember_c5952280-fece-4d6c-8c80-814bbb58da69_terseLabel_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti</link:label>
    <link:label id="lab_bmy_EmplicitiMember_label_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti [Member]</link:label>
    <link:label id="lab_bmy_EmplicitiMember_documentation_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember" xlink:href="bmy-20220331.xsd#bmy_EmplicitiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EmplicitiMember" xlink:to="lab_bmy_EmplicitiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_62cc0a01-c30d-4393-96fa-c71b7e1f3805_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ae51d1e7-b750-47d2-bdee-93fd169b68bc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_983fda9b-92ca-4bd7-9352-c40ec5537760_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income/(Loss), after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_70430f38-1a9f-4609-b3ce-ecd1f56bbc6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4a96d58b-ea24-4c19-8214-758fc38c1f29_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2062Member_1cb4c48a-e769-4c07-907d-42d74e5aca99_terseLabel_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2062Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2062</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2062Member_label_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2062Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2062 [Member]</link:label>
    <link:label id="lab_bmy_SeniorUnsecuredNotesDue2062Member_documentation_en-US" xlink:label="lab_bmy_SeniorUnsecuredNotesDue2062Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2062</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2062Member" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2062Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SeniorUnsecuredNotesDue2062Member" xlink:to="lab_bmy_SeniorUnsecuredNotesDue2062Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2f3750c5-2072-4005-8057-2b83c8836a68_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_cadc6d81-b8f3-4d02-9d2b-0a7fcb715000_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_af237502-b68d-4ef0-8c2f-c5e3427c37d2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities for CERCLA matters</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_167da32c-c868-4026-b31c-d009b6f04b4b_terseLabel_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220331.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_6dd679d4-ae6e-4093-964d-ea84912527b5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_05a50cc9-5f64-4c32-8c2e-d1de6ba76cfd_terseLabel_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A5BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$5 Billion Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220331.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A5BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReblozylMember_6f870023-e93b-427f-8989-e15ebddc6fab_terseLabel_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl</link:label>
    <link:label id="lab_bmy_ReblozylMember_label_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:label id="lab_bmy_ReblozylMember_documentation_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember" xlink:href="bmy-20220331.xsd#bmy_ReblozylMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReblozylMember" xlink:to="lab_bmy_ReblozylMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_de3fc20e-5564-440d-a6f6-b754e0663598_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other termination costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6d4271dc-8227-46e6-8752-0561666b5d46_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_7d0058eb-8f5e-4e1e-a4d4-f088850280ab_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_2f98ee82-ffb1-4068-b5b8-d51a4997d456_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0e515d60-1b5b-48e8-ae3e-590566e99d27_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b10158bb-5442-41ff-b67d-68de8beef305_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by/(Used in) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f5cfd588-81bc-4339-a14e-0866d2dd4b6d_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_e7ad1a25-adf4-47ed-b7a6-dc6de769a14b_terseLabel_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. receivables sold on a nonrecourse basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_label_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Sold On Nonrecourse Basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_documentation_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of receivables sold on a nonrecourse basis during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:href="bmy-20220331.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:to="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad0805d9-0be8-45bf-9c44-9f929f1fe12b_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_e61fe3c8-18b1-4f70-ab26-e56ccd2020ac_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:to="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_1e9cad8e-1663-4d20-aa8e-ec203c333637_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_60cfb3d9-c94c-40e1-98e4-a20c064ff85b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_811457b8-0a02-436b-ac6d-75e7c954bb17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_3e256338-430f-4891-8e5f-810d05e98fca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8176ffd1-9ba4-4a5f-a1c7-aad86a0fd93f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_ec8886c9-77e5-45c1-a788-22190d1c0a37_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_8da88842-12f4-4c33-b893-fd4254f0279c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated depreciation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:to="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbraxaneMember_31451f48-55f3-43a3-b1b0-9cfccdead974_terseLabel_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane</link:label>
    <link:label id="lab_bmy_AbraxaneMember_label_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:label id="lab_bmy_AbraxaneMember_documentation_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember" xlink:href="bmy-20220331.xsd#bmy_AbraxaneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbraxaneMember" xlink:to="lab_bmy_AbraxaneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_48125b3d-5e76-4800-bde0-b349defbaed9_terseLabel_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for provisions for product sales made in prior periods</link:label>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_label_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Provisions for Product Sales made in Prior Periods</link:label>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_documentation_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Provisions for Product Sales made in Prior Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:href="bmy-20220331.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:to="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_b7ee73b9-1b14-4199-a4d5-b6e2a948a464_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_ab362214-ffc6-44ff-bcb2-80c1d2f26073_terseLabel_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_label_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_documentation_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember" xlink:href="bmy-20220331.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ChargebacksandcashdiscountsMember" xlink:to="lab_bmy_ChargebacksandcashdiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_e530cd4f-1cf8-4652-a831-533402135a91_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_48fb0728-1a7e-4495-b3ac-ff76b3b0dd76_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ZeposiaMember_ae5646dc-d1cb-4dd1-a05e-14e99b45f1b3_terseLabel_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia</link:label>
    <link:label id="lab_bmy_ZeposiaMember_label_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia [Member]</link:label>
    <link:label id="lab_bmy_ZeposiaMember_documentation_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember" xlink:href="bmy-20220331.xsd#bmy_ZeposiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ZeposiaMember" xlink:to="lab_bmy_ZeposiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c6f10dbf-1e0f-4a7c-8aa4-c6aa37571d2a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_5aa7dc4f-65b4-4624-9dc4-85f462743d00_terseLabel_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_label_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025 [Member]</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_documentation_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One000NotesDue2025Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member" xlink:href="bmy-20220331.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.000Notesdue2025Member" xlink:to="lab_bmy_A1.000Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_128d504b-1ed5-4848-99e4-ea84da729aa5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of equity investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c76b9b54-3116-4d1b-8020-2db202e87335_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6e94970e-acdf-4894-a2a1-6ee2ad279723_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DocumentAndEntityInformationAbstract_0f979c6d-4b51-464d-8c2f-f8755f7f6558_terseLabel_en-US" xlink:label="lab_bmy_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_bmy_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_bmy_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_bmy_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_bmy_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DocumentAndEntityInformationAbstract" xlink:href="bmy-20220331.xsd#bmy_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract" xlink:to="lab_bmy_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_18f9e2ea-9a88-40e2-b2e6-f47f33f2e920_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_db2600d4-ead1-49c8-a1f1-012d467f5d07_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_b035d9cb-17b2-4301-8f87-e6f0a26ecf55_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_1cc43d5d-ec3a-4472-976f-cd74263dc4f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_7dfd1a60-5630-4327-bfd2-548744ceb46e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_bd7f2f4f-ff6e-430d-97c6-19abcfe2c5d8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_ef173140-a919-4fa7-b744-7f46e048a8f8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8baf7f45-1ce7-4148-b187-0e52ed57bd82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fc58a111-3d58-408f-b45b-818f8e03b27c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbecmaMember_0803e98a-af0b-4394-bcda-b2d2c080605e_terseLabel_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:label id="lab_bmy_AbecmaMember_label_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma [Member]</link:label>
    <link:label id="lab_bmy_AbecmaMember_documentation_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember" xlink:href="bmy-20220331.xsd#bmy_AbecmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbecmaMember" xlink:to="lab_bmy_AbecmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_5795d639-6d90-4cfc-af09-cc28b0eb2bb5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related charges incurred to date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b41eaa4c-4c46-4000-b3dc-a97a55d1153b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d5bc2a5f-9bb1-449b-97ed-7296f0f30929_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_fdbd6008-b83b-409c-9d0d-728eed6c4732_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_4bbbdeeb-c937-4cd4-8354-59ad89089a1c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate debt, lower range of basis point spread</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CheplapharmMember_538245e3-16f9-42ca-9fc2-ea0bcfe165f0_terseLabel_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm</link:label>
    <link:label id="lab_bmy_CheplapharmMember_label_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm [Member]</link:label>
    <link:label id="lab_bmy_CheplapharmMember_documentation_en-US" xlink:label="lab_bmy_CheplapharmMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cheplapharm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember" xlink:href="bmy-20220331.xsd#bmy_CheplapharmMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CheplapharmMember" xlink:to="lab_bmy_CheplapharmMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_e4cb3c2f-c071-4b97-aeb4-76ba2ebcc3a0_terseLabel_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20220331.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_052fbdc0-026e-438c-bc89-e13dec08ab24_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_e28a914c-0fd3-4cac-ba81-9e32c246e60f_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as net investment hedges</link:label>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Investment Hedge Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:to="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_ac69a862-fb5e-4e04-b993-381142834152_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_4e8afc6b-2484-4f55-98a8-ea9a88e199d7_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f3f1a92a-78e3-4477-a00c-71347c43446e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net earnings, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_ed662342-d0c7-4b6f-97ea-e804e4737891_terseLabel_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and regulatory milestone payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_label_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_documentation_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:href="bmy-20220331.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:to="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_6103d0df-82e9-4c3f-9572-23aa7f8f4e5b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_11d6d82f-1637-4fc3-9df6-a012e07055f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements, after tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_41bbb31e-abcb-41fb-afbb-e90ae2c8613b_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_685bae93-dce3-4283-a1eb-5f5de4bdb49f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_e4b295d5-ed2d-4828-ae67-351d2ae78f29_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_716ec9d2-8f2c-4b67-a6ea-f0ad27546771_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_6873cc98-a147-4b1c-b4d6-d52f780981e6_negatedTerseLabel_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent milestone income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_label_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_documentation_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:href="bmy-20220331.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:to="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_98eca66a-553a-46c1-b7e4-783c127c2afa_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ImmaticsMember_48be17fa-55f3-4b1b-8013-a3c2434a4d87_terseLabel_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics</link:label>
    <link:label id="lab_bmy_ImmaticsMember_label_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics [Member]</link:label>
    <link:label id="lab_bmy_ImmaticsMember_documentation_en-US" xlink:label="lab_bmy_ImmaticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immatics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember" xlink:href="bmy-20220331.xsd#bmy_ImmaticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ImmaticsMember" xlink:to="lab_bmy_ImmaticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_89c57679-b4ad-4145-9db1-9d6912350970_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_6d27fede-6304-4ebd-8d8f-4555a01415a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives and Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRegionMember_643b8f15-76e2-43d4-84bf-a122b83bf86b_terseLabel_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Region</link:label>
    <link:label id="lab_bmy_OtherRegionMember_label_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Region [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember" xlink:href="bmy-20220331.xsd#bmy_OtherRegionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRegionMember" xlink:to="lab_bmy_OtherRegionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_91d7e682-8cab-4957-abaf-98722861a992_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative upward adjustments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_8672065c-09e6-42f5-93ab-0ea647f7c998_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized bond discounts and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_74bd5933-9d95-4717-939d-bb1ca90d4c42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_643c7c55-08a0-48ba-8601-7e19827799d4_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f60151e9-e123-4e17-957d-480eb13cdcf2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bmy-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5a14e930-e849-45eb-bcad-119c402123d7,g:c84cb2fd-f418-4547-ab26-f641c106cb69-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="bmy-20220331.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DocumentAndEntityInformationAbstract_f0f64e35-5046-4744-8094-b95d7d2cbc30" xlink:href="bmy-20220331.xsd#bmy_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e8865568-aadb-4bdd-b13b-e022285aa2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_f0f64e35-5046-4744-8094-b95d7d2cbc30" xlink:to="loc_us-gaap_StatementTable_e8865568-aadb-4bdd-b13b-e022285aa2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5716ade1-a3b5-4937-93ce-98dd0005f8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8865568-aadb-4bdd-b13b-e022285aa2e3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5716ade1-a3b5-4937-93ce-98dd0005f8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5716ade1-a3b5-4937-93ce-98dd0005f8e3" xlink:to="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_a1bbe15e-2513-499e-8c87-42942eba4fe8" xlink:href="bmy-20220331.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_CommonStock0.10ParValueMember_a1bbe15e-2513-499e-8c87-42942eba4fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_cbe951fa-bc7d-4e6a-9dda-75328b1a901f" xlink:href="bmy-20220331.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_A1.000Notesdue2025Member_cbe951fa-bc7d-4e6a-9dda-75328b1a901f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_77953759-3e35-405b-ac21-7716f7614211" xlink:href="bmy-20220331.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_A1.750Notesdue2035Member_77953759-3e35-405b-ac21-7716f7614211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_7accb542-82cc-4453-838a-c238473740f7" xlink:href="bmy-20220331.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4abe46df-1832-4e5c-8ed8-a3cf601a1d2a" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_7accb542-82cc-4453-838a-c238473740f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8865568-aadb-4bdd-b13b-e022285aa2e3" xlink:to="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fd53f6c3-c2b9-4948-8be4-2974b0fd40e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentType_fd53f6c3-c2b9-4948-8be4-2974b0fd40e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4c873ddf-91e8-446e-aeed-b1df679c3166" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentQuarterlyReport_4c873ddf-91e8-446e-aeed-b1df679c3166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b1d5ebba-6a41-408f-89a4-c4f0a12b4c80" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentPeriodEndDate_b1d5ebba-6a41-408f-89a4-c4f0a12b4c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_397417ca-796a-42dc-afa5-bb5d2b5fddb0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentTransitionReport_397417ca-796a-42dc-afa5-bb5d2b5fddb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_93886dcc-88a9-4603-a7c7-a79ad1026597" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityFileNumber_93886dcc-88a9-4603-a7c7-a79ad1026597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b48e9091-63d0-4c26-8dcb-961197425069" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityRegistrantName_b48e9091-63d0-4c26-8dcb-961197425069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_343e18ac-ece7-4d1f-bab2-74e5d816482b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_343e18ac-ece7-4d1f-bab2-74e5d816482b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6e5ca6cb-72eb-4499-ac09-2f133d751cca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityTaxIdentificationNumber_6e5ca6cb-72eb-4499-ac09-2f133d751cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_fa1d331c-baea-45f9-b150-789c6a18d009" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressAddressLine1_fa1d331c-baea-45f9-b150-789c6a18d009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_09a9f3e3-0830-4a86-aae9-d40787bbece0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressCityOrTown_09a9f3e3-0830-4a86-aae9-d40787bbece0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d6d08390-df1a-4253-83c9-4331e043528d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressStateOrProvince_d6d08390-df1a-4253-83c9-4331e043528d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7ceb8334-9d96-409c-b0b6-00ba90f5e48b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityAddressPostalZipCode_7ceb8334-9d96-409c-b0b6-00ba90f5e48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d82577cc-5318-49c7-a51e-c41098924a0c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_CityAreaCode_d82577cc-5318-49c7-a51e-c41098924a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f7f4a671-5017-485c-99a9-b075c1064143" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_LocalPhoneNumber_f7f4a671-5017-485c-99a9-b075c1064143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_88c9b14a-c139-4d81-847e-c1ed91d5a782" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_Security12bTitle_88c9b14a-c139-4d81-847e-c1ed91d5a782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8c932a8d-564a-4ec3-9b8a-d7e583ef746a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_TradingSymbol_8c932a8d-564a-4ec3-9b8a-d7e583ef746a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fa4f77d7-a7f1-42e2-bdcb-33d67a4adec3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_SecurityExchangeName_fa4f77d7-a7f1-42e2-bdcb-33d67a4adec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f41480a7-03b0-4457-8fea-be3a2f698c5f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityCurrentReportingStatus_f41480a7-03b0-4457-8fea-be3a2f698c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a1c3dab5-bb29-458d-90d4-779142e6c494" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityInteractiveDataCurrent_a1c3dab5-bb29-458d-90d4-779142e6c494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e9dc40d9-9868-48af-8214-5acebd57b72e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityFilerCategory_e9dc40d9-9868-48af-8214-5acebd57b72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e5430a81-92a3-4b7b-884f-c8343362267d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityEmergingGrowthCompany_e5430a81-92a3-4b7b-884f-c8343362267d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_06dd6604-917e-4a23-abf5-2da0564ad3e6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityShellCompany_06dd6604-917e-4a23-abf5-2da0564ad3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_582ba36b-d532-4c2a-b4d5-567699a2357f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_582ba36b-d532-4c2a-b4d5-567699a2357f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0c2be1cf-df7f-4a78-92f4-d858d3f7d08b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntityCentralIndexKey_0c2be1cf-df7f-4a78-92f4-d858d3f7d08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ab785ddc-44ba-4dec-bd2e-f6bc242f0d86" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentFiscalYearFocus_ab785ddc-44ba-4dec-bd2e-f6bc242f0d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_22106f08-df82-4c11-98b7-4261a8215a96" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_22106f08-df82-4c11-98b7-4261a8215a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_107926ec-d14e-42fe-b6cf-6ee926156b2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_CurrentFiscalYearEndDate_107926ec-d14e-42fe-b6cf-6ee926156b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a322adf3-0c07-4605-934c-6dffa23cd7fa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_AmendmentFlag_a322adf3-0c07-4605-934c-6dffa23cd7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2716e36f-eece-4a05-922f-d52dc7939403" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92c83e5d-d9ba-451f-90b0-f448f3875a5b" xlink:to="loc_dei_EntitySmallBusiness_2716e36f-eece-4a05-922f-d52dc7939403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5f1122ae-3080-49eb-99d5-92b0c22b921d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3ab31667-3b70-44e2-bb11-5f68bdd84bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5f1122ae-3080-49eb-99d5-92b0c22b921d" xlink:to="loc_us-gaap_StatementTable_3ab31667-3b70-44e2-bb11-5f68bdd84bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_2ae9dfd2-607b-4b04-b956-23089602d99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3ab31667-3b70-44e2-bb11-5f68bdd84bd2" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_2ae9dfd2-607b-4b04-b956-23089602d99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_2ae9dfd2-607b-4b04-b956-23089602d99d" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_da63c49b-b698-4419-973a-80b731f869b4" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:to="loc_bmy_NetproductsalesMember_da63c49b-b698-4419-973a-80b731f869b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_c8ea5656-784a-46a8-8d0f-b07435c5a250" xlink:href="bmy-20220331.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_c99dad83-e765-4dd0-ad6f-e570eb5f01c7" xlink:to="loc_bmy_AllianceandotherrevenuesMember_c8ea5656-784a-46a8-8d0f-b07435c5a250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3ab31667-3b70-44e2-bb11-5f68bdd84bd2" xlink:to="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9b486b2b-c0bc-48f3-8ac6-49b83051c408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_Revenues_9b486b2b-c0bc-48f3-8ac6-49b83051c408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bc57e02a-e6f8-4f6d-89d4-9a41970936ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bc57e02a-e6f8-4f6d-89d4-9a41970936ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05bb1d91-47a6-44ca-8b9e-b8beb133df13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05bb1d91-47a6-44ca-8b9e-b8beb133df13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5aa89fef-0a85-4a01-96af-5e4c59af7aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5aa89fef-0a85-4a01-96af-5e4c59af7aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_cee63996-5425-4070-bfbc-2a8d7e0c7892" xlink:href="bmy-20220331.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_bmy_AcquiredIPRD_cee63996-5425-4070-bfbc-2a8d7e0c7892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_790b4558-ba82-48ff-bc91-e473feb60210" xlink:href="bmy-20220331.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_790b4558-ba82-48ff-bc91-e473feb60210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_09ef6ada-f6e3-4407-9a08-deb7afd77849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_09ef6ada-f6e3-4407-9a08-deb7afd77849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9d056898-8fc7-45a4-9316-809478bd732c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_CostsAndExpenses_9d056898-8fc7-45a4-9316-809478bd732c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4f673f8-52f0-4f83-8f6b-e285a7c1aa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4f673f8-52f0-4f83-8f6b-e285a7c1aa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7990a191-af21-4fcd-93d4-94e44c6dfa90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7990a191-af21-4fcd-93d4-94e44c6dfa90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b2ac9ba5-9324-4def-ad08-28ee4f39f1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_ProfitLoss_b2ac9ba5-9324-4def-ad08-28ee4f39f1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb2a38ae-e7fe-4161-b1d0-a76a39c57247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb2a38ae-e7fe-4161-b1d0-a76a39c57247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aa93abe1-edc3-4390-8147-2b493018d7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_NetIncomeLoss_aa93abe1-edc3-4390-8147-2b493018d7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_319c3f38-9a45-4794-a14a-1f4ac5294dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_EarningsPerShareBasic_319c3f38-9a45-4794-a14a-1f4ac5294dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_56d4e7bb-30b0-42ab-aa07-1cb5ac58ddd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d7ea293a-c062-400c-98b0-af191a870f87" xlink:to="loc_us-gaap_EarningsPerShareDiluted_56d4e7bb-30b0-42ab-aa07-1cb5ac58ddd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_da37f4ad-f0ac-4fde-adce-e5afe228f386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_ProfitLoss_da37f4ad-f0ac-4fde-adce-e5afe228f386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c341ca7c-b7cd-47d0-858e-8a0e2f03fa11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c341ca7c-b7cd-47d0-858e-8a0e2f03fa11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_29be7878-1f5a-438c-b0bd-a1bb734f120c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_29be7878-1f5a-438c-b0bd-a1bb734f120c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_190375bd-2d2e-488a-bfa5-5cd411152a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_190375bd-2d2e-488a-bfa5-5cd411152a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_0ae811c3-50a3-41dc-a2d3-ca09ac5f0561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_0ae811c3-50a3-41dc-a2d3-ca09ac5f0561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8374af37-1902-44c3-b953-aeb9877c01f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8374af37-1902-44c3-b953-aeb9877c01f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a99f5937-5f22-4ad1-9e13-311bf79920ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a99f5937-5f22-4ad1-9e13-311bf79920ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1917ce9e-734b-4c5e-ad6b-429ca1af904b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1917ce9e-734b-4c5e-ad6b-429ca1af904b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b709de34-434a-4315-b3c2-d8db88e3e13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a26ac31-0f46-4c10-99a0-7a46d78fa0a0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b709de34-434a-4315-b3c2-d8db88e3e13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a4287143-334f-4aa1-b524-d3fb37aa581d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a4287143-334f-4aa1-b524-d3fb37aa581d" xlink:to="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c0b7a1c0-5b9e-445d-a352-a42a87719466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c0b7a1c0-5b9e-445d-a352-a42a87719466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_ee10bd8f-da97-448b-9613-d841105d7d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_ee10bd8f-da97-448b-9613-d841105d7d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_1cf07800-d58b-4067-b89c-0df997ae1543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:to="loc_us-gaap_ReceivablesNetCurrent_1cf07800-d58b-4067-b89c-0df997ae1543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b2f62dda-894e-4e63-9eab-0dcbc03ddb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:to="loc_us-gaap_InventoryNet_b2f62dda-894e-4e63-9eab-0dcbc03ddb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_31727a2a-8408-40ac-a59b-aa615c1f55b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:to="loc_us-gaap_OtherAssetsCurrent_31727a2a-8408-40ac-a59b-aa615c1f55b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_472bcf12-872f-48d8-8d11-c0c124470a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d5a1d11e-d1d5-49bf-afc3-9637a23a6c89" xlink:to="loc_us-gaap_AssetsCurrent_472bcf12-872f-48d8-8d11-c0c124470a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2a15d04a-4aad-43f3-85cd-48b405b3464c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2a15d04a-4aad-43f3-85cd-48b405b3464c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0ec84c13-6267-4bd2-8741-a2e874914a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:to="loc_us-gaap_Goodwill_0ec84c13-6267-4bd2-8741-a2e874914a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d9434e73-9d9c-4678-8c4c-5e3130cd514d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d9434e73-9d9c-4678-8c4c-5e3130cd514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e62bca41-c203-4082-97aa-b1227a6fe02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e62bca41-c203-4082-97aa-b1227a6fe02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bcecf49b-19ed-42fc-9aa4-0499dc08585f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bcecf49b-19ed-42fc-9aa4-0499dc08585f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_980c6929-9394-48d4-9e40-624c2f93bb88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8d6aea43-5868-437c-98f3-99eaa4e5a9a0" xlink:to="loc_us-gaap_Assets_980c6929-9394-48d4-9e40-624c2f93bb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_3a5dde18-797f-489e-9d74-fbb2cc33079a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a4287143-334f-4aa1-b524-d3fb37aa581d" xlink:to="loc_us-gaap_LiabilitiesAbstract_3a5dde18-797f-489e-9d74-fbb2cc33079a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9a75275f-764a-436e-8532-ef8eca6e32ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3a5dde18-797f-489e-9d74-fbb2cc33079a" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9a75275f-764a-436e-8532-ef8eca6e32ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_120d4d6e-f543-40d7-94d8-305496d79715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a75275f-764a-436e-8532-ef8eca6e32ab" xlink:to="loc_us-gaap_DebtCurrent_120d4d6e-f543-40d7-94d8-305496d79715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2b01ad3b-bd75-457e-98a1-4c83a9fc7c36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a75275f-764a-436e-8532-ef8eca6e32ab" xlink:to="loc_us-gaap_AccountsPayableCurrent_2b01ad3b-bd75-457e-98a1-4c83a9fc7c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_aca35904-9e65-4d30-977a-bb0250346812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a75275f-764a-436e-8532-ef8eca6e32ab" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_aca35904-9e65-4d30-977a-bb0250346812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_283f140d-cd8d-43c0-b914-79328d00b0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a75275f-764a-436e-8532-ef8eca6e32ab" xlink:to="loc_us-gaap_LiabilitiesCurrent_283f140d-cd8d-43c0-b914-79328d00b0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f76aca73-83dd-4861-8a32-75c754920aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3a5dde18-797f-489e-9d74-fbb2cc33079a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f76aca73-83dd-4861-8a32-75c754920aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_07752252-232b-41f8-b448-61522b8e2263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3a5dde18-797f-489e-9d74-fbb2cc33079a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_07752252-232b-41f8-b448-61522b8e2263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3eba922e-1d2a-4727-a147-ff1f94d76433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3a5dde18-797f-489e-9d74-fbb2cc33079a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3eba922e-1d2a-4727-a147-ff1f94d76433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fa6609ad-bd72-4287-a862-d889072c6576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3a5dde18-797f-489e-9d74-fbb2cc33079a" xlink:to="loc_us-gaap_Liabilities_fa6609ad-bd72-4287-a862-d889072c6576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19bc656e-6cfd-4597-9fa8-5101e1b7c79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a4287143-334f-4aa1-b524-d3fb37aa581d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19bc656e-6cfd-4597-9fa8-5101e1b7c79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19bc656e-6cfd-4597-9fa8-5101e1b7c79b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ef2748ad-ad0a-4b8a-b105-d32df538e858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:to="loc_us-gaap_PreferredStockValue_ef2748ad-ad0a-4b8a-b105-d32df538e858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a286fa56-1047-404b-be11-b44f06aeb305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:to="loc_us-gaap_CommonStockValue_a286fa56-1047-404b-be11-b44f06aeb305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3a656dfd-173b-46c7-8a84-355120530ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3a656dfd-173b-46c7-8a84-355120530ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dec4aabd-ba75-4e18-b3ed-2366747a4a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dec4aabd-ba75-4e18-b3ed-2366747a4a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fdbd54ea-b119-4c15-83c9-a9c3a79c6da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fdbd54ea-b119-4c15-83c9-a9c3a79c6da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2e3e0dac-9e3a-4f54-9a7f-288d9ae9d494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:to="loc_us-gaap_TreasuryStockValue_2e3e0dac-9e3a-4f54-9a7f-288d9ae9d494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_19138d3a-c72f-4ba9-b155-c2ce72645d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32024c84-6cb5-431e-84e5-a78d38716bbb" xlink:to="loc_us-gaap_StockholdersEquity_19138d3a-c72f-4ba9-b155-c2ce72645d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_991b030f-cb19-4eae-8d5a-1888d53f69a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19bc656e-6cfd-4597-9fa8-5101e1b7c79b" xlink:to="loc_us-gaap_MinorityInterest_991b030f-cb19-4eae-8d5a-1888d53f69a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a303c30-fb14-42e3-b98d-32934c8d50b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19bc656e-6cfd-4597-9fa8-5101e1b7c79b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a303c30-fb14-42e3-b98d-32934c8d50b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cf3cbaa8-3420-44ae-b4e4-99a5a0db5e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a4287143-334f-4aa1-b524-d3fb37aa581d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_cf3cbaa8-3420-44ae-b4e4-99a5a0db5e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="bmy-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_18e58074-5992-4f47-bb36-3483946cd9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf7c2d51-8938-475f-bf2b-a7fd1eab2a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18e58074-5992-4f47-bb36-3483946cd9c7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf7c2d51-8938-475f-bf2b-a7fd1eab2a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_08d8d3d3-5aa2-4e74-affa-6891ca41098b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf7c2d51-8938-475f-bf2b-a7fd1eab2a1a" xlink:to="loc_us-gaap_ProfitLoss_08d8d3d3-5aa2-4e74-affa-6891ca41098b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf7c2d51-8938-475f-bf2b-a7fd1eab2a1a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a10a32f2-f785-4517-a11e-4c9ad8bc047e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a10a32f2-f785-4517-a11e-4c9ad8bc047e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_27586e06-d1cf-4095-b9af-afa712f56407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_27586e06-d1cf-4095-b9af-afa712f56407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fbd751b9-ecdf-479f-a8f0-4476b4f14a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_ShareBasedCompensation_fbd751b9-ecdf-479f-a8f0-4476b4f14a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_62917161-9cb3-4130-bbba-1a24e29468fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_62917161-9cb3-4130-bbba-1a24e29468fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Pensionsettlementsandamortization_9a0f96c9-7d2b-474d-993b-66a4b323f8d3" xlink:href="bmy-20220331.xsd#bmy_Pensionsettlementsandamortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_bmy_Pensionsettlementsandamortization_9a0f96c9-7d2b-474d-993b-66a4b323f8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_003137bb-877d-402c-9a39-a2a456f662a5" xlink:href="bmy-20220331.xsd#bmy_Divestituregainsandroyalties"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_bmy_Divestituregainsandroyalties_003137bb-877d-402c-9a39-a2a456f662a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredIPRD_6c944fc8-2b70-4480-9a04-8e547c3f6975" xlink:href="bmy-20220331.xsd#bmy_AcquiredIPRD"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_bmy_AcquiredIPRD_6c944fc8-2b70-4480-9a04-8e547c3f6975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_e4363811-eec2-471e-bece-b27dcb7b1529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_GainLossOnInvestments_e4363811-eec2-471e-bece-b27dcb7b1529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6289a9c0-4625-4338-8126-0f16da55ef6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6289a9c0-4625-4338-8126-0f16da55ef6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_929d3fdc-3b8a-456c-8a60-66929386459e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_929d3fdc-3b8a-456c-8a60-66929386459e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9654cb19-af7f-4482-a864-71f20b3a39b2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_6f012a25-a6a5-4c58-8da0-79f01f23945b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_6f012a25-a6a5-4c58-8da0-79f01f23945b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_243ae7c8-b960-4ae0-ba57-6338b5152dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_243ae7c8-b960-4ae0-ba57-6338b5152dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b6630af4-fe7e-47ae-a5d7-af195daa79fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b6630af4-fe7e-47ae-a5d7-af195daa79fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_a9dd6b0d-adfa-4ea5-b345-888cfeaba06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_a9dd6b0d-adfa-4ea5-b345-888cfeaba06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ddfcb189-39b0-43ab-a49d-12f08a821928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ddfcb189-39b0-43ab-a49d-12f08a821928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e238dcf2-1ca7-46c8-a866-25709f590a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e238dcf2-1ca7-46c8-a866-25709f590a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3faced47-94cf-4aa1-bd8c-d19bcf54868c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_0ca3aa42-3022-4ee9-b4f0-aad5f301fef3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3faced47-94cf-4aa1-bd8c-d19bcf54868c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf7c2d51-8938-475f-bf2b-a7fd1eab2a1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_5f5d270c-8673-4a06-908e-88e6d5d73627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_5f5d270c-8673-4a06-908e-88e6d5d73627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8147b2f3-cbe0-460d-b496-c09396428f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8147b2f3-cbe0-460d-b496-c09396428f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_d4dc18df-b75e-4301-a5ba-187adc436674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_d4dc18df-b75e-4301-a5ba-187adc436674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6b27f5de-ca45-42aa-b474-3147e9747080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6b27f5de-ca45-42aa-b474-3147e9747080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_806ef60a-54f4-4e41-b8ea-3f2155fb7f3c" xlink:href="bmy-20220331.xsd#bmy_Divestitureandotherproceeds"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:to="loc_bmy_Divestitureandotherproceeds_806ef60a-54f4-4e41-b8ea-3f2155fb7f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6cb133cf-1ea4-424d-8f97-fcbaa04e217c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6cb133cf-1ea4-424d-8f97-fcbaa04e217c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_083351f2-ff0a-4c44-a206-7625f0955b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19f30369-51cc-4b28-887b-baafb3894e31" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_083351f2-ff0a-4c44-a206-7625f0955b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf7c2d51-8938-475f-bf2b-a7fd1eab2a1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f99e6ee2-641c-4c18-b275-ed70803a93d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f99e6ee2-641c-4c18-b275-ed70803a93d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_c3317ca5-95df-4111-9c3d-6c6f1d63d4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_c3317ca5-95df-4111-9c3d-6c6f1d63d4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ec7a89f6-2ea1-4b02-b9d4-ee620723906e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ec7a89f6-2ea1-4b02-b9d4-ee620723906e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_817f9717-acb4-45bc-b984-f64d4ad2ae07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_817f9717-acb4-45bc-b984-f64d4ad2ae07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f473f47f-5224-4b39-8682-b351f21e211c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:to="loc_us-gaap_PaymentsOfDividends_f473f47f-5224-4b39-8682-b351f21e211c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6008dbb0-93cd-4423-922b-f653a77ad5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6008dbb0-93cd-4423-922b-f653a77ad5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87dcd0e5-f902-4867-a6f8-d81dabb80fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f5652c-ef39-46fe-99ef-c8625935bf65" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87dcd0e5-f902-4867-a6f8-d81dabb80fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d424c300-1ac6-4a37-8818-a2c01855006f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18e58074-5992-4f47-bb36-3483946cd9c7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d424c300-1ac6-4a37-8818-a2c01855006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a3e2876c-0d5d-43bc-b1b0-44bcd8795cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18e58074-5992-4f47-bb36-3483946cd9c7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a3e2876c-0d5d-43bc-b1b0-44bcd8795cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1585ab2-1610-4cb5-9f1e-c50dd40e5de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18e58074-5992-4f47-bb36-3483946cd9c7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1585ab2-1610-4cb5-9f1e-c50dd40e5de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ff97846c-1f44-4f32-9b2c-e77d8b774ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18e58074-5992-4f47-bb36-3483946cd9c7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ff97846c-1f44-4f32-9b2c-e77d8b774ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes" xlink:type="simple" xlink:href="bmy-20220331.xsd#BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_247ff0fd-5664-4fa3-bd22-343d69dcb5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_0a8adeb9-b941-40e3-9e9b-4ffcc5d56b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_247ff0fd-5664-4fa3-bd22-343d69dcb5c0" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_0a8adeb9-b941-40e3-9e9b-4ffcc5d56b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" xlink:type="simple" xlink:href="bmy-20220331.xsd#BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b95312d7-44b4-481a-a977-c8316a6f06c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_35188126-8ea7-473f-8241-6030b008a621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b95312d7-44b4-481a-a977-c8316a6f06c6" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_35188126-8ea7-473f-8241-6030b008a621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_d55a2862-c1cb-49a5-93c8-9ed73264bf49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b95312d7-44b4-481a-a977-c8316a6f06c6" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_d55a2862-c1cb-49a5-93c8-9ed73264bf49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_eeca6a77-0b0f-405a-bb97-cdf5c0624586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b95312d7-44b4-481a-a977-c8316a6f06c6" xlink:to="loc_us-gaap_UseOfEstimates_eeca6a77-0b0f-405a-bb97-cdf5c0624586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_4a8a04c6-c6d4-4a91-ac0b-ca02d0e7f564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b95312d7-44b4-481a-a977-c8316a6f06c6" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_4a8a04c6-c6d4-4a91-ac0b-ca02d0e7f564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8d12fc1a-767c-4fd4-b938-db3a87112a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b95312d7-44b4-481a-a977-c8316a6f06c6" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8d12fc1a-767c-4fd4-b938-db3a87112a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_753f8d60-b052-427f-ba4a-a60478194e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b95312d7-44b4-481a-a977-c8316a6f06c6" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_753f8d60-b052-427f-ba4a-a60478194e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/Revenue" xlink:type="simple" xlink:href="bmy-20220331.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f7f091a3-2a8e-4c6a-adc7-fa244ee26dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_90de02d4-5d74-474d-8a08-ae65f9c782d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f7f091a3-2a8e-4c6a-adc7-fa244ee26dca" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_90de02d4-5d74-474d-8a08-ae65f9c782d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37b97da8-a4ba-4abd-a9e7-f4345e865b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_283ab88d-b6ff-4b6b-bd58-914d95b0ee96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37b97da8-a4ba-4abd-a9e7-f4345e865b04" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_283ab88d-b6ff-4b6b-bd58-914d95b0ee96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_69562843-bbaf-4176-b0f4-6c1e452523d9" xlink:href="bmy-20220331.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37b97da8-a4ba-4abd-a9e7-f4345e865b04" xlink:to="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_69562843-bbaf-4176-b0f4-6c1e452523d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_1f4dde9c-3808-4673-9763-12580db24a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37b97da8-a4ba-4abd-a9e7-f4345e865b04" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_1f4dde9c-3808-4673-9763-12580db24a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f6cbc237-b6b3-481a-ba52-c2bb979486ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f6cbc237-b6b3-481a-ba52-c2bb979486ca" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_77e23460-38a6-4553-a8f0-d016ca7424e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:to="loc_us-gaap_TypeOfArrangementAxis_77e23460-38a6-4553-a8f0-d016ca7424e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_034c4807-a34f-49d8-afe5-c9102bf035c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_77e23460-38a6-4553-a8f0-d016ca7424e7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_034c4807-a34f-49d8-afe5-c9102bf035c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_88cb9cc4-bef5-41ea-857a-d9d4a6d1a3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_034c4807-a34f-49d8-afe5-c9102bf035c1" xlink:to="loc_us-gaap_CollaborativeArrangementMember_88cb9cc4-bef5-41ea-857a-d9d4a6d1a3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a642867c-e85a-4774-bdca-06ae7e333d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a642867c-e85a-4774-bdca-06ae7e333d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a642867c-e85a-4774-bdca-06ae7e333d84" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_3f49279b-b1d9-470d-8041-a66fd975db96" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:to="loc_bmy_NetproductsalesMember_3f49279b-b1d9-470d-8041-a66fd975db96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_fc44a42a-4c00-4c4b-966f-4b539b05dd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:to="loc_us-gaap_CollaborativeArrangementMember_fc44a42a-4c00-4c4b-966f-4b539b05dd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember_99b95273-b48a-4403-989a-efafb3c79dd0" xlink:href="bmy-20220331.xsd#bmy_OtherrevenuesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bfc41d5c-3035-48d4-a115-f1359fb660c8" xlink:to="loc_bmy_OtherrevenuesMember_99b95273-b48a-4403-989a-efafb3c79dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b1d7b0-604d-439e-a8b9-219e4534a7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3a4b7234-ef11-4a2f-ab44-eb1f5f00c2de" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b1d7b0-604d-439e-a8b9-219e4534a7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5c7e0347-a7a8-4ac0-b965-4c63f78f74d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c4b1d7b0-604d-439e-a8b9-219e4534a7d9" xlink:to="loc_us-gaap_Revenues_5c7e0347-a7a8-4ac0-b965-4c63f78f74d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06ff94af-35b4-42b5-8b82-ccab903f3a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06ff94af-35b4-42b5-8b82-ccab903f3a9f" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_9aeee9c0-c492-429e-9bbe-524c6cc5bfb5" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_68205f46-c77c-4630-b85b-8d6fbf8889fb" xlink:href="bmy-20220331.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_68205f46-c77c-4630-b85b-8d6fbf8889fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_e2fe8883-f4cc-4c48-8a5d-62ae79e7ee11" xlink:href="bmy-20220331.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_e2fe8883-f4cc-4c48-8a5d-62ae79e7ee11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_05022156-b475-4fc9-99b5-fb6997350711" xlink:href="bmy-20220331.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_e7975cdd-e6ac-4cce-85cb-14f2d2343526" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_05022156-b475-4fc9-99b5-fb6997350711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_95674de8-5a83-4e00-a6a4-77f4f9886b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_95674de8-5a83-4e00-a6a4-77f4f9886b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_95674de8-5a83-4e00-a6a4-77f4f9886b97" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_b6d50597-a034-458f-97e7-175ce74d7e3c" xlink:href="bmy-20220331.xsd#bmy_SalesRevenueGrossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:to="loc_bmy_SalesRevenueGrossMember_b6d50597-a034-458f-97e7-175ce74d7e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_aeb8d327-e8b2-4ca1-86fb-0618eb2fb010" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_bda3485c-a000-4c6f-bfcf-0adb45adf329" xlink:to="loc_bmy_NetproductsalesMember_aeb8d327-e8b2-4ca1-86fb-0618eb2fb010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_2cd37e7c-e9ec-4d35-8772-c8d6440f5739" xlink:to="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_53f3db5f-68b6-42b4-b178-ed82c072cd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:to="loc_us-gaap_Revenues_53f3db5f-68b6-42b4-b178-ed82c072cd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_79bbaa81-2b99-4696-9a82-1e2bade3043c" xlink:href="bmy-20220331.xsd#bmy_GrosstoNetAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:to="loc_bmy_GrosstoNetAdjustments_79bbaa81-2b99-4696-9a82-1e2bade3043c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_de78e48d-de28-4252-8242-8729914387c1" xlink:href="bmy-20220331.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_e01daff1-d324-40bf-ad6c-aeb3d0c3e933" xlink:to="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_de78e48d-de28-4252-8242-8729914387c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RevenueDisaggregationofRevenuebyProductandRegionDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf3521f4-bfce-4ef0-9ee2-88f829bd1e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf3521f4-bfce-4ef0-9ee2-88f829bd1e0c" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1fdae943-2eaa-492d-b31d-bb884aaff780" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:to="loc_srt_ProductOrServiceAxis_1fdae943-2eaa-492d-b31d-bb884aaff780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1fdae943-2eaa-492d-b31d-bb884aaff780" xlink:to="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_b1459eb1-5905-49bb-ac76-4e0c0774a5a5" xlink:href="bmy-20220331.xsd#bmy_EliquisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_EliquisMember_b1459eb1-5905-49bb-ac76-4e0c0774a5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_b9404218-32db-4c78-802d-428e18db243a" xlink:href="bmy-20220331.xsd#bmy_OpdivoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OpdivoMember_b9404218-32db-4c78-802d-428e18db243a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_5bb92f28-28df-4a5a-8735-5e721b154c74" xlink:href="bmy-20220331.xsd#bmy_PomalystImnovidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_PomalystImnovidMember_5bb92f28-28df-4a5a-8735-5e721b154c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_41b14576-3f1e-449f-9b26-27c894875da2" xlink:href="bmy-20220331.xsd#bmy_OrenciaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OrenciaMember_41b14576-3f1e-449f-9b26-27c894875da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_26d4366c-e66c-4c12-a8fd-83b5881ab58c" xlink:href="bmy-20220331.xsd#bmy_SprycelMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_SprycelMember_26d4366c-e66c-4c12-a8fd-83b5881ab58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_87bb2ded-f1e9-4614-a0d8-c5c32b61adcc" xlink:href="bmy-20220331.xsd#bmy_YervoyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_YervoyMember_87bb2ded-f1e9-4614-a0d8-c5c32b61adcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember_4e1d674c-2310-4e06-92f0-39bdb1d76a6b" xlink:href="bmy-20220331.xsd#bmy_EmplicitiMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_EmplicitiMember_4e1d674c-2310-4e06-92f0-39bdb1d76a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureAndOtherBrandsMember_920e7407-3f12-4388-9aa2-1c7124498f48" xlink:href="bmy-20220331.xsd#bmy_MatureAndOtherBrandsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_MatureAndOtherBrandsMember_920e7407-3f12-4388-9aa2-1c7124498f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_b1bc6277-81e4-41d4-9460-4ab4150c4508" xlink:href="bmy-20220331.xsd#bmy_ReblozylMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_ReblozylMember_b1bc6277-81e4-41d4-9460-4ab4150c4508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_c2f9eb22-0524-4511-bea3-cc969c6367fb" xlink:href="bmy-20220331.xsd#bmy_AbecmaMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_AbecmaMember_c2f9eb22-0524-4511-bea3-cc969c6367fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_6421c64a-da5b-46ca-8b79-18b280c5bb72" xlink:href="bmy-20220331.xsd#bmy_ZeposiaMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_ZeposiaMember_6421c64a-da5b-46ca-8b79-18b280c5bb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_1e9c988c-ad0e-4bab-9f1f-3009d445469d" xlink:href="bmy-20220331.xsd#bmy_BreyanziMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_BreyanziMember_1e9c988c-ad0e-4bab-9f1f-3009d445469d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_7e80dcf1-742b-42ea-b087-7dc8d478ac78" xlink:href="bmy-20220331.xsd#bmy_InrebicMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_InrebicMember_7e80dcf1-742b-42ea-b087-7dc8d478ac78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_7c2f39ae-de87-4258-a5df-42ba13225ad9" xlink:href="bmy-20220331.xsd#bmy_OnuregMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OnuregMember_7c2f39ae-de87-4258-a5df-42ba13225ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdualagMember_91189c6e-4c73-4293-9eed-71d4e1c5b1cc" xlink:href="bmy-20220331.xsd#bmy_OpdualagMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_OpdualagMember_91189c6e-4c73-4293-9eed-71d4e1c5b1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_9af1aaeb-bcd1-4610-bd7b-14f92986acd4" xlink:href="bmy-20220331.xsd#bmy_RevlimidMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_RevlimidMember_9af1aaeb-bcd1-4610-bd7b-14f92986acd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_30306060-9373-4783-ac5e-0a7864bca855" xlink:href="bmy-20220331.xsd#bmy_AbraxaneMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9514520f-9e3a-4411-9e61-ed8824a0956d" xlink:to="loc_bmy_AbraxaneMember_30306060-9373-4783-ac5e-0a7864bca855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0d122e5-9849-4e2a-9da1-7751781ec539" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:to="loc_srt_StatementGeographicalAxis_a0d122e5-9849-4e2a-9da1-7751781ec539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a0d122e5-9849-4e2a-9da1-7751781ec539" xlink:to="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_660ab4a3-2a4a-41c4-9d5e-6d3ee63aae0a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_country_US_660ab4a3-2a4a-41c4-9d5e-6d3ee63aae0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_21fd762f-0ea8-47bb-9a54-596b467c8c6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_srt_EuropeMember_21fd762f-0ea8-47bb-9a54-596b467c8c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestOfWorldMember_9a582851-ebad-4bd3-b982-33eb49fdc320" xlink:href="bmy-20220331.xsd#bmy_RestOfWorldMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_bmy_RestOfWorldMember_9a582851-ebad-4bd3-b982-33eb49fdc320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_c4a100cc-7cbe-4825-9fe5-0c9f6902be87" xlink:href="bmy-20220331.xsd#bmy_OtherRegionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_372f41ca-ac05-4c2c-b683-c8b3ed0719b4" xlink:to="loc_bmy_OtherRegionMember_c4a100cc-7cbe-4825-9fe5-0c9f6902be87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e4a76dd-3712-4c3c-8c43-494ecd469899" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_89248fef-6045-4552-ae99-a755f95807f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:to="loc_us-gaap_Revenues_89248fef-6045-4552-ae99-a755f95807f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_c6d47c62-4b94-4604-83d4-335112a663a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_36dbf558-3bb8-4b33-ba1a-73eaeb9b4bef" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_c6d47c62-4b94-4604-83d4-335112a663a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCES" xlink:type="simple" xlink:href="bmy-20220331.xsd#ALLIANCES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_22a3a418-5a20-4b11-8f8e-0aa55627ff09" xlink:href="bmy-20220331.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_3de4f852-1e73-4162-b748-2ed4872ac802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_22a3a418-5a20-4b11-8f8e-0aa55627ff09" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_3de4f852-1e73-4162-b748-2ed4872ac802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#ALLIANCESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_bf9d1c27-4bf9-4207-a45c-1c81d779a73e" xlink:href="bmy-20220331.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_98eb5bd5-3ce3-4969-a27f-cffa82427083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_bf9d1c27-4bf9-4207-a45c-1c81d779a73e" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_98eb5bd5-3ce3-4969-a27f-cffa82427083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#ALLIANCESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_e03eeff4-ed8c-4ff9-a1b9-9d4a385ff058" xlink:href="bmy-20220331.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_e03eeff4-ed8c-4ff9-a1b9-9d4a385ff058" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_6bee7e22-2263-4fc6-bba6-023b6dcea3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_6bee7e22-2263-4fc6-bba6-023b6dcea3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_6bee7e22-2263-4fc6-bba6-023b6dcea3e2" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_37225e08-507e-4436-8e2a-0224dc1adc26" xlink:href="bmy-20220331.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:to="loc_bmy_NetproductsalesMember_37225e08-507e-4436-8e2a-0224dc1adc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_c32a787c-aa5a-4216-9bef-0548e4b49de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_7ff6ff5c-6d4e-4700-8fd2-e62e52888af2" xlink:to="loc_us-gaap_CollaborativeArrangementMember_c32a787c-aa5a-4216-9bef-0548e4b49de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c994c021-ee64-44aa-9cab-40d4145884be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_2e577750-6ff0-4cc1-b9ce-f61bde56b1ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c994c021-ee64-44aa-9cab-40d4145884be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_860754d2-0f3c-417c-b972-b50e5147e41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c994c021-ee64-44aa-9cab-40d4145884be" xlink:to="loc_us-gaap_CollaborativeArrangementMember_860754d2-0f3c-417c-b972-b50e5147e41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f7b763-3ba3-42b9-8dab-0f5071a82b8e" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bbf84692-136c-4021-b771-19f578a7b899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_Revenues_bbf84692-136c-4021-b771-19f578a7b899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_689f7f8d-1328-4212-9548-7397841e5664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_689f7f8d-1328-4212-9548-7397841e5664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_d2476718-4d85-4382-903f-dbfd542370e0" xlink:href="bmy-20220331.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_d2476718-4d85-4382-903f-dbfd542370e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ecec5d04-02ab-40bd-a9f7-f06a40406be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ecec5d04-02ab-40bd-a9f7-f06a40406be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2994a8e7-d7e6-4970-87f0-0785b40fb875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2994a8e7-d7e6-4970-87f0-0785b40fb875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_b1eea8aa-d39c-4bfc-9c33-233966912afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_ReceivablesNetCurrent_b1eea8aa-d39c-4bfc-9c33-233966912afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_123d78b6-5a79-47ea-9b66-3f2ec8d351c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_AccountsPayableCurrent_123d78b6-5a79-47ea-9b66-3f2ec8d351c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_0c093a4f-35db-4ced-af9d-4ce0bf52e5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_bb00d1b1-c018-4e6e-a553-4b637dd09fea" xlink:to="loc_us-gaap_DeferredIncome_0c093a4f-35db-4ced-af9d-4ce0bf52e5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_ca4a7cdf-b876-43b8-8fd1-2d817d6d3b54" xlink:href="bmy-20220331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_dff1c749-dc9f-44c6-a381-c997e6757c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_ca4a7cdf-b876-43b8-8fd1-2d817d6d3b54" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_dff1c749-dc9f-44c6-a381-c997e6757c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_81faada0-23f5-40e7-ab2b-cd226a6c102e" xlink:href="bmy-20220331.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_5523643e-c015-4852-a9c5-914162f9182d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_81faada0-23f5-40e7-ab2b-cd226a6c102e" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_5523643e-c015-4852-a9c5-914162f9182d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_677f42ad-07b2-4f97-bf7d-b2cce3238451" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_81faada0-23f5-40e7-ab2b-cd226a6c102e" xlink:to="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_677f42ad-07b2-4f97-bf7d-b2cce3238451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6cd09e8c-6256-4fa4-9955-982be031a761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6cd09e8c-6256-4fa4-9955-982be031a761" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9d2b1715-7ca3-43cc-a6fb-80bbf770498e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9d2b1715-7ca3-43cc-a6fb-80bbf770498e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9d2b1715-7ca3-43cc-a6fb-80bbf770498e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_748183b1-11ad-421e-b166-d9dfc11f113c" xlink:href="bmy-20220331.xsd#bmy_DiabetesbusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:to="loc_bmy_DiabetesbusinessMember_748183b1-11ad-421e-b166-d9dfc11f113c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AvaproAvalideAndPlavixMember_1bc1c014-15e7-463a-bd29-89d70d1cf693" xlink:href="bmy-20220331.xsd#bmy_AvaproAvalideAndPlavixMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:to="loc_bmy_AvaproAvalideAndPlavixMember_1bc1c014-15e7-463a-bd29-89d70d1cf693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_24d444db-7875-4a15-8d30-1035121a3431" xlink:href="bmy-20220331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5f6e402-61f5-4865-ab73-90e246c6cde5" xlink:to="loc_bmy_MatureBrandsAndOtherMember_24d444db-7875-4a15-8d30-1035121a3431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b09a79b2-f074-423e-a20d-2cefcea34b8c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:to="loc_srt_CounterpartyNameAxis_b09a79b2-f074-423e-a20d-2cefcea34b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc446d47-e570-44a6-9972-e0be356db1ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b09a79b2-f074-423e-a20d-2cefcea34b8c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc446d47-e570-44a6-9972-e0be356db1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CheplapharmMember_dfe54342-5835-40e2-b128-8c7a44c1d133" xlink:href="bmy-20220331.xsd#bmy_CheplapharmMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc446d47-e570-44a6-9972-e0be356db1ce" xlink:to="loc_bmy_CheplapharmMember_dfe54342-5835-40e2-b128-8c7a44c1d133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_011a5149-474f-4a96-a210-97d941ebafaa" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e0732e93-cf8a-4b33-9e2e-022def7d7c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e0732e93-cf8a-4b33-9e2e-022def7d7c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ce858bfe-eaf6-4c7a-b255-7ca98961a779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ce858bfe-eaf6-4c7a-b255-7ca98961a779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_2386fad0-2238-46fd-b256-8cd608c9fdac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_45c18fe8-1a3f-4fd3-931e-2034d260d54a" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_2386fad0-2238-46fd-b256-8cd608c9fdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7337ecd6-ba42-48c7-9467-01141c6d5096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7337ecd6-ba42-48c7-9467-01141c6d5096" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_61818f23-5ef3-47fd-a8d3-cbe76101f2c4" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_61818f23-5ef3-47fd-a8d3-cbe76101f2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_61818f23-5ef3-47fd-a8d3-cbe76101f2c4" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_e7329260-8490-4999-baed-09fedabd8f91" xlink:href="bmy-20220331.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_e7329260-8490-4999-baed-09fedabd8f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_ed3a6605-f907-4b7a-8896-b15a55017364" xlink:href="bmy-20220331.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:to="loc_bmy_TecentriqRoyaltiesMember_ed3a6605-f907-4b7a-8896-b15a55017364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_96eeb181-6b38-4327-9e33-c898d6914d1d" xlink:href="bmy-20220331.xsd#bmy_OtherRoyaltiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_f40c7dec-65d8-4b25-b5b5-9c0f3e7a8cef" xlink:to="loc_bmy_OtherRoyaltiesMember_96eeb181-6b38-4327-9e33-c898d6914d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_11bb1553-e260-41e8-9715-31824e15056f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:to="loc_srt_CounterpartyNameAxis_11bb1553-e260-41e8-9715-31824e15056f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_11bb1553-e260-41e8-9715-31824e15056f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_4caf1622-5ad0-448f-b02e-41d49e72271f" xlink:href="bmy-20220331.xsd#bmy_ImmaticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:to="loc_bmy_ImmaticsMember_4caf1622-5ad0-448f-b02e-41d49e72271f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_5885dd94-c9a4-4ce4-b295-fdd810c3740b" xlink:href="bmy-20220331.xsd#bmy_DragonflyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_90456a31-4ce9-4388-9378-faeaff8881b3" xlink:to="loc_bmy_DragonflyMember_5885dd94-c9a4-4ce4-b295-fdd810c3740b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_df3016fa-1899-4a4b-a40c-2eb94ff20b61" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_1abc7265-dcec-490b-b858-b32e7f743286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_1abc7265-dcec-490b-b858-b32e7f743286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_5abe472d-3ed0-43db-aa95-ccee60bfb09e" xlink:href="bmy-20220331.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_5abe472d-3ed0-43db-aa95-ccee60bfb09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationOfDeferredIncome_5601cf36-0b3a-424e-bfe5-2145ac3a14a5" xlink:href="bmy-20220331.xsd#bmy_AmortizationOfDeferredIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_AmortizationOfDeferredIncome_5601cf36-0b3a-424e-bfe5-2145ac3a14a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_e28654d7-38f0-4797-81c4-53c8f7558771" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_e28654d7-38f0-4797-81c4-53c8f7558771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_68aa674c-3127-497b-b9f2-b8790a3047e3" xlink:href="bmy-20220331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3df2c019-83b7-427c-a39d-41d3668e2da2" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_68aa674c-3127-497b-b9f2-b8790a3047e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b9c83aa1-1121-4f41-85ae-c4c3bdb272fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:href="bmy-20220331.xsd#bmy_LicensingArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b9c83aa1-1121-4f41-85ae-c4c3bdb272fd" xlink:to="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesAxis_b94ef71b-8fc2-40d4-90ac-782e9a704c61" xlink:href="bmy-20220331.xsd#bmy_LicensingCompaniesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_bmy_LicensingCompaniesAxis_b94ef71b-8fc2-40d4-90ac-782e9a704c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain_d2efefc6-0f34-4ec0-929d-8cdf66f6b811" xlink:href="bmy-20220331.xsd#bmy_LicensingCompaniesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingCompaniesAxis_b94ef71b-8fc2-40d4-90ac-782e9a704c61" xlink:to="loc_bmy_LicensingCompaniesDomain_d2efefc6-0f34-4ec0-929d-8cdf66f6b811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd899095-8629-4ac4-b190-64404339620e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd899095-8629-4ac4-b190-64404339620e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ef72af87-0596-4ee2-88ed-01a642278110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cd899095-8629-4ac4-b190-64404339620e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ef72af87-0596-4ee2-88ed-01a642278110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_5c95e866-434f-4de5-9360-de63214847b8" xlink:href="bmy-20220331.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ef72af87-0596-4ee2-88ed-01a642278110" xlink:to="loc_bmy_MatureBrandsAndOtherMember_5c95e866-434f-4de5-9360-de63214847b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_a821a13e-9f58-45cf-8472-09ae9db4dbb9" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_a821a13e-9f58-45cf-8472-09ae9db4dbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_30d38b25-718c-4697-a52a-04d64e08f151" xlink:href="bmy-20220331.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_a821a13e-9f58-45cf-8472-09ae9db4dbb9" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_30d38b25-718c-4697-a52a-04d64e08f151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DragonflyMember_816ed444-e035-4589-9a7c-7ba693cba669" xlink:href="bmy-20220331.xsd#bmy_DragonflyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_30d38b25-718c-4697-a52a-04d64e08f151" xlink:to="loc_bmy_DragonflyMember_816ed444-e035-4589-9a7c-7ba693cba669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cdee19d1-0667-4340-9770-aee57db2f1ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_srt_CounterpartyNameAxis_cdee19d1-0667-4340-9770-aee57db2f1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5e135c-4d74-4a29-8bb9-044ff2960ef9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_cdee19d1-0667-4340-9770-aee57db2f1ab" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5e135c-4d74-4a29-8bb9-044ff2960ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ImmaticsMember_24e635d0-13fa-455b-a242-f58a7b76c21f" xlink:href="bmy-20220331.xsd#bmy_ImmaticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5e135c-4d74-4a29-8bb9-044ff2960ef9" xlink:to="loc_bmy_ImmaticsMember_24e635d0-13fa-455b-a242-f58a7b76c21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bae774cb-85f7-457b-8f85-d73780d32a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bae774cb-85f7-457b-8f85-d73780d32a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0bd3d411-9783-406b-ba37-49de7af3ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bae774cb-85f7-457b-8f85-d73780d32a98" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0bd3d411-9783-406b-ba37-49de7af3ff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0301b140-bcb5-465b-a79d-71946a869f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0bd3d411-9783-406b-ba37-49de7af3ff55" xlink:to="loc_us-gaap_SubsequentEventMember_0301b140-bcb5-465b-a79d-71946a869f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:href="bmy-20220331.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_8cb45ad2-01d2-4108-9713-b64a6b8fb246" xlink:to="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_4ae14a6f-23dd-4c7b-99b7-217ffbbd5fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_4ae14a6f-23dd-4c7b-99b7-217ffbbd5fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_b950ff25-4161-4aca-aac6-7d07d57851bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_b950ff25-4161-4aca-aac6-7d07d57851bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_1c09554d-3dc7-4be9-9c2a-6c0f554a00eb" xlink:href="bmy-20220331.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_1c09554d-3dc7-4be9-9c2a-6c0f554a00eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_06c9fe89-db82-44fc-aab2-49cad169c195" xlink:href="bmy-20220331.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_06c9fe89-db82-44fc-aab2-49cad169c195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_cc632e24-4c41-4f56-bddf-905af7800d5b" xlink:href="bmy-20220331.xsd#bmy_PaymentToExtinguishFutureRoyaltyObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_63b73df3-fbde-49b1-a45a-dc0983b274f9" xlink:to="loc_bmy_PaymentToExtinguishFutureRoyaltyObligation_cc632e24-4c41-4f56-bddf-905af7800d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENET" xlink:type="simple" xlink:href="bmy-20220331.xsd#OTHERINCOMEEXPENSENET"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_8c7bd2b5-2dcc-43c3-8b50-c6e5c8f9712a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_5d8bea25-dec9-4521-9ef7-d155dd6c73f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_8c7bd2b5-2dcc-43c3-8b50-c6e5c8f9712a" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_5d8bea25-dec9-4521-9ef7-d155dd6c73f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#OTHERINCOMEEXPENSENETTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_09f2d7d4-9631-4833-a896-6280986f9258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_183c7a8e-003a-4d36-b992-9285be52ed66" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_09f2d7d4-9631-4833-a896-6280986f9258" xlink:to="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_183c7a8e-003a-4d36-b992-9285be52ed66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_726b3dfe-e676-4c48-8379-27fd723f3d29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_InterestExpense_726b3dfe-e676-4c48-8379-27fd723f3d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners_4d27477a-68ad-466e-aff4-c9841dcd527a" xlink:href="bmy-20220331.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_bmy_OtherIncomeReceivedFromAlliancePartners_4d27477a-68ad-466e-aff4-c9841dcd527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_36335dcf-71db-4a8a-a7a3-a8b8eadf2dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_GainLossOnInvestments_36335dcf-71db-4a8a-a7a3-a8b8eadf2dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_0c83d4a7-071e-47ca-b5d0-14b7f76bff79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_0c83d4a7-071e-47ca-b5d0-14b7f76bff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ccc2bf8b-8117-4e23-bd6a-32b81d19c9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ccc2bf8b-8117-4e23-bd6a-32b81d19c9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_97684c0d-3527-4eb2-804a-8d90c5e85caf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_97684c0d-3527-4eb2-804a-8d90c5e85caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_fc94eb0f-70eb-44fc-82e4-1e655f1ea4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_RestructuringCharges_fc94eb0f-70eb-44fc-82e4-1e655f1ea4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_a522bade-948a-4602-83b6-bf1201644b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_a522bade-948a-4602-83b6-bf1201644b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceTransitionalServices_ab9f2eda-6207-4f1a-8984-34b70a84d214" xlink:href="bmy-20220331.xsd#bmy_AllianceTransitionalServices"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_bmy_AllianceTransitionalServices_ab9f2eda-6207-4f1a-8984-34b70a84d214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0f60eb61-4e28-4f22-a94d-7a606d245b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0f60eb61-4e28-4f22-a94d-7a606d245b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ab96bd37-642d-401d-84d1-c7fc2f96bcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ab96bd37-642d-401d-84d1-c7fc2f96bcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_e890d23e-490e-4a04-9912-28e40c2fdd84" xlink:href="bmy-20220331.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_bmy_OtherOtherIncomeExpense_e890d23e-490e-4a04-9912-28e40c2fdd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a12cffdc-9f32-4d81-9433-3fed31e6de10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fb24ef34-2996-47c6-adea-fc4a85504117" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a12cffdc-9f32-4d81-9433-3fed31e6de10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_5e4a248f-a51b-4b95-8779-04f02ec7c8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_22aababd-fa90-4628-adcd-cf97afa40fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_5e4a248f-a51b-4b95-8779-04f02ec7c8f3" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_22aababd-fa90-4628-adcd-cf97afa40fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_fab20aef-8901-4a31-b2d2-1f88bbc9fe28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61c2dfa0-893f-4bfe-a1a9-186157f171f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_fab20aef-8901-4a31-b2d2-1f88bbc9fe28" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61c2dfa0-893f-4bfe-a1a9-186157f171f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6417ac06-4280-46c6-b76f-8eccde2348b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61c2dfa0-893f-4bfe-a1a9-186157f171f1" xlink:to="loc_us-gaap_RestructuringPlanAxis_6417ac06-4280-46c6-b76f-8eccde2348b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bd97f863-4a6a-4d7f-a733-acd4b4af1015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_6417ac06-4280-46c6-b76f-8eccde2348b5" xlink:to="loc_us-gaap_RestructuringPlanDomain_bd97f863-4a6a-4d7f-a733-acd4b4af1015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_52192eb4-55f5-4a4d-9a96-bf260e73b99d" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bd97f863-4a6a-4d7f-a733-acd4b4af1015" xlink:to="loc_bmy_CelgeneIntegrationMember_52192eb4-55f5-4a4d-9a96-bf260e73b99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_61c2dfa0-893f-4bfe-a1a9-186157f171f1" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61de6375-e197-4090-be43-4d497e1de929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61de6375-e197-4090-be43-4d497e1de929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_dbb8bce5-4137-4455-a21f-e78a85d70689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa24bd54-7915-4c66-8b0b-197792fa3970" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_dbb8bce5-4137-4455-a21f-e78a85d70689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_53482fac-0847-4ce8-8f38-454d0483aea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_53482fac-0847-4ce8-8f38-454d0483aea7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_4a9ac127-5a66-413d-ab28-f42cb97422b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:to="loc_us-gaap_RestructuringPlanAxis_4a9ac127-5a66-413d-ab28-f42cb97422b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_4a9ac127-5a66-413d-ab28-f42cb97422b4" xlink:to="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_80272ed3-13eb-4f35-80ea-17a92a67d6d7" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:to="loc_bmy_CelgeneIntegrationMember_80272ed3-13eb-4f35-80ea-17a92a67d6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_bf4ac460-21cc-43ba-8d44-db3431546caf" xlink:href="bmy-20220331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_503b2f48-b8aa-4303-99d1-f3a6f4f8b949" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_bf4ac460-21cc-43ba-8d44-db3431546caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a8bc7b5f-3335-427a-9133-75fa70c3aaea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a8bc7b5f-3335-427a-9133-75fa70c3aaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a8bc7b5f-3335-427a-9133-75fa70c3aaea" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_81e7c636-25e4-4331-95a3-4e3ed3d0892c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:to="loc_us-gaap_CostOfSalesMember_81e7c636-25e4-4331-95a3-4e3ed3d0892c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_853a5b5c-8dd1-4e68-9545-eb92ec4cbbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_853a5b5c-8dd1-4e68-9545-eb92ec4cbbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4bda4b96-30ee-4790-af0c-0ae48e1dcda7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_40a3be38-cf71-48a5-91f9-404d650b9cab" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4bda4b96-30ee-4790-af0c-0ae48e1dcda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_157496e2-3415-4ab3-845b-61af5f3d6697" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_1238939b-b90b-48ac-aba8-797296cd5d8f" xlink:href="bmy-20220331.xsd#bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance_1238939b-b90b-48ac-aba8-797296cd5d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ExpectedSynergiesPercentage_92c6edf3-62e1-45d4-b410-513722bb338d" xlink:href="bmy-20220331.xsd#bmy_ExpectedSynergiesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_bmy_ExpectedSynergiesPercentage_92c6edf3-62e1-45d4-b410-513722bb338d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f1bae41a-680c-4925-90b1-d78f7ac79c52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f1bae41a-680c-4925-90b1-d78f7ac79c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_200dd12d-59fb-429d-811f-1c8fe3ddfdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_200dd12d-59fb-429d-811f-1c8fe3ddfdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_cf86b640-37e2-4dd8-95c4-808afdf46a55" xlink:href="bmy-20220331.xsd#bmy_Cashoutlays"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_bmy_Cashoutlays_cf86b640-37e2-4dd8-95c4-808afdf46a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_45ca107b-2e0a-4500-97c2-df045928b324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_88083073-08d5-496a-b93e-eb11a0d80dd9" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_45ca107b-2e0a-4500-97c2-df045928b324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_71015d71-698d-421f-a8f2-bdccb2a33e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_71015d71-698d-421f-a8f2-bdccb2a33e18" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_eb92691c-3aba-4674-81c0-ff1d6b2a6016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:to="loc_us-gaap_RestructuringPlanAxis_eb92691c-3aba-4674-81c0-ff1d6b2a6016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_eb92691c-3aba-4674-81c0-ff1d6b2a6016" xlink:to="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_9857cd2c-70af-4129-8025-95ef2efaffd4" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:to="loc_bmy_CelgeneIntegrationMember_9857cd2c-70af-4129-8025-95ef2efaffd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_5f564c79-3071-4631-8ef5-9c00e5418596" xlink:href="bmy-20220331.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_de778ac7-0671-4126-b03d-8c506786f537" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_5f564c79-3071-4631-8ef5-9c00e5418596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ad69288d-4257-431e-a9d9-75ec4dd56095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ad69288d-4257-431e-a9d9-75ec4dd56095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ad69288d-4257-431e-a9d9-75ec4dd56095" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4b522728-9895-4923-bf64-02d30b3f352e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:to="loc_us-gaap_CostOfSalesMember_4b522728-9895-4923-bf64-02d30b3f352e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f71fefa-920b-4bcd-893b-c366a3e9cbed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f71fefa-920b-4bcd-893b-c366a3e9cbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_01d773a4-8a29-418a-8ee8-c67a6ebf4f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7673e9f5-67ed-4adb-bd0b-a61f907cd5db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_01d773a4-8a29-418a-8ee8-c67a6ebf4f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cd2a4448-62d3-455c-ab30-9f9233e5e922" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_fabbcdb8-3ca7-4576-a909-4d6a899797c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_fabbcdb8-3ca7-4576-a909-4d6a899797c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_b172e752-2049-422b-a88f-89d61b0a3ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_SeveranceCosts1_b172e752-2049-422b-a88f-89d61b0a3ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_da919684-b01e-403a-b07b-fe9d4ea42f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_OtherRestructuringCosts_da919684-b01e-403a-b07b-fe9d4ea42f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a4c83a49-5252-4dbb-a95c-86ec1dc7f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_RestructuringCharges_a4c83a49-5252-4dbb-a95c-86ec1dc7f7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f88e7f3b-a1f4-488d-ad8d-708ce1129a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_f88e7f3b-a1f4-488d-ad8d-708ce1129a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_a6e427f3-20d9-4485-ad7a-0032f396963f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_a6e427f3-20d9-4485-ad7a-0032f396963f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_1449e510-0d6b-4441-b9cb-d459553acaa3" xlink:href="bmy-20220331.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_efe6a487-ef3c-4c11-9e8c-9e44188641d9" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_1449e510-0d6b-4441-b9cb-d459553acaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_dc852ca7-48bc-4d26-8f04-203b4244ea52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_dc852ca7-48bc-4d26-8f04-203b4244ea52" xlink:to="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e3012aac-d6ed-41c5-8178-d72504602cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:to="loc_us-gaap_RestructuringPlanAxis_e3012aac-d6ed-41c5-8178-d72504602cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_579c50ec-d478-4292-8583-0285fdc326fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_e3012aac-d6ed-41c5-8178-d72504602cee" xlink:to="loc_us-gaap_RestructuringPlanDomain_579c50ec-d478-4292-8583-0285fdc326fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_e3571a77-040f-4d88-9a4f-d816c07f6768" xlink:href="bmy-20220331.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c50ec-d478-4292-8583-0285fdc326fc" xlink:to="loc_bmy_CelgeneIntegrationMember_e3571a77-040f-4d88-9a4f-d816c07f6768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0532689e-8bdd-45f4-b023-b004b6c3cb14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0532689e-8bdd-45f4-b023-b004b6c3cb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a1b39510-4781-409f-91cb-1caaf1fe34b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0532689e-8bdd-45f4-b023-b004b6c3cb14" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a1b39510-4781-409f-91cb-1caaf1fe34b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember_6eb732cd-417f-4af1-a59c-a7549887afdd" xlink:href="bmy-20220331.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a1b39510-4781-409f-91cb-1caaf1fe34b4" xlink:to="loc_bmy_AcceleratedStockBasedCompensationMember_6eb732cd-417f-4af1-a59c-a7549887afdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_63d72918-0641-459d-976b-166caff20d91" xlink:to="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_dfa367c3-0323-4970-8575-b1d49f6067d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringReserve_dfa367c3-0323-4970-8575-b1d49f6067d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_66e03b32-68f7-4301-81af-2280828b222e" xlink:href="bmy-20220331.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_66e03b32-68f7-4301-81af-2280828b222e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_9686ee27-1dcc-4948-a097-6188cfaa2fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_9686ee27-1dcc-4948-a097-6188cfaa2fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4e3e6ea1-4e42-437b-8eae-883f6cd8db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_PaymentsForRestructuring_4e3e6ea1-4e42-437b-8eae-883f6cd8db6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4332a697-22e8-431b-b488-f1d1567a0c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringReserve_4332a697-22e8-431b-b488-f1d1567a0c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_80b867cc-48f7-4bf7-b065-75e521237ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_80b867cc-48f7-4bf7-b065-75e521237ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_55eda4e0-872f-4846-93c5-3048ac338c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ec8e900-a73a-4442-b2a9-f904c16f8600" xlink:to="loc_us-gaap_RestructuringCharges_55eda4e0-872f-4846-93c5-3048ac338c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bmy-20220331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_08d6e099-4351-4d4e-a2a3-53f3a543c982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_3a5f6e26-55a0-4082-9cfd-65d69ca5fbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_08d6e099-4351-4d4e-a2a3-53f3a543c982" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_3a5f6e26-55a0-4082-9cfd-65d69ca5fbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_07b9455e-f2e5-44d0-90e0-b384e5923738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_d0d27047-0f53-4bde-baa6-890a0d443a31" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07b9455e-f2e5-44d0-90e0-b384e5923738" xlink:to="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_d0d27047-0f53-4bde-baa6-890a0d443a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_70e7fa72-04df-4f03-b118-0b7178a6aefe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_140667c0-e1ed-4cc9-bb0c-3845829e4a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70e7fa72-04df-4f03-b118-0b7178a6aefe" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_140667c0-e1ed-4cc9-bb0c-3845829e4a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0720f28e-0bbd-4f95-aa6f-a8e0fb599694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70e7fa72-04df-4f03-b118-0b7178a6aefe" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0720f28e-0bbd-4f95-aa6f-a8e0fb599694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6ff6e015-dbb5-42eb-afba-ce23cf9acb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70e7fa72-04df-4f03-b118-0b7178a6aefe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6ff6e015-dbb5-42eb-afba-ce23cf9acb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a163fb7d-8dba-44b1-85b5-d6afd8c747bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f63058a7-3c13-4d1e-9431-8e36fe04f6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a163fb7d-8dba-44b1-85b5-d6afd8c747bf" xlink:to="loc_us-gaap_StatementTable_f63058a7-3c13-4d1e-9431-8e36fe04f6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_28b28373-effb-4a2c-921c-a9407bc197a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f63058a7-3c13-4d1e-9431-8e36fe04f6b8" xlink:to="loc_srt_RangeAxis_28b28373-effb-4a2c-921c-a9407bc197a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_28b28373-effb-4a2c-921c-a9407bc197a9" xlink:to="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c90e854f-0643-4b1b-b038-989e2a1b1785" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:to="loc_srt_MinimumMember_c90e854f-0643-4b1b-b038-989e2a1b1785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ffc174aa-7a74-4202-a2ff-9c89373da0d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a1e03ea7-b02f-4c6b-aac4-3648cab17fa6" xlink:to="loc_srt_MaximumMember_ffc174aa-7a74-4202-a2ff-9c89373da0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_05ce5090-ae86-4769-9105-84102749c7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f63058a7-3c13-4d1e-9431-8e36fe04f6b8" xlink:to="loc_us-gaap_StatementLineItems_05ce5090-ae86-4769-9105-84102749c7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_c2d44f79-f422-4e6a-955a-e7fb792e02ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05ce5090-ae86-4769-9105-84102749c7cd" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_c2d44f79-f422-4e6a-955a-e7fb792e02ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="bmy-20220331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_689aa2ee-124e-4e60-b629-b4c543ceecfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_fd139716-529a-4cf2-93e0-4a7962a3516d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_689aa2ee-124e-4e60-b629-b4c543ceecfe" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_fd139716-529a-4cf2-93e0-4a7962a3516d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="bmy-20220331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_07ae925d-4377-4a94-ae60-4c2d70895f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d012d0d6-8daa-4e3e-b0e1-b513410eef37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_07ae925d-4377-4a94-ae60-4c2d70895f97" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d012d0d6-8daa-4e3e-b0e1-b513410eef37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_20937077-10ed-4c86-a9cc-d1959f204ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97e1cc84-93d4-4097-b971-3a6cfd0da5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20937077-10ed-4c86-a9cc-d1959f204ee4" xlink:to="loc_us-gaap_NetIncomeLoss_97e1cc84-93d4-4097-b971-3a6cfd0da5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dc094a8-2090-4dd4-b23e-bc3a22a8328c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20937077-10ed-4c86-a9cc-d1959f204ee4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dc094a8-2090-4dd4-b23e-bc3a22a8328c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7586a7e4-524c-42cd-9b84-1256b92ee586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20937077-10ed-4c86-a9cc-d1959f204ee4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7586a7e4-524c-42cd-9b84-1256b92ee586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b7b51428-023d-4bf5-88d3-c7064bd342fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20937077-10ed-4c86-a9cc-d1959f204ee4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b7b51428-023d-4bf5-88d3-c7064bd342fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ade06576-f249-4bb4-a5a5-041be77e708a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20937077-10ed-4c86-a9cc-d1959f204ee4" xlink:to="loc_us-gaap_EarningsPerShareBasic_ade06576-f249-4bb4-a5a5-041be77e708a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_debd5e23-5cce-4af0-8a73-598a3d162b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20937077-10ed-4c86-a9cc-d1959f204ee4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_debd5e23-5cce-4af0-8a73-598a3d162b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3706da67-790d-47b3-82a1-e5d651254175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_3560a9d5-979b-4e32-87e4-debffcc963b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3706da67-790d-47b3-82a1-e5d651254175" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_3560a9d5-979b-4e32-87e4-debffcc963b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_723a066e-9f46-4a43-aee8-340e39547c97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_723a066e-9f46-4a43-aee8-340e39547c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_ee339e01-a7db-4764-bc2b-8a70997288b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_ee339e01-a7db-4764-bc2b-8a70997288b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_8c69979e-1198-4cc7-b702-0f55f8fe15ef" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_8c69979e-1198-4cc7-b702-0f55f8fe15ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_2a9de89d-a7ee-443d-8ca4-f9301f45f5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_2a9de89d-a7ee-443d-8ca4-f9301f45f5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1dfde39f-2713-48a3-bbd9-843480ce67cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1dfde39f-2713-48a3-bbd9-843480ce67cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_933472c9-b456-4790-8194-7dde653ffc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_933472c9-b456-4790-8194-7dde653ffc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_90fcc0c0-34cf-482b-915c-ebc7106ede85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_90fcc0c0-34cf-482b-915c-ebc7106ede85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0dd4d4e4-6121-44c6-86d5-84d7be881777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a694fef-5b4c-432a-8f66-f506d5a48f65" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0dd4d4e4-6121-44c6-86d5-84d7be881777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c6036f88-254e-401e-88d8-0468711961ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c6036f88-254e-401e-88d8-0468711961ea" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d365226c-8682-4adb-9437-288e6f439583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d365226c-8682-4adb-9437-288e6f439583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d365226c-8682-4adb-9437-288e6f439583" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_39b35489-dded-4729-8959-af1ea7cb34b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_39b35489-dded-4729-8959-af1ea7cb34b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c87dc6e8-3f8d-4190-90b8-c00559c60b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c87dc6e8-3f8d-4190-90b8-c00559c60b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3988bcd7-9b03-4f42-aa0f-fac58bd8bf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f8af2b9-3a01-4538-b619-78c71a49c0c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3988bcd7-9b03-4f42-aa0f-fac58bd8bf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8322391c-e4a2-470b-96c6-367b5087cd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8322391c-e4a2-470b-96c6-367b5087cd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8322391c-e4a2-470b-96c6-367b5087cd7b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_9bb20fbd-140e-472c-a323-8bba3ee8cbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:to="loc_us-gaap_CertificatesOfDepositMember_9bb20fbd-140e-472c-a323-8bba3ee8cbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_311102aa-2062-4863-8bf1-285074ebd333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:to="loc_us-gaap_CommercialPaperMember_311102aa-2062-4863-8bf1-285074ebd333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_38acf8b2-82f3-4f27-a6f4-fb4bf9515a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f13ce593-df36-450b-ae23-e238dbd52624" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_38acf8b2-82f3-4f27-a6f4-fb4bf9515a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_763bcbbd-fce1-4b0c-814a-36987c390885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_763bcbbd-fce1-4b0c-814a-36987c390885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_ee5a3669-3424-4301-9eb7-f9aacba5d458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_763bcbbd-fce1-4b0c-814a-36987c390885" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_ee5a3669-3424-4301-9eb7-f9aacba5d458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_39401ff5-9010-419b-94b4-81ce3e9e52c0" xlink:href="bmy-20220331.xsd#bmy_ContingentValueRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_ee5a3669-3424-4301-9eb7-f9aacba5d458" xlink:to="loc_bmy_ContingentValueRightsMember_39401ff5-9010-419b-94b4-81ce3e9e52c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1915c1df-46af-4482-8b58-ff60f041027d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1915c1df-46af-4482-8b58-ff60f041027d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16f637b9-8369-4738-ae69-525bc65eff80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1915c1df-46af-4482-8b58-ff60f041027d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16f637b9-8369-4738-ae69-525bc65eff80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_56f313a8-62af-460c-8ba2-2741dd04402a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16f637b9-8369-4738-ae69-525bc65eff80" xlink:to="loc_us-gaap_OtherAssetsMember_56f313a8-62af-460c-8ba2-2741dd04402a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f5871a-656b-4423-bca8-4de637799d31" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a7c92c4-8fe0-4f41-bcaa-72fd9e11437d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a7c92c4-8fe0-4f41-bcaa-72fd9e11437d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d4f87251-afb9-45cb-9e3a-23a51caec627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d4f87251-afb9-45cb-9e3a-23a51caec627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_be96aab8-af45-4ecc-95fe-ff8099a6602a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_DerivativeAssets_be96aab8-af45-4ecc-95fe-ff8099a6602a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_d6d81d79-2135-4e61-b769-eca9c8c30ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_d6d81d79-2135-4e61-b769-eca9c8c30ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_f3af30af-ee29-47e0-b059-c5035ee2ddc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_DerivativeLiabilities_f3af30af-ee29-47e0-b059-c5035ee2ddc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f54418f0-f38b-4a3a-8ccc-0bc802f7a3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6170dad4-a220-4471-b2df-29fa3ad5fdc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f54418f0-f38b-4a3a-8ccc-0bc802f7a3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3d22b5f8-98f5-48cd-bff4-222a9cec6f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddfd2083-ccbf-43e1-800e-04fd802a1bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3d22b5f8-98f5-48cd-bff4-222a9cec6f56" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddfd2083-ccbf-43e1-800e-04fd802a1bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e27208c6-58c9-407c-988a-0a4f119fe3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddfd2083-ccbf-43e1-800e-04fd802a1bfa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e27208c6-58c9-407c-988a-0a4f119fe3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e27208c6-58c9-407c-988a-0a4f119fe3c2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_78994c9b-a085-4d7e-9198-1dad5f073445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:to="loc_us-gaap_CertificatesOfDepositMember_78994c9b-a085-4d7e-9198-1dad5f073445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e3973507-1352-486f-8db9-29843a5c14fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:to="loc_us-gaap_CommercialPaperMember_e3973507-1352-486f-8db9-29843a5c14fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_001d9e29-d22a-48ad-9d4c-208ac376f4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3dabce4c-7954-4cab-8a6f-1e6b20b99e84" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_001d9e29-d22a-48ad-9d4c-208ac376f4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddfd2083-ccbf-43e1-800e-04fd802a1bfa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5c8afb76-3a13-4d86-aec4-606fc815f5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5c8afb76-3a13-4d86-aec4-606fc815f5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_796ae484-7fa3-4423-b35c-4180e6c623ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_796ae484-7fa3-4423-b35c-4180e6c623ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6b0c31bc-fbdf-4810-8373-428899425dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6b0c31bc-fbdf-4810-8373-428899425dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_12970815-7acf-48c2-8e1d-620282913512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a26717b-80a5-4baa-bcc7-705420e1e999" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_12970815-7acf-48c2-8e1d-620282913512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0b811d6d-fc3b-4b52-a164-62c49113bc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4fda7e30-38c1-4e20-84a0-7fa1a875f5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0b811d6d-fc3b-4b52-a164-62c49113bc5f" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4fda7e30-38c1-4e20-84a0-7fa1a875f5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d0139fb2-b853-4623-9a64-fd565785bfbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0b811d6d-fc3b-4b52-a164-62c49113bc5f" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d0139fb2-b853-4623-9a64-fd565785bfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f9065e41-1535-4401-a7bf-31c2c1ad2ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0b811d6d-fc3b-4b52-a164-62c49113bc5f" xlink:to="loc_us-gaap_EquityMethodInvestments_f9065e41-1535-4401-a7bf-31c2c1ad2ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestments_962d3f12-27ac-494b-87f2-f9c2b294efd7" xlink:href="bmy-20220331.xsd#bmy_EquityInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0b811d6d-fc3b-4b52-a164-62c49113bc5f" xlink:to="loc_bmy_EquityInvestments_962d3f12-27ac-494b-87f2-f9c2b294efd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9eb580ff-0035-46d8-a124-dc1a54cae37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNIAbstract_6edbdd6b-85ab-4f10-8c8d-829edb06a5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFVNIAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9eb580ff-0035-46d8-a124-dc1a54cae37c" xlink:to="loc_us-gaap_EquitySecuritiesFVNIAbstract_6edbdd6b-85ab-4f10-8c8d-829edb06a5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_afdf37e9-4340-48df-8076-bc89a72fe01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_6edbdd6b-85ab-4f10-8c8d-829edb06a5ff" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_afdf37e9-4340-48df-8076-bc89a72fe01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_47b98486-c20e-491c-8477-879c2d6f5234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_6edbdd6b-85ab-4f10-8c8d-829edb06a5ff" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_47b98486-c20e-491c-8477-879c2d6f5234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_3e1eee94-9c16-4c2f-a6ca-2500e10081ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFVNIAbstract_6edbdd6b-85ab-4f10-8c8d-829edb06a5ff" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_3e1eee94-9c16-4c2f-a6ca-2500e10081ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_d7951048-76dd-457d-8d30-3d2c7afafb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9eb580ff-0035-46d8-a124-dc1a54cae37c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_d7951048-76dd-457d-8d30-3d2c7afafb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_5892c8b2-77df-4702-b79f-10514cf87839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_d7951048-76dd-457d-8d30-3d2c7afafb9a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_5892c8b2-77df-4702-b79f-10514cf87839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_250d7f53-0d2d-4887-b909-74c330a090db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_d7951048-76dd-457d-8d30-3d2c7afafb9a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_250d7f53-0d2d-4887-b909-74c330a090db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_e300a1a8-1970-4782-b72b-6d9e050e7e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_d7951048-76dd-457d-8d30-3d2c7afafb9a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_e300a1a8-1970-4782-b72b-6d9e050e7e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_b771e74c-1a9e-4e53-8b80-defd7120a2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract_d7951048-76dd-457d-8d30-3d2c7afafb9a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_b771e74c-1a9e-4e53-8b80-defd7120a2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f7dfddd-ded6-4c10-ab76-cf393ae8c694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9eb580ff-0035-46d8-a124-dc1a54cae37c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f7dfddd-ded6-4c10-ab76-cf393ae8c694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f1f68d92-c1c4-4ced-aa9d-3c090da6cc38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f1f68d92-c1c4-4ced-aa9d-3c090da6cc38" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_8f983675-5205-46b6-b6b3-b1fa96a5bd6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_srt_CurrencyAxis_8f983675-5205-46b6-b6b3-b1fa96a5bd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_8f983675-5205-46b6-b6b3-b1fa96a5bd6c" xlink:to="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_886c07c1-6557-4d06-842a-5a4681c64add" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:to="loc_currency_EUR_886c07c1-6557-4d06-842a-5a4681c64add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_f69acec7-5c73-47cd-98e2-fcc731c88ece" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6d062637-71d0-41b0-b92f-8346da32d8d6" xlink:to="loc_currency_JPY_f69acec7-5c73-47cd-98e2-fcc731c88ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_88e232de-339c-4b8a-a948-1f6898368a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_HedgingDesignationAxis_88e232de-339c-4b8a-a948-1f6898368a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8ba5e0a0-be29-4356-b20e-b9c2708e73b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_88e232de-339c-4b8a-a948-1f6898368a1c" xlink:to="loc_us-gaap_HedgingDesignationDomain_8ba5e0a0-be29-4356-b20e-b9c2708e73b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_81ad3a73-a9f7-463c-837b-fd95e295e75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8ba5e0a0-be29-4356-b20e-b9c2708e73b9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_81ad3a73-a9f7-463c-837b-fd95e295e75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea79442e-02a5-44cc-b510-80933f89b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_VariableRateAxis_ea79442e-02a5-44cc-b510-80933f89b6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a3db8e73-0b9a-4609-9583-b397e5217d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ea79442e-02a5-44cc-b510-80933f89b6bd" xlink:to="loc_us-gaap_VariableRateDomain_a3db8e73-0b9a-4609-9583-b397e5217d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d7cef420-b124-422e-912d-6a4af56ba622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a3db8e73-0b9a-4609-9583-b397e5217d6b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d7cef420-b124-422e-912d-6a4af56ba622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_DebtInstrumentAxis_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca80ae1d-9ec1-46b2-a6af-e3137c3cb8ca" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A60BillionUnsecuredSeniorNotesMember_31b2ceed-14f2-430f-96d1-4000f7a3d2fd" xlink:href="bmy-20220331.xsd#bmy_A60BillionUnsecuredSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_A60BillionUnsecuredSeniorNotesMember_31b2ceed-14f2-430f-96d1-4000f7a3d2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2032Member_c781f476-fd70-41cc-9ba4-712c06ade710" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2032Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2032Member_c781f476-fd70-41cc-9ba4-712c06ade710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2042Member_59217a97-f0f2-40e8-8e07-ddb952920c00" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2042Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2042Member_59217a97-f0f2-40e8-8e07-ddb952920c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2052Member_b2beee70-2964-4a40-80fc-82b83e4b98aa" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2052Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2052Member_b2beee70-2964-4a40-80fc-82b83e4b98aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SeniorUnsecuredNotesDue2062Member_9f6da88c-22dc-42ac-a27d-dc2becb9d424" xlink:href="bmy-20220331.xsd#bmy_SeniorUnsecuredNotesDue2062Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_SeniorUnsecuredNotesDue2062Member_9f6da88c-22dc-42ac-a27d-dc2becb9d424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_4f68404f-1635-4da2-861d-74e5a7ba2c83" xlink:href="bmy-20220331.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0916cf0d-0eeb-4a93-a3f4-85578d7c1aa2" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_4f68404f-1635-4da2-861d-74e5a7ba2c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4c1a0e67-8651-49a3-8271-87a83ea6fcac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_CreditFacilityAxis_4c1a0e67-8651-49a3-8271-87a83ea6fcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4c1a0e67-8651-49a3-8271-87a83ea6fcac" xlink:to="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember_dfb371ea-66e7-4d31-a915-ae904a97502f" xlink:href="bmy-20220331.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A2BillionMaximumBorrowingCapacityMember_dfb371ea-66e7-4d31-a915-ae904a97502f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember_6c9735aa-dd70-4b25-b928-c415baaccbbc" xlink:href="bmy-20220331.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A1BillionMaximumBorrowingCapacityMember_6c9735aa-dd70-4b25-b928-c415baaccbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_82119c4c-d69b-4c0c-95d5-4763916a3c12" xlink:href="bmy-20220331.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_82119c4c-d69b-4c0c-95d5-4763916a3c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A5BillionMaximumBorrowingCapacityMember_aa1e478c-fcc8-46bf-bd59-e19ce70f1eb1" xlink:href="bmy-20220331.xsd#bmy_A5BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c5fd1326-c151-4d18-b266-b3ffb866676c" xlink:to="loc_bmy_A5BillionMaximumBorrowingCapacityMember_aa1e478c-fcc8-46bf-bd59-e19ce70f1eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d260f97-8b74-4f61-9b08-302c6e08f5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d260f97-8b74-4f61-9b08-302c6e08f5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f642c748-a575-4fa1-9e86-597bcd22aa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d260f97-8b74-4f61-9b08-302c6e08f5d5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f642c748-a575-4fa1-9e86-597bcd22aa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8c1ee6be-5801-4677-853d-eeca59630947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f642c748-a575-4fa1-9e86-597bcd22aa30" xlink:to="loc_us-gaap_SeniorNotesMember_8c1ee6be-5801-4677-853d-eeca59630947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_52196923-9176-499b-9482-d501fa1878f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_52196923-9176-499b-9482-d501fa1878f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_52196923-9176-499b-9482-d501fa1878f4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_583ed4b4-9f1a-4f38-b1fc-33c2afc51ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_583ed4b4-9f1a-4f38-b1fc-33c2afc51ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_304be913-b0d2-408e-ad00-9864b0d76344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_304be913-b0d2-408e-ad00-9864b0d76344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_d20f3fc1-b8b0-487e-8344-558b36374241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8378e5a5-9c4b-4f43-afe3-c6b8c1de2e63" xlink:to="loc_us-gaap_TreasuryLockMember_d20f3fc1-b8b0-487e-8344-558b36374241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9673a365-f1e3-4439-8ea9-e9f54cc4a75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9673a365-f1e3-4439-8ea9-e9f54cc4a75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f942bf9a-9bee-444d-91ba-78cdfa9b2d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9673a365-f1e3-4439-8ea9-e9f54cc4a75d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f942bf9a-9bee-444d-91ba-78cdfa9b2d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ec57ef12-bf5f-4f6d-8a13-9aaf0a2b8fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f942bf9a-9bee-444d-91ba-78cdfa9b2d3f" xlink:to="loc_us-gaap_SubsequentEventMember_ec57ef12-bf5f-4f6d-8a13-9aaf0a2b8fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7c33d4d2-a326-4c26-9e12-96b15da0a6b4" xlink:to="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5c83aa23-ec1a-484e-9ef4-31c9871a87e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5c83aa23-ec1a-484e-9ef4-31c9871a87e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_45342d18-9def-4ce8-b3dd-3a48afd7ce20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_45342d18-9def-4ce8-b3dd-3a48afd7ce20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_bc52860a-7bcc-46d2-8c9e-2244a9900e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_bc52860a-7bcc-46d2-8c9e-2244a9900e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_345f0113-ac22-4fcc-8fd0-4c1ff138deff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_345f0113-ac22-4fcc-8fd0-4c1ff138deff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d3be3a4c-fb60-4028-aabf-45be70a31d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d3be3a4c-fb60-4028-aabf-45be70a31d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b0b96e2-e971-421a-97c1-922f1f3d63e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b0b96e2-e971-421a-97c1-922f1f3d63e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_9056faa2-aefb-4179-bcae-5ad529b9fe54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_9056faa2-aefb-4179-bcae-5ad529b9fe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_ba8a17f3-b93e-4d94-a82b-9ef679b0caf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_ba8a17f3-b93e-4d94-a82b-9ef679b0caf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_173f4e87-f2d2-42d2-964a-54aede67c27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_173f4e87-f2d2-42d2-964a-54aede67c27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd4cc7cb-176a-4166-b3e0-33608c733405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd4cc7cb-176a-4166-b3e0-33608c733405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4a9cbbb1-bade-4c87-818b-45f3febcaf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_InterestPaidNet_4a9cbbb1-bade-4c87-818b-45f3febcaf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities_154a99a7-0dd9-4f54-a685-e3840fced4c6" xlink:href="bmy-20220331.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_bmy_NumberofRevolvingCreditFacilities_154a99a7-0dd9-4f54-a685-e3840fced4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3acf39a1-cb71-46f8-8be0-f22435e4d306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3acf39a1-cb71-46f8-8be0-f22435e4d306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_b50c593d-e0d5-4a97-8e6f-608a121dfcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_us-gaap_LongTermDebtTerm_b50c593d-e0d5-4a97-8e6f-608a121dfcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LongTermDebtRenewalPeriod_d9b26def-5cbf-4618-8579-b13e34f495d7" xlink:href="bmy-20220331.xsd#bmy_LongTermDebtRenewalPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_504b4f90-24cc-4f63-9c8c-4f2a245bab07" xlink:to="loc_bmy_LongTermDebtRenewalPeriod_d9b26def-5cbf-4618-8579-b13e34f495d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9bb03912-7ee5-47f6-b486-56b2576badb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9bb03912-7ee5-47f6-b486-56b2576badb5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_069ac608-9268-4480-a380-fab5851c2e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:to="loc_us-gaap_HedgingDesignationAxis_069ac608-9268-4480-a380-fab5851c2e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_069ac608-9268-4480-a380-fab5851c2e07" xlink:to="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b62b978d-8eb2-49e5-8eec-397a0313ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b62b978d-8eb2-49e5-8eec-397a0313ab9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b58fdb7e-4dbc-466d-ab93-d16fc1b6f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6b07535d-55bd-4860-8239-f02417d46d92" xlink:to="loc_us-gaap_NondesignatedMember_b58fdb7e-4dbc-466d-ab93-d16fc1b6f2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0ffd98a-4541-4aa4-8b0a-ab54fe8b9c35" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_55cfe1f0-0aef-426e-b4a3-85d955095f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_InterestRateSwapMember_55cfe1f0-0aef-426e-b4a3-85d955095f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_263a85c6-33e0-480e-9785-2c0a22eb2f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_263a85c6-33e0-480e-9785-2c0a22eb2f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ea94c6ef-69eb-41f7-8a02-751785e6d730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ea94c6ef-69eb-41f7-8a02-751785e6d730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_95270c07-168e-4eb1-930c-a5597be7ecb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8dafd49d-976b-484e-a1cb-c997c226feaa" xlink:to="loc_us-gaap_OtherContractMember_95270c07-168e-4eb1-930c-a5597be7ecb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9f855939-6272-4b00-924d-376d615b7dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9f855939-6272-4b00-924d-376d615b7dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9f855939-6272-4b00-924d-376d615b7dba" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_85a8db8c-51e4-4ee2-a8d8-328f32325754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:to="loc_us-gaap_AssetsMember_85a8db8c-51e4-4ee2-a8d8-328f32325754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_06c043cb-a652-4547-befe-ae0ed4aa5255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_590c5e5b-d3d3-4943-9752-b2c6dc6b8d67" xlink:to="loc_us-gaap_LiabilityMember_06c043cb-a652-4547-befe-ae0ed4aa5255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f4f1de6-9c28-4f5a-bdd5-701adfa90d93" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7e368457-b9f1-4896-87ad-cc1b4f71cd83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7e368457-b9f1-4896-87ad-cc1b4f71cd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9e76e7c4-6a83-488e-9588-c437e2dbde49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:to="loc_us-gaap_DerivativeAssets_9e76e7c4-6a83-488e-9588-c437e2dbde49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_11020571-9540-4a9b-8b50-6e7f81c6f01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d7984a0c-2dd8-4ea1-ab6c-65304e742569" xlink:to="loc_us-gaap_DerivativeLiabilities_11020571-9540-4a9b-8b50-6e7f81c6f01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b09fbe4e-30a5-4577-a38b-aaded0e13117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b09fbe4e-30a5-4577-a38b-aaded0e13117" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_771650ad-e1f2-4227-af66-c61b8023a989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_771650ad-e1f2-4227-af66-c61b8023a989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_771650ad-e1f2-4227-af66-c61b8023a989" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_071cd225-63e9-451f-b4ff-ce4c2e82071d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:to="loc_us-gaap_InterestRateSwapMember_071cd225-63e9-451f-b4ff-ce4c2e82071d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_88c3d815-af10-4ceb-a216-3297fd257dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_88c3d815-af10-4ceb-a216-3297fd257dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_18a8d9c9-8c7b-43f3-a876-2ca9c855e71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2206604-c8f9-4b96-a701-1465f3a283d7" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_18a8d9c9-8c7b-43f3-a876-2ca9c855e71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_89959cdb-6f16-4258-9bf4-ffe2accc8e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_89959cdb-6f16-4258-9bf4-ffe2accc8e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89959cdb-6f16-4258-9bf4-ffe2accc8e23" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2c322843-5da6-4848-90fd-cab583334eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:to="loc_us-gaap_CostOfSalesMember_2c322843-5da6-4848-90fd-cab583334eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_e36644c5-a866-4832-a0ae-3eb634843be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_96230813-0359-44e1-aa6f-36ff2ad13edb" xlink:to="loc_us-gaap_OtherIncomeMember_e36644c5-a866-4832-a0ae-3eb634843be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ce247dda-8637-4039-8334-5e46236ac9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0b28f23-66af-44d1-88a0-6fbe5c22af31" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ce247dda-8637-4039-8334-5e46236ac9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_876537e9-dc41-4545-a288-af55cedca686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_ce247dda-8637-4039-8334-5e46236ac9a8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_876537e9-dc41-4545-a288-af55cedca686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c54a068a-9185-49da-87c1-942dd61a4e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c54a068a-9185-49da-87c1-942dd61a4e31" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f4978825-b2f0-440d-81ea-b638c66a79b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f4978825-b2f0-440d-81ea-b638c66a79b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4978825-b2f0-440d-81ea-b638c66a79b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_4b2767a6-4a93-4e47-a005-1d6befa33344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_4b2767a6-4a93-4e47-a005-1d6befa33344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_91b38f62-e612-4639-99a2-3c9b6d789c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:to="loc_us-gaap_InterestRateSwapMember_91b38f62-e612-4639-99a2-3c9b6d789c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_de561035-edf9-4333-bbf6-52cbd0fee143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82f5edb8-6eb1-4f14-8c36-6f05420336f7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_de561035-edf9-4333-bbf6-52cbd0fee143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_484a42aa-5f68-4afd-b88d-9d16f224fa12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_484a42aa-5f68-4afd-b88d-9d16f224fa12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_484a42aa-5f68-4afd-b88d-9d16f224fa12" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1fba0749-4a79-483b-ad9f-559af46fd9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:to="loc_us-gaap_CostOfSalesMember_1fba0749-4a79-483b-ad9f-559af46fd9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_431006fb-0380-4b20-8bed-9c63c8504aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4d8d260-7b36-49a6-9fb8-7e01dce1abbf" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_431006fb-0380-4b20-8bed-9c63c8504aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0192b5e1-3223-43e6-9c5e-61f59f4859d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:to="loc_us-gaap_HedgingDesignationAxis_0192b5e1-3223-43e6-9c5e-61f59f4859d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3c1255c4-2aa0-4272-805c-53c3ff55f808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0192b5e1-3223-43e6-9c5e-61f59f4859d6" xlink:to="loc_us-gaap_HedgingDesignationDomain_3c1255c4-2aa0-4272-805c-53c3ff55f808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_651e9b45-d160-4075-a31c-4d241eef7aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3c1255c4-2aa0-4272-805c-53c3ff55f808" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_651e9b45-d160-4075-a31c-4d241eef7aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_75d63104-6f0e-422a-930a-628b7bbd0e03" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_59bfdee9-5411-448b-8a7c-239f8262da27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralCashFlowHedgeInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:to="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_59bfdee9-5411-448b-8a7c-239f8262da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralCashFlowHedgeInformationAbstract_59bfdee9-5411-448b-8a7c-239f8262da27" xlink:to="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1150c952-9f37-4b1a-9958-18afb8a4e711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1150c952-9f37-4b1a-9958-18afb8a4e711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_dbbebd95-63e8-46f3-bfc9-a02b756e63ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyDerivativesAbstract_4dc73e67-3f52-408c-9683-897ac2a19e12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_dbbebd95-63e8-46f3-bfc9-a02b756e63ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0e67daa4-3a3e-44a5-ac20-6a820555f390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0e67daa4-3a3e-44a5-ac20-6a820555f390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionAbstract_ad7fb947-d1b9-4b81-ae36-2afe4ede8b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_0e67daa4-3a3e-44a5-ac20-6a820555f390" xlink:to="loc_us-gaap_ForeignCurrencyTransactionAbstract_ad7fb947-d1b9-4b81-ae36-2afe4ede8b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_2550a57f-169e-4bbc-bdbf-6bfc699b6ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyTransactionAbstract_ad7fb947-d1b9-4b81-ae36-2afe4ede8b91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_2550a57f-169e-4bbc-bdbf-6bfc699b6ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7c59f587-990f-42da-8dd0-ad4880f39230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_3a3396bd-67e8-48af-9373-f4cb672a719b" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7c59f587-990f-42da-8dd0-ad4880f39230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_24d79640-de9d-4c99-86b1-26b3f374e2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7c59f587-990f-42da-8dd0-ad4880f39230" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_24d79640-de9d-4c99-86b1-26b3f374e2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_95b1b17a-6a20-468f-b113-0a2cc0a1929e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract_24d79640-de9d-4c99-86b1-26b3f374e2b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_95b1b17a-6a20-468f-b113-0a2cc0a1929e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_07d16ba4-3709-4fad-9c60-a4a996f33ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_7d5de8aa-4447-4a93-bf1e-50ab9af0992c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07d16ba4-3709-4fad-9c60-a4a996f33ee2" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_7d5de8aa-4447-4a93-bf1e-50ab9af0992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_2ab8b228-6607-4e03-a7fd-26077cc25600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07d16ba4-3709-4fad-9c60-a4a996f33ee2" xlink:to="loc_us-gaap_LongTermDebtCurrent_2ab8b228-6607-4e03-a7fd-26077cc25600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_d1ad0e9f-1c72-46c3-8a6e-882c966605f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07d16ba4-3709-4fad-9c60-a4a996f33ee2" xlink:to="loc_us-gaap_OtherShortTermBorrowings_d1ad0e9f-1c72-46c3-8a6e-882c966605f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_8a992025-50b9-475c-911e-1503daf620f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07d16ba4-3709-4fad-9c60-a4a996f33ee2" xlink:to="loc_us-gaap_ShortTermBorrowings_8a992025-50b9-475c-911e-1503daf620f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bbc1be1a-ba7b-4aea-aa22-04b5e474b3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e1efc520-e97f-4354-a4cd-97c1a07aef9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bbc1be1a-ba7b-4aea-aa22-04b5e474b3c9" xlink:to="loc_us-gaap_DebtInstrumentTable_e1efc520-e97f-4354-a4cd-97c1a07aef9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1efc520-e97f-4354-a4cd-97c1a07aef9b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b19b178e-4ae4-4926-867c-eeb819af50b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1164ca91-364a-4e37-9fc5-d73b7e3d1fd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b19b178e-4ae4-4926-867c-eeb819af50b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_577b142c-d3e9-4e9f-a519-5bdf06d241bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b19b178e-4ae4-4926-867c-eeb819af50b7" xlink:to="loc_us-gaap_InterestRateSwapMember_577b142c-d3e9-4e9f-a519-5bdf06d241bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1efc520-e97f-4354-a4cd-97c1a07aef9b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_dbe2e025-1827-4c57-9479-a1ed0d505e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_dbe2e025-1827-4c57-9479-a1ed0d505e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_04ac867f-da49-4623-8b36-c91dcc3b7ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DerivativeLiabilities_04ac867f-da49-4623-8b36-c91dcc3b7ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_0815c060-461f-4ce7-a209-95436f50421b" xlink:href="bmy-20220331.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_0815c060-461f-4ce7-a209-95436f50421b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b35b9369-84c0-42a3-8c96-d0c011b28580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b35b9369-84c0-42a3-8c96-d0c011b28580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_8f5134f1-d1d7-4fed-bb5d-c1c7d5a7d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_8f5134f1-d1d7-4fed-bb5d-c1c7d5a7d7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3de808b7-8411-4635-928f-52ba08753c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_LongTermDebt_3de808b7-8411-4635-928f-52ba08753c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9450b383-5a63-4199-b854-1746a405c33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_LongTermDebtCurrent_9450b383-5a63-4199-b854-1746a405c33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ede772f6-9127-4c02-b667-5783461d1a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fb6cb372-ec8f-4739-8639-740bd9dfdf45" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ede772f6-9127-4c02-b667-5783461d1a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLES" xlink:type="simple" xlink:href="bmy-20220331.xsd#RECEIVABLES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_cadc1ff6-9ad2-46c1-9ce8-f8e878b3dcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_d67647d5-bc62-4b64-a73d-6bf4f635a785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_cadc1ff6-9ad2-46c1-9ce8-f8e878b3dcb1" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_d67647d5-bc62-4b64-a73d-6bf4f635a785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#RECEIVABLESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_99c4391e-f0bd-4e78-ad2b-d8497f7dca9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b1295e78-b826-425e-8c73-74e39e2abcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_99c4391e-f0bd-4e78-ad2b-d8497f7dca9b" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b1295e78-b826-425e-8c73-74e39e2abcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RECEIVABLESScheduleofReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_394379e7-ab15-4509-bd4d-35053bb08f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_da1cc2da-aebf-4aea-b911-6ba4f0944c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_394379e7-ab15-4509-bd4d-35053bb08f1d" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_da1cc2da-aebf-4aea-b911-6ba4f0944c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_1f9e4926-ed3f-4440-a7b1-9734ddd496df" xlink:href="bmy-20220331.xsd#bmy_CashDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_394379e7-ab15-4509-bd4d-35053bb08f1d" xlink:to="loc_bmy_CashDiscounts_1f9e4926-ed3f-4440-a7b1-9734ddd496df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_608bfdef-f6aa-4c23-be0f-ff70e3609372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_394379e7-ab15-4509-bd4d-35053bb08f1d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_608bfdef-f6aa-4c23-be0f-ff70e3609372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_124387f0-e538-444b-be1e-1312c8de4b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_394379e7-ab15-4509-bd4d-35053bb08f1d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_124387f0-e538-444b-be1e-1312c8de4b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_07d461cd-0b96-47b5-badf-fbe2fc7cf4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_394379e7-ab15-4509-bd4d-35053bb08f1d" xlink:to="loc_us-gaap_OtherReceivables_07d461cd-0b96-47b5-badf-fbe2fc7cf4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_126a648c-ffee-4125-a749-daea3771b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_394379e7-ab15-4509-bd4d-35053bb08f1d" xlink:to="loc_us-gaap_ReceivablesNetCurrent_126a648c-ffee-4125-a749-daea3771b07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#RECEIVABLESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_7ee01d34-4afa-49c0-966a-d67f76e7f2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9686d2bb-513b-40cb-aa29-b89c76a49237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_7ee01d34-4afa-49c0-966a-d67f76e7f2f1" xlink:to="loc_us-gaap_ConcentrationRiskTable_9686d2bb-513b-40cb-aa29-b89c76a49237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_163eca0f-ffbd-47e6-8015-51a962bddd30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9686d2bb-513b-40cb-aa29-b89c76a49237" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_163eca0f-ffbd-47e6-8015-51a962bddd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b54273dd-568a-4102-a5a4-85d3d291ee70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_163eca0f-ffbd-47e6-8015-51a962bddd30" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b54273dd-568a-4102-a5a4-85d3d291ee70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_e4ee8179-cbe8-4b16-8a36-fce444a17514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b54273dd-568a-4102-a5a4-85d3d291ee70" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_e4ee8179-cbe8-4b16-8a36-fce444a17514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9686d2bb-513b-40cb-aa29-b89c76a49237" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_c6759c20-0128-46b7-8546-a9c6b34632ec" xlink:href="bmy-20220331.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_c6759c20-0128-46b7-8546-a9c6b34632ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_3a552eba-d52d-4a5a-a290-cdc9093aa074" xlink:href="bmy-20220331.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_3a552eba-d52d-4a5a-a290-cdc9093aa074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_852c1fc9-c884-411e-9ea5-5e89e96461b1" xlink:href="bmy-20220331.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_f2d8d32b-d686-43b3-8e8e-ebb09e518362" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_852c1fc9-c884-411e-9ea5-5e89e96461b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIES" xlink:type="simple" xlink:href="bmy-20220331.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_e2c73e37-1d00-4580-8e6c-fa2ece357089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_7d7806b7-5895-4408-b224-3a47d0f6c54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_e2c73e37-1d00-4580-8e6c-fa2ece357089" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_7d7806b7-5895-4408-b224-3a47d0f6c54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_fa0a8fd7-2895-403d-8f1e-8c60acb0ce75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9262be48-0c05-458e-90f4-7d2decee4607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_fa0a8fd7-2895-403d-8f1e-8c60acb0ce75" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9262be48-0c05-458e-90f4-7d2decee4607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_434bcdcb-244c-42a6-93a9-b9d8acf979ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_434bcdcb-244c-42a6-93a9-b9d8acf979ac" xlink:to="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8446390f-703e-4379-81f1-bd403281b308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_68d4fbc2-fdb9-46cc-a109-73cbeaa458e2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8446390f-703e-4379-81f1-bd403281b308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_850fd326-358d-4a4f-b9e9-757a795bba12" xlink:href="bmy-20220331.xsd#bmy_InventoryPurchasePriceFairValueAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8446390f-703e-4379-81f1-bd403281b308" xlink:to="loc_bmy_InventoryPurchasePriceFairValueAdjustmentMember_850fd326-358d-4a4f-b9e9-757a795bba12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_632be52e-0886-4b30-97c8-906bcc8aacb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_632be52e-0886-4b30-97c8-906bcc8aacb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_198a6318-2f29-4169-a3e7-d28533f6e608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_632be52e-0886-4b30-97c8-906bcc8aacb2" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_198a6318-2f29-4169-a3e7-d28533f6e608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentToInventoryMember_831955e2-04fa-4826-8118-785ed5f9731a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentToInventoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_198a6318-2f29-4169-a3e7-d28533f6e608" xlink:to="loc_us-gaap_FairValueAdjustmentToInventoryMember_831955e2-04fa-4826-8118-785ed5f9731a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bb9e9a87-2eb1-483e-b1a8-ef0f14749320" xlink:to="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70f97eee-df43-4290-8562-e6d30e30095e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_70f97eee-df43-4290-8562-e6d30e30095e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7e8c0342-1700-45c5-b73e-6221acc49084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7e8c0342-1700-45c5-b73e-6221acc49084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_19a817ea-6b35-42b8-ae2f-12a3a1932e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_19a817ea-6b35-42b8-ae2f-12a3a1932e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_f5038e0c-45b7-427e-ac78-51c7385db8d3" xlink:href="bmy-20220331.xsd#bmy_Totalinventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_bmy_Totalinventories_f5038e0c-45b7-427e-ac78-51c7385db8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a1147e05-199e-4ad0-8bd4-2a84139ee1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryNet_a1147e05-199e-4ad0-8bd4-2a84139ee1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_13fc20ea-cbf9-454e-8fe8-39689379b8de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryNoncurrent_13fc20ea-cbf9-454e-8fe8-39689379b8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2245f473-1d47-4572-9b8c-806073b530e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2245f473-1d47-4572-9b8c-806073b530e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments_11da5171-5ea4-457a-8062-578b1e346bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_InventoryAdjustments_11da5171-5ea4-457a-8062-578b1e346bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ee03dec7-2792-4355-8286-2b5f3846d5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ee03dec7-2792-4355-8286-2b5f3846d5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5caa6059-36cf-4cbb-9d24-75f4365ef869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2490ccc5-d134-4572-999b-df879f38238d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5caa6059-36cf-4cbb-9d24-75f4365ef869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="bmy-20220331.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d798cee1-9227-4380-b190-5b2b32056499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_5b8ef37d-a69b-424c-ba54-d6e9fddbe97e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d798cee1-9227-4380-b190-5b2b32056499" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_5b8ef37d-a69b-424c-ba54-d6e9fddbe97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_93b3d19e-70dd-41f4-82e9-3dba2903b23b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8828ebbe-f812-4fa4-baf3-8f700e10c2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_93b3d19e-70dd-41f4-82e9-3dba2903b23b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8828ebbe-f812-4fa4-baf3-8f700e10c2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_0ce7afe8-69f5-4a3a-9146-79dd51d34e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_Land_0ce7afe8-69f5-4a3a-9146-79dd51d34e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_96d30c76-ff76-4917-9fed-f2064fc0845a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_96d30c76-ff76-4917-9fed-f2064fc0845a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_527bbf94-8178-411b-a813-7e774a6a73c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_527bbf94-8178-411b-a813-7e774a6a73c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_62f533f9-fcec-494d-9c2a-e9e6857012b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_ConstructionInProgressGross_62f533f9-fcec-494d-9c2a-e9e6857012b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_141a07ba-9599-47cf-8280-3593eaf3c43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_141a07ba-9599-47cf-8280-3593eaf3c43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_144cd248-8ded-40f8-b0dc-b2a53afa32ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_144cd248-8ded-40f8-b0dc-b2a53afa32ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ccba3ff4-3d13-487f-8528-5e461943ae1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ccba3ff4-3d13-487f-8528-5e461943ae1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_18337ef7-aaa3-4a40-b87c-b93250a7fe48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3981d718-b689-4c94-8b5a-272422cbd386" xlink:to="loc_us-gaap_Depreciation_18337ef7-aaa3-4a40-b87c-b93250a7fe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="bmy-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e5e74ba-367d-4371-8e70-711f2d8a5946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b8ba63b6-a986-4b7e-a982-d1403144d621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e5e74ba-367d-4371-8e70-711f2d8a5946" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b8ba63b6-a986-4b7e-a982-d1403144d621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3454fae6-3078-4eb9-911d-6989748f1406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_00c17067-a279-40d6-a232-1987a4d6ac3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3454fae6-3078-4eb9-911d-6989748f1406" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_00c17067-a279-40d6-a232-1987a4d6ac3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e0e6960-4d57-4bc2-baf1-1ea4b65f49f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e0e6960-4d57-4bc2-baf1-1ea4b65f49f4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_25ab7892-b2f5-490e-851b-032866464fcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:to="loc_srt_RangeAxis_25ab7892-b2f5-490e-851b-032866464fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_25ab7892-b2f5-490e-851b-032866464fcb" xlink:to="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a754814e-5d4f-4654-a905-8c2d3ba11fbe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:to="loc_srt_MinimumMember_a754814e-5d4f-4654-a905-8c2d3ba11fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_576cabe3-c983-45cf-898b-af22ee2cb314" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ca3b26f0-2817-4a40-8bee-9c01595f0f14" xlink:to="loc_srt_MaximumMember_576cabe3-c983-45cf-898b-af22ee2cb314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9fda5f2-057f-44f5-898c-15efeb8c0c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9fda5f2-057f-44f5-898c-15efeb8c0c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9fda5f2-057f-44f5-898c-15efeb8c0c62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_0c11ab3e-13ce-488b-a624-c819692c37ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:to="loc_us-gaap_LicensingAgreementsMember_0c11ab3e-13ce-488b-a624-c819692c37ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ed48138c-16dd-4ac1-951b-0971f357b589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ed48138c-16dd-4ac1-951b-0971f357b589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_662b4e2a-d77d-4cd1-844b-6b9d03f1b10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ecbfabc-1b16-41db-bc6c-4f710c6df9ec" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_662b4e2a-d77d-4cd1-844b-6b9d03f1b10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f5fbc7ba-d615-4395-a95d-39db31916d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f5fbc7ba-d615-4395-a95d-39db31916d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_39641236-6842-4a8c-97b0-41e2b0cbeaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f5fbc7ba-d615-4395-a95d-39db31916d65" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_39641236-6842-4a8c-97b0-41e2b0cbeaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c64184a5-191b-47b6-ace3-aa77dc94cdec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_39641236-6842-4a8c-97b0-41e2b0cbeaa2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c64184a5-191b-47b6-ace3-aa77dc94cdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ac60add-2534-42ff-8414-1785ca1fd6a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_58795455-6e1e-4b1e-b358-82be0eadb2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_Goodwill_58795455-6e1e-4b1e-b358-82be0eadb2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_99ca327e-90c4-48f6-b2fc-559a2bd60b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_99ca327e-90c4-48f6-b2fc-559a2bd60b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ecf652b1-fd24-4449-820d-b8334a50332d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ecf652b1-fd24-4449-820d-b8334a50332d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_01724b81-109d-411f-b9e8-70fcf455bca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_01724b81-109d-411f-b9e8-70fcf455bca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_61df1051-4cdb-4a0d-9996-b8684ce9d994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_61df1051-4cdb-4a0d-9996-b8684ce9d994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e894e097-8e77-4e80-a681-7060fa1f0422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e894e097-8e77-4e80-a681-7060fa1f0422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f407599-e050-4007-a440-08cb68b5518c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_69d665f9-dde8-45d0-9e68-ccf2df190fac" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7f407599-e050-4007-a440-08cb68b5518c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6a1dc004-8ba1-4a90-99a6-06c90d428046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_257059b1-f446-4703-bbbe-4e000d808686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6a1dc004-8ba1-4a90-99a6-06c90d428046" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_257059b1-f446-4703-bbbe-4e000d808686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a" xlink:href="bmy-20220331.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_257059b1-f446-4703-bbbe-4e000d808686" xlink:to="loc_bmy_IntangibleAssetNameAxis_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_0706e62f-dfbe-4a57-84c4-c793a4966c27" xlink:href="bmy-20220331.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IntangibleAssetNameAxis_2d3ce9a8-5f2e-4ae5-b545-8b3f0735028a" xlink:to="loc_bmy_IntangibleAssetNameDomain_0706e62f-dfbe-4a57-84c4-c793a4966c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_08175bc1-ad48-432f-9abd-a72602c3ba02" xlink:href="bmy-20220331.xsd#bmy_InrebicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IntangibleAssetNameDomain_0706e62f-dfbe-4a57-84c4-c793a4966c27" xlink:to="loc_bmy_InrebicMember_08175bc1-ad48-432f-9abd-a72602c3ba02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_257059b1-f446-4703-bbbe-4e000d808686" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f4c7546d-2a9c-435f-8eef-d2a340618e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f4c7546d-2a9c-435f-8eef-d2a340618e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fb0d8433-209a-450c-bde3-447d37468eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fb0d8433-209a-450c-bde3-447d37468eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_c07d56cf-e4a7-42b2-913f-df8993dbde7a" xlink:href="bmy-20220331.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_c07d56cf-e4a7-42b2-913f-df8993dbde7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_b3d55b18-7d5c-41dd-a49e-f83ba5ac5b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5d4c976-fa60-442c-a939-1245ffd9d243" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_b3d55b18-7d5c-41dd-a49e-f83ba5ac5b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_9ff47116-961d-4715-8f77-f8d2693c0504" xlink:href="bmy-20220331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_f483cbad-7505-49a1-91c3-e5aa6982fdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_9ff47116-961d-4715-8f77-f8d2693c0504" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_f483cbad-7505-49a1-91c3-e5aa6982fdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_5f83501c-6764-4386-ae13-715bebdab070" xlink:href="bmy-20220331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_dccef867-7f7e-4e58-8fac-b4a4b1b02653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_5f83501c-6764-4386-ae13-715bebdab070" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_dccef867-7f7e-4e58-8fac-b4a4b1b02653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_ebdc913b-785e-49d3-b3c5-dd9777fb5238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_5f83501c-6764-4386-ae13-715bebdab070" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_ebdc913b-785e-49d3-b3c5-dd9777fb5238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ddc7d29c-6e93-4156-8f39-ff95ee0dfa57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_5f83501c-6764-4386-ae13-715bebdab070" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ddc7d29c-6e93-4156-8f39-ff95ee0dfa57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_15870ae7-28d6-40fe-89f7-7110bfcaa739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_5f83501c-6764-4386-ae13-715bebdab070" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_15870ae7-28d6-40fe-89f7-7110bfcaa739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:href="bmy-20220331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_014f4ee3-74ed-4e32-87a6-9dfb8f07dc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:to="loc_us-gaap_PrepaidTaxes_014f4ee3-74ed-4e32-87a6-9dfb8f07dc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment_525b6ab0-c315-44c6-8bea-a7b408e634fa" xlink:href="bmy-20220331.xsd#bmy_ResearchandDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:to="loc_bmy_ResearchandDevelopment_525b6ab0-c315-44c6-8bea-a7b408e634fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_80043f80-6562-42ea-806c-8d02e6c0d2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_80043f80-6562-42ea-806c-8d02e6c0d2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent_93ef4745-d5dd-4f36-a67a-f912d9975e10" xlink:href="bmy-20220331.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:to="loc_bmy_EquityInvestmentsCurrent_93ef4745-d5dd-4f36-a67a-f912d9975e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_65390eba-9696-479b-80ab-32f39fc3695f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:to="loc_us-gaap_RestrictedCash_65390eba-9696-479b-80ab-32f39fc3695f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_6bbcd632-857f-4734-a0f2-bd49c4c4a853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_6bbcd632-857f-4734-a0f2-bd49c4c4a853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_aa5680f2-3fc3-477e-8ff4-8a279c9117e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_34a08bc5-3e97-47c5-91ac-620f807158f0" xlink:to="loc_us-gaap_OtherAssetsCurrent_aa5680f2-3fc3-477e-8ff4-8a279c9117e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:href="bmy-20220331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent_a198db7b-a84b-4e5c-bab2-bebc39fa2339" xlink:href="bmy-20220331.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_bmy_EquityInvestmentsNonCurrent_a198db7b-a84b-4e5c-bab2-bebc39fa2339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_80f8434f-b097-4d01-8fcb-14f26121d5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_us-gaap_InventoryNoncurrent_80f8434f-b097-4d01-8fcb-14f26121d5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0246eeee-139e-46ec-a8f4-1ab7a1bdfa9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0246eeee-139e-46ec-a8f4-1ab7a1bdfa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_c3e22fb3-10de-40e7-a5f8-94ef71219638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_c3e22fb3-10de-40e7-a5f8-94ef71219638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchAndDevelopmentNonCurrent_5d1687d1-ffa6-4a8f-9067-67319666a55c" xlink:href="bmy-20220331.xsd#bmy_ResearchAndDevelopmentNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_bmy_ResearchAndDevelopmentNonCurrent_5d1687d1-ffa6-4a8f-9067-67319666a55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_a955d884-6f99-4d2e-9e87-786ab52d4fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_a955d884-6f99-4d2e-9e87-786ab52d4fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_0cc30bc9-e653-4b65-aefc-d2cd136801f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_0cc30bc9-e653-4b65-aefc-d2cd136801f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d5a9aa7d-c674-4045-ae4d-dd05907f0528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_470ce04d-e054-447a-92f5-758c614f6b29" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d5a9aa7d-c674-4045-ae4d-dd05907f0528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:href="bmy-20220331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns_ce258ed4-fa8d-4475-a015-47242c3d2a6f" xlink:href="bmy-20220331.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_bmy_AccruedRebatesAndReturns_ce258ed4-fa8d-4475-a015-47242c3d2a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_6e94147e-059b-41f0-a864-815e266f68ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_6e94147e-059b-41f0-a864-815e266f68ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d7d8f5e6-3fb9-485d-b9f5-fc769448baa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d7d8f5e6-3fb9-485d-b9f5-fc769448baa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment_ba5144dd-7c91-4577-bc07-54b30efd8b13" xlink:href="bmy-20220331.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_bmy_AccruedResearchAndDevelopment_ba5144dd-7c91-4577-bc07-54b30efd8b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_a5e62ac0-d677-40ce-bd8f-fe72926f017e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_us-gaap_DividendsPayableCurrent_a5e62ac0-d677-40ce-bd8f-fe72926f017e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest_138e033b-c570-47d8-a901-5ce927f370a9" xlink:href="bmy-20220331.xsd#bmy_AccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_bmy_AccruedInterest_138e033b-c570-47d8-a901-5ce927f370a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_a4da6444-fe9d-4f32-b0e5-e731ecb3049e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_a4da6444-fe9d-4f32-b0e5-e731ecb3049e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_066699e1-14d8-4436-95a7-3c0a57b38991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_066699e1-14d8-4436-95a7-3c0a57b38991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_681dc785-066c-4bba-8754-a3152f775406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_681dc785-066c-4bba-8754-a3152f775406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e89144b5-23c4-4df8-95a7-dadb897cca4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_c37a9798-c344-4361-822a-7d6fc0ca8833" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e89144b5-23c4-4df8-95a7-dadb897cca4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:href="bmy-20220331.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_77bdce1c-7732-4360-9f62-191899edd767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_77bdce1c-7732-4360-9f62-191899edd767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_406a99fc-a22f-4ea9-90b1-7ecc456c2e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_406a99fc-a22f-4ea9-90b1-7ecc456c2e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f8a37292-a405-4c10-84a7-9edb03f05d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f8a37292-a405-4c10-84a7-9edb03f05d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_af6e3e4c-ae0e-4a3a-b77d-0e1daf341d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_af6e3e4c-ae0e-4a3a-b77d-0e1daf341d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1fcfe3e7-2cd9-42ad-976e-e794afc3809b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1fcfe3e7-2cd9-42ad-976e-e794afc3809b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_db13bb1c-aed5-44c6-93e4-119cf5ec40d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_db13bb1c-aed5-44c6-93e4-119cf5ec40d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ffd8c28b-4fe4-4d80-9ba0-4e4966e84442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_e3844f43-47a7-454f-a242-db761ed29eb6" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ffd8c28b-4fe4-4d80-9ba0-4e4966e84442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITY" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITY"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_af147449-7c66-446f-a056-fa411cd4922d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6cf7e788-74f3-4569-af4e-545f5f0f49bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_af147449-7c66-446f-a056-fa411cd4922d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6cf7e788-74f3-4569-af4e-545f5f0f49bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_35d23d66-1be5-4256-a85c-da077001b8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_ca71e9ca-e3d5-4017-a91a-c98bbb6daf07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_35d23d66-1be5-4256-a85c-da077001b8d0" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_ca71e9ca-e3d5-4017-a91a-c98bbb6daf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_22f0285b-a879-42a5-879d-7435f9f1873b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_35d23d66-1be5-4256-a85c-da077001b8d0" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_22f0285b-a879-42a5-879d-7435f9f1873b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bec1ba80-b56b-42d5-afa1-eaaf01928f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_35d23d66-1be5-4256-a85c-da077001b8d0" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bec1ba80-b56b-42d5-afa1-eaaf01928f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYScheduleofStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_80ddeaaa-42aa-46eb-afc9-00ad1cd1e628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_02d25855-ece5-41a3-bf8c-5179b0fb8d7f" xlink:href="bmy-20220331.xsd#bmy_EquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_80ddeaaa-42aa-46eb-afc9-00ad1cd1e628" xlink:to="loc_bmy_EquityTable_02d25855-ece5-41a3-bf8c-5179b0fb8d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c1482c1-d06d-4f15-a40f-ed8c1c31efca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_02d25855-ece5-41a3-bf8c-5179b0fb8d7f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c1482c1-d06d-4f15-a40f-ed8c1c31efca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c1482c1-d06d-4f15-a40f-ed8c1c31efca" xlink:to="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_03c2d14b-5f6a-4c67-9e46-43d82d58e013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_CommonStockMember_03c2d14b-5f6a-4c67-9e46-43d82d58e013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fa47648f-6b84-4666-b487-5b9ef2b8549f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fa47648f-6b84-4666-b487-5b9ef2b8549f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_660883fb-9a03-4ae5-8fa2-ad7b3636c468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_660883fb-9a03-4ae5-8fa2-ad7b3636c468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4b604f82-f2ee-4f3c-a013-f2913c6e74c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_RetainedEarningsMember_4b604f82-f2ee-4f3c-a013-f2913c6e74c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4517933e-0d49-49c4-8a8f-63040d853b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_TreasuryStockMember_4517933e-0d49-49c4-8a8f-63040d853b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c13f73d9-8bde-41c7-be4c-09e4c85f1359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_abe2148b-2e9c-4b98-bcf2-bba79830dfe2" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c13f73d9-8bde-41c7-be4c-09e4c85f1359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:href="bmy-20220331.xsd#bmy_EquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_02d25855-ece5-41a3-bf8c-5179b0fb8d7f" xlink:to="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_52f2de39-0b93-42ee-bc27-52fd1dd13937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_SharesIssued_52f2de39-0b93-42ee-bc27-52fd1dd13937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5ed7ed5a-6f85-4a97-8e69-4f99b650e337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_StockholdersEquity_5ed7ed5a-6f85-4a97-8e69-4f99b650e337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_724f39b5-23f3-4169-9c10-dd0dc813e593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_NetIncomeLoss_724f39b5-23f3-4169-9c10-dd0dc813e593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d0a51f12-de95-4748-8aff-f868039c0613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d0a51f12-de95-4748-8aff-f868039c0613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4b421e75-cc28-4f46-9604-1242f30a07bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4b421e75-cc28-4f46-9604-1242f30a07bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_1f6844e8-20a4-4646-9986-6e9791521ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_DividendsCommonStockCash_1f6844e8-20a4-4646-9986-6e9791521ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6e947f8e-6117-4144-b6d2-7b1e38f7f6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6e947f8e-6117-4144-b6d2-7b1e38f7f6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_edf1e409-48d5-4164-b5d0-d81ec2812ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_edf1e409-48d5-4164-b5d0-d81ec2812ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_95ae2f79-c12e-4a64-8770-b136e7d0bdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_95ae2f79-c12e-4a64-8770-b136e7d0bdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_50634e02-10a9-473d-be48-1572e6d5c3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_50634e02-10a9-473d-be48-1572e6d5c3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_4cdf0cd2-d633-4659-b681-be9c1f1019b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_SharesIssued_4cdf0cd2-d633-4659-b681-be9c1f1019b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1eac7b57-45d4-4cb8-9f75-bf2286b1135d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_StockholdersEquity_1eac7b57-45d4-4cb8-9f75-bf2286b1135d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_3eb1647a-fd70-4cea-a653-ed4cbfe598e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_3a12abe0-382a-43dc-b423-4ae507d190aa" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_3eb1647a-fd70-4cea-a653-ed4cbfe598e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4eb32db1-2c3a-4806-b2d3-20c964126b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityTable_a443841e-7fac-4409-a3af-e6028849c5fa" xlink:href="bmy-20220331.xsd#bmy_EquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4eb32db1-2c3a-4806-b2d3-20c964126b11" xlink:to="loc_bmy_EquityTable_a443841e-7fac-4409-a3af-e6028849c5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_342fc10b-a6b9-44e2-b45b-30c108c68e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_a443841e-7fac-4409-a3af-e6028849c5fa" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_342fc10b-a6b9-44e2-b45b-30c108c68e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_cd996120-e8a8-4758-b131-39f605eca143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_342fc10b-a6b9-44e2-b45b-30c108c68e1f" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_cd996120-e8a8-4758-b131-39f605eca143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2022ASRMember_83d04c13-00d4-4a7c-9d79-9685a39993d2" xlink:href="bmy-20220331.xsd#bmy_A2022ASRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_cd996120-e8a8-4758-b131-39f605eca143" xlink:to="loc_bmy_A2022ASRMember_83d04c13-00d4-4a7c-9d79-9685a39993d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:href="bmy-20220331.xsd#bmy_EquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityTable_a443841e-7fac-4409-a3af-e6028849c5fa" xlink:to="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_67c8f71a-9838-4a5d-b053-cf4ec4c8f679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_67c8f71a-9838-4a5d-b053-cf4ec4c8f679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_3673a087-af16-45dc-af96-805606819ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_3673a087-af16-45dc-af96-805606819ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_a4c0d7db-14b6-446f-9477-e4eced43b245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_a4c0d7db-14b6-446f-9477-e4eced43b245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2612871-b29c-453d-8da9-050707e01611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_EquityLineItems_84c87d38-c7ba-4406-9bd6-3862d00481b6" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e2612871-b29c-453d-8da9-050707e01611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYScheduleofComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4464f342-91a2-46b8-a8e9-f2e0dee9d867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4464f342-91a2-46b8-a8e9-f2e0dee9d867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_be650567-642f-42ba-a116-8d9246cf7a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_be650567-642f-42ba-a116-8d9246cf7a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b0ffdba1-9cb6-4b74-b482-7cb784fb9c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b0ffdba1-9cb6-4b74-b482-7cb784fb9c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_011d21a5-0159-4546-99cb-0755c8582b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_011d21a5-0159-4546-99cb-0755c8582b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f2bc8e58-a251-4aad-89ed-3de2333c3f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f2bc8e58-a251-4aad-89ed-3de2333c3f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_32a9225a-0b89-4bc7-96c5-824fc0bdeeac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_32a9225a-0b89-4bc7-96c5-824fc0bdeeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_890e5b97-a3ba-4501-b59e-5f100352fe9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_890e5b97-a3ba-4501-b59e-5f100352fe9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_a0d57627-f91b-4289-96f2-40b6c2ca5ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_a0d57627-f91b-4289-96f2-40b6c2ca5ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e673da88-3fbe-4cfe-bcbb-d8b28086ab7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e673da88-3fbe-4cfe-bcbb-d8b28086ab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_f06eb0b1-cafe-457c-b1e9-63c1935bc073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_f06eb0b1-cafe-457c-b1e9-63c1935bc073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_7c8061c8-cdcf-4064-b83d-dccb8541da46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_7c8061c8-cdcf-4064-b83d-dccb8541da46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_68ae742b-9c80-4331-807c-74b4b67758f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_68ae742b-9c80-4331-807c-74b4b67758f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_9c5d4308-b62e-436c-8ad3-b7dab716f6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_9c5d4308-b62e-436c-8ad3-b7dab716f6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_9c4f1416-c74d-45e9-8b31-675f7d060e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_9c4f1416-c74d-45e9-8b31-675f7d060e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_4c263c76-7511-4493-aec7-35cd7a945172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_4c263c76-7511-4493-aec7-35cd7a945172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_2ca3e202-270b-464c-992b-d5afcc62d6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_2ca3e202-270b-464c-992b-d5afcc62d6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_a7a18b71-3124-4525-ab9e-dfe075e2d098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_a7a18b71-3124-4525-ab9e-dfe075e2d098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_933a9f73-9f9c-446f-8ee8-3fe3de20b059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_933a9f73-9f9c-446f-8ee8-3fe3de20b059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4c50ec52-31c7-43e9-a3b8-149a8e1dc1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_4c50ec52-31c7-43e9-a3b8-149a8e1dc1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_96ce5a95-7492-4686-bd1f-933d47c0b683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_96ce5a95-7492-4686-bd1f-933d47c0b683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_666a226f-25c8-432a-bb76-5d2777946b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_666a226f-25c8-432a-bb76-5d2777946b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_357a5888-950e-4c29-ad2b-9339755ff1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_357a5888-950e-4c29-ad2b-9339755ff1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_d56d2eea-20f4-4f8b-950a-e96fce503620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_d56d2eea-20f4-4f8b-950a-e96fce503620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_14d50c94-e17a-4755-9b20-f1c2296c50f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_14d50c94-e17a-4755-9b20-f1c2296c50f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_df532423-82f0-4ba8-853d-42305275af6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_df532423-82f0-4ba8-853d-42305275af6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d5b0ffb9-a421-4851-997b-63da0c10c5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d5b0ffb9-a421-4851-997b-63da0c10c5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c52a5c9c-ab32-405c-94e3-91f7f5a3df4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c52a5c9c-ab32-405c-94e3-91f7f5a3df4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_c8694f29-53b5-4cd8-be9c-c6ac8f03f991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_c8694f29-53b5-4cd8-be9c-c6ac8f03f991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_f1f568ed-a1f4-42d3-a9aa-ba526e9d8d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_f1f568ed-a1f4-42d3-a9aa-ba526e9d8d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8935745b-c3a5-448f-afd7-034d8a6504ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7aecbab-73b7-4b1f-b752-7950df578f80" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8935745b-c3a5-448f-afd7-034d8a6504ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9377fd9f-f83b-432e-bfbc-ec0c7e64df21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_1992be61-a559-4750-813a-87bbafe2e57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9377fd9f-f83b-432e-bfbc-ec0c7e64df21" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_1992be61-a559-4750-813a-87bbafe2e57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4c6ab855-5f4d-4853-8f90-ffd0680eeb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9377fd9f-f83b-432e-bfbc-ec0c7e64df21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4c6ab855-5f4d-4853-8f90-ffd0680eeb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bdb9e452-8608-4400-ba93-b022d85aa1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9377fd9f-f83b-432e-bfbc-ec0c7e64df21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bdb9e452-8608-4400-ba93-b022d85aa1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5edf8f10-9d38-48bd-b61d-430c794ae66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9377fd9f-f83b-432e-bfbc-ec0c7e64df21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_5edf8f10-9d38-48bd-b61d-430c794ae66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f4ee70c8-9a15-4e4d-87a6-6c752bb74494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9377fd9f-f83b-432e-bfbc-ec0c7e64df21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f4ee70c8-9a15-4e4d-87a6-6c752bb74494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_68fafe84-9f4d-4ab3-9d9f-404e27a1b610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_63a7042c-7ba6-4c30-9e08-ae63ab3f3f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_68fafe84-9f4d-4ab3-9d9f-404e27a1b610" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_63a7042c-7ba6-4c30-9e08-ae63ab3f3f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c90bebc-df35-4a8a-acea-498af93855db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_d3f946eb-cf73-4918-a1f5-c89899204e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c90bebc-df35-4a8a-acea-498af93855db" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_d3f946eb-cf73-4918-a1f5-c89899204e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_469e78c0-6e15-43f3-9aca-4a2f432ba83b" xlink:href="bmy-20220331.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c90bebc-df35-4a8a-acea-498af93855db" xlink:to="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_469e78c0-6e15-43f3-9aca-4a2f432ba83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_5786f933-4552-402b-ae36-18cf5199576b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8c90bebc-df35-4a8a-acea-498af93855db" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_5786f933-4552-402b-ae36-18cf5199576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_06183078-1edd-4662-84b1-da7345d2d133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_06183078-1edd-4662-84b1-da7345d2d133" xlink:to="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1e107d7f-af40-44bb-bf2d-63634e02a651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1e107d7f-af40-44bb-bf2d-63634e02a651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4211e106-7372-4644-a1b1-ab5ce891611f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e107d7f-af40-44bb-bf2d-63634e02a651" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4211e106-7372-4644-a1b1-ab5ce891611f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_81d3f10c-0bec-4d71-8ff3-ee8dbc0f337b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6b97d2fa-33c6-453a-a852-82955007ad4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_CostOfSalesMember_6b97d2fa-33c6-453a-a852-82955007ad4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c39c7e23-d891-46ae-bf30-366c49a701ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c39c7e23-d891-46ae-bf30-366c49a701ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1cc0c464-2175-467c-a7c5-e8cb1f3bcf8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1cc0c464-2175-467c-a7c5-e8cb1f3bcf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_95a45c26-8f8a-436d-8e3a-855e1a9bddac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c1376ea-f2c0-4141-b511-d0dceff913c9" xlink:to="loc_us-gaap_OtherIncomeMember_95a45c26-8f8a-436d-8e3a-855e1a9bddac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_89653d92-7781-4f0d-a79f-57fb4c21ef6f" xlink:to="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b604fba4-ef97-42c6-afad-c04da22a89a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b604fba4-ef97-42c6-afad-c04da22a89a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_89c32a96-6c31-411d-b44c-cda554c1c9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_89c32a96-6c31-411d-b44c-cda554c1c9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2f25fa5f-d209-4cbd-a978-31750696e71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_40514b8d-2c69-4728-8736-803e97dccde7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2f25fa5f-d209-4cbd-a978-31750696e71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7df79fb7-3000-4e82-86a3-f51dec302fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_231fa7c6-2624-4db3-9989-a3ebb445caaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7df79fb7-3000-4e82-86a3-f51dec302fcb" xlink:to="loc_us-gaap_StatementTable_231fa7c6-2624-4db3-9989-a3ebb445caaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_109ddcaa-f0e8-4487-aa32-270c26bab9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_231fa7c6-2624-4db3-9989-a3ebb445caaf" xlink:to="loc_us-gaap_AwardTypeAxis_109ddcaa-f0e8-4487-aa32-270c26bab9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_109ddcaa-f0e8-4487-aa32-270c26bab9b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3f3e632e-1d6e-42ac-9256-99f888dd10cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3f3e632e-1d6e-42ac-9256-99f888dd10cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_f8a694a8-a04a-4cfa-87c0-4134ed2da003" xlink:href="bmy-20220331.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:to="loc_bmy_MarketShareUnitsMember_f8a694a8-a04a-4cfa-87c0-4134ed2da003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_78acec38-b29d-43e2-ad5d-61034602898b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e07a554d-ee7e-41a4-98bd-0d81df0ceb97" xlink:to="loc_us-gaap_PerformanceSharesMember_78acec38-b29d-43e2-ad5d-61034602898b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_231fa7c6-2624-4db3-9989-a3ebb445caaf" xlink:to="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_694aadf4-8447-4d2e-a6c9-795baa1a6e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_694aadf4-8447-4d2e-a6c9-795baa1a6e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9230544-fbea-4def-937c-d4795e5f6888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b64d6f7c-c817-4fbd-939b-2542ad0b4474" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9230544-fbea-4def-937c-d4795e5f6888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6edce608-c3be-4020-a93e-b4e31935f702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_edbd0c27-682f-4beb-a40f-ed6d2860acc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6edce608-c3be-4020-a93e-b4e31935f702" xlink:to="loc_us-gaap_StatementTable_edbd0c27-682f-4beb-a40f-ed6d2860acc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2dcfd6b9-bda1-45ee-9a23-ccce9a998272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_edbd0c27-682f-4beb-a40f-ed6d2860acc4" xlink:to="loc_us-gaap_AwardTypeAxis_2dcfd6b9-bda1-45ee-9a23-ccce9a998272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2dcfd6b9-bda1-45ee-9a23-ccce9a998272" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ec848543-d0be-4c09-ad28-b197558b3a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ec848543-d0be-4c09-ad28-b197558b3a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_cd2a9d48-8046-4a6b-a14e-6e5ac7995d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_cd2a9d48-8046-4a6b-a14e-6e5ac7995d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_aa8edefe-41c9-48a5-a14b-ff474530f27e" xlink:href="bmy-20220331.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_bmy_MarketShareUnitsMember_aa8edefe-41c9-48a5-a14b-ff474530f27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7b687918-7c73-4c5e-84b7-87b522168dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2145ce7b-86b1-4895-b641-c9b9630c4376" xlink:to="loc_us-gaap_PerformanceSharesMember_7b687918-7c73-4c5e-84b7-87b522168dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_edbd0c27-682f-4beb-a40f-ed6d2860acc4" xlink:to="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_28f2da71-97f6-4916-b867-2adc103731ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_28f2da71-97f6-4916-b867-2adc103731ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca70750d-40dd-4c4d-b881-4af9865bd8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_540000e0-b4e2-4bb6-adee-d86e8503fb96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca70750d-40dd-4c4d-b881-4af9865bd8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="simple" xlink:href="bmy-20220331.xsd#LEGALPROCEEDINGSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17701a71-fd40-4f1b-99b2-b1b500233507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_22823775-6f63-4045-a2fa-4eb62647db7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17701a71-fd40-4f1b-99b2-b1b500233507" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_22823775-6f63-4045-a2fa-4eb62647db7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20220331.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_873578ee-8641-42c3-ad39-f3a728f4197d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:href="bmy-20220331.xsd#bmy_LitigationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_873578ee-8641-42c3-ad39-f3a728f4197d" xlink:to="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_de37da69-300b-43c7-b5c7-096e2b153eff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_srt_LitigationCaseAxis_de37da69-300b-43c7-b5c7-096e2b153eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_de37da69-300b-43c7-b5c7-096e2b153eff" xlink:to="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_990e0ebc-62ec-4739-9dd2-a135212b3eca" xlink:href="bmy-20220331.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_990e0ebc-62ec-4739-9dd2-a135212b3eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_3cbe8baf-098b-4193-86fe-780899b31b4a" xlink:href="bmy-20220331.xsd#bmy_CARTKiteLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_CARTKiteLitigationMember_3cbe8baf-098b-4193-86fe-780899b31b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_446cc7c6-87d4-4bf3-a6ba-82f22951118c" xlink:href="bmy-20220331.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_446cc7c6-87d4-4bf3-a6ba-82f22951118c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_56c4abc0-8436-4840-b82f-ddc2a2b32130" xlink:href="bmy-20220331.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_AbilifyProductLiabilityMember_56c4abc0-8436-4840-b82f-ddc2a2b32130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember_7ca71c1f-4a9b-4ef9-9d53-446697e01343" xlink:href="bmy-20220331.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_AbilifyProductLiabilityLitigationMember_7ca71c1f-4a9b-4ef9-9d53-446697e01343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_2da7a592-6aa8-4a87-8bc0-89dd48252fd7" xlink:href="bmy-20220331.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3e1f037f-41f4-43d8-af07-405858194679" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_2da7a592-6aa8-4a87-8bc0-89dd48252fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_c17a9ee1-a8e0-4810-92e7-17c6baaa6262" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_srt_CurrencyAxis_c17a9ee1-a8e0-4810-92e7-17c6baaa6262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_c17a9ee1-a8e0-4810-92e7-17c6baaa6262" xlink:to="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_6419a9ac-379d-41dd-91f9-12484577419e" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:to="loc_currency_AUD_6419a9ac-379d-41dd-91f9-12484577419e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_746e6f72-2417-4b91-a2cf-38c1c3727d0a" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1644efe1-95bc-4850-9d74-5a7b0c8486f2" xlink:to="loc_currency_USD_746e6f72-2417-4b91-a2cf-38c1c3727d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_aff04c44-a0c3-4f47-b335-f520627c6b86" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_dei_LegalEntityAxis_aff04c44-a0c3-4f47-b335-f520627c6b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bd39d89f-5fb8-42f7-be17-7950242eb41b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_aff04c44-a0c3-4f47-b335-f520627c6b86" xlink:to="loc_dei_EntityDomain_bd39d89f-5fb8-42f7-be17-7950242eb41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BristolMyersSquibbMember_b05e722b-e303-4ddf-8ea0-6efcd1804514" xlink:href="bmy-20220331.xsd#bmy_BristolMyersSquibbMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bd39d89f-5fb8-42f7-be17-7950242eb41b" xlink:to="loc_bmy_BristolMyersSquibbMember_b05e722b-e303-4ddf-8ea0-6efcd1804514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_30200b60-e063-401d-a1a2-8faac6cebeed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_srt_StatementGeographicalAxis_30200b60-e063-401d-a1a2-8faac6cebeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_89af510e-0dab-4bde-802c-7b2afaeb0445" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_30200b60-e063-401d-a1a2-8faac6cebeed" xlink:to="loc_srt_SegmentGeographicalDomain_89af510e-0dab-4bde-802c-7b2afaeb0445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_fc23e5fa-f2ea-4127-ac65-da6bda14402f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_89af510e-0dab-4bde-802c-7b2afaeb0445" xlink:to="loc_country_CA_fc23e5fa-f2ea-4127-ac65-da6bda14402f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:href="bmy-20220331.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_adb2ca48-d72c-49ed-abb7-85dc06ca941c" xlink:to="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_9f5159c9-0beb-4bf9-a345-1008494bf163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_9f5159c9-0beb-4bf9-a345-1008494bf163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_6cfeb38b-1dd8-4ed5-8150-6e8ea2d80732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_PaymentsForRoyalties_6cfeb38b-1dd8-4ed5-8150-6e8ea2d80732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_226f06a2-0e84-4c48-a244-897326a5884b" xlink:href="bmy-20220331.xsd#bmy_RoyaltyGuaranteesCommitmentsPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_RoyaltyGuaranteesCommitmentsPercent_226f06a2-0e84-4c48-a244-897326a5884b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_545eeeb6-37a0-4b20-a584-44bf07fd5faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_545eeeb6-37a0-4b20-a584-44bf07fd5faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_772772c1-0a13-4e43-982d-168ef6447f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_772772c1-0a13-4e43-982d-168ef6447f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_0021a28c-2a7e-44eb-9182-0db517bfea25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_0021a28c-2a7e-44eb-9182-0db517bfea25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberDismissed_5ebbee70-ce04-41cf-9edc-6b84d6bd5604" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberDismissed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberDismissed_5ebbee70-ce04-41cf-9edc-6b84d6bd5604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_8014ff8c-40f9-4a63-96d6-907c7e8c1a12" xlink:href="bmy-20220331.xsd#bmy_LossContingencyNumberOfPlaintiffsDismissed"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyNumberOfPlaintiffsDismissed_8014ff8c-40f9-4a63-96d6-907c7e8c1a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_58abd497-c6c3-4014-a338-c43926cff971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_58abd497-c6c3-4014-a338-c43926cff971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberClassAction_fe69069e-10fd-44aa-a9eb-9d7e1a86a54a" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberClassAction"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberClassAction_fe69069e-10fd-44aa-a9eb-9d7e1a86a54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_69fd9f7b-76be-44af-8797-cf4064186bac" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims_69fd9f7b-76be-44af-8797-cf4064186bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LossContingencyPendingClaimsNumberActive_3fb84a49-9442-4bd5-afdd-0cb7605a31d1" xlink:href="bmy-20220331.xsd#bmy_LossContingencyPendingClaimsNumberActive"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_bmy_LossContingencyPendingClaimsNumberActive_3fb84a49-9442-4bd5-afdd-0cb7605a31d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_c3d90471-bb98-4686-96c3-f7bca698f625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_ContractualObligation_c3d90471-bb98-4686-96c3-f7bca698f625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_9e8e9d63-dc3d-4095-871a-59e4390325da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_7565b1d5-c632-4391-80eb-abeb038823e1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_9e8e9d63-dc3d-4095-871a-59e4390325da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746537528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BRISTOL-MYERS SQUIBB COMPANY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0790350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">430 E. 29th Street, 14FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">546-4200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">2,129,064,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000014272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember', window );">Common Stock $0.10 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.10 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member', window );">1.000% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member', window );">1.750% Notes due 2035</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.750% Notes due 2035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember', window );">Celgene Contingent Value Rights</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Celgene Contingent Value Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CELG RT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748125432">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,648<span></span>
</td>
<td class="nump">$ 11,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,471<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, selling and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,260<span></span>
</td>
<td class="nump">2,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">333<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AmortizationofAcquiredIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,417<span></span>
</td>
<td class="nump">2,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">649<span></span>
</td>
<td class="num">(702)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,961<span></span>
</td>
<td class="nump">8,543<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings Before Income Taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,687<span></span>
</td>
<td class="nump">2,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">404<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,283<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Noncontrolling Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings Attributable to BMS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,278<span></span>
</td>
<td class="nump">$ 2,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common share attributable to BMS, basic (in usd per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.60<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share attributable to BMS, diluted (in usd per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,308<span></span>
</td>
<td class="nump">$ 10,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember', window );">Alliance and other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 340<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AmortizationofAcquiredIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Acquired Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AmortizationofAcquiredIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896750339656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="nump">$ 1,283<span></span>
</td>
<td class="nump">$ 2,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Marketable debt securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total Other Comprehensive Income</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive Income</a></td>
<td class="nump">1,322<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive Income Attributable to Noncontrolling Interest</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income Attributable to BMS</a></td>
<td class="nump">$ 1,317<span></span>
</td>
<td class="nump">$ 2,316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746718936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,369<span></span>
</td>
<td class="nump">$ 13,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable debt securities</a></td>
<td class="nump">2,599<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">8,511<span></span>
</td>
<td class="nump">9,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,104<span></span>
</td>
<td class="nump">2,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">4,538<span></span>
</td>
<td class="nump">4,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">30,121<span></span>
</td>
<td class="nump">33,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">6,047<span></span>
</td>
<td class="nump">6,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">20,500<span></span>
</td>
<td class="nump">20,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">40,103<span></span>
</td>
<td class="nump">42,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">1,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">4,845<span></span>
</td>
<td class="nump">5,535<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">103,034<span></span>
</td>
<td class="nump">109,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt obligations</a></td>
<td class="nump">7,522<span></span>
</td>
<td class="nump">4,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">2,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">12,355<span></span>
</td>
<td class="nump">13,971<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">22,821<span></span>
</td>
<td class="nump">21,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">3,809<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">37,450<span></span>
</td>
<td class="nump">39,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">7,309<span></span>
</td>
<td class="nump">7,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">71,389<span></span>
</td>
<td class="nump">73,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Bristol-Myers Squibb Company Shareholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value of stock</a></td>
<td class="nump">43,756<span></span>
</td>
<td class="nump">44,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,229)<span></span>
</td>
<td class="num">(1,268)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">23,948<span></span>
</td>
<td class="nump">23,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less cost of treasury stock</a></td>
<td class="num">(35,187)<span></span>
</td>
<td class="num">(31,259)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Bristol-Myers Squibb Company Shareholders&#8217; Equity</a></td>
<td class="nump">31,580<span></span>
</td>
<td class="nump">35,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">31,645<span></span>
</td>
<td class="nump">36,006<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 103,034<span></span>
</td>
<td class="nump">$ 109,314<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746606744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings</a></td>
<td class="nump">$ 1,283<span></span>
</td>
<td class="nump">$ 2,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization, net</a></td>
<td class="nump">2,584<span></span>
</td>
<td class="nump">2,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(687)<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment charges</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Pensionsettlementsandamortization', window );">Pension settlements and amortization</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Divestituregainsandroyalties', window );">Divestiture gains and royalties</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AcquiredIPRD', window );">Acquired IPRD</a></td>
<td class="nump">333<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Equity investment losses/(gains)</a></td>
<td class="nump">644<span></span>
</td>
<td class="num">(601)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration fair value adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="nump">786<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Rebates and discounts</a></td>
<td class="num">(930)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">831<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(1,073)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">3,812<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Sale and maturities of marketable debt securities</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable debt securities</a></td>
<td class="num">(1,714)<span></span>
</td>
<td class="num">(1,302)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi', window );">Proceeds from sales of equity investment securities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(173)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Divestitureandotherproceeds', window );">Divestiture and other proceeds</a></td>
<td class="nump">402<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition and other payments, net of cash acquired</a></td>
<td class="num">(442)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by/(Used in) Investing Activities</a></td>
<td class="nump">95<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Short-term debt obligations, net</a></td>
<td class="nump">42<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of long-term debt</a></td>
<td class="nump">5,926<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(5,769)<span></span>
</td>
<td class="num">(4,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(1,775)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends</a></td>
<td class="num">(1,185)<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">333<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Used in Financing Activities</a></td>
<td class="num">(5,653)<span></span>
</td>
<td class="num">(7,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="num">(1,737)<span></span>
</td>
<td class="num">(3,652)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</a></td>
<td class="nump">14,316<span></span>
</td>
<td class="nump">14,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at End of Period</a></td>
<td class="nump">$ 12,579<span></span>
</td>
<td class="nump">$ 11,321<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired IPRD</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestitureandotherproceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestitureandotherproceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestituregainsandroyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of gains and royalties as a result of business divestitures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestituregainsandroyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Pensionsettlementsandamortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of expense recognized due to defined benefit pension settlements and curtailments and the amortization of prior service credits and net actuarial loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Pensionsettlementsandamortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3444-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748042392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation and Recently Issued Accounting Standards</a></td>
<td class="text">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221; or &#8220;the Company&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at March&#160;31, 2022 and December&#160;31, 2021 and the results of operations and cash flows for the three months ended March&#160;31, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of goodwill and intangible assets; chargebacks, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Up-front and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statement of earnings. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows is now presented separately in Rebates and discounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective approach. Early adoption is permitted.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747879992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">REVENUE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,586)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,718)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,761)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $74 million and $217 million for the three months ended March&#160;31, 2022, and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div>Revenue recognized from performance obligations satisfied in prior periods was $147 million and $284 million for the three months ended March&#160;31, 2022 and 2021, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748042392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Alliances</a></td>
<td class="text">ALLIANCES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2021 Form 10-K. Significant developments and updates related to alliances during the three months ended March 31, 2022 are set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nektar</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, BMS and Nektar announced that the companies have jointly decided to end the global clinical development program for bempegaldesleukin in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> based on results from pre-planned analyses of two late-stage clinical studies in RCC and bladder cancer. These studies and all other ongoing studies in the program will be discontinued.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747925832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Divestitures, Licensing and Other Arrangements</a></td>
<td class="text">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mature Products and Other</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, product rights to several mature products were sold to Cheplapharm resulting in cash proceeds of $221&#160;million and divestiture gain of $211&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">In-license Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Immatics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, BMS obtained a global exclusive license to Immatics&#8217; TCR bispecific IMA401 program. IMA401 is being studied in oncology and a Clinical Trial Application has been approved by the German federal regulatory authority and the trial is planned to commence in the first half of 2022. BMS and Immatics will collaborate on the development and BMS will be responsible for the commercialization of IMA401 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an up-front payment of $150&#160;million which was included in Acquired IPRD and Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $770&#160;million as well as royalties on global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dragonfly</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, a Phase I development milestone for interlukin-12 (&#8220;IL-12&#8221;) was achieved resulting in a $175&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. These milestones continue to be considered substantive and contingent because the decision to proceed will be based on an assessment of clinical data prior to the specified dates.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoKardia</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, BMS amended the terms of a license arrangement and paid a third party $295&#160;million to extinguish a future royalty obligation related to mavacamten prior to its FDA approval which will result in an Acquired IPRD charge.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747922168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other (Income)/Expense, Net</a></td>
<td class="text">OTHER (INCOME)/EXPENSE, NET<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747813880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">RESTRUCTURING<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition that are currently expected to be approximately $3.0&#160;billion. The synergies are expected to be realized in Cost of products sold (5%), Marketing, selling and administrative expenses (65%) and Research and development expenses (30%). Charges of approximately $3.3&#160;billion are expected to be incurred. The majority of the charges are expected to be incurred through 2022. Cumulative charges of approximately $2.7&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. Cash outlays in connection with these actions are expected to be approximately $3.0&#160;billion. Employee workforce reductions were approximately 60 for the three months ended March&#160;31, 2022 and 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MyoKardia Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, a restructuring and integration plan was initiated to realize expected cost synergies resulting from cost savings and avoidance from the MyoKardia acquisition. Charges of approximately $150&#160;million are expected to be incurred through 2022, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $120 million have been recognized for these actions to date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia Acquisition Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at March 31</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $9 million and $1 million for the three months ended March 31, 2022 and 2021, respectively. Excludes $6 million for the three months ended March 31, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896840281912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2022 and 2021 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that were not taxable in 2021. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits at March&#160;31, 2022 could decrease in the range of approximately $450 million to $500 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#8217;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896856146520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three months ended March&#160;31, 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747868776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; in the Company&#8217;s 2021 Form 10-K, the Company&#8217;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Debt Securities and Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2022 and December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determined fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss/(gain) recognized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized on investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss/(gain) recognized on investments still held</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net (income)/loss of affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges is temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold and Other (income)/expense, net) within the next 24 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $5.3 billion and Japanese yen of $1.3 billion at March&#160;31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-U.S. dollar borrowings of &#8364;950 million ($1.1 billion) at March&#160;31, 2022 are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency interest rate swap contracts of $600 million at March&#160;31, 2022 are designated to hedge Japanese yen currency exposure of BMS&#8217;s net investment in its Japan subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Accumulated other comprehensive loss with a related offset in Other non-current assets or Other non-current liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (0.45% as of March&#160;31, 2022) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Treasury lock contracts were entered into with a total notional value of $3.0&#160;billion to hedge interest rate risk associated with the anticipated issuance of long-term debt. The Treasury lock contracts were terminated upon the issuance of the aggregate $6.0&#160;billion of unsecured senior notes. These contracts were not designated for hedge accounting. The settlement of these contracts were not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Treasury lock contracts were entered into with a total notional value of $2.3&#160;billion to hedge cash payment for the anticipated redemption of long-term debt. The Treasury lock contracts were terminated upon pricing the debt redemption. These contracts were not designated for hedge accounting. The settlement of these contracts were not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 18 months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $45.8 billion at March&#160;31, 2022 and $49.1 billion at December&#160;31, 2021 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, BMS issued an aggregate principal amount of $6.0&#160;billion of debt consisting of $1.75&#160;billion of 2.950% Notes due 2032, $1.25&#160;billion of 3.550% Notes due 2042, $2.0&#160;billion of 3.700% Notes due 2052 and $1.0&#160;billion of 3.900% Notes due 2062 with proceeds net of discount and deferred loan issuance costs of $5.9&#160;billion. The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, BMS purchased aggregate principal amount of $5.2&#160;billion of certain of its debt securities for approximately $5.8&#160;billion of cash in tender offers. In connection with these transactions, a $275&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, BMS purchased aggregate principal amount of $849&#160;million of certain of its debt securities for approximately $880&#160;million of cash pursuant to &#8220;make whole&#8221; redemptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2021, BMS purchased aggregate principal amount of $3.5&#160;billion of certain of its debt securities for approximately $4.0&#160;billion of cash in a series of tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $281&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. In addition, the $500&#160;million 2.875% Notes matured and were repaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $377 million and $435 million for the three months ended March 31, 2022 and 2021, respectively, net of amounts related to interest rate swap contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had four separate revolving credit facilities totaling $6.0&#160;billion, which consisted of a 364-day $2.0&#160;billion facility which expired in January 2022, a three-year $1.0&#160;billion facility which expired in January 2022 and two five-year $1.5&#160;billion facilities that were extended to September 2025 and July 2026, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we entered into a five-year $5.0&#160;billion facility expiring in January 2027, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing five-year $1.5&#160;billion facilities were terminated and the three-year $1.0&#160;billion facility and 364-day $2.0&#160;billion facility expired in accordance with their terms in January 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No borrowings were outstanding under any revolving credit facility at March&#160;31, 2022 or December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747932552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Receivables</a></td>
<td class="text">RECEIVABLES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,156&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, Royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,511&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $423 million and $318 million for the three months ended March 31, 2022 and 2021, respectively. Receivables from the three largest customers in the U.S. represented approximately 60% and 59% of total trade receivables at March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896751628824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories include fair value adjustments resulting from the Celgene acquisition of $368 million at March&#160;31, 2022 and $508 million at December&#160;31, 2021. Other non-current assets include inventory expected to remain on hand beyond 12 months in both periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An out of period adjustment was included in the three months ended March&#160;31, 2022 to reduce the remaining amount of inventory fair value adjustments resulting from the Celgene acquisition by $114&#160;million with a corresponding increase to Cost of products sold of $32&#160;million and Research and development expense of $82&#160;million. The adjustment was not material to previously reported balance sheets or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747925272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $145 million and $135 million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748033096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,038&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,935)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of other intangible assets was $2.5 billion and $2.6 billion for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2022, a $40&#160;million IPRD impairment charge was recorded in Research and development expense following a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Celgene and was being studied as a potential treatment for autoimmune diseases. The charge represented a full write-down.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March 31, 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones of $300&#160;million were achieved resulting in a $385&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $315&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747808328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,535&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,355&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896751639960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text">EQUITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding share repurchase authorization under the program was approximately $15.2 billion as of December 31, 2021. In the three months ended March, 31, 2022, BMS executed accelerated share repurchase ("ASR") agreements to repurchase an aggregate $5.0&#160;billion of common stock. These ASR agreements were funded with cash on-hand and are expected to settle during the second and third quarters of 2022. Approximately 65&#160;million shares of common stock (85% of the $5.0&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. The total number of shares to be repurchased under the ASR agreements will be based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements. The remaining share repurchase capacity under the share repurchase program was approximately $10.2 billion as of March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS repurchased 28&#160;million shares of its common stock for $1.8&#160;billion in the three months ended March&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748005528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Employee Stock Benefit Plans</a></td>
<td class="text">EMPLOYEE STOCK BENEFIT PLANS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $40 million and $17 million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.587%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747824264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings and Contingencies</a></td>
<td class="text">LEGAL PROCEEDINGS AND CONTINGENCIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#8217;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#8217;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS&#8217;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see &#8220;&#8212;Note&#160;7. Income Taxes&#8221;.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 and Anti-PD-L1 Antibody Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute (&#8220;Dana-Farber&#8221;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber&#8217;s claims for damages before May 17, 2019&#8212;the date of the District Court&#8217;s ruling that Dana-Farber was a co-inventor of the patents&#8212;are preempted by federal patent law. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd ("AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR T</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#8220;SKI&#8221;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#8220;Kite&#8221;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 Patent&#8221;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#8217;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#8217;s defenses, finding that Kite willfully infringed the &#8217;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585 million up-front payment and a 27.6% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the &#8217;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#8217;s motions in their entirety. In April 2020, the Court granted in part Juno&#8217;s motion and entered a final judgment awarding to Juno and SKI approximately $1.2 billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the &#8217;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the &#8217;190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing which the Federal Circuit denied on January 14, 2022. Juno and SKI intend to file a petition for a writ of certiorari with the U.S. Supreme Court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Europe</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2020 and January 2021, Sandoz Limited (&#8220;Sandoz&#8221;) and Teva Pharmaceutical Industries Ltd. (&#8220;Teva Limited&#8221;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate (&#8220;SPC&#8221;). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgement issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. We disagree with the ruling and plan to appeal the decision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are similar lawsuits filed in France, Italy, the Netherlands, Portugal, the Republic of Ireland, and Sweden seeking revocation of a composition of matter patent relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, Sandoz informed BMS that it intends to launch its generic apixaban product in the Netherlands as soon as possible. In response, we have requested that the Dutch court issue a preliminary injunction to prevent any infringement of the Dutch apixaban composition of matter patent and related SPC as long as the patent and SPC are in force.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents may be filed in various countries in Europe in the coming months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an aNDA containing a paragraph IV certification seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging the one FDA Orange Book-listed formulation patent expiring in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. No trial date has been scheduled.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#8220;GenRx&#8221;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#8220;GenRx-Apotex&#8221;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#8217;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#8217;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#8220;Full Court&#8221;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449 million AUD ($337 million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#8217;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#8217;s decision and an appeal hearing concluded in February 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Celgene received a Notice Letter from MSN Laboratories Pvt. Ltd. (&#8220;MSN&#8221;) notifying Celgene that MSN had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against MSN in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene has received a Notice Letter from Alembic Pharmaceuticals Limited, Alembic Global Holding SA, and Alembic Pharmaceuticals, Inc. (&#8220;Alembic&#8221;) notifying Celgene that Alembic had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against Alembic in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. Alembic has filed answers and counterclaims alleging that the asserted patents are invalid and/or not infringed. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray") notifying BMS that Xspray had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC (&#8220;Actelion&#8221;), filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the &#8220;&#8217;867 Patent&#8221;). The Complaint alleges that the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringes certain claims of the &#8217;867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834&#160;million, with $417&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. A trial in the New Mexico matter was previously scheduled for April 2022, but was adjourned due to statewide trial delays arising from the COVID-19 pandemic. Trial has been rescheduled for January 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. There have been over 2,500 cases filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately 2,700 cases, comprising approximately 3,900 plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders. In the U.S., less than five cases remain pending in state or federal courts (New Jersey and Massachusetts). There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario). Both class actions have now been certified and will proceed separately, subject to a potential further appeal of the Ontario class certification decision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Byetta*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta*.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This litigation involved lawsuits on behalf of plaintiffs, which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases are pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#8220;JCCP&#8221;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The orders will result in the dismissal of all claims alleging an injury of pancreatic cancer in the MDL and JCCP. Plaintiffs initially appealed the MDL order, but subsequently filed a motion to dismiss their appeal as to Amylin and Lilly. That motion to dismiss was granted on October 5, 2021 making the MDL decision final as to Amylin and Lilly. Plaintiffs may seek appeals in the JCCP. As of March 2022, Plaintiffs&#8217; counsel have submitted dismissals with prejudice in exchange for a waiver of costs on behalf of approximately 75% of the plaintiffs in the JCCP (including injury plaintiffs and spouse/beneficiary plaintiffs) alleging claims against Amylin and Lilly. Additional dismissals are anticipated. BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* to AstraZeneca in February 2014 as part of BMS&#8217;s global diabetes business divestiture and any additional liability to Amylin with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of April 2022, claims are pending in federal and NY state court on behalf of approximately 252 individuals who allege they ingested the product and suffered an injury. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all federal cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco (&#8220;JCCP&#8221;). In August 2021, the MDL and JCCP courts jointly heard evidence regarding the parties&#8217; motions to exclude general causation experts. On September 24, 2021, the JCCP court granted defendants&#8217; motion to exclude plaintiffs&#8217; only general causation expert and largely denied plaintiffs&#8217; motions to exclude defendants&#8217; general causation experts; on January 5, 2022, the MDL court likewise granted defendants&#8217; motion to exclude plaintiffs&#8217; expert and denied entirely plaintiffs&#8217; motions. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the 18 claims previously pending in California state court. As part of BMS&#8217;s global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BMS Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2018, two separate putative class action complaints were filed in the U.S. District for the Northern District of California and in the U.S. District Court for the Southern District of New York against BMS, BMS&#8217;s Chief Executive Officer, Giovanni Caforio, BMS&#8217;s Chief Financial Officer at the time, Charles A. Bancroft and certain former and current executives of BMS. The case in California was voluntarily dismissed. The remaining complaint alleged violations of securities laws for BMS&#8217;s disclosures related to the CheckMate-026 clinical trial in lung cancer. In September 2019, the Court granted BMS&#8217;s motion to dismiss, but allowed the plaintiffs leave to file an amended complaint. In October 2019, the plaintiffs filed an amended complaint. In September 2020, the Court granted BMS&#8217;s motion to dismiss the amended complaint with prejudice. The plaintiffs appealed the Court&#8217;s decision in October 2020. On March 11, 2022, the Second Circuit affirmed the dismissal with prejudice of the amended complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene Securities Litigations</span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2018, </span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#8220;Celgene Securities Class Action&#8221;). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#8217;s 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#8217;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the &#8220;Schwab Action&#8221;). In July 2020, the defendants filed a motion to dismiss the plaintiffs&#8217; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#8217; motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees&#8217; Retirement System in April 2021 (the &#8220;CalPERS Action&#8221;); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the &#8220;DFA Action&#8221; and the &#8220;American Century Action&#8221;), and GIC Private Limited in September 2021 (the &#8220;GIC Action&#8221;), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above Celgene Securities Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#8220;CVR Agreement&#8221;) entered into in connection with the closing of BMS&#8217;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#8220;diligent efforts&#8221; to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $6.4&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#8217; fees. BMS disputes the successor trustee&#8217;s allegations and filed a Motion to Dismiss on July 23, 2021. All discovery is stayed until there is a decision on the Motion to Dismiss.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 relating to the joint proxy statement. That action later was consolidated with another action filed in the same court asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a) and 20(2) of the Securities Exchange Act of 1934. In asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the merger and persons who purchased CVRs for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a), and 20(a) of the Securities Exchange Act of 1934. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants have moved to dismiss the complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff has filed a motion to remand the action to the state court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene&#8217;s former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff has filed a motion to remand the action to the state court.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above CVR Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIV Medication Antitrust Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and two other manufacturers of HIV medications are defendants in related lawsuits pending in the Northern District of California. The lawsuits, filed on behalf of indirect purchasers, allege that the defendants&#8217; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evotaz&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, violate antitrust laws. In July 2020, the Court granted in part defendants&#8217; motion to dismiss, including dismissing with prejudice plaintiffs&#8217; claims as to an overarching conspiracy and plaintiffs&#8217; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remain. In September and October 2020, two purported class actions were also filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. On September 22, 2021, two additional non-class action direct purchaser complaints were filed by a number of retail pharmacy and grocery store chains against BMS and two other manufacturers of HIV medications. These complaints make allegations similar to those raised in the other federal court cases and the New Mexico state court case described below. In October 2021 and March 2022, BMS entered into settlement agreements with the putative class of indirect purchasers and the putative class of direct purchasers, respectively. Both settlements are subject to court approval. In January 2022, BMS reached an agreement to settle the cases filed against it by the retail pharmacy and grocery store chains.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#8217; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. No trial date has been scheduled.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, five additional non-class-action indirect purchaser cases were filed in the Northern District of California, and one additional non-class-action indirect purchaser case was filed in California state court naming BMS and two other manufacturers as defendants. These complaints make allegations similar to those in the other federal court cases. In February 2022, BMS reached a settlement agreement with one of the non-class-action indirect purchaser plaintiffs and in April 2022, two additional indirect purchaser plaintiffs filed non-class suits against BMS and other defendants. In total, there are now seven non-class action indirect purchaser cases pending against BMS among others. No trial date has been scheduled for these remaining cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana, Inc. (&#8220;Humana&#8221;) filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana&#8217;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#8217;s Racketeer Influenced and Corrupt Organizations Act. Humana subsequently dismissed its claims for breach of contract voluntarily. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. A trial has been scheduled for January 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#8217;s complaint makes largely the same claims and allegations as were made in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint, and the Court has stayed discovery pending adjudication of that motion. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, United HealthCare Services, Inc. (&#8220;UHS&#8221;), affiliates of which opted out of the first settlement in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation, filed a lawsuit against Celgene in the U.S. District Court for the District of Minnesota. UHS&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation in addition to certain claims regarding donations directed to copay assistance. The complaint purports to assert claims on behalf of UHS and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In December 2020, Celgene&#8217;s motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. In January 2021, Celgene filed a motion to dismiss UHS&#8217;s complaint, which the Court administratively terminated in June 2021 pending its decision on Celgene&#8217;s pending motion to dismiss Humana&#8217;s complaint. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#8220;HPI&#8221;), a Humana subsidiary, in Delaware Superior Court. Celgene&#8217;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#8217;s breach as well as a declaratory judgment. A trial has been scheduled for March 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Blue Cross Blue Shield Association (&#8220;BCBSA&#8221;) sued Celgene and BMS on behalf of the Federal Employee Program in the U.S. District Court for the District of Columbia. BCBSA&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In April 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, BCBSM Inc., Health Care Service Corporation (&#8220;HCSC&#8221;), Blue Cross and Blue Shield of Florida Inc., and Molina Healthcare, Inc. (&#8220;Molina&#8221;) sued Celgene and BMS in a Minnesota state court. The complaint makes largely the same claims and allegations as were made in the class action litigation but adds allegations on behalf of HCSC only as to alleged off-label marketing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In September 2020, Celgene and BMS removed the action to the U.S. District Court for the District of Minnesota. In March 2021, that Court denied plaintiffs&#8217; motion to remand the action to state court, dismissed Molina for lack of personal jurisdiction and granted defendants&#8217; motion to transfer the action to the District of New Jersey. The case is now pending in the District of New Jersey. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, Cigna Corporation (&#8220;Cigna&#8221;) sued Celgene and BMS in the U.S. District Court for the Eastern District of Pennsylvania. Cigna&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. Cigna&#8217;s complaint purports to assert claims on behalf of Cigna and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser. In May 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In July 2021, Celgene and BMS removed the action to the U.S. District Court for the Northern District of California, and in January 2022, that court granted Molina&#8217;s motion to remand to San Francisco Superior Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, a group of plaintiffs&#8212;MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, &#8220;MSP&#8221;)&#8212;sued Celgene and BMS in the U.S. District Court for the District of New Jersey. MSP&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. MSP purports to pursue assignments from certain named and unnamed entities that allegedly purchased or otherwise provided reimbursement for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and/or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and purports to bring direct and indirect purchaser claims. In February 2022, MSP filed an amended complaint, adding claims arising from the Company's donations to charitable organizations, and adding those organizations as defendants. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BeiGene Arbitration Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2017, Celgene Logistics S&#224;rl (&#8220;Celgene Logistics&#8221;) and BeiGene, Ltd. (together with its assignees, &#8220;BeiGene&#8221;), entered into a License and Supply Agreement (the &#8220;LSA&#8221;) pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As has been disclosed publicly, BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSK Contract Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, &#8220;Plaintiffs&#8221;) filed a complaint against BMS, Celgene and Juno (collectively, &#8220;Defendants&#8221;) alleging that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least 1.5% of worldwide sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs&#8217; claims. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#8217;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#8220;potentially responsible parties,&#8221; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $89 million at March&#160;31, 2022, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746351368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221; or &#8220;the Company&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at March&#160;31, 2022 and December&#160;31, 2021 and the results of operations and cash flows for the three months ended March&#160;31, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Business Segment Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue&#8221;.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates and Judgements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of goodwill and intangible assets; chargebacks, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Up-front and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statement of earnings. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows is now presented separately in Rebates and discounts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective approach. Early adoption is permitted.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaboration Arrangements</a></td>
<td class="text">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896752916152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock', window );">Revenue Recognition Gross-To-Net Adjustments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,586)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,718)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,761)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $74 million and $217 million for the three months ended March&#160;31, 2022, and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Products and Services</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747798200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Collaborative Arrangement and Arrangement Other than Collaborative</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747282632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Products and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsTableTextBlock', window );">Licensing and Other Arrangements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747948648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock', window );">Schedule Of Other Income Expense</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses/(gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfOtherIncomeExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896745444456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia Acquisition Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at March 31</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $9 million and $1 million for the three months ended March 31, 2022 and 2021, respectively. Excludes $6 million for the three months ended March 31, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747813320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747840040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings/(Loss) Per Share, Basic and Diluted</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746579960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2022 and December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock', window );">Schedule of Equity Investments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Debt Securities, Trading, and Equity Securities, FV-NI</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determined fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss/(gain) recognized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized on investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss/(gain) recognized on investments still held</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net (income)/loss of affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivatives and Fair Value</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 18 months.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Fair Value and Other Adjustments to Long Term Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfEquityInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747938808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule Of Receivables</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,156&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, Royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,511&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896747937688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749494936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746403608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule Of Intangible Assets By Major Class</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,038&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,935)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896840593688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent</a></td>
<td class="text"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,535&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,355&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896835100184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stock by Class</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746535464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Share-based Payment Arrangement, Cost by Plan</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $40 million and $17 million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock', window );">Schedule Of Share Based Compensation Additional Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Share-based Payment Arrangement, Nonvested Award, Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.587%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896836738008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,648<span></span>
</td>
<td class="nump">$ 11,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">11,308<span></span>
</td>
<td class="nump">10,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">3,427<span></span>
</td>
<td class="nump">3,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">3,239<span></span>
</td>
<td class="nump">2,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Alliance revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896750061384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Reconciliation of Gross Product Sales to Net Product Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,648<span></span>
</td>
<td class="nump">$ 11,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(5,342)<span></span>
</td>
<td class="num">(4,761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods', window );">Adjustments for provisions for product sales made in prior periods</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember', window );">Gross product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">16,650<span></span>
</td>
<td class="nump">15,559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">11,308<span></span>
</td>
<td class="nump">10,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember', window );">Charge-backs and cash discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(1,763)<span></span>
</td>
<td class="num">(1,586)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember', window );">Medicaid and Medicare rebates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(2,084)<span></span>
</td>
<td class="num">(1,718)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember', window );">Other rebates, returns, discounts and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">$ (1,495)<span></span>
</td>
<td class="num">$ (1,457)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for Provisions for Product Sales made in Prior Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross to Net Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Gross to Net Adjustments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749460264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Revenue by Product and Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,648<span></span>
</td>
<td class="nump">$ 11,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Performance obligation satisfied in previous period</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">7,694<span></span>
</td>
<td class="nump">7,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="nump">2,553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_RestOfWorldMember', window );">Rest of the World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember', window );">Other Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_EliquisMember', window );">Eliquis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">3,211<span></span>
</td>
<td class="nump">2,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OpdivoMember', window );">Opdivo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">1,923<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember', window );">Pomalyst/Imnovid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OrenciaMember', window );">Orencia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_SprycelMember', window );">Sprycel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">483<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_YervoyMember', window );">Yervoy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_EmplicitiMember', window );">Empliciti</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember', window );">Mature and other products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ReblozylMember', window );">Reblozyl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbecmaMember', window );">Abecma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember', window );">Zeposia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_BreyanziMember', window );">Breyanzi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InrebicMember', window );">Inrebic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OnuregMember', window );">Onureg</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OpdualagMember', window );">Opdualag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_RevlimidMember', window );">Revlimid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,797<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember', window );">Abraxane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_OtherRegionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_EliquisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_EliquisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OpdivoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OpdivoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_PomalystImnovidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OrenciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OrenciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_SprycelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_SprycelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_YervoyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_YervoyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_EmplicitiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_EmplicitiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_MatureAndOtherBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ReblozylMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ReblozylMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbecmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbecmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ZeposiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_BreyanziMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_BreyanziMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InrebicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InrebicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OnuregMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OnuregMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OpdualagMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OpdualagMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_RevlimidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_RevlimidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbraxaneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749235624">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,648<span></span>
</td>
<td class="nump">$ 11,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,471<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,260<span></span>
</td>
<td class="nump">2,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">649<span></span>
</td>
<td class="num">(702)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables &#8211; from alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable &#8211; to alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,427<span></span>
</td>
<td class="nump">3,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">1,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement', window );">Marketing, selling and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables &#8211; from alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable &#8211; to alliance partners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncome', window );">Deferred income from alliance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,308<span></span>
</td>
<td class="nump">10,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales | Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,239<span></span>
</td>
<td class="nump">2,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember', window );">Alliance revenues | Alliance revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746680328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net proceeds</a></td>
<td class="nump">$ 397<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="num">(211)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember', window );">Diabetes Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net proceeds</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net proceeds</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture (Gains)/Losses</a></td>
<td class="num">(211)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other | Cheplapharm</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Net proceeds</a></td>
<td class="nump">$ 221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_CheplapharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_CheplapharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749454456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">$ (171)<span></span>
</td>
<td class="num">$ (135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ContingentRegulatoryMilestoneIncome', window );">Contingent milestone income</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AmortizationOfDeferredIncome', window );">Amortization of deferred income</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsIncome', window );">Licensing and Other Arrangements Income</a></td>
<td class="num">(306)<span></span>
</td>
<td class="num">(232)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember', window );">Immatics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_DragonflyMember', window );">Dragonfly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember', window );">Keytruda Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">(221)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember', window );">Tecentriq royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember', window );">Other Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income, nonoperating</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AmortizationOfDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of deferred income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AmortizationOfDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentRegulatoryMilestoneIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Regulatory Milestone Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentRegulatoryMilestoneIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicenseAndOtherArrangementsUpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License and Other Arrangements Upfront Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicenseAndOtherArrangementsUpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_ImmaticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_DragonflyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_DragonflyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896750053608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_PaymentToExtinguishFutureRoyaltyObligation', window );">Payment to extinguish future royalty obligation</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember', window );">Immatics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestonePayments', window );">Contingent and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Mature Products and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from divestiture of businesses, net of cash divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentAndRegulatoryMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent and Regulatory Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentAndRegulatoryMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicenseAndOtherArrangementsUpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License and Other Arrangements Upfront Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicenseAndOtherArrangementsUpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingArrangementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingArrangementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PaymentToExtinguishFutureRoyaltyObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment To Extinguish Future Royalty Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PaymentToExtinguishFutureRoyaltyObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_ImmaticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_ImmaticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746594296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 326<span></span>
</td>
<td class="nump">$ 353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_OtherIncomeReceivedFromAlliancePartners', window );">Royalties and licensing income</a></td>
<td class="num">(477)<span></span>
</td>
<td class="num">(367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Equity investment losses/(gains)</a></td>
<td class="nump">644<span></span>
</td>
<td class="num">(601)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt redemption</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation and other settlements</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AllianceTransitionalServices', window );">Transition and other service fees</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Investment income</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture gains</a></td>
<td class="num">(211)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_OtherOtherIncomeExpense', window );">Other</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="nump">$ 649<span></span>
</td>
<td class="num">$ (702)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AllianceTransitionalServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents other income recognized during the period related to transitional services provided to a former alliance partner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AllianceTransitionalServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherIncomeReceivedFromAlliancePartners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherIncomeReceivedFromAlliancePartners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896742576296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>employee</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ExpectedSynergiesPercentage', window );">Expected synergies, percentage</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ExpectedSynergiesPercentage', window );">Expected synergies, percentage</a></td>
<td class="nump">0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ExpectedSynergiesPercentage', window );">Expected synergies, percentage</a></td>
<td class="nump">0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance', window );">Expected cost savings and avoidance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring and related charges</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related charges incurred to date</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Cashoutlays', window );">Cash outlays</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Workforce reduction of manufacturing, selling, administrative, and research and development personnel | employee</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">MyoKardia Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected restructuring and related charges</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related charges incurred to date</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Cashoutlays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outlays</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Cashoutlays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ExpectedSynergiesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Synergies, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ExpectedSynergiesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896742582504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Schedule of Restructuring and Related Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other termination costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAcceleratedDepreciation', window );">Accelerated depreciation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_RestructuringRelatedCostsAssetImpairments', window );">Asset impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">MyoKardia Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringRelatedCostsAssetImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Costs, Asset Impairments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringRelatedCostsAssetImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746593912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, beginning of period</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation', window );">Restructuring charges</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign currency translation and other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, end of period</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Change in estimates</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Acquisition Plan | Accelerated Stock Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Excluding Accelerated Stock-based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bmy_AcceleratedStockBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bmy_AcceleratedStockBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896752145592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings Before Income Taxes</a></td>
<td class="nump">$ 1,687<span></span>
</td>
<td class="nump">$ 2,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="nump">$ 404<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Tax Rate</a></td>
<td class="nump">23.90%<span></span>
</td>
<td class="nump">19.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746471048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Reasonably possible decrease in unrecognized tax benefits</a></td>
<td class="nump">$ 450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Reasonably possible decrease in unrecognized tax benefits</a></td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896745468360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation</a></td>
<td class="nump">$ 1,278<span></span>
</td>
<td class="nump">$ 2,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - basic (in shares)</a></td>
<td class="nump">2,146<span></span>
</td>
<td class="nump">2,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Incremental shares attributable to share-based compensation plans (in shares)</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">2,164<span></span>
</td>
<td class="nump">2,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common share attributable to BMS, basic (in usd per share)</a></td>
<td class="nump">$ 0.60<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share attributable to BMS, diluted (in usd per share)</a></td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896743200136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 2,599<span></span>
</td>
<td class="nump">$ 2,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">1,454<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">2,013<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents - money market and other securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">1,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents - money market and other securities</a></td>
<td class="nump">9,467<span></span>
</td>
<td class="nump">12,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">2,013<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents - money market and other securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Contingent value rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749981720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 2,598<span></span>
</td>
<td class="nump">$ 2,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">2,599<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2,013<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">2,013<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable debt securities, fair value</a></td>
<td class="nump">$ 261<span></span>
</td>
<td class="nump">$ 403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749021736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable fair values</a></td>
<td class="nump">$ 1,454<span></span>
</td>
<td class="nump">$ 2,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable fair values</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityInvestments', window );">Total equity investments</a></td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="nump">$ 2,968<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748951784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFVNIAbstract', window );"><strong>Equity investments with readily determined fair values</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Net loss/(gain) recognized</a></td>
<td class="nump">$ 598<span></span>
</td>
<td class="num">$ (196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Net loss recognized on investments sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net unrealized loss/(gain) recognized on investments still held</a></td>
<td class="nump">598<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract', window );"><strong>Equity investments without readily determinable fair values</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount', window );">Upward adjustments</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Impairments and downward adjustments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Cumulative upward adjustments</a></td>
<td class="num">(109)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount', window );">Cumulative impairments and downward adjustments</a></td>
<td class="nump">52<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (income)/loss of affiliates</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">$ (137)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFVNIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFVNIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896741262424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)<br> &#8364; in Millions, $ in Millions, &#165; in Billions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>creditFacility</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Variable rate debt, lower range of basis point spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Deferred loan issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,926<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payment for debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_NumberofRevolvingCreditFacilities', window );">Number of revolving credit facilities | creditFacility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="nump">$ 849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payment for debt extinguishment</a></td>
<td class="nump">$ 880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember', window );">$2 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember', window );">$1 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember', window );">$1.5 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term debt, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember', window );">$5 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long-term debt, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LongTermDebtRenewalPeriod', window );">Renewal period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A60BillionUnsecuredSeniorNotesMember', window );">$6.0 Billion Fixed Rate Unsecured Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2032Member', window );">Senior Unsecured Notes Due 2032 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2042Member', window );">Senior Unsecured Notes Due 2042 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2052Member', window );">Senior Unsecured Notes Due 2052 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2062Member', window );">Senior Unsecured Notes Due 2062 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member', window );">2.875% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.45%<span></span>
</td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Treasury lock contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Designated as Hedging Instrument | Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LongTermDebtRenewalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Renewal Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LongTermDebtRenewalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_NumberofRevolvingCreditFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_NumberofRevolvingCreditFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A5BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A60BillionUnsecuredSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A60BillionUnsecuredSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2052Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2052Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2062Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_SeniorUnsecuredNotesDue2062Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896743086808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency interest rate swap contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency interest rate swap contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">5,409<span></span>
</td>
<td class="nump">3,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">2,492<span></span>
</td>
<td class="nump">1,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency forward contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign currency forward contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896743047112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate swap contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate swap contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">(82)<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative, net</a></td>
<td class="num">$ (57)<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749451512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in other comprehensive income</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract', window );"><strong>Non-U.S. dollar borrowings gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Recognized in Other Comprehensive Income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract', window );"><strong>Non-U.S. dollar borrowings gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Recognized in Other Comprehensive Income</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in other comprehensive income</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(82)<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts | Reclassified to Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativesAbstract', window );"><strong>Foreign currency forward contracts gain/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionAbstract', window );"><strong>Cross-currency interest rate swap contracts gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in Other Comprehensive Income</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746313464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Non-U.S. short-term borrowings</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">7,297<span></span>
</td>
<td class="nump">4,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt, total</a></td>
<td class="nump">$ 7,522<span></span>
</td>
<td class="nump">$ 4,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748190920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal Value</a></td>
<td class="nump">$ 43,925<span></span>
</td>
<td class="nump">$ 43,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations', window );">Unamortized basis adjustment from swap terminations</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized bond discounts and issuance costs</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Unamortized purchase price adjustments of Celgene debt</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,408<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">44,747<span></span>
</td>
<td class="nump">44,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">7,297<span></span>
</td>
<td class="nump">4,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">37,450<span></span>
</td>
<td class="nump">39,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of interest rate swap contracts</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_UnamortizedBasisAdjustmentFromSwapTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746673560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RECEIVABLES - Schedule of Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 7,746<span></span>
</td>
<td class="nump">$ 8,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_CashDiscounts', window );">Less charge-backs and cash discounts</a></td>
<td class="num">(561)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less allowance for expected credit loss</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Net trade receivables</a></td>
<td class="nump">7,156<span></span>
</td>
<td class="nump">7,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Alliance, Royalties, VAT and other</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,390<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">$ 8,511<span></span>
</td>
<td class="nump">$ 9,369<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_CashDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_CashDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748849848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>customers</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ReceivablesSoldOnNonrecourseBasis', window );">Non-U.S. receivables sold on a nonrecourse basis | $</a></td>
<td class="nump">$ 423<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_NumberOfLargestPharmaceuticalWholesalers', window );">Number of largest pharmaceutical wholesalers | customers</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue', window );">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_NumberOfLargestPharmaceuticalWholesalers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of the largest pharmaceutical wholesalers used by the company in the territory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_NumberOfLargestPharmaceuticalWholesalers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PercentageOfAggregateTotalTradeReceivablesDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReceivablesSoldOnNonrecourseBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables sold on a nonrecourse basis during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReceivablesSoldOnNonrecourseBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896750010552">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw and packaging materials</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Totalinventories', window );">Total inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,471<span></span>
</td>
<td class="nump">$ 2,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,260<span></span>
</td>
<td class="nump">$ 2,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_FairValueAdjustmentToInventoryMember', window );">Fair Value Adjustment to Inventory</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Inventory adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember', window );">Inventory Purchase Price Fair Value Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, fair value adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Totalinventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents the total inventory, current and non-current, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Totalinventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_FairValueAdjustmentToInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=us-gaap_FairValueAdjustmentToInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmy_InventoryPurchasePriceFairValueAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749967208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">5,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery, equipment and fixtures</a></td>
<td class="nump">3,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">10,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(4,168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,033)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">6,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896743088696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="nump">$ 20,502<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross other intangible assets</a></td>
<td class="nump">66,038<span></span>
</td>
<td class="nump">66,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(25,935)<span></span>
</td>
<td class="num">(23,483)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">40,103<span></span>
</td>
<td class="nump">42,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPRD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">IPRD</a></td>
<td class="nump">3,710<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired marketed product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">60,477<span></span>
</td>
<td class="nump">60,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">$ 1,544<span></span>
</td>
<td class="nump">$ 1,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Acquired marketed product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Acquired marketed product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748869704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of other intangible assets</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_IntangibleAssetNameAxis=bmy_InrebicMember', window );">Inrebic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestoneNonCash', window );">Contingent and regulatory milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Finite-lived intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentAndRegulatoryMilestoneNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent and Regulatory Milestone, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentAndRegulatoryMilestoneNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_IntangibleAssetNameAxis=bmy_InrebicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_IntangibleAssetNameAxis=bmy_InrebicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896750068408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Income taxes</a></td>
<td class="nump">$ 2,182<span></span>
</td>
<td class="nump">$ 2,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ResearchandDevelopment', window );">Research and development</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityInvestmentsCurrent', window );">Equity investments</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other</a></td>
<td class="nump">959<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 4,538<span></span>
</td>
<td class="nump">$ 4,832<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity investments - current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchandDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchandDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896751840216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityInvestmentsNonCurrent', window );">Equity investments</a></td>
<td class="nump">$ 2,185<span></span>
</td>
<td class="nump">$ 2,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventories</a></td>
<td class="nump">843<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">894<span></span>
</td>
<td class="nump">919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ResearchAndDevelopmentNonCurrent', window );">Research and development</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">$ 4,845<span></span>
</td>
<td class="nump">$ 5,535<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestmentsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity investments - non-current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestmentsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchAndDevelopmentNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development - Non-Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchAndDevelopmentNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896750056104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AccruedRebatesAndReturns', window );">Rebates and discounts</a></td>
<td class="nump">$ 5,455<span></span>
</td>
<td class="nump">$ 6,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">930<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AccruedResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends</a></td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AccruedInterest', window );">Interest</a></td>
<td class="nump">356<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,955<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 12,355<span></span>
</td>
<td class="nump">$ 13,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedRebatesAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedRebatesAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896743126488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes payable</a></td>
<td class="nump">$ 4,889<span></span>
</td>
<td class="nump">$ 4,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating leases</a></td>
<td class="nump">852<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred income</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation</a></td>
<td class="nump">409<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">$ 7,309<span></span>
</td>
<td class="nump">$ 7,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749337208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Schedule of Stockholders Equity (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 35,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings</a></td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">$ 2,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 31,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in usd per share)</a></td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares)</a></td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital&#160;in Excess of Par Value of&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">44,361<span></span>
</td>
<td class="nump">44,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program</a></td>
<td class="num">(750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">145<span></span>
</td>
<td class="num">(473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">43,756<span></span>
</td>
<td class="nump">43,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1,268)<span></span>
</td>
<td class="num">(1,839)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1,229)<span></span>
</td>
<td class="num">(1,544)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">23,820<span></span>
</td>
<td class="nump">21,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings</a></td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">2,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(1,150)<span></span>
</td>
<td class="num">(1,098)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 23,948<span></span>
</td>
<td class="nump">$ 22,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares)</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (31,259)<span></span>
</td>
<td class="num">$ (26,237)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Share repurchase program (in shares)</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program</a></td>
<td class="num">$ (4,250)<span></span>
</td>
<td class="num">$ (1,768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Stock compensation (in shares)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares)</a></td>
<td class="nump">794<span></span>
</td>
<td class="nump">692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (35,187)<span></span>
</td>
<td class="num">$ (27,199)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings, noncontrolling interest</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896742579384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Additional Information (Details) - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 10.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember', window );">2022 ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityLineItems', window );"><strong>Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program (in shares)</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bmy_A2022ASRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748154680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Schedule of Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized gains/(losses), pretax</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Unrealized gains/(losses), tax</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gains/(losses), after tax</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Reclassified to net earnings, pretax</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Reclassified to net earnings, tax</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassified to net earnings, after tax</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Derivatives qualifying as cash flow hedges, pretax</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Derivatives qualifying as cash flow hedges, tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivatives qualifying as cash flow hedges, after tax</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Actuarial losses, pretax</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Actuarial losses, tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial losses, after tax</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization, pretax</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Amortization, tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Amortization, after tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlements, pretax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax', window );">Settlements, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Settlements, after tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Pension and postretirement benefits, pre-tax</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and postretirement benefits, tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits, after tax</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Unrealized (losses)/gains, pretax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Unrealized (losses)/gains, tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Marketable debt securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation, pretax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation, tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation, after tax</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income/(Loss), pre-tax</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other comprehensive income/(loss), Tax</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income/(Loss), after tax</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896746313208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="num">(747)<span></span>
</td>
<td class="num">(768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Marketable debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(692)<span></span>
</td>
<td class="num">(680)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (1,229)<span></span>
</td>
<td class="num">$ (1,268)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896751799896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Excess tax benefits from share-based compensation awards</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other (income)/expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896749554200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">7.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 63.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 60.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of units granted (in shares) | shares</a></td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 66.73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896748869704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 1,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139896742561672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)<br> $ in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>patents</div>
</th>
<th class="th">
<div>Mar. 31, 2010 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>lawsuits </div>
<div>numberOfPlaintiffs</div>
</th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_RoyaltyGuaranteesCommitmentsPercent', window );">Running royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought | $</a></td>
<td class="nump">$ 834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Obligation to holders of the contingent value rights | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities for CERCLA matters | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=bmy_BristolMyersSquibbMember', window );">Bristol-Myers Squibb</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought | $</a></td>
<td class="nump">$ 417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember', window );">Anti-PD-1 Antibody Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents | patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember', window );">CAR T Kite Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for royalties | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_RoyaltyGuaranteesCommitmentsPercent', window );">Running royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.276<span></span>
</td>
<td class="nump">0.276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property | Australia, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages paid | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Damages paid | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember', window );">Abilify Product Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember', window );">Abilify Product Liability | CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberClassAction', window );">Class action claims | lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims', window );">Individual injury claims | lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberActive', window );">Pending claims, active | lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember', window );">Abilify Product Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LossContingencyPendingClaimsNumberDismissed', window );">Dismissed cases | lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LossContingencyNumberOfPlaintiffsDismissed', window );">Number of plaintiffs, dismissed cases | numberOfPlaintiffs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember', window );">Onglyza Product Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | numberOfPlaintiffs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LegalProceedingsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LegalProceedingsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyNumberOfPlaintiffsDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Plaintiffs, Dismissed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyNumberOfPlaintiffsDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberActive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Active</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberActive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberClassAction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Class Action</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberClassAction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Dismissed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Number, Individual Injury Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RoyaltyGuaranteesCommitmentsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty Guarantees Commitments, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RoyaltyGuaranteesCommitmentsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=bmy_BristolMyersSquibbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=bmy_BristolMyersSquibbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>bmy-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmy="http://www.bms.com/20220331"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bmy-20220331.xsd" xlink:type="simple"/>
    <context id="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaf793dd12ca7489fb055121b1a3bdaf0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a3d0b17544a425bb39a530b30667d24_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i41a411e531884341ba547408f3ea5589_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia5cba459b4604d78a2eb2e37cd615400_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i121f0f315b1344b1bbc371d09d847028_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if23774cb38994a048379d7991560faf3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3ae83d03fd39427cb3c287eed7f29f40_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie6306d4449874dffb35d51a933fb469c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7c9dc415da6a41559015929ff4b2fe33_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3f792c2e37a74691a4b596f3e72d75f7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7d314318c51d4cd28e75d7001c766243_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ide94636b0fb9453b865109199e79c164_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i88fccac5bb1b44b584ed539c4961816c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibecb66199abc42ad9586b7704e21a96d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6a19efd071324236943f9b6a79698499_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if66c2ddf63414c1da2708bd02f444e26_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i30c290a93ce1414cba872464493792e7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iab5b5b3eca5a4bf6b7a3fc275f47e800_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1f764a709228490cb729d3069830bef8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iafcc828129bf453b96defa43e5ade811_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i00a206daed414aaca2b5ea0669036b4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib42f8d6ac6434217ad0fcc5291152cd1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i833468c7bf03479e8d799e7e25575955_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if29d6014ae774728b9c351ed9adb5183_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibb627f6367e04f72b873f7093f6faf99_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i786e2d92971d47f986b8c786305a835e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i57b03a8caa5b4300851ef8b7fea7189c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic4667f06c84c4e3d81ccdc395f8a42e3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i377bc58a38a9497aac85eb38d8f77344_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i620f145ddb8d41cc99f91a9eefdec0be_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6e7e69fb982e40929bf32259d04c7e4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d92f4fbdf7240a987fb28ecbaee2567_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib36d56bded844dce9f6c54b7a75f2476_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife5940f31f184d2583926339d46b6fb2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i53b18d7498184e29a11bdf5c0452dfd7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ee5dc7e67f14911aa2893ad8777ecef_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c64261ddacf4d27b95761bdf567761c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iac447b2aea184eabafe621a6a696092e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0760f12dccde4f049c0d2d5521e2308f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i04fb13c03f7545ee881c787c4d295cb3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i16bc3dfbe6534e50827c954ef689f936_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic2c11a8ffa114cfcb627155e46eb9da2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaaa96276ff5744b79e5a0e0affc668d8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id634989c491e4b0e83256f5dfd53b780_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6d8859fa6c2b478ebc39980d73bafcbb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie182e216caea49158bf722fa85814ad2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic0fa0dc5d78d499fb86b70327b3a973d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a29d887f67747a3b9f15f234fdcaa11_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i245341e9dc7f42f09fe5c3b260ae0b00_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ba82d969c984e76baeb0c4efd07d7a9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8e6bb5e19053475593dc55eb7a511cab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e86669f8888451993e27f92cec0f586_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic40d1ed6e151472bbc67c2993924ab34_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id4a1e02638b14ced8f45c79321610b71_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2a5dd69022804169bff3d491d0b5bc66_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6141b14c69f141b18709f232e7245e2f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id59ae704af7f443397b0d5d71bd61538_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i354824d64a0547219c5143a42c38faa5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icb8f774b5ae64c91aa84544f0b95bd1c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1105952851aa4f00a91d7d07748e2299_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i562d61545be0472f8e43f9bf2d78869a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i110fc233fca2409280cedc632a84cd9b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0628f1291202410694bad853976cd58f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i88b651390f6e4112bf4d018573ef376e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i232e253c036243df8733675ba5284e0c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2844029f1c864491a3839ffdb5436a62_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:CheplapharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48e1e9ad646d44d5b8ca8791b5c49163_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if4ce232de8d94ca89a2d4818aca93f9b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id5e59050a88c4c7b8c32aaa347079239_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5c64b0fb4f194220a4e3ad3bf15dffa9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i41718b51a26b430a814b359ab230049d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i86d0e6be826d471580d3022cfd601f5c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a5bbf0f5b504271a5ed86f80698f1aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:ImmaticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied7b4f093fb64e948e41d2fae883ac49_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:DragonflyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i54f344a3a508440a9c3136fc21f9a315_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e86a84eeff547878681f2285bc056c0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib2128162b71942e4b776ba571db5378e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f783f786f9448a0b27d839e744d1bc9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i12d6db6adf774cdabcbacab2830666d9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i516e76f80cdd42359e04bf1ea96e1dac_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i23137846d9234c9fb78c793ddf4c010d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i139b81c5b6a346bf9ef0abd2a73d799c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie701346b5a5142f0878b322864036d13_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd467c02ad904fbcb8a3366dc0661626_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2aa2fd0728f24dffbe302d8dc80f1127_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieec5dffc23244b5680735c1a0cc27bf5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i089a12daf0d440d892db99bd3cdae571_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8081637c0eb14bdbb47de184d2f39db5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8f9bd83ec7e541a99e93bba471901a6f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2d88b3f3d9e0482a8367f95ffe5a0705_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie820e29dd7454feeadcfda2589792e32_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iac15ff867ba945e08768717f71115a24_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if3737ead734c472998387ed737334fc1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i094847c77fb343f2ae6b1fc831c2c140_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id81a792f755b44c7bf4c6b878d13f35a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65dc0d7fa7d446be88f8eb295d016860_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e64717c46e2400a97f81398c8d0374c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i28a1e87b23874c8eacd18f1ad4aa9add_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9d63750fda014807bbcd56fb175d10a9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib5de987abfdb443b93461d539e729e92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07a6c1fe57b34a058a7de4f31cf06e2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5440b5726884812b270641d64a0dd80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8730c16fa2124420ad23b93d7bff6eae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id84841d50f3446ed84387ba6ada423f6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i55f98b5adf714f79bd06b87cb1ca1c47_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07436549e87f4e09ba843a7f11c2ef4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i657d695839694e69b3011d5fdff9bfcf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ee548ed4d014862a23a2e41e04dcfb8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9417f816d8346449f70d564c31c8232_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18ef79d98b8b458b8d5ae10afecfa045_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id1eb561378dd46158ad6987dfa95b2e9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia562dbc127b64bca93c9e0e3a0c509f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07c4d4e0667e4d429b61aaf7baf0828b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bd8959f86cb435ba9b5ced3da83baa2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id45f66ca4c144aad9c93d9577eb6610f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia5eeb90de7b546b38702bb042382ad6c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2af25476ca044b10b93598d008520e3a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ided76e89faa14fb89fea1a513818349d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76259749605b40899b4e06aab3db1dd9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55d8abd26bae40a881d0203c7f5d26f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if46527a7d9d040a89955d6678f7dd798_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0b15840afac84e27867bc9638f1a02ca_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i827262d1464b41e18c2ea4b9f616c5b6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4a1b1b455dec4c84be7953f38d2d9bb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d0dd974b62542bd9f7d4c17c8f19a91_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c8000b84b6b4ec1847d7fc23d26aef2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia9b034eee41f46d6adaf1974b8f3b173_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43abbff1f262401fb3df50f9b876709d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id0b4add97b0248e29be39ea97307e4ac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie65d93959a1c4c44be1dedff4f283412_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7ec862f58d95421887612d3ca08ef64f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba04377d339644409c75c7a51794a485_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5a219ea76db64e0e8730984c387c5cce_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf91d20822624a328fbe024d1ac258de_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9bdb869eecbb469c9bf0310b8e728219_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifa8aa0d818c149aa92bb61f130372893_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8c471c3a99b34ecda06e75a57da1ce44_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i1e0b11c565d843cd800a00cce43f9006_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A60BillionUnsecuredSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if3ea42357cdc414391b58ca0ccf786db_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i163f0d0fccd34d7385555f74e0a794a7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9206328440464f8e839a11661b43c8a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i55598a609c114f67a4cd37885de32e1d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic177dd5bb64d454c86bc6072ebd749cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i113230baa650402d97981ca827bc4de6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if54b70af5b76417a806e38ea5e1d407d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia276049873e54e59b3bf07c8d5e24ab4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iba35d244942447b99ebc571324ef1dee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i15954e5f8f0e40debb23d733b33aaa1e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2d9389451e47486e902034a32c3e09c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a9ada9042874bf182eaadf231a4c890_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib92f31c4fa40457aba15667be923fd82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id16452daa2024ee899435e33c8107110_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3096f2c934e04de28c49313517b1c847_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i91abf09684ca431e82f000c3018b6f09_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9f017519dcc04d71a28d222bc83fa92b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90219dc5ee1b4ec399ce30e3c157467c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice8a3ac0991c4c81bd0f404665c335f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic465ba0286fb496c8fae21240e7d3f20_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie4813222bf3b4237ba720be703e50ec0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i61598df0bf2f4820b2d1aa70b7ebdec2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i97cdafa0cdbb43d1a935dd3533f1c50f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58a89f11019b4792a01527b1d0647136_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icaeaf5cae69a45de99a6f4a1e9213d18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4cb747a19155484fb0a6e5942ee35dae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i936bc96f5135495e83a811e835de4a2b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i32cf6ce35e3d4d049918c1ce536767fe_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7c8517489c824a32aa5646d0832375df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03fa5bfd2bd145b2ad628c77bd80cb19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80cf390abecb4fe5b76b4c01abe05068_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b589631ea674d988596b27dfe9491d0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5b1608a17e14eb7b4319cb2fed7bd5f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i89e5eb4f2fc54341a81746b993921e88_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if9c22056c58444adbcb1e2bc577ceb6e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8a2104a59240458e98947f2acda759e4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i78573b9f974642299bc3a4a346f6d3cf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i64626f3fe0164c9c82c44f1051505316_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9cdfda20ae8a4ab98ea04f90f98a6432_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia0511d5a39094272ac5c6248e8167fa4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83d83401572a4528805417b147f0bbc5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5fcdfacdd7c24cc7abd9cc7e5da883d5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i261481db1532401aba4104d90a4ea56e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie37f56aa23264798a7f027c4249e913d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c3c98aa282840c49d1057bd807271bc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i89c5148aeb1d4af989c7f56cfcd9e51d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if068c2cd34c84c29aba8109de255a3f1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i770251dbb1814ce4a3a299dd66902cb9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if5f476f6d59c4d2f8abff0b07711d3ee_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic877b4ebba4a4d2f83ee4834c3bc717a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6eb52be0aee44612b177866eb6f7332c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifc01c81d46124cf59f361dbae533ad7c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib4a9c40fe3e64397a7a9af57cdbd9f2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00f392936d8e4b9f8959e00956d66d32_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01d1accdb09342a1a2cc72896080888b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iccb557e1b6ae4ed18e4f9c9ea9685c16_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2052Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i42a8df9288214a7ba80d4c2e2cea5cd0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:SeniorUnsecuredNotesDue2062Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0487706aaf654d899b5f17f8e3b4d1b1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.875SeniorNotesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i39644068dc2e42e5bcca7dba89dc84f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb0c682ec8e94e719bfd0b0e8c33a3d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d28a8538925455ea6ce8a6e6c60af90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b5f5c10b37c44cab92705107745235c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i22388c8b54454a828847139982eb6182_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i41cc28991d204c169ba5bb001d925552_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5792b37bfd964932bfdc0eec0a2d49b4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id15c48a3d81c47aeae083ac08257cad4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8b430687b90f47298aca5585a93c5694_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib591208aeba1490ababd9ab1c130dc54_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i662965b18d274bd4906976d530ef4ae5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf698719af47427688c9bbce6908e931_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:FairValueAdjustmentToInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id36e61c39dfd400c8b4956a1177b4898_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:FairValueAdjustmentToInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i933b74eb6ef2454e82c1e129ff3a4cf9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d1a44cdc0ce421ab0a6afc5c7148f8d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c8fe212155e47398c07ac122c4d25db_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i813eb01fc49e456daa2b0d45dbf8903a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c163fb38d5e483a957be472e84d0b08_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib51a898c07794b4a919b257dcc42208c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i483be3c323184f15b35cc7d81776ecc4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8493c14f9b494a61ba4d49df885de3a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b3beca4fb5a42a08d14874a43fb86a0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia288c0fb88974230b4554c68b96e40c0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i357734b23ccc4244aea0717e29ca8fad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if0e3744106ea411ba17e209a5e2dc279_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c61398032f94cb8bd85669f01cdd4b5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9dd431d277f4046b343051457c073a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i890c7a1dec204f3a915c8bfcce2acedf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib947345d6e024c65bb07480f1c5e4624_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i697dadbed2b44257b50760bc65e2719b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c750c097be14ed1b3f961e0ba4d7de3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92f35f33ac5447c685cb91ab35c69fc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9b2566864734436ac9a373ddafbcbb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i608fa9b9ad254f68bd39d1a463a30350_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0c3e82138344640a0c4435cba106ff5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78f12ffadf16415ea1fe727617391027_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibe2dda1e1a844b94a00d230f1dc9a71b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0aa70f8ef374fb39ffdf7368e669776_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i67fdaace616b4f16855ab0159be80320_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5f0491e5151b468687df3f28023d25c1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib0b25fb727064bc7a48b809cd18417d0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i25d5887cf1864cefa96ae37a8e8e1c96_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf2feca3e743478f9a47b2a58c1a227c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied7d3446ea3641d08fb57b9e5e60c00f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07ee78978c0642dabebb87cbae54be3f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f9303f5188c4013be07916ae2eca837_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if1f0dedce40941d2abd5021b6192fa7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iddd70bdc8a914f2e8317196accc17156_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic452639b46024f62a782fd7dd48397d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd355c9ad4e04db9835b36253ee62303_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i55c155c4e22f470f85c6fe894ca67745_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1aadaa427a1f4883932758e3886fc82d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4b408d47b276475ab6ccab44f5ca4af1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i72c2ec55ae104cb1a3d45c1093330949_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1685419f0f5b445ebf4b83320b185816_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie4e8bafee98c40e1af0ea0c26079e6d5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iddc410e277f944d999382cf1f25d8280_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i28f83b09252a4c5186eac51e8b3c4f10_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i486782a204b048d79c8c4b6688f16ddb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifaf77c8298f84b9ca929be543d0bdf11_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i22e06670aa924cd2a542b65a45076e7f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i893daceb21d24a07803ca9c59fb74f4f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1153bc1078943e684090d6448e72a28_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icdcc9669f9ef4756ab04f684b3f2016f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idd031bc2a3194da4930ebfbe59a6c5fa_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i08b1a43d479945f78f6ba2f8ef93edae_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1a4494aa926f4aafb4d4f13e1bc379c0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i07493150d868420687804e8b350888ae_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5d74d60f32f84b198678df8d911c9b3c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i590050289ff34ed9b5d3577bac6f2c84_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ief8394f86b214f7d9f855003ba6e8de0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib2c7bf5611944b89b000936b86b2afff_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0ccde1b9c7584766b2b7209f2916527d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d9865ddc7954c648849d381362ca98e_D20150901-20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-09-01</startDate>
            <endDate>2015-09-30</endDate>
        </period>
    </context>
    <context id="ib14a424b066040b5bef8059066e64306_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6d6fa7d30f14437eaa258bc9961b99aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9446604f2db5490f98213dcf99cf2ac0_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i43df7495f1924291aea1c8aaa040cf1e_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i733d93df91dc48439bdd9ef3a9e1b05a_D20100301-20100331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-03-01</startDate>
            <endDate>2010-03-31</endDate>
        </period>
    </context>
    <context id="i3006be3445994b7b9d2b9407bafa2026_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id7c0db74c54043a48910aadd9e2028f4_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i2b238679663048e29218b5914560ecea_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">bmy:BristolMyersSquibbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i668ad442deb24bfd83ce136a88b8f854_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iec03ab8dc1e74dc78cce7f33bcf80a19_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id19c69223ac34dbf8350b9e50ffbf637_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iee6991d7144c4ff5982b421baf4a28cc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibe66d937c77841249eedd821c141f3ec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i04d29be57add402ab3461c9dc80fe525_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="employee">
        <measure>bmy:employee</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="creditfacility">
        <measure>bmy:creditFacility</measure>
    </unit>
    <unit id="customers">
        <measure>bmy:customers</measure>
    </unit>
    <unit id="patents">
        <measure>bmy:patents</measure>
    </unit>
    <unit id="aud">
        <measure>iso4217:AUD</measure>
    </unit>
    <unit id="lawsuits">
        <measure>bmy:lawsuits</measure>
    </unit>
    <unit id="numberofplaintiffs">
        <measure>bmy:numberOfPlaintiffs</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF80LTEtMS0xLTI3Mjk1_04310f9f-bc51-4096-bf87-fdc40ac632cb">0000014272</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF82LTEtMS0xLTI3Mjk1_852979c7-816d-4ff5-a279-cfed5ba3d983">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF83LTEtMS0xLTI3Mjk1_0689c6eb-202d-47e1-bc23-0d69496f0437">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF84LTEtMS0xLTI3Mjk1_c0d4078c-b886-4ab7-b83c-71252e9627c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF85LTEtMS0xLTI3Mjk1_933dc8ec-838d-433d-9251-ae18e09bb312">false</dei:AmendmentFlag>
    <dei:EntitySmallBusiness
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80L2ZyYWc6NDE4MDA1YTIxZjRhNDhiMjhlOWM3YjAyYzExZWY2ZWIvdGFibGU6NTdiN2VmZTg2NDdlNDRjOGEzYThmM2UyMjJkYzhlMjAvdGFibGVyYW5nZTo1N2I3ZWZlODY0N2U0NGM4YTNhOGYzZTIyMmRjOGUyMF8xMC0xLTEtMS0yNzI5NQ_3e65bb46-dae1-4cab-8304-67180c2e8aff">false</dei:EntitySmallBusiness>
    <dei:DocumentType
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDcx_9a35cca5-dc3d-45f5-b2b2-3e5c1f6f8511">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYx_57dfe16e-6ef8-487f-9037-f81dde695605">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNjc_acd9f2b3-49f8-4846-95ee-3840a4647e0f">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY5_101e0d79-337a-4154-84a1-39e71f1ece7d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDcw_ea72f647-7ba3-4c58-b88f-2d65a9cbddc3">001-01136</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV82NTk3MDY5NzY5MTMw_c6a3388d-8ec9-47af-b3c5-1d24e2b60d31">BRISTOL-MYERS SQUIBB COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6YWM4MzQxMmQwNGE3NDM2NmEyOGM1YzBjZWQ0YTZlY2EvdGFibGVyYW5nZTphYzgzNDEyZDA0YTc0MzY2YTI4YzVjMGNlZDRhNmVjYV8wLTAtMS0xLTI3Mjk1_071be5ba-56e1-42ab-9996-47e3d07655ee">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6YWM4MzQxMmQwNGE3NDM2NmEyOGM1YzBjZWQ0YTZlY2EvdGFibGVyYW5nZTphYzgzNDEyZDA0YTc0MzY2YTI4YzVjMGNlZDRhNmVjYV8wLTItMS0xLTI3Mjk1_256ac4ae-7df8-47ed-b7c8-1bb37690795c">22-0790350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDU3_3a1b8432-61c6-4456-98ba-28845cd0d609">430 E. 29th Street, 14FL</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDU4_651b2dba-c856-494b-b062-d0beb387b212">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDU5_a57d77f1-b97c-44c1-a9a7-40e8a459e010">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY4_dc6f9be0-9d90-4ee0-9c31-a7fdbe73f978">10016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY0_275119db-8dd0-4ec3-ab00-57e89314b939">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY1_7448830e-b06d-414b-933b-52ade05b5965">546-4200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8xLTAtMS0xLTI3Mjk1_02f96c3f-3af0-4261-afe1-f0d99116caf7">Common Stock, $0.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8xLTEtMS0xLTI3Mjk1_1d3258c4-e391-441e-b074-c13073770dd1">BMY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id48ed4cda8da4e0db87a64946801b050_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8xLTItMS0xLTI3Mjk1_fdbd53fe-4e3a-4b71-9e64-2f9be50e1f29">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8yLTAtMS0xLTI3Mjk1_9459a5ad-92b6-489b-9863-7f3a64ae83f5">1.000% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8yLTEtMS0xLTI3Mjk1_b53c965c-e68b-438f-8878-b192212b0ff1">BMY25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia6bdc804881c4f68bb429cae22fdee25_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8yLTItMS0xLTI3Mjk1_b8581523-7b91-4afe-a393-21620979a312">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8zLTAtMS0xLTI3Mjk1_4a8c461f-54fe-43fc-b9f0-b16e0266b17d">1.750% Notes due 2035</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8zLTEtMS0xLTI3Mjk1_c3e86530-0c30-4ad7-b7a4-1cfc1e5c1c8f">BMY35</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6b09355ffc1c4592b33e127a53e2ec2b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV8zLTItMS0xLTI3Mjk1_480472b3-8ef6-4270-812a-460e4ae419df">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV80LTAtMS0xLTI3Mjk1_4a57dd52-b626-4061-810d-59545c5985f1">Celgene Contingent Value Rights</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV80LTEtMS0xLTI3Mjk1_25200b4f-ffb3-4215-9070-63ad06f3d3c2">CELG RT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3d55bd4020ad42f684b112c9de02630a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGFibGU6ZWIzYzYxMWUxMzY2NGYxYjk2MGI2ZGI0ZjRjMmNiNmUvdGFibGVyYW5nZTplYjNjNjExZTEzNjY0ZjFiOTYwYjZkYjRmNGMyY2I2ZV80LTItMS0xLTI3Mjk1_c5acfb11-32f7-47e7-83e1-3b1383aa8315">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY2_804949e5-7e09-4861-97c2-04d763cc2393">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDY3_1cd8bcaf-c0b4-4e8b-975e-e7cbf902f179">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYz_000bd87d-7d10-4edc-a69b-85dc6940c3de">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYy_c2e2c99b-54d8-4592-998d-41782ad0d5cb">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yNDYw_5a53cb5f-cdaf-40a0-8179-acb9773f3896">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xL2ZyYWc6ZDdmN2UwNzY5YWFiNDQ0ZDgzODVmMTAwYjliYTg2Y2UvdGV4dHJlZ2lvbjpkN2Y3ZTA3NjlhYWI0NDRkODM4NWYxMDBiOWJhODZjZV8yMzg1_ddbd03f2-147e-42c4-a22e-d6b4938cb067"
      unitRef="shares">2129064271</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMi0xLTEtMS0yNzI5NQ_9765f97b-26cb-402f-8a53-0fa82ddd081d"
      unitRef="usd">11308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMi0zLTEtMS0yNzI5NQ_ea5b2d62-f0ad-4f8e-95b6-4a1ee1eb35be"
      unitRef="usd">10798000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf793dd12ca7489fb055121b1a3bdaf0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMy0xLTEtMS0yNzI5NQ_39e8fe88-cdc5-47a7-9d8b-a9c38be4519a"
      unitRef="usd">340000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a3d0b17544a425bb39a530b30667d24_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMy0zLTEtMS0yNzI5NQ_6bd8634f-113c-45dc-b747-5838ecd1854c"
      unitRef="usd">275000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNC0xLTEtMS0yNzI5NQ_8908325a-dcf8-49e1-9618-791dd8a9c14e"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNC0zLTEtMS0yNzI5NQ_2b7a538e-1cb3-4044-a674-886fc81bed8d"
      unitRef="usd">11073000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0xLTEtMS0yNzI5NQ_48524f70-69e2-4b2e-8874-e1282761b818"
      unitRef="usd">2471000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0zLTEtMS0yNzI5NQ_a476dbbc-df36-4cbd-ae30-6dcbd01382d8"
      unitRef="usd">2841000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNy0xLTEtMS0yNzI5NQ_39bcf7c3-928f-4c82-86d2-a1ddc58c8ead"
      unitRef="usd">1831000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNy0zLTEtMS0yNzI5NQ_4fccf79d-fd2c-4cf2-bb75-4a2242690ded"
      unitRef="usd">1666000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOC0xLTEtMS0yNzI5NQ_dbcb0680-6a49-4a69-8c00-ff29dd04a7b8"
      unitRef="usd">2260000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOC0zLTEtMS0yNzI5NQ_7448520d-9d14-4fa5-8a95-7334ac043b0f"
      unitRef="usd">2219000000</us-gaap:ResearchAndDevelopmentExpense>
    <bmy:AcquiredIPRD
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0xLTEtMS03OTc4Nw_c8fb527e-2f8c-442e-b58a-e9e7053e8277"
      unitRef="usd">333000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0zLTEtMS03OTc5MA_a6397cd8-dfd7-49c2-8321-8741c454f7b6"
      unitRef="usd">6000000</bmy:AcquiredIPRD>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0xLTEtMS0yNzI5NQ_87132521-bf49-41e5-b9b9-b93c7d22002d"
      unitRef="usd">2417000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfOS0zLTEtMS0yNzI5NQ_635aaab8-ac77-440d-8873-1a1b60d9b48e"
      unitRef="usd">2513000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTAtMS0xLTEtMjcyOTU_7117b6ad-8571-4366-970c-6b0a14084c0f"
      unitRef="usd">-649000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTAtMy0xLTEtMjcyOTU_82f6aa97-8cbc-4c55-92d4-b31d8a95bf6c"
      unitRef="usd">702000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTEtMS0xLTEtMjcyOTU_e31f1c29-cf30-499f-a46f-44560cab8dff"
      unitRef="usd">9961000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTEtMy0xLTEtMjcyOTU_3eb5df90-13fa-47a2-8711-659b59c4d2fc"
      unitRef="usd">8543000000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTMtMS0xLTEtMjcyOTU_fcb10733-789a-414b-9208-7e84f8fd0c2f"
      unitRef="usd">1687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTMtMy0xLTEtMjcyOTU_3d15704a-b018-4c35-8ce6-4a06469d94e6"
      unitRef="usd">2530000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTQtMS0xLTEtMjcyOTU_c65c390b-50df-4ca5-9bee-13c9b53fa6bf"
      unitRef="usd">404000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTQtMy0xLTEtMjcyOTU_ba9e4dc0-1994-4f35-8d2c-01da05240612"
      unitRef="usd">501000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTUtMS0xLTEtMjcyOTU_84f42743-e424-4e5d-ad5a-fca15d057949"
      unitRef="usd">1283000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTUtMy0xLTEtMjcyOTU_6359c842-7753-4b55-8196-5c33438b15f3"
      unitRef="usd">2029000000</us-gaap:ProfitLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTYtMS0xLTEtMjcyOTU_fe2007a9-d60a-4e8e-b77e-9df2e6636cd1"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTYtMy0xLTEtMjcyOTU_0c78584a-9a3e-4454-971b-472c4003abec"
      unitRef="usd">8000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTctMS0xLTEtMjcyOTU_733f7b53-d6f5-401f-a13c-351b48b5e33c"
      unitRef="usd">1278000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMTctMy0xLTEtMjcyOTU_1e7b70f3-d339-4d75-8842-e7dc2118129d"
      unitRef="usd">2021000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjAtMS0xLTEtMjcyOTU_c3cb1530-a5cb-4292-a87e-f41613687c32"
      unitRef="usdPerShare">0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjAtMy0xLTEtMjcyOTU_9d470f8d-9915-4d81-9818-fcb2a62d8372"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjEtMS0xLTEtMjcyOTU_8563ad67-9da6-4c9f-94e1-0303dbac7be1"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfMjEtMy0xLTEtMjcyOTU_c2a9f8cd-a749-47c2-ad7f-02b093f649f9"
      unitRef="usdPerShare">0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMi0xLTEtMS0yNzI5NQ_9a97e0ab-6a05-4fde-a92e-27e62249d0fc"
      unitRef="usd">1283000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMi0zLTEtMS0yNzI5NQ_b706532e-d47e-49d7-907d-0ea0d05042e0"
      unitRef="usd">2029000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNC0xLTEtMS0yNzI5NQ_2f205a96-a140-4862-ab99-a3895a783331"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNC0zLTEtMS0yNzI5NQ_396b5742-9029-446a-b034-3eda7810321f"
      unitRef="usd">280000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNS0xLTEtMS0yNzI5NQ_db77b169-9702-4fe1-bd3b-45af9f3ff797"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNS0zLTEtMS0yNzI5NQ_91d4f2c8-d0d8-48f4-b58a-8e9cc97a4da3"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNi0xLTEtMS0yNzI5NQ_5c4729e2-e6ac-48ab-9230-680529ad9feb"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNi0zLTEtMS0yNzI5NQ_41ab3375-1564-427c-8c9c-97e742a23a63"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNy0xLTEtMS0yNzI5NQ_01816ae8-b3ac-47e3-b8e5-3863d8b4d6e0"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfNy0zLTEtMS0yNzI5NQ_c066fca6-4cd4-4ccd-8d07-93e2c8328321"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfOC0xLTEtMS0yNzI5NQ_f90cbf7b-4a7e-41ec-8f28-0044e5805b62"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfOC0zLTEtMS0yNzI5NQ_0940a9bb-c9d6-4eb8-b83e-d8ecf0402d80"
      unitRef="usd">295000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTAtMS0xLTEtMjcyOTU_03e637c4-c982-4d1c-b79f-85e0f3f6ae55"
      unitRef="usd">1322000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTAtMy0xLTEtMjcyOTU_ac3f3ea7-27c4-444a-8ba4-a758da384900"
      unitRef="usd">2324000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTEtMS0xLTEtMjcyOTU_fe2007a9-d60a-4e8e-b77e-9df2e6636cd1"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTEtMy0xLTEtMjcyOTU_0c78584a-9a3e-4454-971b-472c4003abec"
      unitRef="usd">8000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTItMS0xLTEtMjcyOTU_5614a848-a80d-40c1-b5b4-e89495ac495b"
      unitRef="usd">1317000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjI0NTAyODQ2MGJkNjQ0OGFhYmNlN2UyYzk4YTBiODk4L3RhYmxlcmFuZ2U6MjQ1MDI4NDYwYmQ2NDQ4YWFiY2U3ZTJjOThhMGI4OThfMTItMy0xLTEtMjcyOTU_f76507aa-ede4-4398-a562-1b044813f26c"
      unitRef="usd">2316000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMi0xLTEtMS0yNzI5NQ_8195b31c-ed2d-47ae-a399-8e2c75efa1cd"
      unitRef="usd">12369000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMi0zLTEtMS0yNzI5NQ_5859b0d1-b9e3-4602-ade1-86886dff4a71"
      unitRef="usd">13979000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMy0xLTEtMS0yNzI5NQ_2e562d7c-8163-4c0a-aa28-8c14740406b7"
      unitRef="usd">2599000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMy0zLTEtMS0yNzI5NQ_976ba272-5ffe-42ed-9a15-aed451c70bc1"
      unitRef="usd">2987000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNC0xLTEtMS0yNzI5NQ_3ba88a3a-dbf2-4c23-8dfa-78ec503b7a05"
      unitRef="usd">8511000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNC0zLTEtMS0yNzI5NQ_926860bc-cef8-42be-aa90-2a27220a7d31"
      unitRef="usd">9369000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNS0xLTEtMS0yNzI5NQ_8c2db212-8b0d-4802-8cdf-4c31fe2d55f4"
      unitRef="usd">2104000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNS0zLTEtMS0yNzI5NQ_66798a62-0ec3-4fa7-b358-8cc127d86bf3"
      unitRef="usd">2095000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNi0xLTEtMS0yNzI5NQ_b8c9bcc9-7977-431d-9ea6-befbd518c1fb"
      unitRef="usd">4538000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNi0zLTEtMS0yNzI5NQ_531b9aa4-a6bf-4f29-b713-d963eaba9e1b"
      unitRef="usd">4832000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNy0xLTEtMS0yNzI5NQ_6f0cfa12-b91c-43b7-92dc-84f8e4b03389"
      unitRef="usd">30121000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNy0zLTEtMS0yNzI5NQ_a356bf38-5405-40a7-a556-4cb3c74b8cb3"
      unitRef="usd">33262000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOC0xLTEtMS0yNzI5NQ_74c28541-2474-4bcc-9a47-708723b7247e"
      unitRef="usd">6047000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOC0zLTEtMS0yNzI5NQ_48708cce-8f38-43a8-9ae0-08f93ced0332"
      unitRef="usd">6049000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOS0xLTEtMS0yNzI5NQ_62922bdf-0cf2-4a57-bb59-0b77dad89f5f"
      unitRef="usd">20500000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfOS0zLTEtMS0yNzI5NQ_f6c60c3a-0bd8-400d-8dc7-73a9c81f96e8"
      unitRef="usd">20502000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTAtMS0xLTEtMjcyOTU_f57f151a-a190-4217-aafd-363cc48cfb71"
      unitRef="usd">40103000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTAtMy0xLTEtMjcyOTU_49244b6d-2b72-4afb-95f2-d7bf3b422c41"
      unitRef="usd">42527000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTEtMS0xLTEtMjcyOTU_daa28a40-cd24-456c-915b-485221e88d35"
      unitRef="usd">1418000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTEtMy0xLTEtMjcyOTU_920e4fcd-d6ed-4aed-8980-2ceeeb7bd637"
      unitRef="usd">1439000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTMtMS0xLTEtMjcyOTU_8d753150-7a39-4610-aef0-e02b8ec33578"
      unitRef="usd">4845000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTMtMy0xLTEtMjcyOTU_42727595-edad-4757-b7d5-a36d587dea73"
      unitRef="usd">5535000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTQtMS0xLTEtMjcyOTU_d9ea922c-036f-4d8a-bd30-9693aa444136"
      unitRef="usd">103034000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTQtMy0xLTEtMjcyOTU_e1e1b634-4bc7-40a2-8528-1e1598bc7eba"
      unitRef="usd">109314000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTgtMS0xLTEtMjcyOTU_ffffef63-5fe6-4124-b0cf-78de5fc2431c"
      unitRef="usd">7522000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTgtMy0xLTEtMjcyOTU_1fd821bb-b778-47c2-bb3a-04492ef18238"
      unitRef="usd">4948000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTktMS0xLTEtMjcyOTU_10402693-28b2-417a-a1cf-11de38b034a1"
      unitRef="usd">2944000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMTktMy0xLTEtMjcyOTU_dfb22faa-649a-443b-b331-08dbaccafbd8"
      unitRef="usd">2949000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjAtMS0xLTEtMjcyOTU_edee1dce-38dd-4765-a346-bd54f654006c"
      unitRef="usd">12355000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjAtMy0xLTEtMjcyOTU_c2e4322b-ea69-4bb4-b45a-d78ed727439d"
      unitRef="usd">13971000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjEtMS0xLTEtMjcyOTU_1562dfe0-2c79-4523-9229-23c5ab6788ed"
      unitRef="usd">22821000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjEtMy0xLTEtMjcyOTU_44402aa9-505e-44bf-9e53-82c8d4e351cf"
      unitRef="usd">21868000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjItMS0xLTEtMjcyOTU_cb3ca565-84ce-47b8-9f9c-6bbf1b2ea416"
      unitRef="usd">3809000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjItMy0xLTEtMjcyOTU_0942e914-7ea0-4088-9175-0e27364de71e"
      unitRef="usd">4501000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjMtMS0xLTEtMjcyOTU_30ec543e-898c-4b31-a20c-abf7eeb1deb0"
      unitRef="usd">37450000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjMtMy0xLTEtMjcyOTU_9ad9237f-2912-42f7-b4a0-d3910d5f12d3"
      unitRef="usd">39605000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjQtMS0xLTEtMjcyOTU_bfdee2bb-c28f-4305-9364-e4ac865e06f0"
      unitRef="usd">7309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjQtMy0xLTEtMjcyOTU_bdf6740e-1173-42e2-af47-b62447d0060d"
      unitRef="usd">7334000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjUtMS0xLTEtMjcyOTU_187b6860-c88c-4a43-8971-156399a33644"
      unitRef="usd">71389000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMjUtMy0xLTEtMjcyOTU_b59a83ee-a8d8-47d5-81cb-a6d441ef4b04"
      unitRef="usd">73308000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzEtMS0xLTEtMjcyOTU_75cbf5bd-5382-45fe-95f8-96a753c30b08"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzEtMy0xLTEtMjcyOTU_dab07ce2-be04-43a9-9887-44a397778459"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzItMS0xLTEtMjcyOTU_6d297f2a-9557-40dd-bbe5-fdf0548deccc"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzItMy0xLTEtMjcyOTU_2bc43262-0c71-46fd-9947-4f2457175759"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzMtMS0xLTEtMjcyOTU_9011d54f-2588-4b15-af5d-e85ec7ab44cc"
      unitRef="usd">43756000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzMtMy0xLTEtMjcyOTU_f3c4dfd2-5640-40ac-8504-e3c6f3980442"
      unitRef="usd">44361000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzQtMS0xLTEtMjcyOTU_d9a2c7f9-51eb-4206-9e31-5512982b7add"
      unitRef="usd">-1229000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzQtMy0xLTEtMjcyOTU_0bbc230f-8480-4b60-8566-fb31cd8f99aa"
      unitRef="usd">-1268000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzUtMS0xLTEtMjcyOTU_46a941a8-2330-42d1-8766-ef92968bbb3a"
      unitRef="usd">23948000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzUtMy0xLTEtMjcyOTU_8f56fead-9393-4bff-8773-36f68f816a15"
      unitRef="usd">23820000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzYtMS0xLTEtMjcyOTU_8320bdc9-edf6-406c-bac0-2993d35c1107"
      unitRef="usd">35187000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzYtMy0xLTEtMjcyOTU_284635fd-4858-41c0-905c-7477c4bdb414"
      unitRef="usd">31259000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzctMS0xLTEtMjcyOTU_66552e71-3f78-4197-8880-85c134a4953d"
      unitRef="usd">31580000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzctMy0xLTEtMjcyOTU_d3a13f4b-4e42-43b0-a0a1-6dacd06194a0"
      unitRef="usd">35946000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzgtMS0xLTEtMjcyOTU_5497fb79-5fa4-49f8-8396-eeb8acc36abe"
      unitRef="usd">65000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzgtMy0xLTEtMjcyOTU_f44e8bd9-7df4-40ed-b0aa-75e3592e80c9"
      unitRef="usd">60000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzktMS0xLTEtMjcyOTU_6c8b7b0d-4bf5-4928-b79e-f1acc4a1618f"
      unitRef="usd">31645000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfMzktMy0xLTEtMjcyOTU_6918b3a6-0a29-4583-b7e0-29dcc47efdc3"
      unitRef="usd">36006000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNDAtMS0xLTEtMjcyOTU_208b32fc-05b4-4fd7-bda4-4c538bc38124"
      unitRef="usd">103034000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xOS9mcmFnOjFkMTk0ZDg1YjUzYjRiMjQ5ZTU4NTdkNjY5NDRkM2IyL3RhYmxlOmZmOThmNTZkMmQxZTQ2M2ZhZWY0ZWM5ZGE2NTBkZDI0L3RhYmxlcmFuZ2U6ZmY5OGY1NmQyZDFlNDYzZmFlZjRlYzlkYTY1MGRkMjRfNDAtMy0xLTEtMjcyOTU_a9038573-9463-468f-9418-8b769c4b6b20"
      unitRef="usd">109314000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMy0xLTEtMS0yNzI5NQ_0e317584-d80d-4721-8c34-67fecaa62747"
      unitRef="usd">1283000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMy0zLTEtMS0yNzI5NQ_81d18da2-42ab-4912-bc0d-a7d89d7c4dcb"
      unitRef="usd">2029000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNS0xLTEtMS0yNzI5NQ_3f295764-3372-4ba3-aba3-ad5063d62d6f"
      unitRef="usd">2584000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNS0zLTEtMS0yNzI5NQ_72d2ba11-02e3-4dea-b16a-271c3fe7ed34"
      unitRef="usd">2668000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNi0xLTEtMS0yNzI5NQ_a540e068-dc11-4eec-a16c-590604eb2060"
      unitRef="usd">-687000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNi0zLTEtMS0yNzI5NQ_28d9f514-cdb3-4508-8a3b-638c586b18b8"
      unitRef="usd">68000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNy0xLTEtMS0yNzI5NQ_ef2e8e3d-2368-4709-a5fd-85bc63385f54"
      unitRef="usd">107000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNy0zLTEtMS0yNzI5NQ_4c16e9c3-870d-4798-aee9-9d419c44a142"
      unitRef="usd">151000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOC0xLTEtMS0yNzI5NQ_3758d8fd-6ea4-461e-b5ac-a32afde63d61"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOC0zLTEtMS0yNzI5NQ_9586d440-e492-4a33-b546-07fd0350ced6"
      unitRef="usd">339000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <bmy:Pensionsettlementsandamortization
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOS0xLTEtMS0yNzI5NQ_f5f9c207-ad0b-4265-b252-f58b35a79f7e"
      unitRef="usd">7000000</bmy:Pensionsettlementsandamortization>
    <bmy:Pensionsettlementsandamortization
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfOS0zLTEtMS0yNzI5NQ_21fc67d3-de53-4c27-9f0b-7ea9600ad70e"
      unitRef="usd">11000000</bmy:Pensionsettlementsandamortization>
    <bmy:Divestituregainsandroyalties
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTAtMS0xLTEtMjcyOTU_ee81ad0a-831a-4494-ad88-5e47eb975732"
      unitRef="usd">387000000</bmy:Divestituregainsandroyalties>
    <bmy:Divestituregainsandroyalties
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTAtMy0xLTEtMjcyOTU_e6874efb-7f1e-4ad4-9a01-9df523e3d88d"
      unitRef="usd">135000000</bmy:Divestituregainsandroyalties>
    <bmy:AcquiredIPRD
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTEtMS0xLTEtMjcyOTU_a3cb01e7-d0ab-4a41-895b-2394bee16058"
      unitRef="usd">333000000</bmy:AcquiredIPRD>
    <bmy:AcquiredIPRD
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTEtMy0xLTEtMjcyOTU_97d14e94-98b3-41eb-a60d-1a91c4e35a6b"
      unitRef="usd">6000000</bmy:AcquiredIPRD>
    <us-gaap:GainLossOnInvestments
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTItMS0xLTEtMjcyOTU_dc7daae3-d1df-4659-bea8-162c94087f90"
      unitRef="usd">-644000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTItMy0xLTEtMjcyOTU_3fe0b88a-14ad-4d10-977d-754e373ff341"
      unitRef="usd">601000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTMtMS0xLTEtMjcyOTU_1734a893-fd47-4e80-9dfa-ccbe1a854fd7"
      unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTMtMy0xLTEtMjcyOTU_ca06d272-83a4-4215-b46f-e888f0d4616f"
      unitRef="usd">-510000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTQtMS0xLTEtMjcyOTU_6cd8105b-cd07-4bb7-89c6-31622badb25d"
      unitRef="usd">-248000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTQtMy0xLTEtMjcyOTU_fe87f4cb-b88d-4773-ba45-61b551bd0ed8"
      unitRef="usd">-233000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTYtMS0xLTEtMjcyOTU_de710779-ccf0-4290-89c2-818990772084"
      unitRef="usd">-786000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTYtMy0xLTEtMjcyOTU_7b4a70f1-48eb-4ef4-9d8a-7c7a4144b77f"
      unitRef="usd">-67000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTctMS0xLTEtMjcyOTU_ff7f7d5e-0556-4106-a7cd-00ed22047e43"
      unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTctMy0xLTEtMjcyOTU_10aa3fda-9014-413f-a41b-ae9060971397"
      unitRef="usd">-106000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTgtMS0xLTEtMjcyOTU_d9922e42-af4a-4790-96af-b59c24b02df3"
      unitRef="usd">23000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTgtMy0xLTEtMjcyOTU_b164be57-61cc-44bf-9ace-e651e20fa2e1"
      unitRef="usd">303000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMS0xLTEtNjExNzc_53738558-ca3c-4103-81b3-7b72e894227a"
      unitRef="usd">-930000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMy0xLTEtNjExNzA_e36584a4-4c02-4333-ac69-9944c7a1790f"
      unitRef="usd">-221000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMS0xLTEtMjcyOTU_22fcd29d-0acb-448e-a0d6-2964312e3be9"
      unitRef="usd">831000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMTktMy0xLTEtMjcyOTU_5da69901-1c78-4459-b44f-ebf8afd2dda5"
      unitRef="usd">227000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjAtMS0xLTEtMjcyOTU_3212357e-796c-4527-9b48-78118d0fa319"
      unitRef="usd">1073000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjAtMy0xLTEtMjcyOTU_1b2a5f00-9be0-49ea-940c-be8b9d272325"
      unitRef="usd">917000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjEtMS0xLTEtMjcyOTU_1d3e2d0b-100b-4637-ae76-6f9d1ac1eb45"
      unitRef="usd">3812000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjEtMy0xLTEtMjcyOTU_d7aab6f3-7539-437e-888b-ad8356f066ba"
      unitRef="usd">3824000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjMtMS0xLTEtMjcyOTU_84495b7b-f462-45b9-adb4-8dda974c261d"
      unitRef="usd">2100000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjMtMy0xLTEtMjcyOTU_de7fb224-4ec1-40ad-9748-66b3dbcee28a"
      unitRef="usd">782000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjQtMS0xLTEtMjcyOTU_5935de70-03c4-48f8-a7f6-368bfaf345bd"
      unitRef="usd">1714000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjQtMy0xLTEtMjcyOTU_1fedfdfa-1d79-422a-b50e-50ca640d4de1"
      unitRef="usd">1302000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjUtMS0xLTEtMjcyOTU_f5cb9996-cf07-4a8e-869f-6ae29d1b3b9e"
      unitRef="usd">2000000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjUtMy0xLTEtMjcyOTU_d93d19de-ba6b-49b0-b537-11b644371903"
      unitRef="usd">405000000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjYtMS0xLTEtMjcyOTU_820f4451-594a-4ba7-8329-7f49ce4b7aab"
      unitRef="usd">253000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjYtMy0xLTEtMjcyOTU_14dad936-5aaf-45c0-8ff7-59265dacd761"
      unitRef="usd">173000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <bmy:Divestitureandotherproceeds
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjctMS0xLTEtMjcyOTU_8e3b8bce-fe35-456d-b462-32d8c8cdf54a"
      unitRef="usd">402000000</bmy:Divestitureandotherproceeds>
    <bmy:Divestitureandotherproceeds
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjctMy0xLTEtMjcyOTU_2acbb8ac-60e8-4ea7-b83a-e1ea17dfe2a4"
      unitRef="usd">180000000</bmy:Divestitureandotherproceeds>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjgtMS0xLTEtMjcyOTU_e1b65069-a8b0-4f0f-bbb4-147005a18cf3"
      unitRef="usd">442000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjgtMy0xLTEtMjcyOTU_aa779e47-43e0-4716-be4b-ce63660bbefd"
      unitRef="usd">35000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjktMS0xLTEtMjcyOTU_8b93c976-f1d1-4d2f-8132-6941842127c0"
      unitRef="usd">95000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMjktMy0xLTEtMjcyOTU_e677cbd7-4718-485a-91f3-54bfc7fe2223"
      unitRef="usd">-143000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzEtMS0xLTEtMjcyOTU_d1fa0683-e2ca-4109-abd8-adbb041ac6bf"
      unitRef="usd">42000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzEtMy0xLTEtMjcyOTU_2830349f-2ae8-428c-8b8e-c4e978e72f62"
      unitRef="usd">-62000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzItMS0xLTEtMjcyOTU_7fa7840f-a62a-48d3-a527-5e8e7e0c82f7"
      unitRef="usd">5926000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzItMy0xLTEtMjcyOTU_36904476-83a0-47dc-8ef5-4b3e31ad9f40"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzMtMS0xLTEtMjcyOTU_e2ab907a-cdce-41be-871b-9c7174060261"
      unitRef="usd">5769000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzMtMy0xLTEtMjcyOTU_0f24b9fd-1116-4d58-b4f1-3dd51a0e727a"
      unitRef="usd">4522000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzQtMS0xLTEtMjcyOTU_b403ff7d-7f75-4248-b1ac-e4568fcd79ad"
      unitRef="usd">5000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzQtMy0xLTEtMjcyOTU_4703a9e4-e910-493c-b5ff-47c009fd4a28"
      unitRef="usd">1775000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzUtMS0xLTEtMjcyOTU_29aebe80-4b6d-4afe-ab5a-10111ca24ce4"
      unitRef="usd">1185000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzUtMy0xLTEtMjcyOTU_5dc1eb51-bcfd-4820-bb63-524b98de5eb5"
      unitRef="usd">1108000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzYtMS0xLTEtMjcyOTU_3af4c088-49a1-4623-9821-ed44771cbb2b"
      unitRef="usd">333000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzYtMy0xLTEtMjcyOTU_6989a5cd-9bde-4221-89a9-89cf06b32e07"
      unitRef="usd">172000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzctMS0xLTEtMjcyOTU_9da2b2ac-c741-4361-9ba3-96053ee296a5"
      unitRef="usd">-5653000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzctMy0xLTEtMjcyOTU_b2e97a2d-8d0a-4d20-8a36-c75c40cf75ad"
      unitRef="usd">-7295000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzgtMS0xLTEtMjcyOTU_fb2f0287-e72a-4d7a-8640-c98e800c1e65"
      unitRef="usd">9000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzgtMy0xLTEtMjcyOTU_613c987b-51d4-4784-a38e-570e9b7563a7"
      unitRef="usd">-38000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzktMS0xLTEtMjcyOTU_cbbcb15d-7a1a-43c7-8077-9fd6784e14d3"
      unitRef="usd">-1737000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfMzktMy0xLTEtMjcyOTU_d74f613a-fb23-4abc-a20e-25a3d5ba1221"
      unitRef="usd">-3652000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDAtMS0xLTEtMjcyOTU_3d6ac895-d002-4388-973b-89d50c6b626c"
      unitRef="usd">14316000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i121f0f315b1344b1bbc371d09d847028_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDAtMy0xLTEtMjcyOTU_162747e1-8f41-4042-95bb-85f61396c1b4"
      unitRef="usd">14973000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDEtMS0xLTEtMjcyOTU_ee640e09-2e66-4e1d-b07a-4705c25c5323"
      unitRef="usd">12579000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if23774cb38994a048379d7991560faf3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yNS9mcmFnOmUwYTRmYWNkYzU5ZTQzZGZiY2E5ZmU3OGZjNGViM2NlL3RhYmxlOjRmZDRkNTcwYjg4ZDQzZjRiNDk5MzRlMGU1YzJkMzQyL3RhYmxlcmFuZ2U6NGZkNGQ1NzBiODhkNDNmNGI0OTkzNGUwZTVjMmQzNDJfNDEtMy0xLTEtMjcyOTU_5edc77f5-2a7e-47b2-8672-9cd2071c6535"
      unitRef="usd">11321000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8yOC9mcmFnOmMwYzVkMDRlMWNjNDQ0NTk5ODViYWNiMmQ1YTA0NTFmL3RleHRyZWdpb246YzBjNWQwNGUxY2M0NDQ1OTk4NWJhY2IyZDVhMDQ1MWZfNjU5NzA2OTc2NjczMg_2c201ba2-5792-4841-92de-2ca8335a48ca">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company (&#x201c;BMS&#x201d; or &#x201c;the Company&#x201d;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at March&#160;31, 2022 and December&#160;31, 2021 and the results of operations and cash flows for the three months ended March&#160;31, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#x2019;s operational structure, the Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#x201c;&#x2014;Note 2. Revenue&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of goodwill and intangible assets; chargebacks, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Up-front and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statement of earnings. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows is now presented separately in Rebates and discounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective approach. Early adoption is permitted.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY3Mw_4d087c12-a2eb-48af-9aca-8797ea3ceb3f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company (&#x201c;BMS&#x201d; or &#x201c;the Company&#x201d;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at March&#160;31, 2022 and December&#160;31, 2021 and the results of operations and cash flows for the three months ended March&#160;31, 2022 and 2021. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2021 included in the 2021 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY1Mw_93bbaf7c-6c54-4f74-84b5-43742d81b3cc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#x2019;s operational structure, the Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#x201c;&#x2014;Note 2. Revenue&#x201d;.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY1NQ_04a82016-21af-4568-b50a-4ffef62bef4c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of goodwill and intangible assets; chargebacks, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY1Nw_f04cb611-717a-4d2a-a66d-9e2bffe255c1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Up-front and contingent milestone charges in connection with asset acquisitions or licensing of third-party intellectual property rights previously presented in Research and development are now presented in Acquired IPRD in the consolidated statement of earnings. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. Additionally, Rebates and discounts previously presented in Other changes in operating assets and liabilities in the consolidated statements of cash flows is now presented separately in Rebates and discounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zMS9mcmFnOjA5ODFlZmIxMWU1ZjQyMDI4NDVkNjk0MWU2NGIwYmU4L3RleHRyZWdpb246MDk4MWVmYjExZTVmNDIwMjg0NWQ2OTQxZTY0YjBiZThfNDY2OQ_b6ad49c0-393a-412e-a7b9-3e100b8d391d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The amended guidance is effective January 1, 2023 on a prospective approach. Early adoption is permitted.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTY0MQ_fe062ddc-3822-4207-ab61-2bbba3444550">REVENUE&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $74 million and $217 million for the three months ended March&#160;31, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Line Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Empliciti&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature and other products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdualag&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recent LOE Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#x2019;s regional commercial organizations.&lt;/span&gt;&lt;/div&gt;Revenue recognized from performance obligations satisfied in prior periods was $147 million and $284 million for the three months ended March&#160;31, 2022 and 2021, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTYzMQ_397d3474-af4e-480d-b961-5f1e4f04e473">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMi0xLTEtMS0yNzI5NQ_9765f97b-26cb-402f-8a53-0fa82ddd081d"
      unitRef="usd">11308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMi0zLTEtMS0yNzI5NQ_ea5b2d62-f0ad-4f8e-95b6-4a1ee1eb35be"
      unitRef="usd">10798000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ae83d03fd39427cb3c287eed7f29f40_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMy0xLTEtMS0yNzI5NQ_10a1e368-2040-4591-917a-80ffa96e2ac5"
      unitRef="usd">188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6306d4449874dffb35d51a933fb469c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfMy0zLTEtMS0yNzI5NQ_4488dd68-c17d-4e0d-96d2-98a6d90c0e27"
      unitRef="usd">142000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7c9dc415da6a41559015929ff4b2fe33_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNC0xLTEtMS0yNzI5NQ_a7843cc4-0a77-4d31-bf55-d03cd4ca8379"
      unitRef="usd">152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f792c2e37a74691a4b596f3e72d75f7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNC0zLTEtMS0yNzI5NQ_d8abec7b-61be-4b3d-8bed-46d8f5a8d866"
      unitRef="usd">133000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNS0xLTEtMS0yNzI5NQ_9e90798e-5647-4e98-a9b9-b1c192111477"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmIwYjk3YmRkMzIzNTQ2OWRhMzY0MmQ5NzAxMjg4ZWU3L3RhYmxlcmFuZ2U6YjBiOTdiZGQzMjM1NDY5ZGEzNjQyZDk3MDEyODhlZTdfNS0zLTEtMS0yNzI5NQ_f496a7ef-0b06-432d-ae39-5002886928c0"
      unitRef="usd">11073000000</us-gaap:Revenues>
    <bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTYzOA_d50d0271-8a06-4308-961e-aa486ca95e3f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $74 million and $217 million for the three months ended March&#160;31, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock>
    <us-gaap:Revenues
      contextRef="i7d314318c51d4cd28e75d7001c766243_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfMi0xLTEtMS0yNzI5NQ_40055681-55f8-4866-a109-644345b70e05"
      unitRef="usd">16650000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide94636b0fb9453b865109199e79c164_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfMi0zLTEtMS0yNzI5NQ_8bb10dfc-a1e6-4b7f-8bee-ad24f7ba125b"
      unitRef="usd">15559000000</us-gaap:Revenues>
    <bmy:GrosstoNetAdjustments
      contextRef="i88fccac5bb1b44b584ed539c4961816c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNC0xLTEtMS0yNzI5NQ_579b64f0-11d2-453e-98ca-5202a8eeacd1"
      unitRef="usd">1763000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ibecb66199abc42ad9586b7704e21a96d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNC0zLTEtMS0yNzI5NQ_c0949d7f-b9db-4fec-b1ea-b668ac85b95e"
      unitRef="usd">1586000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i6a19efd071324236943f9b6a79698499_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNS0xLTEtMS0yNzI5NQ_f6214d56-d219-4b50-a8dd-0f5a02ee49f4"
      unitRef="usd">2084000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="if66c2ddf63414c1da2708bd02f444e26_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNS0zLTEtMS0yNzI5NQ_902ae4c4-936e-4f01-b08d-c8a2aad68eb5"
      unitRef="usd">1718000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i30c290a93ce1414cba872464493792e7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNi0xLTEtMS0yNzI5NQ_5fa13cb6-bdfc-4ddd-96c8-795d01c827e9"
      unitRef="usd">1495000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="iab5b5b3eca5a4bf6b7a3fc275f47e800_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNi0zLTEtMS0yNzI5NQ_f6d2f977-e3c1-4f59-8c37-e735b9c5f701"
      unitRef="usd">1457000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNy0xLTEtMS0yNzI5NQ_5d3978b6-cefb-4ede-846a-bb94e8e8d813"
      unitRef="usd">5342000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfNy0zLTEtMS0yNzI5NQ_2b4694b6-ece7-430c-824f-bca97b365b82"
      unitRef="usd">4761000000</bmy:GrosstoNetAdjustments>
    <us-gaap:Revenues
      contextRef="ie5c2ba0542d64857a69e08150644cc20_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfOC0xLTEtMS0yNzI5NQ_cb4e8370-72fa-4045-84ed-5dd082917440"
      unitRef="usd">11308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4483e05060a4b349f6c4aeeeda2386d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOmFjMzI2MWYzZmU1ZDRjMTlhNDkwNjczYzEyNmFiM2Y0L3RhYmxlcmFuZ2U6YWMzMjYxZjNmZTVkNGMxOWE0OTA2NzNjMTI2YWIzZjRfOC0zLTEtMS0yNzI5NQ_23e665ef-b464-4b63-879c-ba618966dce1"
      unitRef="usd">10798000000</us-gaap:Revenues>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTAwNA_a03737cb-b105-4f99-8e36-3d7fbe3c6c68"
      unitRef="usd">74000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTA5OTUxMTYzMDIwNw_26a6ae25-510a-4598-97fd-92c6e0ff268d"
      unitRef="usd">217000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTY0OA_562e36ea-ea60-4c96-a885-1f2e0ec2a999">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Line Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Empliciti&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature and other products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Product Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdualag&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recent LOE Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#x2019;s regional commercial organizations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="i1f764a709228490cb729d3069830bef8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNC0xLTEtMS0yNzI5NQ_007cb2a6-306b-45f6-aef0-009cb911b3fa"
      unitRef="usd">3211000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iafcc828129bf453b96defa43e5ade811_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNC0zLTEtMS0yNzI5NQ_c25b754a-3696-40d4-8edf-d6786b9f9e93"
      unitRef="usd">2886000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00a206daed414aaca2b5ea0669036b4b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0xLTEtMS0yNzI5NQ_564210fe-b9d8-4c18-ac8f-f1eb01c70db9"
      unitRef="usd">1923000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib42f8d6ac6434217ad0fcc5291152cd1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0zLTEtMS0yNzI5NQ_e19145de-195a-4de6-b26a-88e0a652beb2"
      unitRef="usd">1720000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i833468c7bf03479e8d799e7e25575955_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0xLTEtMS02MTQxNQ_c5d324e4-d4d9-4e0b-8134-2cc965e41037"
      unitRef="usd">826000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if29d6014ae774728b9c351ed9adb5183_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNS0zLTEtMS02MTQxNQ_950c130d-1a90-4c47-bdba-fe0fd3e2c5a8"
      unitRef="usd">773000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibb627f6367e04f72b873f7093f6faf99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNi0xLTEtMS0yNzI5NQ_b1034d94-09ff-4027-93b1-80c8ccbaeefb"
      unitRef="usd">792000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i786e2d92971d47f986b8c786305a835e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfNi0zLTEtMS0yNzI5NQ_5dad1e28-ff9d-46ad-a230-edbfd3228afc"
      unitRef="usd">758000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57b03a8caa5b4300851ef8b7fea7189c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOC0xLTEtMS0yNzI5NQ_90024cdf-434d-4974-b649-912e2df64bdf"
      unitRef="usd">483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4667f06c84c4e3d81ccdc395f8a42e3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOC0zLTEtMS0yNzI5NQ_864afecf-d2e0-4329-8e6a-d2d132235e9e"
      unitRef="usd">470000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i377bc58a38a9497aac85eb38d8f77344_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0xLTEtMS0yNzI5NQ_6a08d60c-248b-4185-8113-1dbce428d4d9"
      unitRef="usd">515000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i620f145ddb8d41cc99f91a9eefdec0be_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0zLTEtMS0yNzI5NQ_e138e6df-6c98-465f-89b7-029fdc65ff98"
      unitRef="usd">456000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e7e69fb982e40929bf32259d04c7e4b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0xLTEtMS02NTUyNw_cf5053d0-0211-4a4a-8995-97d4937eb328"
      unitRef="usd">75000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3d92f4fbdf7240a987fb28ecbaee2567_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfOS0zLTEtMS02NTUyNw_7d501352-c960-4ba6-a457-b6f4829367bd"
      unitRef="usd">85000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib36d56bded844dce9f6c54b7a75f2476_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMS0xLTEtMjcyOTU_91b533d8-0577-4e83-93a5-bd79251dcca0"
      unitRef="usd">462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ife5940f31f184d2583926339d46b6fb2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMy0xLTEtMjcyOTU_5b466ec1-1367-435e-8229-cc0e1017dd70"
      unitRef="usd">506000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53b18d7498184e29a11bdf5c0452dfd7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMS0xLTEtNjE0MjI_0da97817-69b8-48ec-90c8-317207c72172"
      unitRef="usd">156000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ee5dc7e67f14911aa2893ad8777ecef_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTAtMy0xLTEtNjE0MjI_63718129-fabb-4fc8-a5b7-f438b3a77cbf"
      unitRef="usd">112000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c64261ddacf4d27b95761bdf567761c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTItMS0xLTEtMjcyOTU_4ea73596-0b68-4ad3-a89e-115ff6b14634"
      unitRef="usd">67000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac447b2aea184eabafe621a6a696092e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTItMy0xLTEtMjcyOTU_91647cca-2a6a-4d3d-859f-8835b45a0cf0"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0760f12dccde4f049c0d2d5521e2308f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMS0xLTEtNjE0Mjk_eea3d8ee-1a71-46be-a23b-7e08fbde8363"
      unitRef="usd">36000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04fb13c03f7545ee881c787c4d295cb3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMy0xLTEtNjE0Mjk_faad9aa4-9f1b-4113-9684-ec6e81839f9b"
      unitRef="usd">18000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16bc3dfbe6534e50827c954ef689f936_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMS0xLTEtNjE0MzM_0f5584ab-fb8d-464e-834b-88b4c44cdd31"
      unitRef="usd">44000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2c11a8ffa114cfcb627155e46eb9da2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMy0xLTEtNjE0MzM_36b9daec-12f7-4ce5-8eb5-8c331c7a740e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaaa96276ff5744b79e5a0e0affc668d8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMS0xLTEtMjcyOTU_c0a2b2ee-faed-44f0-a7ea-287d494d82c5"
      unitRef="usd">18000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id634989c491e4b0e83256f5dfd53b780_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTMtMy0xLTEtMjcyOTU_53de4504-52da-4c84-850f-295f02f7faae"
      unitRef="usd">16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d8859fa6c2b478ebc39980d73bafcbb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMS0xLTEtMjcyOTU_b33397b2-1755-471a-9b90-5c05169f78b0"
      unitRef="usd">23000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie182e216caea49158bf722fa85814ad2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTQtMy0xLTEtMjcyOTU_f4cd43d9-2c2c-4875-b960-6a5b7b0e2bb4"
      unitRef="usd">15000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0fa0dc5d78d499fb86b70327b3a973d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTgtMS0xLTEtNzYzNjE_160ab19d-b128-46d0-b827-0289014f48d8"
      unitRef="usd">6000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a29d887f67747a3b9f15f234fdcaa11_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMTgtMy0xLTEtNzYzNjg_f0f54078-9446-47e7-9379-6e89f365a680"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i245341e9dc7f42f09fe5c3b260ae0b00_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMS0xLTEtNjU1MTI_3bb6f6d8-512e-4ea6-9ece-fac11fb8c691"
      unitRef="usd">2797000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ba82d969c984e76baeb0c4efd07d7a9_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMy0xLTEtNjU1MTI_23b8d69a-bcec-42a7-9bd6-4a3d41d3045d"
      unitRef="usd">2944000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8e6bb5e19053475593dc55eb7a511cab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMS0xLTEtNjU1MTU_a194e745-5f3d-4af4-8395-dffc8b29c523"
      unitRef="usd">214000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e86669f8888451993e27f92cec0f586_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMy0xLTEtNjU1MTU_e7020eda-6dbd-4de6-aa65-1a96b61e5ada"
      unitRef="usd">314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjMtMS0xLTEtMjcyOTU_05e754ca-c369-4b0e-b52c-f3c17368fa37"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjMtMy0xLTEtMjcyOTU_5e15dc2a-762b-4abb-9bbb-f9478f408cdd"
      unitRef="usd">11073000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic40d1ed6e151472bbc67c2993924ab34_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMS0xLTEtMjcyOTU_c7a8595b-c188-460d-87e7-babd84e00f63"
      unitRef="usd">7694000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4a1e02638b14ced8f45c79321610b71_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjUtMy0xLTEtMjcyOTU_cf21aa41-e796-456d-815f-ae5c1cd2b6b2"
      unitRef="usd">7010000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a5dd69022804169bff3d491d0b5bc66_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMS0xLTEtMjcyOTU_4ab68cc8-6c91-4f1e-a168-e897545fb690"
      unitRef="usd">2413000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6141b14c69f141b18709f232e7245e2f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjYtMy0xLTEtMjcyOTU_ad31cf87-6c88-4e4b-9938-fdb3179cb539"
      unitRef="usd">2553000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id59ae704af7f443397b0d5d71bd61538_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjctMS0xLTEtMjcyOTU_6c27752b-c47e-4786-9d1a-79be931a075b"
      unitRef="usd">1314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i354824d64a0547219c5143a42c38faa5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjctMy0xLTEtMjcyOTU_5b22ced9-7db4-4d95-9851-ceeae3d1a87d"
      unitRef="usd">1346000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb8f774b5ae64c91aa84544f0b95bd1c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjgtMS0xLTEtMjcyOTU_cd7660d2-f33a-440d-8770-5ab6c445567f"
      unitRef="usd">227000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1105952851aa4f00a91d7d07748e2299_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjgtMy0xLTEtMjcyOTU_2f7e902d-ac13-46a9-b9f7-b03e5c08f380"
      unitRef="usd">164000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjktMS0xLTEtMjcyOTU_cdd5894b-921c-424c-ba8a-eda652f8677e"
      unitRef="usd">11648000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RhYmxlOjQxMzEyZWIwNGYyODQ3MDRhMjMzMmE2YWE4MjAzOTMwL3RhYmxlcmFuZ2U6NDEzMTJlYjA0ZjI4NDcwNGEyMzMyYTZhYTgyMDM5MzBfMjktMy0xLTEtMjcyOTU_bae290a5-b7ee-47da-804e-769383464fc6"
      unitRef="usd">11073000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTM3Mg_26ab43ea-f55f-4a94-8ee2-b4667aa913bc"
      unitRef="usd">147000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNC9mcmFnOmVlZGIwZmRlZTFjZjQxMDY4NGI5YzdmM2U1YWFhMzA5L3RleHRyZWdpb246ZWVkYjBmZGVlMWNmNDEwNjg0YjljN2YzZTVhYWEzMDlfMTA5OTUxMTYzMDI0Mw_a1df620f-c7d8-4ff9-8e46-16c370a5c11f"
      unitRef="usd">284000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RleHRyZWdpb246NjkyNWViYTVjMjQ1NDU5MmJmYTZkYmI4N2E4YzFmYmRfMjgyMg_b984fd86-10e7-4397-b3ec-36d8b64ad451">ALLIANCES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected Alliance Balance Sheet information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2021 Form 10-K. Significant developments and updates related to alliances during the three months ended March 31, 2022 are set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nektar&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, BMS and Nektar announced that the companies have jointly decided to end the global clinical development program for bempegaldesleukin in combination with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Opdivo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; based on results from pre-planned analyses of two late-stage clinical studies in RCC and bladder cancer. These studies and all other ongoing studies in the program will be discontinued.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:CollaborativeArrangementAccountingPolicy
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RleHRyZWdpb246NjkyNWViYTVjMjQ1NDU5MmJmYTZkYmI4N2E4YzFmYmRfMjgxNw_a934aed0-980d-4288-896d-a50af31b2c22">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RleHRyZWdpb246NjkyNWViYTVjMjQ1NDU5MmJmYTZkYmI4N2E4YzFmYmRfMjgxOA_c67082ea-9dcc-4252-b5e6-e1453d1636f6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected Alliance Balance Sheet information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:Revenues
      contextRef="i562d61545be0472f8e43f9bf2d78869a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMy0xLTEtMS0yNzI5NQ_d2a4354a-7f8d-436b-a1fa-e69dfa7a5d8f"
      unitRef="usd">3239000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i110fc233fca2409280cedc632a84cd9b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMy0zLTEtMS0yNzI5NQ_81f71b24-0c91-4a5c-9dc3-481a67fd50be"
      unitRef="usd">2882000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ae83d03fd39427cb3c287eed7f29f40_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNC0xLTEtMS0yNzI5NQ_10a1e368-2040-4591-917a-80ffa96e2ac5"
      unitRef="usd">188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6306d4449874dffb35d51a933fb469c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNC0zLTEtMS0yNzI5NQ_4488dd68-c17d-4e0d-96d2-98a6d90c0e27"
      unitRef="usd">142000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNS0xLTEtMS0yNzI5NQ_19efe211-1666-4f16-b876-312e8453efac"
      unitRef="usd">3427000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfNS0zLTEtMS0yNzI5NQ_2c62db99-24a8-42b3-8c08-a233432a4dfc"
      unitRef="usd">3024000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOC0xLTEtMS0yNzI5NQ_982606eb-aff4-4b1b-a95f-5e1b6c31361d"
      unitRef="usd">1556000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOC0zLTEtMS0yNzI5NQ_d3cb24f9-38a5-4d21-ae61-3a158b1461ff"
      unitRef="usd">1397000000</us-gaap:CostOfGoodsAndServicesSold>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOS0xLTEtMS0yNzI5NQ_42d062b5-a432-4b1f-86dc-e31cd6118364"
      unitRef="usd">-54000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfOS0zLTEtMS0yNzI5NQ_eca85c86-98ba-4627-9852-d5d0b9fa8f8d"
      unitRef="usd">-49000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTAtMS0xLTEtMjcyOTU_75f00f57-5f99-4262-b813-21ba86c1313b"
      unitRef="usd">22000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTAtMy0xLTEtMjcyOTU_050ad0a4-ec06-4edc-8d71-5d1b74d2f37d"
      unitRef="usd">7000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTEtMS0xLTEtMjcyOTU_5bc21a75-03a1-4c4f-ac9f-8372a24789a3"
      unitRef="usd">12000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0628f1291202410694bad853976cd58f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjA0MmVmNTA5M2RmODQ2YzBiOWI2MzExMzcyMGE2ZDRlL3RhYmxlcmFuZ2U6MDQyZWY1MDkzZGY4NDZjMGI5YjYzMTEzNzIwYTZkNGVfMTEtMy0xLTEtMjcyOTU_5fb9bca1-14ae-493d-9fc5-2ae3c9c1c52b"
      unitRef="usd">5000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i88b651390f6e4112bf4d018573ef376e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMi0xLTEtMS0yNzI5NQ_f823c37f-c005-4f65-8bfa-096feec83520"
      unitRef="usd">304000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMi0zLTEtMS0yNzI5NQ_08650b69-f2a2-40f5-a7d2-57b04f5d9918"
      unitRef="usd">320000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i88b651390f6e4112bf4d018573ef376e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMy0xLTEtMS0yNzI5NQ_f5d6dc93-e23f-4a08-9e2a-17bb0215658f"
      unitRef="usd">1504000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfMy0zLTEtMS0yNzI5NQ_ba95cd93-5c51-442f-bc8f-3a1dd77b2f16"
      unitRef="usd">1229000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredIncome
      contextRef="i88b651390f6e4112bf4d018573ef376e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfNC0xLTEtMS0yNzI5NQ_a999fc4c-209e-46a9-8320-979cd0380c05"
      unitRef="usd">326000000</us-gaap:DeferredIncome>
    <us-gaap:DeferredIncome
      contextRef="iaf13ded2b2b04236a1c8340c4ea382e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8zNy9mcmFnOjY5MjVlYmE1YzI0NTQ1OTJiZmE2ZGJiODdhOGMxZmJkL3RhYmxlOjhlMDZiYzhhOGM5YzQ5NWRiYzgxZmQzYzExZjI5OTM2L3RhYmxlcmFuZ2U6OGUwNmJjOGE4YzljNDk1ZGJjODFmZDNjMTFmMjk5MzZfNC0zLTEtMS0yNzI5NQ_d406ea91-3690-4097-8e9b-6e345da117ed"
      unitRef="usd">330000000</us-gaap:DeferredIncome>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTQ4NQ_4742b3b1-604f-4eff-adda-90161de4ec45">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Products and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mature Products and Other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March 31, 2022, product rights to several mature products were sold to Cheplapharm resulting in cash proceeds of $221&#160;million and divestiture gain of $211&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Licensing and Other Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;In-license Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Immatics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March 31, 2022, BMS obtained a global exclusive license to Immatics&#x2019; TCR bispecific IMA401 program. IMA401 is being studied in oncology and a Clinical Trial Application has been approved by the German federal regulatory authority and the trial is planned to commence in the first half of 2022. BMS and Immatics will collaborate on the development and BMS will be responsible for the commercialization of IMA401 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an up-front payment of $150&#160;million which was included in Acquired IPRD and Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $770&#160;million as well as royalties on global net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dragonfly&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March 31, 2022, a Phase I development milestone for interlukin-12 (&#x201c;IL-12&#x201d;) was achieved resulting in a $175&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. These milestones continue to be considered substantive and contingent because the decision to proceed will be based on an assessment of clinical data prior to the specified dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MyoKardia&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, BMS amended the terms of a license arrangement and paid a third party $295&#160;million to extinguish a future royalty obligation related to mavacamten prior to its FDA approval which will result in an Acquired IPRD charge.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTQ5MQ_b9684161-7085-4461-8353-8406b4d41bf4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Products and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy0xLTEtMS0yNzI5NQ_04520eeb-2883-41d7-8aaa-ea61e99fced7"
      unitRef="usd">172000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy0zLTEtMS0yNzI5NQ_c0727fbf-f33d-469f-a78c-87808f609aab"
      unitRef="usd">164000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy01LTEtMS0yNzI5NQ_c744f82b-0001-4c24-b1f0-dd0999bdfcf9"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy03LTEtMS0yNzI5NQ_bdcf9440-dba5-47da-8185-cd348ec2f5a0"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i65efa2432c844039b35a070fa3d4c198_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy05LTEtMS0yNzI5NQ_eda16186-b67a-4235-b407-d9c398fcb534"
      unitRef="usd">170000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i20f63a4eb1d5487fbea1ec78d5454dc7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfMy0xMS0xLTEtMjcyOTU_7e6c84c6-5bb3-4ac7-b60b-0a9981944976"
      unitRef="usd">134000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy0xLTEtMS0yNzI5NQ_4872c1cf-f659-434e-931a-9906838d8886"
      unitRef="usd">225000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i232e253c036243df8733675ba5284e0c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy0zLTEtMS0yNzI5NQ_4c668f38-e3fc-49ba-b94b-3b992e367edd"
      unitRef="usd">16000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy01LTEtMS0yNzI5NQ_c230ea73-7f59-4c28-b5ce-b940e0c59b62"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i232e253c036243df8733675ba5284e0c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy03LTEtMS0yNzI5NQ_0672ce2e-0e62-4225-9640-cc68d1be5177"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy05LTEtMS0yNzI5NQ_67f25d29-25eb-4949-85eb-69e26edea572"
      unitRef="usd">1000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i232e253c036243df8733675ba5284e0c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfNy0xMS0xLTEtMjcyOTU_424f5d78-0de7-4df3-983b-c6a2471c609f"
      unitRef="usd">1000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC0xLTEtMS0yNzI5NQ_0e0e67f1-a287-466c-984b-014f55a2b541"
      unitRef="usd">397000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC0zLTEtMS0yNzI5NQ_8ee320a4-54bf-4865-af8e-246de77dfeb8"
      unitRef="usd">180000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC01LTEtMS0yNzI5NQ_6d59ebbb-ae3a-4b23-9cdd-20052f7204b7"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC03LTEtMS0yNzI5NQ_72a78db5-3f35-4dcb-b984-6115d4546819"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC05LTEtMS0yNzI5NQ_9343a42b-42dd-4350-8f0e-6b704b3a5ace"
      unitRef="usd">171000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjJiZjY4ZmU0NjM0ODRkMjVhMWJkMTUzNDE2ZGVlMzE4L3RhYmxlcmFuZ2U6MmJmNjhmZTQ2MzQ4NGQyNWExYmQxNTM0MTZkZWUzMThfOC0xMS0xLTEtMjcyOTU_057234e5-52f6-44a1-9706-feb6b26a6271"
      unitRef="usd">135000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i2844029f1c864491a3839ffdb5436a62_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzODI0MA_3d2f777f-09f8-4ced-a0d1-cebc385bf497"
      unitRef="usd">221000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i9d510fc10fda47d4b524aec22b4ae16a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzODI1NA_6c5f0ce1-108f-4102-bf7e-13bce5681d2b"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <bmy:LicensingAndOtherArrangementsTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTUwMw_6833b60a-4940-466b-9d30-29e9b29e3fd2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:LicensingAndOtherArrangementsTableTextBlock>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i48e1e9ad646d44d5b8ca8791b5c49163_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMi0xLTEtMS0yNzI5NQ_862479b3-de0c-4a58-aca9-5bd5a9577960"
      unitRef="usd">221000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="if4ce232de8d94ca89a2d4818aca93f9b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMi0zLTEtMS0yNzI5NQ_addcd226-2eb3-4088-9df4-d619c19db290"
      unitRef="usd">192000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="id5e59050a88c4c7b8c32aaa347079239_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMy0xLTEtMS0yNzI5NQ_b328dfa5-5a76-4dc0-aba4-44584cb8a209"
      unitRef="usd">25000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i5c64b0fb4f194220a4e3ad3bf15dffa9_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfMy0zLTEtMS0yNzI5NQ_efa11da9-70c3-463f-9115-0e84c0201cbc"
      unitRef="usd">22000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNS0xLTEtMS0yNzI5NQ_83f262cc-5d3b-4314-b965-fa23d2f86523"
      unitRef="usd">41000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNS0zLTEtMS0yNzI5NQ_5e235b8a-9eb5-47a6-8d3b-53d467a657cd"
      unitRef="usd">0</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNi0xLTEtMS0yNzI5NQ_6769ffbe-a01c-4408-81f8-d027e798709a"
      unitRef="usd">12000000</bmy:AmortizationOfDeferredIncome>
    <bmy:AmortizationOfDeferredIncome
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNi0zLTEtMS0yNzI5NQ_573baa61-e4c9-4c65-8fc8-1cad2a48fe70"
      unitRef="usd">15000000</bmy:AmortizationOfDeferredIncome>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i41718b51a26b430a814b359ab230049d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNy0xLTEtMS0yNzI5NQ_ce42d58c-6ca2-4dc6-abb0-8a0b2cecbb8b"
      unitRef="usd">7000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i86d0e6be826d471580d3022cfd601f5c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfNy0zLTEtMS0yNzI5NQ_e9eb0783-6153-44a1-a058-3c2d19f8ccfa"
      unitRef="usd">3000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfOC0xLTEtMS0yNzI5NQ_f59f652b-c973-4daa-95c9-25a357383ff4"
      unitRef="usd">306000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RhYmxlOjFjNjM0NWEyNWM2NzQxZDI4MGE5ZDcxZmIyYzhhZWM0L3RhYmxlcmFuZ2U6MWM2MzQ1YTI1YzY3NDFkMjgwYTlkNzFmYjJjOGFlYzRfOC0zLTEtMS0yNzI5NQ_5a1d93f8-41e8-4d06-88a1-67aa4aec88f8"
      unitRef="usd">232000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="i3a5bbf0f5b504271a5ed86f80698f1aa_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzMTk2OA_eb28c080-3e49-47d8-9046-c1d076ad311e"
      unitRef="usd">150000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:ContingentAndRegulatoryMilestonePayments
      contextRef="i3a5bbf0f5b504271a5ed86f80698f1aa_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzMTk4Mg_2d43a13d-5622-490d-8cd3-b57ad59ef003"
      unitRef="usd">770000000</bmy:ContingentAndRegulatoryMilestonePayments>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="ied7b4f093fb64e948e41d2fae883ac49_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTYzNDUxMg_3acc663c-975b-4bc6-81a5-48c59ec3454c"
      unitRef="usd">175000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:PaymentToExtinguishFutureRoyaltyObligation
      contextRef="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80MC9mcmFnOmE4ZGI2MWQwYmJlNjRmYjM5M2I5ZTY0YTM0ZTQwOWNlL3RleHRyZWdpb246YThkYjYxZDBiYmU2NGZiMzkzYjllNjRhMzRlNDA5Y2VfMTA5OTUxMTY0ODExMg_c7e79fc1-a86c-4b0c-a619-d05737e47f05"
      unitRef="usd">295000000</bmy:PaymentToExtinguishFutureRoyaltyObligation>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RleHRyZWdpb246MDU4N2YxYzhjNGJhNGRhNGFiMzZlN2FhYzI0ZGFiOTdfNTE_5e35ccc8-66de-45d7-80e2-dd1ad0e37988">OTHER (INCOME)/EXPENSE, NET&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment losses/(gains)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition and other service fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <bmy:ScheduleOfOtherIncomeExpenseTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RleHRyZWdpb246MDU4N2YxYzhjNGJhNGRhNGFiMzZlN2FhYzI0ZGFiOTdfNTQ_993d83af-43ed-42c3-80fd-7d873b14d9e9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment losses/(gains)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition and other service fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</bmy:ScheduleOfOtherIncomeExpenseTextBlock>
    <us-gaap:InterestExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMi0xLTEtMS0yNzI5NQ_d5a5e0d2-452f-44cc-82e2-2a6d16d5ad59"
      unitRef="usd">326000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMi0zLTEtMS0yNzI5NQ_b407bd90-72a9-41b9-84a3-81f662f96a47"
      unitRef="usd">353000000</us-gaap:InterestExpense>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0xLTEtMS04MjE2MQ_cb315d67-f62e-4b99-8562-4d1137357111"
      unitRef="usd">477000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0zLTEtMS04MjE2MQ_5b95e939-7beb-4550-bf91-ece06470315c"
      unitRef="usd">367000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <us-gaap:GainLossOnInvestments
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0xLTEtMS04MjE4Nw_fc0be4a8-3aad-455c-8932-614d6e0f78bf"
      unitRef="usd">-644000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0zLTEtMS04MjE4Nw_6bdd6311-600a-4664-82b0-060d4e2b7cf0"
      unitRef="usd">601000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0xLTEtMS0yNzI5NQ_f3738aad-ed33-430a-820e-ecf1b15caf3a"
      unitRef="usd">105000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMy0zLTEtMS0yNzI5NQ_b82d9597-1ea2-462c-99df-8bc833f9deee"
      unitRef="usd">141000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0xLTEtMS0yNzI5NQ_dd43aa43-0bb3-4692-8b9e-64cf5aa78814"
      unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNC0zLTEtMS0yNzI5NQ_9cbd1148-1c70-441d-8336-13bc7d007928"
      unitRef="usd">-510000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNS0xLTEtMS0yNzI5NQ_3071bc1c-f9b3-470e-b218-6126c3d29971"
      unitRef="usd">-275000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNS0zLTEtMS0yNzI5NQ_7309891c-a1f7-45c0-adc8-9eba3ca9de09"
      unitRef="usd">-281000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:RestructuringCharges
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNi0xLTEtMS0yNzI5NQ_9bd9897b-5a40-43c9-bc3b-30a93d34641a"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfNi0zLTEtMS0yNzI5NQ_39bf5192-4bc0-415b-8df2-1bf0c0e94d1f"
      unitRef="usd">45000000</us-gaap:RestructuringCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOC0xLTEtMS0yNzI5NQ_7b052859-4b7d-46cc-af2e-6dc17c3b34bc"
      unitRef="usd">37000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOC0zLTEtMS0yNzI5NQ_6f71d14c-1e1c-4116-b81a-05479d50cc64"
      unitRef="usd">8000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <bmy:AllianceTransitionalServices
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOS0xLTEtMS0yNzI5NQ_c27f666d-6c84-4a25-8e20-691fdbc6234c"
      unitRef="usd">1000000</bmy:AllianceTransitionalServices>
    <bmy:AllianceTransitionalServices
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfOS0zLTEtMS0yNzI5NQ_9d2982d9-96f7-4a26-9b87-5bc74d248f93"
      unitRef="usd">15000000</bmy:AllianceTransitionalServices>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTAtMS0xLTEtMjcyOTU_3240a23f-b94f-4cf5-b086-3e4aa38a23af"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTAtMy0xLTEtMjcyOTU_376103fb-4c4b-4253-85a0-f9c93e015a78"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTItMS0xLTEtMjcyOTU_0e9fb960-ac5b-460d-9ccd-c5175ea0bd20"
      unitRef="usd">211000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTItMy0xLTEtMjcyOTU_6a5862bf-5bde-4bb6-a202-72814312b55b"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <bmy:OtherOtherIncomeExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTgtMS0xLTEtMjcyOTU_f1941667-2112-4042-978b-694ce9e17629"
      unitRef="usd">-11000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTgtMy0xLTEtMjcyOTU_71248fff-63b2-4989-9bf2-27e230a7d0a5"
      unitRef="usd">12000000</bmy:OtherOtherIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTktMS0xLTEtMjcyOTU_80a12b51-76e7-4221-9fad-46c1a80913c6"
      unitRef="usd">-649000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80My9mcmFnOjA1ODdmMWM4YzRiYTRkYTRhYjM2ZTdhYWMyNGRhYjk3L3RhYmxlOmE2OWYxNmIwMTYwNDQ3MjBiZWVjYmIwMGUwYTZlZDc2L3RhYmxlcmFuZ2U6YTY5ZjE2YjAxNjA0NDcyMGJlZWNiYjAwZTBhNmVkNzZfMTktMy0xLTEtMjcyOTU_4f31c58f-2e2c-4948-bbb7-4f009544aa4d"
      unitRef="usd">702000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE5MA_57a0db55-118a-4fa0-a600-e74823511571">RESTRUCTURING&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition that are currently expected to be approximately $3.0&#160;billion. The synergies are expected to be realized in Cost of products sold (5%), Marketing, selling and administrative expenses (65%) and Research and development expenses (30%). Charges of approximately $3.3&#160;billion are expected to be incurred. The majority of the charges are expected to be incurred through 2022. Cumulative charges of approximately $2.7&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. Cash outlays in connection with these actions are expected to be approximately $3.0&#160;billion. Employee workforce reductions were approximately 60 for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;MyoKardia Acquisition Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, a restructuring and integration plan was initiated to realize expected cost synergies resulting from cost savings and avoidance from the MyoKardia acquisition. Charges of approximately $150&#160;million are expected to be incurred through 2022, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $120 million have been recognized for these actions to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoKardia Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $9 million and $1 million for the three months ended March 31, 2022 and 2021, respectively. Excludes $6 million for the three months ended March 31, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <bmy:RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance
      contextRef="i54f344a3a508440a9c3136fc21f9a315_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjk1_42cd306b-2d10-49d8-94aa-54696d9b0f01"
      unitRef="usd">3000000000</bmy:RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance>
    <bmy:ExpectedSynergiesPercentage
      contextRef="i9e86a84eeff547878681f2285bc056c0_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNjU5NzA2OTc3MDczOA_3b0e7b36-e1b3-485b-91e4-c5b123fb1652"
      unitRef="number">0.05</bmy:ExpectedSynergiesPercentage>
    <bmy:ExpectedSynergiesPercentage
      contextRef="ib2128162b71942e4b776ba571db5378e_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNjU5NzA2OTc3MDc0Nw_077f3f38-588a-49f3-ac21-ecbab862c0b3"
      unitRef="number">0.65</bmy:ExpectedSynergiesPercentage>
    <bmy:ExpectedSynergiesPercentage
      contextRef="i2f783f786f9448a0b27d839e744d1bc9_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNjU5NzA2OTc3MDc0Mg_b7044946-a617-41bb-9184-4b324817ae5a"
      unitRef="number">0.30</bmy:ExpectedSynergiesPercentage>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i12d6db6adf774cdabcbacab2830666d9_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNDk2_59f2c6f1-0bf9-4bde-a07b-cddeb6d5f777"
      unitRef="usd">3300000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i12d6db6adf774cdabcbacab2830666d9_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfNTc3_a4b81344-d429-4a79-b2ac-ad2d8dea197a"
      unitRef="usd">2700000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <bmy:Cashoutlays
      contextRef="i12d6db6adf774cdabcbacab2830666d9_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfOTAw_0fa0993e-2778-461a-8690-dbb2de3f71bd"
      unitRef="usd">3000000000</bmy:Cashoutlays>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="i516e76f80cdd42359e04bf1ea96e1dac_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfOTUz_e4c870e0-d7aa-4048-929d-5d288b0f2901"
      unitRef="employee">60</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i23137846d9234c9fb78c793ddf4c010d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMTIyMg_b077a501-9eae-4541-b901-17024bfb1389"
      unitRef="usd">150000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i23137846d9234c9fb78c793ddf4c010d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE5OTAyMzI1ODIzMQ_f271b7d7-3f25-4eeb-a9df-385487905539"
      unitRef="usd">120000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE4OA_5487fcb3-5511-4497-890c-d3faf838003d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoKardia Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i516e76f80cdd42359e04bf1ea96e1dac_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMi0xLTEtMS0yNzI5NQ_96f1049a-c1e5-49eb-9a7e-e001d795cbdd"
      unitRef="usd">127000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i139b81c5b6a346bf9ef0abd2a73d799c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMi0zLTEtMS0yNzI5NQ_5f7b6162-f2d6-4c16-bd3c-8efb80530566"
      unitRef="usd">173000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ie701346b5a5142f0878b322864036d13_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMy0xLTEtMS0yNzI5NQ_6de0d6cf-e130-453a-b57e-b67133bc5ba5"
      unitRef="usd">3000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="icd467c02ad904fbcb8a3366dc0661626_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMy0zLTEtMS0yNzI5NQ_c8ca4e22-19ae-45d4-bfb3-01b890faeb00"
      unitRef="usd">37000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNS0xLTEtMS0yNzI5NQ_3cfd0c37-e26a-4923-9a55-61005ec6d9bb"
      unitRef="usd">130000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNS0zLTEtMS0yNzI5NQ_470d75c1-11a0-4fea-b471-c2d7f53615d6"
      unitRef="usd">210000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNy0xLTEtMS0yNzI5NQ_9ffaaa55-caee-40c9-b055-ccfa3986bff7"
      unitRef="usd">22000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfNy0zLTEtMS0yNzI5NQ_6b8ac51c-6d1a-40a8-b04f-27c5bdd453ab"
      unitRef="usd">44000000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOC0xLTEtMS0yNzI5NQ_56893c72-7df0-44ca-a28c-05da2b26cf7f"
      unitRef="usd">1000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOC0zLTEtMS0yNzI5NQ_98312e46-1784-41d6-b361-3845554b3c12"
      unitRef="usd">1000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOS0xLTEtMS0yNzI5NQ_5b6003c7-6d98-45d1-a1d3-9fee363bdb9f"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfOS0zLTEtMS0yNzI5NQ_8b093615-8fe5-4164-9b37-f622934b0381"
      unitRef="usd">45000000</us-gaap:RestructuringCharges>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTAtMS0xLTEtMjcyOTU_ceb74098-83ba-4a43-b1a3-2edb47e7b433"
      unitRef="usd">105000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTAtMy0xLTEtMjcyOTU_5de737b0-2d5b-4979-bab6-029a17d66ba9"
      unitRef="usd">141000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTEtMS0xLTEtMjcyOTU_306ffa7a-0dd1-4ac7-b9af-796a3c625d7b"
      unitRef="usd">2000000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTEtMy0xLTEtMjcyOTU_33c1dc1a-1a8d-4895-a807-9b44f5b51fb0"
      unitRef="usd">0</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTItMS0xLTEtMjcyOTU_b65bb14f-c3b0-4a06-b61b-d0ce68f6b5c2"
      unitRef="usd">0</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTItMy0xLTEtMjcyOTU_6ddd6a9d-d24a-42db-b852-3380da1b09fc"
      unitRef="usd">24000000</bmy:RestructuringRelatedCostsAssetImpairments>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTQtMS0xLTEtMjcyOTU_13d9b33f-90cd-4674-a500-f175c73ca96b"
      unitRef="usd">130000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTQtMy0xLTEtMjcyOTU_ffffdf62-5dc2-44ff-8c9d-67f27965cdc3"
      unitRef="usd">210000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i2aa2fd0728f24dffbe302d8dc80f1127_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTYtMS0xLTEtMjcyOTU_a09a7b55-d995-4012-8176-6634023787be"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ieec5dffc23244b5680735c1a0cc27bf5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTYtMy0xLTEtMjcyOTU_69fabaf2-d1d3-43d7-8b75-238cc261f319"
      unitRef="usd">24000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i089a12daf0d440d892db99bd3cdae571_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTctMS0xLTEtMjcyOTU_e6d3c323-a2f1-415e-8fcc-e877d0ca9e3c"
      unitRef="usd">2000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8081637c0eb14bdbb47de184d2f39db5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTctMy0xLTEtMjcyOTU_402bfec5-a437-45aa-a173-df05d540ef83"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8f9bd83ec7e541a99e93bba471901a6f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTktMS0xLTEtMjcyOTU_d01cbacc-0837-4353-b62d-e2d1dd1d2785"
      unitRef="usd">128000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i2d88b3f3d9e0482a8367f95ffe5a0705_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMTktMy0xLTEtMjcyOTU_9f1eb377-ea72-4b8e-a515-ae3e7caee5c0"
      unitRef="usd">186000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMjAtMS0xLTEtMjcyOTU_a4909dc9-c7d0-4575-ba5b-98ddd80f0277"
      unitRef="usd">130000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOjQ2ZGQyMjRjNjQ1NzQ1NTRiZjQ3NzAzMzAzODdhMjk3L3RhYmxlcmFuZ2U6NDZkZDIyNGM2NDU3NDU1NGJmNDc3MDMzMDM4N2EyOTdfMjAtMy0xLTEtMjcyOTU_68a2e9ab-562b-48fc-923b-07de3c4ca6c5"
      unitRef="usd">210000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjE4OQ_296ef8e3-3095-436d-9c3f-dd0828019db1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $9 million and $1 million for the three months ended March 31, 2022 and 2021, respectively. Excludes $6 million for the three months ended March 31, 2021 of accelerated stock-based compensation relating to the Celgene Acquisition Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMi0xLTEtMS0yNzI5NQ_2596ff18-b380-41b8-9003-329cf4bb36f5"
      unitRef="usd">101000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i121f0f315b1344b1bbc371d09d847028_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMi0zLTEtMS0yNzI5NQ_b563aef6-464a-4678-8aa4-544df7d2c2bc"
      unitRef="usd">148000000</us-gaap:RestructuringReserve>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMy0xLTEtMS0yNzI5NQ_1e61f55b-c53f-4820-b07e-b7b7794db519"
      unitRef="usd">23000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfMy0zLTEtMS0yNzI5NQ_e8de5187-6749-4655-9d29-3b4dcdf8121f"
      unitRef="usd">39000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNC0xLTEtMS0yNzI5NQ_812371b6-c5f2-4484-8344-f586d27e61eb"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNC0zLTEtMS0yNzI5NQ_7e613ede-a5a5-45b3-bced-ecfd9ac0c8e2"
      unitRef="usd">-2000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:PaymentsForRestructuring
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNS0xLTEtMS0yNzI5NQ_d866a923-df66-4505-bfa7-128b47f9a88c"
      unitRef="usd">21000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNS0zLTEtMS0yNzI5NQ_f9e1edab-ff71-4baf-b4f0-a7b69cf1a319"
      unitRef="usd">59000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNi0xLTEtMS0yNzI5NQ_5eba60b2-d27a-4169-8863-b77362f41d8a"
      unitRef="usd">102000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if23774cb38994a048379d7991560faf3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RhYmxlOmY3MTUxNzM2ZmI5OTQ0MzJhZmMxNWJhMTNhZGM3ODgzL3RhYmxlcmFuZ2U6ZjcxNTE3MzZmYjk5NDQzMmFmYzE1YmExM2FkYzc4ODNfNi0zLTEtMS0yNzI5NQ_260c8868-ee52-4023-819b-15065e63cd19"
      unitRef="usd">126000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjAxMQ_c7b46a22-6611-416a-8d4d-2b304e0cff25"
      unitRef="usd">9000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjAxOA_93bd0580-1a8c-4b11-8520-9e2d39c28ef5"
      unitRef="usd">1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringCharges
      contextRef="ie820e29dd7454feeadcfda2589792e32_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80Ni9mcmFnOmNhOTZiMzQzOGY0YTRlZjFiMTZhMzk5MmE4ODQ3ODAxL3RleHRyZWdpb246Y2E5NmIzNDM4ZjRhNGVmMWIxNmEzOTkyYTg4NDc4MDFfMjA3MA_d7cd832f-a9e6-4161-b565-156d864b6cd4"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMjIzNg_151648ee-223c-4b18-8afe-7b1c9ffad359">INCOME TAXES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2022 and 2021 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that were not taxable in 2021. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that the amount of unrecognized tax benefits at March&#160;31, 2022 could decrease in the range of approximately $450 million to $500 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#x2019;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMjIyOQ_aee68269-57fd-4ffa-8dff-66c20da1be48">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMi0xLTEtMS0yNzI5NQ_fcb10733-789a-414b-9208-7e84f8fd0c2f"
      unitRef="usd">1687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMi0zLTEtMS0yNzI5NQ_3d15704a-b018-4c35-8ce6-4a06469d94e6"
      unitRef="usd">2530000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMy0xLTEtMS0yNzI5NQ_c65c390b-50df-4ca5-9bee-13c9b53fa6bf"
      unitRef="usd">404000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfMy0zLTEtMS0yNzI5NQ_ba9e4dc0-1994-4f35-8d2c-01da05240612"
      unitRef="usd">501000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfNC0xLTEtMS0yNzI5NQ_a2415179-d9ad-486b-9856-0de6be5fcb6a"
      unitRef="number">0.239</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RhYmxlOmZmNDY1ZTgyODAzNDQzNDBhMTUyZTI5ZWIzYjMxNGUxL3RhYmxlcmFuZ2U6ZmY0NjVlODI4MDM0NDM0MGExNTJlMjllYjNiMzE0ZTFfNC0zLTEtMS0yNzI5NQ_096c92e3-bf64-4c6f-bec9-4aadd63da907"
      unitRef="number">0.198</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="iac15ff867ba945e08768717f71115a24_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMTExMQ_e212e304-ae7f-4e0e-a471-cce1d75df896"
      unitRef="usd">450000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="if3737ead734c472998387ed737334fc1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml80OS9mcmFnOjI5OTIxNGU5MmNiNzRjNmNhNTNmY2YyNGVmZDM0M2NjL3RleHRyZWdpb246Mjk5MjE0ZTkyY2I3NGM2Y2E1M2ZjZjI0ZWZkMzQzY2NfMTExNw_08dfdf96-9c0c-4606-89dc-19ea1255360a"
      unitRef="usd">500000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RleHRyZWdpb246MTY2OWVlMGVjZTgyNDU2ZTk3Njk5MDJlOWY1ODY5YmVfMjc1_a249c75c-e5a3-4bcc-bb69-48af2d9e56d4">EARNINGS PER SHARE&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts in Millions, Except Per Share Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental Shares Attributable to Share-Based Compensation Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RleHRyZWdpb246MTY2OWVlMGVjZTgyNDU2ZTk3Njk5MDJlOWY1ODY5YmVfMjkz_e5fa0212-e14c-4c07-a5a4-f9e3121cf216">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts in Millions, Except Per Share Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental Shares Attributable to Share-Based Compensation Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMi0xLTEtMS0yNzI5NQ_9edbba8f-57fc-45da-9c03-b1a57fe1e17e"
      unitRef="usd">1278000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMi0zLTEtMS0yNzI5NQ_c7e6445f-f3d8-4d08-ae19-ba01525a8ce7"
      unitRef="usd">2021000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNC0xLTEtMS0yNzI5NQ_046f228b-6a9d-4642-b09b-a3d60d8cd639"
      unitRef="shares">2146000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNC0zLTEtMS0yNzI5NQ_293a4566-8ffb-443f-90c3-067f91cf9ebc"
      unitRef="shares">2236000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNS0xLTEtMS0yNzI5NQ_8247ad3c-aea3-4294-83da-abf276e794d3"
      unitRef="shares">18000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNS0zLTEtMS0yNzI5NQ_ef595dc1-34b4-4a8f-b5a1-cecfd5587eb4"
      unitRef="shares">29000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNi0xLTEtMS0yNzI5NQ_a2b87c14-3b32-4f0b-9a8c-94edb5fd4724"
      unitRef="shares">2164000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfNi0zLTEtMS0yNzI5NQ_32a3c183-ca85-486c-bbd4-935eb417ab07"
      unitRef="shares">2265000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfOS0xLTEtMS0yNzI5NQ_c3cb1530-a5cb-4292-a87e-f41613687c32"
      unitRef="usdPerShare">0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfOS0zLTEtMS0yNzI5NQ_9d470f8d-9915-4d81-9818-fcb2a62d8372"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMTAtMS0xLTEtMjcyOTU_8563ad67-9da6-4c9f-94e1-0303dbac7be1"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81Mi9mcmFnOjE2NjllZTBlY2U4MjQ1NmU5NzY5OTAyZTlmNTg2OWJlL3RhYmxlOmZlMTIyNWFiOGUxODRkNjg5ODY0NDEzMGRkYWNkYTEwL3RhYmxlcmFuZ2U6ZmUxMjI1YWI4ZTE4NGQ2ODk4NjQ0MTMwZGRhY2RhMTBfMTAtMy0xLTEtMjcyOTU_c2a9f8cd-a749-47c2-ad7f-02b093f649f9"
      unitRef="usdPerShare">0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY5OA_151243fc-6efd-4145-b844-bef478a8f76e">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents - money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As further described in &#x201c;Item 8. Financial Statements and Supplementary Data&#x2014;Note 9. Financial Instruments and Fair Value Measurements&#x201d; in the Company&#x2019;s 2021 Form 10-K, the Company&#x2019;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Marketable Debt Securities and Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determined fair values&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss/(gain) recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized on investments sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss/(gain) recognized on investments still held&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net (income)/loss of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Qualifying Hedges and Non-Qualifying Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges is temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold and Other (income)/expense, net) within the next 24 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $5.3 billion and Japanese yen of $1.3 billion at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Non-U.S. dollar borrowings of &#x20ac;950 million ($1.1 billion) at March&#160;31, 2022 are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross-currency interest rate swap contracts of $600 million at March&#160;31, 2022 are designated to hedge Japanese yen currency exposure of BMS&#x2019;s net investment in its Japan subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Accumulated other comprehensive loss with a related offset in Other non-current assets or Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (0.45% as of March&#160;31, 2022) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, Treasury lock contracts were entered into with a total notional value of $3.0&#160;billion to hedge interest rate risk associated with the anticipated issuance of long-term debt. The Treasury lock contracts were terminated upon the issuance of the aggregate $6.0&#160;billion of unsecured senior notes. These contracts were not designated for hedge accounting. The settlement of these contracts were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, Treasury lock contracts were entered into with a total notional value of $2.3&#160;billion to hedge cash payment for the anticipated redemption of long-term debt. The Treasury lock contracts were terminated upon pricing the debt redemption. These contracts were not designated for hedge accounting. The settlement of these contracts were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of outstanding derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swap contract loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. dollar borrowings gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 18 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of long-term debt was $45.8 billion at March&#160;31, 2022 and $49.1 billion at December&#160;31, 2021 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March 31, 2022, BMS issued an aggregate principal amount of $6.0&#160;billion of debt consisting of $1.75&#160;billion of 2.950% Notes due 2032, $1.25&#160;billion of 3.550% Notes due 2042, $2.0&#160;billion of 3.700% Notes due 2052 and $1.0&#160;billion of 3.900% Notes due 2062 with proceeds net of discount and deferred loan issuance costs of $5.9&#160;billion. The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, BMS purchased aggregate principal amount of $5.2&#160;billion of certain of its debt securities for approximately $5.8&#160;billion of cash in tender offers. In connection with these transactions, a $275&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, BMS purchased aggregate principal amount of $849&#160;million of certain of its debt securities for approximately $880&#160;million of cash pursuant to &#x201c;make whole&#x201d; redemptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March 31, 2021, BMS purchased aggregate principal amount of $3.5&#160;billion of certain of its debt securities for approximately $4.0&#160;billion of cash in a series of tender offers and &#x201c;make whole&#x201d; redemptions. In connection with these transactions, a $281&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. In addition, the $500&#160;million 2.875% Notes matured and were repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest payments were $377 million and $435 million for the three months ended March 31, 2022 and 2021, respectively, net of amounts related to interest rate swap contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, we had four separate revolving credit facilities totaling $6.0&#160;billion, which consisted of a 364-day $2.0&#160;billion facility which expired in January 2022, a three-year $1.0&#160;billion facility which expired in January 2022 and two five-year $1.5&#160;billion facilities that were extended to September 2025 and July 2026, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, we entered into a five-year $5.0&#160;billion facility expiring in January 2027, which is extendable annually by one year with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. Concurrently with the entry into this facility, the commitments under our existing five-year $1.5&#160;billion facilities were terminated and the three-year $1.0&#160;billion facility and 364-day $2.0&#160;billion facility expired in accordance with their terms in January 2022. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No borrowings were outstanding under any revolving credit facility at March&#160;31, 2022 or December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcyNA_0bae2b43-d34b-4134-8d4f-970e26a6c8a3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents - money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi0xLTEtMS0yNzI5NQ_4fd6d59f-21d6-4b79-8632-7bf4c3e70921"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi0zLTEtMS0yNzI5NQ_c733c6eb-e74c-4158-b0c5-bd21d4d0dd7c"
      unitRef="usd">9467000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi01LTEtMS0yNzI5NQ_2953f426-937d-47e4-b02f-1c6b5904d8ef"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi03LTEtMS0yNzI5NQ_f1c0a7ba-c1d2-4962-b37c-273241dc757b"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi05LTEtMS0yNzI5NQ_535b2adc-d5dd-44ad-93fa-4115731d2bc0"
      unitRef="usd">12225000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMi0xMS0xLTEtMjcyOTU_b6dc8d5f-6f9b-403f-8235-c164591dfe8c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1e64717c46e2400a97f81398c8d0374c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC0xLTEtMS0yNzI5NQ_98ee5f32-cdd1-49fd-b078-1ed73b9f1b86"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i28a1e87b23874c8eacd18f1ad4aa9add_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC0zLTEtMS0yNzI5NQ_a657ea4a-844b-4c99-b028-fedf7ca2af08"
      unitRef="usd">2013000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d63750fda014807bbcd56fb175d10a9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC01LTEtMS0yNzI5NQ_6f2bc1a7-57fa-407c-b5f7-36d45dd8989a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5de987abfdb443b93461d539e729e92_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC03LTEtMS0yNzI5NQ_21e9dac1-b62e-4f73-820e-56f38ba76c84"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i07a6c1fe57b34a058a7de4f31cf06e2c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC05LTEtMS0yNzI5NQ_59583998-6bcb-4b58-8012-32c9b64d112c"
      unitRef="usd">2264000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5440b5726884812b270641d64a0dd80_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNC0xMS0xLTEtMjcyOTU_672616fe-39a1-4759-8209-8fe4f9f692bf"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8730c16fa2124420ad23b93d7bff6eae_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS0xLTEtMS0yNzI5NQ_e22ada9a-f976-4139-9400-f3fd4f163a6f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id84841d50f3446ed84387ba6ada423f6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS0zLTEtMS0yNzI5NQ_4c99f6d0-9da7-48d2-ba0d-6039685188e0"
      unitRef="usd">325000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i55f98b5adf714f79bd06b87cb1ca1c47_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS01LTEtMS0yNzI5NQ_e6b86918-ed89-411c-b44f-09fdf1d87aa0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i07436549e87f4e09ba843a7f11c2ef4b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS03LTEtMS0yNzI5NQ_9824a5d9-c29f-4818-9e3c-5de37680e87c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i657d695839694e69b3011d5fdff9bfcf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS05LTEtMS0yNzI5NQ_4fb19395-747f-4706-9e8d-c673e5e27a8e"
      unitRef="usd">320000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ee548ed4d014862a23a2e41e04dcfb8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNS0xMS0xLTEtMjcyOTU_5c5bf4b9-12a5-4029-a71a-0cd738a68492"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib9417f816d8346449f70d564c31c8232_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi0xLTEtMS0yNzI5NQ_93649112-fb0c-4e9c-a39d-975ce77a159a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i18ef79d98b8b458b8d5ae10afecfa045_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi0zLTEtMS0yNzI5NQ_34b88870-dd4b-4e08-90a9-9c9660bf55e2"
      unitRef="usd">261000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id1eb561378dd46158ad6987dfa95b2e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi01LTEtMS0yNzI5NQ_b9d6f521-81a7-4519-a20a-37c1abd383d3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia562dbc127b64bca93c9e0e3a0c509f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi03LTEtMS0yNzI5NQ_657a3394-5a04-4b1c-a1b2-9ec6d54df697"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i07c4d4e0667e4d429b61aaf7baf0828b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi05LTEtMS0yNzI5NQ_90a3d51f-7bbc-443c-adb0-c923feb5c4a1"
      unitRef="usd">403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5bd8959f86cb435ba9b5ced3da83baa2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNi0xMS0xLTEtMjcyOTU_3a85aa47-0c33-4987-8450-2b1d4374d934"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeAssets
      contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy0xLTEtMS0yNzI5NQ_2c66ad08-8c51-4597-97fe-f71237081c90"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy0zLTEtMS0yNzI5NQ_963d0e55-fc68-4378-bc7e-ce0e9cc95313"
      unitRef="usd">288000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy01LTEtMS0yNzI5NQ_6dda514e-0a8e-4ec2-a610-6fd7963524bf"
      unitRef="usd">10000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy03LTEtMS0yNzI5NQ_bbf23459-7258-4524-9bd3-ec87b42494b9"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy05LTEtMS0yNzI5NQ_8eeb027f-b7fe-4e54-bd72-082e5275dd7c"
      unitRef="usd">206000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfNy0xMS0xLTEtMjcyOTU_099d9720-7edc-46d1-bdda-fb1aae77a937"
      unitRef="usd">12000000</us-gaap:DerivativeAssets>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id45f66ca4c144aad9c93d9577eb6610f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC0xLTEtMS0yNzI5NQ_f47dac98-6056-41bf-af82-eebee7738ecd"
      unitRef="usd">1410000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia5eeb90de7b546b38702bb042382ad6c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC0zLTEtMS0yNzI5NQ_d89bade2-100a-4545-adb3-8461886020eb"
      unitRef="usd">44000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2af25476ca044b10b93598d008520e3a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC01LTEtMS0yNzI5NQ_06902d9e-044c-4f0a-a742-09fad554d879"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ided76e89faa14fb89fea1a513818349d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC03LTEtMS0yNzI5NQ_3b81a400-df71-4889-806b-b30e4067570c"
      unitRef="usd">1910000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i76259749605b40899b4e06aab3db1dd9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC05LTEtMS0yNzI5NQ_a7156e83-8f45-4b8c-a7c7-a97d6539902b"
      unitRef="usd">109000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i55d8abd26bae40a881d0203c7f5d26f7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOC0xMS0xLTEtMjcyOTU_a0e49ae8-4962-4b90-97a2-aebf58447606"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeLiabilities
      contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS0xLTEtMS0yNzI5NQ_1d8d05bd-525d-4d52-8c9b-eedb18c01cfb"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS0zLTEtMS0yNzI5NQ_4fbbac74-4e2d-457e-8252-cb08caccb6bf"
      unitRef="usd">58000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS01LTEtMS0yNzI5NQ_eb34a72f-83ea-4adb-82db-67aa193dc3cc"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS03LTEtMS0yNzI5NQ_1c072510-d78a-4b48-9ea0-3ddcae929920"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS05LTEtMS0yNzI5NQ_b8f8ba53-fb1c-431a-a59a-ba68cd3a3a31"
      unitRef="usd">25000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfOS0xMS0xLTEtMjcyOTU_dd195b79-7c87-4c8e-9d36-2a78d942c641"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if46527a7d9d040a89955d6678f7dd798_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtMS0xLTEtMjcyOTU_0f532e48-c4b0-4443-977d-08a940189266"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0b15840afac84e27867bc9638f1a02ca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtMy0xLTEtMjcyOTU_20fa5a5b-4943-4e3d-ac12-a0a88a45b31b"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i827262d1464b41e18c2ea4b9f616c5b6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtNS0xLTEtMjcyOTU_27bed916-0952-44b5-b595-db150f440a20"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4a1b1b455dec4c84be7953f38d2d9bb5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtNy0xLTEtMjcyOTU_7c991b43-605f-4bef-a3b9-32f3045a6341"
      unitRef="usd">8000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1d0dd974b62542bd9f7d4c17c8f19a91_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtOS0xLTEtMjcyOTU_984ab3a3-5fd0-46a5-974f-53c945fd42dc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8c8000b84b6b4ec1847d7fc23d26aef2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTEtMTEtMS0xLTI3Mjk1_7c99f6f0-98fe-4777-aec8-d576150b408f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id8b9accf8c5243ff9ac7aff11bd99cba_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItMS0xLTEtMjcyOTU_14723d6e-a4f1-40af-a038-7624f05858d7"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i094847c77fb343f2ae6b1fc831c2c140_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItMy0xLTEtMjcyOTU_7bc20124-6b03-4cc4-8c81-d508252c3481"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id81a792f755b44c7bf4c6b878d13f35a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItNS0xLTEtMjcyOTU_c3fed2b8-cf39-4c67-9c1d-17b9440dedd7"
      unitRef="usd">34000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iff1de5ce47324c2fb72e6c5bcb3a3065_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItNy0xLTEtMjcyOTU_78e4fafd-d382-44f1-b867-2916b2bd072c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i65dc0d7fa7d446be88f8eb295d016860_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItOS0xLTEtMjcyOTU_8b8d13ef-f9e9-4eea-88f2-998cc7eb2241"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6d46c78bea8e4ef9a28b608ba4aabeca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZhMGU0NDAzZjJiMzQ1MmNiNzdkNGIxODRiZGQ0YmQzL3RhYmxlcmFuZ2U6ZmEwZTQ0MDNmMmIzNDUyY2I3N2Q0YjE4NGJkZDRiZDNfMTItMTEtMS0xLTI3Mjk1_135d56c8-91e4-4daf-a058-8d1f36396112"
      unitRef="usd">35000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY1MA_325a7682-6fb1-42aa-8cd2-33e929d306a3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xLTEtMS0yNzI5NQ_79035f37-2e49-4dd6-babc-25df5969bd1a"
      unitRef="usd">2013000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0zLTEtMS0yNzI5NQ_d340a40b-dd5b-44a1-a6ce-70babb893106"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy01LTEtMS0yNzI5NQ_41c08c6d-c7c4-4ac7-bc31-5e1f328910e9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifdd54f4445514f5bbfc3b39bede0e0a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy03LTEtMS0yNzI5NQ_f8119236-0f33-4e68-95e3-55b5277bd446"
      unitRef="usd">2013000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy05LTEtMS0yNzI5NQ_58ec6b83-bcbc-437c-9f7b-df003bc97f69"
      unitRef="usd">2264000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xMS0xLTEtMjcyOTU_d6134e80-5564-4302-9456-81737fa7ef3a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xMy0xLTEtMjcyOTU_238bbe04-eca4-4a48-bbb5-189d788c9295"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9b034eee41f46d6adaf1974b8f3b173_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfMy0xNS0xLTEtMjcyOTU_836ad72e-6e7e-4a93-b906-f3750f828ed7"
      unitRef="usd">2264000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xLTEtMS0yNzI5NQ_1a4c41a3-cf79-42f6-9d6b-a89f7ffcc1d4"
      unitRef="usd">325000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0zLTEtMS0yNzI5NQ_af1bea93-1148-4387-8ce9-11e64a3cdc9d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC01LTEtMS0yNzI5NQ_439892ee-13ad-49c1-83e0-46b4ce1a798d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43abbff1f262401fb3df50f9b876709d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC03LTEtMS0yNzI5NQ_7a6eefc8-7cec-4c0a-a31c-13505f68ccfa"
      unitRef="usd">325000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC05LTEtMS0yNzI5NQ_6aa32e68-3840-456b-84d2-b4c6e889e9ac"
      unitRef="usd">320000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xMS0xLTEtMjcyOTU_0b13e770-aff5-4c7a-8f4a-f332110b3bfe"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xMy0xLTEtMjcyOTU_8a2842d6-f663-4156-8834-013bec6221bd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id0b4add97b0248e29be39ea97307e4ac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNC0xNS0xLTEtMjcyOTU_1b99bc3c-786b-4097-8ba1-14ed9491da8d"
      unitRef="usd">320000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xLTEtMS0yNzI5NQ_bae89cd8-2c19-4aa3-9af2-98d3e4f88e82"
      unitRef="usd">260000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0zLTEtMS0yNzI5NQ_8ec1ccb7-99cc-43dd-80a7-a538e2a8d877"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS01LTEtMS0yNzI5NQ_2de10b30-efe8-48c8-a80d-030742f57868"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie65d93959a1c4c44be1dedff4f283412_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS03LTEtMS0yNzI5NQ_ce2d5d44-3315-4589-afcf-72e42b598c4d"
      unitRef="usd">261000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS05LTEtMS0yNzI5NQ_14d77178-6d5d-47bb-906d-11b0d5e2cf72"
      unitRef="usd">401000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xMS0xLTEtMjcyOTU_6e8bce69-ae28-4ac8-9db9-4caf7502971d"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xMy0xLTEtMjcyOTU_c60e7a15-60c3-403a-8260-c0105af8075d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7ec862f58d95421887612d3ca08ef64f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNS0xNS0xLTEtMjcyOTU_99160e10-9160-45bf-bb28-89100533b2a6"
      unitRef="usd">403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xLTEtMS0yNzI5NQ_c07c6fed-c25b-4020-b6d9-9f2f82d1eaa1"
      unitRef="usd">2598000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0zLTEtMS0yNzI5NQ_5cef8070-0465-4532-989a-34241f27cff0"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi01LTEtMS0yNzI5NQ_f9a794fd-c97c-4d93-9496-82b8dceaa64e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi03LTEtMS0yNzI5NQ_4708c804-fe24-4b01-94ed-dcf0ea4dbdd1"
      unitRef="usd">2599000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi05LTEtMS0yNzI5NQ_13ede9e3-94e2-4529-963b-311db43e44a3"
      unitRef="usd">2985000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xMS0xLTEtMjcyOTU_697514d4-c03c-4794-b99d-2f460769614f"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xMy0xLTEtMjcyOTU_327e47ec-9d4b-4dd4-9e8c-9ebf6b4649a0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjIwOTkzMTA2ZmM4ZTQ1Yjk5YTQxY2JjN2FlNjg3MGU1L3RhYmxlcmFuZ2U6MjA5OTMxMDZmYzhlNDViOTlhNDFjYmM3YWU2ODcwZTVfNi0xNS0xLTEtMjcyOTU_e794ebf0-acb7-486c-a74c-fa2bf7c06d36"
      unitRef="usd">2987000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <bmy:ScheduleOfEquityInvestmentsTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY2NQ_340d8521-d02c-4a50-8d98-8df40b1bb197">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfEquityInvestmentsTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMS0xLTEtMS0yNzI5NQ_fe35d97d-31fe-46c0-9980-a9f407f61bf1"
      unitRef="usd">1454000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMS0zLTEtMS0yNzI5NQ_243df356-1173-48ba-becb-c552558a95ea"
      unitRef="usd">2019000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMi0xLTEtMS0yNzI5NQ_34db866c-2dde-4a40-9286-dc2e6ffe3fde"
      unitRef="usd">330000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMi0zLTEtMS0yNzI5NQ_ffd4b52f-fb0b-4cb1-9711-1c4557ebf4c9"
      unitRef="usd">283000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMy0xLTEtMS0yNzI5NQ_5d0df849-4d46-483b-9415-b5df408f5410"
      unitRef="usd">629000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfMy0zLTEtMS0yNzI5NQ_9330da2a-3f46-47fb-a8cf-72d791d9a5aa"
      unitRef="usd">666000000</us-gaap:EquityMethodInvestments>
    <bmy:EquityInvestments
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfNC0xLTEtMS0yNzI5NQ_229c4e5d-e688-4088-a751-1725bec46432"
      unitRef="usd">2413000000</bmy:EquityInvestments>
    <bmy:EquityInvestments
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjYzNDY0ODc2Nzc0MjQyNGFiZjlmMDFmMWE3MDNiOGNkL3RhYmxlcmFuZ2U6NjM0NjQ4NzY3NzQyNDI0YWJmOWYwMWYxYTcwM2I4Y2RfNC0zLTEtMS0yNzI5NQ_e9101bbc-8887-4247-bbb2-8a1def2a6a1c"
      unitRef="usd">2968000000</bmy:EquityInvestments>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcyOA_52a505ff-370c-4902-9b38-e799b4ba0ccb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determined fair values&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss/(gain) recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized on investments sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss/(gain) recognized on investments still held&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative upward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative impairments and downward adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net (income)/loss of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year's presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMi0xLTEtMS0yNzI5NQ_d0378f05-8d1c-444f-85cb-43e774f258ba"
      unitRef="usd">-598000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMi0zLTEtMS0yNzI5NQ_3918b44b-c1cc-4658-8d8e-10e42b660cbf"
      unitRef="usd">196000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMy0xLTEtMS0yNzI5NQ_d1ebd563-787b-451b-a85c-7459bec4ca5e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMy0zLTEtMS0yNzI5NQ_9386b62b-10fe-4a7d-961a-df1906b79da2"
      unitRef="usd">-3000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNC0xLTEtMS0yNzI5NQ_28e032c3-7780-4bc6-a450-bd9abe779475"
      unitRef="usd">-598000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNC0zLTEtMS0yNzI5NQ_4aecebe9-ad60-4270-8c78-7837cc99cce7"
      unitRef="usd">199000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNi0xLTEtMS0yNzI5NQ_dde1cc53-3361-45aa-b5f5-43503d174766"
      unitRef="usd">6000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNi0zLTEtMS0yNzI5NQ_9f403bed-7043-478c-8930-5ae8c6209e5a"
      unitRef="usd">269000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNy0xLTEtMS0yNzI5NQ_d4ee5843-2de2-4508-a7d4-2e3c0f43a7b7"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfNy0zLTEtMS0yNzI5NQ_0cba1ae1-e31f-40cd-ab52-50afe285e14c"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfOS0xLTEtMS0yODAyNw_3f1b6c3f-874e-46e7-80c2-37682649967c"
      unitRef="usd">109000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="if23774cb38994a048379d7991560faf3_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfOS0zLTEtMS0yNzYzNQ_3ee21869-76a9-4c87-a732-c6481839787e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTAtMS0xLTEtMjgwMjc_f873df08-17be-4a59-8c43-d72bdebb1e86"
      unitRef="usd">52000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="if23774cb38994a048379d7991560faf3_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTAtMy0xLTEtMjc2MzU_7f072882-57b4-4571-8491-2c85f2b80236"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTItMS0xLTEtMjcyOTU_b73cb0a2-c9e3-4daf-aaff-bbdd9b92f3f8"
      unitRef="usd">-50000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMTU3ZGI5ZDg3YzQ1Yjg4ZjkxMzA2NzE5ZWRiYmIwL3RhYmxlcmFuZ2U6NWYxNTdkYjlkODdjNDViODhmOTEzMDY3MTllZGJiYjBfMTItMy0xLTEtMjcyOTU_84df8100-90b7-4033-b9bf-417480d0ea36"
      unitRef="usd">137000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iba04377d339644409c75c7a51794a485_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzMxMA_d232c678-5af1-48a1-882a-b311c71f82f0"
      unitRef="eur">5300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5a219ea76db64e0e8730984c387c5cce_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzMzMw_a0b5f9fe-37bf-4bf7-b239-665918f27767"
      unitRef="jpy">1300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaf91d20822624a328fbe024d1ac258de_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNTQxMw_3f31415a-5380-4565-aa76-35900bd09c28"
      unitRef="eur">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaf91d20822624a328fbe024d1ac258de_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNTQxNw_4881d0e6-b021-4b26-8df4-13c77b396a0c"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9bdb869eecbb469c9bf0310b8e728219_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNTg2MQ_a65b2c6c-942c-428b-8336-b45509bb38ba"
      unitRef="usd">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ifa8aa0d818c149aa92bb61f130372893_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU2OQ_9b0a29d3-e1c5-4077-8f97-6c5e3efaf53e"
      unitRef="number">0.0045</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjYxNA_d3d55403-b9ea-45c0-b0be-62f2c73a2427"
      unitRef="number">0.046</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8c471c3a99b34ecda06e75a57da1ce44_I20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY1MTI0NA_aeb582b0-7584-4917-88be-5ab980ed8070"
      unitRef="usd">3000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1e0b11c565d843cd800a00cce43f9006_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY1MTI0MQ_555edd07-1a09-4558-ae7f-b6237559074c"
      unitRef="usd">6000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if3ea42357cdc414391b58ca0ccf786db_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY1MTI1OA_0fa4403f-2a5f-4984-beab-8b9dfff5230e"
      unitRef="usd">2300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY1OQ_ecd8eb49-8941-4052-8abb-be3577801257">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of outstanding derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i163f0d0fccd34d7385555f74e0a794a7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xLTEtMS0yNzI5NQ_9dd07696-2cde-4806-9dab-af200d9169b9"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i9206328440464f8e839a11661b43c8a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0zLTEtMS0yNzI5NQ_73c301e4-39f3-4ba4-b751-c6706cf9ec3e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i55598a609c114f67a4cd37885de32e1d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC01LTEtMS0yNzI5NQ_4e455a18-6bf1-4233-b0be-ff21f2eb28b6"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i9206328440464f8e839a11661b43c8a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC03LTEtMS0yNzI5NQ_c44a97f7-acb2-4adb-9c5d-929100c9d409"
      unitRef="usd">-3000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic177dd5bb64d454c86bc6072ebd749cb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC05LTEtMS0yNzI5NQ_55a43b23-648a-4118-b9f5-41fbde758094"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i113230baa650402d97981ca827bc4de6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xMS0xLTEtMjcyOTU_8043e3ce-1793-4c92-aa1e-24df62d86383"
      unitRef="usd">10000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if54b70af5b76417a806e38ea5e1d407d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xMy0xLTEtMjcyOTU_021a0ceb-91ef-4686-800e-b73bd1be30b0"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i113230baa650402d97981ca827bc4de6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNC0xNS0xLTEtMjcyOTU_6e9ac854-80e0-4e25-aedb-90d8d682757d"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia276049873e54e59b3bf07c8d5e24ab4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xLTEtMS0yNzI5NQ_d12c8ccb-9ecd-4be2-9e2f-95a2f8ada21f"
      unitRef="usd">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="iba35d244942447b99ebc571324ef1dee_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0zLTEtMS0yNzI5NQ_32b3168f-f3c0-4ed6-8cda-c564cfa6879f"
      unitRef="usd">37000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i15954e5f8f0e40debb23d733b33aaa1e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS01LTEtMS0yNzI5NQ_5dfc60c4-dd8e-43df-86fd-1c9114ad927d"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="iba35d244942447b99ebc571324ef1dee_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS03LTEtMS0yNzI5NQ_3fcb2729-796a-42fd-90a0-b60a1d08b90d"
      unitRef="usd">-1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2d9389451e47486e902034a32c3e09c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS05LTEtMS0yNzI5NQ_8b41a2ef-418d-43b1-91f8-5b001ca4a9e2"
      unitRef="usd">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i7a9ada9042874bf182eaadf231a4c890_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xMS0xLTEtMjcyOTU_3b525538-424e-4c83-91d7-e08edf0b6f6e"
      unitRef="usd">26000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib92f31c4fa40457aba15667be923fd82_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xMy0xLTEtMjcyOTU_1f185f05-d677-4329-a007-ff32e0dac0f3"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i7a9ada9042874bf182eaadf231a4c890_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNS0xNS0xLTEtMjcyOTU_b9775df1-d8ea-4210-98b4-5497eb2f90ee"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id16452daa2024ee899435e33c8107110_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xLTEtMS0yNzI5NQ_0543c2ac-5609-4804-861d-7ddbae05b0d2"
      unitRef="usd">5409000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i3096f2c934e04de28c49313517b1c847_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0zLTEtMS0yNzI5NQ_505b9c56-673d-4366-91cb-10100fb2cdb9"
      unitRef="usd">230000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i91abf09684ca431e82f000c3018b6f09_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi01LTEtMS0yNzI5NQ_fa33e5b8-f6c5-4a59-9a4e-3c1f594a2915"
      unitRef="usd">2492000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i3096f2c934e04de28c49313517b1c847_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi03LTEtMS0yNzI5NQ_1808c978-dbf1-40e4-9bd7-eac18eda1d6d"
      unitRef="usd">-44000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9f017519dcc04d71a28d222bc83fa92b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi05LTEtMS0yNzI5NQ_7b21edcc-97df-4462-83aa-522de11424aa"
      unitRef="usd">3587000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i90219dc5ee1b4ec399ce30e3c157467c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xMS0xLTEtMjcyOTU_4683d6c1-5245-41e5-9a17-ef8d940323dd"
      unitRef="usd">161000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ice8a3ac0991c4c81bd0f404665c335f3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xMy0xLTEtMjcyOTU_d353267a-4797-435d-9c1c-d40e0b971543"
      unitRef="usd">1814000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i90219dc5ee1b4ec399ce30e3c157467c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfNi0xNS0xLTEtMjcyOTU_6119b4c7-890e-4a7d-aa55-a6818f67aabc"
      unitRef="usd">-20000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic465ba0286fb496c8fae21240e7d3f20_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xLTEtMS0yNzI5NQ_fdee5e8d-f846-4741-9d65-f92d62d0295f"
      unitRef="usd">744000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ie4813222bf3b4237ba720be703e50ec0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0zLTEtMS0yNzI5NQ_359a3226-b8ea-454b-b26f-e4f04279bf65"
      unitRef="usd">21000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i61598df0bf2f4820b2d1aa70b7ebdec2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS01LTEtMS0yNzI5NQ_db7ce0b8-6cf1-4ab4-b589-9f8b50708a90"
      unitRef="usd">629000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ie4813222bf3b4237ba720be703e50ec0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS03LTEtMS0yNzI5NQ_0fb885b9-131c-49d4-a488-5ebae6f72b47"
      unitRef="usd">-10000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i97cdafa0cdbb43d1a935dd3533f1c50f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS05LTEtMS0yNzI5NQ_4c9550eb-9ff1-4442-9adb-566be5de69bb"
      unitRef="usd">883000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i58a89f11019b4792a01527b1d0647136_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xMS0xLTEtMjcyOTU_4729efcf-362a-4ed5-a031-006f394f0b77"
      unitRef="usd">9000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icaeaf5cae69a45de99a6f4a1e9213d18_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xMy0xLTEtMjcyOTU_585444f9-5a2a-44f3-a782-6776dce2413e"
      unitRef="usd">568000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i58a89f11019b4792a01527b1d0647136_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfOS0xNS0xLTEtMjcyOTU_68fe1960-0bea-4522-afce-1d754d529b72"
      unitRef="usd">-5000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4cb747a19155484fb0a6e5942ee35dae_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMS0xLTEtMjcyOTU_c0c9f1a4-8431-4203-9846-c7809b8f1080"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i936bc96f5135495e83a811e835de4a2b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMy0xLTEtMjcyOTU_6e7f676d-cc64-46ae-8deb-0fe3d7dcd952"
      unitRef="usd">10000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i32cf6ce35e3d4d049918c1ce536767fe_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtNS0xLTEtMjcyOTU_faa664f0-3c8a-4560-b758-31409fd3d0e0"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i936bc96f5135495e83a811e835de4a2b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtNy0xLTEtMjcyOTU_1f16f07a-111f-4a15-b11c-41de1160a1db"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7c8517489c824a32aa5646d0832375df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtOS0xLTEtMjcyOTU_81485805-e7c7-4145-b5c6-d20b6ef71557"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i03fa5bfd2bd145b2ad628c77bd80cb19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMTEtMS0xLTI3Mjk1_b8c676bc-2475-481f-a96a-39ada52cdbfc"
      unitRef="usd">12000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i80cf390abecb4fe5b76b4c01abe05068_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMTMtMS0xLTI3Mjk1_6c0f265b-4b07-4924-8ead-f378795a8000"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i03fa5bfd2bd145b2ad628c77bd80cb19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjE5NjY3YTBhNGUxMzRjNzFhMzg5YmM4ZDFlMmFkNWM1L3RhYmxlcmFuZ2U6MTk2NjdhMGE0ZTEzNGM3MWEzODliYzhkMWUyYWQ1YzVfMTEtMTUtMS0xLTI3Mjk1_6c270609-bb51-4778-881b-b864c82fbd56"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcwOQ_5b1c2bee-65b4-4692-afbe-afb4ecd70a7e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swap contract loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. dollar borrowings gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 18 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5b589631ea674d988596b27dfe9491d0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi0xLTEtMS0yNzI5NQ_6830bbee-c8ee-4f07-b0e4-76646fcbb1dd"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic5b1608a17e14eb7b4319cb2fed7bd5f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi0zLTEtMS0yNzI5NQ_fa41221d-4f4e-4d97-a5f1-3d02b7f5080b"
      unitRef="usd">-11000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i89e5eb4f2fc54341a81746b993921e88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi01LTEtMS0yNzI5NQ_39a1b1ba-8b49-45f3-b315-3e243e9af259"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if9c22056c58444adbcb1e2bc577ceb6e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMi03LTEtMS0yNzI5NQ_c30857b7-923b-40b5-b48f-e7459b433327"
      unitRef="usd">-8000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i8a2104a59240458e98947f2acda759e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy0xLTEtMS0yNzI5NQ_2f3d7fe8-789d-4dcd-a785-fe8a55502b83"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i78573b9f974642299bc3a4a346f6d3cf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy0zLTEtMS0yNzI5NQ_93b8b1b8-ca9c-4eba-a65e-2df4f671b5ff"
      unitRef="usd">-4000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i64626f3fe0164c9c82c44f1051505316_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy01LTEtMS0yNzI5NQ_f1280663-0c4f-432b-abc7-7c254f9953ae"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9cdfda20ae8a4ab98ea04f90f98a6432_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfMy03LTEtMS0yNzI5NQ_50e1b7ad-8e56-4256-b298-0f530644c737"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia0511d5a39094272ac5c6248e8167fa4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC0xLTEtMS0yNzI5NQ_51ca0989-109b-4cbc-bcc6-cd66b472327c"
      unitRef="usd">-82000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i83d83401572a4528805417b147f0bbc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC0zLTEtMS0yNzI5NQ_d15b9afd-ea7f-4f79-9861-7efe4f769f65"
      unitRef="usd">-57000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5fcdfacdd7c24cc7abd9cc7e5da883d5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC01LTEtMS0yNzI5NQ_4e114422-e470-49be-abbd-08bcd60f450c"
      unitRef="usd">67000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i261481db1532401aba4104d90a4ea56e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmZmNjE0NTU1MzUwNTQzYjc5NWNiY2VmYjVlZDlhNTFlL3RhYmxlcmFuZ2U6ZmY2MTQ1NTUzNTA1NDNiNzk1Y2JjZWZiNWVkOWE1MWVfNC03LTEtMS0yNzI5NQ_2e1e733b-e6d0-434a-8136-69bbc8a3bcf3"
      unitRef="usd">-32000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie37f56aa23264798a7f027c4249e913d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNC0xLTEtMS0yNzI5NQ_14f7e348-9699-4917-a03d-70e4ff41690f"
      unitRef="usd">120000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0c3c98aa282840c49d1057bd807271bc_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNC0zLTEtMS0yNzI5NQ_2d3e696e-0882-48b0-97e7-11aa23ee5a7c"
      unitRef="usd">259000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia0511d5a39094272ac5c6248e8167fa4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNS0xLTEtMS0yNzI5NQ_2b45775a-3601-412d-86f6-644efd8f2286"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i5fcdfacdd7c24cc7abd9cc7e5da883d5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNS0zLTEtMS0yNzI5NQ_3f9e8035-2c65-48f6-bbdb-a1923cf13670"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i89c5148aeb1d4af989c7f56cfcd9e51d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNi0xLTEtMS03NTM0Mg_952a2f13-5a8f-452c-9d87-b3ee3e54d226"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="if068c2cd34c84c29aba8109de255a3f1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfNi0zLTEtMS03NTM0Mg_e95f2967-4c49-4e1c-80bf-2f0ce9445496"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i770251dbb1814ce4a3a299dd66902cb9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTItMS0xLTEtMjcyOTU_7b55bb92-46a6-4d63-b026-47f9c991cddf"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if5f476f6d59c4d2f8abff0b07711d3ee_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTItMy0xLTEtMjcyOTU_9a3b51d6-814d-402f-915c-b4dcc3015e97"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ic877b4ebba4a4d2f83ee4834c3bc717a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTYtMS0xLTEtMjcyOTU_f9f616ae-a488-449c-b68d-c3f2003de026"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i6eb52be0aee44612b177866eb6f7332c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjVmMDAxNzY3ZmI4YzRhOGE5NTMxYmM5MjMzZmJkNTM4L3RhYmxlcmFuZ2U6NWYwMDE3NjdmYjhjNGE4YTk1MzFiYzkyMzNmYmQ1MzhfMTYtMy0xLTEtMjcyOTU_ece739d7-b05e-48f1-b471-7f806a725593"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTY2Ng_f0f6f7c2-9f4e-4443-9d60-08984ea4cce5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMS0xLTEtMS0yNzI5NQ_2d837c1e-2c46-4da8-9e5e-9e9b7b7eb27a"
      unitRef="usd">130000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMS0zLTEtMS0yNzI5NQ_681bc2d0-7df3-4779-96b6-35b9ed302d97"
      unitRef="usd">105000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMi0xLTEtMS0yNzI5NQ_8f8199af-ce28-4ae7-81e0-dbd6a20bf40f"
      unitRef="usd">7297000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMi0zLTEtMS0yNzI5NQ_b9c81c57-2506-4c62-aac7-97e17e595df4"
      unitRef="usd">4764000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMy0xLTEtMS0yNzI5NQ_85cf0d31-840f-41a0-bc5c-cfef82ed5f33"
      unitRef="usd">95000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfMy0zLTEtMS0yNzI5NQ_00e56433-23c4-4430-8be5-ec4aded57995"
      unitRef="usd">79000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfNC0xLTEtMS0yNzI5NQ_80ca20c0-e02f-4727-a977-1f39acceba26"
      unitRef="usd">7522000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOmUzMmFiZTQ5NWUyZDRjN2JhMmViNThjOTVkYWU4M2QzL3RhYmxlcmFuZ2U6ZTMyYWJlNDk1ZTJkNGM3YmEyZWI1OGM5NWRhZTgzZDNfNC0zLTEtMS0yNzI5NQ_94047438-966e-410d-a0d2-4df63741ffbd"
      unitRef="usd">4948000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfOTcwMw_8644e38f-a198-466e-80a8-c8e210134ad9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMS0xLTEtMS0yNzI5NQ_cf2b8fc6-344c-4531-97a2-210f22cba344"
      unitRef="usd">43925000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMS0zLTEtMS0yNzI5NQ_b7cfb7b9-d809-4106-9e12-e1818d39b19b"
      unitRef="usd">43095000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ifc01c81d46124cf59f361dbae533ad7c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNC0xLTEtMS0yNzI5NQ_a3285be5-9dd9-4e6d-85f5-b1db6eaa334a"
      unitRef="usd">-4000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib4a9c40fe3e64397a7a9af57cdbd9f2e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNC0zLTEtMS0yNzI5NQ_732a213f-8c4c-4a0e-9d29-4763c8714278"
      unitRef="usd">10000000</us-gaap:DerivativeLiabilities>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNS0xLTEtMS0yNzI5NQ_6b300801-53b0-43f9-8a23-cc7874d45c97"
      unitRef="usd">113000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNS0zLTEtMS0yNzI5NQ_ded39c89-7764-4ba9-a38d-7eb23a3ce59f"
      unitRef="usd">119000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNi0xLTEtMS0yNzI5NQ_ffaff6d0-2a5a-433c-88ff-0d42314ce8a2"
      unitRef="usd">303000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNi0zLTEtMS0yNzI5NQ_a94394b6-8473-48c5-8133-0b6483b2562d"
      unitRef="usd">263000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNy0xLTEtMS0yNzI5NQ_edd09f16-58a5-41f1-8e8d-19cce9d4590e"
      unitRef="usd">1016000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfNy0zLTEtMS0yNzI5NQ_90887090-448a-4563-8cf6-dfe289551936"
      unitRef="usd">1408000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebt
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfOC0xLTEtMS0yNzI5NQ_70ebd085-425b-4791-9088-da1d0afb0645"
      unitRef="usd">44747000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfOC0zLTEtMS0yNzI5NQ_fd798d8b-8c56-42a8-a4a9-360dbbcfeb13"
      unitRef="usd">44369000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTAtMS0xLTEtMjcyOTU_393a11f4-6251-4934-af28-bf3caa46e358"
      unitRef="usd">7297000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTAtMy0xLTEtMjcyOTU_49880a2a-f7c3-40fd-b959-f99328745c8c"
      unitRef="usd">4764000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTEtMS0xLTEtMjcyOTU_55b82868-8827-496c-bd6c-4aabb9343713"
      unitRef="usd">37450000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTEtMy0xLTEtMjcyOTU_c19143e8-d0e1-4a13-b74f-3619809c72d1"
      unitRef="usd">39605000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTItMS0xLTEtMjcyOTU_d4a834ad-60b6-44ce-aaba-c9f7438711cf"
      unitRef="usd">44747000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RhYmxlOjA3Yjc4MTMxNDY0ZTRjZDQ4MjU2ZmY5YjMyYzBmMmZiL3RhYmxlcmFuZ2U6MDdiNzgxMzE0NjRlNGNkNDgyNTZmZjliMzJjMGYyZmJfMTItMy0xLTEtMjcyOTU_c68cc951-551d-4468-8392-345e542b1dc3"
      unitRef="usd">44369000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODEzMA_ee038c82-5fb4-496d-9905-42d258fa8978"
      unitRef="usd">45800000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODE0Mw_410706c8-91ad-4527-a1ab-094af4f40b65"
      unitRef="usd">49100000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1e0b11c565d843cd800a00cce43f9006_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzI5ODUzNDg5NDczNg_555edd07-1a09-4558-ae7f-b6237559074c"
      unitRef="usd">6000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i00f392936d8e4b9f8959e00956d66d32_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDUxMw_863e820e-1add-4b3e-95d8-0ce245be8856"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i00f392936d8e4b9f8959e00956d66d32_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE1NQ_a98746d8-285a-4e10-90a3-1b8118c1e06f"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i01d1accdb09342a1a2cc72896080888b_I20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDUyOA_397e147b-f7bd-4a85-ae3d-99410d26074e"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i01d1accdb09342a1a2cc72896080888b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE2Mw_3ee78539-44bf-498c-b9fb-a45498da6f23"
      unitRef="number">0.03550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iccb557e1b6ae4ed18e4f9c9ea9685c16_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDU0Mw_9ca617d0-d9cd-47df-b3a3-5f2d69187906"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iccb557e1b6ae4ed18e4f9c9ea9685c16_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE3MQ_bdd2d9d4-9c29-41dc-8de0-43cea79f53ca"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i42a8df9288214a7ba80d4c2e2cea5cd0_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDU1Nw_74c17811-0f6a-4a4b-b387-cb777cf6c046"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i42a8df9288214a7ba80d4c2e2cea5cd0_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE3OQ_08446939-ab72-48e6-8df3-092526ff306c"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMzI5ODUzNDg5NDc1MA_8938e5ec-848b-4a1a-8b7f-f837cd2d0de7"
      unitRef="usd">5900000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTY0OTI2NzQ1MzQ3NA_8cec6a94-ab97-4658-bc15-0e64b5e45012"
      unitRef="usd">5200000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTY0OTI2NzQ1MzQ2MA_8dcb9f7e-6d00-4dec-b9a5-17c9878dabe6"
      unitRef="usd">5800000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTY0OTI2NzQ1MzQ4OA_a1761cbc-acf2-4bfc-a6b1-e5364c2cf376"
      unitRef="usd">-275000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDEzMA_fd969f26-099d-4fd0-b9fb-79ff7c4897a1"
      unitRef="usd">849000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMTA5OTUxMTY0MDE1Ng_0a91c3c9-3644-400d-9d3c-4b09366f1d0e"
      unitRef="usd">880000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODQ3MA_944c883b-c8f8-414f-b344-2874622ffa88"
      unitRef="usd">3500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODUyNQ_b96b727c-1f39-410f-9967-c508e4657ed6"
      unitRef="usd">4000000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODYzNg_ebdfe871-d945-4cfc-9e57-59953b5ba450"
      unitRef="usd">-281000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0487706aaf654d899b5f17f8e3b4d1b1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODgxNw_c432397b-a58d-46f5-b298-99f258512361"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPaidNet
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODkxOQ_b076e2e7-32e7-4c40-ad71-f80c1e8d54f1"
      unitRef="usd">377000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfODkyNg_b57e2733-0297-4f2f-a572-f57b6e4f4216"
      unitRef="usd">435000000</us-gaap:InterestPaidNet>
    <bmy:NumberofRevolvingCreditFacilities
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDIwNw_f4591119-3243-4267-b909-055bb8e25975"
      unitRef="creditfacility">4</bmy:NumberofRevolvingCreditFacilities>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQxMw_43c87825-4ca7-4dc6-bf31-773c615901c8"
      unitRef="usd">6000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i39644068dc2e42e5bcca7dba89dc84f8_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQyNw_dd59db11-323f-4ec8-969b-213fdf4b48c9"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifb0c682ec8e94e719bfd0b0e8c33a3d6_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ0MQ_1eafe7cf-0120-49da-bc8f-f86f032e2bfc"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1d28a8538925455ea6ce8a6e6c60af90_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ1NQ_b78cee2a-310f-440f-a7ef-f4eca3782779"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebtTerm
      contextRef="i2b5f5c10b37c44cab92705107745235c_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE5NQ_00553a85-931e-41f4-8407-38adf922967d">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2b5f5c10b37c44cab92705107745235c_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODM5OQ_0b3542ca-2a4f-494b-a922-52c8cb7b355f"
      unitRef="usd">5000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bmy:LongTermDebtRenewalPeriod
      contextRef="i2b5f5c10b37c44cab92705107745235c_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE5Nw_07dd54ab-758c-43e5-97aa-4b6b75100ecd">P1Y</bmy:LongTermDebtRenewalPeriod>
    <us-gaap:LongTermDebtTerm
      contextRef="i22388c8b54454a828847139982eb6182_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfNjU5NzA2OTc5MDE5OQ_dc9c8b75-9e51-4fb0-81f0-8ec03b01d9b7">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i22388c8b54454a828847139982eb6182_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ2OQ_c5062bb3-f99c-4136-88b1-624628c39fd5"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i41cc28991d204c169ba5bb001d925552_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ4Mw_7c090e58-477e-4efa-b23e-75c24de4e4e6"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5792b37bfd964932bfdc0eec0a2d49b4_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81NS9mcmFnOjE0YmRlYzIzZjgyNDRjMTBiMGY4N2RiNzJiZDZlMDc0L3RleHRyZWdpb246MTRiZGVjMjNmODI0NGMxMGIwZjg3ZGI3MmJkNmUwNzRfMjE5OTAyMzI3ODQ5Nw_544c5a2d-a25d-4de1-b42b-4c296c8bc1fe"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjY2_135fd73d-cf5c-4bdb-853c-e5f6548449c5">RECEIVABLES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, Royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-U.S. receivables sold on a nonrecourse basis were $423 million and $318 million for the three months ended March 31, 2022 and 2021, respectively. Receivables from the three largest customers in the U.S. represented approximately 60% and 59% of total trade receivables at March&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjY4_afeec1ae-1e37-4c63-a102-b5b854bdf365">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, Royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMS0xLTEtMS0yNzI5NQ_442f9b59-fea4-4bed-a147-cf68e69dfde1"
      unitRef="usd">7746000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMS0zLTEtMS0yNzI5NQ_44e48cf5-4559-4298-bbd8-5ac86b651595"
      unitRef="usd">8723000000</us-gaap:AccountsReceivableGrossCurrent>
    <bmy:CashDiscounts
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMi0xLTEtMS0yNzI5NQ_ef2d597b-36ca-4b4c-bcc8-8ea9e5df4809"
      unitRef="usd">561000000</bmy:CashDiscounts>
    <bmy:CashDiscounts
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMi0zLTEtMS0yNzI5NQ_9a94bdd2-2e79-48a4-84a4-6d6f2a4cb53d"
      unitRef="usd">723000000</bmy:CashDiscounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMy0xLTEtMS0yNzI5NQ_9b0a1e79-ac5e-477c-acbb-f052b45ddbdf"
      unitRef="usd">29000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfMy0zLTEtMS0yNzI5NQ_d0f83f8c-64a1-4088-9054-a7db2f840e4d"
      unitRef="usd">21000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNC0xLTEtMS0yNzI5NQ_bc7cc594-567f-4e92-95b3-8f2a763bf2e8"
      unitRef="usd">7156000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNC0zLTEtMS0yNzI5NQ_a4bcb29e-0662-49c1-9686-fb1d134f6f2c"
      unitRef="usd">7979000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivables
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNS0xLTEtMS0yNzI5NQ_2b83bc23-bb4a-447f-824f-2c1c1325f46b"
      unitRef="usd">1355000000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNS0zLTEtMS0yNzI5NQ_436fb64c-b8db-488e-8f0f-ab1b84c2f98f"
      unitRef="usd">1390000000</us-gaap:OtherReceivables>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNi0xLTEtMS0yNzI5NQ_fd5841d1-bdc7-4f43-8b3f-30d18f3884a9"
      unitRef="usd">8511000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RhYmxlOmFiOTE4NWMxMmEwMzQ1YzY5NzUwM2RhMzdlZTU5ZTQ5L3RhYmxlcmFuZ2U6YWI5MTg1YzEyYTAzNDVjNjk3NTAzZGEzN2VlNTllNDlfNi0zLTEtMS0yNzI5NQ_0e29399a-3642-43ff-8495-2884be29a7c2"
      unitRef="usd">9369000000</us-gaap:ReceivablesNetCurrent>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfODM_6fc5ac9d-1291-4040-8151-92fceefce92f"
      unitRef="usd">423000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfOTA_7de62b2c-1d28-4a95-9e8b-fa2cdc499609"
      unitRef="usd">318000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:NumberOfLargestPharmaceuticalWholesalers
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMTQ3_efce52db-04bd-4a94-86c1-2d5cd978a593"
      unitRef="customers">3</bmy:NumberOfLargestPharmaceuticalWholesalers>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="id15c48a3d81c47aeae083ac08257cad4_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjA2_123e902d-23d2-4365-8437-ff30353b6ed3"
      unitRef="number">0.60</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="i8b430687b90f47298aca5585a93c5694_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml81OC9mcmFnOjRmMDgzODA5OWM4NzRhMTI4YzhlODA1NzE1YTBmNjgzL3RleHRyZWdpb246NGYwODM4MDk5Yzg3NGExMjhjOGU4MDU3MTVhMGY2ODNfMjE5OTAyMzI1NTg0MA_9a0f0dac-a226-4ca6-a380-1a00103297f7"
      unitRef="number">0.59</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMjU0_5464068b-ffd5-4e85-ad7a-b8f96d50ccab">INVENTORIES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total inventories include fair value adjustments resulting from the Celgene acquisition of $368 million at March&#160;31, 2022 and $508 million at December&#160;31, 2021. Other non-current assets include inventory expected to remain on hand beyond 12 months in both periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An out of period adjustment was included in the three months ended March&#160;31, 2022 to reduce the remaining amount of inventory fair value adjustments resulting from the Celgene acquisition by $114&#160;million with a corresponding increase to Cost of products sold of $32&#160;million and Research and development expense of $82&#160;million. The adjustment was not material to previously reported balance sheets or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMjU4_edaea792-fb79-4d12-9aab-e3e683616c93">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMS0xLTEtMS0yNzI5NQ_e470ff1f-4abe-475e-aae2-242490522263"
      unitRef="usd">449000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMS0zLTEtMS0yNzI5NQ_7e72f3d2-44ce-419e-83bb-91d514e02688"
      unitRef="usd">543000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMi0xLTEtMS0yNzI5NQ_2c6dc50c-fc0d-41d4-88a4-36635c167de5"
      unitRef="usd">2052000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMi0zLTEtMS0yNzI5NQ_81566e3d-5d53-4c1d-89c7-b897e90a7e7d"
      unitRef="usd">2111000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMy0xLTEtMS0yNzI5NQ_d481dfa8-da67-4c82-b140-c399ac440637"
      unitRef="usd">446000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfMy0zLTEtMS0yNzI5NQ_cea2e786-2103-4472-a00c-8af7249fb51f"
      unitRef="usd">350000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <bmy:Totalinventories
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNC0xLTEtMS0yNzI5NQ_c8e5bb91-28e3-43b0-ba22-1e6c136313ff"
      unitRef="usd">2947000000</bmy:Totalinventories>
    <bmy:Totalinventories
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNC0zLTEtMS0yNzI5NQ_f279cbb9-e919-472a-a3df-39ee2072aee2"
      unitRef="usd">3004000000</bmy:Totalinventories>
    <us-gaap:InventoryNet
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNi0xLTEtMS0yNzI5NQ_8c2db212-8b0d-4802-8cdf-4c31fe2d55f4"
      unitRef="usd">2104000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNi0zLTEtMS0yNzI5NQ_66798a62-0ec3-4fa7-b358-8cc127d86bf3"
      unitRef="usd">2095000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNy0xLTEtMS0yNzI5NQ_64b8e695-e86b-44be-8d16-900e0d700081"
      unitRef="usd">843000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RhYmxlOmUzZjIxMGI2OTJiYzQ1NDZiN2Q5MzcxNzQ1MDI0NzIzL3RhYmxlcmFuZ2U6ZTNmMjEwYjY5MmJjNDU0NmI3ZDkzNzE3NDUwMjQ3MjNfNy0zLTEtMS0yNzI5NQ_36c70a5a-71c7-44f5-84ca-91cd1ca29f51"
      unitRef="usd">909000000</us-gaap:InventoryNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ib591208aeba1490ababd9ab1c130dc54_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTIw_c3a2560b-6cb3-4460-8efd-d61ca8645042"
      unitRef="usd">368000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i662965b18d274bd4906976d530ef4ae5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTMz_104ac39a-151d-4505-82e8-d32c1655be37"
      unitRef="usd">508000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:InventoryAdjustments
      contextRef="ibf698719af47427688c9bbce6908e931_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTA5OTUxMTYyOTMyNQ_8c84f8cf-6d75-4159-bc6c-3ab84c05bce8"
      unitRef="usd">114000000</us-gaap:InventoryAdjustments>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id36e61c39dfd400c8b4956a1177b4898_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTA5OTUxMTYyOTM4Nw_c81d0e01-081b-4077-90e7-004cc7aa6fcf"
      unitRef="usd">32000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id36e61c39dfd400c8b4956a1177b4898_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82MS9mcmFnOjZlYmZjNjg4NjU0ZjQ0NDRhODdiODRmZGU0NzUwOTkwL3RleHRyZWdpb246NmViZmM2ODg2NTRmNDQ0NGE4N2I4NGZkZTQ3NTA5OTBfMTA5OTUxMTYyOTQzMQ_0fd3934f-706b-4cb2-8ef0-eef635097478"
      unitRef="usd">82000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfMTUx_1372cbed-4ec3-4131-92bc-2de8d46f6906">PROPERTY, PLANT AND EQUIPMENT&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $145 million and $135 million for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfMTQx_c3a5a99e-b1f7-494a-8bc0-27c145040681">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMS0xLTEtMS0yNzI5NQ_dfaa1081-b063-4b6e-939c-08d722f90071"
      unitRef="usd">168000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMS0zLTEtMS0yNzI5NQ_54c48202-0644-4b75-b6eb-5b71f1ea8e46"
      unitRef="usd">169000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMi0xLTEtMS0yNzI5NQ_b673d4e8-113a-4147-8083-0aef214aeeb8"
      unitRef="usd">5941000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMi0zLTEtMS0yNzI5NQ_c09aec49-c47e-46dd-9fea-a26d7db97593"
      unitRef="usd">5897000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMy0xLTEtMS0yNzI5NQ_b4341f88-ba90-4919-9880-d0513890c917"
      unitRef="usd">3306000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfMy0zLTEtMS0yNzI5NQ_28872730-46a8-4d92-8344-67637a15b0e8"
      unitRef="usd">3252000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNC0xLTEtMS0yNzI5NQ_e89f6f08-f37a-471e-ac40-5fb097be76c1"
      unitRef="usd">800000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNC0zLTEtMS0yNzI5NQ_b209fe00-6b67-4fe7-9086-9abc4c9d4763"
      unitRef="usd">764000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNS0xLTEtMS0yNzI5NQ_1a5244b4-d097-4955-b69a-c22e7469f9d2"
      unitRef="usd">10215000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNS0zLTEtMS0yNzI5NQ_3a29c485-511d-4e98-aa3b-5b796ffd4bd3"
      unitRef="usd">10082000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNi0xLTEtMS0yNzI5NQ_4d4b6222-8f1a-4400-aa18-c0fdc612bd5c"
      unitRef="usd">4168000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNi0zLTEtMS0yNzI5NQ_b0d51c70-2596-4b2f-8936-2e4b00b8962c"
      unitRef="usd">4033000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNy0xLTEtMS0yNzI5NQ_0a61a1f7-e729-4d0f-ae05-145aa922e8ec"
      unitRef="usd">6047000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RhYmxlOjJhZTUzN2Q5MjgzNDRlZTI4NTM1ODFmNDE4MWYxMjA4L3RhYmxlcmFuZ2U6MmFlNTM3ZDkyODM0NGVlMjg1MzU4MWY0MTgxZjEyMDhfNy0zLTEtMS0yNzI5NQ_c6ce23a4-ca13-45bb-a384-12f118c70a35"
      unitRef="usd">6049000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfNzI_f32dda61-a415-49a1-ae1f-ccba024c98f8"
      unitRef="usd">145000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml82NC9mcmFnOjg1ZjdiZjVlNDlmNjRiMWQ5MGRmY2RiYjhmODU3YTg3L3RleHRyZWdpb246ODVmN2JmNWU0OWY2NGIxZDkwZGZjZGJiOGY4NTdhODdfMTA5OTUxMTYyNzkzNQ_99be4631-ff66-4725-a2b9-b9599715c4c7"
      unitRef="usd">135000000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTg4Mg_de034f16-f775-4ae5-99e7-88ae4217b37f">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of other intangible assets was $2.5 billion and $2.6 billion for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March 31, 2022, a $40&#160;million IPRD impairment charge was recorded in Research and development expense following a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was obtained in the acquisition of Celgene and was being studied as a potential treatment for autoimmune diseases. The charge represented a full write-down.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March 31, 2021, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inrebic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; EU regulatory approval milestones of $300&#160;million were achieved resulting in a $385&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $315&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTg3Mw_011fc1aa-40dd-4b50-b01a-a86e28244f85">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMS0zLTEtMS0yNzI5NQ_555545c0-8447-4d0d-b887-6d2556f638fd"
      unitRef="usd">20500000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMS01LTEtMS0yNzI5NQ_d575c91b-a54c-45cf-b964-2eec50f1d610"
      unitRef="usd">20502000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i933b74eb6ef2454e82c1e129ff3a4cf9_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmZlYTRjMGI2MGJmYjQ4Yjk5OTFjYzZkZGJiMWIxMmYwXzQ_ac8a4a4f-29c5-4109-9ee9-1175a67b650c">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9d1a44cdc0ce421ab0a6afc5c7148f8d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmZlYTRjMGI2MGJmYjQ4Yjk5OTFjYzZkZGJiMWIxMmYwXzk_1f24c3ee-159e-4d6b-b1cc-36d8dba14e52">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0c8fe212155e47398c07ac122c4d25db_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC0zLTEtMS0yNzI5NQ_63904f12-1cbc-4445-bbb4-5d1baa26df0d"
      unitRef="usd">307000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i813eb01fc49e456daa2b0d45dbf8903a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNC01LTEtMS0yNzI5NQ_d8c45295-612e-4eb4-b3a5-2a134254402f"
      unitRef="usd">307000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1c163fb38d5e483a957be472e84d0b08_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmQ0Y2JhZjU3N2VmNjRmOGE4ZTdhNDM3ZDU2YjM1YjlmXzQ_18aebdb3-956d-4807-84a4-3c78f313ba24">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib51a898c07794b4a919b257dcc42208c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOmQ0Y2JhZjU3N2VmNjRmOGE4ZTdhNDM3ZDU2YjM1YjlmXzk_fc0f70bd-7485-4df9-a3e7-dad7042f5e6b">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i483be3c323184f15b35cc7d81776ecc4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS0zLTEtMS0yNzI5NQ_4a236cce-e620-479c-90c7-f0d652686071"
      unitRef="usd">60477000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8493c14f9b494a61ba4d49df885de3a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNS01LTEtMS0yNzI5NQ_ce6ab06e-d3c3-4f0b-9201-5811fb010ef5"
      unitRef="usd">60454000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0b3beca4fb5a42a08d14874a43fb86a0_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOjAwMjk0ZDI1ZTc4MjRhZjg5OGIxNTg1ZWEyMjYyZDc1XzQ_295b3e4d-7821-4813-914b-36c98ddb6ef9">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia288c0fb88974230b4554c68b96e40c0_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi0xLTEtMS0yNzI5NS90ZXh0cmVnaW9uOjAwMjk0ZDI1ZTc4MjRhZjg5OGIxNTg1ZWEyMjYyZDc1Xzk_a8cf17e3-1228-4ea4-b988-43da2134c335">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i357734b23ccc4244aea0717e29ca8fad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi0zLTEtMS0yNzI5NQ_4807bc71-a3ef-4ae9-9ed0-b61bad091261"
      unitRef="usd">1544000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if0e3744106ea411ba17e209a5e2dc279_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNi01LTEtMS0yNzI5NQ_5f1aac05-5e13-4804-ad19-664ebb9f8484"
      unitRef="usd">1499000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1c61398032f94cb8bd85669f01cdd4b5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNy0zLTEtMS0yNzI5NQ_d86352f3-3fc9-42df-81e1-82bc825e257a"
      unitRef="usd">3710000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib9dd431d277f4046b343051457c073a0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfNy01LTEtMS0yNzI5NQ_5e520fcc-9d44-429f-8d2b-0360d6755da6"
      unitRef="usd">3750000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOC0zLTEtMS0yNzI5NQ_1a42ac24-9a49-4f3e-b088-9ebe6cbaa622"
      unitRef="usd">66038000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOC01LTEtMS0yNzI5NQ_d65f4f4f-bb6a-4fd0-a84d-f15817e0713a"
      unitRef="usd">66010000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOS0zLTEtMS0yNzI5NQ_4f79c024-a0ae-4666-a3a7-5674f1b39cce"
      unitRef="usd">25935000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfOS01LTEtMS0yNzI5NQ_86c0a883-2067-48ee-b106-ff1c79131c47"
      unitRef="usd">23483000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMTAtMy0xLTEtMjcyOTU_b114591b-f593-4561-9e15-89000e2c897d"
      unitRef="usd">40103000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RhYmxlOmEyMTU5ZDMyZWY5MTRhMWJiMTk1Yzk4OTk5MmViODRkL3RhYmxlcmFuZ2U6YTIxNTlkMzJlZjkxNGExYmIxOTVjOTg5OTkyZWI4NGRfMTAtNS0xLTEtMjcyOTU_ccc4d2d9-0d50-4845-8826-cea71e1fe9d8"
      unitRef="usd">42527000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMjMz_227803ce-1b5c-44c0-b724-f8e91a3e62ad"
      unitRef="usd">2500000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTA5OTUxMTYyOTc5MA_4373d016-9b55-458f-92cd-a2199a12e052"
      unitRef="usd">2600000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTA5OTUxMTYzMjk0Mg_18706ccc-fc7c-4a55-844f-8d249b82d945"
      unitRef="usd">40000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <bmy:ContingentAndRegulatoryMilestoneNonCash
      contextRef="i890c7a1dec204f3a915c8bfcce2acedf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTQxMw_923cde87-f0b2-4572-aee4-5e9529cfcd9a"
      unitRef="usd">300000000</bmy:ContingentAndRegulatoryMilestoneNonCash>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="ib947345d6e024c65bb07480f1c5e4624_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTQ0NQ_cffe9e28-e583-4fe5-8884-7b650c21dcfa"
      unitRef="usd">385000000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ib947345d6e024c65bb07480f1c5e4624_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83MC9mcmFnOmFlNTJjMjk3MDhiMzQzYjJhNWQ3NmE2YmYwMDgyMjcwL3RleHRyZWdpb246YWU1MmMyOTcwOGIzNDNiMmE1ZDc2YTZiZjAwODIyNzBfMTU5Nw_91bc4046-caa2-4409-bd2e-ed354b050585"
      unitRef="usd">315000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzcx_a9879f03-cf0a-48fc-abaf-9628f7e13f88">SUPPLEMENTAL FINANCIAL INFORMATION&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzcy_2efe26cb-89db-422f-8263-7262833a6604">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMS0xLTEtMS0yNzI5NQ_50fe05e5-1d60-4639-835c-3db5876f3ca5"
      unitRef="usd">2182000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMS0zLTEtMS0yNzI5NQ_7bdcda30-5753-4f18-984a-7ca078239f83"
      unitRef="usd">2786000000</us-gaap:PrepaidTaxes>
    <bmy:ResearchandDevelopment
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMi0xLTEtMS0yNzI5NQ_a223f52f-3eb4-43d1-9f77-b926f7d8c184"
      unitRef="usd">604000000</bmy:ResearchandDevelopment>
    <bmy:ResearchandDevelopment
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMi0zLTEtMS0yNzI5NQ_39a8f2fe-0bb5-4b80-840a-2b9aa39d68a8"
      unitRef="usd">514000000</bmy:ResearchandDevelopment>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0xLTEtMS01OTQ3Mg_2bfb272f-b751-4453-a397-80ad860341e7"
      unitRef="usd">410000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0zLTEtMS01OTQ2Nw_89d800ef-9098-4016-a696-2d3c505fee47"
      unitRef="usd">361000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <bmy:EquityInvestmentsCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0xLTEtMS0yNzI5NQ_688fb3f1-6891-4624-aa5f-51a622d1bd5a"
      unitRef="usd">228000000</bmy:EquityInvestmentsCurrent>
    <bmy:EquityInvestmentsCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfMy0zLTEtMS0yNzI5NQ_4ee5cf17-ef5f-429a-a6cf-a26c72c460b2"
      unitRef="usd">255000000</bmy:EquityInvestmentsCurrent>
    <us-gaap:RestrictedCash
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNC0xLTEtMS0yNzI5NQ_40d479af-5375-4e19-b9fb-c28741416a3c"
      unitRef="usd">155000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNC0zLTEtMS0yNzI5NQ_3b4f6f49-6449-42b6-a88d-d40db066c8b3"
      unitRef="usd">140000000</us-gaap:RestrictedCash>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNS0xLTEtMS0yNzI5NQ_a0c915e3-3115-40fe-a4a4-c1852d75b0be"
      unitRef="usd">959000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNS0zLTEtMS0yNzI5NQ_a9d04cd8-7089-40f6-b29c-6783d2f05b3b"
      unitRef="usd">776000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNi0xLTEtMS0yNzI5NQ_3b35026c-b8cc-4126-a793-9c73c0050dfe"
      unitRef="usd">4538000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmZjYjU3NzFiMGQxYjQyNjU5NWMwZjlhYzg2NjZhMzQ4L3RhYmxlcmFuZ2U6ZmNiNTc3MWIwZDFiNDI2NTk1YzBmOWFjODY2NmEzNDhfNi0zLTEtMS0yNzI5NQ_256943d6-a0a4-4acc-9e67-c79da2a493cf"
      unitRef="usd">4832000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzc1_ca681f47-f258-445b-909b-69ded5697847">&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMS0xLTEtMS0yNzI5NQ_16fe1343-7f0c-41fc-b569-e0e1e1d8414c"
      unitRef="usd">2185000000</bmy:EquityInvestmentsNonCurrent>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMS0zLTEtMS0yNzI5NQ_fee2a9ab-edc7-4191-992c-2ccd2b07b926"
      unitRef="usd">2713000000</bmy:EquityInvestmentsNonCurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMi0xLTEtMS0yNzI5NQ_a9362ee0-c303-43c3-a55c-d4acad163df4"
      unitRef="usd">843000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMi0zLTEtMS0yNzI5NQ_e7e1dc6a-565b-421f-b580-364f4791ebb3"
      unitRef="usd">909000000</us-gaap:InventoryNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMy0xLTEtMS0yNzI5NQ_cefc409a-1bb5-4dfa-a554-4fb83b0a7292"
      unitRef="usd">894000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfMy0zLTEtMS0yNzI5NQ_f975dea1-7408-407c-a985-83b95ab91769"
      unitRef="usd">919000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNC0xLTEtMS0yNzI5NQ_ccd93cc5-1c1d-403d-a822-6cae98453c36"
      unitRef="usd">321000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNC0zLTEtMS0yNzI5NQ_f0af96f4-3f33-45cb-b804-ec416cd0406c"
      unitRef="usd">317000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <bmy:ResearchAndDevelopmentNonCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0xLTEtMS01OTQ3OQ_b7426c59-5c09-4d86-94ed-c1dfc358b57a"
      unitRef="usd">319000000</bmy:ResearchAndDevelopmentNonCurrent>
    <bmy:ResearchAndDevelopmentNonCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0zLTEtMS01OTQ5Ng_3379f054-85f9-4c96-baf8-55a6ea66d96a"
      unitRef="usd">248000000</bmy:ResearchAndDevelopmentNonCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0xLTEtMS0yNzI5NQ_8daa6ffb-61d1-43ae-8cca-9cd24bd9b04e"
      unitRef="usd">55000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNS0zLTEtMS0yNzI5NQ_79f31f7c-1a19-4854-a7f3-34f6691e6170"
      unitRef="usd">197000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNi0xLTEtMS0yNzI5NQ_16e98168-0058-492d-82ba-14568f20337e"
      unitRef="usd">228000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNi0zLTEtMS0yNzI5NQ_44fe89b0-defd-486e-8526-60c70bdb1242"
      unitRef="usd">232000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNy0xLTEtMS0yNzI5NQ_1d8fcaf6-fe0a-4310-954d-d69e49367222"
      unitRef="usd">4845000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmUwZjAwNGU4YTM4YjRmNjQ4Zjg0MDhiNzNhYzZjMzJmL3RhYmxlcmFuZ2U6ZTBmMDA0ZThhMzhiNGY2NDhmODQwOGI3M2FjNmMzMmZfNy0zLTEtMS0yNzI5NQ_75b6078e-00c4-4de8-b88e-a061a2532f00"
      unitRef="usd">5535000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzcw_18554a1e-2616-48b4-b4d8-666c2772c1aa">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <bmy:AccruedRebatesAndReturns
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMS0xLTEtMS0yNzI5NQ_14bcae9e-8554-466f-b6da-cfefc0612021"
      unitRef="usd">5455000000</bmy:AccruedRebatesAndReturns>
    <bmy:AccruedRebatesAndReturns
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMS0zLTEtMS0yNzI5NQ_c7dc7366-69e7-4a13-8109-309565a71a61"
      unitRef="usd">6399000000</bmy:AccruedRebatesAndReturns>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMi0xLTEtMS0yNzI5NQ_abc10ec9-2c57-425e-bbea-589bb8abf8c5"
      unitRef="usd">930000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMi0zLTEtMS0yNzI5NQ_413be784-bb7e-485f-8d62-93dba4765ad1"
      unitRef="usd">754000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMy0xLTEtMS0yNzI5NQ_bce25b45-f131-4fb6-bdb3-932e3cabecbc"
      unitRef="usd">662000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMy0zLTEtMS0yNzI5NQ_6e61fb0e-0fc5-4dd3-85fe-04c8427dab32"
      unitRef="usd">1375000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bmy:AccruedResearchAndDevelopment
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNC0xLTEtMS0yNzI5NQ_90a7f424-ebe4-4629-bbdb-c15651e57bc1"
      unitRef="usd">1321000000</bmy:AccruedResearchAndDevelopment>
    <bmy:AccruedResearchAndDevelopment
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNC0zLTEtMS0yNzI5NQ_6f130165-788a-4412-8aef-5a734d6b80ad"
      unitRef="usd">1373000000</bmy:AccruedResearchAndDevelopment>
    <us-gaap:DividendsPayableCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNS0xLTEtMS0yNzI5NQ_ebe525a5-b2e5-4283-89b5-b8ea9ff9c091"
      unitRef="usd">1151000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNS0zLTEtMS0yNzI5NQ_58ff674e-743b-4632-b083-4de8ba3bbdff"
      unitRef="usd">1186000000</us-gaap:DividendsPayableCurrent>
    <bmy:AccruedInterest
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNi0xLTEtMS0yNzI5NQ_fdccaa1b-bf8e-49bc-8dee-b64a2c01fcd6"
      unitRef="usd">356000000</bmy:AccruedInterest>
    <bmy:AccruedInterest
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNi0zLTEtMS0yNzI5NQ_b127a9f8-bd2a-454f-ab91-1d69a0798855"
      unitRef="usd">378000000</bmy:AccruedInterest>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNy0xLTEtMS0yNzI5NQ_a183a756-43c8-4d2e-a7b9-f796472d53c8"
      unitRef="usd">354000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfNy0zLTEtMS0yNzI5NQ_98ed966d-39a8-4679-a86c-19ef63a998a6"
      unitRef="usd">410000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfOC0xLTEtMS0yNzI5NQ_c07ec80e-3585-4633-a553-192e3fd63806"
      unitRef="usd">171000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfOC0zLTEtMS0yNzI5NQ_af22ff9c-c150-4ddd-9ab9-1f0e6af0301f"
      unitRef="usd">169000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTAtMS0xLTEtMjcyOTU_505f5b80-e1fc-4978-9a81-79d613b58ea9"
      unitRef="usd">1955000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTAtMy0xLTEtMjcyOTU_05757552-0682-409e-b411-92e3131ee5bc"
      unitRef="usd">1927000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTEtMS0xLTEtMjcyOTU_31548193-821c-4eb9-853b-6a21663ab9ad"
      unitRef="usd">12355000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOmY3NTA4YzI0MTA1ZTQyYWI5OWMwMjM2NjI3NTFjY2YzL3RhYmxlcmFuZ2U6Zjc1MDhjMjQxMDVlNDJhYjk5YzAyMzY2Mjc1MWNjZjNfMTEtMy0xLTEtMjcyOTU_5bb48fb5-0e2f-432b-ac30-ebe27f80c7e6"
      unitRef="usd">13971000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RleHRyZWdpb246OGI3ODY0YzliNGNlNDkzYzhlNGE0ODA1ZTI4OTA5M2NfMzgz_2a9e1126-0998-4904-949c-5de9f58b95f1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMS0xLTEtMS0yNzI5NQ_b23950c0-e5fd-47c3-9bc7-43f677505231"
      unitRef="usd">4889000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMS0zLTEtMS0yNzI5NQ_52b42b61-dade-4c93-94d7-9ca862573d7b"
      unitRef="usd">4835000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMi0xLTEtMS0yNzI5NQ_f0d0ec68-7082-4e73-a39e-f3163d8cd74a"
      unitRef="usd">625000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMi0zLTEtMS0yNzI5NQ_43e24499-a028-4b7e-98eb-868cd3cf124d"
      unitRef="usd">654000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMy0xLTEtMS0yNzI5NQ_0fcc70b6-10a5-4f4c-a836-38a9286d6ba9"
      unitRef="usd">852000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfMy0zLTEtMS0yNzI5NQ_2ac7cda1-39d5-4aac-acf2-1d219263acbd"
      unitRef="usd">874000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNC0xLTEtMS0yNzI5NQ_b2376698-e486-4887-89b4-e74a21527961"
      unitRef="usd">319000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNC0zLTEtMS0yNzI5NQ_715b7f61-aeee-4f65-8467-ba548ce512a3"
      unitRef="usd">326000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNS0xLTEtMS0yNzI5NQ_d4ac5434-b16e-47d5-870c-78d42bdeb4fe"
      unitRef="usd">409000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNS0zLTEtMS0yNzI5NQ_33a23102-6378-43c2-8cbd-1f28041e420f"
      unitRef="usd">427000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNi0xLTEtMS0yNzI5NQ_d44cd371-ee55-4f5b-be9d-dc8618673af4"
      unitRef="usd">215000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNi0zLTEtMS0yNzI5NQ_4c172e14-4b7e-4ddd-b71d-9b6a52c01dee"
      unitRef="usd">218000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNy0xLTEtMS0yNzI5NQ_475e5b17-f8d9-4b11-9716-b2a0cec63a33"
      unitRef="usd">7309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83My9mcmFnOjhiNzg2NGM5YjRjZTQ5M2M4ZTRhNDgwNWUyODkwOTNjL3RhYmxlOjVkYmI0MzdmZTdkZDQxZGFiYTM1MDU2NjZhNWIwMjZhL3RhYmxlcmFuZ2U6NWRiYjQzN2ZlN2RkNDFkYWJhMzUwNTY2NmE1YjAyNmFfNy0zLTEtMS0yNzI5NQ_08ae21ee-af39-4d4c-a611-54c454d389ab"
      unitRef="usd">7334000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjA5NA_725ece5f-5d44-43bd-a7a7-8ac681e43da2">EQUITY&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outstanding share repurchase authorization under the program was approximately $15.2 billion as of December 31, 2021. In the three months ended March, 31, 2022, BMS executed accelerated share repurchase ("ASR") agreements to repurchase an aggregate $5.0&#160;billion of common stock. These ASR agreements were funded with cash on-hand and are expected to settle during the second and third quarters of 2022. Approximately 65&#160;million shares of common stock (85% of the $5.0&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. The total number of shares to be repurchased under the ASR agreements will be based on volume-weighted average prices of BMS's common stock during the terms of the ASR transactions less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreements. The remaining share repurchase capacity under the share repurchase program was approximately $10.2 billion as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS repurchased 28&#160;million shares of its common stock for $1.8&#160;billion in the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Other Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjA4Mg_19d2731a-d1af-4ae8-a7d3-f31fb0639cb2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.54 for the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the three months ended March 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:SharesIssued
      contextRef="i697dadbed2b44257b50760bc65e2719b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xLTEtMS0yNzI5NQ_740d393a-815f-4475-9862-aa780334344b"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i697dadbed2b44257b50760bc65e2719b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0zLTEtMS0yNzI5NQ_c32e1875-1da3-4d69-aa5d-263b24991b8b"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c750c097be14ed1b3f961e0ba4d7de3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi01LTEtMS0yNzI5NQ_9fe74e7c-5b69-48f1-9d81-61b6a3fe69ec"
      unitRef="usd">44361000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i92f35f33ac5447c685cb91ab35c69fc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi03LTEtMS0yNzI5NQ_6a63456a-efc4-4d5d-81d9-5a47a4d8b4b8"
      unitRef="usd">-1268000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9b2566864734436ac9a373ddafbcbb0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi05LTEtMS0yNzI5NQ_49b6e827-cb89-4df3-8849-919af1e835b0"
      unitRef="usd">23820000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i608fa9b9ad254f68bd39d1a463a30350_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xMS0xLTEtMjcyOTU_d941bd55-7946-4efe-b685-37f4c0a703d0"
      unitRef="shares">747000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i608fa9b9ad254f68bd39d1a463a30350_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xMy0xLTEtMjcyOTU_a61ca77d-d6b1-4eb7-a533-e233b8c07b62"
      unitRef="usd">-31259000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if0c3e82138344640a0c4435cba106ff5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMi0xNS0xLTEtMjcyOTU_dd825ab1-bda9-4bd8-af0c-b251b74b1044"
      unitRef="usd">60000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i78f12ffadf16415ea1fe727617391027_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMy05LTEtMS0yNzI5NQ_6e9381a2-a9da-48a6-bdc0-4a4d0d5e1a9a"
      unitRef="usd">1278000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibe2dda1e1a844b94a00d230f1dc9a71b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfMy0xNS0xLTEtMjcyOTU_66662785-27ea-41bc-96ef-5029a1e87b7d"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if0aa70f8ef374fb39ffdf7368e669776_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNC03LTEtMS0yNzI5NQ_ff474faf-6b5e-480e-8b29-8aed5dc10eb2"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i78f12ffadf16415ea1fe727617391027_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNS05LTEtMS0yNzI5NQ_91c16133-39a1-4171-8641-ce5899a28fcf"
      unitRef="usd">1150000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i67fdaace616b4f16855ab0159be80320_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNi01LTEtMS0yNzI5NQ_203c2e37-ad17-4add-86e0-ec354968c897"
      unitRef="usd">750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNi0xMS0xLTEtMjcyOTU_9fee33db-6c08-4605-828d-5dc9e316bcac"
      unitRef="shares">65000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNi0xMy0xLTEtMjcyOTU_7df9e593-557a-4bf3-a1e5-ed0f8ae56d05"
      unitRef="usd">4250000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i67fdaace616b4f16855ab0159be80320_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNy01LTEtMS0yNzI5NQ_0abbd69d-eb02-48d4-bd54-c8be40892e3a"
      unitRef="usd">145000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNy0xMS0xLTEtMjcyOTU_087abe00-9548-4b4b-b52b-4028a0077a09"
      unitRef="shares">18000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i459d61bdfb474316a1815cd0c81a7ca9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfNy0xMy0xLTEtMjcyOTU_86df7de6-d80f-49af-8533-bfa4e897b01a"
      unitRef="usd">322000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i5f0491e5151b468687df3f28023d25c1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xLTEtMS0yNzI5NQ_529593de-40b6-47bf-b663-44726604227f"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5f0491e5151b468687df3f28023d25c1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0zLTEtMS0yNzI5NQ_c7128c77-e182-4b67-a4b5-604c145b938b"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0b25fb727064bc7a48b809cd18417d0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS01LTEtMS0yNzI5NQ_ab918149-3ee6-4fab-9619-e1a18bee5889"
      unitRef="usd">43756000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25d5887cf1864cefa96ae37a8e8e1c96_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS03LTEtMS0yNzI5NQ_29cbb5f9-9e4d-4bd0-ac39-7647fd4b7f76"
      unitRef="usd">-1229000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf2feca3e743478f9a47b2a58c1a227c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS05LTEtMS0yNzI5NQ_b5284073-629b-4424-a88e-e521e87d443d"
      unitRef="usd">23948000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ied7d3446ea3641d08fb57b9e5e60c00f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xMS0xLTEtMjcyOTU_dec90457-b931-463f-ac1d-bed8644ba980"
      unitRef="shares">794000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ied7d3446ea3641d08fb57b9e5e60c00f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xMy0xLTEtMjcyOTU_e90c7e0d-7b18-4bfa-b3d7-7efd7737031e"
      unitRef="usd">-35187000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07ee78978c0642dabebb87cbae54be3f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmE2YjMzOWVhYTQxZjQ4ZDM4ODcwOWUxNDk4NDc1YTEwL3RhYmxlcmFuZ2U6YTZiMzM5ZWFhNDFmNDhkMzg4NzA5ZTE0OTg0NzVhMTBfOS0xNS0xLTEtMjcyOTU_9208b1db-f336-41e4-8750-4bcecb99dd54"
      unitRef="usd">65000000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjE5OTAyMzI1Nzc2OA_bfa4464a-b7ef-4944-9829-4f6f512a5c86"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SharesIssued
      contextRef="i3f9303f5188c4013be07916ae2eca837_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xLTEtMS0yNzI5NQ_57d03837-8acb-4997-8b22-367853ea4045"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3f9303f5188c4013be07916ae2eca837_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0zLTEtMS0yNzI5NQ_0313a45c-a6dc-4408-b926-2f060bb3ef45"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1f0dedce40941d2abd5021b6192fa7a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi01LTEtMS0yNzI5NQ_2521fdf6-a743-4f0f-b385-fbac8f6d2adb"
      unitRef="usd">44325000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iddd70bdc8a914f2e8317196accc17156_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi03LTEtMS0yNzI5NQ_20a85a3e-0388-46db-9f2f-7d4daef0ae9a"
      unitRef="usd">-1839000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic452639b46024f62a782fd7dd48397d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi05LTEtMS0yNzI5NQ_a3de8c21-5f76-4536-92b8-b2547ab98d10"
      unitRef="usd">21281000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="icd355c9ad4e04db9835b36253ee62303_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xMS0xLTEtMjcyOTU_3e480ec4-5eab-49e8-80b3-61e2e098276b"
      unitRef="shares">679000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icd355c9ad4e04db9835b36253ee62303_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xMy0xLTEtMjcyOTU_989cdba6-8aaa-4065-8300-e869fbc67430"
      unitRef="usd">-26237000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55c155c4e22f470f85c6fe894ca67745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMi0xNS0xLTEtMjcyOTU_c371ff97-d761-415f-bedd-4b96cc66f093"
      unitRef="usd">60000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1aadaa427a1f4883932758e3886fc82d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMy05LTEtMS0yNzI5NQ_45e323c0-1aa3-4de6-8d5b-6cb6a15e4078"
      unitRef="usd">2021000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4b408d47b276475ab6ccab44f5ca4af1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfMy0xNS0xLTEtMjcyOTU_d371e31f-c1c0-45a3-8d7e-5e6c2326e73d"
      unitRef="usd">-8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i72c2ec55ae104cb1a3d45c1093330949_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNC03LTEtMS0yNzI5NQ_2a608795-360e-4c15-819e-d23e9e1ce87e"
      unitRef="usd">295000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1aadaa427a1f4883932758e3886fc82d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNS05LTEtMS0yNzI5NQ_1dcda713-94b3-47d1-a1fa-44ce278eb96c"
      unitRef="usd">1098000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNi0xMS0xLTEtMjcyOTU_45b385c7-6262-4a3f-9fc7-e3d53dd0f5db"
      unitRef="shares">28000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNi0xMy0xLTEtMjcyOTU_c896c781-568b-4532-abb8-4882f3a17d44"
      unitRef="usd">1768000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1685419f0f5b445ebf4b83320b185816_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNy01LTEtMS0yNzI5NQ_9cb9d2e8-4f3e-49bb-816e-b31a68c1dca2"
      unitRef="usd">-473000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNy0xMS0xLTEtMjcyOTU_3a101a7e-30bc-42b0-b58e-fe2e592dffdd"
      unitRef="shares">15000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i18e94dfecae84387854d4bf38e41318e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfNy0xMy0xLTEtMjcyOTU_94a137dd-751d-4970-b955-a80184fa278a"
      unitRef="usd">806000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ie4e8bafee98c40e1af0ea0c26079e6d5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xLTEtMS0yNzI5NQ_24550c7a-d34a-42ac-aaea-b67e244fb7f5"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie4e8bafee98c40e1af0ea0c26079e6d5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0zLTEtMS0yNzI5NQ_eca59feb-4075-4d48-a4ae-df3a96f24afc"
      unitRef="usd">292000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iddc410e277f944d999382cf1f25d8280_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS01LTEtMS0yNzI5NQ_7c56f0b1-b131-4cd7-a1cb-1f2d9aed3e23"
      unitRef="usd">43852000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28f83b09252a4c5186eac51e8b3c4f10_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS03LTEtMS0yNzI5NQ_7f4a6d0b-94ab-45fe-bb07-b48503b80f5c"
      unitRef="usd">-1544000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i486782a204b048d79c8c4b6688f16ddb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS05LTEtMS0yNzI5NQ_62355dcf-e4cd-4e5c-b17e-fa6727838c74"
      unitRef="usd">22204000000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ifaf77c8298f84b9ca929be543d0bdf11_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xMS0xLTEtMjcyOTU_01af6238-1e8a-476b-89c9-a53dba734d1d"
      unitRef="shares">692000000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ifaf77c8298f84b9ca929be543d0bdf11_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xMy0xLTEtMjcyOTU_3e08f3b7-0731-4fe9-bb01-cba0c0c38896"
      unitRef="usd">-27199000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i22e06670aa924cd2a542b65a45076e7f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOmVmYWM0NzE4Njg1MDQ2N2ViMDQwMTg0NGU0Mzc0NThkL3RhYmxlcmFuZ2U6ZWZhYzQ3MTg2ODUwNDY3ZWIwNDAxODQ0ZTQzNzQ1OGRfOS0xNS0xLTEtMjcyOTU_5631bab3-0443-4ff4-880f-85050e3d3e83"
      unitRef="usd">68000000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjE5OTAyMzI1Nzc2NA_de11a6ee-456b-4895-82d2-9332538e7aaf"
      unitRef="usdPerShare">0.49</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfODg1_cca37af9-b4a1-4839-b1e0-38da2e19d33c"
      unitRef="usd">15200000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i893daceb21d24a07803ca9c59fb74f4f_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTA5OTUxMTYzNzA1OA_7f5d755c-9b86-45c6-ba4e-3b61559ac1fe"
      unitRef="usd">5000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia1153bc1078943e684090d6448e72a28_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTA5OTUxMTYzNzIxNw_07474c7c-f5e8-4c26-8658-78174ba450b4"
      unitRef="shares">65000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i893daceb21d24a07803ca9c59fb74f4f_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTA5OTUxMTYzNzI1Ng_2c355528-628a-4b22-92f2-40c970358c92"
      unitRef="usd">5000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTIwNQ_2f99791b-be1b-4be3-8631-295a5842c255"
      unitRef="usd">10200000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTIzNQ_d96e93fd-3b45-4858-a2f9-9eb872b2ddd3"
      unitRef="shares">28000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMTI2OQ_9335c82f-998a-431a-9eb4-abffa9eec3f2"
      unitRef="usd">1800000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjEwOA_81f1d0ba-f96e-4981-a8b0-afc08e3c11d7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Other Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses)/gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC0xLTEtMS0yNzI5NQ_86a08e23-d60d-4414-80e4-2b34d6aa09e2"
      unitRef="usd">120000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC0zLTEtMS0yNzI5NQ_bdd0af73-50b5-4d6c-a7fb-25baf368d5d3"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC01LTEtMS0yNzI5NQ_c9afc525-3165-4a3c-8026-6fa9246c4370"
      unitRef="usd">104000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC03LTEtMS0yNzI5NQ_e6beda4c-a7e6-4b7c-9437-0fcffd83db05"
      unitRef="usd">259000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC05LTEtMS0yNzI5NQ_ff2e1cd1-6d55-42ab-b376-c63438592088"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNC0xMS0xLTEtMjcyOTU_4acfcebf-51c3-4cea-a7b5-e9ec025e0303"
      unitRef="usd">248000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS0xLTEtMS0yNzI5NQ_324c607b-0e49-4798-a6f1-d889ccd08111"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS0zLTEtMS0yNzI5NQ_51a6f523-6cef-45dd-b44a-a26086db88ea"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS01LTEtMS0yNzI5NQ_17e977a7-5747-4523-b8b0-7641f1750902"
      unitRef="usd">73000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS03LTEtMS0yNzI5NQ_9f07cd1d-2336-4fce-92a7-7a902f81f947"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS05LTEtMS0yNzI5NQ_1229b0b0-6ff9-4cd4-8258-cd037a186c4e"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNS0xMS0xLTEtMjcyOTU_67295899-6446-4391-981c-68f17b88b491"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi0xLTEtMS0yNzI5NQ_a330dd88-0373-42c3-a969-57b37b76fcbf"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi0zLTEtMS0yNzI5NQ_768ee582-f4e5-40a7-82f5-2e2e4e178ef9"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi01LTEtMS0yNzI5NQ_30910c64-3d82-445d-aa45-3f4430d65020"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi03LTEtMS0yNzI5NQ_6b502cae-a897-4cc8-9d12-13486349ea62"
      unitRef="usd">295000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi05LTEtMS0yNzI5NQ_24f9c63d-7983-4c48-9eb6-885ed1dd345a"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfNi0xMS0xLTEtMjcyOTU_edf78902-9235-4b1d-a992-6c91968e355c"
      unitRef="usd">280000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS0xLTEtMS0yNzI5NQ_792d4fff-839b-4ad1-b994-39d1acd3819c"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS0zLTEtMS0yNzI5NQ_43b75118-54ff-49c9-a6ba-8a1ba01e2f15"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS01LTEtMS0yNzI5NQ_0df9380c-efeb-4d2e-bbc9-961ea56373af"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS03LTEtMS0yNzI5NQ_54bce399-a147-4422-ba79-4eb1755be598"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS05LTEtMS0yNzI5NQ_e0648a33-255e-470c-b038-45135aa42605"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfOS0xMS0xLTEtMjcyOTU_c4719a83-1819-41b4-bdbf-299ce18b6b94"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtMS0xLTEtMjcyOTU_44ccb393-bf1b-427c-b200-d86d45621b3d"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtMy0xLTEtMjcyOTU_ff4d3af7-2a3b-47cf-a7c9-dc27c55ef10b"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtNS0xLTEtMjcyOTU_4440e135-1b24-444b-a6e5-a0a5ff7b8e8d"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtNy0xLTEtMjcyOTU_321f20c4-a6a9-4a4c-849c-3c2e033e2fb8"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtOS0xLTEtMjcyOTU_dd889fd5-9f26-428b-a8ba-6e4d55101441"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTAtMTEtMS0xLTI3Mjk1_36b42f24-e6b4-402b-8f98-bb3a5edfee68"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtMS0xLTEtMjcyOTU_77ff2abb-a4b6-4069-906b-d24b1fe94aaa"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtMy0xLTEtMjcyOTU_00a6206e-7f46-4cd2-8ed8-2c6f60d30462"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtNS0xLTEtMjcyOTU_4f67d2ea-7382-4e93-9376-886d60574d83"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtNy0xLTEtMjcyOTU_80a7dd8b-1fe3-48d8-b05a-68b47d83ca27"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtOS0xLTEtMjcyOTU_ffcb311a-6cf6-4a68-9772-23e6f63d8de2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTEtMTEtMS0xLTI3Mjk1_11d6fcf9-c00e-4619-aa44-cd71bf673806"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItMS0xLTEtMjcyOTU_b0a0b982-750a-4e06-b121-471592e36ebd"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItMy0xLTEtMjcyOTU_3b87e772-dc34-433d-83fc-31c17937c89e"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItNS0xLTEtMjcyOTU_e2881945-3c17-4184-b0ce-245bdc30a77d"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItNy0xLTEtMjcyOTU_cfcda4c0-1108-46f0-970e-46f91b721138"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItOS0xLTEtMjcyOTU_3d4db5a8-c973-4c2f-895a-6b8524a330c8"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTItMTEtMS0xLTI3Mjk1_42e97db9-4181-4b58-bffb-adb5d70ffc87"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtMS0xLTEtMjcyOTU_ef295358-f579-4c75-83c2-acea72096225"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtMy0xLTEtMjcyOTU_8b13bb7f-06f9-4b8e-be85-3d9b18054de0"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtNS0xLTEtMjcyOTU_4d2fd180-82c4-4ca1-9875-c2532b573008"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtNy0xLTEtMjcyOTU_9736ff6b-b8d0-4cf2-9ae2-61d03e592ae6"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtOS0xLTEtMjcyOTU_739a8df2-1ed6-484d-bf45-f8d278f18a2e"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTUtMTEtMS0xLTI3Mjk1_32fd842f-b829-4446-955f-516a657d20b3"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctMS0xLTEtMjcyOTU_f04d1ae1-f225-4fc5-9f29-1c3eae7a2985"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctMy0xLTEtMjcyOTU_2cf72b1f-3d37-4133-9982-7f684a1f358e"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctNS0xLTEtMjcyOTU_e69a2557-3f73-4d05-b1ea-9849cb4224eb"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctNy0xLTEtMjcyOTU_20638f70-0714-48b2-b0d0-77af2152f8e6"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctOS0xLTEtMjcyOTU_a0c1a134-9e46-404e-b33a-70af0e3b97be"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTctMTEtMS0xLTI3Mjk1_26635677-b90e-42f8-9c7d-d1e9aa7f15a4"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktMS0xLTEtMjcyOTU_2cd18ae7-8c1d-4dbd-87c2-9cd3a408c19e"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktMy0xLTEtMjcyOTU_b2826b83-762a-40e2-8a91-ff1d09968e0c"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktNS0xLTEtMjcyOTU_928e9e66-b829-458c-8e32-7227b0e1ceb0"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktNy0xLTEtMjcyOTU_c3cf775e-55b9-4a9c-bc66-741f7e3361f8"
      unitRef="usd">332000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktOS0xLTEtMjcyOTU_56e90117-29f6-45e2-bf8e-1ed3cc1b47d1"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjUxY2Y1MmM4ZTIzYzRhM2Q4MDhlMWRmM2U0MTNhNDAzL3RhYmxlcmFuZ2U6NTFjZjUyYzhlMjNjNGEzZDgwOGUxZGYzZTQxM2E0MDNfMTktMTEtMS0xLTI3Mjk1_61d5f227-0042-41a6-a466-08e27837d3ac"
      unitRef="usd">295000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RleHRyZWdpb246NmNlYmY1YTQ4MTQzNGY2ZmIxY2JmOWU5MDc0ZDMyOWZfMjEwNw_2437a561-7799-421e-a29b-f9bc39cffd5b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other Comprehensive Income, net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMS0xLTEtMS0yNzI5NQ_5ad599ee-107d-4ca5-a8e0-f36b3640749a"
      unitRef="usd">209000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMS0zLTEtMS0yNzI5NQ_c37aed12-c2df-4dbf-9b9b-b5332cdb1b97"
      unitRef="usd">178000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMi0xLTEtMS0yNzI5NQ_3a717885-820f-45f6-b354-608771bbb940"
      unitRef="usd">747000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMi0zLTEtMS0yNzI5NQ_c1ce77c3-496c-432c-94d6-c0849d2acaf9"
      unitRef="usd">768000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMy0xLTEtMS0yNzI5NQ_2b5498f9-21f1-493c-9c1d-688e8afe407e"
      unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfMy0zLTEtMS0yNzI5NQ_cab9463d-4e81-4cf1-bc9a-d2c78b658bad"
      unitRef="usd">2000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNC0xLTEtMS0yNzI5NQ_75c0dfe0-19c5-4e60-8d53-69d8b8ab3261"
      unitRef="usd">-692000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNC0zLTEtMS0yNzI5NQ_966b9b9c-e8ab-4b75-b841-7526524e0af1"
      unitRef="usd">-680000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNS0xLTEtMS0yNzI5NQ_dce9a5f3-16eb-4f2b-8de9-544cc633229e"
      unitRef="usd">-1229000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5cba459b4604d78a2eb2e37cd615400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml83Ni9mcmFnOjZjZWJmNWE0ODE0MzRmNmZiMWNiZjllOTA3NGQzMjlmL3RhYmxlOjhmMDE5M2ZiZTQ1NDRkNDM5NmJiNWE0NjAzYzI2Njc5L3RhYmxlcmFuZ2U6OGYwMTkzZmJlNDU0NGQ0Mzk2YmI1YTQ2MDNjMjY2NzlfNS0zLTEtMS0yNzI5NQ_2052b2f4-cc78-443f-915b-0cadf58ea163"
      unitRef="usd">-1268000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDAy_472b8173-27a6-470e-9c31-0721182143f4">EMPLOYEE STOCK BENEFIT PLANS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $40 million and $17 million for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDA0_cc35419f-5684-4d92-aba9-f1b4cd27e5ca">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $40 million and $17 million for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2aa2fd0728f24dffbe302d8dc80f1127_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMi0xLTEtMS0yNzI5NQ_0d15a6e9-174e-40a5-8427-8acc27fe5151"
      unitRef="usd">8000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ieec5dffc23244b5680735c1a0cc27bf5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMi0zLTEtMS0yNzI5NQ_a7c2f6c8-574d-4000-b2e1-d839e8298bac"
      unitRef="usd">15000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i089a12daf0d440d892db99bd3cdae571_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMy0xLTEtMS0yNzI5NQ_c0825b2a-3a86-4102-add7-5077511de426"
      unitRef="usd">48000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8081637c0eb14bdbb47de184d2f39db5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfMy0zLTEtMS0yNzI5NQ_21615c31-8c35-4cbb-b39e-b9e47a5e34fd"
      unitRef="usd">60000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icdcc9669f9ef4756ab04f684b3f2016f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNC0xLTEtMS0yNzI5NQ_c9383b63-b3dd-4aa8-bb5a-5ee170e3f291"
      unitRef="usd">51000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idd031bc2a3194da4930ebfbe59a6c5fa_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNC0zLTEtMS0yNzI5NQ_088a6fec-719d-42ed-b81d-82a1275bba6d"
      unitRef="usd">70000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i08b1a43d479945f78f6ba2f8ef93edae_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNS0xLTEtMS0yNzI5NQ_94e4588f-9e37-46ef-94fb-d35496070bc5"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1a4494aa926f4aafb4d4f13e1bc379c0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNS0zLTEtMS0yNzI5NQ_2e7f6c0e-2b74-4925-83c1-7fa515521889"
      unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNi0xLTEtMS0yNzI5NQ_ed041e76-1f4a-4605-8dc4-4df3b48f403e"
      unitRef="usd">107000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfNi0zLTEtMS0yNzI5NQ_4eff98d1-d2d7-4527-8059-6af793e4563c"
      unitRef="usd">151000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfOC0xLTEtMS0yNzI5NQ_130868a9-ee14-4500-a23c-2a013d74ccab"
      unitRef="usd">22000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBmZDRjMjZjOWQ5ZTRmZTZiMTE0NmNiZWE5YWMyM2JhL3RhYmxlcmFuZ2U6MGZkNGMyNmM5ZDllNGZlNmIxMTQ2Y2JlYTlhYzIzYmFfOC0zLTEtMS0yNzI5NQ_36c3cc96-7019-4e09-a9c1-f7dfef90f243"
      unitRef="usd">31000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfMjE3_192f2583-aacb-4bcc-a91d-20c40bf3b792"
      unitRef="usd">40000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i41a411e531884341ba547408f3ea5589_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfMjI0_1e5d25ba-e662-41ef-88af-c5f615464970"
      unitRef="usd">17000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDA2_39283e65-59f3-4fd5-852b-3961600e33f2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i07493150d868420687804e8b350888ae_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMi0xLTEtMS0yNzI5NQ_3a2553a7-a8eb-4e82-9cdf-273f60c58e75"
      unitRef="shares">7200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i07493150d868420687804e8b350888ae_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMi0zLTEtMS0yNzI5NQ_80349bb0-140e-4b05-96ce-85533128b3d6"
      unitRef="usdPerShare">63.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMy0xLTEtMS0yNzI5NQ_5504f1d0-eed4-4ef0-b35a-aa5b9b493544"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfMy0zLTEtMS0yNzI5NQ_07cac7f7-e401-4261-a5df-2aaa380d60ed"
      unitRef="usdPerShare">60.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfNC0xLTEtMS0yNzI5NQ_8817fbd9-9f24-4a9f-9bd0-4507fc0eb88e"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjBhZWJlMGZmMDcxMjRlYTRiODc3YjZkNzY1ODBkYzBlL3RhYmxlcmFuZ2U6MGFlYmUwZmYwNzEyNGVhNGI4NzdiNmQ3NjU4MGRjMGVfNC0zLTEtMS0yNzI5NQ_f795824f-9c48-407e-b92f-61e086d0a0bf"
      unitRef="usdPerShare">66.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RleHRyZWdpb246Y2Y1MDBkYzBlYmQ4NGFlOTllOTgxY2VkOTRjNDljNjBfNDAx_caf05ce7-06b1-4d37-b3f4-bf1a40e29e94">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i5d74d60f32f84b198678df8d911c9b3c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS0xLTEtMS0yNzI5NQ_c1244acc-644c-477e-b9ef-85b5fd9ff9a2"
      unitRef="usd">3000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i590050289ff34ed9b5d3577bac6f2c84_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS0zLTEtMS0yNzI5NQ_a8cd6272-d497-4a15-b112-fa494975db8f"
      unitRef="usd">1003000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ief8394f86b214f7d9f855003ba6e8de0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS01LTEtMS0yNzI5NQ_e5018af2-5ae5-43d1-ba67-9a28b7258d82"
      unitRef="usd">90000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ib2c7bf5611944b89b000936b86b2afff_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMS03LTEtMS0yNzI5NQ_cfcdbe57-d323-4690-895f-a4ea5982ca66"
      unitRef="usd">157000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i0ccde1b9c7584766b2b7209f2916527d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi0xLTEtMS0yNzI5NQ_349df3ef-1327-4978-be2b-ef4c15f1abd1">P0Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i07493150d868420687804e8b350888ae_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi0zLTEtMS0yNzI5NQ_94a3a2b9-5d2d-4f0b-a5d1-ebf0c920f038">P3Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i340609e55d6c47a3a65163697c089ce4_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi01LTEtMS0yNzI5NQ_8c5068c7-dbd4-4150-9e46-2d09af051858">P3Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i538cc99203ac4d0fa0756fa397d2127b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84Mi9mcmFnOmNmNTAwZGMwZWJkODRhZTk5ZTk4MWNlZDk0YzQ5YzYwL3RhYmxlOjg3ZGJmMjg0ODQwMDQ1MjI5MTBkYTUwOGNmYjE2MzNiL3RhYmxlcmFuZ2U6ODdkYmYyODQ4NDAwNDUyMjkxMGRhNTA4Y2ZiMTYzM2JfMi03LTEtMS0yNzI5NQ_f3bba49a-ddc7-45e0-ab28-6755104c033a">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDI4Mzg_1d53567c-35d2-4b4d-b7ed-a24883f98223">LEGAL PROCEEDINGS AND CONTINGENCIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#x2019;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#x2019;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS&#x2019;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#x2019;s tax contingencies, see &#x201c;&#x2014;Note&#160;7. Income Taxes&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;INTELLECTUAL PROPERTY&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Anti-PD-1 and Anti-PD-L1 Antibody Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2015, Dana-Farber Cancer Institute (&#x201c;Dana-Farber&#x201d;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber&#x2019;s claims for damages before May 17, 2019&#x2014;the date of the District Court&#x2019;s ruling that Dana-Farber was a co-inventor of the patents&#x2014;are preempted by federal patent law. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd ("AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CAR T&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#x201c;SKI&#x201d;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#x201c;Kite&#x201d;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; product infringes certain claims of U.S. Patent No. 7,446,190 (the &#x201c;&#x2019;190 Patent&#x201d;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#x2019;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#x2019;s defenses, finding that Kite willfully infringed the &#x2019;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585 million up-front payment and a 27.6% running royalty on Kite&#x2019;s sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; through the expiration of the &#x2019;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#x2019;s motions in their entirety. In April 2020, the Court granted in part Juno&#x2019;s motion and entered a final judgment awarding to Juno and SKI approximately $1.2 billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite&#x2019;s sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* from December 13, 2019 through the expiration of the &#x2019;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the &#x2019;190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing which the Federal Circuit denied on January 14, 2022. Juno and SKI intend to file a petition for a writ of certiorari with the U.S. Supreme Court.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - Europe&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November 2020 and January 2021, Sandoz Limited (&#x201c;Sandoz&#x201d;) and Teva Pharmaceutical Industries Ltd. (&#x201c;Teva Limited&#x201d;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate (&#x201c;SPC&#x201d;). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgement issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. We disagree with the ruling and plan to appeal the decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are similar lawsuits filed in France, Italy, the Netherlands, Portugal, the Republic of Ireland, and Sweden seeking revocation of a composition of matter patent relating to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, Sandoz informed BMS that it intends to launch its generic apixaban product in the Netherlands as soon as possible. In response, we have requested that the Dutch court issue a preliminary injunction to prevent any infringement of the Dutch apixaban composition of matter patent and related SPC as long as the patent and SPC are in force.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional infringement and invalidity actions involving &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patents may be filed in various countries in Europe in the coming months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013; U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an aNDA containing a paragraph IV certification seeking approval of a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onureg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. and challenging the one FDA Orange Book-listed formulation patent expiring in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - Australia&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#x201c;GenRx&#x201d;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#x201c;GenRx-Apotex&#x201d;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#x2019;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#x2019;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#x201c;Full Court&#x201d;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449 million AUD ($337 million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#x2019;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#x2019;s decision and an appeal hearing concluded in February 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pomalyst&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, Celgene received a Notice Letter from MSN Laboratories Pvt. Ltd. (&#x201c;MSN&#x201d;) notifying Celgene that MSN had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pomalyst&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. In response, Celgene initiated a patent infringement action against MSN in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Celgene has received a Notice Letter from Alembic Pharmaceuticals Limited, Alembic Global Holding SA, and Alembic Pharmaceuticals, Inc. (&#x201c;Alembic&#x201d;) notifying Celgene that Alembic had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. In response, Celgene initiated a patent infringement action against Alembic in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents. Alembic has filed answers and counterclaims alleging that the asserted patents are invalid and/or not infringed. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sprycel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray") notifying BMS that Xspray had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC (&#x201c;Actelion&#x201d;), filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the &#x201c;&#x2019;867 Patent&#x201d;). The Complaint alleges that the sale of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infringes certain claims of the &#x2019;867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; State Attorneys General Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834&#160;million, with $417&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. A trial in the New Mexico matter was previously scheduled for April 2022, but was adjourned due to statewide trial delays arising from the COVID-19 pandemic. Trial has been rescheduled for January 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRODUCT LIABILITY LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and Otsuka are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs allege &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; caused them to engage in compulsive gambling and other impulse control disorders. There have been over 2,500 cases filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately 2,700 cases, comprising approximately 3,900 plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders. In the U.S., less than five cases remain pending in state or federal courts (New Jersey and Massachusetts). There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario). Both class actions have now been certified and will proceed separately, subject to a potential further appeal of the Ontario class certification decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Byetta*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta*.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This litigation involved lawsuits on behalf of plaintiffs, which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases are pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#x201c;JCCP&#x201d;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The orders will result in the dismissal of all claims alleging an injury of pancreatic cancer in the MDL and JCCP. Plaintiffs initially appealed the MDL order, but subsequently filed a motion to dismiss their appeal as to Amylin and Lilly. That motion to dismiss was granted on October 5, 2021 making the MDL decision final as to Amylin and Lilly. Plaintiffs may seek appeals in the JCCP. As of March 2022, Plaintiffs&#x2019; counsel have submitted dismissals with prejudice in exchange for a waiver of costs on behalf of approximately 75% of the plaintiffs in the JCCP (including injury plaintiffs and spouse/beneficiary plaintiffs) alleging claims against Amylin and Lilly. Additional dismissals are anticipated. BMS sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* to AstraZeneca in February 2014 as part of BMS&#x2019;s global diabetes business divestiture and any additional liability to Amylin with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* is expected to be shared with AstraZeneca.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and AstraZeneca are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As of April 2022, claims are pending in federal and NY state court on behalf of approximately 252 individuals who allege they ingested the product and suffered an injury. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all federal cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco (&#x201c;JCCP&#x201d;). In August 2021, the MDL and JCCP courts jointly heard evidence regarding the parties&#x2019; motions to exclude general causation experts. On September 24, 2021, the JCCP court granted defendants&#x2019; motion to exclude plaintiffs&#x2019; only general causation expert and largely denied plaintiffs&#x2019; motions to exclude defendants&#x2019; general causation experts; on January 5, 2022, the MDL court likewise granted defendants&#x2019; motion to exclude plaintiffs&#x2019; expert and denied entirely plaintiffs&#x2019; motions. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the 18 claims previously pending in California state court. As part of BMS&#x2019;s global diabetes business divestiture, BMS sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to AstraZeneca in February 2014 and any potential liability with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is expected to be shared with AstraZeneca.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SECURITIES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;BMS Securities Class Action&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since February 2018, two separate putative class action complaints were filed in the U.S. District for the Northern District of California and in the U.S. District Court for the Southern District of New York against BMS, BMS&#x2019;s Chief Executive Officer, Giovanni Caforio, BMS&#x2019;s Chief Financial Officer at the time, Charles A. Bancroft and certain former and current executives of BMS. The case in California was voluntarily dismissed. The remaining complaint alleged violations of securities laws for BMS&#x2019;s disclosures related to the CheckMate-026 clinical trial in lung cancer. In September 2019, the Court granted BMS&#x2019;s motion to dismiss, but allowed the plaintiffs leave to file an amended complaint. In October 2019, the plaintiffs filed an amended complaint. In September 2020, the Court granted BMS&#x2019;s motion to dismiss the amended complaint with prejudice. The plaintiffs appealed the Court&#x2019;s decision in October 2020. On March 11, 2022, the Second Circuit affirmed the dismissal with prejudice of the amended complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Celgene Securities Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 2018, &lt;/span&gt;&lt;span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;two&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#x201c;Celgene Securities Class Action&#x201d;). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#x2019;s 2020 outlook and projected sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Otezla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and (3) the new drug application for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#x2019;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the &#x201c;Schwab Action&#x201d;). In July 2020, the defendants filed a motion to dismiss the plaintiffs&#x2019; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#x2019; motion to dismiss consistent with its decision in the Celgene Securities Class Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The California Public Employees&#x2019; Retirement System in April 2021 (the &#x201c;CalPERS Action&#x201d;); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the &#x201c;DFA Action&#x201d; and the &#x201c;American Century Action&#x201d;), and GIC Private Limited in September 2021 (the &#x201c;GIC Action&#x201d;), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No trial dates have been scheduled in any of the above Celgene Securities Litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Value Rights Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#x201c;CVR Agreement&#x201d;) entered into in connection with the closing of BMS&#x2019;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#x201c;diligent efforts&#x201d; to obtain FDA approval of liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) before a contractual milestone date, thereby avoiding a $6.4&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#x2019; fees. BMS disputes the successor trustee&#x2019;s allegations and filed a Motion to Dismiss on July 23, 2021. All discovery is stayed until there is a decision on the Motion to Dismiss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 relating to the joint proxy statement. That action later was consolidated with another action filed in the same court asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a) and 20(2) of the Securities Exchange Act of 1934. In asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the merger and persons who purchased CVRs for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and sections 10(b), 14(a), and 20(a) of the Securities Exchange Act of 1934. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants have moved to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff has filed a motion to remand the action to the state court.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene&#x2019;s former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff has filed a motion to remand the action to the state court.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No trial dates have been scheduled in any of the above CVR Litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;OTHER LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;HIV Medication Antitrust Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and two other manufacturers of HIV medications are defendants in related lawsuits pending in the Northern District of California. The lawsuits, filed on behalf of indirect purchasers, allege that the defendants&#x2019; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Atripla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Evotaz&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, violate antitrust laws. In July 2020, the Court granted in part defendants&#x2019; motion to dismiss, including dismissing with prejudice plaintiffs&#x2019; claims as to an overarching conspiracy and plaintiffs&#x2019; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remain. In September and October 2020, two purported class actions were also filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. On September 22, 2021, two additional non-class action direct purchaser complaints were filed by a number of retail pharmacy and grocery store chains against BMS and two other manufacturers of HIV medications. These complaints make allegations similar to those raised in the other federal court cases and the New Mexico state court case described below. In October 2021 and March 2022, BMS entered into settlement agreements with the putative class of indirect purchasers and the putative class of direct purchasers, respectively. Both settlements are subject to court approval. In January 2022, BMS reached an agreement to settle the cases filed against it by the retail pharmacy and grocery store chains.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#x2019; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Atripla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, five additional non-class-action indirect purchaser cases were filed in the Northern District of California, and one additional non-class-action indirect purchaser case was filed in California state court naming BMS and two other manufacturers as defendants. These complaints make allegations similar to those in the other federal court cases. In February 2022, BMS reached a settlement agreement with one of the non-class-action indirect purchaser plaintiffs and in April 2022, two additional indirect purchaser plaintiffs filed non-class suits against BMS and other defendants. In total, there are now seven non-class action indirect purchaser cases pending against BMS among others. No trial date has been scheduled for these remaining cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, Humana, Inc. (&#x201c;Humana&#x201d;) filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana&#x2019;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#x2019;s Racketeer Influenced and Corrupt Organizations Act. Humana subsequently dismissed its claims for breach of contract voluntarily. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. A trial has been scheduled for January 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, Humana filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#x2019;s complaint makes largely the same claims and allegations as were made in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#x2019;s complaint, and the Court has stayed discovery pending adjudication of that motion. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, United HealthCare Services, Inc. (&#x201c;UHS&#x201d;), affiliates of which opted out of the first settlement in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; antitrust class action litigation, filed a lawsuit against Celgene in the U.S. District Court for the District of Minnesota. UHS&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation in addition to certain claims regarding donations directed to copay assistance. The complaint purports to assert claims on behalf of UHS and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. In December 2020, Celgene&#x2019;s motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. In January 2021, Celgene filed a motion to dismiss UHS&#x2019;s complaint, which the Court administratively terminated in June 2021 pending its decision on Celgene&#x2019;s pending motion to dismiss Humana&#x2019;s complaint. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#x201c;HPI&#x201d;), a Humana subsidiary, in Delaware Superior Court. Celgene&#x2019;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#x2019;s breach as well as a declaratory judgment. A trial has been scheduled for March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, Blue Cross Blue Shield Association (&#x201c;BCBSA&#x201d;) sued Celgene and BMS on behalf of the Federal Employee Program in the U.S. District Court for the District of Columbia. BCBSA&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. In April 2021, the parties&#x2019; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, BCBSM Inc., Health Care Service Corporation (&#x201c;HCSC&#x201d;), Blue Cross and Blue Shield of Florida Inc., and Molina Healthcare, Inc. (&#x201c;Molina&#x201d;) sued Celgene and BMS in a Minnesota state court. The complaint makes largely the same claims and allegations as were made in the class action litigation but adds allegations on behalf of HCSC only as to alleged off-label marketing of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In September 2020, Celgene and BMS removed the action to the U.S. District Court for the District of Minnesota. In March 2021, that Court denied plaintiffs&#x2019; motion to remand the action to state court, dismissed Molina for lack of personal jurisdiction and granted defendants&#x2019; motion to transfer the action to the District of New Jersey. The case is now pending in the District of New Jersey. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, Cigna Corporation (&#x201c;Cigna&#x201d;) sued Celgene and BMS in the U.S. District Court for the Eastern District of Pennsylvania. Cigna&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. Cigna&#x2019;s complaint purports to assert claims on behalf of Cigna and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser. In May 2021, the parties&#x2019; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. In July 2021, Celgene and BMS removed the action to the U.S. District Court for the Northern District of California, and in January 2022, that court granted Molina&#x2019;s motion to remand to San Francisco Superior Court. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, a group of plaintiffs&#x2014;MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, &#x201c;MSP&#x201d;)&#x2014;sued Celgene and BMS in the U.S. District Court for the District of New Jersey. MSP&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. MSP purports to pursue assignments from certain named and unnamed entities that allegedly purchased or otherwise provided reimbursement for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and/or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and purports to bring direct and indirect purchaser claims. In February 2022, MSP filed an amended complaint, adding claims arising from the Company's donations to charitable organizations, and adding those organizations as defendants. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BeiGene Arbitration Matter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2017, Celgene Logistics S&#xe0;rl (&#x201c;Celgene Logistics&#x201d;) and BeiGene, Ltd. (together with its assignees, &#x201c;BeiGene&#x201d;), entered into a License and Supply Agreement (the &#x201c;LSA&#x201d;) pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Vidaza&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abraxane&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in China. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As has been disclosed publicly, BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abraxane&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MSK Contract Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, &#x201c;Plaintiffs&#x201d;) filed a complaint against BMS, Celgene and Juno (collectively, &#x201c;Defendants&#x201d;) alleging that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least 1.5% of worldwide sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abecma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs&#x2019; claims. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;GOVERNMENT INVESTIGATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ENVIRONMENTAL PROCEEDINGS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#x2019;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CERCLA Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to CERCLA matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#x201c;potentially responsible parties,&#x201d; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $89 million at March&#160;31, 2022, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i9d9865ddc7954c648849d381362ca98e_D20150901-20150930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMjY4NA_39453b51-4535-4e70-9bc9-ed50eb773a93"
      unitRef="patents">6</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:PaymentsForRoyalties
      contextRef="ib14a424b066040b5bef8059066e64306_D20191201-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDY1NQ_f61ab3f3-69ad-4f16-ac1f-e743a34d908e"
      unitRef="usd">585000000</us-gaap:PaymentsForRoyalties>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i6d6fa7d30f14437eaa258bc9961b99aa_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDY4MA_a7ef0793-5541-4308-ad56-8fe6d88bf726"
      unitRef="number">0.276</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:PaymentsForRoyalties
      contextRef="i9446604f2db5490f98213dcf99cf2ac0_D20200401-20200430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNTIxNA_39da3860-308b-48ad-9478-04f570943477"
      unitRef="usd">1200000000</us-gaap:PaymentsForRoyalties>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i43df7495f1924291aea1c8aaa040cf1e_I20200430"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNTI2Nw_7ea62269-087b-4e5c-95b2-ba999c8baff7"
      unitRef="number">0.276</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i733d93df91dc48439bdd9ef3a9e1b05a_D20100301-20100331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfOTkyNg_62b86fd7-e3d6-49bb-86bf-8ed5fbfc48d3"
      unitRef="aud">449000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i3006be3445994b7b9d2b9407bafa2026_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfOTkzNA_7038ef21-14d0-4a43-93b8-4c040eb08e97"
      unitRef="usd">337000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="id7c0db74c54043a48910aadd9e2028f4_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1OA_b06cf715-0470-4c9d-973c-ac4e7cecd25e"
      unitRef="usd">834000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i2b238679663048e29218b5914560ecea_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTc3MjA_5f7b3ab9-1be0-4851-896f-0d15ea03f50b"
      unitRef="usd">417000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i668ad442deb24bfd83ce136a88b8f854_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTg1OTY_6af32cd7-8300-4278-a43c-2d709b4fedd4"
      unitRef="lawsuits">2500</us-gaap:LossContingencyPendingClaimsNumber>
    <bmy:LossContingencyPendingClaimsNumberDismissed
      contextRef="i668ad442deb24bfd83ce136a88b8f854_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTkxNTA_687277cc-06d9-47f6-8121-a9273f9fc841"
      unitRef="lawsuits">2700</bmy:LossContingencyPendingClaimsNumberDismissed>
    <bmy:LossContingencyNumberOfPlaintiffsDismissed
      contextRef="i668ad442deb24bfd83ce136a88b8f854_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTkxODU_549b2c08-2925-44fb-ae20-5bb454ef8ae0"
      unitRef="numberofplaintiffs">3900</bmy:LossContingencyNumberOfPlaintiffsDismissed>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iec03ab8dc1e74dc78cce7f33bcf80a19_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTkzNTE_cd8b99ff-f00e-47f2-bce4-d894419c430f"
      unitRef="lawsuits">5</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTk1Mjk_fc6fa93f-763a-4e1a-9504-15353aef726a"
      unitRef="lawsuits">11</us-gaap:LossContingencyPendingClaimsNumber>
    <bmy:LossContingencyPendingClaimsNumberClassAction
      contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1Mw_364e33ff-2c83-49d0-8479-d5b83925357f"
      unitRef="lawsuits">4</bmy:LossContingencyPendingClaimsNumberClassAction>
    <bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims
      contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1NA_ed8fc5ff-5b2c-4640-8aca-fc4ab8047ca1"
      unitRef="lawsuits">7</bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMTk2MjE_fc6fa93f-763a-4e1a-9504-15353aef726a"
      unitRef="lawsuits">11</us-gaap:LossContingencyPendingClaimsNumber>
    <bmy:LossContingencyPendingClaimsNumberActive
      contextRef="id19c69223ac34dbf8350b9e50ffbf637_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk1MTY1NQ_612471b6-586d-4aee-99ba-92455745821b"
      unitRef="lawsuits">2</bmy:LossContingencyPendingClaimsNumberActive>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="iee6991d7144c4ff5982b421baf4a28cc_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfMjIxNzE_3c443a34-e6a5-43f2-9dc0-48baa81e058b"
      unitRef="numberofplaintiffs">252</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:ContractualObligation
      contextRef="ibe66d937c77841249eedd821c141f3ec_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk2NzQyNQ_54b3572e-f85c-41dc-a92f-625b9db0692f"
      unitRef="usd">6400000000</us-gaap:ContractualObligation>
    <bmy:RoyaltyGuaranteesCommitmentsPercent
      contextRef="i04d29be57add402ab3461c9dc80fe525_I20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNjU5NzA2OTk4MjExOQ_1e23f8a2-d8f2-47d4-82f8-15bcce6bfbb2"
      unitRef="number">0.015</bmy:RoyaltyGuaranteesCommitmentsPercent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i3f5f7794c20a4dd6a4fa7996fa043575_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml84NS9mcmFnOmZhOTI3MjQ4OGJkMjQ5ODRiMGIxOTEwMjZlOGI0NDBkL3RleHRyZWdpb246ZmE5MjcyNDg4YmQyNDk4NGIwYjE5MTAyNmU4YjQ0MGRfNDI0MTI_eecd706b-d072-4fa9-87ac-642dffee1826"
      unitRef="usd">89000000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0zLTEtMS0yNzI5NQ_a476dbbc-df36-4cbd-ae30-6dcbd01382d8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0zLTEtMS0yNzI5NQ_a476dbbc-df36-4cbd-ae30-6dcbd01382d8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0xLTEtMS0yNzI5NQ_48524f70-69e2-4b2e-8874-e1282761b818"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0xLTEtMS0yNzI5NQ_48524f70-69e2-4b2e-8874-e1282761b818"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RleHRyZWdpb246N2Q5YjRkZmRiZDM4NDljNDhjOTk2MWY1NjZkMGIyODFfMzYy_a932c4fd-6e60-41e7-96da-4585dfa23e35" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RleHRyZWdpb246N2Q5YjRkZmRiZDM4NDljNDhjOTk2MWY1NjZkMGIyODFfMzYy_a932c4fd-6e60-41e7-96da-4585dfa23e35" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes amortization of acquired intangible assets</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0zLTEtMS0yNzI5NQ_a476dbbc-df36-4cbd-ae30-6dcbd01382d8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RleHRyZWdpb246N2Q5YjRkZmRiZDM4NDljNDhjOTk2MWY1NjZkMGIyODFfMzYy_a932c4fd-6e60-41e7-96da-4585dfa23e35"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RhYmxlOjAxMjU5N2U3YmI4ZTRhODVhMDcyZTllOGNlNzY4YzU5L3RhYmxlcmFuZ2U6MDEyNTk3ZTdiYjhlNGE4NWEwNzJlOWU4Y2U3NjhjNTlfNi0xLTEtMS0yNzI5NQ_48524f70-69e2-4b2e-8874-e1282761b818"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRlNDcxOTQ3Mjg2MzQwZGQ5MjUwNmY4MGZlMDQ3NjQyL3NlYzpkZTQ3MTk0NzI4NjM0MGRkOTI1MDZmODBmZTA0NzY0Ml8xNi9mcmFnOjdkOWI0ZGZkYmQzODQ5YzQ4Yzk5NjFmNTY2ZDBiMjgxL3RleHRyZWdpb246N2Q5YjRkZmRiZDM4NDljNDhjOTk2MWY1NjZkMGIyODFfMzYy_a932c4fd-6e60-41e7-96da-4585dfa23e35"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>92
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MA<'^0@*;%7SF!&\W)N[W_?JV,4B%GML217A6MV GW@SS5&UP <9$=3\$S'5
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M8*R/P[7Q";R;0L/X"*&["3)I* _5$WU2MJJIBR\4JO??TE2 F&P4AGT;J+?
MBT-_<2/97A^#7YE4AVI]N2,X(CP74,\WC,G333Y!^>EE^"]02P,$%     @
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M&K_Z\2!R>/?0N%HNA7%4 'KEYXK0S3POP'>^Z.H>6$'_OP3G_P%02P,$%
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MIX81ZKM]J_Y@//,2%J45QH8!:E 1LD9?N3TA.)6W7<4/231,G7'7QSXQ'UH
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MG9^>GTT2!?J;8)OXT8(3)S9?_+O!-R<Y%L#[M;6AOV$'PU?LS9]02P,$%
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MQ61> A*FURSMZI!%HJJ4Y(W><>4DA;G-9)(Q;D3]6*18U.'V<4OG8C 23VA
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MV$$;\'RMT0[K"S+0_D%S\2]02P,$%     @ ]%6=5)5\9',E P  =@8  !D
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MSY_>O/]P>_/QXO;CS>6O/QZ//$SRAU':J)_7ZO$+Z@E=&>US1^]U)K/'^B-
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MV[Q$R6Q?5ZCH9J>-9(Z.9A_;RB K@I$4<98DHU@RKJ+9),A69C;1M1-<X<J
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M:+P"W>\T);H]> ?=?V[V'5!+ P04    " #T59U4<5L*HZ$3  "_/P  &0
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M8ZD&P*1(U:P3%,.$B:,25^2':)FJA+6DHMC_MHI<J^RJ&@2$S?6)1QEO;86
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M#/@4M#I%":3<,B:CZZ3QGF\5#FC=ITU"ES;I$C/J=<"$ 0UY])1-57<SK<Z
MMFW5;?7]M-#-Y"+>>6%0AL$APF<0JDHTVBO3,<$G>,YTID/7UHXY*:(HRZBP
M?E>,W,QR#$CTW(X$1( 0&R54,NN4&HPR588/@XSU[[],CRJ3M2L.D @,"W9J
MSE;,+8%&2X-CD%6=E%=VN_NUI2LV+S$<O>X$CJ\AL<CRQY.%NI@LRSW\(:$N
M%J,: 6XG%2G9/#<W]>\3MMY7J0S+_&R@$M+IT<;YP=TA)/R<R4SJ$<&8C(=I
MJ0F?MOFPXD[>\JEVMG#^7>S,T^ZK?LYQ/K5.%]WA8CXUT5+=U%0Q@!MOJ:1
M,*Q*67/)6KT^'\_GU3DEY^1QY5PF93Z;C'BJLA.ZZZS.E"C0Z#!MKG99MTF.
M(32$JPXP@(0OQ<:C3F1!/PE#A.3NMGQ,(K[G[6/G(1UR^:9%PBU9>F7G/P,<
M=/KC,PZH>SR;7 3>OIZW-*V]G@*]F!O[?_5BJY_O*1E=\$6V6CX[C8*"UT^)
M6$-P)95IDTIH?H:@FM#?JR.B>[G+E;A ;JJN_Q01$Y_5E<+V5.?^J='0]FPV
MIEV;X6VH*M:F-3>RY>**N%.)+HY5<EWMJ]O#Y2D$Z:'J'=.-^X 3PN=-F%4K
M(CP\AH&.%NJGMK1H=:#FTPU[A=*9=)Q8O2T_>93XK.'Y%FI>53=0-&DXK_^U
MV(DH_%:$ :W)OS0I^$B[?@6\ H%\MJYK(FRPW!2^IGLES=S>QT!O>;L--=(O
M5!C#,B6H>-X(FBU^4YT]:X4T\+BE6Q9*C?XT8!!E-@94K$3>,. A I"-C9E!
MNVVOMDEXYY##[CO*!"B@?9F\ZP>^E]:/JJ&K!_[I./V<!G%'_;ZZ?%K^.OU:
M_2B[&JY^V@X6'NA8.I)K3!T!%9\I2&B^Y,F.?Z*]2G)8(7_<2 _;HP%XOTX0
MB_476J#\S?[K_P%02P,$%     @ ]%6=5-AU1D,G P  Q08  !D   !X;"]W
M;W)K<VAE971S+W-H965T,34N>&ULA55M3]LP$/XKIXA)3,J:)ND+G=I*+3 -
M"1 JC'V8]L%-KHV%8V>V2\N_W]D)H=4*^]#X[9Z[YQZ?K^.MTD^F0+2P*X4T
MDZ"PMOH:128KL&2FHRJ4=+)2NF26EGH=F4HCRSVH%%'2[0ZBDG$93,=^[TY/
MQVIC!9=XI\%LRI+IESD*M9T$<?"ZL>#KPKJ-:#JNV!KOT?ZH[C2MHM9+SDN4
MABL)&E>38!9_G?><O3=XY+@U>W-PF2R5>G*+JWP2=!TA%)A9YX'1\(SG*(1S
M1#3^-#Z#-J0#[L]?O7_SN5,N2V;P7(F?/+?%)#@+(,<5VPB[4-OOV.33=_XR
M)8S_PK:V'?0"R#;&JK(!$X.2RWIDNT:'/<!9]QU T@ 2S[L.Y%E>,,NF8ZVV
MH)TU>7,3GZI'$SDNW:7<6TVGG'!VNK@\O[QZG,VO+^_'D26';CO*&O"\!B?O
M@%.X4=(6!BYECODA/B(B+9ODE<T\^=#A#=,=2.,0DFZ2?. O;;-+O;_A._YF
M6:8VTAI88(;\F2T%AL!6%C7,!-4CDQD"53:<:\RYA6ME#/R:+8W55"Z_/V#0
M:QGT/(/T/7W;P.:8OO\!OUT.7"@AF#; )=QP(:BB#9!<6>'UNJ PY9+2<HL'
MS7*D%]-&AA,8AL/>@,:S<)BD<(V49U8PO<8O2Y8]&6 RAXR9 G)N&LU.^X/X
M,YR2_><:P XDPUU%+PL)5FLGG':GR8@@">%NJ:'8?X@,P[@_H.]H.'(WP)VW
M$!;JA0G+T83P.'OP7)0M*)LX3/M]]QUU]Z[0^#SZ<4SC*$P'([A5\LN/SGWG
M()91@OS0PP>I)!VHC3;HGC WL$6-<-(C*<I:3!_T)(W/V@V7(Y&@GT:$LBYT
M=(6^I[NK4P^E"2TU&B<*]1GQTCE@O-*JW',GG/3&-B\<ZWMUQTT6U& -2J<N
MJRJM=ISZ#_F$0?>3#]<??0*U JLL$T=D9O88QX,B.4+X6+E'>ZV%>*Y] Z7:
M<252=YEVM^W1L[HUO9G7#9X8K3E5K< 50;N=83\ 73?->F%5Y1O54ED2Q4\+
M^I]![0SH?*64?5VX .T_U_0O4$L#!!0    ( /15G52V"IH2C0,  - '   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;*5537/B.!#]*UVN'%G\ 20P
M!53E:VIS2"9%LC.'J3T(N\':R&J/)$/X]]N2P2&I)'.8BV5)W4_O/7WT=$OF
MR9:(#IXKI>TL*IVKO\2QS4NLA.U3C9IG5F0JX;AKUK&M#8HB)%4JSI+D-*Z$
MU-%\&L;NS7Q*C5-2X[T!VU25,+L+5+2=16ET&%C(=>G\0#R?UF*-#^C^J>\-
M]^(.I9 5:BM)@\'5+#I/OUP,?7P(^"YQ:X_^P2M9$CWYSDTQBQ)/"!7FSB,(
M;C9XB4IY(*;Q:X\9=4OZQ./_ _K7H)VU+(7%2U(_9.'*632.H,"5:)1;T/9O
MW.L9>;R<E U?V+:QV6D$>6,=5?MD9E!)W;;B>>_#4<(X^2 AVR=D@7>[4&!Y
M)9R83PUMP?AH1O,_06K(9G)2^TUY<(9G)>>Y^<W=]^N[QV^+F^N':>P8T _'
M^3[YHDW./D@>P"UI5UJXU@46K_-C)M*QR0YL+K)/ 6^%Z<,@[4&69-DG>(-.
MW2#@G7VD3F]0.S*['MSQ ?]YOK3.\$'X]Q/L88<]#-B#WV!+M.\Y]YOD%]OA
MBI02QH+4<"N5XK-J@8W(R^#$%>98+=&$SE>I)>]U 6NBPL()#(<3_HZ& _C!
MA]]#U(9RM!:R7C+*^)NF*2S$%H0NH!;YDUA+O>83Y-!(H2PCG,)@E, C.:$8
MH!/%N%EO,CSC=M!+DB'<O)E+><RWR60$WUS)%#7IO_+&& X#82TZ"V.F-DDF
M[\!+G:NF0%@):6 C5(,@BO_XQ/.5YT2#EB^6Y[HR5 'C ]_=-6H.RW\UTLIP
MJVD%)X/3,5^-X!P(=^2=/T5!^,DH>17RRE2.2OL?*SCP/'#? 3[7_*;P+CAB
MFO[E X8M_4)+W!$W:095>S-X;DFNA)KMYBWKPSD'-\[S;H>.1,-6=,L5/M.+
M=J5!/*"AOV=O!08619-CB&\)>=]$18T.*[U0_S.SESLX2=-AY^16LC(!.;%A
MMF;A'H$%<'6PZ'E=DFVE&F*"O) E5;1[EKWL!QNV0(M!E>\4N.%B40=+O->:
MP7S.N,OIPV.);YW3Y+IS[1?G(K61U%BU8WTU&;]C2Z&$9J?"@VF!S%ZZ]0MP
MI3/""[7]]]Z'^.B5K="L0RVQK)Y=;A_<;K0K5^?M*_T2WM8ZWD&^AA84KC@U
MZ9^-(C!M_6@[CNKP9O/9X0H0?DLNN6A\ ,^OB-RAXQ?HBOC\?U!+ P04
M" #T59U48%5A3-L"   H!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6R=56UOVC 0_BNGJ!]6"36OO+0")&C95JETC+:;IFD?3'(0JTZ<VLYH__W.
M#J1,:IFT#]@^YY[G7GQW#+=2/>H<T<!S(4H]\G)CJ@O?UVF.!=-GLL*2OJRE
M*I@A46U\72EDF0,5PH^"H.<7C)?>>.CN%FH\E+41O,2% ET7!5,O4Q1R._)"
M;W^QY)O<V M_/*S8!N_0/%0+19+?LF2\P%)S68+"]<B;A!?3Q.H[A6\<M_K@
M##:2E92/5KC.1EY@'4*!J;$,C+;?>(E"6")RXVG'Z;4F+?#PO&?_Z&*G6%9,
MXZ44WWEF\I$W\"##-:N%6<KM9]S%T[5\J13:K;!M=!.RF-;:R&(')KG@9;.S
MYUT>#@"#X!U M -$SN_&D//RBADV'BJY!66UB<T>7*@.3<[QTC[*G5'TE1/.
MC!?++XO9\OY'!Q8WD]M[F-Q>P>SKP_5B/KN]'_J&3%A%/]W131NZZ!VZ&.:R
M-+F&69EA]C?>)]=:_Z*]?]/H*.&<J3.(PPY$010=X8O;>&/'UW\O7D7UK,P+
MQ2M8:8"5&<R>:EY1H1GX.5EIHZA2?ATQE;2F$F<J_A]3;Z7V'W3'7@JNI!!,
M:> ES+D05/ :*'=I[I)WA2D6*U1.N+&.G$#8&[CU'*8U%QDO-QJZG?,DI'5P
MWB=TFI,+BOS'-D$6NN;/IE:H(>[$08_6J!O!)1DTJFY:C9RHE-R0CH9!$$"_
ME\ G)4FJVIQ4;4Y>V<.@$X5=NP6#"&XLG*5I7=2"&<RHV6CNI)PY&Q^2#D5P
M:O<@CD]A<93Y!'J=(.GO]G-*R $5/M.(TPA;IN$D3+K49RZ#CN,DC%\O: B"
MR9%^"A&*IM31EOI!LFVE.B@=2*0L5.AFCW@Y>ZNL_(/N+5!MW(S2D,JZ-$TC
MM[?M&)PTW?^JWLQ0<F+#Z>4%K@D:G/6['JAF+C6"D96;!2MI:+*X8TZC')55
MH.]K*<U>L ;:/X?Q'U!+ P04    " #T59U4D>OD.^\$  #>"@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q."YX;6R-5FUOVS80_BN$5VPKX-FR9"5IEP1P
MXJPUD#9!DJX?AGV@I;/%E1)5DJJ3_OH]1\F*LR99/E@FI;OGGGOC\7!C[!=7
M$'EQ6^K*'0T*[^NWX['+"BJE&YF:*GQ9&5M*CZU=CUUM2>9!J=3C.(KVQJ54
MU>#X,+R[M,>'IO%:571IA6O*4MJ[$])F<S28#+8OKM2Z\/QB?'Q8RS5=D_]4
M7UKLQCU*KDJJG#*5L+0Z&LPF;T^F+!\$_E2T<3MKP9XLC?G"FT5^-(B8$&G*
M/"-(_'VC4]*:@4#C:X<YZ$VRXNYZB_Y'\!V^+*6C4Z,_J]P71X.#@<AI)1OM
MK\SF/77^I(R7&>W"4VQ:V309B*QQWI2=,AB4JFK_Y6T7AQV%@^@)A;A3B /O
MUE!@.9=>'A]:LQ&6I8'&B^!JT 8Y57%2KKW%5P4]?_SNXF+^>7%^+F8?Y^+B
MYOW9E5A\O)E]?+<X.3\3L^OKLYOKP[&')98?9QWJ28L:/X&:B ^F\H439U5.
M^4/],1CV-.,MS9/X6< /THY$,AF*.(KC9_"2WNTDX.T_Y;8Q^49I+625BT7E
M9;562TUBYAQY)^;*9=JXQI+X:[9TWJ)X_G[&[+0W.PUFDY>8O? %V1^-/Q;M
M_T%]00[%W&@MK1.J$A_  !V![#BO4-B4BT^.5HT6Y^@0)Q#LK C1GE-&Y1(L
M>=.3?X4L#-,HVB[BSA5U[XH,KKP%8(8&!F8J?O[I()Y,?A>35-P1,TFB_?";
M95\;94$"I\(78C:U-7F3>6&YI2#XH^Y>-)SN[X>_="I.9:V\U.H[=)U9^8U$
MXG:THDYK,DRG4SRG;]Z(Q>757"3#?7S$,XW$.VN<$^9Q3\3>WC!*#L(?-,X)
MHC++FK+1(7ZR--:K[S*<-+_&Z?!-DK[&(AE.#Y+73\4' 9Q&PTF4\"(>IC&"
ML0M$MS5'3YC5D[PV$BCQ*!7+-JFALO!BKW^!@UM &3]+),JV+XG[<B?1W%9!
M%0ML+;F:PGFI[T8HT9<!#(44KZ81CJG6<@BQ*FNI+(YQ+[)"VC4%RI8R8QD!
MY7A%C@(.V\\)-DT=Y+?NKU"Z9J.J-?!SRE08"-Z('%T*-JIJZ($>PB4K(*.6
MO5J'4$HM,E/6IJF"2:A5W5C8*%\$]VJKC%5][ &2-=8R7JUJXIX3IJZ1G::"
M%+F1N(%6C\I>F:7'&&R]8DC)E>W4%@^S9TV D9WXDM@GYYM<<0FAHD1M/"PJ
MT/48L3ZXPPF4C3>J+!MHPVO"&-K:;V-J"2/909J!!%H9<P3.T&^YV50OSB">
MB\K24F7B[!,PUUS=QMX)6:,EOX$54HN@F@H=#8=>)=%]MC=DV>-"(1,Y5Q#F
M(ON'6* LDH.TEU159MD%SF$?IN<.@/^6/0IMY=$.H"*76KF"[02DNM8JDRR(
MR4R60;V\%5I)M(/R*.99]4A)!E\F]PRW);JNPID"%TZ-"X75,7,X9W3(&9O-
MI+5WS $A:@*:+Y1KN:**,R(.=5MDYA\4'G:H&2[?)J0LDZX0*Q2Y:Y4[/Q^D
MF#G1UX9+HPT; [N'"K^X'[A\XV,#?*D_ZU=POOO:.)9\C,B6*<^)T6.3;[QS
MYR@)!/EF!?,,U%X_^K?]Y6W6WEGNQ=N;'VIPK3".-*V@&HWVTT&;^>W&FSK<
M8);&XSX4E@4NH&19 -]7!FW3;=A ?Z4]_A=02P,$%     @ ]%6=5.8?&&U=
M!     H  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&ULI599;^,V$/XK
M V$?6L"U+5%GD 3(B1K8'$@V[4/1!UH:V\12I):D[?C?=T@I3K*;!-WVP1:/
M.;[Y9H;DX5:;KW:%Z."QE<H>12OGNH/)Q-8K;+D=ZPX5[2RT:;FCJ5E.;&>0
M-T&IE9-D.LTG+1<J.CX,:[?F^%"OG10*;PW8==MRLSM%J;='41P]+=R)Y<KY
MA<GQ8<>7>(_NH;LU-)OLK32B166%5F!P<12=Q >GJ9</ G\(W-H78_"1S+7^
MZB>SYBB:>D HL7;> J?/!L]02F^(8'P;;$9[EU[QY?C)^F6(G6*9<XMG6OXI
M&K<ZBLH(&ESPM71W>OL[#O%DWEZMI0W_L.UETSR">FV=;@=E0M *U7_YX\##
M"X5R^HY",B@D 7?O** \YXX?'QJ]!>.ER9H?A%"#-H$3RB?EWAG:%:3GCN\?
M;F\_7UQ=7'\Y^0R7L^N3Z[,9C6;7ES=W5R=?9C?7AQ-'?KSTI!YLGO8VDW=L
M,KC2RJTL7*@&F]?Z$\*W!YD\@3Q-/C1XQ<T86#R"9)HD']AC^Z!9L%>\%_2Z
MZR12:3DNX5(HKFI!HYGJB]Q7RU\G<^L,U<S?'_A+]_[2X(_]9W]OD?RA3=^L
M![;C-1Y%U(T6S0:C?Y%-.-=2<F-!*+@24I)O"\1OO0H$GV.-[1S-$]LQ@:QU
MB^#X(UKX!,DH+I/P+<H<[LAQT.6JH5[84(]W/DS(IRED<0IG5 B>1>#6HK.0
MQE-@>0P7W];"[0C$!JWS&A:2I(0DR[Q-9T3ML(&:VQ7\PG^%F-;C= HW;D78
MJJR"HLB'6;TVQKL</'R"=)2Q,GQ+EOQTO&\@ZZ/.^JAC1I1L:%T;08R4*8-J
M6L%-AX8RJ98@D0X)VJA2J.(*;H<#S#/4:0H-G3"A%H"1.Q87[[/(2#])RS<I
M\8Q4Q<!!X(Z"[6=*J]_>8*5,?0@9L9,%"]];K8D:84E8+V"Q5HVE0W<O095*
M\-2:RO9,MQU7.R]/N_.U"YPZ#>3<'XA4J,VK3>@D5SX!7N!A?#\.@:*M?1MY
MPU(XL>S[CM"ZOE7L&,X\+/$*QW:%BHY(MVH,WQ(8TEZB(NXEK"UZX7HH.8(J
M=WY?XC(,GZV,?[HJ[G#.'64U9$C86J_[PLA&:>99S4>LJE[W2L6F4&0I7+2=
MU#M$ M;256K[.+VA.0%?"+*3YPG$(U9D[Y<";1,,+\3@7&Q$@SY!\2C._&I,
MO3A3#GV(P+(<6$%5HW=<.E^DC&#XSONA2.."M/-JJ)MX5/FJ&E5)\5UO2<'G
MPF<IG %Q,F(AZIB-*K+POXZ4CN_X7&)?H64U]&WV4=_D208YA?1CSV4)E$5*
M+A=(P!M"%#SY/F))_KS^*A4IM6^Z#SF),_J5;[32:Q**$9M6_9>E\-8E,7EQ
M*[=HEN'MX>N3:J>_H/>K^^?-27^K/XOW;R-B<RF(58D+4IV.BRP"T[\W^HG3
M7;CCY]K1BR$,5_1$0^,%:'^AM7N:> ?[1]_Q/U!+ P04    " #T59U4@Y8\
M%PP(  "P%@  &0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6SE6%UOX[H1
M_2L#-VT=P&M;LF7+:39 DMV+!NC>IDGV%D71!UJB;=Z51"])Y>/^^IXA_2''
M<;*[N'WJ0V*)X@QGSLP9#GGZH,T7NY#2T6-95/9]:^'<\J37L]E"EL)V]5)6
M^#+3IA0.KV;>LTLC1>Z%RJ(7]_NC7BE4U3H[]6/7YNQ4UZY0E;PV9.NR%.;I
M0A;ZX7TK:JT';M1\X7B@=W:Z%'-Y*]WGY;7!6V^C)5>EK*S2%1DY>]\ZCTXN
MACS?3_A%R0?;>";V9*KU%WZYRM^W^FR0+&3F6(/ S[V\E$7!BF#&UY7.UF9)
M%FP^K[7_Y'V'+U-AY:4N_JERMWC?2EN4RYFH"W>C'_XJ5_XDK"_3A?7_Z2',
MC3 YJZW3Y4H8%I2J"K_B<85#0R#M'Q"(5P*QMSLLY*W\()PX.S7Z@0S/AC9^
M\*YZ:1BG*@[*K3/XJB#GSC[^X_/5W;].>PZZ>*27K>0N@EQ\0&Y GW3E%I8^
M5KG,=^5[L&%C2+PVY")^5>$G8;HTB#H4]^/X%7V#C6,#KV]\R+&OM7)/]._S
MJ74&L?_/*SJ'&YU#KW/PJLZ7P'I#SH-,=PM),UV !ZJ:DQ/30J[(H'Z3EK*%
MJ.;X517)8#PX1PY";F&DI#( +AEP ES98H/7"5WJ$M_IUNGL"UV*I7*B8$T?
M'S-I+>D970M#OXBBEOP2YIUG65W6A7!0^'<L9%@-N+U@TMU+^IN&Z(UTX#9F
M?!2F@N&6[L!^6YNGE9:?=97!- //V*^KRDDCK:,/&!#&DJARNET($US[I#!-
M5W8]M#5K-7"I(7LA"E%ED@34R$R64]BV<C:BN#.)!W1$\23&_^&P,QA%>&A'
MG7B4'O.'02>-^S0>CGD8<G$RX?%1GWY&G=LX\J<_I'$4_^7@+P3'Z=YH\B)6
M5P"AE =5#29OKG8I[()R=:]RA-BBM&2 #[BWQ?&;LO ]2OJ'YWEL4427-=(&
M18R61L^-*/<5C5]2,TJH/02*C4\A]O 9VX,5OL+NP3=,7C 4$1K$\6:@$>G=
MG'X>YD%GG(Q688XGJS!/ABF-)T,?YJ03I6,?YL1C=@C/)6*7!;I8#\L#\I6.
M^MUD^.V,Z_[OV!S]/[&Y_P*;XR2$.1V$,"/@:42C\82'XU$G'HQ_A,UQAXO'
M\]'T1]@<3_8S^W>F<W^2_@YT/NA RFN,1^EW$;H]' _VC6I'R3&E_=&;E-ZK
MW"C321QBG0R'/M9Q)^X/:>2_M^-Q)YJ$RIW^&*6'DV^G79<N/MT2X"2QTK(/
M<(=$[1::*9[3](F4LW2AA<F9AA^40:^IC<6L=5W@U;=J/'59QNNWH8@<6HMR
M#8%*.]+30LW!:ZHM.=V<*JHGLDN9J9G*J*H]L[!$4-_9:E@()+783I6/2V5"
MD'-6S*PNQ1--N89AEH<'IN?*<C5058UWQ)/7<VC*N]NR87W>* NS,CVO/#*8
MR9!G3'YOL,A0 XWTHVO?UU7$6E8^,[HDMU8:$-GHJYTJU&^^SG+55<:Z=Z@^
MX0%'#2HEHI('//%N'1SBZ7O8KL,7?*_A9\B.->8/'/XEWAX56GY9/-%1E'1C
MFH9"1\*'<*\GZ:)BO)IEG<W.T?%I)A]E5G.E%EF&(XKQ57O/VG;K_/:F=4QB
M#JTX"KG]^.,;/OKL.$JZ_8VAL'+-" Z0AP8"T-?4YGDRJ[V=#\HM*&.&Z>K=
M@C/"_V$"L@6)C2E8W$KGL-/EM5F'PR).J\ENH4"%K[4PV#4\4F&O/-]!%/MS
MN;(RY,)S8ZF=)G_D05:_X]76V1V^J$P>!U^0-!(%W).3<6:K5)45-7N(E'$[
M:1L2QFG>7I^SAYV=-M?)&^GR'$:8QY.G?AKLO-=%7<IW#_Y0R%&^1XCG*U.]
MOS#NSW;7ZP:F@*^T:P1X,9QA4)7]2=92P4V ".2L*^>=M/7T5P2)K1;YKS@X
M!LM@O*U%Y<>WBEF @Z:"OL8Z6Z<"-D;RR?Y%*F5B*3)N;+:P'"QE+]&JOT>K
MYRT6![")/W:M_<3A<KH#(Y?<HZB;;I2KUZG9(/&=+UKE4E<>/&A_I3GP^0;#
M0Q-H3U9=*^]SZV:IV2%=&[1>CW2'O_,9PN"?7AR\\X8VS]<-0S](H^X%7V58
M)EJA9D\<'=CAJ3N#*;20.5K/$_I<(=L+7T'GB*+MM0OT@-+RCAJA]>*==^1?
M^MQ"XY3DAR*_$Z.SON']U5KL&('[%=HMN6ZW>#\&3X^A":<&] 6#$1H$;NZ_
MPT8:)$$H\CV5;R7BM$_7JVL?3M0E=A' A.V#\Q(TJ^0,03]!P^M0:12X&]P"
M]EY9-$+/2.W$/YV7VKAUO6]/CPE6QL<TI F.#/QVZPM:8 M_W[:(T<[S-YA$
M\9C: !2KPZ$VFBMT.PC=%QF.![F<.BZ7X+E3SP*T#DW/1\K;"!4(!5L9^?>?
MM$$]J0CR1E;94R@*Q<HUK.O_(LR<!"3Y_94$/J+$GYQXZA&?4/%OX!NOT&#[
MB"#*5XWZZ?MY\ )4SNN,.QE=8-]EX)K3PJIMY1<Z[O$&4EG9X0P*+!.-P\HT
M](O<080!I!HZAL66BJ\ST:OU14P\<M>S1\R7Z-AD5&,S_X[4!4!]QBP:I]^4
M'.WQ$+"V?=-]."D0Z_BM2$]BCFV*TWCSS*<]0-D.0)Q4.V?FU27)2Y=AO<8M
M8BG-W-^5<FW%%A,N%#>CF^O8\W +N9T>[G+AWESYC6H&T7YWG+3(A/O1\.+T
MTM])3K5SNO2/"RFPC? $?)]I[=8OO,#FDOKLOU!+ P04    " #T59U4U(X1
M>@$$  #I"   &0   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6R55OMOXC@0
M_E=&N>K42BQY0('K 1)TJ:ZZ;8M*NZO3Z7XPR4"L.G;.-H_>7[]C)V6SW9;5
M283X,8]OYAM[,MPI_61R1 O[0D@S"G)KRXLP-&F.!3-M5:*DG972!;,TU>O0
ME!I9YI4*$291U L+QF4P'OJUN1X/U<8*+G&NP6R*@NGG*0JU&P5Q\+)PS]>Y
M=0OA>%BR-2[0/I9S3;/P8"7C!4K#E02-JU$PB2^F72?O!3YSW)G&&%PD2Z6>
MW.0Z&P61 X0"4^LL,'IM\1*%<(8(QK^US>#@TBDVQR_6KWSL%,N2&;Q4X@O/
M;#X*!@%DN&(;8>_5[@^LXSEW]E(EC/^'727;ZP60;HQ51:U," HNJS?;UWEH
M* RB=Q226B'QN"M''N5'9MEXJ-4.M),F:V[@0_7:!(Y+1\K":MKEI&?'LYOY
MI[N_9C-8/-Q=_@G3V>WLZOH!YI\FMPN8%:50SXBPL"I]@BE*7'$+<\&D@=-;
M9=&<#4-+,)RQ,*U=3BN7R3LN.W"CI,T-S&2&V??Z(<$_Q)"\Q#!-CAJ\8;H-
MG;@%290D1^QU#CGI>'O]=^PM<J;Q@^,Z@SE[IA*T,-&:R37Z\=^3I;&:ZNF?
M(\ZZ!V==[ZSS'@%'<OQ6;G]B[1B=WD,=5ZH*.M>&^:.!>S=&V#$#]%LI06?5
M7,!#K@E8DRV@7*>Y3_9'DF+: )=PPX4@.\83X/YBN%3&@EI!J56V2:T!HT0&
M)S"@)SYW9I[0<KEN 9U0BF(-3&; ,BIQ[I+KSBIT!]"+X!X->J].(L,M722E
MY^$\AGX$=S9'#:=<4DAX%M:QM$#2C?;K+X,D3GZ''CPHRP28GV6 P$5]#S&&
M:V\1+-O#LF;EE)W1)L5X0BGPLS>$<)^*38;&#="8YA[E5JL"3*/ OH/!=DQG
MI)$S"SO4"%LTEH24)F.H4^XT**LGW8@N Y]TGY63N'^8TT5-!@B2)Z^HR,-7
MY'FBG*8CJT6WJRG1WX_BN4VT(\A-L:2TDJ^-=+C75/X.B=-QUG?^NL/L ]NB
MIML;5HQKV#*Q02 03L2K0,8L_@],/NIF#3YZ]\TBJU:^O "8U "N'(#/'@!5
MC-4\=7@]XW4,_;8CKM=IQYVZ "LFZNVX'5&YM?L)S%'[=B=3?"71A5ZOW>^\
M6?S5 ;XKK9\U,%0;%>S:K[]BZJ6FM^;ZH]28JK7D_[TND]0=+BI!5ZBM*'+O
MWR)?M7V8[1V3I/$#0R5JKC('^1D==N+V1ZM64:U"PW%$,5/&Z.E"TG[S>@T;
M[:= O?9-UI"]C;15)SJL'OKXI&I?W\2KCP!*SYI3]@2N2)7(. ] 5XVUFEA5
M^F:V5)9:HQ_F]"V"V@G0_DI15ZHGSL'AZV;\%5!+ P04    " #T59U4)4][
MS?TH   JAP  &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6SM/6E3&TF6
M?Z6"Z9G%'0(C <8>NQTA"^QF&@,+N&=[-O9#J2HEI5VJTM2!4/_Z?5=>I9+
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M\C,4> :2G_9O]]$2KH$O:J BX%ZB+OS-?@W0^0C4#[!L4%56"(PO"$\@ZZ0
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M--K=&?YCYUF+ZX?_^+?*\^$$,('X6D7G<[# ?M?61ZRL]VZ<X@D?YIHA=5D
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M\" ;"09F,0=W%?ASSWH+@>?>BT8J0^O\$8_AX^UE=!&/BQ*M1G15KN_K_3"
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M?4L1P!;4IS_SZP^P7!^.S NL,4BT.X$)$;VP';%/L"4%'\%BR'N=-DX&,A7
M]%>-#9G[\V.Q'8 #?1/2M6S#[4JXV*V Z_][H\8J8?+&2A1=8($)UHF$0PEK
M>;%DS(DG)=U#U%(D 5O8-/I<-975>&UYL6MSLC'>,'HLR\NZ8?+9A9/?K0"T
M\8_1<+X"88=I)\Y(KF>V.(YQH2EV_STB6I:4Q),WQO99VZ*2 ONDP#V<4 NS
M1_0<SV5V4P:/"T_@.TX5'@>KM%H QSISDF7Z&(S3"<K14JH'_7*#L@X%((K=
M>?P9)%OMM90R$3H^] QA1VS8U%$81=36PE532<8YGM2VA8<!%?U(S<YSV!5
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M<QOT_;@T!6Q+F6BHKI#^6%R@&F-:;%P!YM'[.[<Q\_<FK [1V.]!6&I:=:B
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M[4A.HUW!#5)B>$:]%+4RT]D'FCR(UG++A'@J,UTRJ,_$JF!0,&XXC@R8^1F
MMF#P8\V,H_'R+!V+Z@1#UI^X[Z,S2=?GD%/(<CLG(C@/OEJ;OJ]:GO35\F1O
M<M^9K(2E[&;VS[;Z^$X1ZB+-9^&+-TN#V%4::(Q^ D<0AB0:8 GO&&F^(8T3
M(\[:$+@SR+[AE(/!L3Z"OYQ@4N_T1E46,6N\,RFT,9%]9P9<GZ._D3C4%7I:
MF#AVR(]0$\V*9Y62[ITH<,!"*(2G@2Z(A.81M0/0)PTE8^]V-3H95)>;JR=9
M&EBO;^\N._ZZX:G>/]PN=*!20#K=!I\9DU.:9@;5GDL:T?:.L%+9LA7W1I(5
MB W?"FKM4O_2TFK++6*=\'5WVEX-N?(&,R+ZYJ;!4<#&E*35V@367(KN*VJC
MC/+<"MTC$+V3&A5?=P6\T[8;M@7YX5)^K$%Q![;_E>9NU75?M3_MJ_WIUTH5
MY^&0:\ ICAW<=TT!?+D.\#%:L_H#R3_)?=U\?DTG@/#7GZ+ZL>["5[-$L2)F
M.W63-9YF9AJ-I1>^FDS/X4*6K2L9K8L6/@?782*WB?Y4^G1_-XQ<_VP80DZN
M[DT4') +6;I-XVFRGT^RM9;2L7H%;&0T8*V(=.=YX('&]<0P6_5W#UB JO3H
M<SVE=((ZP6S1<B5\3:\XV65Z3]<9-BB#'I'QE!_;641QT*+$P;IC_J3+D8E,
M#@-T4Y2PQ 85L46<DZY#DBO[:;'3NY.Z]I85OP=Q OO.?+(Q\8@-'?C WE_
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MA0%##[0 [^E'ENX+'=#_>OSR_U!+ P04    " #T59U4P$5\F7P%  #F#
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M#S/\V*KN5MU-C&S=378N#1*5&];X(T*5%<#]A91F,[$&AE^;V?]02P,$%
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MH78;:'VKE#V\. ?U76[\'U!+ P04    " #T59U4'1"VPBL#  !H!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q]5>MOHS@0_U=&W.H$4E7 Y+5[
M2:0^.&VE;1NUN8=TN@\.3,!:@[.V:=K_?L>&<%W=ME\,MF=^C\$>ED>EOYH:
MT<)S(UNS"FIK#Y_BV!0U-MR<JP.VM+-7NN&6IKJ*S4$C+WU2(V.6)+.XX:(-
MUDN_MM'KI>JL%"UN-)BN:;A^N42ICJL@#4X+#Z*JK5N(U\L#K_ 1[1^'C:99
M/**4HL'6"-6"QOTJN$@_74Y<O _X4^#1O'H'YV2GU%<WN2E70>($H<3".@1.
MCR>\0BD=$,GX-F &(Z5+?/U^0O_=>R<O.V[P2LF_1&GK5; (H,0][Z1]4,?/
M./B9.KQ"2>-'./:QDWD 16>L:H9D4M"(MG_RYZ$.KQ(6R1L);$A@7G=/Y%5>
M<\O72ZV.H%TTH;D7;]5GDSC1NH_R:#7M"LJSZ_OMY_P!PIN[J_O;/(KSOS?Y
MW6-^!G?Y%L(MWTDTT3*VQ.3BXV) O>Q1V1NH&=RJUM8&\K;$\L?\F!2.,ME)
MYB5[%_"6ZW/(TC-@"6/OX&6C[<SCS=^R;6O4<*=:.MV:6]%6<-,6JD$(\V<Z
M\ 8C^.=B9ZRF8_/O.X23D7#B";,W"!_I-I6=1+C?0T\^\ UT/ZOQ^XC;6B/^
M4&>@*A6U+].UDI)K Z*%6R$EG7_C2^>&E*@M:C06L">'#Y"QF1NG&3RH%RZM
M0 .\+4&*PMU JH\8ZC.9SR,(LQF-^;=.V!?:>2(PNJD6I#(&31Q6U Y,!+/)
M!,)9DD:>LG*5IILXL!I(DRFDDQ2NR 11.(""E(H2A\@4PFF:1/"%8('F)>XL
MM8(2FX/?9_,IL$4*&ZV>A.\3U*; 6=-=83OM=+,,)E/X(JRH>E!G2_E/8-!:
MB4ZX(4?.UB*"K>8DX7^1^HDJ 7LDV2'Y"=.I,S4:/U7'J0T_1G MW)8@#0B^
M&!"RE/)^_67!4O;;< 92,IBR:)B%/4@4#P4Z@Y:Z\@>JXD<:PWG"HI^=Q/C5
M[6]05[['&:IDU]J^$8RK8QN]Z+O'?^%]#Z8#5#FM$O>4FIS/IP'HOJ_U$ZL.
MOI?LE*7.Y%]K^A6@=@&TOU?*GB:.8/RYK+\#4$L#!!0    ( /15G50M&KL2
M0@0  /X)   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;*56;4_K-A3^
M*T=9-5&)D29MH;"V$G"Y&]IEJZ!L'Z9]<)/3QL*Q<VV'TOWZG>.T66%0;9HJ
MI;%S7I[S\OAXO#;VR16('EY*I=TD*KRO+N+89066PIV8"C5]61I;"D]+NXI=
M95'D0:E4<=KKG<:ED#J:CL/>S$['IO9*:IQ9<'59"KNY0F76DRB)=AOW<E5X
MWHBGXTJL\ ']8S6SM(I;*[DL43MI-%A<3J++Y.)JR/)!X%>):[?W#AS)PI@G
M7MSFDZC'@%!AYMF"H+]GO$:EV!#!^+JU&;4N67'_?6?]<XB=8ED(A]=&_29S
M7TRB400Y+D6M_+U9_XC;> + S"@7GK!N9(>]"++:>5-NE0E!*77S+UZV>=A3
M&'VDD&X5TH"[<110?A)>3,?6K,&R-%GCEQ!JT"9P4G-1'KREKY+T_/3^YF%^
M_W@]?[R__?D'.)J+A4+7'<>>;+-$G&WM7#5VT@_L].'.:%\XN-$YYJ_U8\+4
M DMWP*[2@P;OA#V!?G(,:2]-#]CKMX'V@[VSCP)%YVV=^=I*O8)KXSP(G0-M
MHWU&^/T+R<.MQ]+]<<#;H/4V"-[Z_\I;XT@)CWGP[-[+[T&#S,T+5XD,)Q&1
M+V".IO,"86D4$8N]5-8\RQP=>-K."F%7]&ZW;KVAUWU,4DLO!5/"P6(#?E,A
MF"5D!.\"YH5%?%51H'ID12C()_(HK",+<">5(FZY4"1^)$ $6R&E\C+[6DLG
M _5F2FCH0)*>\?.,>F5C?A(VE^*?8GWHG\'<>*':&$BGWZ-GFO3@IJR4V1 X
MCY;H(((B@V8QPM"!P0!^H0S8=R02^LTX2^%(H1/M34[2/@R&<*L]KFRCAR]T
M^CG"D/2&D P2PIO1B6)#3G.D4F2RD4SAVV]&:9)^#Y?.T6$JRTI(2\<7^=U]
M20<'(@LM216@,N:$R($S*J=O.^4.JU,5GM 3UF.@DTWMFDOD%*FD4$)!][ T
MF3B2.C,E=N-M.,>@"6&2CB 9G1Z =( (PY8(PX-$>* IDM<J]-9K4NR81\TW
MWS8?I^ ]:AQV\9H%S721?[[A 6?)4? YRWQ(BHH[, P*ZDAT_XL(7Z182"7]
M!H2'3YAAN:!2]!/.<"\\!Z.#W7@DNMR1_7.@^4/3A;JXMA9U1FRU0CO5-!Y'
M9IHR)UTX2KLP$YNF[XY2WAF>=U^#V440D*2!F*?!VZW.5,TGB" HW(1LG^K"
MB52M!4))(X\1+JTI.<.:,TQ9(/B2!B4M2*ES3O,J9"5 ["3MDD-EDSXDMVR2
MBV^2&Q+)BIS,8W9:89C@:G,"-R];H)W3_VPU87!BC\8T8[.G[WBTYW1.E,R0
M)K.A33A.ZA.V_-'1=O(>3^*]F5PB]2#?/!PYJ+5OQG.[VUYN+IN9_K=X<S,B
M^"M)O:5P2:J]DS/B@VUN&\W"FRI,^(7Q=%\(KP5=T-"R 'U?&N-W"W;07OFF
M?P%02P,$%     @ ]%6=5*]_C"96 @  !P4  !D   !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL?51M;]HP$/XKIVB5-JDB(8$"%2!!R[1^8$/ 7J1I'TQR
M(58=F]E.8?]^9P=2*A6^Q#[[GN>>N]QYN%?ZV12(%@ZED&84%-;N[L/0I 66
MS+34#B7=Y$J7S)*IMZ'9:629!Y4BC*/H+BP9E\%XZ,\6>CQ4E15<XD*#J<J2
MZ7]3%&H_"MK!Z6#)MX5U!^%XN&-;7*']OEMHLL*&)>,E2L.5!(WY*)BT[Z<=
MY^\=?G#<F[,]N$PV2CT[XRD;!9$3A )3ZQ@8+2_X@$(X(I+Q]\@9-"$=\'Q_
M8O_L<Z=<-LS@@Q(_>6:+4= /(,.<5<(NU?X+'O/I.KY4">._L*]]DT$ :66L
M*H]@4E!R6:_L<*S#&: ?70#$1T#L==>!O,I'9MEXJ-4>M/,F-K?QJ7HTB>/2
M_925U73+"6?'3U\?OLUGL)[\FJW@XYIM!)I/P] 2M7,(TR/-M*:)+] D,%?2
M%@9F,L/L+3XD28VN^*1K&E\EG#/=@J1]"W$4QU?XDB;/Q//U+N4I4U4BK-D!
M'KE)A3*51O@]V1BKJ3/^7 G1:4)T?(CD0H@5#4Q6"025PT*K%^X;E^8&7H.C
M>:^VUWG7A49\4U^@ZJ2%+\^C$H)I US"G M!$8TOF?NT8<:TY')K8(JD ]\(
M@0_0OKWK]VB-;[M)=$4S=*(.="/BRW/T8^0+N606(4Y: [B!]J#5AYOWJAB>
M-6>)>NM'T$"J*FGK/FU.FRF?U,W]ZEX_$93VEE." G."1JU>-P!=CUUM6+7S
MK;Y1E@;';PMZJ5 [![K/E;(GPP5HWK[Q?U!+ P04    " #T59U4-+2/N.X"
M  !(!@  &0   'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6R=5=MNVD 0_961
M&U6-1/&%2T@*2)#2)E*3(FC:AZH/BSW@5=>[[NXZI'_?V34X] (/?=GKS)DS
MXYWCX5;I[R9'M/!4"&E&06YM>16&)LVQ8*:M2I1TLU:Z8):V>A.:4B/+O%,A
MPB2*^F'!N S&0W\VU^.AJJS@$N<:3%443/^<HE#;41 '^X,%W^36'83C8<DV
MN$3[4,XU[<(&)>,%2L.5!(WK43")KZ9=9^\-/G/<FH,UN$Q62GUWF]ML%$2.
M$ I,K4-@-#WB-0KA@(C&CQUFT(1TCH?K/?H[GSOELF(&KY7XPC.;CX)! !FN
M627L0FUO<)=/S^&E2A@_PK:V[5T$D%;&JF+G3 P*+NN9/>WJ<. PB(XX)#N'
MQ/.N WF6;YEEXZ%66]#.FM#<PJ?JO8D<E^ZC+*VF6TY^=CR;+.YO[]\O83Y;
MP/)FLIC!JT]L)="<#T-+ 9Q9F.[ IC58<@2L W=*VMS 3&:8_>X?$K&&7;)G
M-TU. MXQW89.W((D2I(3>)TFVX['NSB6+=.2RXV!.6I8YDPC?)VLC-7T.+Z=
MP.\V^%V/WSF"OZ2>R2J!H-:PCQ6^^J",.7\.V8(I,SP%)C-XRT5E_RQ579F3
MD5RO7IF2I3@*J!D-ZD<,QI]RC?C;-P"J8)K[$DX*54EK@$NXXT)02Y@6S)Y2
M+.U!.=PC\M5V0PSW) M-T2;6:KZJK'L>8!5,[Y;P8"@(:</?.<%LOH1K)M)*
M,-^ 9Q"WDHL!S4G+87_Q'8/9Z\DC:A( N%9%07:>B(&/E366\"@TO'PQ2.+X
MS2Y(THJ[?1J33A]N9:J11,(RL7?\DZ8_?DVNQ(E"D)R9FM!<,&D@'D!R^3]D
M]GD2G7[7T>GWGFM54D4/(7;4SR!J]R,_748-0M3N7=(PN(1_O<'PH+L+U!NO
M8092]SGK1F].&YF<U.KP;%YK++V&#:><!:[)-6I?] +0M6[5&ZM*KQ4K94EY
M_#(GJ4?M#.A^K93=;UR YN<Q_@502P,$%     @ ]%6=5,W"QI>A"0  51\
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M,H6",>/ZE#VO).<[974=2@U ,SYH8O.QV +).AHH'#R@BD)QK ;=)8)NCZI
ML<Q,=#YA>9SIVF%03:S/0(JL\U0BF5?AT*S85,'^ )?W-#2VQU8<E(@[>(>]
MOP3YE_5K)%'PSO_8;-=VL9VN$X#P)%UC:F$L8&TN7K.]Z0XB[=4FW21Y9;-I
M((@BJ%>?$Q]#UZ^5602!"AA&SX!4M%B@\#'9SK? Q1WVC-$H#T*/;"UC(8L
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MCRL>(8#3!'Q?"*&W+\2@O$F__#]02P,$%     @ ]%6=5)$4!;^Z @  G04
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M-:H7])(;*013&G@%]UP(>N\:*(=9X9)X0_>5*7FUBT?%<J1Z:B7 )QCZP]Z
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M+A),7LO[!+'!&;W@G$5'%=XPU85>V($HB*(C^GJ-WSVG;_B.OH>4*?QHXYG
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M+GU5$2]&T&(AV=),<4],JIG0W"9J;"=<!ZCS!6-RN] )JC\"T_]02P,$%
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M5UUOFS 4_2L6VD,K=05#/IHIB92O;4AMVB5M]S#MP04GH %FMFE6:3]^MB%
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M[ M%-)VJTP4GL1I,GP@78ZZZ],27"*8R0-S?$,+W"WE _FTS_@=02P,$%
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MA4;0/ZZ@5V?:!<#[A5+V>> 6*+K__K]02P,$%     @ ]%6=5 1 ;?NE P
M]0L  !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULM5;?;^(X$/Y71M$^
M[$J])@X_NP(D"MPN4LM6T.X]G.[!)"9$Z\2L[93RW]_820-'@]6'ZPO$SGPS
MW\S87V:P%_*7VC*FX27CN1IZ6ZUW7WU?15N6474M=BS'-QLA,ZIQ*1-?[22C
ML05EW ^#H.MG-,V]T<#N/<C10!2:ISE[D*"*+*/R<,NXV \]XKUN+--DJ\V&
M/QKL:,)63#_M'B2N_-I+G&8L5ZG(0;+-T!N3KU/2-0!K\3-E>W7R#":5M1"_
MS&(>#[W ,&*<1=JXH/CWS":,<^,)>?RNG'IU3 ,\?7[U_J=-'I-94\4F@O^5
MQGH[]/H>Q&Q#"ZZ78O^=50EUC+](<&5_85_9!AY$A=(BJ\#(($OS\I^^5(4X
M :"?9D!8 <+W EH5H'4.:%\ M"M VU:F3,7684HU'0VDV(,TUNC-/-AB6C2F
MG^:F[RLM\6V*.#V:SG_.%JO'^>/3<K:Z@KOY!)?SQ3<8+Z;PX_'[; GCY7*\
M^#:[GRT>5_ 'C.,X-2VC'.9Y>?!, S]/F:8I5U_0Y&DUA<^?OL G2'.X3SE'
M S7P-?(U4?VHXG9;<@LO<"-P+W*]53#+8Q8WX"=N?,N!][%.=;'"UV+=ADZ'
MXYV\AE9P!6$0ADU\W/![:N#D(GSZ?CAQ9-.J6]^R_GH7_-VED;F_>0)C*6F>
M,+S.6L'?=V@'<\TR]8\C2KN.TK916A>B/$@1,18KV$B108R77.E4%Y*!V,"Z
MP/A,*::N($>1PZV(JFUEUMSS,ES'AC.J]CQJW?0&_O-I(=_:D'Y0V_PGCTZ=
M1\>9Q_2$>8)ZVG2>)Z6+]DG<D) S;F]M+C#KULRZ3F:K8JW8[P*;![-G_'4T
MK5>[['W@T>C74?KNHT$/QB]H >Q%8[0BQ=YO"EMC*0Z4ZP.(-4\3*S%- M)_
MT^CPIM-<SIN:U8V3U3PSBA8I1X(D.*IK\(&%)"<J3IRDGW9XO;"4N[*DC8>S
M<G%Z\DCGPMDCX3%RZ(P\P;"8G^DCS6,<!9*"4RWD ;]6'&^,P$2=K,(WK'J]
M2ZR.TD9:3E;WU!XB%)^XB+#@AMH/O6725>VCI)'V1W;U*#G$K3G_NW:2!H$*
M.V<"U6!$NA<:<M0HXA:I=\EGY:/CU,\&H_/CXI_,0QF3B9TK%42BR'7YM:]W
MZ]EU;">VL_V)F6GMG'5T4P[$^#%., O@;(,N@^L>\I'EC%DNM-C9J6LM-,YP
M]G&+<SF3Q@#?;X30KPL3H)[T1_\"4$L#!!0    ( /15G52<E$HM^0,  /D,
M   9    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;(V76V_B.!2 _XH5S0-(
MI;D28 1(+64UE:8M*IW=E5;[$,@!K$EBQC;0_OL]=D*@B9/9%\CE7#X?^UPR
M/C'^4^P )'E/DTQ,K)V4^Z^V+=8[2"-QR_:0X9L-XVDD\99O;;'G$,5:*4UL
MSW%".XUH9DW'^MF"3\?L(!.:P8(3<4C3B'_<0\).$\NUS@]>Z78GU0-[.MY'
M6UB"_+%?<+RS2RLQ32$3E&6$PV9BW;E?9VZH%+3$GQ1.XNJ:J*6L&/NI;A[C
MB>4H(DA@+96)"/^.,(,D49:0XU=AU"I]*L7KZ[/U/_3B<3&K2,",)7_16.XF
MUM B,6RB0R)?V>D;% OJ*WMKE@C]2TZ%K&.1]4%(EA;*2)#2+/^/WHM 7"F@
M';."5RAX586@0<$O%'R]T)Q,+^LADM%TS-F)<"6-UM2%CHW6QM703&WC4G)\
M2U%/3E_>OLU?2>?Q>?;R-._:\[\7\^?E_(8\S]](CRSQU,2'!,C+AKS('7#R
MF*U9"F3^CN=( .D\@(QH(KHH_&/Y0#I?NN0+H1EYHDF"VR3&MD1*Y<M>%T3W
M.9'70.23)Y;)G2#S+(;XL[Z-JRN7Z)V7>.^U&GR*^"WQW1OB.9YGX)G]?W6W
M!<<O(^YK>X.FB.LX/K,,4Y%'DF;;<U [152[Y)^[E9 <C_B_+0Z#TF&@'?H-
M#A\S"1R$))";-VU);J&O+:C,/TY]+QS;Q^LP&63Z?BGS":U?HO5;T5[91Y1(
M"H)$64P2NE;U 0-"=4!,H+F]X JB%PP&%5*#D!\.S*AAB1JVHLY_':C\0+(C
MAA+KF"0)$P*$W=EBL11=$VQ8XPB#H,):E^F%CFMF'92L@]_N^%:=+:R3Q:8;
M$W%0\^TZ_0J?029HP!N6>,-6O!GF-^ZRBN$:2P2-(6<U(0[K[BN =8E>WW7,
MA*.2<-1*^!VWEF#P8EA);%8QI/LFP%'-O3>HQM @,VR(H>M<"K?3RKC@[$AU
M-\5F3E2"\\-:'CA&UEATG3J$7^$TR 3]!LZK!N.VQY)*NLW/HDIRILN? "D3
M4&ED[A"N(8.K66X2&C;0>A=:KY7VC4=X(FNT_(BUB6S G$>%S4\DU6-JE&D*
M[J67N/YO,KTL1\TUL[#QV;53Y3,(C1KP+IW';6\]#U3A43R50'29-.(%=<^>
M6XM?7:HAR=U+]W';VX]NQ4:D>@>I QFZC.LU(%VZC-O>9O+IH)-O9M<NJO<-
MR4 :0<-:4PZ#496T+M0;.%54^VJ(3(%O]6PML$(?,ID/6^73<GZ_TU-KY?F]
MFNOU<'HQDW\4X"BUQ4- $MB@2>=V@$@\G[/S&\GV>E1=,8F#K[[<X;<)<"6
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M T%I#<SW7 B]WU@']2^I_Q=02P,$%     @ ]%6=5,VQV2X9 @  U00  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3$N>&ULO51-C],P$/TK5K2'70GJ-&T6
MM$HC]6,1/12JE@6N3C)IK/5'L)VVRZ_'=M*HP+;<N"0>>]Z;]VR/DX-4S[H"
M,.C(F="3H#*F?L!8YQ5PH@>R!F%72JDX,394.ZQK!:3P(,YP%(;WF!,J@C3Q
M<VN5)K(QC I8*Z0;SHEZF0&3ATDP#$X3&[JKC)O :5*3'6S!/-5K92/<LQ24
M@]!4"J2@G 33X<,L=OD^X2N%@SX;(^<DD_+9!<MB$H1.$##(C6,@]K>'.3#F
MB*R,'QUGT)=TP//QB?V#]VZ]9$3#7+)OM##5)'@?H )*TC"SD8>/T/GQ G/)
MM/^B0YM['P4H;[21O -;!9R*]D^.W3Z< :+A!4#4 2*ONRWD52Z((6FBY $I
MEVW9W,!;]6@KC@IW*%NC["JU.),N/\T_KQ[1E^GWQRUZBZ9%0=UN$8:6HCUR
MMW>W"S"$,GV';A 5:$49L],ZP<9*<$0X[\K-VG+1A7(KH@9H-'R#HC"*GK8+
M='MS]SL+M@9Z%U'O(O*THTNT5%#>\"M,HYYI=)5I T1;^QE[0;74FF8,["'G
M]KYK<-8;H2"7.T%_0H$,.:(,!)34O+H7;:G8EW+=L4_'<9C@_2OZQKV^\76G
MY/@/IW'/%/\_I_%?3N/P3Z?X[):ZAK=W84>%1@Q*BPH'[RQ<M4W4!D;6_N)F
MTM@V\,/*OCN@7()=+Z4TI\#U0O^2I;\ 4$L#!!0    ( /15G53# K/I/0,
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M$Z#7EYRKCXGI=M7/K?L.4$L#!!0    ( /15G51^A< ZC ,   T+   9
M>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;)U6VV[B.A3]E:UH'EKIM+E0;A4@
M44IUD 94P3#GV24&/./8C.W =+[^;"=IFB8A@_H"L;TO:RW;VWMPDNJGWE-J
MX'?$A1XZ>V,.]ZZK-WL:$7TK#U3@RE:JB!@<JIVK#XJ2,'&*N!MX7L>-"!/.
M:)#,/:O10,:&,T&?%>@XBHAZ?:!<GH:.[[Q-+-EN;^R$.QH<R(ZNJ%D?GA6.
MW#Q*R"(J-),"%-T.G;%_/_$#ZY!8?&?TI O?8*F\2/G3#F;AT/$L(LKIQM@0
M!/^.=$(YMY$0QZ\LJ)/GM([%[[?H3PEY)/-"-)U(_A\+S7[H]!P(Z9;$W"SE
MZ5^:$6K;>!O)=?(+I\S6<V 3:R.CS!D11$RD_^1W)D3! >/4.P290U!VN#OC
MT,H<6@G1%%E"ZY$8,AHH>0)EK3&:_4BT2;R1#1-V&U=&X2I#/S-ZFBW&B\EL
M_!5FB]6WY7H^77Q;P7CQ"$_CV1*^C[^NIS"?CE?KY31=NUGA40IC3D%N8?HK
M9N859N)(M<'=-1JN'JDAC.MKN('UZA&NOES#%V "YHQSW#D]< T"M^G=30;R
M(049G '9@KD49J]A*D(:?O1WD7#..GAC_1 T!IP3=0LM_Q\(O""HP3.YW-UO
M@-/*-Z&5Q.N>B9>IR HJGIC9@[V7C+_BL314X>;3$+:$*3@2'E/=D/@N3WR7
M)&Z=2;S .L&EUN[5#F_\-2;<R)U@?\HBIYJFL=I)+%L>CJ-VOS=PCT7AJC8W
M?K^3&WU V<Y1MB]"68 '6 &*<FG):R&G@>\*<+P2X*I%JQYM)T?;^2O:6.#6
M\01HO;P5_ 8O!^QI/8M.!6-5^*H-"M^OI]+-J70_<R[Q-:@<3?*"!>&RP]G+
ML_<:A5P?3D2%0,(?<9:]3IM>E7>G)$V-2= Y(TT_!]=O!#>+#D@VU82($$)Y
M$I? [5>P!"6T50N_'JKOO==XKQ'L)(YB3NQ["?%%HF;Q/IXFKU]"VIS5-B#W
M^D V=.A@AZ&I.E)G! T'PR\\6OZEA-@G-R++\.%2E;>B&<4G" ;O!(-&@OG-
M X'EY(J)C8SHM9M407QVR7;+.".F?,\R:D&U4)?+7HW-C=_JEDZ:6V@L(JIV
M2;^E82-C8=+7-I_->[IQTLF4YA]LKY<T+.]ATD81W](=$QHXW6)([[:+D%3:
M>Z4#(P])^_(B#39#R><>BP]5U@#7MU*:MX%-D'? H_\!4$L#!!0    ( /15
MG539ELX_7P@   DN   9    >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;+U:
M;6^C.!#^*U:N=^I*W00,AF2OK90FX3:GME>EVSV=3O?!29P4+2\YFS1;Z7[\
MV4!Q"&!(BO9+&\ S?CPS?F;\<KD+Z3?V3$@$OOM>P*XZSU&T^=3KL<4S\3'K
MAAL2\"^KD/HXXH]TW6,;2O R%O*]'M0TJ^=C-^A<7\;O'NCU9;B-/#<@#Q2P
MK>]C^GI#O'!WU=$[;R]F[OHY$B]ZUY<;O":/)'K:/%#^U,NT+%V?!,P- T#)
MZJHSU#]]MJ$0B%M\=<F.[?T&8BCS,/PF'J;+JXXF$!&/+"*A O-_+V1$/$]H
MXCC^395VLCZ%X/[O-^U./'@^F#EF9!1Z?[K+Z/FJT^^ )5GAK1?-PMUGD@X(
M"7V+T&/Q7[!+VVH=L-BR*/1388[ =X/D/_Z>&F)/ .H5 C 5@$T%C%3 :"I@
MI@)F4P&4"J"F E8J8#45L%,!^T# 0!4"_52@'WLW<4?LRS&.\/4E#7> BM9<
MF_@1!T0LS5WH!B)V'R/*O[I<+KIVIO?#^]%T> NF]X]?9D]WD_LOCV!X/P;.
M<#H#7X>W3Q-P-QD^/LTFR;>/8+A<NB+PL >F03)]1!B>CTF$78]] +_\U#<L
M\U?@!N#.]3S^D5V L_SC+S_I%HJ;W*3O+GL1'Y" U5NDX&\2\+ "O [NPB!Z
M9F 2+,FR1'ZDEC<4\CUNR,R:\,V:-U"I<+BA76!H%P!J$#X]CL'YV8<R6&HM
M=UAHT>NTC)MKT:NU3([ ,GF:@?/4N66ZG"-T_?[PE] E@J!,U6]J50Z9=P'L
MUYGHLUK+F"P*)EI0PJ/;P0O7<Z-714P8V0PSXD[LRDZH^X(%0X._;_DW,(V(
MS_Y1:#8SS6:LV:C0_$#=8.%N^#3\BKTM*0NT1 &*%8@T]G)M&@.(+GLO^U8J
M:Z4-9*L<.I2A0TIT7S%U\=PC@.*(\'0RCRX SY2$\A?!FH!P)9*.R\ F=(,(
M)*FW; SJ;LRNI?U<%M>GB3E'B^6,8V7&L91Z;L-@_3$BU$\-L\(N!2]57K2*
M_D%]33OP8DFK@;[7*@?4SH#:2J!CLB*43PGN.AP E[$M#A8$+$(6E1'V*-%F
M[H%  VCED8[M M(*E/T,95^)<O(]<H/UUF7/O*R*1&@)LY;AZQ?QP4-+CHN-
M#%1ER$$&<:">K/@UQL;S90P.D!SF,JR#(M:"U\?%1J96A5779%6@U<0G8X#G
M]!@I=S_Q-R+'EZ98K8  V@<,,RYKU-<K4.[5+KH2Y33@4XBP"&P2XY9&9*HC
MYTW;/L17;&0:%02H0XD/*O'=;_TYYSL>CI2\A-X+]S=(\@N?\'&"<0D#_P%5
MSDGF=MI1#E\%.IF7=$/M8Y&,.+8\HM<+45ZZ_M8'\Y!RI3%HO.%?*Z 9A=EL
M54>@S&VZ.KD];N>,_+L54V;R4I@@>:4R)>FHY5RL2T;7U93>F(-N]")3]\U!
MA<$D4>MJICZ>8&[T(A'W^U6>DURLJ\GX#+Z5]. NC:2;+))&I9&4[TE2JCYH
MV9U0,B"L8<!69L<(EA"?5DC==:WR8Y#\"-7\>*:_SQ-0,AV$;7M"\A3\$3PU
M2GO9M[%>XHF:5ODQ2#:#:C8[T[OHG;Z0) ?;)CDH20[6U*TM^:+(@#HJ^J*F
M57X,DBBAFB@/:^_XY[D;@%>"*2M?KZLUHD2T='5]JJ1SBF3>(I*Q80UCOS<V
M)6/#MAG;D(QM_!#&3GO9CSI4R0"&Y&)#S<4G1%V-1D74G2SIG"*9MXC,&8:Z
M.IZ1@.RP!S8\)L+2E7^- CT&4SK^$P6=$P3SH]_;%5)GM3.KJV6SSG&_\R7V
M3&R4/ 6,++9BQ?U( I?7<O=A1)0&ETG(,-N>?#+I&.J-D09[4:F&9@L%0Z8D
M0YV24C-)N\4& ^,M 5 S(%]>-36DS""&W;8A)1<;:BYN8LA^,2_:J,J0DIL-
M]0Y%MIH6&W:E2^D:!; [0*5;<2?*.<?+Y?=19>HPU:E#&4/F$3%DRGQ@ZFUO
M"TMF-=4TU61C&!9C"%;%D"E9S52S6GT,U2@PNJ@\ADZ4<XZ7RP]];S.^9L-"
M%4/HF!B2I&NV7>F;DE9--:TVB:%B?5Z]:C4ENYKJRK9!#*D5&%V[_$C@1#GG
M>+G\T"7YFVKR5\:0=4P,2=8WVZ[(D:15I*;5!C&$BM5V]7H;279%#7>&*V.H
M1H'1'50<*YTFYQPOEQ^Z)'^D)G_8[=OHYUR@@&4<0%!7=2 Y'K5]H(DDB:+W
M'FF.4?&TLG)3 .T=5JKK5[X\6_)"/(Z;.0Z^@3]6*T+?BO+SV^G-'[,/JB%*
M8D56V^:3U(EJMC8$S-)H5\MI7;,\ZYXHYQPOEQ^Q9$RD9LPQ8>XZX#Y: LS
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MUX<3Q;?)!O 35XJ'R>&&T243L8&^ON)<O9[$>\K9_Q ,_P=02P,$%     @
M]%6=5.XJ2NYY P  "PX  !D   !X;"]W;W)K<VAE971S+W-H965T-3DN>&UL
MO5=M;]HP$/XKIV@?6JDT;[RT%2!1H!M2816,[<.T#VYB(%IB,]N43MJ/W]E)
M$TI#5&V(+^"7N^>>\Q.??.TM%S_EBE(%STG,9,=:*;6^L6T9K&A"Y"5?4X8[
M"RX2HG JEK9<"TI"XY3$MN<X33LA$;.Z;;/V(+IMOE%QQ.B# +E)$B)^W]*8
M;SN6:[TL3*/E2ND%N]M>DR6=435?/PB<V3E*&"64R8@S$'31L7KN3=]SM(.Q
M^!K1K=P9@T[ED?.?>C(*.Y:C&=&8!DI#$/Q[HGT:QQH)>?S*0*T\IG;<';^@
MWYGD,9E'(FF?Q]^B4*TZUI4%(5V03:RF?/N)9@DU-%[ 8VE^89O9.A8$&ZEX
MDCDC@R1BZ3]YS@YBQP%QRAV\S,';=Z@?</ S!]\DFC(S:0V((MVVX%L0VAK1
M],"<C?'&;"*F99PI@;L1^JGNW6C2F_1'O7L8369?IO/Q</)E!KW) .YZHRE\
M[=W/AS >]F;SZ3#=J\& BNB)Z..'$9-*;%!6)2_@(WXU<';/I3R'LP%5)(IQ
M5(/Y; !G'\[A ^#^.(ICU$^V;87T-0D[R*C>IE2] U1]&'.F5A*&+*3A:W\;
MT\YS]UYRO_4J <=$7(+O7H#G>%X)G_[[W=T*.GXNA6_P_ -X(Z:HH%*!((J"
MW)(U!)BPP"]=PA_H<]SB"U@+'F[TDN1QU2G4\[!U$[9U(.Q[U/Q^CTXP4C21
M/RI"-O*0C<I,4^C80.-5#G,&%\"H*OLR4KR&P=.5Z:GKM.VG7:VJ+%Z1;.8D
MF_\CQV>UH@+.(A;PA)[;]!D+JRQ+X%7P5AZ\=2I1KO*05T<6)<6K[QQYS77W
M9"FQN2K7Y3KG>5W)LR^08BW8"$%9\!M+RE%OC>L4A=,YE43N3K5VCRQ2!EBO
MN#J5)J^)>@51[X@J_=ME<HO*ZOHGTZJHJV[]V%K5W]Z6^KY8)3;^ ;6*>NQ6
M%V1\$>%[AT&N%[X/MT2$_W>5BDKK-D\F3U%AW=:QY6F5%#-O7Y^W1LW6 7V*
MTNQ6U^9WZ?./EZBHN^[UJ53RBBKK.4=6*0/<?0G4&JT]E<J,?&]/)GOG69U0
ML33=AL0SWS"5OC+SU;RCZ9EW_-[Z+78Z:5]2P*1M$KXAEQ&3$-,%0CJ7+60D
MTLXCG2B^-H_W1ZZP%3##%79K5&@#W%]PKEXF.D#>_W7_ E!+ P04    " #T
M59U4UUV*T_<#   M#P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6R]
M5]]OVC 0_E>L: ^M5$CL\+,") IT0RJL@K$]N\1 M,1FMBGMM#]^YR1-((1T
M>Z O$-MWY^_N<[[X.GLA?ZH-8QJ]A %776NC]?;6MM5RPT*JJF++.*RLA RI
MAJ%<VVHK&?4BIS"PB>,T[)#ZW.IUHKE'V>N(G0Y\SAXE4KLPI/+UC@5BW[6P
M]38Q\]<;;2;L7F=+UVS.]&+[*&%DIU$\/V1<^8(CR59=JX]O!X08A\CBN\_V
MZN 9F52>A/AI!F.O:SD&$0O84IL0%/Z>V8 %@8D$.'XE0:UT3^-X^/P6_3Y*
M'I)YHHH-1/##]_2F:[4LY+$5W05Z)O9?6))0W<1;BD!%OVB?V#H66NZ4%F'B
M# A"G\?_]"4IQ($#Q"EV((D#R3O4SCBXB8,;)1HCB](:4DU['2GV2!IKB&8>
MHMI$WI"-SPV-<RUAU0<_W;L?3_O3P;C_@,;3^;?98C*:?INC_G2([OOC&?K>
M?UB,T&34GR]FHWBM@C[#Z;"O'H12UPB8^,*\M<_7J&\8\?4KNAHR3?T 5BMH
M,1^BJT_7Z!/R.9KX00#<J8ZM ;H!8"\3F'<Q3'(&IHLF@NN-0B/N,>_8WX:4
MT[S)6]YWI#3@A,HJ<O$-(@XA!7@&_^Z.2^"X*0UN%*]YC@8AX<!Q8%Q*QI>O
M"%[0/94>6D+:$LZZ0NNHZH&I^FW)CK5TQUJTHWMFQQE;BC7W?S//,"/TADG8
M+ 0MV)B7])G!-(Q9$5=QY'H4V>C$<P\3IV,_'];OU(;4VZG-$>1Z"KG^'N2
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M-#1+T>,&^EDFC0&LKX30;P.S0=HA]_X"4$L#!!0    ( /15G53;_('QK0(
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M965T-C(N>&ULM9;?<]HX$,?_E1U/']J9)OZ)#1U@AD(RQPQA,A#2A\X]*+8
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M)@JVQ%:%(;^!JM6&I=K0JO;Z<$_#'0&^-@MMR:R(@@$,JU4V2I4-J\KAS>W
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MY 'Z\RGGZN4F'Z \U.W\!U!+ P04    " #T59U4X7\#)? "   S"   &0
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M=;BK0#EERU*:-O R\%N>UW-?JEG;8=2N&'U0VRK5MFK53M,,$Z&;A#):N4I
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M/+^*YYMX_IEX$QJS#)#$;]!8O$(=&K7NSGW?<]NJ3OOC$C481>U69?0)+*C
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M(MY(Q#(!8N@;EC>E[W3!P57$W$N4>;';];5;:S9;;?]UOU0NHS JC3X!UDK
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M>>-5&/:J%IT'#=LNTUUB0$D;K;$A#-M0"PV<66P[27?L0$D;L+$:#%O-755
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M'8]Q) LD!SQ)98D!_X)W5:*08W2.7/=MI]IQMW3<-3I^6(9TC;/J*1*P2<*
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MLUM^8$9R6:J&F&<OF#=52=>;D5\,[C4L%,U>ES&07PQFOY!D=B:;-,M[W<9
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M;GS)9_/?P*_^ %!+ 0(4 Q0    ( /15G50'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ]%6=5)C@
M<?[O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ ]%6=5)E<G",0!@  G"<  !,              ( !S0$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #T59U4MK&VNM(%  !Y
M&P  &               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ ]%6=5#A8?!_3!   AA$  !@              ("!%@X
M 'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( /15G53HJ%ZF
MB ,  *4*   8              " @1\3  !X;"]W;W)K<VAE971S+W-H965T
M,RYX;6Q02P$"% ,4    " #T59U4R'R< =P%   S&   &
M@('=%@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ ]%6=
M5"9VD]U<!P  WAX  !@              ("![QP  'AL+W=O<FMS:&5E=',O
M<VAE970U+GAM;%!+ 0(4 Q0    ( /15G50?]-73UPD  #$8   8
M      " @8$D  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M" #T59U4,H.DJ!T%  !Q"P  &               @(&.+@  >&PO=V]R:W-H
M965T<R]S:&5E=#<N>&UL4$L! A0#%     @ ]%6=5 :1\,N8!@  T0X  !@
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M970Q,BYX;6Q02P$"% ,4    " #T59U471%.02L#  #S!@  &0
M    @(%H40  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (
M /15G51Q6PJCH1,  +\_   9              " @<I4  !X;"]W;W)K<VAE
M971S+W-H965T,30N>&UL4$L! A0#%     @ ]%6=5-AU1D,G P  Q08  !D
M             ("!HF@  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"
M% ,4    " #T59U4M@J:$HT#  #0!P  &0              @($ ;   >&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( /15G51@56%,VP(
M "@&   9              " @<1O  !X;"]W;W)K<VAE971S+W-H965T,3<N
M>&UL4$L! A0#%     @ ]%6=5)'KY#OO!   W@H  !D              ("!
MUG(  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #T59U4
MYA\8;5T$    "@  &0              @('\=P  >&PO=V]R:W-H965T<R]S
M:&5E=#$Y+GAM;%!+ 0(4 Q0    ( /15G52#ECP7# @  + 6   9
M      " @9!\  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%
M  @ ]%6=5-2.$7H!!   Z0@  !D              ("!TX0  'AL+W=O<FMS
M:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #T59U4)4][S?TH   JAP
M&0              @($+B0  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+
M 0(4 Q0    ( /15G53F"9J8=0L  $D>   9              " @3^R  !X
M;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ ]%6=5,!%?)E\
M!0  Y@P  !D              ("!Z[T  'AL+W=O<FMS:&5E=',O<VAE970R
M-"YX;6Q02P$"% ,4    " #T59U4;*#=\OL#  "6"   &0
M@(&>PP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( /15
MG52]XE?-2P0  -<)   9              " @=#'  !X;"]W;W)K<VAE971S
M+W-H965T,C8N>&UL4$L! A0#%     @ ]%6=5!T0ML(K P  : 8  !D
M         ("!4LP  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
M    " #T59U4+1J[$D($  #^"0  &0              @(&TSP  >&PO=V]R
M:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( /15G52O?XPF5@(   <%
M   9              " @2W4  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL
M4$L! A0#%     @ ]%6=5#2TC[CN @  2 8  !D              ("!NM8
M 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #T59U4S<+&
MEZ$)  !5'P  &0              @('?V0  >&PO=V]R:W-H965T<R]S:&5E
M=#,Q+GAM;%!+ 0(4 Q0    ( /15G521% 6_N@(  )T%   9
M  " @;?C  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @
M]%6=5/D1;QR% @  ,P4  !D              ("!J.8  'AL+W=O<FMS:&5E
M=',O<VAE970S,RYX;6Q02P$"% ,4    " #T59U4X>9=#;,"  "P!0  &0
M            @(%DZ0  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4
M Q0    ( /15G51_JH1K%@,  $H&   9              " @4[L  !X;"]W
M;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ ]%6=5.6ZB!:.!
MT0L  !D              ("!F^\  'AL+W=O<FMS:&5E=',O<VAE970S-BYX
M;6Q02P$"% ,4    " #T59U4  R,5_L%   )$@  &0              @(%@
M]   >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( /15G50S
MULK12P0  # *   9              " @9+Z  !X;"]W;W)K<VAE971S+W-H
M965T,S@N>&UL4$L! A0#%     @ ]%6=5(O9K\84 P  % P  !D
M     ("!%/\  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /15G539K!@$\@,   D0   9              "
M@2X5 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ ]%6=
M5 1 ;?NE P  ]0L  !D              ("!5QD! 'AL+W=O<FMS:&5E=',O
M<VAE970T-2YX;6Q02P$"% ,4    " #T59U4G)1*+?D#  #Y#   &0
M        @($S'0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0
M   ( /15G528?"\AV0,  .4-   9              " @6,A 0!X;"]W;W)K
M<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ ]%6=5( RB.L0!   !Q
M !D              ("!<R4! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q0
M2P$"% ,4    " #T59U402GT@4(#  "^"0  &0              @(&Z*0$
M>&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( /15G501T#^\
ME (  )X&   9              " @3,M 0!X;"]W;W)K<VAE971S+W-H965T
M-3 N>&UL4$L! A0#%     @ ]%6=5,VQV2X9 @  U00  !D
M ("!_B\! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " #T
M59U4PP*SZ3T#  !\"0  &0              @(%.,@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( /15G53R_!^$O@8  +0N   9
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M970U-RYX;6Q02P$"% ,4    " #T59U4,):+I1@%  !/(   &0
M    @($R4 $ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    (
M /15G53N*DKN>0,   L.   9              " @8%5 0!X;"]W;W)K<VAE
M971S+W-H965T-3DN>&UL4$L! A0#%     @ ]%6=5-==BM/W P  +0\  !D
M             ("!,5D! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"
M% ,4    " #T59U4V_R!\:T"  "*!@  &0              @(%?70$ >&PO
M=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( /15G53Q(*%(>0,
M %4*   9              " @4-@ 0!X;"]W;W)K<VAE971S+W-H965T-C(N
M>&UL4$L! A0#%     @ ]%6=5*.L0J[= @  X <  !D              ("!
M\V,! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " #T59U4
M)4^,@/ "   $"   &0              @($'9P$ >&PO=V]R:W-H965T<R]S
M:&5E=#8T+GAM;%!+ 0(4 Q0    ( /15G51GB+V$"@0  -$-   9
M      " @2YJ 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%
M  @ ]%6=5&;3=W=. P  $0H  !D              ("!;VX! 'AL+W=O<FMS
M:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " #T59U4@"\[B'P$  #@%0
M&0              @('T<0$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+
M 0(4 Q0    ( /15G53A?P,E\ (  #,(   9              " @:=V 0!X
M;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ ]%6=5+TW?D?L
M @  -@@  !D              ("!SGD! 'AL+W=O<FMS:&5E=',O<VAE970V
M.2YX;6Q02P$"% ,4    " #T59U4;L<G!Q8#  #G"   &0
M@('Q? $ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( /15
MG52=%TW'4 ,  "@*   9              " @3Z  0!X;"]W;W)K<VAE971S
M+W-H965T-S$N>&UL4$L! A0#%     @ ]%6=5%ID+=_U @  5@@  !D
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M=#<V+GAM;%!+ 0(4 Q0    ( /15G52J+V< 4 ,  *L*   9
M  " @:V8 0!X;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @
M]%6=5+993>GD @  A @  !D              ("!-)P! 'AL+W=O<FMS:&5E
M=',O<VAE970W."YX;6Q02P$"% ,4    " #T59U48(T$4!T#  "<"@  &0
M            @(%/GP$ >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4
M Q0    ( /15G53!P:TKRP4  ,\9   9              " @:.B 0!X;"]W
M;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ ]%6=5-DBV*I; P
MZA0   T              ( !I:@! 'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" #T59U4EXJ[',     3 @  "P              @ $KK $ 7W)E;',O+G)E
M;'-02P$"% ,4    " #T59U4^Z,82@4&  "2-   #P              @ $4
MK0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ]%6=5+3%"JYH @  1R\
M !H              ( !1K,! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ ]%6=5"P!9SL; @  #BX  !,              ( !YK4!
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %@ 6  ?&   ,K@!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>306</ContextCount>
  <ElementCount>377</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>114</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes</Role>
      <ShortName>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - ALLIANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCES</Role>
      <ShortName>ALLIANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - OTHER (INCOME)/EXPENSE, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENET</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2131109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2143110 - Disclosure - RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLES</Role>
      <ShortName>RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2147111 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2150112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2153113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2157114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2163115 - Disclosure - EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITY</Role>
      <ShortName>EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2169116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2174117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/Revenue</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - ALLIANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESTables</Role>
      <ShortName>ALLIANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENETTables</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHERINCOMEEXPENSENET</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RESTRUCTURING</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INCOMETAXES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2329307 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2332308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESTables</Role>
      <ShortName>RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2348310 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIES</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2351311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2354312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2358313 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2364314 - Disclosure - EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYTables</Role>
      <ShortName>EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EQUITY</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2370315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Revenue - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RevenueDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Revenue - Reconciliation of Gross Product Sales to Net Product Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails</Role>
      <ShortName>Revenue - Reconciliation of Gross Product Sales to Net Product Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenue - Disaggregation of Revenue by Product and Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails</Role>
      <ShortName>Revenue - Disaggregation of Revenue by Product and Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - ALLIANCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESDetails</Role>
      <ShortName>ALLIANCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails</Role>
      <ShortName>DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails</Role>
      <ShortName>OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHERINCOMEEXPENSENETTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2421409 - Disclosure - RESTRUCTURING - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails</Role>
      <ShortName>RESTRUCTURING - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails</Role>
      <ShortName>RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - INCOME TAXES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails</Role>
      <ShortName>INCOME TAXES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2430414 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2433415 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2434416 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2435417 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails</Role>
      <ShortName>RECEIVABLES - Schedule of Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - RECEIVABLES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESDetails</Role>
      <ShortName>RECEIVABLES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLESTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIESTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2452428 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2455429 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2456430 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2459431 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2460432 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2461433 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462434 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2465435 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails</Role>
      <ShortName>EQUITY - Schedule of Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2466436 - Disclosure - EQUITY - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYAdditionalInformationDetails</Role>
      <ShortName>EQUITY - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2467437 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails</Role>
      <ShortName>EQUITY - Schedule of Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2468438 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2471439 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2472440 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2473441 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="bmy-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2475442 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</ParentRole>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bmy-20220331.htm">bmy-20220331.htm</File>
    <File>bmy-20220331.xsd</File>
    <File>bmy-20220331_cal.xml</File>
    <File>bmy-20220331_def.xml</File>
    <File>bmy-20220331_lab.xml</File>
    <File>bmy-20220331_pre.xml</File>
    <File>bmyex31a_20220331.htm</File>
    <File>bmyex31b_20220331.htm</File>
    <File>bmyex32a_20220331.htm</File>
    <File>bmyex32b_20220331.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="935">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmy-20220331.htm": {
   "axisCustom": 3,
   "axisStandard": 33,
   "contextCount": 306,
   "dts": {
    "calculationLink": {
     "local": [
      "bmy-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmy-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmy-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmy-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmy-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmy-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 645,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 6
   },
   "keyCustom": 51,
   "keyStandard": 326,
   "memberCustom": 62,
   "memberStandard": 50,
   "nsprefix": "bmy",
   "nsuri": "http://www.bms.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.bms.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - OTHER (INCOME)/EXPENSE, NET",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENET",
     "shortName": "OTHER (INCOME)/EXPENSE, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - RESTRUCTURING",
     "role": "http://www.bms.com/role/RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - INCOME TAXES",
     "role": "http://www.bms.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.bms.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143110 - Disclosure - RECEIVABLES",
     "role": "http://www.bms.com/role/RECEIVABLES",
     "shortName": "RECEIVABLES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147111 - Disclosure - INVENTORIES",
     "role": "http://www.bms.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
     "shortName": "CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163115 - Disclosure - EQUITY",
     "role": "http://www.bms.com/role/EQUITY",
     "shortName": "EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2174117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies",
     "shortName": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Revenue (Tables)",
     "role": "http://www.bms.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - ALLIANCES (Tables)",
     "role": "http://www.bms.com/role/ALLIANCESTables",
     "shortName": "ALLIANCES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - OTHER (INCOME)/EXPENSE, NET (Tables)",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENETTables",
     "shortName": "OTHER (INCOME)/EXPENSE, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - RESTRUCTURING (Tables)",
     "role": "http://www.bms.com/role/RESTRUCTURINGTables",
     "shortName": "RESTRUCTURING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.bms.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329307 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.bms.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - RECEIVABLES (Tables)",
     "role": "http://www.bms.com/role/RECEIVABLESTables",
     "shortName": "RECEIVABLES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348310 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.bms.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358313 - Disclosure - Supplemental Financial Information (Tables)",
     "role": "http://www.bms.com/role/SupplementalFinancialInformationTables",
     "shortName": "Supplemental Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364314 - Disclosure - EQUITY (Tables)",
     "role": "http://www.bms.com/role/EQUITYTables",
     "shortName": "EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS (Tables)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Revenue - Disaggregation of Revenue (Details)",
     "role": "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails",
     "shortName": "Revenue - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i7c9dc415da6a41559015929ff4b2fe33_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenue - Reconciliation of Gross Product Sales to Net Product Sales (Details)",
     "role": "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails",
     "shortName": "Revenue - Reconciliation of Gross Product Sales to Net Product Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:GrosstoNetAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenue - Disaggregation of Revenue by Product and Region (Details)",
     "role": "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails",
     "shortName": "Revenue - Disaggregation of Revenue by Product and Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - ALLIANCES (Details)",
     "role": "http://www.bms.com/role/ALLIANCESDetails",
     "shortName": "ALLIANCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "ie58682a1d3024bf8b1259bdf1905e088_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ACQUISITIONS - Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i65efa2432c844039b35a070fa3d4c198_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RoyaltyIncomeNonoperating",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Licensing and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:LicensingAndOtherArrangementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:ContingentRegulatoryMilestoneIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "role": "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
     "shortName": "DIVENSTITURES, LICENSING AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i9bd6569de3e64ecfba49b3ab77331743_D20220401-20220430",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:PaymentToExtinguishFutureRoyaltyObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)",
     "role": "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
     "shortName": "OTHER (INCOME)/EXPENSE, NET - Schedule Of Other Income Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i9e86a84eeff547878681f2285bc056c0_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ExpectedSynergiesPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421409 - Disclosure - RESTRUCTURING - Additional Information (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
     "shortName": "RESTRUCTURING - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i9e86a84eeff547878681f2285bc056c0_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ExpectedSynergiesPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
     "shortName": "RESTRUCTURING - Schedule of Restructuring and Related Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "ia5cba459b4604d78a2eb2e37cd615400_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
     "shortName": "RESTRUCTURING - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "ia5cba459b4604d78a2eb2e37cd615400_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "role": "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "iac15ff867ba945e08768717f71115a24_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - INCOME TAXES - Additional Information (Details)",
     "role": "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
     "shortName": "INCOME TAXES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "iac15ff867ba945e08768717f71115a24_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430414 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://www.bms.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433415 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "id8b9accf8c5243ff9ac7aff11bd99cba_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434416 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Available-for-sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435417 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Summary of Equity Investments Carrying Amount (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS -Schedule of Equity Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "ifc01c81d46124cf59f361dbae533ad7c_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivatives and Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i9206328440464f8e839a11661b43c8a8_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i5b589631ea674d988596b27dfe9491d0_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Derivative Instruments, Gain (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i5b589631ea674d988596b27dfe9491d0_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes",
     "shortName": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Gain/(Loss) on Hedging Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "ic877b4ebba4a4d2f83ee4834c3bc717a_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Short-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Long-term and Current Debt Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:UnamortizedBasisAdjustmentFromSwapTerminations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - RECEIVABLES - Schedule of Receivables (Details)",
     "role": "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails",
     "shortName": "RECEIVABLES - Schedule of Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ReceivablesSoldOnNonrecourseBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - RECEIVABLES (Details)",
     "role": "http://www.bms.com/role/RECEIVABLESDetails",
     "shortName": "RECEIVABLES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:ReceivablesSoldOnNonrecourseBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.bms.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452428 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455429 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Intangible Assets By Major Class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456430 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459431 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Revenue",
     "role": "http://www.bms.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460432 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461433 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462434 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "ia5cba459b4604d78a2eb2e37cd615400_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465435 - Disclosure - EQUITY - Schedule of Stockholders Equity (Details)",
     "role": "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails",
     "shortName": "EQUITY - Schedule of Stockholders Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466436 - Disclosure - EQUITY - Additional Information (Details)",
     "role": "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
     "shortName": "EQUITY - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467437 - Disclosure - EQUITY - Schedule of Comprehensive Income (Loss) (Details)",
     "role": "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
     "shortName": "EQUITY - Schedule of Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468438 - Disclosure - EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3f5f7794c20a4dd6a4fa7996fa043575_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471439 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Stock Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i07493150d868420687804e8b350888ae_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472440 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Schedule of Share-based Compensation Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i07493150d868420687804e8b350888ae_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i5d74d60f32f84b198678df8d911c9b3c_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473441 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS - Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i5d74d60f32f84b198678df8d911c9b3c_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - ALLIANCES",
     "role": "http://www.bms.com/role/ALLIANCES",
     "shortName": "ALLIANCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i04d29be57add402ab3461c9dc80fe525_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bmy:RoyaltyGuaranteesCommitmentsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475442 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i04d29be57add402ab3461c9dc80fe525_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bmy:RoyaltyGuaranteesCommitmentsPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20220331.htm",
      "contextRef": "i3c8c5ad75a0e46b8aebe626491ab022c_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 114,
   "tag": {
    "bmy_A1.000Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One000NotesDue2025Member",
        "label": "1.000% Notes due 2025 [Member]",
        "terseLabel": "1.000% Notes due 2025"
       }
      }
     },
     "localname": "A1.000Notesdue2025Member",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1.5BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1.5 Billion Maximum Borrowing Capacity [Member]",
        "label": "$1.5 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$1.5 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A1.5BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1.750Notesdue2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One750NotesDue2035Member",
        "label": "1.750% Notes due 2035 [Member]",
        "terseLabel": "1.750% Notes due 2035"
       }
      }
     },
     "localname": "A1.750Notesdue2035Member",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1 Billion Maximum Borrowing Capacity [Member]",
        "label": "$1 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$1 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A1BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2.875SeniorNotesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% Senior Notes due 2021 [Member]",
        "label": "2.875% Senior Notes due 2021 [Member]",
        "terseLabel": "2.875% Senior Notes due 2021"
       }
      }
     },
     "localname": "A2.875SeniorNotesdue2021Member",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2022ASRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 ASR",
        "label": "2022 ASR [Member]",
        "terseLabel": "2022 ASR"
       }
      }
     },
     "localname": "A2022ASRMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2 Billion Maximum Borrowing Capacity [Member]",
        "label": "$2 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$2 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A2BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A5BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$5 Billion Maximum Borrowing Capacity",
        "label": "$5 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$5 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A5BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A60BillionUnsecuredSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$6.0 Billion Unsecured Senior Notes",
        "label": "$6.0 Billion Unsecured Senior Notes [Member]",
        "terseLabel": "$6.0 Billion Fixed Rate Unsecured Senior Notes"
       }
      }
     },
     "localname": "A60BillionUnsecuredSeniorNotesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ALLIANCESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALLIANCES [Abstract]",
        "label": "ALLIANCES [Abstract]",
        "terseLabel": "ALLIANCES [Abstract]"
       }
      }
     },
     "localname": "ALLIANCESAbstract",
     "nsuri": "http://www.bms.com/20220331",
     "xbrltype": "stringItemType"
    },
    "bmy_AbecmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abecma",
        "label": "Abecma [Member]",
        "terseLabel": "Abecma"
       }
      }
     },
     "localname": "AbecmaMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbilifyProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abilify Product Liability Litigation",
        "label": "Abilify Product Liability Litigation [Member]",
        "terseLabel": "Abilify Product Liability Litigation"
       }
      }
     },
     "localname": "AbilifyProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbilifyProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abilify Product Liability [Member]",
        "label": "Abilify Product Liability [Member]",
        "terseLabel": "Abilify Product Liability"
       }
      }
     },
     "localname": "AbilifyProductLiabilityMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbraxaneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abraxane [Member]",
        "label": "Abraxane [Member]",
        "terseLabel": "Abraxane"
       }
      }
     },
     "localname": "AbraxaneMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AcceleratedStockBasedCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Stock Based Compensation [Member]",
        "label": "Accelerated Stock Based Compensation [Member]",
        "terseLabel": "Accelerated Stock Based Compensation"
       }
      }
     },
     "localname": "AcceleratedStockBasedCompensationMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AccruedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest",
        "label": "Accrued Interest",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedRebatesAndReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.",
        "label": "Accrued rebates and returns",
        "terseLabel": "Rebates and discounts"
       }
      }
     },
     "localname": "AccruedRebatesAndReturns",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.",
        "label": "Accrued Research And Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopment",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquiredIPRD": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired IPRD",
        "label": "Acquired IPRD",
        "terseLabel": "Acquired IPRD"
       }
      }
     },
     "localname": "AcquiredIPRD",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquisitionsDivestituresandOtherArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "label": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "terseLabel": "Acquisitions, Divestitures and Other Arrangements [Abstract]"
       }
      }
     },
     "localname": "AcquisitionsDivestituresandOtherArrangementsAbstract",
     "nsuri": "http://www.bms.com/20220331",
     "xbrltype": "stringItemType"
    },
    "bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for Provisions for Product Sales made in Prior Periods",
        "label": "Adjustments for Provisions for Product Sales made in Prior Periods",
        "terseLabel": "Adjustments for provisions for product sales made in prior periods"
       }
      }
     },
     "localname": "AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AllianceTransitionalServices": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents other income recognized during the period related to transitional services provided to a former alliance partner.",
        "label": "Alliance Transitional Services",
        "negatedTerseLabel": "Transition and other service fees"
       }
      }
     },
     "localname": "AllianceTransitionalServices",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AllianceandotherrevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliance and other revenues [Member]",
        "label": "Alliance and other revenues [Member]",
        "terseLabel": "Alliance and other revenues"
       }
      }
     },
     "localname": "AllianceandotherrevenuesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AmortizationOfDeferredIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of deferred income",
        "label": "Amortization of deferred income",
        "negatedTerseLabel": "Amortization of deferred income"
       }
      }
     },
     "localname": "AmortizationOfDeferredIncome",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AmortizationofAcquiredIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Acquired Intangible Assets",
        "label": "Amortization of Acquired Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationofAcquiredIntangibleAssets",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AntiPD1AntibodyLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anti-PD-1 Antibody Litigation [Member]",
        "label": "Anti-PD-1 Antibody Litigation [Member]",
        "terseLabel": "Anti-PD-1 Antibody Litigation"
       }
      }
     },
     "localname": "AntiPD1AntibodyLitigationMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AvaproAvalideAndPlavixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Avapro, Avalide, and Plavix [Member]",
        "terseLabel": "Plavix* and Avapro*/Avalide*"
       }
      }
     },
     "localname": "AvaproAvalideAndPlavixMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BreyanziMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breyanzi",
        "label": "Breyanzi [Member]",
        "terseLabel": "Breyanzi"
       }
      }
     },
     "localname": "BreyanziMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BristolMyersSquibbMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bristol-Myers Squibb",
        "label": "Bristol-Myers Squibb [Member]",
        "terseLabel": "Bristol-Myers Squibb"
       }
      }
     },
     "localname": "BristolMyersSquibbMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CARTKiteLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAR T Kite Litigation [Member]",
        "label": "CAR T Kite Litigation [Member]",
        "terseLabel": "CAR T Kite Litigation"
       }
      }
     },
     "localname": "CARTKiteLitigationMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CashDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reductions to trade receivables incurred during the period attributable to cash discounts.",
        "label": "Cash Discounts",
        "negatedTerseLabel": "Less charge-backs and cash discounts"
       }
      }
     },
     "localname": "CashDiscounts",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Cashoutlays": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outlays",
        "label": "Cash outlays",
        "terseLabel": "Cash outlays"
       }
      }
     },
     "localname": "Cashoutlays",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_CelgeneContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Contingent Value Rights [Member]",
        "label": "Celgene Contingent Value Rights [Member]",
        "terseLabel": "Celgene Contingent Value Rights"
       }
      }
     },
     "localname": "CelgeneContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CelgeneIntegrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Integration [Member]",
        "label": "Celgene Integration [Member]",
        "terseLabel": "Celgene Acquisition Plan"
       }
      }
     },
     "localname": "CelgeneIntegrationMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ChargebacksandcashdiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charge-backs and cash discounts [Member]",
        "label": "Charge-backs and cash discounts [Member]",
        "terseLabel": "Charge-backs and cash discounts"
       }
      }
     },
     "localname": "ChargebacksandcashdiscountsMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CheplapharmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cheplapharm",
        "label": "Cheplapharm [Member]",
        "terseLabel": "Cheplapharm"
       }
      }
     },
     "localname": "CheplapharmMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CommonStock0.10ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CommonStock010ParValueMember",
        "label": "Common Stock $0.10 Par Value [Member]",
        "terseLabel": "Common Stock $0.10 Par Value"
       }
      }
     },
     "localname": "CommonStock0.10ParValueMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ContingentAndRegulatoryMilestoneNonCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent and Regulatory Milestone, Non-Cash",
        "label": "Contingent and Regulatory Milestone, Non-Cash",
        "terseLabel": "Contingent and regulatory milestone"
       }
      }
     },
     "localname": "ContingentAndRegulatoryMilestoneNonCash",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentAndRegulatoryMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent and Regulatory Milestone Payments",
        "label": "Contingent and Regulatory Milestone Payments",
        "terseLabel": "Contingent and regulatory milestone payments"
       }
      }
     },
     "localname": "ContingentAndRegulatoryMilestonePayments",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentRegulatoryMilestoneIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Regulatory Milestone Income",
        "label": "Contingent Regulatory Milestone Income",
        "negatedTerseLabel": "Contingent milestone income"
       }
      }
     },
     "localname": "ContingentRegulatoryMilestoneIncome",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BMY Contingent Value Rights [Member]",
        "label": "Contingent Value Rights [Member]",
        "terseLabel": "Contingent value rights"
       }
      }
     },
     "localname": "ContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_DiabetesbusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diabetes business [Member]",
        "label": "Diabetes business [Member]",
        "terseLabel": "Diabetes Business"
       }
      }
     },
     "localname": "DiabetesbusinessMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Divestitureandotherproceeds": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.",
        "label": "Divestiture and other proceeds",
        "terseLabel": "Divestiture and other proceeds"
       }
      }
     },
     "localname": "Divestitureandotherproceeds",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Divestituregainsandroyalties": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the amount of gains and royalties as a result of business divestitures.",
        "label": "Divestiture gains and royalties",
        "negatedTerseLabel": "Divestiture gains and royalties"
       }
      }
     },
     "localname": "Divestituregainsandroyalties",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document and Entity Information [Abstract]",
        "label": "Document and Entity Information [Abstract]",
        "terseLabel": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.bms.com/20220331",
     "xbrltype": "stringItemType"
    },
    "bmy_DragonflyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dragonfly",
        "label": "Dragonfly [Member]",
        "terseLabel": "Dragonfly"
       }
      }
     },
     "localname": "DragonflyMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EliquisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eliquis [Member]",
        "terseLabel": "Eliquis"
       }
      }
     },
     "localname": "EliquisMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EmplicitiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Empliciti [Member]",
        "label": "Empliciti [Member]",
        "terseLabel": "Empliciti"
       }
      }
     },
     "localname": "EmplicitiMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments",
        "label": "Equity investments",
        "totalLabel": "Total equity investments"
       }
      }
     },
     "localname": "EquityInvestments",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityInvestmentsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments - current",
        "label": "Equity investments - current",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsCurrent",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityInvestmentsNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments - non-current",
        "label": "Equity investments - non-current",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsNonCurrent",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity [Line Items]",
        "label": "Equity [Line Items]",
        "terseLabel": "Equity [Line Items]",
        "verboseLabel": "Equity [Line Items]"
       }
      }
     },
     "localname": "EquityLineItems",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_EquityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity",
        "label": "Equity [Table]",
        "terseLabel": "Equity [Table]"
       }
      }
     },
     "localname": "EquityTable",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_ExpectedSynergiesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Synergies, Percentage",
        "label": "Expected Synergies, Percentage",
        "terseLabel": "Expected synergies, percentage"
       }
      }
     },
     "localname": "ExpectedSynergiesPercentage",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bmy_GrosstoNetAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments",
        "label": "Gross to Net Adjustments",
        "negatedTerseLabel": "Gross to Net Adjustments"
       }
      }
     },
     "localname": "GrosstoNetAdjustments",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_GrosstoNetAdjustmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Axis]",
        "terseLabel": "Gross to Net Adjustments [Axis]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsAxis",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_GrosstoNetAdjustmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Domain]",
        "terseLabel": "Gross to Net Adjustments [Domain]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsDomain",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_GrosstoNetAdjustmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Gross to Net Adjustments [Table]",
        "label": "Gross to Net Adjustments [Line Items]",
        "terseLabel": "Gross to Net Adjustments [Line Items]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsLineItems",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_ImmaticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immatics",
        "label": "Immatics [Member]",
        "terseLabel": "Immatics"
       }
      }
     },
     "localname": "ImmaticsMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InrebicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inrebic [Member]",
        "label": "Inrebic [Member]",
        "terseLabel": "Inrebic"
       }
      }
     },
     "localname": "InrebicMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_IntangibleAssetNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Name",
        "label": "Intangible Asset Name [Axis]",
        "terseLabel": "Intangible Asset Name [Axis]"
       }
      }
     },
     "localname": "IntangibleAssetNameAxis",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_IntangibleAssetNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Name",
        "label": "Intangible Asset Name [Domain]",
        "terseLabel": "Intangible Asset Name [Domain]"
       }
      }
     },
     "localname": "IntangibleAssetNameDomain",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InventoryPurchasePriceFairValueAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Purchase Price Fair Value Adjustment",
        "label": "Inventory Purchase Price Fair Value Adjustment [Member]",
        "terseLabel": "Inventory Purchase Price Fair Value Adjustment"
       }
      }
     },
     "localname": "InventoryPurchasePriceFairValueAdjustmentMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_KeytrudaRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Keytruda Royalties",
        "label": "Keytruda Royalties [Member]",
        "terseLabel": "Keytruda Royalties"
       }
      }
     },
     "localname": "KeytrudaRoyaltiesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LegalProceedingsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Proceedings And Contingencies [Line Items]",
        "terseLabel": "Legal Proceedings And Contingencies [Line Items]"
       }
      }
     },
     "localname": "LegalProceedingsAndContingenciesLineItems",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicenseAndOtherArrangementsUpfrontPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and Other Arrangements Upfront Payments",
        "label": "License and Other Arrangements Upfront Payments",
        "terseLabel": "Upfront payments"
       }
      }
     },
     "localname": "LicenseAndOtherArrangementsUpfrontPayments",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Axis]",
        "terseLabel": "Licensing and Other Arrangements [Axis]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsAxis",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingAndOtherArrangementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Domain]",
        "terseLabel": "Licensing and Other Arrangements [Domain]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsDomain",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LicensingAndOtherArrangementsIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements Income",
        "label": "Licensing and Other Arrangements Income",
        "negatedTerseLabel": "Licensing and Other Arrangements Income"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsIncome",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Table Text Block]",
        "terseLabel": "Licensing and Other Arrangements"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsTableTextBlock",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_LicensingArrangementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements",
        "label": "Licensing Arrangements [Line Items]",
        "terseLabel": "Licensing Arrangements [Line Items]"
       }
      }
     },
     "localname": "LicensingArrangementsLineItems",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingArrangementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements [Table]",
        "label": "Licensing Arrangements [Table]",
        "terseLabel": "Licensing Arrangements [Table]"
       }
      }
     },
     "localname": "LicensingArrangementsTable",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingCompaniesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Companies",
        "label": "Licensing Companies [Axis]",
        "terseLabel": "Licensing Companies [Axis]"
       }
      }
     },
     "localname": "LicensingCompaniesAxis",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingCompaniesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Companies",
        "label": "Licensing Companies [Domain]",
        "terseLabel": "Licensing Companies [Domain]"
       }
      }
     },
     "localname": "LicensingCompaniesDomain",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LitigationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation [Table]",
        "terseLabel": "Litigation [Table]"
       }
      }
     },
     "localname": "LitigationTable",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LongTermDebtRenewalPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Renewal Period",
        "label": "Long-term Debt, Renewal Period",
        "terseLabel": "Renewal period"
       }
      }
     },
     "localname": "LongTermDebtRenewalPeriod",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bmy_LossContingencyNumberOfPlaintiffsDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Plaintiffs, Dismissed",
        "label": "Loss Contingency, Number of Plaintiffs, Dismissed",
        "terseLabel": "Number of plaintiffs, dismissed cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffsDismissed",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberActive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Active",
        "label": "Loss Contingency, Pending Claims, Number, Active",
        "terseLabel": "Pending claims, active"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberActive",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberClassAction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Class Action",
        "label": "Loss Contingency, Pending Claims, Number, Class Action",
        "terseLabel": "Class action claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberClassAction",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Dismissed",
        "label": "Loss Contingency, Pending Claims, Number, Dismissed",
        "terseLabel": "Dismissed cases"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberDismissed",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_LossContingencyPendingClaimsNumberIndividualInjuryClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Number, Individual Injury Claims",
        "label": "Loss Contingency, Pending Claims, Number, Individual Injury Claims",
        "terseLabel": "Individual injury claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumberIndividualInjuryClaims",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_MarketShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market share units [Member]",
        "terseLabel": "Market share units"
       }
      }
     },
     "localname": "MarketShareUnitsMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureAndOtherBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mature and Other Brands",
        "label": "Mature and Other Brands [Member]",
        "terseLabel": "Mature and other products"
       }
      }
     },
     "localname": "MatureAndOtherBrandsMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureBrandsAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mature Brands and Other",
        "label": "Mature Brands and Other [Member]",
        "terseLabel": "Mature Products and Other"
       }
      }
     },
     "localname": "MatureBrandsAndOtherMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MedicaidandMedicarerebatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Medicare rebates [Member]",
        "label": "Medicaid and Medicare rebates [Member]",
        "terseLabel": "Medicaid and Medicare rebates"
       }
      }
     },
     "localname": "MedicaidandMedicarerebatesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MyoKardiaAcquisitionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MyoKardia Acquisition Plan",
        "label": "MyoKardia Acquisition Plan [Member]",
        "terseLabel": "MyoKardia Acquisition Plan"
       }
      }
     },
     "localname": "MyoKardiaAcquisitionPlanMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NetproductsalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net product sales [Member]",
        "label": "Net product sales [Member]",
        "terseLabel": "Net product sales"
       }
      }
     },
     "localname": "NetproductsalesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NumberOfLargestPharmaceuticalWholesalers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of the largest pharmaceutical wholesalers used by the company in the territory.",
        "label": "Number Of Largest Pharmaceutical Wholesalers",
        "terseLabel": "Number of largest pharmaceutical wholesalers"
       }
      }
     },
     "localname": "NumberOfLargestPharmaceuticalWholesalers",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_NumberofRevolvingCreditFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Number of Revolving Credit Facilities",
        "terseLabel": "Number of revolving credit facilities"
       }
      }
     },
     "localname": "NumberofRevolvingCreditFacilities",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_OnglyzaProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onglyza Product Liability Litigation",
        "label": "Onglyza Product Liability Litigation [Member]",
        "terseLabel": "Onglyza Product Liability Litigation"
       }
      }
     },
     "localname": "OnglyzaProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OnuregMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onureg",
        "label": "Onureg [Member]",
        "terseLabel": "Onureg"
       }
      }
     },
     "localname": "OnuregMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OpdivoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Opdivo [Member]",
        "terseLabel": "Opdivo"
       }
      }
     },
     "localname": "OpdivoMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OpdualagMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opdualag",
        "label": "Opdualag [Member]",
        "terseLabel": "Opdualag"
       }
      }
     },
     "localname": "OpdualagMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OrenciaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Orencia [Member]",
        "terseLabel": "Orencia"
       }
      }
     },
     "localname": "OrenciaMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherIncomeReceivedFromAlliancePartners": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.",
        "label": "Other Income Received From Alliance Partners",
        "negatedTerseLabel": "Royalties and licensing income"
       }
      }
     },
     "localname": "OtherIncomeReceivedFromAlliancePartners",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.",
        "label": "Other Other Income Expense",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherOtherIncomeExpense",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherRegionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Region [Member]",
        "terseLabel": "Other Region"
       }
      }
     },
     "localname": "OtherRegionMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Royalties",
        "label": "Other Royalties [Member]",
        "terseLabel": "Other Royalties"
       }
      }
     },
     "localname": "OtherRoyaltiesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherrebatesreturnsdiscountsandadjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other rebates, returns, discounts and adjustments [Member]",
        "label": "Other rebates, returns, discounts and adjustments [Member]",
        "terseLabel": "Other rebates, returns, discounts and adjustments"
       }
      }
     },
     "localname": "OtherrebatesreturnsdiscountsandadjustmentsMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherrevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues [Member]",
        "label": "Other revenues [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherrevenuesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PaymentToExtinguishFutureRoyaltyObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment To Extinguish Future Royalty Obligation",
        "label": "Payment To Extinguish Future Royalty Obligation",
        "terseLabel": "Payment to extinguish future royalty obligation"
       }
      }
     },
     "localname": "PaymentToExtinguishFutureRoyaltyObligation",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Pensionsettlementsandamortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of expense recognized due to defined benefit pension settlements and curtailments and the amortization of prior service credits and net actuarial loss.",
        "label": "Pension settlements and amortization",
        "terseLabel": "Pension settlements and amortization"
       }
      }
     },
     "localname": "Pensionsettlementsandamortization",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_PercentageOfAggregateTotalTradeReceivablesDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.",
        "label": "Percentage Of Aggregate Total Trade Receivables Due",
        "terseLabel": "Percent of aggregate total trade receivables due from three pharmaceutical wholesalers"
       }
      }
     },
     "localname": "PercentageOfAggregateTotalTradeReceivablesDue",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmy_PlavixAustraliaIntellectualPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix Australia Intellectual Property [Member]",
        "label": "Plavix Australia Intellectual Property [Member]",
        "terseLabel": "Plavix Australia Intellectual Property"
       }
      }
     },
     "localname": "PlavixAustraliaIntellectualPropertyMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PomalystImnovidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pomalyst/Imnovid [Member]",
        "label": "Pomalyst/Imnovid [Member]",
        "terseLabel": "Pomalyst/Imnovid"
       }
      }
     },
     "localname": "PomalystImnovidMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ReblozylMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reblozyl [Member]",
        "label": "Reblozyl [Member]",
        "terseLabel": "Reblozyl"
       }
      }
     },
     "localname": "ReblozylMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ReceivablesSoldOnNonrecourseBasis": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables sold on a nonrecourse basis during the year.",
        "label": "Receivables Sold On Nonrecourse Basis",
        "terseLabel": "Non-U.S. receivables sold on a nonrecourse basis"
       }
      }
     },
     "localname": "ReceivablesSoldOnNonrecourseBasis",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "label": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "terseLabel": "Revenue Recognition Gross-To-Net Adjustments"
       }
      }
     },
     "localname": "ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ResearchAndDevelopmentNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development - Non-Current",
        "label": "Research and development - Non-Current",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentNonCurrent",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ResearchandDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development",
        "label": "Research and Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchandDevelopment",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest of the World"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance",
        "label": "Restructuring and Related Activities, Business Acquisition, Expected Cost Savings and Avoidance",
        "terseLabel": "Expected cost savings and avoidance"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesBusinessAcquisitionExpectedCostSavingsAndAvoidance",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "label": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesExcludingAcceleratedStockbasedCompensation",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestructuringRelatedCostsAssetImpairments": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Related Costs, Asset Impairments",
        "label": "Restructuring Related Costs, Asset Impairments",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "RestructuringRelatedCostsAssetImpairments",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RevlimidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revlimid [Member]",
        "label": "Revlimid [Member]",
        "terseLabel": "Revlimid"
       }
      }
     },
     "localname": "RevlimidMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_RoyaltyGuaranteesCommitmentsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Guarantees Commitments, Percent",
        "label": "Royalty Guarantees Commitments, Percent",
        "terseLabel": "Running royalty"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsPercent",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bmy_SalesRevenueGrossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Revenue, Gross [Member]",
        "label": "Sales Revenue, Gross [Member]",
        "terseLabel": "Gross product sales"
       }
      }
     },
     "localname": "SalesRevenueGrossMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ScheduleOfEquityInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Equity Investments",
        "label": "Schedule of Equity Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Investments"
       }
      }
     },
     "localname": "ScheduleOfEquityInvestmentsTableTextBlock",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfOtherIncomeExpenseTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Income Expense [Text Block]",
        "terseLabel": "Schedule Of Other Income Expense"
       }
      }
     },
     "localname": "ScheduleOfOtherIncomeExpenseTextBlock",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Schedule of Provision for Income Taxes [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfProvisionForIncomeTaxesTableTextBlock",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Schedule Of Share Based Compensation Additional Information [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Compensation Additional Information"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.",
        "label": "Selling, General and Administrative Expense - Collaborative Arrangement",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralandAdministrativeExpenseCollaborativeArrangement",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_SeniorUnsecuredNotesDue2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Due 2032",
        "label": "Senior Unsecured Notes Due 2032 [Member]",
        "terseLabel": "Senior Unsecured Notes Due 2032"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2032Member",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SeniorUnsecuredNotesDue2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Due 2042",
        "label": "Senior Unsecured Notes Due 2042 [Member]",
        "terseLabel": "Senior Unsecured Notes Due 2042"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2042Member",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SeniorUnsecuredNotesDue2052Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Due 2052",
        "label": "Senior Unsecured Notes Due 2052 [Member]",
        "terseLabel": "Senior Unsecured Notes Due 2052"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2052Member",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SeniorUnsecuredNotesDue2062Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Due 2062",
        "label": "Senior Unsecured Notes Due 2062 [Member]",
        "terseLabel": "Senior Unsecured Notes Due 2062"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2062Member",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SprycelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sprycel [Member]",
        "terseLabel": "Sprycel"
       }
      }
     },
     "localname": "SprycelMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SupplementalFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Financial Information [Abstract]",
        "label": "Supplemental Financial Information [Abstract]",
        "terseLabel": "Supplemental Financial Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalFinancialInformationAbstract",
     "nsuri": "http://www.bms.com/20220331",
     "xbrltype": "stringItemType"
    },
    "bmy_TecentriqRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tecentriq royalties",
        "label": "Tecentriq royalties [Member]",
        "terseLabel": "Tecentriq royalties"
       }
      }
     },
     "localname": "TecentriqRoyaltiesMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Totalinventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the total inventory, current and non-current, as of the balance sheet date.",
        "label": "Total inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "Totalinventories",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_UnamortizedBasisAdjustmentFromSwapTerminations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.",
        "label": "Unamortized Basis Adjustment From Swap Terminations",
        "terseLabel": "Unamortized basis adjustment from swap terminations"
       }
      }
     },
     "localname": "UnamortizedBasisAdjustmentFromSwapTerminations",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_YervoyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yervoy [Member]",
        "terseLabel": "Yervoy"
       }
      }
     },
     "localname": "YervoyMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ZeposiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zeposia",
        "label": "Zeposia [Member]",
        "terseLabel": "Zeposia"
       }
      }
     },
     "localname": "ZeposiaMember",
     "nsuri": "http://www.bms.com/20220331",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AUD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia, Dollars",
        "terseLabel": "Australia, Dollars"
       }
      }
     },
     "localname": "AUD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "Currency [Domain]",
        "verboseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r88",
      "r90",
      "r166",
      "r167",
      "r353",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r352",
      "r376",
      "r437",
      "r439",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r615",
      "r672",
      "r675",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r352",
      "r376",
      "r437",
      "r439",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r615",
      "r672",
      "r675",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r244",
      "r410",
      "r413",
      "r617",
      "r671",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r244",
      "r410",
      "r413",
      "r617",
      "r671",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r352",
      "r376",
      "r425",
      "r437",
      "r439",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r615",
      "r672",
      "r675",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r352",
      "r376",
      "r425",
      "r437",
      "r439",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r615",
      "r672",
      "r675",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r89",
      "r90",
      "r166",
      "r167",
      "r353",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r245",
      "r246",
      "r410",
      "r414",
      "r674",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r245",
      "r246",
      "r410",
      "r414",
      "r674",
      "r685",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Account Receivables [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r66",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts payable \u2013 to alliance partners"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r248",
      "r249"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r17",
      "r43",
      "r248",
      "r249"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Net trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r37",
      "r627",
      "r649"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r39",
      "r627",
      "r649"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r632",
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.",
        "label": "Accrued Liabilities",
        "terseLabel": "Accrued liabilities for CERCLA matters"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r72"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r62",
      "r307"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r98",
      "r103",
      "r434"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r92",
      "r100",
      "r102",
      "r103",
      "r553"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r46",
      "r100",
      "r102",
      "r103",
      "r653",
      "r680",
      "r681"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r99",
      "r103",
      "r112",
      "r113",
      "r114",
      "r170",
      "r171",
      "r172",
      "r513",
      "r676",
      "r677",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Supplemental Financial Information"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r44",
      "r456",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Capital in excess of par value of stock"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r453",
      "r454",
      "r455",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital\u00a0in Excess of Par Value of\u00a0Stock"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r441",
      "r449",
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based Payment Arrangement, Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r50",
      "r250",
      "r271"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Less allowance for expected credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r153",
      "r291",
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r162",
      "r226",
      "r236",
      "r242",
      "r269",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r507",
      "r514",
      "r558",
      "r581",
      "r583",
      "r625",
      "r648"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r85",
      "r162",
      "r269",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r507",
      "r514",
      "r558",
      "r581",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r258"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r259"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r256",
      "r277"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r253",
      "r257",
      "r277",
      "r631"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Marketable debt securities, fair value",
        "verboseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r443",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r523",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r26",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r436",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r436",
      "r438",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r152",
      "r495"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration fair value adjustments",
        "verboseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r492",
      "r493",
      "r494"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Integration expenses"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r487",
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories, fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r15",
      "r59",
      "r155"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents - money market and other securities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r148",
      "r155",
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at End of Period",
        "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at Beginning of Period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r148",
      "r562"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r159",
      "r162",
      "r186",
      "r190",
      "r191",
      "r193",
      "r195",
      "r203",
      "r204",
      "r205",
      "r269",
      "r338",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r374",
      "r375",
      "r379",
      "r383",
      "r558",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for collaborative arrangements.",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "terseLabel": "Collaboration Arrangements"
       }
      }
     },
     "localname": "CollaborativeArrangementAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r497",
      "r498",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Alliances"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Alliance revenues"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Alliance Statement [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r170",
      "r171",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r42",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r108",
      "r110",
      "r111",
      "r124",
      "r639",
      "r666"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income Attributable to BMS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r108",
      "r110",
      "r123",
      "r505",
      "r506",
      "r518",
      "r638",
      "r665"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling Interest",
        "verboseLabel": "Comprehensive Income Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r108",
      "r110",
      "r122",
      "r504",
      "r518",
      "r637",
      "r664"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r292",
      "r296",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r247",
      "r555",
      "r556",
      "r683",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r210",
      "r212",
      "r213",
      "r214",
      "r555",
      "r557",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r247",
      "r555",
      "r556",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r158",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r399",
      "r400",
      "r411"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Performance obligation satisfied in previous period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Obligation to holders of the contingent value rights"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r426",
      "r435",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r127",
      "r617"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r426",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-currency interest rate swap contracts"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r211",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "verboseLabel": "Short-term debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r161",
      "r168",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r577",
      "r626",
      "r628",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r349",
      "r368",
      "r369",
      "r575",
      "r577",
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal Value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r358",
      "r368",
      "r369",
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r74",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rates"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r75",
      "r161",
      "r168",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r75",
      "r161",
      "r168",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r371",
      "r391",
      "r392",
      "r393",
      "r394",
      "r574",
      "r575",
      "r577",
      "r578",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r356",
      "r574",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized bond discounts and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r356",
      "r574",
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Unamortized purchase price adjustments of Celgene debt"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Reasonably possible decrease in unrecognized tax benefits"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncome": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Income",
        "terseLabel": "Deferred income from alliance"
       }
      }
     },
     "localname": "DeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeNoncurrent": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Income, Noncurrent",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredIncomeNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r163",
      "r469",
      "r474",
      "r475",
      "r476"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r34",
      "r422",
      "r423",
      "r424",
      "r435",
      "r624",
      "r647"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r153",
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r153",
      "r223"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization, net"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r86",
      "r87",
      "r90",
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Variable rate debt, lower range of basis point spread"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain (loss) on derivative, net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r90",
      "r524",
      "r527",
      "r532",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r522",
      "r524",
      "r532",
      "r536",
      "r537",
      "r539",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r86",
      "r87",
      "r90",
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Fair value of interest rate swap contracts",
        "verboseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Employee Stock Benefit Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r153",
      "r304",
      "r309"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedLabel": "Divestiture (Gains)/Losses",
        "negatedTerseLabel": "Divestiture gains",
        "terseLabel": "Divestiture gains"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r436",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r29",
      "r72"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r125",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r184",
      "r186",
      "r193",
      "r194",
      "r195",
      "r199",
      "r200",
      "r544",
      "r545",
      "r640",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per common share attributable to BMS, basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r125",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r186",
      "r193",
      "r194",
      "r195",
      "r199",
      "r200",
      "r544",
      "r545",
      "r640",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per common share attributable to BMS, diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected weighted-average period in years of compensation cost to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Excess tax benefits from share-based compensation awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r112",
      "r113",
      "r114",
      "r170",
      "r171",
      "r172",
      "r174",
      "r180",
      "r182",
      "r202",
      "r270",
      "r390",
      "r395",
      "r453",
      "r454",
      "r455",
      "r470",
      "r471",
      "r543",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r571",
      "r676",
      "r677",
      "r678",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r60",
      "r227",
      "r267"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 2.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFVNIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI [Abstract]",
        "terseLabel": "Equity investments with readily determined fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 1.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity investments",
        "verboseLabel": "Equity investments with readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]",
        "terseLabel": "Equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r266",
      "r668"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "negatedTerseLabel": "Net loss recognized on investments sold"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r266",
      "r668"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Net loss/(gain) recognized"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails": {
       "order": 3.0,
       "parentTag": "bmy_EquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSummaryofEquityInvestmentsCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount",
        "terseLabel": "Impairments and downward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount",
        "terseLabel": "Cumulative impairments and downward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "negatedTerseLabel": "Upward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "negatedTerseLabel": "Cumulative upward adjustments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAdjustmentToInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value adjustment to acquisition-date inventory allocated (included) to (in) reported pro forma earnings (supplemental pro forma information).",
        "label": "Fair Value Adjustment to Inventory [Member]",
        "terseLabel": "Fair Value Adjustment to Inventory"
       }
      }
     },
     "localname": "FairValueAdjustmentToInventoryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r546",
      "r547",
      "r548",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r358",
      "r368",
      "r369",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r547",
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r358",
      "r426",
      "r427",
      "r432",
      "r435",
      "r547",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r358",
      "r368",
      "r369",
      "r426",
      "r427",
      "r432",
      "r435",
      "r547",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r358",
      "r368",
      "r369",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r547",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r358",
      "r368",
      "r369",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r523",
      "r529",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r366",
      "r388",
      "r542",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r292",
      "r294",
      "r297",
      "r300",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r292",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r297",
      "r618"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Finite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Derivatives [Abstract]",
        "terseLabel": "Foreign currency forward contracts gain/(loss):"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Line Items]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Line Items]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative instruments designated as foreign currency fair value hedging instruments.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Table]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Table]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Transaction [Abstract]",
        "terseLabel": "Cross-currency interest rate swap contracts gain:"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r130",
      "r153",
      "r255"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Equity investment losses/(gains)"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation and other settlements"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r153",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt redemption"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralCashFlowHedgeInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Cash Flow Hedge Information [Abstract]",
        "terseLabel": "Derivatives qualifying as cash flow hedges"
       }
      }
     },
     "localname": "GeneralCashFlowHedgeInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r287",
      "r288",
      "r583",
      "r623"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r522",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r153",
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of other intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r153",
      "r303"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "IPRD"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r118",
      "r226",
      "r235",
      "r238",
      "r241",
      "r243",
      "r620",
      "r634",
      "r642",
      "r669"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings Before Income Taxes",
        "totalLabel": "Earnings Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r119",
      "r153",
      "r224",
      "r267",
      "r633",
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net (income)/loss of affiliates"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r436",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r310",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r164",
      "r465",
      "r467",
      "r468",
      "r472",
      "r477",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r165",
      "r181",
      "r182",
      "r225",
      "r463",
      "r473",
      "r479",
      "r670"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "terseLabel": "Rebates and discounts"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r195"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Incremental shares attributable to share-based compensation plans (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r293",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "IPRD"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r293",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r290",
      "r295"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets",
        "totalLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r116",
      "r222",
      "r573",
      "r576",
      "r641"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r144",
      "r149",
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryAdjustments": {
     "auth_ref": [
      "r82",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.",
        "label": "Inventory Adjustments",
        "terseLabel": "Inventory adjustments"
       }
      }
     },
     "localname": "InventoryAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r52",
      "r283"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r16",
      "r81",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Other non-current assets",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r54",
      "r55",
      "r283"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw and packaging materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r53",
      "r283"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r129",
      "r221"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedTerseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]",
        "terseLabel": "Non-derivatives qualifying as net investment hedges"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r25",
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Proceedings and Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r70",
      "r162",
      "r237",
      "r269",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r508",
      "r514",
      "r515",
      "r558",
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r49",
      "r162",
      "r269",
      "r558",
      "r583",
      "r630",
      "r656"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r73",
      "r162",
      "r269",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r508",
      "r514",
      "r515",
      "r558",
      "r581",
      "r582",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r38",
      "r357",
      "r367",
      "r368",
      "r369",
      "r628",
      "r651"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofLongtermandCurrentDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Debt, Term",
        "terseLabel": "Long-term debt, term (in years)"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r75",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r331",
      "r332",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Damages paid"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r331",
      "r332",
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Number of patents"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r26",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery, equipment and fixtures"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r18",
      "r71"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r14",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Divestitures, Licensing and Other Arrangements"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r80",
      "r162",
      "r269",
      "r338",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r558",
      "r629",
      "r655"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NameOfReportingCategoryDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of reporting category or type of financial instrument.",
        "label": "Name of Reporting Category [Domain]",
        "terseLabel": "Name of Reporting Category [Domain]"
       }
      }
     },
     "localname": "NameOfReportingCategoryDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Used in Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows From Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Provided by/(Used in) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r148",
      "r151",
      "r154"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Flows From Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r13",
      "r106",
      "r109",
      "r114",
      "r120",
      "r154",
      "r162",
      "r173",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r192",
      "r226",
      "r235",
      "r238",
      "r241",
      "r243",
      "r269",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r545",
      "r558",
      "r635",
      "r662"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Earnings",
        "totalLabel": "Net Earnings Attributable to BMS",
        "verboseLabel": "Net Earnings Attributable to BMS Used for Basic and Diluted EPS Calculation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/EARNINGSPERSHAREDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r106",
      "r109",
      "r114",
      "r181",
      "r182",
      "r511",
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net earnings, noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r395",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]",
        "terseLabel": "Nonrecurring Adjustment [Axis]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]",
        "terseLabel": "Nonrecurring Adjustment [Domain]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r169",
      "r183",
      "r218",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r72"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r84",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "totalLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r523",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets",
        "totalLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r97",
      "r100",
      "r433"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Actuarial losses, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "negatedTerseLabel": "Actuarial losses, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax": {
     "auth_ref": [
      "r101",
      "r504"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax",
        "negatedTerseLabel": "Settlements, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r93",
      "r100",
      "r559",
      "r560",
      "r563"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation",
        "verboseLabel": "Foreign currency translation, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r92",
      "r100",
      "r559",
      "r560",
      "r563"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Recognized in Other Comprehensive Income",
        "verboseLabel": "Foreign currency translation, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r95",
      "r96",
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Unrealized (losses)/gains, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r95",
      "r96",
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r95",
      "r96",
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "negatedTerseLabel": "Unrealized (losses)/gains, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r112",
      "r113",
      "r121",
      "r268",
      "r564",
      "r569",
      "r571",
      "r636",
      "r663"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other Comprehensive Income/(Loss), pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r94",
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges",
        "totalLabel": "Derivatives qualifying as cash flow hedges, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": {
     "auth_ref": [
      "r94",
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax",
        "totalLabel": "Derivatives qualifying as cash flow hedges, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "negatedTotalLabel": "Derivatives qualifying as cash flow hedges, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r94",
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gains/(losses), after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r94",
      "r100",
      "r526",
      "r530",
      "r540"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Recognized in other comprehensive income",
        "verboseLabel": "Unrealized gains/(losses), pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "negatedTerseLabel": "Unrealized gains/(losses), tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r100",
      "r104"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassified to net earnings, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r100",
      "r104",
      "r531"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Reclassified to net earnings, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Reclassified to net earnings, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r100",
      "r104",
      "r433"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Settlements, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r100",
      "r104",
      "r433"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Settlements, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r92",
      "r101",
      "r561",
      "r570"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Foreign currency translation, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Recognized in Other Comprehensive Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r107",
      "r110",
      "r112",
      "r113",
      "r115",
      "r121",
      "r390",
      "r564",
      "r569",
      "r571",
      "r636",
      "r663"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive Income/(Loss), after tax",
        "totalLabel": "Total Other Comprehensive Income",
        "verboseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r98",
      "r100",
      "r433",
      "r435"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTotalLabel": "Pension and postretirement benefits, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r98",
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      },
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefits",
        "negatedTotalLabel": "Pension and postretirement benefits, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r97",
      "r100",
      "r433"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Actuarial losses, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r98",
      "r101",
      "r504"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "totalLabel": "Pension and postretirement benefits, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r100",
      "r104",
      "r105",
      "r433"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r100",
      "r104",
      "r105",
      "r433"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Amortization, after tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Amortization, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r101",
      "r112",
      "r121",
      "r463",
      "r478",
      "r480",
      "r564",
      "r567",
      "r571",
      "r636",
      "r663"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTotalLabel": "Other comprehensive income/(loss), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherContractMember": {
     "auth_ref": [
      "r90",
      "r426",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is classified as other.",
        "label": "Other Contract [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativesandFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r421",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other (Income)/Expense, Net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r72",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      },
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income)/expense, net",
        "negatedTotalLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Reclassified to Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r19",
      "r22",
      "r286"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Alliance, Royalties, VAT and other"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r153"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other termination costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherShortTermBorrowings": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.",
        "label": "Other Short-term Borrowings",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r145",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "terseLabel": "Payments for royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "terseLabel": "Payment for debt extinguishment"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition and other payments, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r254"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable debt securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39",
      "r422",
      "r423",
      "r424",
      "r435"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance share units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r41",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r20",
      "r22",
      "r285",
      "r286"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting category or type of financial instruments related to a group of items that represent revenue.",
        "label": "Principal Transaction Revenue, Description of Reporting Category [Axis]",
        "terseLabel": "Principal Transaction Revenue, Description of Reporting Category [Axis]"
       }
      }
     },
     "localname": "PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from divestiture of businesses, net of cash divested",
        "verboseLabel": "Net proceeds"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Issuance of long-term debt",
        "verboseLabel": "Deferred loan issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r139",
      "r143"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Short-term debt obligations, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r133",
      "r134",
      "r254"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Sale and maturities of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": {
     "auth_ref": [
      "r146",
      "r262"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Proceeds from Sale of Equity Securities, FV-NI",
        "terseLabel": "Proceeds from sales of equity investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r13",
      "r106",
      "r109",
      "r114",
      "r147",
      "r162",
      "r173",
      "r181",
      "r182",
      "r226",
      "r235",
      "r238",
      "r241",
      "r243",
      "r269",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r504",
      "r510",
      "r512",
      "r517",
      "r518",
      "r545",
      "r558",
      "r642"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net Earnings",
        "totalLabel": "Net Earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r313",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r61",
      "r306"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r32",
      "r33",
      "r308",
      "r583",
      "r643",
      "r658"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment",
        "totalLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r32",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r43",
      "r51",
      "r583",
      "r657",
      "r684"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables",
        "totalLabel": "Receivables",
        "verboseLabel": "Receivables \u2013 from alliance partners"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/RECEIVABLESScheduleofReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r460",
      "r616",
      "r702"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r157",
      "r622",
      "r652"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r24",
      "r34",
      "r157",
      "r686"
     ],
     "calculation": {
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r315",
      "r317",
      "r320",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r316",
      "r319",
      "r326",
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and related charges incurred to date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r316",
      "r319",
      "r326",
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected restructuring and related charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Workforce reduction of manufacturing, selling, administrative, and research and development personnel"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r153",
      "r314",
      "r323",
      "r326"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Provision for restructuring",
        "totalLabel": "Provision for restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHERINCOMEEXPENSENETScheduleOfOtherIncomeExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r316",
      "r317",
      "r326",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r153"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "totalLabel": "Total charges"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r317",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring reserve, end of period",
        "periodStartLabel": "Restructuring reserve, beginning of period"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.",
        "label": "Restructuring and Related Cost, Accelerated Depreciation",
        "terseLabel": "Accelerated depreciation"
       }
      }
     },
     "localname": "RestructuringReserveAcceleratedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r317",
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Change in estimates"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r317",
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation and other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r45",
      "r395",
      "r456",
      "r583",
      "r654",
      "r679",
      "r681"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r170",
      "r171",
      "r172",
      "r174",
      "r180",
      "r182",
      "r270",
      "r453",
      "r454",
      "r455",
      "r470",
      "r471",
      "r543",
      "r676",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r412",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r117",
      "r162",
      "r219",
      "r220",
      "r234",
      "r239",
      "r240",
      "r244",
      "r245",
      "r247",
      "r269",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r558",
      "r642"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails",
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyIncomeNonoperating": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Income, Nonoperating",
        "negatedLabel": "Royalty Income",
        "negatedTerseLabel": "Royalty income, nonoperating"
       }
      }
     },
     "localname": "RoyaltyIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails",
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSLicensingandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule Of Receivables"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r103",
      "r569",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERACQUISITIONSDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Cost by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income Loss"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r75",
      "r168",
      "r368",
      "r370",
      "r391",
      "r392",
      "r393",
      "r394",
      "r574",
      "r575",
      "r578",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Fair Value and Other Adjustments to Long Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r524",
      "r532",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivatives and Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings/(Loss) Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueDisaggregationofRevenuebyProductandRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Products and Services"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r292",
      "r296",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule Of Intangible Assets By Major Class"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r31",
      "r56",
      "r57",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Gross to Net Adjustments [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueReconciliationofGrossProductSalestoNetProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r321",
      "r322",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r317",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stock by Class"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Business Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/RESTRUCTURINGAdditionalInformationDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r153"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Employee termination costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of units granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r440",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Stock compensation (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "auth_ref": [
      "r64",
      "r660"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.",
        "label": "Short-term Bank Loans and Notes Payable",
        "terseLabel": "Non-U.S. short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBankLoansAndNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r35",
      "r583",
      "r626",
      "r650"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "totalLabel": "Short-term debt, total"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofShorttermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r159",
      "r162",
      "r186",
      "r190",
      "r191",
      "r193",
      "r195",
      "r203",
      "r204",
      "r205",
      "r269",
      "r338",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r374",
      "r375",
      "r379",
      "r383",
      "r390",
      "r558",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r78",
      "r112",
      "r113",
      "r114",
      "r170",
      "r171",
      "r172",
      "r174",
      "r180",
      "r182",
      "r202",
      "r270",
      "r390",
      "r395",
      "r453",
      "r454",
      "r455",
      "r470",
      "r471",
      "r543",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r571",
      "r676",
      "r677",
      "r678",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/DocumentandEntityInformation",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r202",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/DocumentandEntityInformation",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleofSharebasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.bms.com/role/INCOMETAXESAdditionalInformationDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r41",
      "r42",
      "r395",
      "r442",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r41",
      "r42",
      "r390",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchase program (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r41",
      "r42",
      "r390",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r42",
      "r47",
      "r48",
      "r162",
      "r251",
      "r269",
      "r558",
      "r583"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Bristol-Myers Squibb Company Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Bristol-Myers Squibb Company Shareholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r113",
      "r162",
      "r170",
      "r171",
      "r172",
      "r174",
      "r180",
      "r269",
      "r270",
      "r395",
      "r453",
      "r454",
      "r455",
      "r470",
      "r471",
      "r502",
      "r503",
      "r516",
      "r543",
      "r558",
      "r564",
      "r565",
      "r571",
      "r677",
      "r678",
      "r716"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r160",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r389",
      "r395",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r572",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r572",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r572",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVENSTITURESLICENSINGANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Net Investment Hedge Activity [Abstract]",
        "terseLabel": "Derivatives qualifying as net investment hedges"
       }
      }
     },
     "localname": "SummaryOfNetInvestmentHedgeActivityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Acquired marketed product rights"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofIntangibleAssetsByMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r366",
      "r388",
      "r542",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAvailableforsaleSecuritiesDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Treasury lock contracts"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r77",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r42",
      "r390",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Share repurchase program (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r77",
      "r396",
      "r397"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Less cost of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r390",
      "r395",
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Share repurchase program"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r316",
      "r317",
      "r326",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax [Abstract]",
        "terseLabel": "Non-U.S. dollar borrowings gain:"
       }
      }
     },
     "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSGainLossonHedgingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedTerseLabel": "Net unrealized loss/(gain) recognized on investments still held"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r215",
      "r216",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates and Judgements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r185",
      "r195"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted-average common shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r184",
      "r195"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3444-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=28183603&loc=d3e692-112598"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL108322424-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r703": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r704": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r705": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r706": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r707": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r708": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r709": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r711": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r712": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r713": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r714": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r715": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(d))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e526-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0000014272-22-000114-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000014272-22-000114-xbrl.zip
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MV*S3'8F:%ZENI'19L,H674A("ZF.A2: (H611A@M;8,<X9WMFCO/&%(N&95
M\FRR8O"$ DH0I58G!:T:)%UWMFONI O92LEL4 <1*MR83+)U2T<OK2NX>+SK
M;V6A--5@S6:006>O04C#T@1&>2\,U 7;S.=%Y/"P02(UWP;KIA*J9B]2IK 3
MY%@PNZ0@)8<Q!_Z'3$;/XF8:Y /OK-1\.#YE)7B9HS2Z;BV-$4$*R$$@$)J[
MT:MF6ZF9B!1I5XQ%5%I9<$S/V>$IET!!H"!U;I#CFV-H9^* 1-*) 47EE0>1
M(&0.[\=9)DXY&5.#K,4<0SN;D>>0#+L"I"@S($?5(54U3DPY AFY>%H[TSFQ
ML1O:8'CX6%WL7D]9.3GB:_V56VJDW2C"^J3JSE?)0U*!:8:7(F12AF/N(A?.
M;MQ2X9J)Y7).*#90,4HO(1&@1A5"SM8&H5(,"V>Y9CU"-QL38@JX.D]E0H*L
MBL=8BHC".2FSIB8%*LU >2:ZG+QS$2AR&(ICE!E9\.PV=$Q..FR0+L_9MB&S
MUV!+T:A( AE2L%)%Z9RW_*LM3FO5I.!AGK&=31)4$C)YCAP85TC%A*(MNV0D
MHS7FLP)J<ZVN\Y*#=#T[IP"RUQ2%-%G0P6$MY%[J7L4QAZ)H_I<#S"$\4UR^
M(XH.*FB;/4$,Q0<32(A@+)/8K!M0$^=YO[?'77]8M_C>/CVBSV&Y^F[>/R /
ME^\E/KG5Q3[BXWLN'Q-WGFJ(K@J9)2;63!$T*)2H4G+*!RN\\-XW8(7S#V,#
M?X7-C<OAO A#2M$81S):)* LV3Z4D )AL-XD:1=0&,R=,'RK^(9"GTM0WBL)
MZ")ZD2$I4HG0I-R HGH_+ SV3AB^Y2: 0V5A$8LUD'T(T13IBB<=(<LH)Y2N
MB<*PI.Y[9SY!)%=)4/*:R=Q/ '/<ZTQ022R\G5'!-%XB>M'QAX1#ENOQVTV:
M/#UK<G[!\Q;GW^L5+X5=!PL@K,^L]Z#(Q)30<:#E0TX>2@,6]C[YK ,^A?UQ
MI]OEIFMXTCD\/GS<'PSZ[SER?H)'W/@O5]S."YDO423K%25/ <C)$$L649!/
M' KKW(!*;M]$2"X&0C(KC]YH'Y0!8PAMK>IMR28KL#1A%[-O(W3?+ 9&BMT9
M$UP1M4L "6-03A@IG .CM&G @-(W,9HI0E/<L%)I[Y./!L  >F:EM5!E"&SZ
MHI6^ 8,6\ZI%4XP89$J*N2%;/ $<+H:()D;NRLRFSYA&8[08"!D7%-LXY@A,
M[()6_"$)HB1090A-V'A]/OG<3R'TD<\?#T?]0QH,+Z?RYT=_F,5G:1)X9H->
M)G!(2,+7746\,BYA;@+J_5ZB.@]=)[_J0/SCTZ^CZB=G'?15X_F%_O.<N B:
M8RT7@RC@5/"8T!AO,.AD;( &$,7YA6F*&\R:()6HJ8LHH1:]JNLB,,HDM<C)
M-$";'A\/.ST:#I?2OX\[P\['">5J9E9[[_AJ_<'IB^-!VL<AO1AT$CW%SN!/
M[![34CY@_*YG8OEZ=H"P*E@3I<_*060O)VQP-ALMJ "2F7^M:@!<4]2N8H-W
M,B";0.Y(RZ0_Q)C(!N$I:#G_VK7>[PWJP/* R<?'[O\BT?MK?+;[%U V1+.R
MMF1ETB&7#$)P< ;!6)2R)E7YX!N4/36/F,T^A2IH'1W4JD)%<=1-7B5)4H52
M-$(J34IU?=IA<DS/.^\HK_98X/<ZL4N3>J^/3]?PH#]XTD4VL5]47TSU.BP2
M>P,:9T#_=$+!<#!ZN%G7=DSN5+^N\:-QP+*0 I0E B2.,1.!DECK]V-))CD)
MOO@FK/*X#+!)A#FMJ<(;$LU&"A [E5+W%)3&$#@=?!(.DU2J)F6;W(#LE/E%
M]WIB6*DI"ED2! )C,Z**(@-#57P0&N>?;3<"L"G.3B5I=8G:9U-3WS$8%UG5
M%'FH\XA-('%_VZ=>KTQL4]KO];O]O=/'')9]=>(BFNMH)/JQD78!:A:P#%$9
MEU,"%AV?&BI,<^#O;Z$PL36*I)-F7^&A2!.U2<EES^&E)9:H!?7]-X[T]?
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M"V2Q3L18ZVUU7: MIH#:Z9RQQ,0.;&$@VZ01=GJ45W#0Z_3VFC+D:H4O&&+
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M\+D.0C@+SF"T*6$$*"8A8*.V,9TS)9P]MDXECKF,09("4I2H,]0"U$%KS0%
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M:8UR3=C?;![\R>SY0,A, 4S.R85:G!Z\AY"UE]JJA&&2I<5!6!@#63]H,6]
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MF='@(9%K;)<!,9<!(7,VT%ZEW*O]Z<LQD9=>VW;0@UZOTY]GM^ @'L?>,$?
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MN\*$,'?-70AA60AA6KX'(A3F%CE,-.*>":1]S/G[L>32!,.CK/9[6?./XJR
M)%O"_=XW@_Z7SC 3#N#T_H)L>3>,'E^00:^/G1XO8B^FSJC0XYWH\>V,7O)2
M>&:P0P*'G,/!"F1<C(@P;YQ@R4H'>HEC7K9W5Q>M"U)+!:WW1NN4F''61!X\
M1L28? HQBYF<H &38+&@'$M"US8$;GZ^E160,DOH7<JE.2<>IK*;VPQE _(2
MJ#&O+,M"<'[<^6Y&Z6B>.%6<H<@I<&<4 =D@+$K>$A&P4(:;[!FB>LGW<<H^
M[I*HI(+\!2%_2C5))HS7G"*E!$/<"5!-Q$@$*Q_&F79$))9=0)C.*W=#V<%]
M0OZA'[VZK8E;]S[.H2?,L@N(ECLY'<1C6(9VOHS=\R"#]Q*L3C='HT''G8VL
MZ\;#_DW>^<*^=V#?H]D=N4@Q5M:@(+$%W:4C<DI%9$*B44HF?2"P9IW3BK4Q
MFFN.SJ<GS 8+B)TK;/"@;#"EQ;!76FAND;$LYAA:CHPB#G%%/8P69EW,T73+
MS08KH,.6W+G5N@KFUJC?>K%[L# 1?RWM7M<]C\JZ_[.XYU^9Z6;NXA/&Y&7D
M2%GESV]F\;,'51E+RL$"/\@D$,<D(9O+'#-!'-=.1,9\Y=]33ZTH9R&Z0G2+
MUM6%Z!9'=%,2FD3E%$Y =(P9Q&&V0CI[-Z,*GA*B"36A=F<N^8&TQLKH)AY(
M8=#UH7^6Y6Z#3Z3<KY6-'1 KO:ZZ6%.=QD'K9?_D!*:6@V,[N+G:U3SV(IMW
MCQ48?3\)ZUF&= 0O[+#C[Q/#M&H"]KI'7%Z-^B8.*EZ9[Z*<3DO5"9]-OJX:
M51>J%!=5^L^J]--LGBC/O"."862%=XA30Y'5*J+$B21,:N497=O S^Y?\:1Y
MD<2%@E:<@NZY7"X4M!@*FEH8F\!A7:P#,H8(6!AK@HPF&B7OJ)4T:*8J"C+-
MIZ 5T)I+GOIJJ],]&\50SMP_MCP;&Z*PXYW8<3:/E1:2V2 5,L'F$N@F(<,C
M09AA%F ,*Q=)9D?1_ )6Y6!\XQ5-0>TOHG9*TWAJ3=(^(*MR%0+E85D55$*8
M.FQ8 II-)J-6-Q^U#=4TOU<Q(O!OZ'S9^%_X,;EBW!,H2Y/G1/]( I_.AJ-.
M.J]?ZO1"[(V>H_RA>5. _B<&H%4N7_NOVMRS/S,YI'Y_U.N/XE)BL!O_O7_^
MX7TX=93+-H7/?MK__.%DO_-A:Y>WM[J?VEO'G_8./]/=]T>D_>G#Y]W7.^=[
M6Z_2[O>C\[^M8=3S%)",$N<R'C !RF 1%UJ$9"F+3.3]RKJ#]OO5OLYH=/K\
M]]^_?OWZ[)L;=)_U!Q]_IQBSWP?P]N^3SZYM;'_SW;, 1K1WJ)]SQ1P;SR[0
M.3WX3NS@8Z=7[9F8BT&U\;]N\/O&S#4_?7-RPRMCU\<<S;CPN4I=.U)?[K4/
M]O[<V=H\W-YJ'1S"/[O;[<.#UMZKULN]W3?[V__>;A_L_+7=VFG#W]N-?YZM
M?K=K!T.P=&NWT^WF3#"-;_-O[]J;[[9VP +_NF8PU3%SDWFBWKOS^2E/A_'Y
MY)<_)GS:Z57WKR[Z8SQJZ]G@>5[B3<T350_4;__QM1-&QUG!/,.UBAFO+L??
M/'[[6?76U.Q5OZ?X,ZWHC6_C9^3&]WYV6P(:6,I?NNW/W^.&+Z:Q^K:W79Y9
M^69/PQVW3A<CS/]Q5JY&]/4*[.*9S&V>J2:*QWFJ&?:HDX(?#V)L[<+GCH>M
M;9 ^H;6;BU*W&%F_Q9;PZ@\.<ZMN_.EL]Y.U[QUB<9H]CK(W:%X/?)L0@%7J
M.+)PH#78A]QHO_'/4FR40-P2B%O2B<S3,;>#VX>;L-A_2W=?_^<SM 'OO7X%
M[[6[;?KN'*[E1X<O.GM;G_F,8^[36V@/M&_KZ"M\'VUOP7>]?]7)#KD/A__Y
MM'=X?+S[>H?#OVFW,U,=U%BC(K8.28L%XBE$9 V-B"HP'^4FX.2?9C:10G*%
MY$KFE*4DN>E:J4YA*1BP6N J(B UA0Q6 >%H<< "<QIQ29SR<%*9W#%3Y2VX
M$WKZD?BC+J/ZPWG\<7+=JI1J=J./<I+=ENV%UB#ZKAT..PF:7F7;SF=ZXUAF
M/_]AE#VY0!6X[ MTRA>XY7_/H$'I/*>AL<.6M\/C5NKVO[:.8_A8ZD<\H JO
M!O<UN2;RE/42S/(*K/+O;)37MM/++VZF41SL3XWRS5XXM-_*+':'6:S]<D:J
MTT2QL$:B7*\6<2TILLX89)DVPBK-LC4WV+P.RS5(BA> +[9^;0'XHP!\6J8R
M(YU0G((XI09Q+G.Q!\81BP'@#<:D)(%,U:7 0SEB]H_%'C*8@4NRZ#SM#T>#
M..H,XDGLC5JN3F)>JCXL4D8-X7GAM[O0[=ADP*75I][\8+5QYODW7>B!S9"C
MMO*KDY1?A7GOPKP',](J.*4<D089A2GB*1+D G.("YM,8BDIHX!YFY^.OA2/
M>$QI54#?9-!/RRU# D_4:Q1PT+">2APYH2W2T7AOE.7!YG3*]][W*(>L5MYW
MM6L'GV,=;QBB&[6&T9\-.J/.D_-5_=9XE;7YQ7:ZV5*O^H,#H,^#"U,5AKT?
MP\YN+@O/%361HBBM!X:UN8@IPTAJ+*BQP:3HUC9F5=6_FK.2+;ZJ7P?XXRBJ
M O#% 7Q:0H&%'6-*("(D1YPJC[0W'I9147%J*;,R2Z@F WP%Q-.2NZH I_!G
MKP4P'<2>/V^-!G"W;N58?F(^JF;+I[&A7H[M=)C-5+<S^_\OC7:Q53#H#,$
M6T"_O8]OH$?ZH1#OKQ#O^8RRPD03::-&CF5EI2)#3D>!F)8L:,>#S!$MY#[,
M6WQ5#0;_PTNK OY' _^TZO)8RN2KY!<!5)?W >F %3(L4J\9A?_(VH9L,O97
M0'4MX9F.P_[(=ELW!ZR54JK-C[HJ)/H+)+HW&TV5#/8N*8>XS3'!),+2-5&-
M,.8\"HV%DW1M@RUY0'"IH=K8S<("^45#?EHW8<.Q-<XA;P*(I^A@^:191$%'
MGS#'-.A\#,#<NX9?.030['(#2WB/QAIUI07SO$7R:D^*#UGR%O[JGN6^?),S
M5O5[MRMZ6<[8S>F,W>%LXG3,HF3*<YA=-44\$(^<,@EI$7%B2=HH1#Y)S.BL
M5[)I\<MEU[<YRKB00)-)8"K-I_4L&UHAFIF <VZ1=I8CJX0.EFEN<'72EE'>
M>!)8 <GU:V=I&R>Y9JK@_@CMU@3;]]DM?L+.C(?4;4^H./E#L?!LBO04*<;*
M&A0DMHA''4&*J8A,2#1*R:0/9&WCWFZ.QRU.OM#MXR?,!@\IX H;+((-IC09
M]DH+#4K,6!9!DPF.C"(.<44]C!9F7?1K&_<N)OVX;+ "8FU%_&,S8NW%[L$O
M>L['^9>O*;9:DF_-K8-69N)Z2!E;O CSF[%V9O2KD(1;S36R&@?$L2?("<=1
MU(8;83W\<)4KD:CY;M7- 4_+D;6P,&MAUF8N"0JSSI59I]8"24F!E;4HAL@1
M9P8X5DB*B,.<:\(2E;[RSY+9\-'58M:&+AANK.+T\#57KJ_0='@<6]8#8N&[
MJP1]N0#0L&4'\'(OUPF*'P>VVSJU@SKUX7$<QLPFE5WM*(96ZO1LSW?@0\,1
MO)#/XPUG"PC=JAC0N&5,0M-/^\-.'J?/![%;I1&\+,R2V>[*5>.QB"\OL0Z:
M=S:Z^9*F]#[[L2NN_LRMK3DQ<D4,K.ZU9!R'8*C ,FF<(N9*<OHW,6N3BXXO
M@G).[<>(W"#:S\CF%%_/;?>K/1^N_?YC.:=.#UWM].G^NMEJ#1C0UQ<1>K&_
M<W"X]R?:/=K>/V@=O'VW\^)%5<)ILWW4^ I(/U2A>K'YYV;[Y7;KX-_;VX<'
MC6_[JE6<:AI73,W7/ZG,-G5"]*+5RU1!2RRJ*-4B*FBI197[NET%K=4I/K1Y
M<'"5ZFX67$M5&.>R#%6>1V]97^@.P:1+U1E;T<<3%P=7^^/'LD%/PM->G;L<
MM3:KZIO/;S$>[A>6_DMAS;<-DEM((Y]:VH2<G;=*[UFE1X__/>M\L=V\EKK/
M*<]5<^I=]X@KXY9C222E#/<46QZ"M#Q998Q,%G,FE/A[YY;['#" -GLA_[-]
M.8PV1R_M8)"7^'_9[EE<#K_<WL'$+_?J<[[FP]9'<O3IW?>C3_N=W4]OQ8?#
M=[Q]&#ZW/QV)]M;^YUVZ<W[AESN!^QT>G[0//WS>/7G[#;Z7[M(/QQ_>'^$/
M[W?%A]?;M'WXXO.'K1T\[9?[<'(D]EX?D?;)V_,/6Z_@&8^^?SAYU?WP:1^>
MH?OYZ/"(Y';O?MJ_K@J3)D8X1CR*@0;$E8W(,F.0CM0K$9,E/N1T#NM,WOM
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MDP&2=2WG54.I>=G.FQ3J5I*!-%F8S&01N,)7)97 7+EJ9T:EY (,5DB!-/?
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M(HE.E:M#\GD5.RBNCI5BB\6Y.@I;/#I;3.D?:8AVS$J$+<WEG#4#MLC5G4T
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M+$7NQD4[,U(A>!6LC0P%$A+B4ACDHM6(2.H-S!8JF7PZ@L\KFW%Q':RTZZ"
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MNKQXJD=GB/F^64R-]>,,O<"P]5-#\$>->56-0W><=>V@4N%?.O%K/<@G!LL
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M:X%(HA%'3ZTQ9A5R_F5I 5)CCXYZ\:A8*7GK'9>CJ;GAY8:>104NR9&Q55[
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M+BMQ?T5Y7I,1[@,\M#7L#W[;:7>ZWYKAE26A6R0++V-<:J]<PHPK$W50N2)
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MC]QLU"Q@E@(SG"KOF*=:Q1A4HB;QAU2VKU#PSBC8>#?'R BV)#*I8=@Y1EP
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M$LOHD$V)(^X(_&9$0B(2)STC3)*BHH00Y:\H4=4EKM#ID73I"IV>!)UFM>O
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M)QC/]KOY0/6[5TNH<*S"L?+T>A$<6SJ=JW!L6><0<[4GHX3-QDLDG&.(6Z\
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M@OM<76?>/^DZ($WH$VQ2EV(X8N2SVR7PN]Y1'+&R4]LKD OFNEN#:2Y6<K'
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MU-O;?!?>L[NU^1V IA7_Y^/PX$LX=93+?;HM * N&EMU?G#R\;CQ_A\ N1T
MK>V+W;VOP_V](PY]X/6M/U/]9%O4-P^%LC@X(1 AV@*B6(RLQ!A%Q35E@A"A
MR&C[*!PE-K,?A.%<8F(%Y<9RZK +F!O-$A8,4Q'26BT"XI_F==<[ X'YN/UI
M[^/G=WN?/^XTWL_+RNQ"OX^ S,C;:"I_WL[K_4I,AV IU8E&3@+5E! '%\>8
M*W)&L_;<,C6W]8-,C> 5=N?NR(/E+8!Z[.6KUC;>Q=91[,3:IO_/67,<&ONA
M93O+&?/RC44.GJD!,I@W-7L]]UT1$=R<*BT%>-ZIG=M^K=D^'<7MQU"SN4(X
M7 8C!5=]B[5!%QX#_;J(M3[TRS8[&>]KO;-.#9X#'PX[L7>4*XO#V\Y:F?K4
M4J_;AH75A\W1?H,/1E7'[;=N,^1@N]'W0)AJD]FQ4[,S.+:#FNW%FC_K]:!1
MK6%1!,OGUD%C'%Q]>MKK?@<J-HCPY7\M0/L$\ @@"\P*K#G'UGA&F$R>DF0L
M(^)P)P\=H3-L3T\;97\*K)-LZE-+;GO<@5QUYM-H2.#.S<F 7'>PZIRU4>@6
M"SHWX)([FE<'SU_)(:<^,"P=HH%@('Y!(P-L#PDNC0S&X83)V@9;GX^:&>G-
MKMEJP5_KM;WCZ;6:U]?,JAJO\BPCM3Q/M6ZJP3H+,-7]3/)"[78% Z;,Q=[,
M8C-12ZMY)I6@7&BEI28)H%4XCX7T."^V>1,-G5YKDW7S:=+P#['G02;LT95*
M@>@K6Q>-D\^B<;%)=_<\JV_YB]W-0^9P5(Y)%$E.^0Q#C R)''GA0)B3(U+0
MM8WY2-/__O5-K6Y[7V.&K3>U?H3%,D9*&]J @B#J(QB<U.%;=!$X2J@FDKK,
M66%/=4I)4#85 <;!E([5(EC*(L"-\T.L5&) 8)#0F<>9Q) %9$?1.^NTI!X[
MMK8A;UH%Q8P#L$?;\\?%'R%^BZWN:1&#>M^YITD!U0*Y3T##M,6.JJ"9 5[)
M W'>5'._G+FO'QTZA3DW7 )S)PIQXC( Y.P0CE&NB;)16-@FYG>)__YUO39.
M>ID!__[4@M @@Y,V)*6X#];!JO/640V[EX2=ZN;)OJ(6/]';\HXTS2)(Q1EN
M7!I;7^FA,(EZF0C"+N7,9R$BBY5#/H3H9! P0RISAMORY(XYPTTDH=DI6&D8
M\8FV/>GV<NEY6#F9SOKQ0OK!C7!=KWMV=%S+JP&6WEG[K#7:8?P+687YW\ZX
M-WO=+?BX6HLWKT6 IT/+G2:@<Z# *:Q%JPQRU'ID PTZ1$N,RBF;U^<S\%U?
MB\<6EHB+$;0NT'./.@53A:45L@X&BZMUELV.<_I=9T)GXO?HSZY5%'Y3BZ#W
M=8<1=+S8:X_K/L$[.C$U!X7Z-M;;O(^M;-6.V7C:]5^1L_V8K83M_*3BMC?%
M,LQ-O_:PJX>,4U$=GPU"]_SRBWZ_ZYO%@\^;@^,:*$M9<)J#/DB&[1_7NF>#
MEAWV,R6'YW?B:/T7U\+S^EEQS)_<*''/)T1YX\[-'[>^DHZ;I&-W;Q,H6[+8
M&!8154HC+HE%6AJ,@G,T1.!.Q(4[:7?;DZ5\WNU]A>'V69_+JENQ.LYC;W8]
MW+H<)D(Q:SD@,JIL9H9-A%,F3,3<)1*MD9$$^[.#]YW&GPM ;*-@D[OI0W=D
M/NAOMYJ%3,5PN5[PJULOGR\.(_=:X0@+1%F;72PU,M0$) +5VN%$3;8&R/GE
M4I2"R%LT;+^P2MHPM<?]6NP$@(MZ)OVC]<3(FV)C+B K'_RMKZJ=\$<VT_JP
M^[^V%YKVM5E-*5[$:CJRD8[VFXF)]'(/&ED_'V(;O9J%*>OHDI05R@A3FL->
MEI/EF>24]LJP$!+W@&'AEAWNQ[4#'JRL//?A^),;./=VAEEWQ4I9 1N'B38B
M+CA!#G ,$84I[#&.,)W]QL5MFV#[Y^K*-:WC3;'BBH++(ROG8Y#&$=\K_EZ^
MEO,$R_?>6LZK6\0GVP*XW+!^L4-VMW8NZG\?)@J\306%6*("\1@=LKDL/-."
M:V6P$"PO:'K#-MW^D;HSWL.G:/]8 9K9I>==#Z9VG#'J,PG;PNF87[WMQ='R
M_/V\&0;'$[?,J;O&WB#XZA;K^MW6V>#V6Z:VMFRQB[UGVMER0K%KHS/U\[@W
M:<VI/8K(P3;V%=D$C7UK6^=9=_GM6I] X-'T ,[V_?8]_Q'.MN]P5OVX+A:?
M_#'H&*VXFWX )/U7[%W!=S</L\@G[Q@2@A#$N5%(&^Q18,DFS33&+,QZ2Y22
M(6:#7^JV6MWSO#V>YB)S 9X^;??KC:9]1 BG2>35>7J_YH:UP? TYATP;X]O
M%^/&A;?5%2H5GF@P BU[VH]O)[_\/O'6:G:*?A0W_=Z&1H+\CJ%,G,YYH14O
M''U])=GK>"3=X\".\9O'7Z\77\UXUHV^4WQ=*WKKUWB=W/K=CQY+\+J0\EZ/
M_?%WW/#'::R^ZV-?CL_?[4$^/XT0-'.7WN!T/=HOG\:Y6/_,:6^46+\P&]1'
M9H/M*[-!C9$WM\8O/_&8/VO\U.PPWI+&+0-4K[#GUD=,[_9$;E,Q [<YW/XH
M=*Q\:RC3B*7T]E;A6L4A(X\N7E4LY/WB+7[J6KF8P_U/UNIJ1^?\K//ECKQ9
MQ /S8><H/RM?FA6N[%G9[\?!3OO4-GO9@Z=L54WOJ8J-HG!._J;0EF']Y.,)
MO)\T+N#?WL?FP0FTYV+SH@[_=K?"<7TJ<F<2A=/8.OAZL+4S;+ROT\;69P;_
M2./]7VWH*ZMOU2_@'V_0[>'N7DCU&\H/RT0P-Q9Y$@7B)CIDK(HH8DR",L*[
M$+)=Y[:S[,>1C9<1GUBAVVM -\*,T\0+)RWCTB43$[8N4*L8"(CQ#RS.7*';
M$M%MMER-2,I)(BE*-$C$?2ZZ%YA'.B:G<[R,D!+032VKNOISH-L*$.47F.7L
M#N?IKR.1T@)(&A4F&4*%%833A+72CE&J)<=,!L(JGE@6)!W.\409(@[2)Q0)
MPX@+9I$3P!.=5(0Q!]MC3J_T8!RM\J"55WQ]X%)Y3&TPF"?GG;:,21D\EGF/
ME141*H_XSA(AK[WED5)$3.&/$CARR3&$B=,&)QL=QC?6#"^;_+XXME.^!K^4
M*Y=D;QWA,"LYG]SK#FQK<NA<65LK>\33E0*JMN''V88;\V6NF4\!>Z90I#*'
MLU*&C!4"25@%(OH<_.[6-L@-,8TOQQY165LK="M1?:0*W1X-W6:5#*XP;$N>
M($(L1CQ%BQQ7!'D:5!),$A%DKFWVDM&MM#1YQA>:T )CEVT$N<,SIF9E)M'>
M4AY?GB:6=BFLM(?*]DVQ*D5,RD.JIJTH>UA-CK!T#>A3A)'(D7H%/R 5#UB$
M!\R?%9B4K,UJC;<Q(HZ]00[G/WVRS&CI4E+  ^;SNI:M^N'259D*<LK4M^=4
M2RK(>1#DS*H>>1?P@G@D \E)!*P&R.$)4>6%"R&?5[JU#<Y+#SDK0"I?H#?'
MJ 3,3QEE=1;\:!2LF(%Y6TV%BPO@XNZ[.2HFI#;,*XI42!AQ[BVR5'N$1;#4
M4>F32FL;5?FZ%1;5QRF+48GJ0T5UEL(8S0@%,$5$Y227)$CDF"2(:2Z$X(YY
M0E^"J*X @WF!9K$/.7:]GZ$@9]2X%JE^+Q;S\+.W%PV:CWS(7ITW+8Z8\Z?I
MPDF,@=V TF=T=FHCR)+ D$DQ,LE<< ;(#7W)SOT+6Z JX7[V,^9*N.\CW+-T
M2#ML\I$QTBD')A+)D7%,H20I-8P[S#19V^#SF=]?CG"O %-Z@;:>G:G,>),4
M>)6AY\F(T*22SKMNVXV-;5,S,IUDJT+017S^]S;GZM/ZZ&!; VJDF;.(6\Z0
M(Y8A&H/C*BK'&<NYY!Z,H97YI[P"O'2R4PGPXPGP3(54$:)BRF%$@W"(FUQH
MP#J),#66J""ELSGI)J^,0I51Z":8V)RJ\A#B:2_FP@RP/!YB$5IMM'Q<NT^N
M1M7[%J>F96MJ5BJX7 @NM^?X#L,R):LLPB$0X#M>(6=L0LI(R[RD(BBWMK&"
M;D>5_#Z-:>=G\CN=2SPUO\> +F*O6\GUHG(]0X,8\R1X8A&Q.B"NC4!68X6,
MXSP))TAR> VD6%-"?R^]=*\ %7J!5I\BXB=711Z'_%0FG\?G0'.5E:>5PYD0
MK'Z%GDM!SYTY5N2D<([PA#P#39);+)&3Q*& ?90Z22<\71IZ5I:@\LKUTKC1
M@G)=R>]B\CO#?F0(05H34*#<(DZ#0TX+BAC3.%CBL$D>M)H'NS97-J#R-_BE
M7+G4U"UTG8J2L\LJ>TN5WZ ,!L8JO\$2M^*_YZ@T8<$XQA(RV ?$I>+("HQ1
M(DIXQ;PULDK?4L';*X:W*GW+2X*W&4TC\_^0)$4B>(HX3PEI#XJ'5(DJ(X4/
MGE7Y6ZK\+57^EG*K3:56E3*&YSJ)I[UN %SO9[$/5>J65Y)'@5I+4\ J%WCE
M(247&:9!!Z]Q(H2JQU5_JA.&)?"&_3FUR&)CE1,"!6,$XIA0I(F22$K&,65*
M*Q=?SOELE?2E JMQO8KH!6"4IXQR[H346#'AB<7>4^62J)29,H'2[+&)2=;9
M1%'((8&<!86T4P)1IF'Z)$F,F&4<FU3^(BOI+U*WO:]Q *U]4^O'5BL7_+:=
M4+.AW>PT08J+PM^5#\EMT(FUL80&FW#@' =M:'#&Y-I;P4:A2&7F+@UT^CD^
M]__9>].FMI)L;?2O[.">\]ZJ"">5\V"?(((RM@]U6Z++QN47?W'D:(2%1&LP
MQK_^KMQ; B&!#4: @.SH< '2SIW3\ZPAUUH9):P3HPR!KDX0)R(BG;Q'42L5
ML+<F,K^$.-H2*[*Z^-58$\F4Q]$1[H)S7(5(- \T,1/<+:L^Q4Y;#J[G5"(P
MQEP"G199SA3BPEIDB6(H)"R"X#@FS1Y.)-B#TXM6K\,/Y9M/P2_:E"#\K=/S
M_</X^Q^3S/1G52^.2KK6I6(J@4ZI6?0J"DZL,=$PYRQ7Q&!B92IJYLJ(HR\+
M:F; Q,.^]0CK+(Z88,A)&E"D8++#_ZG2(E\]KE?>1"\)6[]^(!"T=BRQ8"+F
MFEK-I$I&I!2%Q0H7']M*(7A.H32)1,>40M$JBKC3$5E!0+^,+*I<_%UX# C6
M<N41_ ATGA\HW(\WA/9\0$"ST@LQ 4\S FV94_-HQ$T)OWTHXN9@L9Z1Y0:;
MX WR*N0[R)5 S@J'C XA:)PP56HIX;=+A,X]>S0+<1;B+(&]3XXXY\_"M:71
M6(>$I YQG3PRE#F$58C,<V^E%TL)[%U9XEQ1_?Z/D85I@?^&SM>-Z>2WQX<
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M1YH8AXC 4D3)?,CJ*Z'+*B1RG[QX0>+?3-[3Y THL\]SHL]3TB03JOE3IQ?
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MB*/QW@A&V-H&U;J \_&"<UFWLQ1PW@R<"T5B0K""\(BPU1'QZ"FRDF D4U
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MAR_[AZ[3J_GW;"U>SM+R5%TY*4K)-9225F-)G$]$2X+1"*:^YPXCSCE#1JF
ML+:&8Z(-E7)MHR2)/F+X8D>$!MPFZS6/5&FIG#>2Z40LIO[*KO9?@F^Q-98#
MZY/SL*8X66&%0]P HGED 5E/*+(Y5,IRX1@I!]U/ =R:*BII(%QRQTDDVM-H
MN3-)DNR0O_(UVP7<]P?N]IS,ILK%8(A$V @*,ML)Y(01* "1X\2!RHNC_DF
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M@]9!&]K?QNTWP!5OMH^A'?;QS39K'?[UI7T(_?W^-NWL[M'VWY\8QT$+2E#
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M5-;.\QGEL&D,)C_+D/R^4=;3XM%H*OGR?W(70#\=P/N<'79 V[J"GIX7^OQ
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M]U^!Y_PYL@ $&B\DDHIESYJ48+M[APB&)4Z.^I +O%#V"(/Q"SA/$X*)=0D
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M%Y[]!='@K0D#K G70F.!HO(*]):#!@LO4:#8R9@4$4(5#7X%&HQ9LL*E0%T
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M]V^I/MW)6FJ&74[0> T_>,(*N=R_3TG)9?+.D=Q>:$X;%+,JS!.?QB[ ]SJ
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M+N;54;/L#2^@#C^$^U!T^(%T>,*#\,00SJ)& 4<(:"QAR"F>$)/$:&R\HH&
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M'9@$CW2(F8_31ZM,$LS;K/L*_T[WQ>QYHWQ *B1#M::$6^6LQH%[&BG<6_B
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M/]UD6^N?\HD@#FZ2TC0'2A: .WB9>7X)4HIY6!Z#B=>W."1V=DQT?$8L1T0
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M?-598- :C.%T5'O?[8[J_=W)G'$A9Q$N8\+GV(W'MOT1KMT+!1QN!H?C7:S
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MF":6(FN"15Q;"::SQXA;'G 0D5ACJZ-9];A$K$6#"]"692K+M!+[H8LT!$L
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MT(FBFSL*ZJ5\%JG\E06ZMPT6Z*?O];W]\\;Y-MG=_J*2"$H(CXS3$LQ0+Q$
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M[2AR.&"DE$V4")IT/I.;NUM=4?PEWO8?EO&PF/+WHMCC1W,6>V()X\C$W,<
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M+:?)H=D_;MFS_#3QUP!91J[FR"( :SZR",":CRP"L.8CBP"L^<@B &L^L@C
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M)5^'J,A/6E+K5KFF_DJN:0M49,;CM)LIL<M)_,(FZ.EL (]EY5V">^KVVG8
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M6W-[3L[EA_;]H$ZE*A2ZD F,B%AEU5%EFT2 ,PQKR[F/1*MQ1I7G8\J\G-]
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MGW)O\&%YZ"&=CST@G(-H/K\%(8B7I=(5@A"U@($ZI0"!P<EH6"EP@.>Y9M0
ME_)/3!&=5NH351GED@!(@96QVV75:_*]#_P6TR@\S?=6('U%X#=D3=\;/0U!
M?P!.,@=>(!S-K6+ NS!V@!1_DZZ3JT-A*"_Y_4Q9MQSU$,-4#]M3IOFR)/Y"
M3%.=Z4LRSI*.TH*.L&H\750V7@/A((A%>E_Y/(7UC5XR?,"/,%T$32WJMC6G
MKL>W)LG4Y:%FU*LIJ)6L=6N5?)?_FTX2,+@$PS4.?S%>OQ(?O7JS* E&#J^P
M5*/7Z;UVWKRVWAC(6JMQL\>R6<J+\1CV8XD"9S:]<G$6R%V\[!Z/XRC&2 @3
M("3CXB+6\T"L'CT4?5USR%'6VEDA<I\>S:8T$Z@1]G\XQC9>J&QMRYG 15G@
MA8"4(O'MT,TX.8;G-+./QT+S6C;@TQ5H7^='I?(E!Y;E*JLC]M1K5ZXR&)*N
M*[XK>'$X;Z5'5#V6L]G/L[ RB#W5,UO#_F 1K@Q^7,>5$;&9HQG@G[24\5CM
MV3P%\$4OS5+];SG:3Z5<L=SS.C$&Z3PH(&5;"V<II<V' ?=WG5W>[\/[<'IT
M>OZN!5;4^Q/1TN?RP\79Q<?3BW,"%3X\^GAZ!-^\/_UX^NX0/][JS=C"C#)B
M=<9AEL5)Q*<I!H/)9?U>%D8U8E_7ZF(DPQ$49% ],0B@RF,2G[[H6#,IRP=5
M;823%+%TLI&*C;F6&P/LX3=VQX* 7HIK../? C>N56WA3T.&C4!J'7I^%!V+
M),1'X]BRH,>-5N"7,2 ID>5>*_@85[8L$(IQ9Q&2:ED#/Q\$4C):T@B>()!/
MRP@H0X7:!T0"/D.]/\,NC)7.".M$KKV!V_&<@>WV[([=9?9P9'88P_0%F.G0
M%ZU;S8Z &,,_K.%C(M=71+$Z=KT<5N/+I][Y7X?6Q<>OYMG'/\V+P\].I^_Z
M [/7[MB#3MMV1UY[-.BZ;>;:?.!RU[-Z_-7/PZX]%\<6.44RF-T2>7?K$(7E
M6%U0*D;]?K=C#[DULLRATQN9=J_? 7N8::)X(53RCRZ\X_!SSQ\X7>:,VJ;#
M@1*&/;,]'/7]=L<S>YQUNGZOX[SZV3;G,QIJE("2(@F<7&9F 5<YF.$R"PJR
MZY'@A%?2]X+L0/I(QLBRD(9\@OPN.D<!AQ6MB? _ C9<INU1LZ#@)A;MSV2_
MH1(INYS0;%,MGF)N7Y#>B/R)A&/+.XZZ[AWU.9-E*]5$KSF&79&(DFEC-+_2
MQJ50?.E1U8)71*<F2&CO"_!O3"KS<M$R"964.UB^TJ1!U$Y3:AN(,R5W$;']
MBS].C]OF".$_/#X.7+"/Z >%U@U+JKV^XI3JZGJ6YZAGZ3:\GN7!^I29>I;^
M8.AY'=X?.MRUG=[0Z0X=9V"-7-_QF#VR&]K-!>RNXT]''\'2.OSE%,RM/W?%
MYGK0-@AJ^?RJCG>^(Z6"@C@P+LF9$OB^T@)3D;0K3/Z:O2^:6@E3'SFL>KSH
MB)[6G#\3GJ2R1IL@E B="(@K!D9%N6S 2VN<$KM7P><8G0Q$7P%545_VQ2/K
MAXH)&":6YY&LPA"^C++26Z TTIKWJS;Y$(_7G_YO(^:^DB%[D:7Y5T;Z@!NW
MZZ;K K(MNA)5,\.;95C.GL%&<$.JUUI<2;U+\_X@:L9'V8MC:FD870.O$TZ3
M\20/4_1L7K.Q4R )"0X8T)=<M!2.0V1=<>*I'KZ)1!(A%8R:]"XUF!1GF\5H
M[@]!2-N6QT'/=T R@[PVNWTV'#I#?]BS"7ER+O>[\U W)]&%](B8Y8(.3DN-
MI;UKX?3QVKSX^.?G/O.[ENL-VL-N!XPE:S!L,U"=VI8WZ(P<V^>>!PJ0U>IU
M.O,)X$*$%H@:I-0+C$"9)DMX,A*9M$0T$3^C'C"R:2S\^(A%S)-]#_Z9>P$U
M;KTDT#^@IK,\S(("E;#LVU8OF2/@Q>JKU0S)2\>%J3')$U"Z2W_0?0'3\YBJ
M=:):A.A7JGECLYXJQ-R?8?@*[A>85$R(R:DHI"E[3:/U2'_-&&H@%7"27G4P
M?':=,+K$U$'[EMI*:9:W@.4ISH;B5.' B<@AV=>%C3B4<*"2%,Z.W^.(.^SD
M /]5JI^@:T'+U7;S9;N.PG.L(NH?8PH.M6;PFU^&25::WB% [\,L\EA5AFE>
MN9A7?OUV_O'P<W\XL 8#UVUW^MZH;0_\?GMH6F:;C:Q!UQ_Y[M VD5<.EO+*
M%I&F='*L2!H"MSGV)X6R\P)$(NCBPB\U+$TC#]((V..?>_;(L=S.L&V-K%[;
MMGVGS;C5:?<<Q^[9W!\RWGGU<[<U6D0CY1&W*NI54;=I."P5B).B.7DPJ6$&
M+! 56'!:]BFGI(FI<%96!BLC0TA,I>2=EM*Q982BB3:P\G4Y&'<[7>8,/=?D
M ]MS!T/7Y0._VW5<?]AAYNAYU#S=J+.@RK_./YY\=KVA,QKY?MOO=#AR+JOM
MN-QN>\.1;9LCU^YV_%<_^V *+%/RA->ZJK )J8@45E?V7E<S:$ LUGHPOE'6
M VI_Z]*2!S/MCRRKR]RN[3G^L-OK."/>Z_B^X_>[@P<9G::F[Z4F\^S+U\^^
MV_?9J.NW!_TN:]O<9.U1KV.WS5ZWUV4<V[ZP5S]CPU$>+:.G.<W?>/WBY+":
M<@1_I^DA3>E^JM@K6IB-P)[=?>[V;=[M I.QW&&W;8^\3GMH#T9MK^<,NR -
MN[T!,AG@$@N( C=9I6RT7IXSK$8*I_#);>#E+#PEAZ_X3E/%4JHX/_S,O:'O
M]H J>J 7M>V^#53!7-;V71OT@HX]<!DHS>EB7A$4&ZY<[,*: S%RD1? *EJ.
M;!>5P+RLLR\G3R%'L"'4(^SJQU% 9SUN<4A9HYH[+.<.__K<-RU[8#K]=F_8
M]]HVX[P]&CE !Y;=ZPWLWM RG5<_9W?Q_/E3=H5(S'TMX8)*$8)ZQ;]R[G!7
M^..PN4 08\\ A/ZO#R5+*XKOA+4E"T:H\LJC7I<*JP=L)BPMR:A30IH[V#>3
M  \,!-H!2@ NI>!]ZL!!\O7RO76DUMT Z5\SA/?+%(P!M@41O,/Q%#Y$1#@!
M&S@/.B>*2=\'!*:U.P$^>4('&_7C$CI>9;=$\+O:H00^=/@-"WT\C:K[1$#0
M"%\M5\K#I!(O+-V\TD'L3(UT$N=IF=@K F$.C[B/X8A$]F"K(H<G63V.@-&+
M,?L2)R4L6Y%J4'IT*BG)I88#$[J)51QS-K,@A5L@ #(IF\;(T^:!O0N2V6BR
M,:+7@;!.X-&8,>8F' C'A?W'7LUT4^D TWC,"X<LGCZY8V52QUT21]=^CCEI
M++N9/]*%T:L9K!K*63>. WX=4Z)'1*$%ZD1#Q4LQ-GNDBU_BP E3N(@H7.4$
MVY.4CP2-PS@$;0-3SU6%U#^/CB[K<*,%B([,1RQ8T4SC30QQI?EXC)RL:%-6
M.!B53V>"\:E)T;]RQ5]3GKV3(H 3[IA*M,=(M+C(_!8S'UU>"[Q@'R18CI31
MJ@TG83!6^FL6#3U-4;ZCUFO6>QF)<Q/.3"'%X=L\+)(MI5-55H#"U[-%U1+,
M5/#Y.5I://%:FA'6FI-0J.('"3+PD!@Q-W)!]Z)BBQ$-4$Q2]B%5N9[4(T0(
MIE+VX'I9MN"WF'ZIMB\NR_5DM1Y0]E<%H(1S*_)71?^Z9>^J+!3;*E 2%9/=
M[.3.B!TYI'A;<696J_)368]%5>TI#P5_A!T9!QE.MCBA5'BL18O70! -_R8P
M>55W-A;<BEZT;IS.BH5ZG&70^T&I99/9K#":M/&ZC/ MD!L(=TMBXL=2,%1'
MO"E)2)&4PA.8V\9*EX_*:DFQC:1_GTO@T30.FX9RU@!^3]2)H%W_@;-PV0R^
MEFE3+QPF,$!A%PO KFL!"0)ZG,.Q+M1!>8HQ#A#&'/3-+$^X!/.:5C,72AVN
MO!9$G)+U-%6/V^PA!0+13V'Q(B+@#4L4Q''E_/;*!KJ(KL/I7]M@!*FLENI-
MVR%39_8@-I_+2# N!0!S*8XJ+0WK6FI+8)Q+%0>8'4(/9D7LM[!E7.PR'M^R
MU,VQ5QZ)MX"JRS%8)TP/4KADTJ"HF0S0WFA@T7DS#DZH.-6J%R7WZR:"4JDI
M5>C/:E+1?>K*X]-"..^/1J8W,&W;M7V_-QI:CFV9#O-M9@U=]P&4W8="\/,9
M(OOKS_YR^NW\KY//7=>VNZQKMWF?]=IVU[?:(\_%$C2'L:').[VA\^IGJ[>@
MW_L2-P#=2\(T4.F-BL62'IK[/N47%K;*7$ZB; FP1D(E62=< +$7D7TR>87H
M!A$0I?#:1*&]DMVP0B[E"64_UE,I?P?+)W>_3JF= P@Z<HN")3GC0EERHZ31
M(DLVB</5 LN/MK31>*>NH4'JQO?8VM5&V[/6H/(.?8D#LNZ0(WNEX9OP:^3%
M"J$7\WEX81$IVQ?3M;\)#]8"&QI!DK&XY:*&IFNW*A,J)U+8@*7$KK^M^K+)
MG(U&499E<Z U@SRY1H8E ?;G'[%@4?-S6;K,M]4>WKUJJUW<=+%$K)*\"U+^
MG6NM+$HN!IW["2YNZ:KH%(29V^U49[?@!.;\)FBM%S/%G^6@,,/5EJZ,6:!C
M<ZCN0Z6RJ)9/49!V1<B(4J1'VD*MIMJ@35 !'C9"I2%9AHE*!;G9UF,CMO>Q
MYJ,N]WV2<E^[X>6^#Y;OSI3[NH[IFJ"7#0>>;;.N.>JXOL\<FW<'\)BAU]!R
MWZN3HT\?3C^>[@ZVTOT18I W5]P%\Y2P6R@)SQ!9>$V:_)(^>0&J>+-Z^%U<
M9! 8DSPCCE%+12A1[638HZBLFM>M[ZU0FBE,64$YOXKS^<?@;OP9)U^K0'BM
MFNYP=(-5TB??X*!H-1<^*/ 8W'B'7H8H"F J\(H@7O2S7T$QC\@JD3\S),1=
M!F?1@D$LP5#7X8'Q"X9?8C^KH4+)@#Q]A!!"U&U53B252DZE/5-=,<*HR"TP
M8$K,*%4LU1M)9#N+W@UU)#[/ (TKE&BBB,51TB@&I6E#JTN5%=^@0]7Z/!&V
MQ0UWOY[!)^V.U0="@!=B<ZT">P-F=RW#361NU%IFC*JP2$JSK+YX+A(D(DZP
MBOA.V9*ERRGD&'S)1 <[PJX&S=3C7KE^FH**'I43J#RCQ+U>^-OJ]%7'C36F
M+X**LT^>"0V)TZN&:ZK!MR5-.X+JNA"!JE#E3;.JRE^)GH!'0>)23S\@6J!
M;R:<.!.KD@;L_)9LC'6;(Y!__C.R;@6366'?I7_A^^'GGG#^2]S=&+V+I#&U
M2<VWZ&D'TN.>>3S[AE#ZW08-@(7"LB8BE8!2I%>5$Q)/*18R9J6RWR5XL%4
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M32]+!..:4Y3ZXMU#OV1J*!&^^/K.Y$-1M@(F1%'[,R4NX3.!AI_.PGO.X)7
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M8$(]YJ73]21/^%>&@82$30C3H,C]A?F'"@2PT*LN:RZ46IE>);6H"A=?=1T
M6XB7//BX%AD1JE\-<Z+2WL@I"T.5*L56:DA<JE>$SX!]D\ARD8V)*T!TK6II
M;FN!;L;*),T;.$TLYL6,55@JM5N;B 905/QNR ZIU;ZH;&J46XFM3W.!^B'@
M5@E[ M:,;:4R8VG;7@&D.=.YMV-[ULCAO0'87G;'8D[7[ILN=H#L^+QG]:AS
MK]6Q.V:U<^_I^:^J=:\SGO[T04SC'9B/J-3R%)E[0/AZZ24R^2@K^O2VK?UM
MU&N??3GY=O&OSR:WNOZ066UOZ%MM>^#9[:'E#]MFSW%=WG=\Q[%>_6P>].8:
M]?Y 2?1Q$GIW"#+2T&K10X>[XPWKN<6ECN]$VG/E I7:PAQ#J#5& RV)OI#H
MRDLPE7?=&W&O''QW\<?)A_.SD_./QNGY'R=7JC/ U2XL>3%MO<<*<F&OSZ#[
MN.3THA"F0F-3;%^V/JE%/V> <6%]0(LB2_TZ#V4RSM10VG-+YA80L'2,[V-Y
M=A/+EC]5'WL) ^=BH;L*M4HG!*9F3CAV,,)"51(G/,W#K"4DL'#AR08Z^-\6
M]9$NYUF RE"?;[PTLC^VG#9FV081-CD*N *]PQZ'0<T?+W)SLQL$8N78N 7]
M]6&!Y4W.S,+>0 ]EAM.8Q&D:.*%L"^ FP9CP&="M2*G^N+\9$\W+?3BY5#F,
MW> 6X8!Y).#)$7 J#SVY<K'F<CWHH*\MICK]';[,)^=_G'ZXH-M\^!XC14<G
M)\>GY^]V^#(#_2/N%Q(T*7D"6%[<7VJ4+N!."+U%)"KPZ#9(8D7W%1JM7#L!
M_Z$Z?*:J<3U1KA ^ZA+1E6X5&)74$"A.8(8"YJQJ]AZ=?#AZ?R@ZA!7:)):J
M"!#O@D8) HV('OM1>H'X"+4^-E: R(+N"X_]!!7'(/+R5':[1WT[P&YHI):7
M$;@\2>3]D(V3TH J^Q(<>8?)*]3E/DX)- 7W$_='M"@ ]3@(!;.2_,<3N-%!
MXJD<#9VB_!PIRL.&IR@W/N5X,;L4%U*&6AZ!%KDM//+?,ZXON6[)Y(@?E:K%
MNMPNJ#D(!<_#YV33">I4"*(%:Q]3 ?$DICY_I&DAWRNZD001LB-9P$T]_["(
M1\4B22<ZJ;'MRP)ETC@$(QS+J&*I+?&$6K$(74LP.F+'C,8IUIIFP)0Y"0\8
M+C@9,%".J5_((0G/,D15I,;#"7L>L7B+5<ERP[))<R!5//P'_S8199LXIIUB
M\#2ZAN=A!2-,6> 1D\21?I%BATB8E<<@V6M+>DM*+ZWK)CFF4@3,4<SY[H:3
M+CDE!148N,-4;67A!%&G E^(MGCE<DC-O<&?@ECR<_2(U)>8<BDU!'+@WY<Z
M+/+4F_%6=/V>/QB,;-?J,-OS^LSVV6 TZONL8W=[ ^6MZ'9KWHIV7SDK\K1]
MS=CDIT-:MO>^7/61D&R'D7<>1U+,O3($5<&+OV4_1?FX[<596SZW<&CT]\V?
M<7S:.?MX^IESUQMT^D[;ZPRL-AS$J#T<,+?=MRW/]SDWAU;_U<_#T9P/ YM)
MAK)9)R5?_^-O9K_SMELX) 4S*7"(1"OR-!\3,"5'+**"(\0)#N<$:%W_SG!9
M5*571^3_M*H_%F5I6/8Z%JJ<I/0Q\@$9F 7KB$771,QI#M,2I/P:KQX"&&3L
M:X'O!Y=)_#":5EA5(M*J\&811Y*6H[B0;T16MGRCX!-<+'@1@\ G5^#"BQF'
M5*0BR_3@%Y5&K85N6X9\*/70^"7)H_0N<+\:'^.[*+T))L9OP/2-*_<FCD/C
M@](=X:"NX+IJS>PY-+/1<LT,IRL8"[<'YL@>6,-^U^YXWLCJ=?H^^F<[]@!N
MV^?A\-6FU+DFJF6G&1\+EF(=&&>'YX?O3M"BE4;,E7%\>G7TZ>KJ].+<.#P_
MAO\_?/_GU>F5<?&K\>OI^>'YT2D8OT<7P.<^JC$?3JX^O?](0RXN3SXL\7!M
MEU9WQB(F4$<+\PY91)ZFJ@P%!H33-$A%[RU49^A/8;P57AI$R(Q<H91%$I0"
M/34JK9%2^ DCN^CB1& .-^2 <0BW4S6:%C@-U4[3-7S0\E5%4]]4ZB4"6#R*
M,W)U$1OU#!ZF7$@'\H[!K/Z5 ]_E";###V3JH_+X*PAYP^RT_T5.N.B&$>+Q
MC=1=T9WDR4*V.$\6;T1KX2Z0_X^E-X8?QG<+_$;WT\MJ=W]DOFH&D2WQ*/W?
MDZ-/'T__.#&N/IV='7[X<W>MI%^2(,WBL'V&P+C&U7_SP'%4&J1P)5V'(*Y#
MQ-9>Z#>>8AOK%/41<06#5+4_CZG-7[7IE<Q> +J.XEL!U$M=N\CE2;[1&QY.
M$&(XH$N">@#V0\,G47HY6F/P:"ZZH5SD&'Z$>Q-,Z'*A<^9Z*F<@&FEQV58M
MA4M D$^D_DH:GP@]6@0B%WO%I^6=!D-2IDS[,? ;8<")=2@ +HZ[!!;:C?)*
M3<4DQ0^(I2S?QH >J3:.+":Y=](WIK:/+#*J_E'6([8Z+_:1X,'5#J+W"CM)
MSNP=5>RBFBG5T#OL&!T&_%:ZJ.^X &;&CIL3Y#AHW4P%&#IVL8'7,0SE(D2L
M%X#>G"!2YD^P *1;.(/7#O730QYH9/DXELWY;CA,F$:\ 7MP/,XC^D<+#B/Q
M MA+X.38$@?'1CQ/Z-OBH%70 *TT.F%1 "ZJ1B*X#P+1F*#0_2GQ/9R[#[/
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M420.TW&30.A47I)?U]O9@0ET@W17]KZ5OT7-2/P%NT48B3-=/5HP)9@3M;7
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M30!ZI"8 /5(3@!ZI"4"/U 2@1VH"T",U >B1F@#T2$T >J0F #U2$X >J0E
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M-0'L^4A- 'L^4A/ GH_4!+#G(S4![/E(30![/E(3P)Z/U 2PYR,U >SY2$T
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M%,HH :LV"*=Y@YJ44[F,@S(83L"P9TD83(3%1L*'16P&BR9#8(\D%&$$GZ;
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M)QWMJ&5H=9K]RGPO.Y*ZS765?86DES[=ZZQ]N%?Y5UM\Y3[X5U]IQM6!].W
M$V_>"E5.@J6##XM%;K$IWUDWR%5B8WXW4730;[16%\$E1D_E:^WLE4_D:RF&
M;-5;W9(KD"MJ$SI7AKA>\I,N'VS#>SM!@JZ:V7B5^/AD "JW"#FRCGJ/RXQ\
M AAM1Q9PQ2U[SRV'5K?SP'C!SG#+CD<;-A2TJT(.&[<>WU)KA9\WT77BWDK>
MEC+W%6G._WN>;V3SWV]K#!'\@.8I+_Q"!_S-LC=2,^FP$]3*!PS;W6*.5ES4
MU&=Q Q)39/C-%!E>YHH,JT%X)1J$M[ <M#A&\76[K]/QO&SB^!WS%+-VYWI.
M)+7Z\B9<AM3OKW1]G\_]4 RDO='^4V??62A&V)*.NM1AA\UK<*'A42** QSI
M?/"ZW>PRC8(W>N9<<^$(3>NN4:VP\E""!3?FH2G,"(,I5WWZ-,;*A9\S5X)4
MW6Q_,#TV$4>?W,1C0$:SWTB1L5RV/TI$;:_\SQ4 7>8*@(X7%P!5^J \^F"E
MTBVF3X2BM#.E4A3-7O=1BD)+*!M%DVH_-I+79@OI,W,CIQ9UP]PK0ZM0,G"Z
MH&2@XJWR\-:R^@Y#VCEN>FT*PA_(2=C#-E&&'>P_0 9&)-'35)\-U>@8UTS\
M&ZG;,N?;CYK^KKH';;8 FB*'K<P248/(*!<W;^8A%X\$7-O)%.5BPR26GGYZ
MA.W ]XJ!%Z<R[RK7K@F<DO)Q 6>:SB,];9/FU(>!QY))#?[K4Q]P'/<$/R!7
MI 8]<,)4<1.P-ES@XYP>8'1J!TPA Q5,4,UQJ&T]  W$1-9W.&V=C1,A71<6
M2,!EP-[\ K^ED)X>#\HC/3DT>K=*4]#V]C<%[=0/^RNWF5QYV6:CWNWU'K3L
MRW?:I,VNW!9T>T*A]S<^7'HJ<%0UFWPNF&\TL:UJ-EDUF]Q\L\FMDY<[4>1Q
M&O)1X ]Q@(TQKIZOD]BJ*1(;A<@F.ZEM],6;_6YI^JBE@-A ,E!%R%M.R#1S
MK?5^JXAY![3?%M9JG'LX0,F.LH"#"A,(-A0;Z+&V6?'??='64 ^3\!NOUMA"
MP?;L:-H!V;6%EKNJ,UL83GWY>NR-0N+P)=,ZG\4RW7$$K=O3X]D1M ,2ZPZI
MWFR77'2M)+3N>_,[L^Z7F_$[[<@])6C*+5(>W,GI*6"S82NWXHR*,YY.V9:6
M+TJJI$TM23FR/-A6YNW,%'YD]D!6^'%<["RUJTD]VYB*MWICL)E:B*/>.GEY
M)AN/N8$_$CB<&UY_$HIK&221.\T&>'N4=HL)_&X2R6N< Z\3]W"F=[G2\;_!
MHNXTBC>'TU<_+\\1W+L1VIW&\A':>S(,>TW9K=L;G>OV1F>FO=$74>5-EU%8
MW]&.BJF")UU^4.\HX3QX6-*T !U V9370F<Z6_G4S6ONPG4ZJQ*3G@/:EXR%
M!UI"1G82D980;G#S0CG,53IFE8ZY<6^B2L>LTC&K=,PJ';-*QZP.=3$A!:D%
M#"A3U;;Y7,RM;%>U]=VHVJT'GIEN2ZNIBI#WA)"[CVNJ]M*$O -J;POS,"_2
M'BH8&LA*-5748L_:9A]T^OV=Z,F\H^AI]\J$GAT06%MHIY_-1CN9&T21B-X>
MC+CTHSGZ>/X$OPUW^N]4HU;*C:*#7J/YTL-62B",*CMK-KPP"M7!O5C28'['
MU7>SL6Z58V5AO32*.NNVK:^LK)VTLDZR\V,[ (_0$4IV[9EU]< A#I5M]6*V
M5;?9J&RK/;>M/@78H]UGCAA@FT!'>),'RZKMU=VMM9M(5.;52Z/HL#*O*O,*
M<Y'#X%I&Z MBGC0>.X>)'2?8V7S/+*Q6-2FXY!CJ/+ W426S=LS*DK$<J0!6
MED4<B3AV!24=[YFY== NTUE496G-8.>P1,C9 7FUA3;650@WRSEY%5YC6_BA
MV$2OELVR1)D.H2HC:Q8YW1)A9P<$UA8:6.=92L-^9E^M$\JM+*J7QLY1B9"S
M=0*J?!O>EBOWP50]E2CY99R$@E$6V[Z9IJUF99R6%SV/ZNI<*8$2;WA;KJP
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MPR>/\A"7=RNM)-GC)=E]C18R63;D,M1M9KF#T"7D$=9R36ES)!8*[E #6Y"
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MV6D?P<A)*GQ3QG[:,A1D-7"/'$@7X87;6N8:J$KE7)6E*NKTN;Y0RPU598=
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MR?D;2 Q87X^+YJUJ]'<FICL3X$+X8_P:B,KGJD4>*%%0+=,H#2RA'@_"M&&
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M5\'-2EZ35S'+A44R0"31G?!'FPQXHQR4D_1#+-X4W H7^L)6E4MHFR,1P#4
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M+*8WL4$2*^D<>.(&KXV2R 9G5.K6L-RY!I/:')*2*LQ);UN&=N*A[+%U)H(
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M<1\Z)=-BATVK?]C#K])4!(1!>A)!^?P8*K)T\W!5 H9=HVP%I->49&;!?WN
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MWZ5>6?UZ^["S)9V7#H_J_=9J&WIXYZ7%$[XWV7M)4ZYN1134ER:OO&A'C@T
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MN#=Y#P;ZV$,-'4[*!L>OL?BS=%KCV!L)7_%KR<!U);"N,Y3_*1G$?@$^!>\
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MC*0BW8++A+"%#SL:E[(B%MXT-EF.%JI,P"9AMJC,A%R3U9)4W;*%]/N[[71
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M(ZJ&L.HB&5Y\-I+!B(/%;C8B!7@L:*C9Q>P?7SR.S6HG%SPPG#(/?4G&2D0
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M?8\]WQ]BSPZM8 R(+0=>'P;I!Z55>C@+OK8OC4)7QSZEN5)M,[Y:S$=CC+3
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M[+"P<24HO.*@#!(N,AXQ?J,LG:D %T'??$9^L6/,AWX9_VBC!:4>:>HP__@
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M@.BY7DL8GD18;QR>V**9S^HC_#9]CPFEC]G[53*KA&;<P.)$^!!:;]P!$R\
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M&>\0X,#E'763QE?5D#,5JZ(JYV($-3=;6MZ" +.RK_H'O4XTPJQ15+S)15+
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MO$0RP"XS'60D<7!DF)6UR5!8TVDN]D;D#:JU]JY UEQO_2!U9S'1R&B7I#3
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MS!J)2);/1-UKU-=-:@8URZDC4K;61//]9XW.][.WX^7XPTH\)Q>=448.28
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M&JVD7A'EPR@=0EIBA^#JJLB&<+N!^YN4&9L41@\LY\*9-L(S'[2M ]-2X-9
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M"/!NN-@PREM_7G]$6.#?_O1_ 5!+ P04    " #T59U4YGHJ_D]Z  #:,P4
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MJ(V4AG)63@EDYAA80[/=5#K@,90?6C[Q??J<QA=I-G!>6NVYQSEY? ULQM<
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M!64UGA]V66W2&D3,W4>U-"<ZX&J:/;P.V6$R@6NP]Z!"]!#]7E:9)3X/*E'
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M*_TEDJ?)_@Y2;GI5\'H(_KK?$:.<*L,0BJ0E+<@3ZQ4EB#270L*9LE9-BU?
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MZ+RU_';]H\XR^;__ZW\ 4$L#!!0    ( /15G51XS]2CBBD! *M$#  4
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M16G"B79=21IQB 2-(4V8@#%C*B$!EU$D732DM\6YZ<@.,-"S!K-_5>^VF%4
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M;'];%=+LKNAIY@_UT?L??[JE^<KG#FY_9UVV1>N'^XGV8-]^,+NL; ,."*_
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MUZH"$6<R0MH+8$CK@YZ%XRRE$/.4IG&883TIL%UI[6YJ;A*Q0UOM9-;!V3O
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MZ5>OS'*>#INR+!UW#SVZMKK='_:6$6<R3AF4 D4047/*GN$0IE1%*<]H)N+
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MH]/&H5I2<!2;:GO?!?DTJV!U*5I-[=+%H#!)5*RG6#&/*$0$*RTJ:0QY0+)
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M+FW/=$&IBF8T<WS]P#NS#/M0K&\+>N^F8%;DVVF7-RZG4:T=7%#AO:JWN:[
M#O,5,*A!#=N?7+F0Y%6HK!J>5*)<J'@I3D[W#CR908M5OKHM;V11O6J'H3RD
M049YS"%3FF?$I( D0C$, IDE-)6",Z=CUF=;FIOSM ,*-%)0074\$W&64CN%
M\4+4R+)RS)%V?\9P?'K)\'O$X&QKTQX9Z#/ZZ A [PU#"TI7RS>4FQG=.[JA
MN_(%2I D24W5JQ!)[:B8*O0X49!SC@@G%(5VQ[#Z&IJ=-M3UE%M@@4';6^3
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M6%CA.1Y]= 6P]L$&DP \4^!!**"= @>< 1L((K!_UFP!!<[F]8,+W&^^/M#
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MATY\W3Z(%(@0F*: H2P%D!$(L*G^("E,95J0# GK%&]'V4N;TGOUHYW^46-
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M[3>ZCI[?Y$,AYT? CCZNQG7RM<?4D#K3S2!D0:GFO*19:6;0V&.*&;XX;,K
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M-;:_Y^G]#-^@PBZ$\;\VU=_?K9NB"5U%9],UI_HAZ[L,<I%FL@"0FYK_D&)
M4XE!FM%$%C3A%#I5F;&0N;0OAM'4]-)^:'5U#>P;Q]C.Y0^,W,3LO]?V)MKA
MUVF\+PN_TSIDH)TU1($CZ<;ESAPJ9PW$:2R<_:W>30Q-O2S]MFWO,&$B9[D
M!2:I\4PA(##) 98JA:F$*656F;)GGKTT&MGIY=QF;P_6N+MX!003\\&A,NFU
M*#BW%_1!8R8/S1H5GXY_QW:/]_C;WS%W5[]C5<_T\3NYY)I(VW7;TZ(?@]9D
M3!_RQS%-*:1)!HK8;+/J!31@!.= (A*+ LM",*MS($>Y2R.M0Q2D62IT^>8V
M\9!7@3].=!-!.C$)CJ'IDK=_%< ^<;M!@9X]B-?Q]?4,Y[7&R"JV=_QI+Q#H
M:VWB^:A?^]O=^?VWI\W_H94HZ2W_QV-9E^;=,ONRNUU03>B(*0YH1KG)I)"
MI04!,"]@ADB1$<%L*7U8U-)8?*]MU%.W.2ZQIY<1<,<I.QQD$[/T9;0\=BA'
M8+,GXG#PS<2]'B^=$^O: 3) M",/F(U;[0SITZGE'7Z[@F_+-5WSDJ[>K>MM
M]7B(C%)4%E ADT$! 42( <9S"4A69")/:<I2JT2T$3E+X\Z]FM%!3Z]HITNX
MVNW^!4!K8MKT <IYAV\$AJ"[>I=DS;J3-V+P\>[=V.6^W1G?;+[3<GU'&2]2
M6"1 L (!*&(%F$@4R 6EJ2(PI\KJ-.#XP4N;]+]T-9):[1S*13U#:WAF7X/!
MQ%/9UGR/'HK/;;VR:6+WL)F[)#XWX;0MXM'??5,9FSQT$^O\IOQ1"KD6]2=9
M-4GH;TQERTJ*.T%R)&(J0)8STQ8,8L HT]_EN#F7XY DA<LGV4;HTJ;J7M%(
M=!HV53@>:Q$]Z-5^4XW#L1B'%?9VG^W0B$X\\7=%-(R^-]%>XQL3.=<6S#!1
M=ZW:(7,I[4$*G%]I(7CFG$M[*$[S,!WN]4REDJN5:?@JU[*BJ]NUN!7?RW5I
MNN"8D/5=!FBWN(649EAA#& !8P!93@'#* 9Q(?)$)0BK.'9*KW*1OC2>^HU6
M?Y=;K?Y-5+=V=-$W?1,<4["<1L..L";#>&+FZO2^B3K-VS2+9[KOL\ #ACE=
M!5O8]"XG#>9-^?(!YR0-S.LA5P9&O342ODGQZV8CC@.C$,XRE)ND=$( C+4#
MQHHX!6DNTX1 I"!QJO%M(7-IE+;3-+HWJGK&10U ;,=8@8&;F*=Z<5%[^!J%
MYPB+&D=HFK"H ;DO$Q8U#L3%L"B+6SU;_;55Q>J/:N^]W:DB5GD6*Z"@9AJH
MEWO:@\(4**0X$H7&G5./9*\SHJRFR/R)6GO]'-O.G<'2CDU\H9FIT5RG7=-:
M;A0:]_YREXT/VUCNC)QY.\I=-O2DE=S I>Y'U%\EUP^KRG]\WCS1U;;<>^=)
M@FB<% C$64;U3%?(G*Y P%"2QU2@C&;6\4:7A"S-?]CK&54[1>T/5B\B.3S/
M0^$S\40_ XW'X?-%C.R/G4-@-=.!L\OKY'32/(;!P!GSQ5MG.UT>4[Y_KCQZ
MK9]G\WYC<B,W6UE_K6C3FJ^) ?JLI94_3/!/_::L^6I3/U:]&+4X2S,L& 0T
M%R9ID6M&E/JG@I$X4S%"><I=%EA>6BR-,GO:NGE$?F-@YS--CNS$9-OH;_HG
M-6ERC0V]>,&>&='!CNAODS17N@K*H#Z:GR:S>G%7@77LYUWW,#]B_.7[PVKS
M)&6S9__QP7P>NP]TQC.48[.Q1$ROEPP3@*G*02QRR1C)5$J=R.^BI*417%MI
MJ]70D>(NHVE'8T$PFGJ;>[AH_4V'W 0[W*/H!&6?R])F99A1HX]99/R&\ V(
MCQM='EJ/F/;GMQ]?O_MD;M%_Z#CMTZ;>5G);MC7O^P4LWFZJ#W*[*US1[&Z9
MFC2I3+.,40*R K%N&XK)&, B+HB2>1)K-@I7<V@6HQ:ZX77;5@_IFM^V37&#
M-C2>_FVQ8]OE#_[_G#I'-R=]D_N=N0RM10:TW?LT6TOEV<9QMC;,TUNTB%)*
MLPZ>2[OG^93R].C_\6@:0S)S+,VW=VE**<VS''!FFK?(C  &$0%QAHLXR5*1
M$J<"P\\?OS3?O=4N^MM./\< ^2/L+)UV;T0FYG5[,-Q=\;,VA_6_GXN8U^D^
M:]Z)IWW^*O<CF2]R76ZJOZQKR?727C1; &\>91IGZ6ZWG%"!$B4 3PC6[F^"
M :%Z*I,"$84SF,+<N@73J+2E3>I6X6BO<;M-%FF=(Z.T_6'$.,[C)S=!T9MZ
MJ3X,G,=QCL6;:GVN$Q3)F0YX?%]%I\,>:V &3GW&GS';\8^U.?US(/N;/%,,
M=UU27SWM?_S/4E;Z0=^>WLL?&@V3&0<SD2,2<Y *7@#(N *,P1APH2"7-):R
MP$X9AU9BET; O8Z_>V6;XXD/MW_U2T2T0]_._PJ/Z<2T? V<[NF*3NB$S5ZT
M$SUO,J,3'">YC6YWNZ<ZOND^8__O(ZWTS%X]?98/FVI[QWFNO3R4 P13 J B
MFH<PX:"(%><IY!FARC;K\8*,I9'.3LUHKV?4*FJ?"GD)S6%>"831Q"3B#H]3
MJN0( -Y9DY>>.UL"Y8AA_5S*L4L#+O3@SGU&4.6"BPP@K'T-F,<0L%Q _1/-
MA3(-(PNKB6XE;6E3?M"[AB$6>C# 0L\'O9=<Z,&@"ST8<*'G@^02%GH#KV*8
MA=XQ,#X+/;B<A=ZQ.58+O9.;KLMI>+NI/DM3D()OFRX(=RAF6,8B!Y+0!$ 2
MFSHR@H&DH%0HH2A,XRL2&X[E+?2P=Z>N7W+#":AV*[:K,)HYS4%M3/Q=3\GP
MN0Z78)@DX>%$V(MD/5PR^5+JP\7KKRYML:O,1U),:2I CH@ D,>Q27[ ("<,
M\Y0+1813+N6)A*7Y6OTZ"]ZU*9R"VZZ"9.+IWD=C@LBUBZ9/54OB)2+5+AHY
M4"5B\LBT#W)K\B;; _K_E.)>[H[;7TE-[?+D-'_=M$"#4/M9B!!0)";X59 4
M4&FJ,#.9*DQ3G!5./2?"J[@T/M%:;N[7INF4:;1P.:0H7!B9Y]#:D=7+#MC$
M;&<1\&4RP0]&1HV51P%?K#'V-.[+[&3/%M]UW5C,%K3EJ>9B(K&N@]DEO.I*
M2?[5-EJ)K2+[3@^4YKE(L@)D:9%IMY RP%06 \YPG,=2Q!G//1:)E^0M=)'8
M(X+2@\0OHFM'Q5>!-5])C0Z@5L>;@/TT;'$(7CCCK+#9JV4,F7RN1,;@]7[T
M\%?3J)>MY&<]X9J#:4J,>PASD.<<:_<0(<#RA '"*$=$0DX*JSKNEP0LS;G;
MZ1<9!;U._$\@M)O[UP S\9QWPL1YLE\R/.@D/Q$RZ^2^9.+QI+YXW16KQ0^;
M]>9!FKI=Z_N6*KKJ7?O8WUPEA')FDKVY_O(G(@<X9RF((<MC 3&-A5/<M)W8
MI4W\=J705WN_4.@T_]D[V-IR(!S6:T'AG64-=C6R?HLI:Z#"+Y#&1<^_Z+&&
MX^Q"QOYN3\+:/?R]I'K":RXL5^7VZ?5C56E'YTYQ6BBDW1#)35.$@A+ ,IX
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M/N@90>MO49?T%(Y(AJ$)RAX71,U*&</F'O/$R-77Y[F_V7RGY?J.D21G1!#
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M#[(<!6N2V,K+4E\DI'(4A$N1E.,W7KM>O>6\>I2BQVY'ZP[M)D (20XHB3,
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ME,24<0*M^LA<%K$TO[S5,JJ-FM&CT=/>[;P XKA;?CTT$\_X4U0"5[4>1F#
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M)3=W+6;E.F^0CJG/_T%N3%A7V[M#9O-K_:"O^@%=7&:<HTRA&(-<\0+ !,6
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MWL9LI@K#%,8"(+UX )## A!"*8"DB!/)<9X63FW!SXM9&B$\TS(R:KI%OXZ
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MED8?SW4U<:>=MGY%SP9QMB.04.A-O03P!LZ]&;@%(F%[@0\)G+<5N(7I)YW
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M# &$/ 6$80(PQPD6BA.*K59>5M*61G![A7N1SWV=G?+^[/ >9K3@*$[,6R\
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M86U%=;QF:T>T,Z2LV5Z;4BY6ML;4R9:>FP_##+R;Z_;JPSDPKP\VDE?DR@Z
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M8 (@L?U71)("C/(,(Q@CF"J?U4";L*E]EH>Z[H*??NY^*[IN+GXHS ;^D"_
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M+]TZ7F7E#N4/:BQW7=LSS5UM]B4:;S>;5<&?-^5&P_)\@NR,JXQ@+##0,:<
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M?1OVP]<?Z4+8C04"XC8P)>P@JP,T1M=FZX(R4A.R!K03+H'K0;?+'+DVM!,
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M%@D8PAQ0SB!,<\()=DI&[I S-4>\H6H9EBN5C;;:NF=NM4';SKH! 1N8/<?
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MEDU^^_SX/"]#&ELIM[;BK/7<*">0P42!&(G$'JEA@!KG':0RS[#$*>'*JU*
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M[_'BW_W[3;U?;(K-2[V0_:J>[*&+Q?V=<0V?US.!N$I@D@ M8F(K"B> 0TY
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MRF=UJOKV8SKSEQ[E)W\\*>N9W+TLU.J^4.OZF!B[5S--)4&,:2#BW+@4-!:
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M62* C&/*<QU##IV;%SO*G!H/_;<DJO6.:L6CG>;15G7W(*4K\MW!W@'P')B
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MIUD4I F#02Y2B"*9P#Q6[Y% D!1E,F-J+(YX>PPV/-/70,=20%<JA.>MO4U
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M41* K:ZU_XJKIVI,NV'@_EN[X> E)%,/DN?(6#C)\7))..8BG$[7LSQQ+OK
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MMSPY:146:8$L@Z@UU;)>7I6 .7AG;62\/']@L!-\AR]!'-G [Z6K!G+^3YR
MT;]FE[4-YH=:FDGJ['(BAMX7[8E]702QCXF#SUP2L'@HUGO!\E"%:+TRTD@-
MY#.@>DP$M+T .K'+/;<Q^PP4C 02O:X)*T/?"1^18_%,/=5AM>V#_.$+-<<%
M>.\:WAO0G_,R+'JK#GZ4X4FPS*<L%472]1*ZY!J"C *22\&Y+&FE/M5%>A"X
M-E)V.2X4=]),;W9SF(.[GX[>'KU[=7SRK\?'I[UU<7ODH7T>RG6AN_\CN)^G
M<YS'*<X^+%;3#>IOH(9*.,L5[9U2U1[3R"%HH2#)$J1%U&Z@)FY=J#O42EW?
MZ+GEU26#&8E7O9GU(6T]"R^2UE9&5%FC'^B,\6LZFCETZP<5]PW0 4)O(%B^
MIG[;)O>6B:21)\XS))YT[8I0 $N=6V=(&D*BB6Z86U0/DC,N@ [1[X-0.438
M#2"FGL/5_9S^<_RWR^EGG!$SJZ/U*UPNK\C)^W><7>9)9,$BCPQTO:FNE$Z
M4@N@E884LW.OS#!)]D[DM8"H@V!PWPGJ72<- .U77/XU;^*(+ZG]F]EF.7,6
MDBN0T%MBQ062$T7$R2G.F4XV#=17\@FBQCVF[Q]4?<F_ 2A]S#'3JB!6:E;Q
MA@D>"[..,4B:Z%?,6 C.1V"I>&\Q<_WDW.M#6E$\0,ZXY]K]P^=PF3< G#?S
MST3U8GE%+$R"*$:DA.!\G1F0#0DB8R#:8XA,IA0&RDO=I6+<P]_^8;*WA!M
MQ^;TXBN13"2W@G@F#A0C][!6W*'VM6#8<!UYT3H,8U.^I67<0]#^D7*@M!O
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MXDF!K^WQ% ;%-8M*WY\O]$A?\[M/[:1U_S*T?H"\1M;T4<CQ_,;/C*+X'(0
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M]XU;*)_J1U=C RZ?W6=AN_BD%45Q"E(QUJJ/*"($0TLGNB!S8I;[T*GI?3?
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M9B%+;5+@L5/PV@E1G<D:;ZC-X9I?#*V&D3>R5Y_RQ0PO/N'R?&M54\E:225
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MS&QT,BFTP"S/560(85-&J((MUH12!IH#VIW&<?M0/0/T!E)7 X?-#W#VY<R
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MHI9;A)AJRY8 41J#),08\C#G?7^82M9#P#:<KAH XM,=G[<\,9ZLE4B1*U*
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MX+W3"&QOM74(O>L#6HP2T2H'J"V9VH+$178&M+<AULV[*-E!P-=#'+:_GE\
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M:SNUE%+ET&8,UA-2NH3/+FI^[);M)?,.0+,L,KZ2STUQNC1&J4@>I#.5 2D
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MZ !4:VH,/ _2%2,@&RY &0JSO$<!,OI@DG4^LK;;>G8H\!AI5LP>0!I ^!U
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M@V:P>-[+W5='':#NN<O@J3 W\GR$U@RU+<"-)P&'$"&D4,#0U6"\#R9@FV3
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MVM]6X'2QK.7\.L>43Z9I66%U]ZW%W1OS5Y+S*_H?__,T&6L4^5,0HB%9!*,
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MHW/<]&L[G#TV8PVU=X2&;N<'Z@U_N+71:_A<O1TDI=*J8#8@6<V5Y>#!<Y[
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MCFG=QI=)B*HAR'9'U[A/6GNC:W]E=)C >_M__GCW];]VR,)=_P_W3:6M^OY
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M)\H!,HT*KE*=T'VW]77#V@F'\"N(J?X8M<TORG_*K5+__1__!U!+ P04
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M8G=NS'Z6?;>.O=?,]NDOO>[Z??PW4$L! A0#%     @ ]%6=5(@/GJ3$I0(
MM DB !               ( !     &)M>2TR,#(R,#,S,2YH=&U02P$"% ,4
M    " #T59U4<,5'_6(8  "&#P$ $               @ 'RI0( 8FUY+3(P
M,C(P,S,Q+GAS9%!+ 0(4 Q0    ( /15G50Q*/PAJ3   -_T 0 4
M      "  8*^ @!B;7DM,C R,C S,S%?8V%L+GAM;%!+ 0(4 Q0    ( /15
MG53F>BK^3WH  -HS!0 4              "  5WO @!B;7DM,C R,C S,S%?
M9&5F+GAM;%!+ 0(4 Q0    ( /15G51XS]2CBBD! *M$#  4
M  "  =YI P!B;7DM,C R,C S,S%?;&%B+GAM;%!+ 0(4 Q0    ( /15G50
MV!Z,G+H  /!9"  4              "  9J3! !B;7DM,C R,C S,S%?<')E
M+GAM;%!+ 0(4 Q0    ( /15G53YP^,#4 @  'LE   5              "
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8=&U02P4&      H "@"0 @  EVD%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
